data_2rs4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rs4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.08 128.34 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.988 1.267 . . . . 0.0 110.423 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.9 m -100.37 125.6 46.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.277 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -101.44 128.02 47.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.999 1.319 . . . . 0.0 110.518 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.19 95.79 6.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -99.9 152.36 20.25 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.901 -0.5 . . . . 0.0 110.829 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -60.31 -13.84 15.05 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -97.97 -11.14 23.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 113.624 171.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.87 167.84 13.72 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.651 1.596 . . . . 0.0 113.408 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.3 137.25 41.02 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.754 1.622 . . . . 0.0 112.821 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -133.2 140.48 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.752 2.021 . . . . 0.0 108.561 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.96 134.18 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.464 1.105 . . . . 0.0 110.266 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.02 133.88 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.483 1.913 . . . . 0.0 110.039 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -99.64 126.86 45.72 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.898 1.679 . . . . 0.0 108.44 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -89.08 146.77 24.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.24 1.016 . . . . 0.0 110.999 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -103.65 73.73 1.2 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 122.669 1.224 . . . . 0.0 111.458 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.86 -26.28 64.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.77 -1.104 . . . . 0.0 112.48 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.87 -27.97 49.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.253 1.021 . . . . 0.0 111.672 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.72 -18.87 15.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.104 1.362 . . . . 0.0 113.222 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.0 55.39 1.19 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.665 1.186 . . . . 0.0 113.123 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.72 -44.97 27.6 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.47 2.78 . . . . 0.0 112.952 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.27 -41.82 80.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.108 0.563 . . . . 0.0 110.971 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -65.42 -45.43 83.94 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.175 0.59 . . . . 0.0 111.789 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.97 -43.09 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.583 0.753 . . . . 0.0 111.761 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.66 -42.48 79.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.96 1.254 . . . . 0.0 111.797 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -70.2 -37.95 75.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.733 0.813 . . . . 0.0 111.626 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.91 -48.96 79.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.432 1.093 . . . . 0.0 111.713 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.98 -37.97 79.07 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.593 0.757 . . . . 0.0 111.456 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -57.25 -33.88 68.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.361 1.065 . . . . 0.0 112.808 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 18.5 m-85 -76.84 -44.73 31.13 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.462 -0.774 . . . . 0.0 112.493 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -59.98 -35.98 76.16 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.63 -0.669 . . . . 0.0 111.658 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.78 -34.28 77.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.026 2.13 . . . . 0.0 112.945 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.43 -14.48 52.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.029 0.932 . . . . 0.0 113.372 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.51 19.23 60.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.553 1.073 . . . . 0.0 113.885 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 54.4 t80 -68.27 -17.72 64.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.13 -3.63 44.19 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.269 -0.894 . . . . 0.0 113.137 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.5 135.29 54.97 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.135 -0.978 . . . . 0.0 108.952 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 54.16 47.17 23.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.531 1.533 . . . . 0.0 113.689 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.3 p -114.37 151.23 33.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.836 0.855 . . . . 0.0 112.532 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 pt -103.3 162.05 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.45 86.41 6.77 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -80.05 2.63 23.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -169.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -144.25 143.16 30.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.967 2.167 . . . . 0.0 113.46 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.14 131.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 110.271 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.2 mt -137.65 129.64 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.613 1.565 . . . . 0.0 108.15 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.84 133.5 54.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.756 0.822 . . . . 0.0 111.782 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 9.37 65.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 123.895 0.759 . . . . 0.0 114.947 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -141.89 -177.3 5.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 110.872 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -179.25 5.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.869 1.667 . . . . 0.0 115.379 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.9 pt -114.31 135.91 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.885 1.274 . . . . 0.0 112.446 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.31 150.77 25.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.434 1.094 . . . . 0.0 110.653 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.87 34.66 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.05 -2.32 61.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.811 1.672 . . . . 0.0 115.662 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.31 -14.94 65.29 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 118.921 1.361 . . . . 0.0 115.833 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.38 167.09 23.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.744 1.217 . . . . 0.0 112.782 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.55 164.5 18.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.729 1.612 . . . . 0.0 110.711 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.38 -11.91 28.02 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.514 2.809 . . . . 0.0 116.811 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.59 15.94 62.23 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.088 0.851 . . . . 0.0 114.477 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.1 mmt 61.42 26.46 16.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.058 1.743 . . . . 0.0 113.221 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -83.22 127.18 33.4 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.834 1.254 . . . . 0.0 109.357 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -73.57 119.24 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.966 0.906 . . . . 0.0 110.145 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -69.43 164.83 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.136 0.974 . . . . 0.0 113.472 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 66.04 9.47 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.814 1.645 . . . . 0.0 111.494 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.4 p -69.18 134.47 49.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.932 1.293 . . . . 0.0 112.219 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -137.71 174.05 10.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.022 2.129 . . . . 0.0 111.965 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.12 66.24 5.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.451 1.5 . . . . 0.0 113.605 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.62 135.76 62.66 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.284 2.656 . . . . 0.0 111.067 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.08 151.61 7.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 125.849 1.66 . . . . 0.0 108.166 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 157.11 27.45 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.638 0.732 . . . . 0.0 111.565 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -81.81 103.68 11.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.33 1.052 . . . . 0.0 111.198 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.75 23.83 1.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.529 1.132 . . . . 0.0 113.289 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.6 -19.86 66.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 119.863 -1.773 . . . . 0.0 113.784 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -65.44 8.82 0.14 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.344 1.458 . . . . 0.0 114.516 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -77.97 -10.06 59.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.144 1.378 . . . . 0.0 113.426 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.66 81.62 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.101 1.334 . . . . 0.0 114.83 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.77 158.61 26.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.498 1.149 . . . . 0.0 112.706 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -130.69 155.07 47.23 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.18 111.56 23.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.489 2.316 . . . . 0.0 110.478 -174.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -142.3 170.38 15.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.327 1.451 . . . . 0.0 111.175 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -38.88 117.13 0.63 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.979 1.712 . . . . 0.0 111.948 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.86 33.29 30.46 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 124.352 0.977 . . . . 0.0 114.787 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.1 p -123.39 157.68 32.82 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.897 1.348 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.78 136.7 54.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -138.27 160.77 38.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.982 171.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.6 mtt -84.04 143.22 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.39 147.89 22.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.641 1.176 . . . . 0.0 111.766 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 165.62 14.03 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.27 1.028 . . . . 0.0 113.518 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -81.56 -57.14 3.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.136 0.974 . . . . 0.0 110.873 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -151.47 -38.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.082 1.353 . . . . 0.0 113.68 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.89 156.46 35.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.014 1.326 . . . . 0.0 111.48 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.91 -23.91 76.44 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.63 2.22 . . . . 0.0 114.324 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -103.37 33.0 3.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.539 1.536 . . . . 0.0 112.746 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.3 p -118.2 26.09 9.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.42 1.488 . . . . 0.0 113.158 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.13 98.8 2.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.676 1.191 . . . . 0.0 108.574 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.2 p -90.04 -68.64 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.519 1.128 . . . . 0.0 111.691 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.32 20.07 1.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.731 1.212 . . . . 0.0 113.445 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -110.41 142.7 41.76 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.805 -1.185 . . . . 0.0 111.145 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -143.77 168.16 20.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.48 1.512 . . . . 0.0 111.036 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 24.0 p90 -142.86 158.3 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.353 0.661 . . . . 0.0 111.878 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 mt -111.12 118.38 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -75.27 108.78 8.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.08 0.552 . . . . 0.0 110.137 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.03 -11.02 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.42 165.15 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.985 2.514 . . . . 0.0 111.274 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.25 120.99 25.07 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.843 0.457 . . . . 0.0 109.843 169.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -140.93 74.81 1.48 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.711 1.243 . . . . 0.0 112.459 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.62 -34.57 62.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.153 1.781 . . . . 0.0 114.406 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -59.41 -13.71 9.53 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.89 -8.51 59.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -80.92 177.04 9.31 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.464 . . . . 0.0 114.174 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -89.77 140.76 29.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.877 1.271 . . . . 0.0 112.695 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.2 p -109.34 -61.02 1.69 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.761 1.224 . . . . 0.0 113.351 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.975 0 C-N-CA 124.459 1.028 . . . . 0.0 113.65 -173.846 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.31 -113.33 2.47 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.153 1.835 . . . . 0.0 114.877 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.98 148.02 50.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 113.067 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.39 126.62 31.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.05 94.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -80.46 -15.36 56.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.63 176.65 8.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.557 1.17 . . . . 0.0 113.951 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.17 154.18 48.03 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.854 -1.154 . . . . 0.0 112.335 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.49 139.49 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.651 0.739 . . . . 0.0 109.865 170.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 t -111.18 -42.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.765 1.626 . . . . 0.0 110.99 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.88 154.76 42.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.469 1.508 . . . . 0.0 109.997 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.21 16.3 25.62 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 123.849 0.737 . . . . 0.0 114.217 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -34.78 67.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.891 1.345 . . . . 0.0 112.256 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.15 -30.44 70.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.1 t -76.27 -40.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.943 1.297 . . . . 0.0 110.408 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.61 -41.89 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.277 -0.889 . . . . 0.0 110.867 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.54 -25.37 63.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.131 1.372 . . . . 0.0 112.355 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -74.57 -52.6 11.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.384 1.074 . . . . 0.0 110.208 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -53.65 -35.56 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.327 1.851 . . . . 0.0 112.793 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.47 -11.46 32.0 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.68 -15.82 10.69 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.718 1.628 . . . . 0.0 114.165 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.53 -63.33 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.45 1.125 . . . . 0.0 112.707 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -176.83 153.64 1.07 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.752 1.621 . . . . 0.0 111.499 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.4 p -125.9 148.67 49.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.985 1.314 . . . . 0.0 112.842 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.263 169.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.07 138.89 49.05 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.798 1.665 . . . . 0.0 109.559 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -30.74 54.51 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.856 -0.527 . . . . 0.0 112.152 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.15 149.04 32.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.879 0.872 . . . . 0.0 109.848 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -84.03 119.74 25.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 111.313 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.99 108.69 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.318 1.047 . . . . 0.0 109.242 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 148.28 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.884 1.326 . . . . 0.0 111.574 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.1 mt -87.24 103.35 13.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.16 -38.37 60.93 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.71 -0.619 . . . . 0.0 110.197 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 p -151.61 166.96 29.61 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.03 142.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 110.629 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -135.42 128.4 31.47 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.061 1.344 . . . . 0.0 110.205 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.74 124.04 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.518 -0.739 . . . . 0.0 109.02 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -113.36 150.5 32.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.253 1.421 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.753 1.621 . . . . 0.0 113.323 -169.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.2 t -124.68 132.45 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m -104.86 124.89 50.25 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.812 1.245 . . . . 0.0 110.152 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -98.34 132.14 44.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.659 1.184 . . . . 0.0 110.45 169.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -104.22 98.39 8.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -103.77 151.95 22.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.068 -0.395 . . . . 0.0 111.267 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -60.53 -9.36 3.65 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.27 -8.15 18.47 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.815 1.246 . . . . 0.0 114.014 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.51 163.96 10.93 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.411 1.482 . . . . 0.0 113.617 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.43 137.99 44.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.812 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.52 140.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.352 1.861 . . . . 0.0 108.886 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 t -122.34 137.66 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.566 1.147 . . . . 0.0 110.326 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.59 138.43 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.587 1.955 . . . . 0.0 110.409 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -100.5 128.76 46.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.013 2.125 . . . . 0.0 107.713 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 p -88.45 146.46 25.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.303 1.041 . . . . 0.0 111.201 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -102.85 73.79 1.29 Allowed 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 122.614 1.197 . . . . 0.0 111.293 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.59 -27.65 65.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.352 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.15 -29.19 57.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.426 1.09 . . . . 0.0 111.53 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.85 -27.56 14.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.835 1.254 . . . . 0.0 112.835 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.89 61.72 4.33 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.8 0.84 . . . . 0.0 113.188 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.11 -43.7 23.07 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.32 2.68 . . . . 0.0 112.906 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -69.2 -40.54 77.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.484 0.583 . . . . 0.0 110.852 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -64.86 -47.54 77.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.315 0.646 . . . . 0.0 111.593 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.63 -44.51 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 111.342 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -55.95 -48.26 76.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.55 1.068 . . . . 0.0 112.039 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -68.12 -38.32 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.572 0.624 . . . . 0.0 111.878 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.13 -49.04 79.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.329 1.051 . . . . 0.0 111.673 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.35 -38.18 81.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.555 0.742 . . . . 0.0 111.554 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -59.1 -33.36 70.76 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.847 0.859 . . . . 0.0 112.665 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 -43.95 50.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.909 0.777 . . . . 0.0 112.285 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.33 -36.15 79.36 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.578 -0.701 . . . . 0.0 111.687 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.71 -34.1 77.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.087 2.155 . . . . 0.0 112.86 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.71 -13.34 56.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.963 0.905 . . . . 0.0 113.267 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.97 18.61 62.83 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.628 1.109 . . . . 0.0 113.939 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.65 -17.56 64.12 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -96.7 -5.42 38.82 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.414 -0.804 . . . . 0.0 113.022 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -67.67 136.07 53.78 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.59 44.46 29.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.353 1.461 . . . . 0.0 113.828 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -109.32 164.4 12.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.865 0.866 . . . . 0.0 111.742 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.3 pt -124.75 159.05 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -91.14 96.59 10.66 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -88.39 -11.46 46.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -143.27 136.15 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.939 1.245 . . . . 0.0 113.374 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -135.4 145.11 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 128.145 2.578 . . . . 0.0 109.018 169.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -133.14 131.18 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.734 1.614 . . . . 0.0 108.188 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.62 126.77 28.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.111 0.964 . . . . 0.0 112.594 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.1 11.81 70.97 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 123.81 0.719 . . . . 0.0 114.81 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.15 -176.98 4.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.495 1.918 . . . . 0.0 110.979 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.72 -179.25 7.26 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.2 pt -118.95 134.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.485 1.514 . . . . 0.0 112.91 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -112.18 146.47 38.03 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.746 1.219 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.23 35.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.693 1.437 . . . . 0.0 116.693 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.94 -4.69 85.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.952 1.739 . . . . 0.0 115.602 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -15.84 64.84 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -169.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -146.61 164.71 31.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.746 1.273 . . . . 0.0 112.939 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.19 161.82 31.95 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.502 1.521 . . . . 0.0 110.003 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -63.29 -13.0 33.18 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.298 2.665 . . . . 0.0 117.729 -169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.44 14.96 64.08 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 123.908 0.766 . . . . 0.0 114.496 171.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.1 mmm 58.1 39.44 26.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.343 1.857 . . . . 0.0 112.988 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -92.28 127.95 37.95 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.369 1.467 . . . . 0.0 109.53 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -75.37 123.67 25.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.423 1.089 . . . . 0.0 111.166 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -73.44 162.75 28.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.72 73.51 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.561 1.544 . . . . 0.0 111.538 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 p -72.0 131.58 43.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.299 1.039 . . . . 0.0 112.118 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -137.37 175.04 9.96 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.463 1.905 . . . . 0.0 112.527 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 50.62 69.49 2.57 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.746 1.619 . . . . 0.0 113.996 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.49 135.68 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.189 2.592 . . . . 0.0 111.515 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.88 154.04 7.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.298 1.839 . . . . 0.0 108.535 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 158.07 18.47 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.23 0.612 . . . . 0.0 111.829 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -72.54 127.64 33.16 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.198 0.599 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -113.03 12.05 19.13 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.022 1.329 . . . . 0.0 112.73 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 -11.71 46.67 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.197 -1.565 . . . . 0.0 113.762 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -58.62 -1.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.95 0.83 29.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.122 1.369 . . . . 0.0 111.569 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.71 10.14 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.708 1.623 . . . . 0.0 114.094 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.8 mt -78.64 157.07 28.75 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.78 158.44 36.55 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -117.68 109.84 17.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.786 2.034 . . . . 0.0 110.717 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -136.0 169.87 16.91 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.703 1.201 . . . . 0.0 111.537 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.1 126.27 24.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.988 0.899 . . . . 0.0 111.079 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.7 24.45 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.923 1.249 . . . . 0.0 114.651 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.5 p -123.86 159.11 30.33 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.172 1.486 . . . . 0.0 113.096 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.69 137.78 54.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.3 159.0 42.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.007 0.523 . . . . 0.0 111.923 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 94.7 mmm -78.34 138.21 38.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.089 -0.382 . . . . 0.0 110.518 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.94 150.31 25.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.106 0.562 . . . . 0.0 110.66 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -115.3 160.77 19.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.536 1.134 . . . . 0.0 112.896 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.8 m -75.56 -52.46 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.054 0.942 . . . . 0.0 111.285 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.27 -57.39 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.559 1.544 . . . . 0.0 110.716 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.99 157.47 78.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.946 1.298 . . . . 0.0 112.115 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.25 -23.09 73.03 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.48 2.787 . . . . 0.0 114.068 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -111.52 36.78 3.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.739 1.615 . . . . 0.0 112.41 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 p -121.15 26.52 8.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.388 1.475 . . . . 0.0 113.843 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.62 99.67 10.34 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.364 1.466 . . . . 0.0 109.447 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -87.07 -71.55 0.55 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.186 . . . . 0.0 112.618 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.9 38.73 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -129.36 152.3 49.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.374 1.07 . . . . 0.0 111.903 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.18 168.41 19.81 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.504 1.522 . . . . 0.0 110.716 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 84' ' ' ALA . 8.1 p90 -144.03 159.49 42.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.16 0.584 . . . . 0.0 111.055 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 mt -116.42 120.12 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.44 102.8 5.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.167 0.587 . . . . 0.0 109.525 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.28 -18.05 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.88 165.69 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.592 1.557 . . . . 0.0 111.663 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -78.48 119.4 21.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.792 0.437 . . . . 0.0 110.03 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -143.03 63.02 1.39 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 123.009 1.385 . . . . 0.0 111.758 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.27 -11.9 53.15 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -172.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -64.42 -13.68 52.6 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.579 -1.325 . . . . 0.0 113.573 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.06 -13.88 58.96 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.529 1.132 . . . . 0.0 113.431 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -69.32 167.06 17.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.39 1.476 . . . . 0.0 114.904 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -70.2 138.3 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -143.77 21.9 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.343 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.09 -54.88 0.83 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.853 1.216 . . . . 0.0 114.259 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -143.82 158.96 43.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.429 1.492 . . . . 0.0 111.72 -169.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 35.0 t -93.66 119.19 32.36 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.646 -0.658 . . . . 0.0 112.657 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.2 82.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.218 1.407 . . . . 0.0 108.66 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -77.5 -13.25 59.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.914 0.886 . . . . 0.0 112.309 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.08 177.56 8.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 122.751 1.262 . . . . 0.0 114.278 -169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -141.96 154.29 44.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.511 1.124 . . . . 0.0 112.792 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.36 143.49 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.68 0.753 . . . . 0.0 110.394 172.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.8 t -117.11 -40.99 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.79 1.636 . . . . 0.0 111.122 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -145.19 155.12 43.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.869 1.667 . . . . 0.0 109.75 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.92 16.37 23.89 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.817 0.723 . . . . 0.0 114.327 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -33.55 66.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.834 1.317 . . . . 0.0 112.33 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.52 -29.14 69.16 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.545 0.738 . . . . 0.0 112.551 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.01 -41.52 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.256 1.423 . . . . 0.0 110.238 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.24 -39.89 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.879 -1.138 . . . . 0.0 111.042 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.0 -30.47 68.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.112 1.365 . . . . 0.0 111.953 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.09 -42.89 62.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.986 0.914 . . . . 0.0 111.168 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.13 -25.12 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.494 1.517 . . . . 0.0 112.409 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -86.39 -23.3 26.18 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.39 -7.61 69.32 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.986 1.755 . . . . 0.0 114.779 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.79 -27.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 84.55 163.54 0.1 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.522 2.329 . . . . 0.0 114.057 -169.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 p -118.92 143.98 46.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.196 1.398 . . . . 0.0 113.668 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 125.034 1.302 . . . . 0.0 111.426 169.835 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 119.529 -0.272 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.54 137.57 70.17 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.709 1.606 . . . . 0.0 110.512 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -32.17 61.89 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -84.91 147.38 26.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.184 0.593 . . . . 0.0 110.544 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.18 116.73 23.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.196 0.998 . . . . 0.0 111.071 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 91.0 t -114.85 108.06 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.316 1.047 . . . . 0.0 108.483 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.52 141.34 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.439 1.114 . . . . 0.0 111.932 -169.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.2 mt -83.61 103.44 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.38 -36.87 66.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.186 0.594 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.6 t -154.37 165.22 37.04 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -133.76 141.07 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.791 2.037 . . . . 0.0 110.431 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -135.76 131.75 35.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 110.187 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.62 124.07 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.309 -0.869 . . . . 0.0 108.82 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.7 t -117.36 150.3 39.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.077 1.351 . . . . 0.0 112.749 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.93 1.692 . . . . 0.0 113.629 -169.707 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 120.318 0.104 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.9 t -123.46 129.97 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.4 m -104.36 123.68 47.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.98 1.312 . . . . 0.0 110.205 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.36 132.31 42.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.568 1.147 . . . . 0.0 110.688 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -103.18 103.13 13.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -106.48 151.49 24.89 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.966 -0.459 . . . . 0.0 111.126 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -60.57 -7.63 2.3 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -108.28 -8.71 15.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.005 1.322 . . . . 0.0 114.094 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.96 163.5 11.17 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.505 1.526 . . . . 0.0 113.859 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.04 138.82 44.29 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.034 1.734 . . . . 0.0 112.957 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.82 141.51 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.512 1.925 . . . . 0.0 109.062 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -124.62 135.66 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 110.805 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 139.72 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.743 2.017 . . . . 0.0 110.389 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -105.07 125.77 51.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.638 1.975 . . . . 0.0 108.844 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -88.96 147.5 24.28 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.379 1.072 . . . . 0.0 111.553 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -104.94 74.52 1.13 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.792 1.282 . . . . 0.0 111.202 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.76 -26.3 64.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.618 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.81 -28.0 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 111.386 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -95.83 -29.13 14.39 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.388 1.475 . . . . 0.0 112.398 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.74 58.55 3.32 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 0.0 113.003 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -60.87 -43.19 32.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.493 2.795 . . . . 0.0 112.932 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -68.33 -40.38 81.63 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.741 0.7 . . . . 0.0 110.893 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 m -63.91 -51.33 64.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.641 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.57 -38.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -56.33 -49.58 73.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.601 1.091 . . . . 0.0 111.484 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -68.81 -36.74 78.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.412 0.551 . . . . 0.0 112.19 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.59 -49.63 77.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.763 1.225 . . . . 0.0 111.426 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.71 -34.71 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.368 -0.833 . . . . 0.0 112.449 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -45.2 77.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.573 0.349 . . . . 0.0 110.261 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.45 -40.68 81.0 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.593 -0.692 . . . . 0.0 111.456 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.77 -40.06 86.95 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.878 -0.514 . . . . 0.0 111.397 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -72.67 -30.07 63.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.376 1.47 . . . . 0.0 113.385 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -79.41 -16.54 56.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.631 0.65 . . . . 0.0 112.372 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.66 17.39 56.81 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.497 1.046 . . . . 0.0 113.298 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.04 -41.66 97.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.438 1.095 . . . . 0.0 113.121 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -81.49 -15.21 55.67 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.27 5.31 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.87 17.49 1.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.064 1.346 . . . . 0.0 112.986 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.7 p -81.67 163.17 22.7 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.126 -0.984 . . . . 0.0 112.345 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -119.26 165.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.08 89.45 6.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.412 1.485 . . . . 0.0 108.573 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -85.68 -3.06 58.78 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.92 134.6 45.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.822 1.646 . . . . 0.0 111.173 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.42 135.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.504 1.522 . . . . 0.0 110.807 169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.79 128.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.61 1.564 . . . . 0.0 108.429 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.26 132.2 49.57 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.611 0.764 . . . . 0.0 111.691 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.05 10.99 66.21 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 123.956 0.789 . . . . 0.0 115.029 -174.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.01 -177.23 5.34 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.121 1.769 . . . . 0.0 111.019 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -83.75 177.41 8.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.44 140.0 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.61 1.564 . . . . 0.0 111.857 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -123.41 148.5 46.06 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 0.0 111.287 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.16 -178.1 27.39 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.557 1.075 . . . . 0.0 114.51 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 -1.09 89.27 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.31 0.957 . . . . 0.0 115.342 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.94 -27.06 32.56 Favored Glycine 0 N--CA 1.473 1.102 0 CA-C-N 118.931 1.366 . . . . 0.0 115.391 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.22 161.86 37.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -88.62 164.46 31.96 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 126.048 1.739 . . . . 0.0 109.69 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.31 -11.49 30.42 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.337 2.692 . . . . 0.0 117.518 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 17.16 59.81 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.273 0.94 . . . . 0.0 114.61 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.7 mmm 59.46 37.83 22.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.152 1.781 . . . . 0.0 113.31 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.074 1.349 . . . . 0.0 109.468 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -74.19 131.92 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 124.143 1.925 . . . . 0.0 111.792 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -75.93 -179.29 4.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 110.322 -3.127 . . . . 0.0 114.519 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.65 56.49 3.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 112.869 -1.968 . . . . 0.0 112.066 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 p -69.41 106.25 2.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.084 1.354 . . . . 0.0 110.824 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -137.87 169.25 18.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 111.947 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 48.49 62.89 11.3 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.486 1.514 . . . . 0.0 113.183 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -58.11 134.79 64.34 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.539 2.826 . . . . 0.0 111.749 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.24 152.55 4.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.356 1.862 . . . . 0.0 107.837 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 158.67 17.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.192 0.597 . . . . 0.0 110.67 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -71.43 134.6 46.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.179 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.38 14.09 12.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.765 1.226 . . . . 0.0 112.627 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.49 59.93 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.434 -1.416 . . . . 0.0 113.93 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.93 0.21 0.24 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.629 1.972 . . . . 0.0 115.822 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -81.37 -3.45 52.79 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.036 1.334 . . . . 0.0 112.556 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.44 24.77 49.77 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.578 1.085 . . . . 0.0 114.942 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 159.1 28.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 117.707 0.753 . . . . 0.0 112.616 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -131.39 154.47 48.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -98.65 100.02 11.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.669 1.987 . . . . 0.0 110.118 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.1 p -130.68 165.24 23.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.306 1.042 . . . . 0.0 111.603 -175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -55.34 121.97 10.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.64 1.176 . . . . 0.0 110.771 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 49.82 6.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.72 1.153 . . . . 0.0 113.923 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -136.21 163.51 30.21 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.16 0.98 . . . . 0.0 112.523 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.79 140.81 51.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.725 0.81 . . . . 0.0 112.709 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -137.91 157.82 45.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.894 -0.504 . . . . 0.0 112.019 169.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -82.37 140.6 33.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.498 0.319 . . . . 0.0 111.303 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.64 144.68 25.08 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.575 0.75 . . . . 0.0 111.469 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -114.58 159.81 20.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.026 1.33 . . . . 0.0 112.978 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.3 m -77.67 -54.86 5.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.068 1.347 . . . . 0.0 112.051 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -153.65 -40.38 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.696 1.199 . . . . 0.0 113.078 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.04 157.18 35.41 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.868 1.267 . . . . 0.0 111.267 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.73 -26.13 64.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 114.429 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -105.77 33.9 3.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.58 1.552 . . . . 0.0 112.779 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.9 p -123.07 35.71 4.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.379 1.472 . . . . 0.0 113.161 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.66 107.93 20.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.086 1.754 . . . . 0.0 109.826 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 p -91.65 -67.82 0.83 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.393 1.077 . . . . 0.0 112.584 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.87 -17.15 1.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -78.34 143.53 36.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 122.116 0.96 . . . . 0.0 112.194 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.03 167.97 20.89 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.316 1.847 . . . . 0.0 110.816 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 5.6 p90 -145.34 161.44 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.577 0.751 . . . . 0.0 111.726 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.39 115.45 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 108.16 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -73.4 101.23 3.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.713 0.805 . . . . 0.0 110.193 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 -16.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.1 167.28 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 128.129 2.572 . . . . 0.0 111.057 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -78.31 121.84 24.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.124 0.57 . . . . 0.0 110.667 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -145.85 68.98 1.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 123.266 1.508 . . . . 0.0 111.306 -170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.59 -13.02 61.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -64.4 -12.83 46.98 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.614 -1.304 . . . . 0.0 113.224 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.98 -7.16 59.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.626 1.171 . . . . 0.0 113.972 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.18 179.6 5.61 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -79.82 142.1 35.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.361 1.465 . . . . 0.0 112.171 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -107.71 -59.45 1.83 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.459 1.104 . . . . 0.0 113.682 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.132 0 C-N-CA 123.859 0.742 . . . . 0.0 114.363 -172.439 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 5.5 p-90 . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.05 -108.17 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.617 1.58 . . . . 0.0 116.013 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.69 142.8 46.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.419 1.488 . . . . 0.0 111.554 -169.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.21 118.45 25.67 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -170.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.38 84.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.691 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -78.19 -13.75 59.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.004 0.922 . . . . 0.0 112.083 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.96 177.2 8.71 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.496 1.141 . . . . 0.0 113.672 -170.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.98 149.81 43.72 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.845 -1.159 . . . . 0.0 111.928 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.07 136.69 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.605 -0.684 . . . . 0.0 110.414 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.72 -42.29 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.356 1.862 . . . . 0.0 110.834 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -143.26 154.86 44.25 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.466 1.506 . . . . 0.0 109.862 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.36 13.9 37.24 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.911 0.767 . . . . 0.0 114.754 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.5 mmm -54.19 -35.95 62.89 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.43 1.615 . . . . 0.0 112.381 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.95 -33.43 75.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.693 0.797 . . . . 0.0 112.385 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.59 -42.64 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.925 1.29 . . . . 0.0 110.39 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.71 -40.29 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.23 1.012 . . . . 0.0 111.237 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.38 -26.01 60.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.892 1.277 . . . . 0.0 112.78 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.39 -41.51 27.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.914 1.286 . . . . 0.0 111.18 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.7 mt -54.87 -31.79 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.899 1.679 . . . . 0.0 112.771 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -90.59 -15.27 30.86 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.3 -16.24 18.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.707 1.623 . . . . 0.0 114.475 -172.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.18 -59.5 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.834 1.317 . . . . 0.0 112.29 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.96 153.53 2.61 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.471 1.508 . . . . 0.0 111.587 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.3 p -133.67 147.75 51.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.96 1.304 . . . . 0.0 112.366 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.054 0 C-N-CA 123.247 0.451 . . . . 0.0 113.201 169.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.02 131.79 24.7 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 N-CA-C 108.027 -1.566 . . . . 0.0 108.027 169.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -31.15 63.44 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.67 -0.644 . . . . 0.0 111.797 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -83.26 150.3 26.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 109.103 168.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.25 117.75 23.17 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.102 -0.999 . . . . 0.0 110.651 -170.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.3 102.82 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.04 143.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 112.287 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.0 mt -82.64 103.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.04 -27.34 57.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.557 1.143 . . . . 0.0 111.697 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -163.38 169.33 19.13 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.52 140.82 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.287 1.835 . . . . 0.0 110.477 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.3 m -133.84 135.0 43.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.271 1.428 . . . . 0.0 110.073 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.68 125.73 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.6 t -122.6 150.78 42.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.763 1.625 . . . . 0.0 111.927 -171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.73 1.212 . . . . 0.0 113.246 -179.629 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -125.7 129.56 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.077 0.951 . . . . 0.0 109.41 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -104.71 123.28 47.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.589 1.156 . . . . 0.0 110.055 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.56 134.59 38.25 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 110.598 169.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -105.9 101.78 11.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -106.21 151.13 25.17 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.041 -0.412 . . . . 0.0 110.949 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -60.78 -7.8 2.57 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -108.14 -8.33 15.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.954 1.302 . . . . 0.0 114.101 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.24 160.9 9.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.046 1.307 . . . . 0.0 114.124 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.15 138.08 43.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.852 1.661 . . . . 0.0 112.702 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -134.21 141.01 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.111 1.764 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.7 t -123.16 136.65 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.736 1.214 . . . . 0.0 110.68 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mt -127.12 138.75 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.495 1.918 . . . . 0.0 110.323 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.84 122.21 45.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.492 1.917 . . . . 0.0 109.142 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 p -85.91 148.18 25.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.312 1.045 . . . . 0.0 111.83 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -104.22 73.82 1.15 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.702 1.239 . . . . 0.0 111.359 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.75 -26.85 64.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.502 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.15 -30.87 58.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.262 1.025 . . . . 0.0 111.53 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.29 -26.43 15.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.833 1.253 . . . . 0.0 112.991 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.03 59.0 3.46 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.99 0.916 . . . . 0.0 112.833 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.63 -43.77 25.22 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.251 2.634 . . . . 0.0 112.72 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -69.77 -41.15 75.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.513 0.597 . . . . 0.0 110.957 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -62.73 -49.9 73.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.482 0.713 . . . . 0.0 111.265 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.63 -44.32 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.307 0.643 . . . . 0.0 111.477 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -55.72 -47.7 76.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.771 1.168 . . . . 0.0 112.014 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -68.0 -39.13 83.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.43 0.559 . . . . 0.0 111.667 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.7 -48.47 81.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.683 1.193 . . . . 0.0 111.542 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.96 -38.31 79.34 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 111.653 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.86 -33.73 70.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.956 0.902 . . . . 0.0 112.529 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.392 -0.817 . . . . 0.0 112.287 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.03 -35.2 76.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.791 -0.568 . . . . 0.0 111.596 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -64.99 -34.19 77.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.909 2.084 . . . . 0.0 113.006 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -81.78 -15.74 53.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.831 0.852 . . . . 0.0 113.086 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.89 15.18 56.83 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.121 1.344 . . . . 0.0 113.979 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -65.48 -31.58 72.73 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.198 0.999 . . . . 0.0 113.678 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -87.64 -15.47 37.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.19 0.7 5.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.435 1.494 . . . . 0.0 114.574 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -144.85 50.35 1.26 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.129 1.772 . . . . 0.0 110.252 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.5 p -119.81 169.83 9.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.466 1.106 . . . . 0.0 111.945 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.72 167.14 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -169.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -95.3 93.92 7.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.378 1.471 . . . . 0.0 107.764 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -86.46 -0.86 56.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -140.39 141.17 35.61 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.089 1.768 . . . . 0.0 112.67 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.87 132.73 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.187 1.795 . . . . 0.0 111.152 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.98 128.72 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.022 1.729 . . . . 0.0 108.292 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -68.97 139.42 55.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.782 -0.574 . . . . 0.0 111.249 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.59 9.12 68.71 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -144.79 -177.12 5.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.788 2.035 . . . . 0.0 110.55 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.87 178.1 6.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.016 1.726 . . . . 0.0 114.501 -171.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -114.21 136.94 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.016 1.326 . . . . 0.0 111.765 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -103.62 147.26 27.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.137 0.975 . . . . 0.0 110.761 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.05 31.38 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 122.637 1.132 . . . . 0.0 114.849 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.92 72.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.668 -1.073 . . . . 0.0 114.434 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.49 -22.87 41.96 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-N 119.624 1.712 . . . . 0.0 114.729 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.35 166.07 26.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.799 1.24 . . . . 0.0 112.912 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.83 162.19 27.85 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.956 1.702 . . . . 0.0 110.402 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -60.77 -13.2 25.21 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.696 2.93 . . . . 0.0 118.505 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.26 17.23 59.7 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.122 0.867 . . . . 0.0 114.592 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mmm 58.46 36.46 25.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.072 1.749 . . . . 0.0 113.114 -173.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -92.07 131.32 37.43 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.296 1.438 . . . . 0.0 109.386 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -71.04 124.43 24.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.495 1.118 . . . . 0.0 110.107 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.38 159.14 32.1 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.3 75.27 8.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.245 1.418 . . . . 0.0 111.484 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.2 p -69.0 127.53 33.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.546 1.139 . . . . 0.0 112.409 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.5 177.32 7.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.62 1.968 . . . . 0.0 111.484 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 50.42 68.33 3.52 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.593 1.557 . . . . 0.0 113.617 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.81 147.46 88.48 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.252 2.635 . . . . 0.0 111.597 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.68 149.6 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.813 1.645 . . . . 0.0 109.155 -174.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 155.49 29.0 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.581 0.705 . . . . 0.0 110.419 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -78.71 134.45 37.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.397 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.69 14.39 12.61 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.941 0.896 . . . . 0.0 112.11 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.53 -17.03 64.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.569 -1.332 . . . . 0.0 113.764 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -63.5 -0.97 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.388 1.875 . . . . 0.0 115.482 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -79.77 -5.63 55.7 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.701 1.2 . . . . 0.0 113.017 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.65 21.06 49.03 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.531 1.063 . . . . 0.0 114.942 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.05 155.47 39.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.911 0.855 . . . . 0.0 111.75 170.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -133.63 155.38 49.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -90.31 107.11 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.428 2.291 . . . . 0.0 109.439 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -137.67 169.43 17.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.918 1.287 . . . . 0.0 110.869 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -49.63 124.82 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.798 1.239 . . . . 0.0 111.458 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.78 41.14 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.274 1.416 . . . . 0.0 115.048 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.9 p -121.95 160.86 23.96 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.536 1.668 . . . . 0.0 113.584 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.91 137.91 54.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.659 0.784 . . . . 0.0 112.965 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.47 160.49 38.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.817 0.447 . . . . 0.0 112.143 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 96.7 mmm -79.1 139.74 38.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.158 0.583 . . . . 0.0 111.341 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.45 112.22 23.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.502 0.721 . . . . 0.0 110.292 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -75.48 157.26 34.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 0.0 112.709 -174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.0 m -70.81 -51.09 28.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.873 0.869 . . . . 0.0 110.934 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -160.12 -58.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.322 1.449 . . . . 0.0 110.373 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.24 79.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.61 1.164 . . . . 0.0 111.889 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.77 -31.48 88.39 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.825 2.35 . . . . 0.0 113.459 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -101.62 46.46 0.93 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.346 1.858 . . . . 0.0 112.294 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.6 p -133.99 32.2 3.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.96 54.66 1.33 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.989 1.716 . . . . 0.0 113.643 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -54.42 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -154.74 36.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -135.27 151.54 50.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.311 1.444 . . . . 0.0 110.097 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.58 172.21 13.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.061 1.344 . . . . 0.0 111.667 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -147.2 161.56 40.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.402 -0.811 . . . . 0.0 111.524 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 mt -115.5 115.84 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -76.69 102.68 6.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.903 0.881 . . . . 0.0 110.156 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.81 -21.93 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.268 -0.895 . . . . 0.0 112.968 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.01 168.55 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.813 1.645 . . . . 0.0 111.959 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.22 123.44 29.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.323 0.649 . . . . 0.0 110.291 169.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -144.79 76.82 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.828 1.299 . . . . 0.0 112.707 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.07 -34.88 66.37 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.209 1.804 . . . . 0.0 114.583 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -59.88 -12.58 7.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.84 -9.57 59.26 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.48 -177.08 5.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -169.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -77.05 141.21 40.39 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.289 1.836 . . . . 0.0 112.473 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.2 p -107.79 -57.16 2.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.24 1.016 . . . . 0.0 113.59 173.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 C-N-CA 124.428 1.013 . . . . 0.0 113.427 -171.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.353 2.8 p-90 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.93 -95.35 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.387 1.47 . . . . 0.0 115.948 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -129.19 138.22 51.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.513 1.125 . . . . 0.0 112.11 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.92 121.82 26.97 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.76 87.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.013 1.325 . . . . 0.0 108.178 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -77.81 -15.61 58.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.431 0.692 . . . . 0.0 111.88 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.4 178.69 7.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.572 1.177 . . . . 0.0 113.942 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -138.93 154.38 48.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.659 1.183 . . . . 0.0 112.325 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 140.44 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.624 0.726 . . . . 0.0 110.271 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.79 -42.52 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.715 1.606 . . . . 0.0 111.213 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.49 152.86 41.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.591 1.556 . . . . 0.0 109.791 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.89 13.97 22.26 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.85 0.738 . . . . 0.0 114.67 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -34.94 68.81 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.125 1.462 . . . . 0.0 112.301 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.94 -30.7 71.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.8 0.84 . . . . 0.0 112.486 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.27 -41.38 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.416 1.087 . . . . 0.0 110.131 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.89 -40.23 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.489 -0.757 . . . . 0.0 111.091 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.58 -28.56 63.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.776 1.23 . . . . 0.0 112.349 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -74.65 -44.16 51.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.473 1.109 . . . . 0.0 110.699 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.61 -29.25 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.641 1.576 . . . . 0.0 112.633 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -94.48 -11.42 29.69 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.54 -14.65 13.77 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.631 1.586 . . . . 0.0 114.5 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.6 m -62.11 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.86 1.33 . . . . 0.0 112.428 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -175.07 156.59 2.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.658 1.583 . . . . 0.0 111.645 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 p -123.72 150.04 44.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.293 1.437 . . . . 0.0 112.281 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 CA-C-O 122.835 1.242 . . . . 0.0 113.252 172.282 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.23 142.61 46.3 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.96 1.773 . . . . 0.0 109.412 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -30.83 61.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.601 -0.687 . . . . 0.0 112.63 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.97 145.24 32.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.905 0.882 . . . . 0.0 110.078 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.64 120.59 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.383 1.073 . . . . 0.0 110.436 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.64 99.93 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.175 0.99 . . . . 0.0 108.358 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.32 143.0 36.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.79 1.236 . . . . 0.0 112.216 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.3 mt -83.13 103.86 10.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.89 -28.89 60.82 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.381 1.073 . . . . 0.0 111.18 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.7 t -164.02 169.54 17.8 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.0 139.85 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.716 2.007 . . . . 0.0 110.055 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -133.06 133.11 42.58 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.291 1.437 . . . . 0.0 110.134 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.73 125.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.274 -0.891 . . . . 0.0 108.864 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 t -121.55 140.44 52.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.07 1.348 . . . . 0.0 112.024 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 112.217 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.46 131.25 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.544 -1.347 . . . . 0.0 110.624 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.2 m -102.67 126.38 49.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.631 1.172 . . . . 0.0 110.184 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.1 123.34 44.23 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.875 1.27 . . . . 0.0 109.753 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -98.79 109.64 22.37 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 p -121.88 158.82 28.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 112.147 -169.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -7.2 34.94 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.62 -26.39 10.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.579 1.552 . . . . 0.0 113.392 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.68 145.52 4.24 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.311 1.91 . . . . 0.0 113.282 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.0 132.8 32.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.302 1.041 . . . . 0.0 112.277 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.43 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.828 1.651 . . . . 0.0 109.199 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.21 138.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.099 0.96 . . . . 0.0 110.506 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -131.79 135.67 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.671 1.989 . . . . 0.0 110.13 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -104.18 125.73 50.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.116 1.766 . . . . 0.0 108.946 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -88.28 146.97 25.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.108 0.963 . . . . 0.0 112.036 -175.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -104.67 74.36 1.14 Allowed 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 122.887 1.327 . . . . 0.0 110.973 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.66 -25.48 63.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.35 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.25 -31.78 60.91 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.5 1.12 . . . . 0.0 111.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -94.02 -27.28 16.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.625 1.17 . . . . 0.0 113.027 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.62 59.43 3.87 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.546 0.738 . . . . 0.0 112.919 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -61.72 -43.98 23.7 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.328 2.686 . . . . 0.0 112.723 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -67.51 -40.54 85.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.283 0.492 . . . . 0.0 110.708 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -49.16 74.74 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.597 0.759 . . . . 0.0 111.948 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.4 -40.8 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.33 -48.31 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.789 1.177 . . . . 0.0 111.718 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.51 -36.03 78.31 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.56 0.744 . . . . 0.0 112.128 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -60.4 -51.4 69.66 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.38 -34.8 73.0 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.639 -0.663 . . . . 0.0 111.558 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -55.8 -36.44 67.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.978 0.911 . . . . 0.0 112.351 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -76.35 -42.53 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.602 -0.686 . . . . 0.0 112.586 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.6 m -60.78 -35.31 76.12 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.589 -0.694 . . . . 0.0 111.779 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -32.32 73.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 112.694 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -81.7 -13.28 58.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.96 18.25 65.66 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.616 1.103 . . . . 0.0 114.14 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.58 -17.37 64.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.41 -7.22 48.26 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.459 -0.776 . . . . 0.0 112.998 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -69.17 135.41 50.61 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 51.93 45.21 28.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.992 1.717 . . . . 0.0 114.253 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -104.05 160.05 15.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.504 0.722 . . . . 0.0 110.907 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.9 pt -123.42 162.31 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -91.42 115.76 28.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -116.7 -3.63 11.73 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -139.18 132.68 30.3 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.424 1.011 . . . . 0.0 111.291 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.18 146.48 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.91 2.084 . . . . 0.0 108.913 169.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -142.56 135.16 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.446 1.898 . . . . 0.0 107.415 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -64.21 134.8 55.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.324 0.65 . . . . 0.0 111.86 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.17 13.5 67.28 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.848 0.737 . . . . 0.0 114.848 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.15 -177.28 5.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.311 1.844 . . . . 0.0 111.033 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -178.71 5.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.584 1.954 . . . . 0.0 115.16 -169.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 pt -120.01 142.47 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.022 1.329 . . . . 0.0 113.113 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -113.93 148.4 36.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.058 1.343 . . . . 0.0 112.083 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.41 178.79 32.71 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 -14.91 37.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 115.815 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.6 -10.67 76.15 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 116.738 1.455 . . . . 0.0 116.738 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -144.09 168.88 18.96 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.161 1.481 . . . . 0.0 113.359 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.83 162.85 18.7 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 126.895 2.078 . . . . 0.0 110.737 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -58.9 -15.22 25.98 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.019 3.146 . . . . 0.0 118.807 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 18.42 57.48 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.051 0.834 . . . . 0.0 114.715 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.0 mmt 59.4 27.3 16.37 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.588 1.555 . . . . 0.0 112.696 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.07 123.09 29.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.867 1.267 . . . . 0.0 109.169 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -73.17 121.2 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.005 0.922 . . . . 0.0 110.331 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -69.19 164.83 21.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.11 67.08 7.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.83 1.652 . . . . 0.0 111.704 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -66.17 125.93 27.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.781 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -133.09 173.66 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.827 2.051 . . . . 0.0 111.96 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 46.24 66.32 5.62 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.478 1.511 . . . . 0.0 113.711 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.55 137.52 74.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.337 2.691 . . . . 0.0 111.172 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.5 150.78 7.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.689 1.596 . . . . 0.0 108.655 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 151.92 29.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.259 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -87.37 101.59 13.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.697 1.599 . . . . 0.0 110.438 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.43 18.69 3.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.801 1.24 . . . . 0.0 113.836 -169.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.74 -21.5 63.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.432 1.493 . . . . 0.0 114.18 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.52 -2.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.846 2.058 . . . . 0.0 115.536 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -77.11 0.9 19.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.187 0.995 . . . . 0.0 112.282 169.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 35.74 27.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.905 1.24 . . . . 0.0 112.888 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.0 144.59 43.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.421 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.84 154.46 49.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.71 114.78 26.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.065 2.146 . . . . 0.0 110.572 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.5 p -138.8 171.98 13.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.933 1.293 . . . . 0.0 111.009 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -51.78 125.89 16.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.805 1.242 . . . . 0.0 110.959 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.4 36.43 39.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.848 1.213 . . . . 0.0 114.803 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.7 p -120.72 158.81 26.67 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.892 1.346 . . . . 0.0 112.89 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.44 136.3 54.54 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.61 158.23 44.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.291 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.7 mmt -81.38 132.49 35.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.69 0.396 . . . . 0.0 110.902 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.11 161.13 24.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.5 0.72 . . . . 0.0 110.573 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -133.02 158.42 42.76 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 m -74.01 -57.08 4.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.895 1.278 . . . . 0.0 112.777 -169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -158.61 -47.67 0.06 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.079 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.65 157.9 71.62 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.543 1.137 . . . . 0.0 111.359 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.84 -21.3 71.94 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.182 2.588 . . . . 0.0 114.584 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.74 42.2 2.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.604 1.962 . . . . 0.0 112.337 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.6 p -117.45 33.59 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.837 1.255 . . . . 0.0 113.861 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.63 14.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.277 1.431 . . . . 0.0 108.943 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -91.91 -60.09 1.95 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.49 33.33 0.32 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.79 140.08 53.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.216 1.406 . . . . 0.0 110.657 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -142.04 168.2 20.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.088 1.355 . . . . 0.0 111.354 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 84' ' ' ALA . 18.6 p90 -144.12 160.3 41.15 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.538 0.735 . . . . 0.0 111.849 172.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.9 mt -114.26 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.211 1.004 . . . . 0.0 108.419 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.32 100.32 2.61 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.8 0.84 . . . . 0.0 110.217 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.23 -25.99 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 121.199 -0.938 . . . . 0.0 113.188 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 m -114.97 166.56 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.998 1.719 . . . . 0.0 111.633 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.69 122.84 27.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.02 0.528 . . . . 0.0 110.11 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -141.95 71.77 1.36 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.927 1.346 . . . . 0.0 112.596 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -52.29 -35.71 51.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.235 2.214 . . . . 0.0 114.445 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -59.88 -12.77 8.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.73 -14.18 55.01 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -73.16 161.91 30.04 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.284 1.434 . . . . 0.0 114.462 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -69.71 144.41 52.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.216 0.606 . . . . 0.0 112.312 173.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.8 p -126.22 -59.29 1.32 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.797 1.239 . . . . 0.0 113.089 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 C-N-CA 123.987 0.803 . . . . 0.0 113.974 -176.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.42 -82.3 1.36 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.564 1.078 . . . . 0.0 115.139 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -137.36 154.63 49.98 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.199 1.4 . . . . 0.0 112.176 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -84.67 117.17 23.61 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.928 -0.482 . . . . 0.0 111.801 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.1 81.0 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.842 1.257 . . . . 0.0 108.755 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.74 -13.99 60.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 0.0 112.258 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.86 178.09 8.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.74 1.257 . . . . 0.0 113.648 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -137.25 154.09 50.21 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.918 -1.113 . . . . 0.0 112.339 171.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.12 143.94 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.772 0.796 . . . . 0.0 109.697 171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.79 -39.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.734 1.614 . . . . 0.0 110.861 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -146.46 148.89 32.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.52 1.528 . . . . 0.0 110.549 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 116.98 7.45 12.79 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 77.1 mmm -56.62 -36.21 69.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.584 1.692 . . . . 0.0 113.099 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -62.87 -30.3 71.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.631 0.773 . . . . 0.0 112.202 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.98 -40.93 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.044 1.738 . . . . 0.0 110.673 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.64 -39.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.034 0.934 . . . . 0.0 110.946 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.89 -25.57 61.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.993 1.317 . . . . 0.0 112.717 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -76.55 -42.86 41.45 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.12 1.368 . . . . 0.0 110.975 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.24 -34.45 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.877 1.271 . . . . 0.0 112.111 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -91.49 -14.68 30.03 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.57 -20.64 14.42 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.106 1.336 . . . . 0.0 114.332 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.92 -63.88 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 118.598 1.199 . . . . 0.0 112.172 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.42 155.79 5.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -137.19 152.17 49.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.993 1.317 . . . . 0.0 112.135 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.857 0 C-N-CA 125.199 1.381 . . . . 0.0 111.404 170.382 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -57.74 128.79 30.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 120.759 1.307 . . . . 0.0 110.248 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.74 45.28 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.55 159.45 26.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.615 0.766 . . . . 0.0 110.467 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.49 109.67 16.17 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.612 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.17 94.0 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.74 144.32 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -168.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.4 104.4 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 106.25 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.45 -41.02 61.53 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.811 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -151.21 166.26 31.4 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.48 141.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.052 1.741 . . . . 0.0 110.764 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.5 m -133.88 129.66 36.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.006 1.322 . . . . 0.0 110.243 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.04 120.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -109.64 137.98 46.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.706 1.202 . . . . 0.0 111.752 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.571 1.948 . . . . 0.0 112.151 -178.454 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.92 130.52 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 121.13 -0.981 . . . . 0.0 109.597 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 m -103.67 120.95 41.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.039 0.936 . . . . 0.0 110.087 172.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -92.4 119.51 32.01 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -93.88 119.07 32.31 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -121.82 160.54 24.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.976 0.893 . . . . 0.0 113.125 -169.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -73.06 -4.64 33.81 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -120.5 -20.07 7.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.441 1.497 . . . . 0.0 114.412 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.67 117.32 1.08 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.001 1.762 . . . . 0.0 110.771 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.88 145.7 55.35 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.531 0.732 . . . . 0.0 111.763 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.7 141.88 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.772 1.629 . . . . 0.0 109.664 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.08 134.09 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.465 1.106 . . . . 0.0 110.072 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.79 137.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.345 1.858 . . . . 0.0 110.102 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -105.57 123.36 47.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.446 1.898 . . . . 0.0 109.259 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.9 p -87.1 148.61 25.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.158 0.983 . . . . 0.0 112.005 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.13 72.9 0.9 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.888 1.328 . . . . 0.0 111.856 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.64 -25.58 64.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.536 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -77.25 -28.99 53.79 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.379 1.071 . . . . 0.0 111.566 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -99.29 -21.11 16.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.081 1.352 . . . . 0.0 113.406 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.52 56.22 1.31 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.274 1.029 . . . . 0.0 113.244 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.01 -45.07 25.72 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.478 2.785 . . . . 0.0 113.088 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.94 -41.29 74.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.646 0.657 . . . . 0.0 111.245 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.9 m -63.9 -48.27 77.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.551 0.74 . . . . 0.0 111.281 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.67 -43.41 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.717 0.807 . . . . 0.0 111.463 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -57.17 -45.32 83.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.816 1.189 . . . . 0.0 112.019 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -69.36 -36.8 77.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.512 0.596 . . . . 0.0 111.821 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.09 -48.91 79.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.342 1.057 . . . . 0.0 111.728 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.18 -36.84 80.24 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.269 -0.894 . . . . 0.0 111.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -58.45 -34.8 71.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 112.499 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -73.63 -43.34 59.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 112.161 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.8 m -58.38 -38.44 77.31 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.735 -0.603 . . . . 0.0 111.762 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -65.39 -35.77 81.94 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.327 2.251 . . . . 0.0 112.691 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -81.17 -16.03 54.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 0.0 113.046 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.69 19.36 63.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.962 0.792 . . . . 0.0 113.052 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.26 -37.61 75.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 113.036 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -78.37 -9.84 59.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.714 0.406 . . . . 0.0 111.892 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.27 131.04 48.05 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.297 -0.877 . . . . 0.0 108.844 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.5 t30 62.38 20.86 12.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.054 2.142 . . . . 0.0 116.7 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -82.05 144.54 30.75 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.741 -1.224 . . . . 0.0 113.414 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -101.14 155.92 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -86.41 72.97 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.87 2.068 . . . . 0.0 108.402 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -69.45 -9.61 54.41 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.62 125.26 45.29 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.572 1.149 . . . . 0.0 110.508 -172.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.95 131.01 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.767 1.227 . . . . 0.0 112.042 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.42 131.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.697 1.999 . . . . 0.0 108.182 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.06 138.14 54.13 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.624 0.77 . . . . 0.0 112.008 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.02 67.74 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.702 0.668 . . . . 0.0 114.641 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.12 -177.22 5.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.607 1.963 . . . . 0.0 110.316 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.29 177.86 6.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.218 1.807 . . . . 0.0 114.196 -171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 pt -116.39 140.82 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.896 1.278 . . . . 0.0 111.937 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -118.4 149.04 41.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.954 1.301 . . . . 0.0 111.372 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.6 -176.61 29.85 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.052 0.834 . . . . 0.0 114.978 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 -11.41 70.47 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.054 1.312 . . . . 0.0 115.632 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.32 60.06 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 118.879 1.34 . . . . 0.0 115.839 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.0 157.05 44.25 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -83.66 164.74 43.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 126.306 1.842 . . . . 0.0 109.32 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.04 -14.61 44.49 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.509 2.806 . . . . 0.0 117.087 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.71 18.83 56.81 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.438 1.018 . . . . 0.0 114.44 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.5 34.11 15.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.2 1.8 . . . . 0.0 112.94 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.32 131.22 37.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.389 1.476 . . . . 0.0 109.448 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.41 130.81 42.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 124.172 1.939 . . . . 0.0 111.603 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.85 -176.9 1.45 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 110.212 -3.176 . . . . 0.0 113.761 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.91 54.47 2.74 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.897 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 p -73.56 104.11 4.4 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.865 1.266 . . . . 0.0 111.571 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -133.47 178.44 6.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.872 2.069 . . . . 0.0 112.067 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.93 68.11 3.86 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.417 1.487 . . . . 0.0 113.798 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -61.95 138.31 72.73 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.168 2.579 . . . . 0.0 111.338 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.39 152.83 5.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 126.268 1.827 . . . . 0.0 108.024 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 155.05 27.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.153 0.502 . . . . 0.0 111.032 169.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.9 128.98 34.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.609 0.764 . . . . 0.0 111.124 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -111.12 15.13 21.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.942 1.297 . . . . 0.0 112.867 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -11.68 28.1 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -75.19 39.24 0.14 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -113.37 -6.49 13.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.21 . . . . 0.0 114.191 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.18 3.66 65.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.444 1.497 . . . . 0.0 115.2 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.19 158.24 19.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.606 1.203 . . . . 0.0 112.878 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.49 156.8 48.09 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.7 1.2 . . . . 0.0 113.521 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -90.25 93.21 9.25 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.496 1.918 . . . . 0.0 109.755 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.7 p -122.86 166.02 15.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.261 1.025 . . . . 0.0 111.319 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -55.37 114.38 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.265 1.826 . . . . 0.0 110.26 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 43.04 5.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.904 1.24 . . . . 0.0 114.633 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.7 p -134.91 165.46 25.26 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.842 1.321 . . . . 0.0 113.512 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mp -124.35 142.84 50.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 112.775 174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.6 156.72 47.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.724 -0.61 . . . . 0.0 111.853 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -83.94 136.93 33.89 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.175 -0.328 . . . . 0.0 111.258 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.66 155.25 20.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.717 0.807 . . . . 0.0 111.608 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -118.91 159.22 24.19 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.677 1.191 . . . . 0.0 112.674 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.3 m -72.25 -52.23 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.011 0.924 . . . . 0.0 110.805 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -159.56 -58.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.458 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.24 157.4 85.0 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 111.75 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -55.81 -34.69 92.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.841 2.36 . . . . 0.0 113.118 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -99.59 35.3 2.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.25 1.42 . . . . 0.0 112.917 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -123.35 27.53 7.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.506 1.522 . . . . 0.0 113.491 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 103.92 16.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.623 1.569 . . . . 0.0 109.638 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.5 p -88.41 -74.78 0.45 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.851 1.26 . . . . 0.0 112.519 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.71 -20.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.042 1.337 . . . . 0.0 113.643 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -71.04 145.32 50.0 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 121.029 -1.044 . . . . 0.0 112.441 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -141.81 168.06 20.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.32 1.848 . . . . 0.0 110.402 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -146.05 160.14 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.576 0.75 . . . . 0.0 111.753 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.5 mt -113.27 113.9 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.226 1.01 . . . . 0.0 108.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.78 93.88 2.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.989 . . . . 0.0 110.418 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.15 -23.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 163.67 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.483 1.513 . . . . 0.0 111.223 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -77.78 117.56 19.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.174 0.59 . . . . 0.0 109.8 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -143.64 64.95 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 123.113 1.435 . . . . 0.0 112.268 -169.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -66.31 -13.24 60.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.83 -13.82 38.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.654 -1.279 . . . . 0.0 113.453 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.02 -9.81 59.72 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.45 1.1 . . . . 0.0 113.949 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.12 -177.81 3.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -81.39 145.01 31.03 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.731 1.612 . . . . 0.0 111.785 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.4 p -111.75 -59.08 2.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.478 1.111 . . . . 0.0 113.468 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.051 0 C-N-CA 124.068 0.842 . . . . 0.0 113.865 -173.296 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.327 7.0 p-90 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.33 -91.31 1.36 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.427 1.489 . . . . 0.0 115.458 -169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -134.57 144.79 48.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.579 1.151 . . . . 0.0 112.041 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.5 t -83.67 124.06 30.45 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.978 -0.451 . . . . 0.0 112.066 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.29 88.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -78.09 -15.44 58.88 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.626 0.77 . . . . 0.0 112.14 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.23 177.87 8.68 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.599 1.19 . . . . 0.0 113.341 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -136.13 151.45 49.79 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.98 -1.075 . . . . 0.0 112.247 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.36 135.64 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.76 -40.95 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.9 1.68 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -144.28 144.71 31.62 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.19 1.396 . . . . 0.0 110.677 174.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.06 -0.09 10.69 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 124.737 1.161 . . . . 0.0 115.629 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -55.92 -37.59 69.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.435 1.618 . . . . 0.0 113.17 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.99 -34.14 75.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.703 0.801 . . . . 0.0 111.936 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.03 -39.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.16 1.784 . . . . 0.0 110.905 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.34 -39.32 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 121.204 -0.935 . . . . 0.0 111.121 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 8.8 t70 -74.3 -22.86 59.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.066 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.8 -43.2 47.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.939 1.295 . . . . 0.0 111.082 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.8 mt -54.69 -35.12 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.221 1.408 . . . . 0.0 112.195 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.2 pttp -90.31 -18.93 24.7 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -96.49 -22.06 20.13 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.977 1.275 . . . . 0.0 114.225 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.8 t -81.41 -63.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 118.378 1.089 . . . . 0.0 112.055 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -162.63 152.72 16.31 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 51.8 p -140.36 152.83 46.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.944 1.697 . . . . 0.0 111.619 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 114.386 0.515 . . . . 0.0 114.386 169.757 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.24 140.24 52.8 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -28.06 60.52 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.99 153.96 27.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.429 1.091 . . . . 0.0 110.257 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.2 109.68 11.26 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.007 -1.058 . . . . 0.0 110.788 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.24 94.28 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.828 1.251 . . . . 0.0 107.709 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.68 152.05 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.405 1.574 . . . . 0.0 113.756 -169.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.81 104.16 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.79 -39.77 66.43 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.116 -0.99 . . . . 0.0 111.01 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -152.3 170.88 18.97 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.16 143.15 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.505 1.522 . . . . 0.0 111.458 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.8 m -135.23 130.61 35.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 110.534 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.9 121.31 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -113.65 150.2 33.52 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.308 1.443 . . . . 0.0 112.525 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.317 1.447 . . . . 0.0 114.091 -169.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.72 129.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.889 0.876 . . . . 0.0 108.992 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.3 m -103.68 123.65 47.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.674 1.19 . . . . 0.0 109.891 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -97.35 132.01 43.48 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.562 1.145 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -104.99 98.71 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p -103.67 152.06 22.24 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.052 -0.405 . . . . 0.0 111.192 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -60.54 -10.35 4.95 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -103.62 -8.08 20.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.834 1.253 . . . . 0.0 113.748 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.8 165.98 12.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.921 1.724 . . . . 0.0 113.485 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.94 138.49 42.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.813 1.645 . . . . 0.0 112.949 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.93 139.26 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.271 1.828 . . . . 0.0 108.886 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -120.22 135.53 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.452 1.101 . . . . 0.0 110.002 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 138.51 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.499 1.919 . . . . 0.0 110.106 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -103.77 126.32 50.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.566 1.946 . . . . 0.0 108.912 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 p -90.29 147.96 23.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.34 1.056 . . . . 0.0 111.527 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.11 72.89 1.02 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.794 1.283 . . . . 0.0 111.35 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.56 -25.5 64.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.603 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -77.24 -24.84 51.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.464 1.105 . . . . 0.0 111.547 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -99.9 -28.1 13.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 112.381 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.68 57.9 3.0 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.803 0.841 . . . . 0.0 112.718 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -60.93 -43.42 30.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.593 2.862 . . . . 0.0 112.711 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -68.88 -40.83 79.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.819 0.736 . . . . 0.0 110.715 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.9 m -62.37 -50.37 71.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.691 0.796 . . . . 0.0 111.813 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.3 t -67.21 -38.89 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.131 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.49 -46.63 86.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.673 1.124 . . . . 0.0 111.422 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.88 -42.73 97.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.189 0.996 . . . . 0.0 111.977 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -59.27 -50.46 73.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.283 1.033 . . . . 0.0 111.619 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.22 -36.24 71.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.788 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.64 -38.07 71.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.728 0.811 . . . . 0.0 111.864 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.93 -40.77 60.64 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.727 -0.608 . . . . 0.0 112.339 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.3 m -61.34 -36.05 79.1 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.277 -0.89 . . . . 0.0 111.607 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -31.76 72.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.16 1.784 . . . . 0.0 112.93 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -81.61 -13.54 57.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.282 1.033 . . . . 0.0 113.476 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.77 18.3 61.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.51 1.052 . . . . 0.0 114.006 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.63 -17.53 62.87 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.34 -7.29 35.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.66 136.49 54.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.292 0.951 . . . . 0.0 109.154 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.5 t30 53.82 41.68 31.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.813 1.645 . . . . 0.0 114.586 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.9 p -102.11 167.31 10.1 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.908 0.883 . . . . 0.0 110.643 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -125.56 160.71 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -83.95 80.54 9.13 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -66.41 -14.21 61.82 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -169.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -150.96 143.74 24.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.275 1.852 . . . . 0.0 113.877 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.44 147.44 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 128.064 2.546 . . . . 0.0 108.201 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.5 mt -130.76 130.71 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.862 1.665 . . . . 0.0 107.493 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -61.63 134.95 57.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.852 0.461 . . . . 0.0 111.087 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 8.6 65.02 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.44 -176.89 5.22 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.481 1.913 . . . . 0.0 111.341 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -179.39 7.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -169.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.2 pt -115.4 135.35 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.703 1.601 . . . . 0.0 112.364 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -112.64 149.0 33.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.491 1.516 . . . . 0.0 111.351 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.55 175.76 36.39 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.11 66.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.145 1.831 . . . . 0.0 115.443 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.79 -15.02 62.1 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 118.745 1.272 . . . . 0.0 115.819 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.68 164.83 31.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.659 1.229 . . . . 0.0 113.331 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.91 164.46 28.42 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.858 1.663 . . . . 0.0 110.703 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.78 -14.91 39.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.451 2.767 . . . . 0.0 117.927 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.22 17.89 58.38 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.169 0.89 . . . . 0.0 114.563 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 32.7 18.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.845 1.658 . . . . 0.0 112.569 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -88.87 130.96 35.31 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.751 1.62 . . . . 0.0 109.537 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.96 124.98 27.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.322 1.049 . . . . 0.0 111.511 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -76.3 167.7 21.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.698 1.199 . . . . 0.0 113.485 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.68 77.84 3.33 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.345 1.458 . . . . 0.0 111.361 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.7 p -72.41 95.01 1.7 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.852 1.261 . . . . 0.0 111.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -110.95 171.46 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.169 1.788 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 51.45 64.48 7.88 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.548 1.539 . . . . 0.0 114.088 169.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -60.15 139.17 85.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.237 2.625 . . . . 0.0 111.808 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.83 150.41 6.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.348 1.459 . . . . 0.0 108.519 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.0 161.67 22.92 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.766 0.827 . . . . 0.0 111.369 169.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -73.22 121.37 20.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.403 0.681 . . . . 0.0 111.664 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -105.02 15.88 26.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.837 1.255 . . . . 0.0 113.215 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -14.09 49.75 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.307 -1.496 . . . . 0.0 114.568 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.45 2.64 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.913 2.085 . . . . 0.0 116.139 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.31 -3.39 58.22 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.421 1.489 . . . . 0.0 112.866 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 26.85 49.47 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.229 0.919 . . . . 0.0 114.976 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.75 160.54 27.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.571 0.748 . . . . 0.0 112.861 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -127.48 155.24 44.04 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -103.73 73.5 1.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.942 2.097 . . . . 0.0 111.6 -170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.9 p -103.31 167.65 9.68 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.473 0.709 . . . . 0.0 111.46 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -57.45 127.14 30.5 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.923 0.868 . . . . 0.0 111.282 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.39 26.72 42.22 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.086 1.327 . . . . 0.0 114.828 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.3 p -115.43 159.62 20.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.456 1.628 . . . . 0.0 112.777 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.53 136.32 53.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -136.64 161.03 37.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.273 0.559 . . . . 0.0 111.706 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -81.06 139.29 35.79 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.962 -0.461 . . . . 0.0 111.457 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 168.89 11.36 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.884 1.274 . . . . 0.0 110.905 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -105.08 160.24 15.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.164 1.385 . . . . 0.0 112.452 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.1 m -83.64 -52.16 6.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 0.0 110.719 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -161.25 -50.21 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.277 1.431 . . . . 0.0 112.217 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -85.46 160.47 53.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.943 1.297 . . . . 0.0 112.501 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.07 -16.52 55.4 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.245 2.63 . . . . 0.0 115.217 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -124.78 47.28 2.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.708 1.603 . . . . 0.0 111.141 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.9 p -119.46 25.78 9.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.26 1.424 . . . . 0.0 114.393 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.32 93.68 0.87 Allowed 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.936 -1.103 . . . . 0.0 108.907 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.5 p -89.04 -52.21 5.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.626 0.77 . . . . 0.0 111.779 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.36 -5.04 0.19 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -80.43 134.32 35.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.984 -1.072 . . . . 0.0 110.07 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.79 168.4 19.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.486 1.914 . . . . 0.0 110.673 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 12.5 p90 -147.1 161.82 40.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 111.842 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.83 119.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -69.76 100.15 1.46 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.22 -17.91 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.403 -0.81 . . . . 0.0 113.146 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.06 168.14 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 127.923 2.489 . . . . 0.0 111.256 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -68.92 113.47 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.706 1.202 . . . . 0.0 112.138 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.41 54.18 1.49 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.966 1.706 . . . . 0.0 111.58 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.0 -26.27 65.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -62.54 -13.73 34.21 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -85.8 -6.42 59.11 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.653 1.181 . . . . 0.0 114.069 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -71.73 179.48 3.09 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.184 1.394 . . . . 0.0 114.425 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -85.72 143.9 28.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.821 1.248 . . . . 0.0 111.991 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.8 p -112.7 -60.15 1.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 113.419 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 C-N-CA 123.797 0.713 . . . . 0.0 114.378 -173.294 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 7.5 p-90 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.32 -100.3 1.52 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.549 1.547 . . . . 0.0 115.688 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -126.3 150.6 48.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.667 1.587 . . . . 0.0 111.483 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.2 t -82.95 118.44 23.48 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.3 87.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.685 1.194 . . . . 0.0 108.227 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -78.71 -14.28 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.545 0.738 . . . . 0.0 112.234 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.89 177.62 7.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.626 1.203 . . . . 0.0 113.96 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -140.77 152.23 45.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.689 1.196 . . . . 0.0 112.345 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.91 142.89 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.598 0.713 . . . . 0.0 110.152 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.3 -41.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.86 1.664 . . . . 0.0 110.852 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -145.09 155.7 43.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.895 1.678 . . . . 0.0 109.682 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.31 23.13 Favored Glycine 0 N--CA 1.467 0.765 0 C-N-CA 123.867 0.746 . . . . 0.0 114.407 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -32.57 66.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.766 1.283 . . . . 0.0 112.325 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.83 -29.01 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 112.658 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.0 -40.05 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.315 1.446 . . . . 0.0 110.48 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.31 -39.41 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.803 -1.185 . . . . 0.0 110.982 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.35 -30.54 69.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -73.11 -44.51 60.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.829 1.252 . . . . 0.0 111.126 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.05 -25.03 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.432 1.493 . . . . 0.0 112.409 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -84.24 -25.45 29.41 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.16 -8.68 64.37 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.784 1.659 . . . . 0.0 114.747 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.3 -26.15 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 82.83 163.46 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.313 2.245 . . . . 0.0 114.376 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 68.3 p -111.8 151.05 29.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.135 1.374 . . . . 0.0 113.632 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 123.333 1.518 . . . . 0.0 112.537 169.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -59.36 135.74 67.3 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 120.756 1.306 . . . . 0.0 111.033 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -31.51 60.24 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.35 0.66 . . . . 0.0 112.687 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.48 147.87 35.65 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.486 0.714 . . . . 0.0 110.435 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.26 109.78 16.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.426 0.631 . . . . 0.0 110.027 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.41 100.14 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.85 141.22 42.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.525 1.13 . . . . 0.0 111.726 -169.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.3 103.41 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.39 -35.61 58.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.015 0.926 . . . . 0.0 110.859 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.56 165.01 34.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.12 139.59 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.205 1.802 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -135.39 130.31 34.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.775 1.23 . . . . 0.0 110.198 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.6 t -86.81 120.13 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t -114.18 147.3 39.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.027 1.331 . . . . 0.0 112.426 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.539 1.536 . . . . 0.0 113.46 -169.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 119.925 -0.083 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.76 128.2 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.979 0.912 . . . . 0.0 109.37 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.4 m -102.51 126.23 49.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 109.917 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -100.93 117.72 35.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.54 1.136 . . . . 0.0 109.329 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.25 112.53 24.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -118.81 163.89 16.21 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.479 0.656 . . . . 0.0 112.239 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -69.7 -6.29 30.72 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -118.65 -20.63 8.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 114.16 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.14 142.52 3.47 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 126.982 2.23 . . . . 0.0 113.64 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.88 136.26 47.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.65 1.18 . . . . 0.0 113.303 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.26 141.14 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.35 1.46 . . . . 0.0 109.596 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -124.92 136.34 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.912 1.285 . . . . 0.0 110.257 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -126.5 139.96 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 126.725 2.01 . . . . 0.0 110.1 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -107.14 124.72 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.587 1.955 . . . . 0.0 109.245 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -85.85 147.99 26.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.205 1.002 . . . . 0.0 111.555 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.93 74.85 1.01 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 122.651 1.215 . . . . 0.0 111.404 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.77 -26.23 64.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.503 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -77.75 -26.61 50.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.327 1.051 . . . . 0.0 111.712 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.85 -21.37 15.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.905 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.69 55.44 1.6 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.915 1.286 . . . . 0.0 113.069 -172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -60.63 -43.39 32.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.554 2.836 . . . . 0.0 112.953 -172.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -70.34 -41.11 73.62 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.553 0.615 . . . . 0.0 110.671 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 m -62.85 -52.37 63.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.676 0.39 . . . . 0.0 111.474 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.33 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 118.801 -0.618 . . . . 0.0 111.24 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -57.66 -48.16 80.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.569 1.077 . . . . 0.0 111.359 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.1 -41.17 82.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.954 0.902 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.18 -48.1 82.86 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.695 1.198 . . . . 0.0 111.682 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.96 -37.47 72.79 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.361 0.664 . . . . 0.0 111.415 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -59.08 -33.79 71.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.352 0.661 . . . . 0.0 112.607 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -73.77 -43.82 57.85 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.469 -0.77 . . . . 0.0 112.205 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.52 -37.19 82.83 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.33 -0.856 . . . . 0.0 111.503 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -62.61 -33.54 75.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.814 2.046 . . . . 0.0 112.883 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -83.79 -14.85 50.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.084 0.953 . . . . 0.0 113.503 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 17.5 53.5 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.082 0.849 . . . . 0.0 114.15 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -73.73 -18.47 60.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.196 1.498 . . . . 0.0 114.832 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -98.26 -6.6 30.79 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.2 -0.938 . . . . 0.0 112.35 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -71.57 129.33 38.48 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.934 -1.103 . . . . 0.0 108.792 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.7 43.99 17.95 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.089 1.355 . . . . 0.0 113.752 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.3 p -109.32 167.26 10.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.435 1.094 . . . . 0.0 111.829 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.8 pt -120.45 161.58 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.82 83.42 7.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.773 1.229 . . . . 0.0 108.177 168.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -60.8 -28.63 68.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.684 1.993 . . . . 0.0 115.025 -169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -132.0 136.55 47.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.787 1.176 . . . . 0.0 111.378 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.57 130.03 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.643 1.977 . . . . 0.0 110.944 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.3 mt -137.19 126.78 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 108.276 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.1 136.54 57.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.298 0.639 . . . . 0.0 111.628 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.24 9.23 63.61 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -142.54 -177.23 5.18 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.948 1.699 . . . . 0.0 111.025 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.93 179.89 6.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.835 1.654 . . . . 0.0 114.393 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.26 136.64 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.807 1.243 . . . . 0.0 112.364 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.55 141.96 34.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.661 1.184 . . . . 0.0 110.489 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.09 165.97 27.23 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 123.033 1.352 . . . . 0.0 115.801 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.62 -8.48 65.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.439 1.495 . . . . 0.0 115.831 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.54 -20.87 76.15 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.061 1.431 . . . . 0.0 116.065 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -143.68 170.06 16.56 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.757 1.278 . . . . 0.0 113.067 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -100.08 162.61 20.45 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 111.147 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.9 -13.26 29.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.838 3.025 . . . . 0.0 117.886 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 17.17 59.83 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.768 0.699 . . . . 0.0 114.389 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt 60.44 25.5 15.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.711 1.604 . . . . 0.0 112.967 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -82.77 125.17 30.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.58 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -76.08 120.28 21.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 110.952 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -72.15 163.85 27.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.226 1.011 . . . . 0.0 113.632 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.27 69.23 8.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.968 1.707 . . . . 0.0 111.542 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -72.84 130.3 40.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.514 1.526 . . . . 0.0 112.706 -173.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -133.56 174.87 9.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.467 1.907 . . . . 0.0 112.641 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 49.39 68.21 3.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.654 1.582 . . . . 0.0 114.009 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -61.14 133.93 49.72 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.171 2.581 . . . . 0.0 111.418 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.61 153.26 4.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.949 1.7 . . . . 0.0 108.012 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -74.83 161.2 29.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.54 0.336 . . . . 0.0 110.156 169.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.0 -42.88 69.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -168.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 61.34 -0.21 0.38 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.205 2.602 . . . . 0.0 117.717 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.39 -12.29 61.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.763 -1.836 . . . . 0.0 113.897 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -62.74 8.05 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.969 1.708 . . . . 0.0 115.101 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -79.21 -10.94 59.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.384 1.473 . . . . 0.0 112.832 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.6 81.35 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.055 1.312 . . . . 0.0 115.193 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.13 158.58 29.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.555 1.177 . . . . 0.0 112.535 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -128.53 150.3 50.23 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -87.15 65.44 8.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.477 1.911 . . . . 0.0 112.029 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.3 p -100.39 166.99 10.68 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.812 0.845 . . . . 0.0 112.424 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -52.27 123.22 10.2 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.699 1.599 . . . . 0.0 111.09 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.0 43.65 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 114.926 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.2 p -116.25 159.28 22.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.364 1.582 . . . . 0.0 113.682 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.95 134.72 55.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.826 0.85 . . . . 0.0 112.454 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.411 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -132.45 157.32 44.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 173.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -80.9 140.64 35.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.327 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.14 162.19 15.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.66 0.784 . . . . 0.0 111.231 172.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -129.75 164.65 23.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.461 1.104 . . . . 0.0 112.893 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.6 m -72.4 -54.54 9.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.67 0.788 . . . . 0.0 110.905 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.11 -52.13 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.627 1.571 . . . . 0.0 112.193 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.04 157.19 76.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.751 1.221 . . . . 0.0 111.776 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.2 -24.98 76.44 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.122 2.548 . . . . 0.0 114.296 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -109.12 33.64 4.17 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.478 1.511 . . . . 0.0 112.649 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.7 p -118.84 26.3 9.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.34 1.456 . . . . 0.0 113.88 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.51 100.85 13.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.209 1.404 . . . . 0.0 109.51 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.0 p -89.15 -57.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.065 0.946 . . . . 0.0 113.201 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -162.39 48.44 0.17 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -136.71 147.5 46.8 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.832 -1.167 . . . . 0.0 111.381 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.82 168.22 20.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.114 1.366 . . . . 0.0 111.78 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -147.61 162.44 39.12 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.239 0.616 . . . . 0.0 111.371 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.1 mt -116.05 115.85 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.053 0.941 . . . . 0.0 108.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -73.6 96.12 2.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.379 0.671 . . . . 0.0 110.062 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.42 -22.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.06 -1.025 . . . . 0.0 113.189 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.55 166.66 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.633 . . . . 0.0 110.862 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.71 114.73 13.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.326 0.584 . . . . 0.0 111.629 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -124.94 59.44 1.22 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.063 1.745 . . . . 0.0 111.554 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.09 -14.89 63.32 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.15 -14.05 62.53 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.849 -1.157 . . . . 0.0 113.266 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.2 -8.27 59.64 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.379 1.072 . . . . 0.0 113.695 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.36 -176.94 2.4 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -74.69 147.51 41.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.05 1.74 . . . . 0.0 113.034 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.4 p -103.15 -61.19 1.44 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.652 1.581 . . . . 0.0 113.107 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 C-N-CA 125.142 1.353 . . . . 0.0 112.618 -170.016 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.348 2.4 p-90 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.913 0.863 . . . . 0.0 112.958 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.88 -85.72 1.26 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.371 1.463 . . . . 0.0 115.905 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -137.1 132.97 34.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.957 1.303 . . . . 0.0 111.79 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.59 128.78 34.79 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.58 90.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.574 1.15 . . . . 0.0 107.935 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -78.94 -14.86 58.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.716 0.806 . . . . 0.0 111.904 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.01 177.33 9.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.579 1.18 . . . . 0.0 112.929 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -136.31 153.99 50.99 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.592 -1.317 . . . . 0.0 112.232 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.33 140.01 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.591 0.71 . . . . 0.0 109.403 169.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.99 -42.24 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.704 1.602 . . . . 0.0 110.519 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.43 147.0 32.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.563 1.545 . . . . 0.0 109.902 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.12 7.15 10.4 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.523 0.969 . . . . 0.0 115.523 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -56.32 -37.51 70.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.695 1.747 . . . . 0.0 112.716 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.47 -29.03 70.23 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.84 0.856 . . . . 0.0 112.431 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.11 -44.98 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.423 1.489 . . . . 0.0 110.443 172.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.84 -38.52 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.165 -0.959 . . . . 0.0 111.25 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.84 -23.51 60.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 112.457 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -78.92 -42.4 27.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.191 1.396 . . . . 0.0 111.182 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.37 -35.52 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.558 1.143 . . . . 0.0 111.87 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -84.98 -18.14 35.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.1 15.41 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.179 1.371 . . . . 0.0 114.422 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.42 -57.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.806 1.303 . . . . 0.0 113.106 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.33 5.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 112.024 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.2 p -142.84 153.52 43.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.2 1.4 . . . . 0.0 112.119 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.136 0 O-C-N 122.135 -0.353 . . . . 0.0 113.234 169.744 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.08 143.79 55.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 121.711 1.607 . . . . 0.0 109.324 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.46 58.17 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.44 159.11 16.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.211 1.405 . . . . 0.0 110.216 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.51 112.57 17.98 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.854 -1.154 . . . . 0.0 111.477 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.6 94.21 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.15 147.49 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -168.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 63.8 mt -85.76 104.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.992 1.717 . . . . 0.0 107.988 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -78.94 -30.47 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.081 1.353 . . . . 0.0 112.612 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 t -155.29 162.43 40.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.06 0.944 . . . . 0.0 113.119 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.03 139.6 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.69 1.596 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.7 m -136.39 128.61 29.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.594 1.157 . . . . 0.0 110.779 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.79 118.08 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.2 t -112.63 150.19 31.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.635 1.574 . . . . 0.0 112.295 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.346 1.458 . . . . 0.0 113.627 -170.081 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.865 -0.588 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.39 130.27 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 120.684 1.584 . . . . 0.0 110.394 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -101.24 123.16 44.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.446 1.098 . . . . 0.0 110.346 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -97.83 130.73 44.73 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.977 1.311 . . . . 0.0 110.286 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -103.6 97.84 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -101.51 152.35 20.87 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.064 -0.398 . . . . 0.0 111.269 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -60.85 -9.09 3.62 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -107.49 -8.44 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 114.147 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.45 162.23 10.61 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 123.109 1.394 . . . . 0.0 113.653 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.13 137.72 45.34 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.452 1.501 . . . . 0.0 112.651 172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.91 140.77 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.392 1.877 . . . . 0.0 108.685 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.47 135.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.384 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.13 134.55 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.559 1.944 . . . . 0.0 110.473 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -101.73 127.64 48.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.138 1.775 . . . . 0.0 108.796 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.4 p -88.28 149.27 23.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.386 1.075 . . . . 0.0 111.25 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.81 73.26 0.94 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.898 1.332 . . . . 0.0 111.656 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.76 -26.14 64.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.518 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -78.14 -26.2 47.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.333 1.053 . . . . 0.0 111.638 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.77 -22.02 14.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 113.183 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.85 55.31 1.19 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.855 1.262 . . . . 0.0 113.674 -171.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.63 -42.98 35.38 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.532 2.821 . . . . 0.0 113.147 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.31 -38.04 78.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 111.043 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.3 m -68.28 -47.99 66.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.153 0.581 . . . . 0.0 111.904 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.48 -39.43 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.337 0.655 . . . . 0.0 111.6 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -52.64 -49.36 65.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.543 1.065 . . . . 0.0 112.104 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.6 -38.05 77.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.459 0.704 . . . . 0.0 111.562 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.01 -50.34 74.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.472 1.109 . . . . 0.0 111.82 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.31 -35.18 73.5 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.51 -0.744 . . . . 0.0 111.638 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.07 -33.19 70.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 112.694 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.54 -43.42 39.22 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.378 -0.826 . . . . 0.0 112.376 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -58.84 -40.36 84.01 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.731 -0.605 . . . . 0.0 111.706 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -61.03 -39.66 90.65 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.362 1.865 . . . . 0.0 113.387 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -77.48 -16.23 58.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.031 0.933 . . . . 0.0 112.632 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.9 62.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.988 0.804 . . . . 0.0 112.836 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.95 -35.76 75.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.53 1.165 . . . . 0.0 113.122 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.72 -8.61 59.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.733 0.413 . . . . 0.0 112.089 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.04 132.12 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.15 -0.969 . . . . 0.0 108.809 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 56.1 t30 58.17 30.82 19.95 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -170.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -88.61 167.24 13.54 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.6 162.58 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -89.11 82.72 6.57 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -70.95 -12.85 61.77 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -168.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -147.54 135.09 20.88 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.649 1.568 . . . . 0.0 112.679 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -135.45 147.61 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 127.235 2.214 . . . . 0.0 109.516 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.87 132.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.139 1.776 . . . . 0.0 107.376 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.34 133.41 55.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.355 0.662 . . . . 0.0 111.897 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.53 11.1 61.7 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.989 0.804 . . . . 0.0 115.039 -172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.63 -177.12 4.91 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 111.164 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -83.65 179.9 7.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -169.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.0 pt -115.24 136.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.075 1.75 . . . . 0.0 112.168 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -115.8 149.38 38.64 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.142 1.377 . . . . 0.0 111.413 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.49 179.99 30.2 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 122.164 0.869 . . . . 0.0 115.235 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.12 -2.14 87.47 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.627 1.108 . . . . 0.0 115.493 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -25.17 43.73 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 118.965 1.383 . . . . 0.0 115.095 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -143.5 164.83 29.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.89 164.34 16.68 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.469 1.908 . . . . 0.0 110.441 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.32 -11.53 25.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.468 2.778 . . . . 0.0 117.492 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.15 16.1 60.47 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.042 0.829 . . . . 0.0 114.575 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mmt 60.8 27.1 16.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.394 1.877 . . . . 0.0 113.16 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.49 126.92 33.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.915 1.286 . . . . 0.0 109.561 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.49 127.55 33.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 124.017 1.865 . . . . 0.0 111.002 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -71.23 174.83 5.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 110.494 -3.048 . . . . 0.0 114.95 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 47.79 1.55 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.649 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.5 p -69.75 119.56 14.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.493 1.117 . . . . 0.0 112.308 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -132.82 173.41 11.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.748 2.419 . . . . 0.0 111.377 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 44.61 73.43 0.97 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.829 1.652 . . . . 0.0 114.359 169.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.83 144.5 26.68 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.78 2.987 . . . . 0.0 113.523 171.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.18 150.96 6.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.197 1.799 . . . . 0.0 107.993 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 151.93 26.96 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.269 0.627 . . . . 0.0 110.049 169.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -74.7 116.48 15.45 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.89 -77.87 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.088 0.555 . . . . 0.0 110.08 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.66 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.934 3.293 . . . . 0.0 118.202 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -75.05 27.51 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.395 2.278 . . . . 0.0 114.327 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.33 -5.57 18.99 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.379 2.272 . . . . 0.0 113.961 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.04 82.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 115.379 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.47 155.65 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.354 1.077 . . . . 0.0 112.527 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.01 154.0 51.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -90.79 62.05 4.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.083 1.753 . . . . 0.0 112.059 -169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.6 p -96.72 169.07 10.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.75 0.82 . . . . 0.0 111.768 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -54.02 127.42 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.667 1.187 . . . . 0.0 111.268 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.84 29.23 55.17 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.78 1.181 . . . . 0.0 114.66 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.5 p -115.35 159.16 21.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.472 1.636 . . . . 0.0 112.912 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.87 137.22 52.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.976 0.893 . . . . 0.0 113.152 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -137.53 161.57 36.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.973 0.892 . . . . 0.0 111.693 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 138.48 31.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.242 1.417 . . . . 0.0 111.71 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.73 137.34 35.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.984 0.914 . . . . 0.0 112.45 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -81.15 155.93 25.97 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.431 1.492 . . . . 0.0 112.264 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -80.41 -55.15 5.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.191 0.996 . . . . 0.0 111.065 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -154.55 -54.87 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.475 1.51 . . . . 0.0 110.975 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.5 79.88 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.9 0.88 . . . . 0.0 111.318 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.29 -22.81 74.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.552 2.168 . . . . 0.0 114.292 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.72 37.05 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.692 1.597 . . . . 0.0 112.303 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.4 p -114.42 23.96 12.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.462 1.505 . . . . 0.0 113.691 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.25 97.79 9.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 109.173 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -83.57 -69.34 0.64 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.735 1.214 . . . . 0.0 111.868 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.44 -14.1 1.98 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 113.249 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -74.06 141.56 45.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.228 1.013 . . . . 0.0 111.821 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -141.75 168.17 20.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.093 2.157 . . . . 0.0 111.047 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 13.1 p90 -145.96 162.65 37.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.055 0.942 . . . . 0.0 111.638 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -116.57 118.85 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.583 1.153 . . . . 0.0 108.311 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -71.71 98.89 2.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.414 0.686 . . . . 0.0 109.737 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -75.2 -17.47 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 113.318 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.6 167.19 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 128.537 2.735 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -75.65 115.5 15.39 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.712 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -125.0 55.65 1.36 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.116 1.766 . . . . 0.0 111.991 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.08 -16.01 60.82 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -66.54 -14.45 62.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.83 -1.169 . . . . 0.0 113.45 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.4 mt -82.23 -9.07 59.63 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.621 1.169 . . . . 0.0 113.607 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -71.64 -178.74 2.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.155 1.382 . . . . 0.0 114.363 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -83.65 144.31 29.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.145 1.378 . . . . 0.0 113.107 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.3 p -104.46 -63.06 1.25 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.833 1.653 . . . . 0.0 112.911 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.016 0 C-N-CA 125.316 1.436 . . . . 0.0 112.836 -170.229 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.469 ' HB3' ' H ' ' A' ' 111' ' ' SER . 17.7 p-90 . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.13 -100.5 2.01 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.224 1.392 . . . . 0.0 114.857 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.32 141.65 51.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.116 1.366 . . . . 0.0 111.643 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 36.3 t -79.49 126.98 31.56 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.944 -0.473 . . . . 0.0 112.159 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.88 94.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -81.88 -14.41 56.24 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.301 0.64 . . . . 0.0 111.939 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 176.88 8.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.41 1.1 . . . . 0.0 113.88 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -139.76 153.78 47.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.447 1.099 . . . . 0.0 112.647 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.03 140.18 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.599 0.714 . . . . 0.0 110.132 170.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.62 -42.28 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.091 1.756 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -144.72 155.26 43.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.552 1.541 . . . . 0.0 109.771 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.67 15.78 28.33 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 123.878 0.752 . . . . 0.0 113.964 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -34.95 67.87 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.761 1.28 . . . . 0.0 112.319 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.69 -29.41 69.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.581 0.753 . . . . 0.0 112.657 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.37 -42.63 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.229 1.412 . . . . 0.0 110.278 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.96 -39.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.957 . . . . 0.0 111.357 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.42 -21.24 61.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.689 1.596 . . . . 0.0 112.71 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -86.32 -43.72 12.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.769 1.628 . . . . 0.0 111.447 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.16 -29.1 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.416 1.486 . . . . 0.0 112.585 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -81.29 -16.49 52.34 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.91 -2.35 11.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.311 1.434 . . . . 0.0 114.544 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.82 -55.07 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.039 1.419 . . . . 0.0 112.012 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 177.93 148.4 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.686 1.995 . . . . 0.0 111.258 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 p -121.66 149.86 42.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.348 1.459 . . . . 0.0 112.947 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 C-N-CA 124.875 1.226 . . . . 0.0 112.141 175.511 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.4 130.49 23.93 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.088 1.192 . . . . 0.0 109.364 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -26.6 30.7 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.87 140.8 42.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.62 0.768 . . . . 0.0 109.418 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.38 109.83 17.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.419 0.628 . . . . 0.0 110.78 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.95 107.51 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.63 142.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 124.417 1.087 . . . . 0.0 111.446 -170.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.25 103.41 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.68 -37.72 62.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.21 0.604 . . . . 0.0 110.831 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 t -152.32 165.77 33.91 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 t -138.86 141.6 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.945 1.698 . . . . 0.0 110.641 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -134.0 126.1 29.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.022 1.329 . . . . 0.0 110.087 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.84 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -115.4 150.23 36.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.299 1.44 . . . . 0.0 112.412 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.429 1.492 . . . . 0.0 113.614 -169.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.17 126.39 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -97.97 124.91 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.939 1.296 . . . . 0.0 109.892 173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.95 121.69 42.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 109.974 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -97.2 108.76 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -120.16 159.61 24.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -68.54 -8.57 42.67 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -109.17 -25.28 10.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 113.677 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.74 145.16 4.12 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.479 1.99 . . . . 0.0 113.402 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.7 133.74 36.54 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.268 -1.136 . . . . 0.0 112.672 172.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.12 143.38 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.95 1.7 . . . . 0.0 109.252 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.8 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.308 1.043 . . . . 0.0 110.239 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.71 139.56 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.698 1.999 . . . . 0.0 110.265 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -104.09 124.55 49.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 108.132 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -85.87 148.81 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 111.547 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -106.89 73.41 0.94 Allowed 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.78 1.276 . . . . 0.0 111.608 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.72 -26.49 64.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.413 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.5 -27.14 51.75 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.327 1.051 . . . . 0.0 111.412 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -99.31 -24.64 14.76 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.213 1.405 . . . . 0.0 112.922 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.48 57.77 2.26 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.404 1.082 . . . . 0.0 113.162 -169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.66 -44.38 26.76 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.232 2.621 . . . . 0.0 112.906 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -71.95 -39.78 69.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.756 0.707 . . . . 0.0 111.38 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -64.04 -47.54 79.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 111.215 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.26 -42.37 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.612 0.765 . . . . 0.0 111.595 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -54.89 -47.42 74.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.764 1.166 . . . . 0.0 111.967 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -71.18 -36.01 71.82 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.339 0.518 . . . . 0.0 112.032 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.63 -48.88 79.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.134 0.974 . . . . 0.0 111.611 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.64 -36.05 73.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.4 -0.812 . . . . 0.0 111.826 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -58.67 -35.32 72.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.586 0.755 . . . . 0.0 112.338 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.394 -0.816 . . . . 0.0 111.958 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -58.84 -38.11 77.97 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.665 -0.647 . . . . 0.0 111.808 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -65.69 -35.83 81.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.053 2.141 . . . . 0.0 112.703 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -81.63 -16.02 52.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.704 0.802 . . . . 0.0 113.107 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.29 20.24 60.92 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.295 0.95 . . . . 0.0 113.215 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.12 -38.47 76.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.371 1.068 . . . . 0.0 113.179 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -82.12 -7.75 59.63 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.044 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.53 130.35 42.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.2 t30 55.08 46.78 23.39 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 114.262 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.6 p -110.62 162.51 14.66 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.301 1.04 . . . . 0.0 111.489 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.2 pt -122.72 161.85 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -86.45 81.85 8.16 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.843 1.257 . . . . 0.0 107.609 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -71.96 -7.96 51.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -146.0 135.22 22.83 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.55 1.523 . . . . 0.0 112.183 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.61 143.48 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.784 2.034 . . . . 0.0 110.556 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.35 129.72 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.853 1.661 . . . . 0.0 108.135 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -62.96 129.35 39.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.538 0.735 . . . . 0.0 111.65 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.61 10.48 67.14 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -142.49 -177.19 5.16 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.152 1.781 . . . . 0.0 110.765 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -81.71 178.82 8.11 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -169.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.29 135.81 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.679 1.591 . . . . 0.0 112.17 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -110.29 150.85 28.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.728 1.211 . . . . 0.0 111.206 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.68 175.79 33.42 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.33 2.9 85.06 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.329 1.442 . . . . 0.0 115.411 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.14 -26.14 49.45 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 118.953 1.377 . . . . 0.0 114.509 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.11 164.62 30.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.256 1.022 . . . . 0.0 113.396 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -97.41 164.59 17.36 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.768 1.627 . . . . 0.0 110.145 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -61.27 -15.26 39.1 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.51 2.807 . . . . 0.0 118.196 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.22 16.68 58.23 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.887 0.756 . . . . 0.0 114.284 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.6 mmm 58.1 37.85 26.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.818 2.047 . . . . 0.0 113.331 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -83.25 123.06 29.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.919 1.288 . . . . 0.0 109.122 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.41 119.94 17.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 124.196 1.951 . . . . 0.0 110.337 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.62 179.7 1.64 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 110.332 -3.122 . . . . 0.0 114.513 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 61.66 6.75 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.166 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -69.48 106.43 2.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.179 1.392 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.65 168.27 20.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.806 2.043 . . . . 0.0 111.995 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 49.12 61.35 14.17 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 113.007 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.4 129.85 36.88 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.731 2.954 . . . . 0.0 111.507 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.95 153.23 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.209 1.804 . . . . 0.0 108.154 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 162.66 18.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 112.19 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -76.5 123.07 25.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.796 0.838 . . . . 0.0 110.943 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.13 15.22 22.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.0 112.89 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -12.38 58.52 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.618 -1.301 . . . . 0.0 114.288 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -62.88 6.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 114.438 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -77.46 -11.54 59.86 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.134 1.774 . . . . 0.0 113.211 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.92 69.34 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.737 1.161 . . . . 0.0 114.891 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.39 156.93 26.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.882 1.341 . . . . 0.0 112.936 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -125.51 149.65 48.11 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -89.31 66.5 7.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 111.417 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.0 p -95.07 163.87 13.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.537 0.735 . . . . 0.0 111.514 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 124.88 15.74 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.765 0.793 . . . . 0.0 111.33 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.11 46.32 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.374 1.464 . . . . 0.0 115.391 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.0 p -115.17 160.37 19.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.627 1.713 . . . . 0.0 113.536 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.31 134.64 55.1 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -131.68 157.41 43.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.346 0.658 . . . . 0.0 111.381 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 35.7 mtp -84.23 138.1 33.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.223 -0.298 . . . . 0.0 111.061 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.52 155.83 17.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.161 0.985 . . . . 0.0 111.381 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -117.17 164.42 14.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.491 1.116 . . . . 0.0 113.2 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.8 m -76.66 -58.33 3.34 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.195 0.998 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -152.89 -58.31 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.991 1.716 . . . . 0.0 110.879 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.12 156.87 79.07 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.864 1.265 . . . . 0.0 112.047 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.66 -26.09 71.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.48 2.787 . . . . 0.0 114.249 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -108.18 33.37 4.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.507 1.523 . . . . 0.0 112.758 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -118.55 28.82 8.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.452 1.501 . . . . 0.0 113.693 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.13 106.28 18.26 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.732 1.613 . . . . 0.0 109.427 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.5 p -94.0 -69.02 0.77 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 0.0 113.139 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.81 -24.84 2.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.5 mp0 -67.06 140.58 57.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.528 1.131 . . . . 0.0 111.27 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -136.83 168.39 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.123 1.769 . . . . 0.0 110.358 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.442 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 10.9 p90 -143.23 162.04 36.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.247 0.619 . . . . 0.0 111.552 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.3 mt -114.38 118.89 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -70.12 96.76 1.1 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -73.71 -17.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.299 -0.876 . . . . 0.0 113.117 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -134.47 165.72 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 128.259 2.624 . . . . 0.0 110.78 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.57 116.58 14.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.758 0.823 . . . . 0.0 111.549 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -123.42 63.41 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.371 1.468 . . . . 0.0 112.535 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -52.34 -35.16 50.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.342 1.457 . . . . 0.0 114.327 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -65.61 -13.72 59.67 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.85 -9.05 58.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -74.01 -178.86 3.48 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -171.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -78.89 150.82 32.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.34 1.456 . . . . 0.0 112.839 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -127.48 -39.92 1.82 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.244 0 CA-C-N 118.944 0.793 . . . . 0.0 114.205 -177.683 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.286 5.4 p-90 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.55 -105.98 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.928 1.728 . . . . 0.0 114.86 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.24 141.06 51.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.533 1.533 . . . . 0.0 111.672 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -85.15 124.58 31.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -73.59 97.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 108.414 170.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -79.76 -15.94 56.52 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.544 0.737 . . . . 0.0 111.656 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.83 8.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.567 1.175 . . . . 0.0 113.843 -170.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -139.95 153.71 46.99 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.563 -1.335 . . . . 0.0 112.466 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.46 137.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.723 0.773 . . . . 0.0 109.924 170.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.13 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.331 1.852 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -141.74 148.65 39.35 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.521 1.528 . . . . 0.0 110.031 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.89 13.2 20.63 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.944 0.783 . . . . 0.0 114.87 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 69.5 mmm -54.69 -38.06 66.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.405 1.602 . . . . 0.0 112.377 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.76 -29.04 70.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.049 0.94 . . . . 0.0 112.439 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.98 -43.55 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.689 1.596 . . . . 0.0 110.336 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.18 -38.4 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.218 1.007 . . . . 0.0 111.198 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.9 -22.26 60.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.585 1.554 . . . . 0.0 112.857 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -81.39 -43.86 18.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.368 1.467 . . . . 0.0 111.395 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.5 mt -55.18 -33.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.097 1.359 . . . . 0.0 112.045 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -85.17 -16.59 39.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.35 12.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.166 1.365 . . . . 0.0 114.268 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.5 m -72.81 -57.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.607 1.203 . . . . 0.0 113.613 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.68 156.51 7.89 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.994 0.917 . . . . 0.0 113.324 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.9 p -141.71 152.13 43.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.392 1.477 . . . . 0.0 111.972 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 C-N-CA 123.114 0.387 . . . . 0.0 113.263 171.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.0 135.36 34.71 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 121.378 1.385 . . . . 0.0 109.548 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -29.59 48.76 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 154.23 22.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 110.636 169.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -84.53 109.61 18.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.998 0.904 . . . . 0.0 111.312 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.19 94.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.5 141.67 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -168.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.48 103.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.596 1.958 . . . . 0.0 106.786 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.02 -39.8 60.88 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.614 -0.679 . . . . 0.0 111.119 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -150.07 165.99 31.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -137.97 142.1 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.745 1.618 . . . . 0.0 111.001 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.7 m -136.33 129.59 31.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.766 1.227 . . . . 0.0 110.384 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.74 122.55 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -118.88 150.45 39.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.705 1.602 . . . . 0.0 112.044 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.628 1.171 . . . . 0.0 113.699 -172.331 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.31 124.75 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.97 0.908 . . . . 0.0 109.575 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 125.19 45.95 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.967 0.907 . . . . 0.0 110.314 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -96.87 135.34 38.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.674 1.19 . . . . 0.0 110.6 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -105.82 101.43 10.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -106.36 151.96 24.2 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.075 -0.39 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.83 -8.09 2.82 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -105.38 -10.46 16.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.781 1.232 . . . . 0.0 114.03 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.59 162.16 10.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.124 1.345 . . . . 0.0 113.592 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.21 138.1 45.42 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.667 1.587 . . . . 0.0 112.401 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.6 mt -135.61 140.36 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.299 1.84 . . . . 0.0 108.9 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.77 133.26 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.583 1.153 . . . . 0.0 110.682 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.54 139.16 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.551 1.94 . . . . 0.0 109.909 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -101.5 129.45 47.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.884 2.074 . . . . 0.0 108.452 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -93.43 145.98 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.412 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -103.96 72.08 1.08 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.897 1.332 . . . . 0.0 111.699 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.97 -26.13 63.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.502 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -77.58 -29.43 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.201 1.001 . . . . 0.0 111.698 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.7 -20.74 16.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.943 1.297 . . . . 0.0 113.285 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.65 56.79 1.55 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.516 1.126 . . . . 0.0 113.224 -171.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.18 -45.3 23.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.433 2.756 . . . . 0.0 113.116 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -69.48 -39.73 77.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.784 0.72 . . . . 0.0 111.449 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -63.44 -48.26 78.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.723 0.809 . . . . 0.0 111.24 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.17 -41.23 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.408 0.683 . . . . 0.0 111.512 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -54.42 -48.47 71.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.705 1.139 . . . . 0.0 112.329 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -70.56 -35.99 73.38 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.608 0.64 . . . . 0.0 111.922 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.84 -50.92 71.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.447 1.099 . . . . 0.0 111.418 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 -36.35 73.17 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.697 0.799 . . . . 0.0 111.959 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.89 -34.8 70.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -76.27 -39.19 54.97 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.519 -0.738 . . . . 0.0 112.442 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.45 -35.77 76.64 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.11 -0.994 . . . . 0.0 111.565 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -31.08 71.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.105 1.762 . . . . 0.0 112.763 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.21 -14.31 57.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.225 1.01 . . . . 0.0 113.345 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.52 15.38 62.0 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.69 1.138 . . . . 0.0 114.04 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -68.17 -18.96 64.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.438 1.495 . . . . 0.0 114.689 -171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.78 -13.5 21.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.23 1.71 8.81 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -145.24 49.38 1.26 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.28 1.432 . . . . 0.0 111.055 170.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.9 p -113.57 170.39 8.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.36 162.2 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -103.15 130.93 50.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.647 1.579 . . . . 0.0 107.368 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.96 -40.39 1.51 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -87.66 116.81 26.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.609 1.095 . . . . 0.0 109.627 -175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.03 129.75 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.489 1.516 . . . . 0.0 110.413 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.7 mt -141.47 129.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.021 1.728 . . . . 0.0 107.856 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -65.96 134.94 54.01 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.697 0.799 . . . . 0.0 111.819 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.5 13.5 68.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.811 0.72 . . . . 0.0 114.79 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -142.98 -177.32 5.28 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.903 1.681 . . . . 0.0 111.542 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.58 179.93 6.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.12 1.768 . . . . 0.0 114.975 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.0 pt -120.83 142.63 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -118.19 147.7 43.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 112.225 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.34 -177.6 30.61 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 122.151 0.862 . . . . 0.0 115.216 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.74 -5.82 82.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.362 1.458 . . . . 0.0 115.622 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.01 -16.08 63.8 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 -169.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.05 163.76 34.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.805 1.302 . . . . 0.0 112.366 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.13 163.0 30.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.303 1.041 . . . . 0.0 111.11 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.54 -12.9 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.187 3.258 . . . . 0.0 117.33 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.47 13.55 67.0 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.074 0.845 . . . . 0.0 114.833 172.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.8 mmt 59.71 29.64 19.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.374 1.87 . . . . 0.0 112.868 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -81.24 124.08 29.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.827 1.251 . . . . 0.0 109.197 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -72.97 114.72 11.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.535 0.734 . . . . 0.0 109.88 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -71.99 165.2 24.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.59 73.29 10.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.798 1.639 . . . . 0.0 111.033 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -70.41 129.31 38.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.864 0.866 . . . . 0.0 111.09 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -140.29 172.09 13.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.545 1.938 . . . . 0.0 111.513 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 48.42 62.66 11.71 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.396 1.478 . . . . 0.0 113.127 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -55.87 129.23 33.84 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.125 2.55 . . . . 0.0 110.339 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.63 149.18 4.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 107.536 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 158.45 27.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.691 0.758 . . . . 0.0 111.133 171.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -85.24 131.06 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.334 1.054 . . . . 0.0 111.217 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.36 15.92 17.92 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.224 1.01 . . . . 0.0 112.715 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.01 -11.36 28.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -74.43 40.41 0.13 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.932 1.693 . . . . 0.0 112.173 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -117.88 -3.48 11.18 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.419 2.287 . . . . 0.0 114.006 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.63 4.55 72.96 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.48 1.514 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.91 157.64 20.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.614 1.207 . . . . 0.0 113.124 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.04 158.85 43.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.616 1.166 . . . . 0.0 113.754 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -94.78 102.25 14.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.983 1.713 . . . . 0.0 110.563 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.4 p -133.5 168.03 19.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.787 1.235 . . . . 0.0 111.663 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.95 121.49 7.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.848 1.259 . . . . 0.0 110.692 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.91 24.54 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.503 1.525 . . . . 0.0 114.992 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.4 p -122.31 159.96 26.34 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.38 1.59 . . . . 0.0 113.734 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -122.24 139.49 53.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.836 0.854 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -138.46 159.24 42.57 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.843 -0.536 . . . . 0.0 111.881 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.9 mmm -78.75 137.7 37.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.919 0.488 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.69 148.85 29.99 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.122 0.569 . . . . 0.0 110.978 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.19 162.55 18.48 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.995 1.318 . . . . 0.0 112.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.6 m -77.37 -55.48 5.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.872 0.869 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.3 -56.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.977 1.311 . . . . 0.0 111.069 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.66 157.27 86.17 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 111.556 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.96 -35.53 94.49 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.869 2.379 . . . . 0.0 113.671 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -98.82 32.62 2.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.965 1.706 . . . . 0.0 113.359 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.5 p -117.24 33.91 5.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.006 1.322 . . . . 0.0 113.426 -173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.12 109.79 21.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.793 1.637 . . . . 0.0 110.186 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 p -94.94 -66.94 0.88 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.264 1.425 . . . . 0.0 113.449 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.67 -22.64 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.52 145.18 47.66 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 120.574 -1.329 . . . . 0.0 112.088 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -140.32 168.22 20.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 127.409 2.283 . . . . 0.0 109.611 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 11.9 p90 -144.81 159.9 42.13 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.125 0.57 . . . . 0.0 111.703 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.52 117.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 0.0 108.273 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.78 111.44 14.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.642 0.777 . . . . 0.0 110.707 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.13 -6.32 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 m -129.11 165.06 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.895 1.678 . . . . 0.0 111.154 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -80.27 117.4 21.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.89 0.476 . . . . 0.0 109.917 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -142.14 63.92 1.4 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.019 1.39 . . . . 0.0 111.822 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.31 -13.52 60.64 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -172.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.88 -14.03 41.41 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.689 -1.257 . . . . 0.0 113.427 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.01 -10.51 59.78 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.53 1.132 . . . . 0.0 113.729 173.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -75.44 -176.45 3.18 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -82.1 143.7 31.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.693 1.597 . . . . 0.0 112.288 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.4 p -108.62 -59.28 1.89 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.499 1.119 . . . . 0.0 113.631 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.238 0 C-N-CA 124.081 0.848 . . . . 0.0 114.161 -172.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.288 8.3 p-90 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.7 -98.54 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.629 1.585 . . . . 0.0 116.506 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -126.31 139.83 53.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.957 1.303 . . . . 0.0 111.809 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.94 122.85 28.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.878 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.75 89.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.551 1.14 . . . . 0.0 108.182 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.43 -15.22 59.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.369 0.667 . . . . 0.0 112.36 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.72 175.8 9.39 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -138.11 152.65 48.96 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.965 -1.085 . . . . 0.0 112.458 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.37 139.63 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.542 0.687 . . . . 0.0 110.476 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.95 -43.34 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.388 1.475 . . . . 0.0 111.165 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -145.96 154.02 41.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.379 1.472 . . . . 0.0 110.339 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.88 15.06 29.8 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.009 0.814 . . . . 0.0 113.395 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 23.0 mtp -57.84 -34.64 69.93 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.65 1.18 . . . . 0.0 111.938 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.55 -31.44 72.5 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.921 0.888 . . . . 0.0 112.407 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t -72.16 -43.12 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.444 1.097 . . . . 0.0 109.89 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.585 -0.697 . . . . 0.0 111.001 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.44 -26.38 61.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.82 1.248 . . . . 0.0 112.644 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -78.32 -41.39 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.054 1.342 . . . . 0.0 110.978 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mt -55.7 -30.1 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.447 1.899 . . . . 0.0 112.772 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -92.76 -11.1 34.71 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.04 -11.95 13.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.509 1.528 . . . . 0.0 114.413 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.16 -59.32 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.572 1.186 . . . . 0.0 112.799 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.94 143.22 0.93 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 112.431 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.0 p -112.07 148.75 33.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.435 1.494 . . . . 0.0 112.587 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 CA-C-O 123.198 1.444 . . . . 0.0 113.7 174.035 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.87 137.66 45.83 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 121.66 1.573 . . . . 0.0 109.858 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -27.64 43.04 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.768 -0.582 . . . . 0.0 112.281 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.72 140.71 44.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 109.635 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -84.22 130.44 34.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.67 0.748 . . . . 0.0 109.836 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.15 109.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.329 1.452 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.89 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.384 1.074 . . . . 0.0 111.566 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 mt -84.07 103.83 11.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.75 -28.35 60.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.2 t -163.89 169.53 18.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.38 140.07 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.496 1.919 . . . . 0.0 110.416 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.8 m -130.04 124.96 34.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 109.891 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.68 123.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -115.58 150.39 36.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.808 1.243 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.775 1.63 . . . . 0.0 113.413 -169.812 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.69 127.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.236 -0.915 . . . . 0.0 109.545 169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -102.35 120.92 41.3 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 110.119 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.7 132.12 41.23 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 110.843 169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -104.51 101.42 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -106.42 152.21 23.91 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.066 -0.396 . . . . 0.0 111.193 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.48 -9.77 4.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.93 -7.55 19.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 0.0 114.027 170.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.29 166.69 12.26 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.864 1.697 . . . . 0.0 113.683 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.09 137.6 41.53 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.097 1.759 . . . . 0.0 113.044 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -133.09 141.15 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.586 1.954 . . . . 0.0 108.971 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.49 135.78 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.457 1.103 . . . . 0.0 110.359 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 mt -122.98 139.84 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 126.339 1.855 . . . . 0.0 110.162 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -107.21 123.57 48.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.168 1.787 . . . . 0.0 109.113 172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.0 p -87.85 148.1 24.81 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.486 1.115 . . . . 0.0 111.914 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -105.73 73.66 1.02 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 122.655 1.217 . . . . 0.0 111.209 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.31 -26.06 64.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.581 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.99 -24.45 47.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.327 1.051 . . . . 0.0 111.595 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.2 -21.98 13.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.342 1.457 . . . . 0.0 112.862 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.65 55.59 1.81 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.199 1.4 . . . . 0.0 112.982 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.64 -43.77 30.53 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.509 2.806 . . . . 0.0 112.762 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -69.54 -40.09 77.08 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.006 0.821 . . . . 0.0 111.055 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -63.57 -49.37 73.68 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.947 0.499 . . . . 0.0 111.423 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.23 -38.05 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.399 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -55.74 -50.43 70.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.503 1.047 . . . . 0.0 111.433 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.6 -48.28 82.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.914 1.286 . . . . 0.0 111.199 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.17 -50.52 73.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 111.171 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -73.12 -36.07 66.67 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.524 0.73 . . . . 0.0 111.654 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -58.8 -36.33 74.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.949 0.5 . . . . 0.0 111.601 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 2.9 m-85 -77.75 -39.36 44.58 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 76.1 m -61.48 -36.33 80.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.967 . . . . 0.0 111.46 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -34.2 77.07 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 112.765 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.21 -14.06 57.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.367 1.067 . . . . 0.0 113.404 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.09 16.91 62.04 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.871 1.224 . . . . 0.0 114.258 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 45.9 t80 -71.81 -17.59 62.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -93.74 -12.81 28.36 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.98 2.94 7.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -146.12 43.92 1.23 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.229 1.412 . . . . 0.0 111.357 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 p -104.8 169.45 8.44 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.262 -0.899 . . . . 0.0 112.923 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 pt -127.85 163.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -89.29 119.16 29.51 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -93.08 -30.52 15.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.46 1.504 . . . . 0.0 114.289 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -133.99 138.93 45.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.997 0.919 . . . . 0.0 112.389 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.83 133.6 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 127.292 2.237 . . . . 0.0 109.699 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.2 mt -138.65 130.15 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.169 1.788 . . . . 0.0 107.891 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -63.58 135.6 56.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.439 0.696 . . . . 0.0 111.875 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.56 9.97 62.74 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -141.85 -177.09 5.03 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.439 1.896 . . . . 0.0 110.975 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.13 -178.16 5.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.961 1.704 . . . . 0.0 115.42 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 pt -121.3 136.05 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 112.559 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -116.5 149.92 38.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.429 1.092 . . . . 0.0 112.124 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.6 -179.77 36.5 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.42 1.328 . . . . 0.0 116.42 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.08 -12.16 68.58 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.668 1.604 . . . . 0.0 115.979 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.5 -15.17 69.19 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.881 1.513 . . . . 0.0 116.881 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.04 166.22 25.23 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.033 1.417 . . . . 0.0 112.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.13 163.17 20.51 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.87 1.668 . . . . 0.0 111.239 169.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.49 -13.89 27.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.051 3.167 . . . . 0.0 118.301 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.37 14.46 65.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.936 0.779 . . . . 0.0 114.677 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 mmm 57.77 38.66 27.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.776 1.63 . . . . 0.0 112.733 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.55 126.44 36.64 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.433 1.493 . . . . 0.0 109.493 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -73.44 118.46 16.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.848 0.859 . . . . 0.0 110.346 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -73.36 166.5 23.08 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.32 73.96 5.94 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.945 1.698 . . . . 0.0 111.671 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 p -68.76 122.72 19.16 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.621 1.168 . . . . 0.0 111.71 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -137.81 170.12 16.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 111.226 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 48.23 61.15 14.39 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.327 1.451 . . . . 0.0 113.386 169.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.08 139.29 89.93 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.698 2.932 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.41 148.24 6.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.457 1.503 . . . . 0.0 107.968 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 155.99 19.63 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.771 0.828 . . . . 0.0 110.843 170.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -71.71 126.1 28.83 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -107.47 11.38 28.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.79 1.236 . . . . 0.0 113.013 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -12.62 45.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -171.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.56 0.94 0.26 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.406 1.482 . . . . 0.0 113.944 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -72.25 -11.26 60.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.791 1.236 . . . . 0.0 112.939 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.61 7.59 85.91 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.305 1.431 . . . . 0.0 114.695 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.69 153.25 38.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.464 1.132 . . . . 0.0 112.226 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -130.63 151.57 50.94 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -93.45 99.52 11.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 110.921 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.2 p -129.96 168.21 17.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.555 1.142 . . . . 0.0 111.496 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 124.9 18.57 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.71 1.204 . . . . 0.0 110.976 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.61 46.99 8.27 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.537 1.065 . . . . 0.0 113.807 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.8 p -134.75 163.36 29.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 118.304 1.052 . . . . 0.0 112.942 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.36 139.08 54.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.817 . . . . 0.0 112.997 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -136.7 159.86 40.56 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.086 0.47 . . . . 0.0 111.731 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -82.88 141.13 32.45 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.687 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.01 162.0 14.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.188 0.995 . . . . 0.0 111.025 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -137.4 158.74 43.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.212 1.405 . . . . 0.0 112.274 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 m -72.35 -54.94 8.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.46 1.104 . . . . 0.0 111.661 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.87 -49.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.113 1.365 . . . . 0.0 112.425 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 156.1 77.77 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.594 1.158 . . . . 0.0 111.21 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.01 -27.72 80.44 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.081 2.521 . . . . 0.0 113.653 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -109.34 35.63 3.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.514 1.526 . . . . 0.0 112.515 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -118.07 31.82 6.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.517 1.527 . . . . 0.0 113.671 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.54 105.14 17.22 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.009 1.724 . . . . 0.0 109.038 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.2 p -97.57 -45.39 6.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.37 12.59 0.23 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -104.96 139.72 39.25 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.358 -1.464 . . . . 0.0 111.489 -169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -141.51 168.42 19.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.051 1.74 . . . . 0.0 111.527 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 10.7 p90 -147.79 162.08 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.97 117.79 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.744 1.218 . . . . 0.0 108.783 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -76.57 100.8 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.861 0.864 . . . . 0.0 110.596 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.78 -19.27 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.81 167.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.812 1.645 . . . . 0.0 111.761 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.81 120.7 24.44 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.964 -0.46 . . . . 0.0 110.092 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -146.2 62.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 123.001 1.381 . . . . 0.0 111.937 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.64 -13.23 58.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -62.76 -13.91 38.55 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.507 -1.371 . . . . 0.0 113.381 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.25 -9.26 59.72 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.583 1.153 . . . . 0.0 113.821 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -73.8 179.91 3.99 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -81.0 145.89 30.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.348 1.459 . . . . 0.0 112.257 169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.3 p -115.8 -59.34 2.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.581 1.152 . . . . 0.0 113.613 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.008 0 C-N-CA 124.17 0.891 . . . . 0.0 114.028 -172.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.282 7.2 p-90 . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.33 -93.42 1.13 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.316 1.436 . . . . 0.0 114.834 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.21 142.27 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.259 1.424 . . . . 0.0 111.721 -169.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.22 127.41 34.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.2 92.27 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.597 1.159 . . . . 0.0 108.22 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -80.38 -14.92 57.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.857 0.863 . . . . 0.0 112.031 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.98 8.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.335 1.064 . . . . 0.0 113.252 -170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -138.94 149.98 45.38 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.842 -1.161 . . . . 0.0 112.041 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 p -78.8 134.99 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.424 0.63 . . . . 0.0 110.464 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.96 -41.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.326 1.85 . . . . 0.0 110.736 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -143.98 155.81 44.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.667 1.587 . . . . 0.0 109.853 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.21 16.79 26.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.754 0.692 . . . . 0.0 114.734 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.05 -32.91 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.371 1.585 . . . . 0.0 112.437 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.66 -29.06 68.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.574 0.75 . . . . 0.0 112.684 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.06 -38.55 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.533 1.533 . . . . 0.0 110.463 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.6 -41.4 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.8 -1.188 . . . . 0.0 110.658 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.7 -30.6 70.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.134 1.373 . . . . 0.0 111.652 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.98 -46.89 61.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.51 0.724 . . . . 0.0 111.12 173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 98.6 mt -68.73 -25.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.993 1.317 . . . . 0.0 112.142 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -85.13 -17.62 36.69 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.883 -1.136 . . . . 0.0 113.864 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.67 -8.73 54.14 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.058 1.79 . . . . 0.0 115.181 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -26.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 83.55 164.59 0.12 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.357 2.263 . . . . 0.0 114.663 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.2 p -114.27 151.5 32.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.909 1.683 . . . . 0.0 113.599 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.905 0 C-N-CA 125.032 1.301 . . . . 0.0 110.688 169.575 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -60.3 140.04 89.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.887 1.725 . . . . 0.0 110.761 169.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -32.38 62.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.62 150.18 31.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.726 0.774 . . . . 0.0 111.198 169.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.95 110.01 16.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 110.617 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.38 106.24 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.143 0.977 . . . . 0.0 108.372 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.74 142.2 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.652 1.181 . . . . 0.0 112.176 -169.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mt -84.36 103.87 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.78 -30.96 59.29 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.536 1.134 . . . . 0.0 111.533 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 p -162.76 171.47 16.73 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -135.52 143.75 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.329 1.452 . . . . 0.0 110.786 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -132.79 130.28 39.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.351 1.46 . . . . 0.0 109.764 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.66 125.46 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.1 t -121.15 150.5 41.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.588 1.555 . . . . 0.0 111.838 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.356 1.062 . . . . 0.0 112.999 -179.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.504 2.258 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -129.75 130.47 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 120.846 -1.159 . . . . 0.0 110.273 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.1 m -101.07 127.11 47.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.493 1.117 . . . . 0.0 110.235 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -101.66 124.03 46.63 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.778 1.231 . . . . 0.0 110.054 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.53 106.64 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.5 p -117.55 160.12 21.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.303 0.573 . . . . 0.0 112.114 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -68.5 -7.88 36.14 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -111.24 -25.69 9.56 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.522 . . . . 0.0 113.591 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.48 144.95 4.09 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.164 1.84 . . . . 0.0 113.538 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.96 133.6 38.06 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.383 1.073 . . . . 0.0 112.38 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -130.86 144.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.788 1.635 . . . . 0.0 109.379 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.4 136.79 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.274 1.03 . . . . 0.0 110.517 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -126.38 139.83 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.888 2.075 . . . . 0.0 110.189 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -102.46 127.69 49.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.69 1.996 . . . . 0.0 107.753 171.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -88.79 147.63 24.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.162 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -104.48 74.11 1.15 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.695 1.236 . . . . 0.0 111.391 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.69 -27.52 65.08 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.212 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.87 -31.37 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.528 1.131 . . . . 0.0 111.529 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -96.39 -24.51 16.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.6 1.16 . . . . 0.0 113.066 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.1 61.36 4.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.662 0.785 . . . . 0.0 112.971 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.37 -45.07 15.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.201 2.601 . . . . 0.0 112.583 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -69.48 -39.97 77.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.858 0.754 . . . . 0.0 111.13 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.4 m -63.23 -48.19 79.29 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.739 0.816 . . . . 0.0 111.249 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.26 -41.81 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.409 0.684 . . . . 0.0 111.803 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.26 -47.87 74.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.72 1.146 . . . . 0.0 112.129 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -37.11 73.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.097 0.559 . . . . 0.0 111.813 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.75 -49.0 79.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.333 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.78 -37.09 70.5 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.591 0.757 . . . . 0.0 111.821 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.094 0.558 . . . . 0.0 112.436 172.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.81 -41.83 59.2 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.438 -0.789 . . . . 0.0 112.522 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.21 -37.33 79.95 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.424 -0.797 . . . . 0.0 111.51 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.82 -35.04 78.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.803 2.041 . . . . 0.0 112.788 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -82.65 -13.15 56.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.023 0.929 . . . . 0.0 113.39 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.49 19.43 64.12 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.481 1.039 . . . . 0.0 114.154 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.53 -17.61 64.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.073 1.349 . . . . 0.0 114.524 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.49 -4.28 45.22 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.342 -0.848 . . . . 0.0 113.211 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -67.85 136.7 54.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 109.405 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.7 t30 49.29 46.35 23.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.829 1.652 . . . . 0.0 114.211 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -103.77 161.6 13.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.506 0.722 . . . . 0.0 111.921 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 pt -122.48 162.2 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -169.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -94.79 114.92 26.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.071 1.349 . . . . 0.0 107.945 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.96 1.11 14.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -134.22 133.55 41.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.333 1.424 . . . . 0.0 110.43 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.13 133.64 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.127 1.371 . . . . 0.0 111.125 170.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.41 130.48 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.988 1.715 . . . . 0.0 108.186 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -63.83 134.62 55.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.712 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.45 68.86 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.741 0.686 . . . . 0.0 114.667 -173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.07 -177.19 5.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.234 1.813 . . . . 0.0 111.266 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.76 179.73 6.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.384 1.874 . . . . 0.0 114.974 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 pt -119.58 139.52 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.106 1.363 . . . . 0.0 112.317 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.4 148.74 33.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.874 1.27 . . . . 0.0 111.121 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.01 -176.41 33.09 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 115.259 0.864 . . . . 0.0 115.259 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.52 24.15 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.44 1.495 . . . . 0.0 115.252 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.56 -14.61 75.61 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.1 1.333 . . . . 0.0 115.689 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -141.5 167.66 21.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.721 1.208 . . . . 0.0 112.944 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -107.87 156.07 38.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.267 2.227 . . . . 0.0 109.329 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.83 128.8 31.44 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.102 2.535 . . . . 0.0 112.956 -170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.31 15.94 36.53 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.598 1.57 . . . . 0.0 113.505 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmm 61.66 37.44 15.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.241 1.416 . . . . 0.0 112.26 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.77 118.3 21.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.695 1.198 . . . . 0.0 108.882 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.59 126.35 29.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.491 0.663 . . . . 0.0 111.213 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -78.74 167.45 21.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.217 1.007 . . . . 0.0 113.366 171.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.47 75.1 5.19 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.833 1.653 . . . . 0.0 110.768 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.8 p -73.4 134.95 44.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.134 0.974 . . . . 0.0 111.842 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -138.68 171.93 13.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.941 2.096 . . . . 0.0 112.0 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 51.88 66.48 5.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.616 1.566 . . . . 0.0 113.365 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.27 136.06 69.75 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.297 2.665 . . . . 0.0 111.405 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.74 150.69 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.475 1.51 . . . . 0.0 109.413 -170.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 157.66 21.77 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.915 0.486 . . . . 0.0 111.969 175.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -71.54 131.24 42.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.472 0.709 . . . . 0.0 110.131 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -117.44 13.58 14.47 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.054 1.342 . . . . 0.0 111.961 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.8 63.37 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.571 -1.331 . . . . 0.0 113.739 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -60.72 4.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.613 1.965 . . . . 0.0 115.914 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -84.67 4.23 33.49 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.876 1.67 . . . . 0.0 111.808 168.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.65 28.04 27.88 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.204 1.383 . . . . 0.0 113.961 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.58 143.43 40.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.002 0.921 . . . . 0.0 112.771 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.51 156.3 48.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.747 1.219 . . . . 0.0 113.702 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -110.83 110.78 21.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.598 2.359 . . . . 0.0 109.778 -171.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 p -137.65 171.65 14.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.43 1.092 . . . . 0.0 110.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -47.85 120.26 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.54 1.136 . . . . 0.0 111.362 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.03 21.5 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.717 1.151 . . . . 0.0 114.949 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.1 p -121.95 160.51 24.68 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.669 1.235 . . . . 0.0 112.937 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.15 136.49 54.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.686 0.794 . . . . 0.0 112.828 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.61 159.15 42.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.886 -0.509 . . . . 0.0 111.948 172.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 97.5 mmm -82.39 134.8 35.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.852 0.461 . . . . 0.0 110.86 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.12 154.51 21.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.244 1.018 . . . . 0.0 110.3 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -120.74 158.25 27.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.363 1.065 . . . . 0.0 113.034 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.8 m -69.27 -56.49 7.4 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.905 0.882 . . . . 0.0 110.73 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -150.69 -56.09 0.16 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.806 1.642 . . . . 0.0 110.23 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.51 157.34 72.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.947 1.299 . . . . 0.0 112.401 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -56.54 -25.77 60.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.683 2.922 . . . . 0.0 113.999 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -107.53 36.62 2.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.57 1.548 . . . . 0.0 112.687 -177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -126.74 28.03 5.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.27 1.428 . . . . 0.0 113.905 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.7 76.51 4.95 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.423 1.489 . . . . 0.0 112.469 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -70.19 -60.38 2.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.816 1.247 . . . . 0.0 114.233 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.21 -8.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -169.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -81.21 140.52 34.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.729 -1.232 . . . . 0.0 109.694 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -140.47 168.33 20.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.88 1.672 . . . . 0.0 111.251 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 19.7 p90 -146.81 161.73 40.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.657 0.783 . . . . 0.0 111.966 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.34 116.94 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.49 1.116 . . . . 0.0 108.537 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.72 98.15 4.02 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 110.689 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 -24.86 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 113.066 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.71 168.94 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.479 1.512 . . . . 0.0 112.024 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.41 120.51 23.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.732 1.213 . . . . 0.0 110.371 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -142.22 74.73 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.204 1.478 . . . . 0.0 112.209 -170.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.77 -34.93 70.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.894 2.077 . . . . 0.0 114.094 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.46 -13.17 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.46 -11.62 58.39 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -72.64 172.23 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.71 155.45 40.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.588 1.155 . . . . 0.0 112.107 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -139.65 -55.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.317 0 N-CA-C 116.769 1.467 . . . . 0.0 116.769 -177.191 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.258 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.92 -72.68 0.9 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.112 1.339 . . . . 0.0 115.378 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -139.68 150.1 44.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.04 1.336 . . . . 0.0 111.843 -169.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.6 t -87.98 120.35 29.23 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.647 -0.658 . . . . 0.0 112.543 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -77.52 82.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.253 1.421 . . . . 0.0 108.537 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -74.38 -14.52 60.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.024 0.929 . . . . 0.0 112.419 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.99 177.84 8.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.567 1.175 . . . . 0.0 113.904 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.79 153.9 47.24 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.888 -1.132 . . . . 0.0 112.606 172.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.09 141.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.711 0.767 . . . . 0.0 110.201 172.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.81 -40.2 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.786 1.634 . . . . 0.0 111.107 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -144.81 148.89 34.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.345 1.458 . . . . 0.0 110.674 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.88 10.11 21.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.579 1.085 . . . . 0.0 114.899 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -38.2 72.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.85 1.325 . . . . 0.0 112.433 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.961 0.904 . . . . 0.0 112.107 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.1 t -77.52 -43.71 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.518 . . . . 0.0 110.283 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.59 -38.16 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.291 -0.881 . . . . 0.0 111.099 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.43 -19.74 60.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.173 1.389 . . . . 0.0 113.044 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -86.19 -39.11 16.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.745 1.618 . . . . 0.0 111.669 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.0 mt -53.13 -36.02 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.622 1.569 . . . . 0.0 112.09 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -84.61 -17.71 37.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.89 -20.36 16.77 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.291 1.424 . . . . 0.0 114.296 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.23 -59.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.614 1.207 . . . . 0.0 113.155 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.98 148.21 4.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 112.359 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.4 p -138.03 151.11 47.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.214 1.406 . . . . 0.0 111.861 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.955 0 C-N-CA 123.163 0.411 . . . . 0.0 112.639 169.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.84 134.55 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 121.386 1.391 . . . . 0.0 108.932 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -27.95 51.43 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.3 157.7 22.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.582 1.153 . . . . 0.0 110.369 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.13 111.48 18.29 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.135 -0.978 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.67 94.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.646 1.578 . . . . 0.0 107.071 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.42 143.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -169.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.1 mt -86.43 103.98 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.815 2.046 . . . . 0.0 106.728 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.76 -41.77 61.99 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.673 -0.642 . . . . 0.0 110.863 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.5 t -150.2 165.82 31.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.78 142.46 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.112 1.765 . . . . 0.0 111.178 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.2 m -135.21 128.58 32.24 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.89 1.276 . . . . 0.0 110.245 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.73 122.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -113.59 150.4 33.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.137 1.375 . . . . 0.0 112.275 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.061 1.344 . . . . 0.0 113.622 -170.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.94 127.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.909 0.884 . . . . 0.0 109.364 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.4 m -102.31 124.17 47.41 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.815 1.246 . . . . 0.0 109.901 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -101.46 125.3 48.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.588 1.155 . . . . 0.0 110.474 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -96.9 94.47 7.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 172.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -96.67 152.33 18.76 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.833 -0.542 . . . . 0.0 110.765 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -59.35 -14.34 11.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.96 -13.57 21.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.739 1.215 . . . . 0.0 113.655 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 167.74 14.94 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 123.242 1.468 . . . . 0.0 113.125 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.91 136.9 38.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.341 1.457 . . . . 0.0 112.835 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.2 mt -133.97 139.3 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.663 1.985 . . . . 0.0 108.643 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.1 t -123.56 134.93 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.594 1.158 . . . . 0.0 110.385 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -121.0 139.0 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.655 1.982 . . . . 0.0 110.094 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -103.79 125.78 50.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.56 1.944 . . . . 0.0 108.823 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -87.77 147.24 25.27 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.407 1.083 . . . . 0.0 111.361 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.52 74.41 1.25 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.692 1.234 . . . . 0.0 111.251 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.71 -25.9 64.09 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.607 1.163 . . . . 0.0 112.674 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.33 -28.01 56.72 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.559 1.144 . . . . 0.0 111.346 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -96.82 -30.6 13.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 112.725 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.61 58.59 3.38 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.761 0.824 . . . . 0.0 113.194 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -60.53 -42.71 38.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.583 2.855 . . . . 0.0 112.928 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -69.37 -41.43 76.54 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.655 0.661 . . . . 0.0 110.793 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.1 m -62.23 -49.86 74.05 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.393 0.677 . . . . 0.0 111.481 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -42.64 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.447 0.699 . . . . 0.0 111.401 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.2 -44.59 88.19 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.646 1.112 . . . . 0.0 111.567 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -65.45 -42.28 92.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.305 1.042 . . . . 0.0 111.868 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.9 -48.55 81.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.182 0.993 . . . . 0.0 111.731 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -38.49 81.49 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.91 0.884 . . . . 0.0 111.675 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -56.3 -36.24 68.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.172 0.989 . . . . 0.0 112.094 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -75.51 -43.56 48.35 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.526 -0.734 . . . . 0.0 112.626 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.7 m -61.69 -36.82 81.97 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.61 -0.681 . . . . 0.0 111.877 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.29 71.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.135 1.774 . . . . 0.0 112.824 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.42 -15.48 49.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.337 1.055 . . . . 0.0 113.378 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.66 51.57 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.524 0.583 . . . . 0.0 113.849 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -73.02 -18.11 61.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.117 1.459 . . . . 0.0 114.688 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -100.83 -5.2 26.54 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.143 -0.973 . . . . 0.0 112.273 169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -69.58 130.66 43.05 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.913 -1.117 . . . . 0.0 108.484 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t30 57.08 46.2 19.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.252 1.421 . . . . 0.0 113.698 -169.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -116.23 153.26 32.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.809 0.844 . . . . 0.0 112.449 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -104.93 163.44 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -95.7 94.81 7.92 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -89.08 -2.16 58.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -168.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -138.99 139.85 38.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.114 1.779 . . . . 0.0 112.304 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 132.0 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 126.624 1.97 . . . . 0.0 111.019 169.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.06 129.46 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.058 1.743 . . . . 0.0 108.027 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.71 133.41 55.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.387 0.675 . . . . 0.0 111.574 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.78 10.29 64.02 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -141.34 -177.34 5.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.008 1.723 . . . . 0.0 111.266 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.4 -178.9 5.72 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -169.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.6 pt -116.93 137.2 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.143 1.377 . . . . 0.0 112.275 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -109.15 149.29 29.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.685 1.194 . . . . 0.0 110.625 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.25 174.21 34.1 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 122.473 1.041 . . . . 0.0 115.381 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.72 0.74 75.3 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.932 1.253 . . . . 0.0 115.253 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 -19.27 62.74 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.255 1.527 . . . . 0.0 115.678 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -147.87 165.29 31.08 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.508 1.123 . . . . 0.0 113.193 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.69 163.88 28.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.19 1.396 . . . . 0.0 109.926 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -60.29 -15.63 36.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.551 2.834 . . . . 0.0 118.325 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.27 19.79 53.08 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.179 0.895 . . . . 0.0 114.558 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.05 32.35 19.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.92 126.7 35.2 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.321 1.448 . . . . 0.0 109.162 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.16 127.98 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.717 0.807 . . . . 0.0 110.829 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -72.69 165.52 24.62 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.268 170.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.52 74.48 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.736 1.614 . . . . 0.0 111.088 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 p -73.0 140.76 47.55 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.596 1.158 . . . . 0.0 112.703 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -141.76 178.06 7.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.991 2.116 . . . . 0.0 111.887 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 51.68 65.17 6.76 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 125.784 1.634 . . . . 0.0 114.346 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -57.12 133.26 56.54 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.316 2.677 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.16 150.87 7.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 126.101 1.76 . . . . 0.0 108.72 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 157.85 23.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 169.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -76.52 126.14 30.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.597 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -108.18 14.39 25.06 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.233 1.413 . . . . 0.0 112.915 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -15.79 62.73 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.325 -1.485 . . . . 0.0 114.111 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.94 0.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.123 1.769 . . . . 0.0 115.77 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -79.39 -3.87 48.41 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.883 1.273 . . . . 0.0 112.126 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.39 31.55 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.891 1.234 . . . . 0.0 114.619 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.3 mt -80.43 159.3 25.69 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -131.43 156.34 45.76 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -103.82 115.41 30.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.232 2.213 . . . . 0.0 110.302 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -139.94 167.91 21.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.685 1.194 . . . . 0.0 111.442 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -51.72 119.79 4.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.388 1.475 . . . . 0.0 110.715 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.16 28.87 21.69 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.922 1.249 . . . . 0.0 114.977 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.4 p -122.58 158.94 28.82 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.169 1.484 . . . . 0.0 112.897 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.69 139.28 53.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.681 0.753 . . . . 0.0 112.756 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -137.49 159.7 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.738 170.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -80.28 141.21 35.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.101 0.56 . . . . 0.0 111.641 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 154.18 19.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.27 0.628 . . . . 0.0 111.516 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -141.0 158.1 44.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.292 1.437 . . . . 0.0 112.713 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 m -72.25 -55.5 7.09 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.881 0.872 . . . . 0.0 113.006 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -159.47 -54.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.276 1.031 . . . . 0.0 111.57 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.71 158.84 86.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.2 1.0 . . . . 0.0 111.365 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.01 -27.69 85.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.832 2.355 . . . . 0.0 113.358 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -109.21 36.15 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.499 1.52 . . . . 0.0 112.511 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.0 p -115.58 30.56 7.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.456 1.502 . . . . 0.0 113.318 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 101.91 14.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.015 1.326 . . . . 0.0 110.092 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 p -91.52 -64.35 1.13 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.187 0.995 . . . . 0.0 113.001 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.81 42.37 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -133.87 153.91 51.42 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.069 -1.02 . . . . 0.0 112.955 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -145.54 168.21 21.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.749 2.02 . . . . 0.0 110.958 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 11.0 p90 -144.63 159.69 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 111.208 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.6 mt -113.0 118.07 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.19 108.22 6.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.192 0.597 . . . . 0.0 109.798 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.94 -14.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.35 168.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.376 2.271 . . . . 0.0 111.226 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.69 119.24 24.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.469 0.708 . . . . 0.0 109.525 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -141.07 77.17 1.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.975 1.369 . . . . 0.0 113.15 -169.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.24 -34.73 61.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.024 2.13 . . . . 0.0 114.514 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -61.79 -12.7 18.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.09 -10.64 57.66 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.41 178.14 6.12 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -83.94 142.38 30.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.971 1.308 . . . . 0.0 111.814 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -111.35 -58.74 2.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.599 1.159 . . . . 0.0 113.42 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 C-N-CA 124.241 0.924 . . . . 0.0 113.346 -173.187 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.306 6.6 p-90 . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.2 -86.9 1.26 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.362 1.458 . . . . 0.0 115.758 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -139.54 149.94 44.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.883 1.273 . . . . 0.0 111.796 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.9 t -81.27 119.53 23.76 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.732 -0.605 . . . . 0.0 112.408 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.44 84.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -77.06 -14.81 59.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.64 0.776 . . . . 0.0 111.942 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 177.42 8.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.622 1.201 . . . . 0.0 113.783 -170.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -140.64 154.56 46.47 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.768 -1.208 . . . . 0.0 112.333 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.48 140.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.64 0.733 . . . . 0.0 110.084 170.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.97 -42.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 111.008 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -144.5 153.54 41.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 109.93 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 103.47 15.03 24.19 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 123.878 0.751 . . . . 0.0 114.289 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.1 68.54 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.028 1.414 . . . . 0.0 112.263 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -65.74 -30.07 70.68 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.746 0.818 . . . . 0.0 112.466 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.49 -43.13 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.8 1.24 . . . . 0.0 110.092 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.25 -40.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.816 0.846 . . . . 0.0 111.332 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.83 -27.29 62.81 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.93 1.292 . . . . 0.0 112.367 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.13 -42.27 32.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.463 1.105 . . . . 0.0 111.205 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.11 -30.14 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.935 1.694 . . . . 0.0 112.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -91.82 -20.11 21.83 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.78 -17.53 27.88 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.498 1.523 . . . . 0.0 114.738 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.44 -51.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 118.887 1.344 . . . . 0.0 112.722 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.97 155.77 5.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.189 1.396 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.8 p -135.87 150.96 49.56 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 0.0 112.312 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.111 0 C-N-CA 123.032 0.348 . . . . 0.0 112.819 169.93 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.2 135.03 24.1 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.766 1.644 . . . . 0.0 109.375 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -24.98 39.83 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.28 150.24 35.32 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.431 1.092 . . . . 0.0 110.738 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.19 116.94 21.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.798 0.839 . . . . 0.0 111.249 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.03 110.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.573 1.149 . . . . 0.0 108.579 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.08 152.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.415 1.486 . . . . 0.0 110.871 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.96 103.25 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.4 -25.02 36.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.691 0.797 . . . . 0.0 112.113 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -154.35 161.76 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.513 0.725 . . . . 0.0 112.714 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.5 t -134.41 139.2 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.696 1.598 . . . . 0.0 110.157 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.8 m -136.54 131.01 33.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.739 1.216 . . . . 0.0 110.588 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.85 122.95 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -119.31 150.25 40.44 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.079 1.352 . . . . 0.0 112.277 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.294 1.438 . . . . 0.0 113.753 -170.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 131.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.989 -1.694 . . . . 0.0 111.514 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.0 m -102.32 123.93 46.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.022 0.929 . . . . 0.0 110.091 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -98.98 132.83 44.0 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.95 1.3 . . . . 0.0 110.677 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -104.83 98.89 8.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -104.6 152.51 22.36 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.962 -0.461 . . . . 0.0 110.835 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.413 HD21 HG12 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -59.44 -20.43 55.02 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -89.8 -15.92 31.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.845 1.258 . . . . 0.0 113.187 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.06 165.3 12.44 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.741 1.639 . . . . 0.0 113.191 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -72.98 137.69 45.61 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.519 1.528 . . . . 0.0 112.534 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.7 mt -134.47 140.71 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.256 1.822 . . . . 0.0 108.764 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.31 132.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 110.479 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.92 135.75 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 110.04 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -98.19 130.46 44.93 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.928 1.691 . . . . 0.0 107.224 171.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -92.13 146.57 23.62 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.22 1.008 . . . . 0.0 110.505 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -102.14 73.9 1.4 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.843 1.306 . . . . 0.0 111.006 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.97 -25.5 64.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.209 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.77 1.228 . . . . 0.0 111.508 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.08 -27.54 15.04 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.861 1.264 . . . . 0.0 112.801 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.25 58.13 3.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -61.11 -42.64 34.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.519 2.813 . . . . 0.0 113.146 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.16 -40.55 78.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.8 m -61.05 -53.57 55.58 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.541 0.736 . . . . 0.0 111.845 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.1 -41.73 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.839 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -54.14 -49.22 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.918 1.236 . . . . 0.0 111.969 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.52 -38.88 81.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.376 0.67 . . . . 0.0 111.935 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.67 -49.52 77.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 0.0 111.767 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.58 -34.31 67.36 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.56 0.744 . . . . 0.0 111.811 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -57.78 -33.45 68.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.69 0.796 . . . . 0.0 112.556 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -75.4 -44.21 45.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.437 -0.79 . . . . 0.0 112.333 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.2 -35.81 78.17 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.6 -0.688 . . . . 0.0 111.765 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.84 -34.54 78.15 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.353 2.261 . . . . 0.0 112.789 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -82.11 -14.12 56.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.882 0.873 . . . . 0.0 113.152 171.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.7 18.58 61.45 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.562 1.077 . . . . 0.0 113.814 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.55 -24.04 67.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.72 1.26 . . . . 0.0 114.19 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -89.21 -7.7 55.02 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.304 0.642 . . . . 0.0 112.687 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -64.36 135.67 56.38 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.938 -1.101 . . . . 0.0 108.793 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.25 22.98 12.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.5 p -88.73 162.48 16.23 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.116 -0.99 . . . . 0.0 111.392 169.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 pt -122.38 164.76 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -97.99 96.75 8.37 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -90.24 -8.27 51.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -134.37 138.49 44.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.37 1.441 . . . . 0.0 113.471 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.48 134.37 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.961 2.505 . . . . 0.0 109.272 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 90.1 mt -138.07 129.28 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.733 1.613 . . . . 0.0 108.029 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -61.63 132.77 54.34 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.25 0.62 . . . . 0.0 111.849 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.01 10.17 61.28 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.15 -177.16 5.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.892 1.677 . . . . 0.0 111.314 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -178.66 6.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.083 1.753 . . . . 0.0 115.558 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.7 pt -115.96 138.06 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.186 1.394 . . . . 0.0 112.563 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -108.68 149.35 29.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.516 1.126 . . . . 0.0 111.056 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.89 175.9 32.78 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.454 1.03 . . . . 0.0 114.965 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 6.78 83.6 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.627 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.71 -25.53 35.02 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 119.717 1.758 . . . . 0.0 115.71 -172.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -149.73 169.78 20.26 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.663 1.185 . . . . 0.0 113.054 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.46 164.47 16.58 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.892 1.677 . . . . 0.0 110.064 168.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.87 -12.88 33.98 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.877 3.051 . . . . 0.0 117.437 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.19 14.65 61.71 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.786 0.708 . . . . 0.0 114.449 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.0 mmt 59.71 29.77 19.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.396 1.878 . . . . 0.0 112.879 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.03 125.49 32.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.961 1.304 . . . . 0.0 109.367 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -71.57 121.94 19.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.412 1.085 . . . . 0.0 110.231 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -66.68 159.2 28.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.35 73.38 8.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.409 1.483 . . . . 0.0 111.57 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 p -68.03 121.27 15.74 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.507 1.123 . . . . 0.0 112.596 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -130.93 176.66 8.05 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.098 1.759 . . . . 0.0 111.954 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 49.25 67.27 4.65 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.674 1.59 . . . . 0.0 113.99 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.66 140.1 91.99 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.38 2.72 . . . . 0.0 111.765 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -111.76 152.59 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.038 1.735 . . . . 0.0 109.046 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.27 0.1 OUTLIER -76.23 158.93 31.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.237 0.615 . . . . 0.0 110.355 169.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.27 -56.58 20.0 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 70.95 3.68 4.74 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.46 -15.09 63.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 119.919 -1.738 . . . . 0.0 114.126 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -59.94 3.8 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.118 2.567 . . . . 0.0 116.151 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -84.22 5.72 25.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.421 1.489 . . . . 0.0 112.257 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.71 32.71 32.6 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.816 1.198 . . . . 0.0 113.299 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.11 140.56 39.05 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.417 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -131.69 147.74 52.53 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -99.13 85.87 3.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 111.642 -169.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.5 p -112.57 168.32 9.75 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.506 0.723 . . . . 0.0 112.109 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -55.89 130.16 42.5 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.667 1.187 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.24 35.41 33.95 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.179 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.9 p -125.92 161.91 26.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.78 1.29 . . . . 0.0 113.354 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 mp -120.49 136.09 54.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.792 0.837 . . . . 0.0 112.896 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -132.09 159.19 39.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.468 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -84.64 141.12 30.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.62 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.31 154.02 19.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.467 0.707 . . . . 0.0 111.112 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -133.39 162.92 30.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.827 1.251 . . . . 0.0 113.572 -171.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -76.95 -56.23 4.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.617 1.167 . . . . 0.0 113.109 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -159.09 -54.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.543 1.137 . . . . 0.0 111.76 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.28 161.82 71.45 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.509 1.124 . . . . 0.0 111.53 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.31 -20.14 69.78 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.147 2.565 . . . . 0.0 114.071 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.28 42.13 2.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.356 1.862 . . . . 0.0 111.983 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.5 p -125.79 30.79 5.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.186 1.394 . . . . 0.0 113.638 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.0 104.48 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.816 1.647 . . . . 0.0 109.527 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.2 p -89.73 -72.73 0.54 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.455 1.102 . . . . 0.0 113.204 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.27 36.43 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.32 149.8 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.03 1.332 . . . . 0.0 111.621 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.18 168.41 21.06 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.476 1.511 . . . . 0.0 111.673 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 14.7 p90 -146.37 162.1 38.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 30.4 mt -115.01 116.03 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.539 1.136 . . . . 0.0 108.181 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -71.31 99.09 1.87 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.72 0.808 . . . . 0.0 109.772 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.4 m -77.83 -16.36 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 113.212 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.55 166.28 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 128.292 2.637 . . . . 0.0 110.968 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.0 119.66 19.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.226 0.536 . . . . 0.0 111.331 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -126.85 55.37 1.56 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.015 1.726 . . . . 0.0 111.641 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.56 -12.14 50.37 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -69.51 -14.92 63.12 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.819 -1.176 . . . . 0.0 113.349 169.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.37 -14.91 56.69 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -66.79 172.48 4.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.071 2.148 . . . . 0.0 116.595 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.05 155.81 40.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.871 1.268 . . . . 0.0 112.402 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.7 t -140.92 -53.78 0.48 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -178.169 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.252 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.54 -71.37 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.991 1.282 . . . . 0.0 114.048 -174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -133.73 131.85 39.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.939 0.896 . . . . 0.0 111.899 -169.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.3 t -93.04 126.16 37.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.425 0.69 . . . . 0.0 112.523 -172.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.82 89.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.189 0.995 . . . . 0.0 109.225 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -75.23 -15.18 60.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.354 1.062 . . . . 0.0 112.015 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.66 176.36 10.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.315 1.055 . . . . 0.0 113.828 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -140.37 151.19 44.78 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 112.264 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.04 133.6 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.575 0.702 . . . . 0.0 110.349 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.67 -43.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.339 1.856 . . . . 0.0 110.812 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -143.07 154.77 44.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.546 1.538 . . . . 0.0 109.964 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.75 14.92 33.05 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.787 0.708 . . . . 0.0 114.478 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 81.9 mmm -54.89 -36.11 64.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.27 1.535 . . . . 0.0 112.275 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.36 -30.48 71.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.849 0.86 . . . . 0.0 112.612 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.49 -40.77 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.978 1.311 . . . . 0.0 110.377 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.65 -42.56 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.272 -0.892 . . . . 0.0 110.93 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.08 -25.08 63.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.314 1.445 . . . . 0.0 112.22 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -75.76 -52.19 11.0 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.049 0.94 . . . . 0.0 110.398 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 53.6 mt -53.01 -36.41 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.364 1.865 . . . . 0.0 112.686 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.02 -14.44 31.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.88 -18.23 11.83 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.828 1.68 . . . . 0.0 113.882 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.31 -59.41 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.412 1.106 . . . . 0.0 113.051 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.56 162.39 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.768 1.227 . . . . 0.0 112.677 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.0 p -136.07 151.4 49.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.496 1.518 . . . . 0.0 112.389 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.175 0 C-N-CA 123.146 0.403 . . . . 0.0 113.436 170.063 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -69.95 138.64 37.68 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.14 1.893 . . . . 0.0 109.852 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -31.18 38.0 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -79.17 149.42 31.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.83 0.852 . . . . 0.0 111.398 169.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.0 114.38 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.495 1.118 . . . . 0.0 111.229 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.24 105.67 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 108.402 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG12 HD21 ' A' ' 7' ' ' ASN . 1.4 pt -128.12 143.82 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.558 0.743 . . . . 0.0 111.565 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.16 103.34 11.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.17 -36.66 66.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.294 0.637 . . . . 0.0 110.476 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 t -153.92 166.0 34.35 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.21 141.38 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.642 1.977 . . . . 0.0 110.58 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 125.09 30.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.184 1.394 . . . . 0.0 109.909 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.67 125.47 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.205 0.602 . . . . 0.0 109.878 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.2 t -111.49 150.77 29.45 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.33 1.452 . . . . 0.0 112.138 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.676 1.19 . . . . 0.0 113.241 -172.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.15 130.75 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.045 0.938 . . . . 0.0 109.265 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -106.19 121.69 44.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.795 1.238 . . . . 0.0 110.148 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.68 135.61 33.94 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.495 1.118 . . . . 0.0 110.72 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -107.25 101.1 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -103.92 152.75 21.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.895 -0.503 . . . . 0.0 111.016 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -60.1 -7.49 1.87 Allowed 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -109.31 -8.04 15.15 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.074 1.35 . . . . 0.0 114.215 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.52 165.89 12.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.374 1.464 . . . . 0.0 113.742 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.78 138.82 39.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.364 1.866 . . . . 0.0 112.838 174.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -135.4 140.9 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.303 1.841 . . . . 0.0 109.066 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.04 136.87 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.553 1.141 . . . . 0.0 110.562 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.22 139.43 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.73 2.012 . . . . 0.0 110.465 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -101.81 126.91 48.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.862 2.065 . . . . 0.0 107.659 171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 p -88.62 147.58 24.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.171 0.989 . . . . 0.0 111.085 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.02 74.33 1.3 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.688 1.232 . . . . 0.0 111.156 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.74 -26.92 64.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.547 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -75.73 -30.87 59.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.291 1.036 . . . . 0.0 111.437 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 -28.7 14.53 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 113.011 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.8 56.99 3.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -60.1 -43.63 34.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 112.758 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -68.08 -40.17 82.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.756 0.707 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 m -65.14 -48.12 74.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.569 0.748 . . . . 0.0 111.6 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -68.38 -39.51 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.921 0.888 . . . . 0.0 112.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.16 -47.16 75.53 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.677 1.126 . . . . 0.0 111.816 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -69.3 -38.66 78.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.339 0.655 . . . . 0.0 111.88 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.09 -47.6 84.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 0.0 111.539 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.56 -38.57 74.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.25 0.62 . . . . 0.0 111.374 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -63.14 -29.66 70.97 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -73.62 -42.84 60.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.302 -0.874 . . . . 0.0 111.967 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.16 -37.61 85.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.541 -0.725 . . . . 0.0 111.463 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -58.42 -37.87 76.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.468 2.307 . . . . 0.0 113.438 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -81.73 -15.0 55.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.707 1.203 . . . . 0.0 113.531 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.8 61.03 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.872 1.225 . . . . 0.0 114.362 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -69.58 -17.72 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.542 1.537 . . . . 0.0 114.963 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.92 -13.03 21.42 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.55 1.23 8.53 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -147.19 53.59 1.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.206 1.402 . . . . 0.0 110.606 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.4 p -114.36 171.94 7.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.185 0.994 . . . . 0.0 113.121 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 pt -127.65 166.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -98.93 110.44 23.05 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -109.15 0.81 19.97 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -152.66 129.94 11.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.53 1.513 . . . . 0.0 111.591 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.66 141.21 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.664 1.986 . . . . 0.0 111.168 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.61 127.62 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.142 1.377 . . . . 0.0 108.66 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -64.63 132.88 50.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 0.0 111.659 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 10.74 66.01 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.01 0.814 . . . . 0.0 114.908 -173.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -144.56 -174.84 4.43 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.82 2.048 . . . . 0.0 110.412 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.58 -179.93 7.46 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.7 pt -123.34 142.73 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.169 1.387 . . . . 0.0 113.8 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -122.79 147.81 46.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.826 1.65 . . . . 0.0 112.363 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.68 -175.74 32.02 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.73 73.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.148 1.832 . . . . 0.0 115.641 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.86 -16.05 60.33 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.79 164.87 28.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.583 1.192 . . . . 0.0 112.705 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -94.92 161.94 26.76 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.926 1.691 . . . . 0.0 110.806 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -60.75 -8.84 10.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.007 3.138 . . . . 0.0 117.613 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.68 12.96 67.08 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.151 0.882 . . . . 0.0 115.039 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mmt 59.68 29.12 18.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.282 1.833 . . . . 0.0 112.822 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.01 131.22 34.15 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.303 1.441 . . . . 0.0 109.403 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -73.53 121.02 19.93 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.094 0.958 . . . . 0.0 110.339 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -72.34 164.77 25.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.86 71.85 7.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.513 1.525 . . . . 0.0 111.332 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 p -70.86 107.92 4.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 111.824 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -111.28 175.98 5.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.454 1.902 . . . . 0.0 111.808 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.08 65.8 5.46 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.464 1.505 . . . . 0.0 113.576 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -58.03 132.12 47.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.998 2.465 . . . . 0.0 110.364 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.85 147.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.607 1.163 . . . . 0.0 109.656 -173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 155.31 29.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.991 0.917 . . . . 0.0 112.145 172.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -75.14 129.56 37.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.987 0.915 . . . . 0.0 110.828 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -112.29 14.33 20.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.207 1.403 . . . . 0.0 113.124 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.99 -15.45 59.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.247 -1.533 . . . . 0.0 113.477 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -59.25 -0.97 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -80.39 -3.03 48.11 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.117 1.367 . . . . 0.0 112.095 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.8 27.19 27.31 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.099 1.333 . . . . 0.0 114.495 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.61 158.57 28.42 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.962 0.881 . . . . 0.0 112.999 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -130.58 159.24 37.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.684 1.194 . . . . 0.0 114.024 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -106.9 115.15 29.69 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.068 2.147 . . . . 0.0 109.927 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.3 p -140.95 168.41 19.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.81 1.244 . . . . 0.0 111.241 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -54.49 125.15 18.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.117 0.967 . . . . 0.0 110.91 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.84 31.97 25.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.26 1.41 . . . . 0.0 115.075 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.1 p -123.79 159.77 28.78 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.31 1.555 . . . . 0.0 113.342 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -123.68 138.47 54.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 0.0 113.191 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -135.9 157.78 46.0 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.823 -0.548 . . . . 0.0 112.184 169.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.0 mmm -79.6 136.17 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.865 0.466 . . . . 0.0 110.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.58 142.19 27.9 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.798 0.839 . . . . 0.0 110.749 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -85.83 154.03 21.84 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.413 1.085 . . . . 0.0 112.677 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -70.14 -51.99 27.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.801 0.841 . . . . 0.0 110.178 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -157.56 -57.96 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.424 1.489 . . . . 0.0 110.451 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.41 154.73 83.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.18 0.992 . . . . 0.0 111.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.69 -19.27 64.53 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.93 2.42 . . . . 0.0 114.45 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -112.69 38.21 2.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.845 1.658 . . . . 0.0 112.332 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -122.17 30.26 6.66 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.319 1.447 . . . . 0.0 113.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.08 61.55 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.446 1.499 . . . . 0.0 113.035 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -58.82 -65.33 0.68 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.904 1.681 . . . . 0.0 113.946 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.83 0.55 0.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.7 146.43 24.52 Favored 'General case' 0 N--CA 1.462 0.175 0 O-C-N 120.515 -1.366 . . . . 0.0 110.51 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -141.14 168.28 20.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.758 1.623 . . . . 0.0 110.479 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.413 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 7.1 p90 -145.33 159.27 43.31 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.103 0.561 . . . . 0.0 111.87 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.82 119.49 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.101 1.36 . . . . 0.0 108.267 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -78.28 119.74 22.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.55 0.74 . . . . 0.0 110.774 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -98.74 -8.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.9 164.51 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.689 1.596 . . . . 0.0 111.32 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -80.8 119.1 22.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.996 0.518 . . . . 0.0 109.993 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -137.58 70.67 1.4 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.955 1.359 . . . . 0.0 112.149 -169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.57 -35.79 54.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.251 2.22 . . . . 0.0 114.404 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -59.72 -14.24 13.41 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.27 -13.33 57.19 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -73.6 169.83 16.45 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.25 145.63 55.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.625 0.77 . . . . 0.0 112.981 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -115.05 -59.54 2.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.522 1.529 . . . . 0.0 113.09 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 C-N-CA 125.32 1.438 . . . . 0.0 112.077 -171.098 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.58 -58.94 0.64 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 116.559 1.383 . . . . 0.0 116.559 -169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -141.65 151.11 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.365 1.066 . . . . 0.0 112.215 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.2 t -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.835 -0.541 . . . . 0.0 112.456 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.3 83.38 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.766 1.226 . . . . 0.0 108.594 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -77.6 -14.03 59.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.021 0.928 . . . . 0.0 112.129 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.45 177.83 7.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.771 1.272 . . . . 0.0 114.343 -169.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -141.43 153.63 45.12 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.65 1.18 . . . . 0.0 112.417 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 143.7 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.688 0.756 . . . . 0.0 110.323 173.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.45 -41.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.736 1.614 . . . . 0.0 110.936 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -147.03 154.52 41.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.678 1.591 . . . . 0.0 110.108 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.25 14.21 24.79 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 123.866 0.746 . . . . 0.0 114.603 172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -34.62 63.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.055 1.427 . . . . 0.0 112.305 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.15 -30.02 71.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.687 0.795 . . . . 0.0 112.577 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.2 t -75.97 -43.22 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.052 1.341 . . . . 0.0 110.271 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.62 -38.42 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.362 -0.836 . . . . 0.0 110.973 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -26.42 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.339 1.456 . . . . 0.0 112.6 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -76.91 -42.27 40.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.724 1.21 . . . . 0.0 110.821 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.6 mt -57.61 -29.26 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.568 1.547 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -89.82 -14.04 35.3 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.15 -14.0 17.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.745 1.64 . . . . 0.0 114.627 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 -57.74 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 118.778 1.289 . . . . 0.0 112.445 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.61 144.95 0.89 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.7 1.6 . . . . 0.0 111.157 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -129.05 150.07 50.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.043 1.337 . . . . 0.0 112.946 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 C-N-CA 124.343 0.973 . . . . 0.0 112.256 170.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.47 129.29 18.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.245 1.296 . . . . 0.0 108.897 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -25.21 32.31 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.709 0.403 . . . . 0.0 111.857 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.9 146.7 37.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.004 0.922 . . . . 0.0 109.155 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.32 109.99 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.403 0.621 . . . . 0.0 111.326 -171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.88 109.1 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.218 1.007 . . . . 0.0 108.589 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.9 142.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -172.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -84.01 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -76.95 -27.07 54.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.801 1.24 . . . . 0.0 111.794 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.4 t -163.17 168.66 20.46 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.67 140.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.276 1.831 . . . . 0.0 110.488 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -131.53 133.12 44.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.355 1.462 . . . . 0.0 110.001 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.69 123.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.4 t -118.21 150.35 39.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.254 1.421 . . . . 0.0 112.533 -173.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.542 1.537 . . . . 0.0 113.649 -170.029 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.04 128.28 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.921 1.237 . . . . 0.0 110.387 174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -99.9 126.53 46.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.514 1.125 . . . . 0.0 110.262 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -102.52 127.62 49.51 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.091 1.356 . . . . 0.0 110.29 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -101.16 99.43 9.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -103.77 152.27 22.06 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.842 -0.536 . . . . 0.0 111.293 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -60.39 -9.52 3.68 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -106.99 -9.56 16.2 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.805 1.242 . . . . 0.0 114.189 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.02 163.23 11.55 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.046 1.359 . . . . 0.0 113.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.28 138.18 43.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.636 1.574 . . . . 0.0 112.736 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.18 139.85 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.521 1.928 . . . . 0.0 108.43 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.63 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 110.352 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -125.03 134.11 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.357 1.863 . . . . 0.0 110.04 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.14 127.75 47.55 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.678 . . . . 0.0 108.605 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 p -88.92 146.48 24.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -104.31 73.94 1.15 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.701 1.239 . . . . 0.0 111.434 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.19 -25.06 64.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.503 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 -24.04 46.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.593 1.157 . . . . 0.0 111.873 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -107.4 -16.74 14.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.501 1.521 . . . . 0.0 113.29 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 50.6 0.52 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.841 1.256 . . . . 0.0 114.352 -172.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.22 -40.82 56.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.568 2.845 . . . . 0.0 113.859 -170.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -71.68 -35.17 70.2 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.646 -0.659 . . . . 0.0 110.851 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.4 m -70.49 -47.95 58.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.56 -43.5 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.089 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -58.77 -45.54 89.56 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.672 1.123 . . . . 0.0 111.619 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.98 -43.78 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.342 1.057 . . . . 0.0 111.937 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.51 -47.7 84.51 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 111.693 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.98 -37.72 72.74 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.565 0.746 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.64 -29.49 70.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.92 0.888 . . . . 0.0 112.937 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -77.01 -43.14 35.82 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.512 -0.743 . . . . 0.0 112.536 170.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.0 m -62.09 -37.53 85.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.206 -0.934 . . . . 0.0 111.515 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -57.2 -37.37 72.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.127 2.571 . . . . 0.0 113.581 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.3 -15.25 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.766 1.226 . . . . 0.0 113.381 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.88 18.12 56.78 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.988 0.804 . . . . 0.0 113.935 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.2 -17.96 60.83 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -99.47 -8.37 24.76 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.147 -0.97 . . . . 0.0 112.068 169.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.35 130.24 41.43 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.01 44.37 22.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 114.226 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 p -109.9 167.7 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.214 1.006 . . . . 0.0 110.926 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.0 162.16 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.68 85.06 6.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.499 1.12 . . . . 0.0 108.033 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -74.88 -10.81 59.85 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -146.72 138.22 24.38 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.237 1.835 . . . . 0.0 114.182 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.76 146.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.155 2.582 . . . . 0.0 110.46 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.7 mt -137.94 131.86 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.183 1.793 . . . . 0.0 107.85 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.47 137.22 57.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.553 0.741 . . . . 0.0 112.049 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 12.73 62.21 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.864 0.745 . . . . 0.0 114.644 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -142.54 -177.13 5.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.169 1.788 . . . . 0.0 111.412 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -178.79 7.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.971 1.709 . . . . 0.0 114.576 -173.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.7 pt -119.49 142.62 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.417 1.087 . . . . 0.0 113.237 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -110.89 150.2 29.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.944 1.297 . . . . 0.0 111.512 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.78 176.13 35.7 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.35 0.57 67.05 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.085 1.802 . . . . 0.0 115.354 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -16.93 65.12 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.013 1.407 . . . . 0.0 115.494 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -145.38 166.4 25.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.824 1.25 . . . . 0.0 112.987 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.91 162.26 24.62 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.841 1.657 . . . . 0.0 110.493 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.96 -13.17 29.6 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.655 2.903 . . . . 0.0 117.709 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.12 16.62 60.56 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.053 0.835 . . . . 0.0 114.5 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.8 30.19 19.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 112.575 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.04 126.12 33.93 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.037 1.335 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.25 119.96 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.362 1.065 . . . . 0.0 110.675 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.86 162.78 28.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.17 70.35 3.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.769 1.628 . . . . 0.0 111.591 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -73.35 142.71 47.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.927 1.291 . . . . 0.0 113.049 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -141.76 175.46 9.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.982 2.113 . . . . 0.0 111.943 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 52.55 67.87 3.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.689 1.595 . . . . 0.0 114.09 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -60.59 134.49 54.82 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.204 2.603 . . . . 0.0 111.51 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.1 152.13 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.811 1.644 . . . . 0.0 107.999 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 160.49 19.89 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.098 0.559 . . . . 0.0 111.757 170.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.16 132.98 41.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.164 0.586 . . . . 0.0 110.998 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -118.42 15.42 13.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.425 1.49 . . . . 0.0 112.674 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -15.96 46.13 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 119.957 -1.714 . . . . 0.0 114.179 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.28 4.48 0.5 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.13 1.372 . . . . 0.0 113.568 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -75.7 -9.68 58.79 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.775 1.23 . . . . 0.0 112.898 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.62 1.67 82.89 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.754 1.645 . . . . 0.0 114.822 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.09 153.58 32.08 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.259 1.029 . . . . 0.0 112.13 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -130.98 150.85 51.94 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -87.97 77.66 8.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.625 1.97 . . . . 0.0 111.629 -169.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 p -110.34 168.07 9.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -46.19 121.82 3.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 111.372 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.6 36.78 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.23 1.395 . . . . 0.0 114.823 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -118.66 157.72 26.89 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.121 1.46 . . . . 0.0 113.586 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -117.96 135.08 54.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 112.831 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -134.47 159.7 40.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.485 0.659 . . . . 0.0 111.962 172.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ptp -70.12 145.12 51.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.536 0.734 . . . . 0.0 111.233 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 150.56 20.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.265 0.626 . . . . 0.0 110.066 169.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -127.68 160.5 31.45 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.519 1.127 . . . . 0.0 112.856 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -87.78 58.27 4.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.996 1.718 . . . . 0.0 110.213 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.341 18.1 pt20 54.49 -38.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 130.186 3.395 . . . . 0.0 117.648 -169.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.34 149.29 84.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.347 1.43 . . . . 0.0 111.3 173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.13 -35.18 66.03 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.471 2.114 . . . . 0.0 113.715 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -106.09 41.18 1.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 0.0 112.406 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -130.05 27.74 5.1 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.22 1.408 . . . . 0.0 113.839 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.58 104.69 16.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.47 1.508 . . . . 0.0 108.644 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -91.08 -52.31 4.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.282 1.033 . . . . 0.0 112.949 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -161.08 41.41 0.16 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.311 1.044 . . . . 0.0 113.064 -170.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -131.17 145.24 51.88 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.974 -1.078 . . . . 0.0 111.602 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.59 168.32 21.56 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.398 1.879 . . . . 0.0 111.594 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -146.5 163.78 34.62 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.029 0.932 . . . . 0.0 111.566 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.18 118.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.587 1.155 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.04 108.24 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.675 0.79 . . . . 0.0 110.915 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.74 -12.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 113.725 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.55 167.19 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.44 1.496 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.51 113.15 4.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.731 1.612 . . . . 0.0 112.115 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.7 62.34 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.309 1.443 . . . . 0.0 111.643 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.81 -35.69 66.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.343 1.457 . . . . 0.0 114.106 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -65.18 -12.98 56.94 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.51 -8.05 59.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.342 1.057 . . . . 0.0 113.443 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -77.71 -172.35 2.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.683 1.193 . . . . 0.0 113.84 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -81.87 146.43 29.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.36 1.464 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.9 p -107.58 -61.87 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.658 1.583 . . . . 0.0 113.349 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 C-N-CA 125.515 1.531 . . . . 0.0 112.335 -169.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.404 ' HB3' ' H ' ' A' ' 111' ' ' SER 0.31 5.6 p-90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 122.246 1.022 . . . . 0.0 113.542 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.77 -99.18 1.31 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.221 1.391 . . . . 0.0 115.388 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.5 132.92 45.88 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.306 1.042 . . . . 0.0 112.328 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.52 126.46 30.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.17 94.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.402 1.081 . . . . 0.0 108.242 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -82.05 -14.7 55.5 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.866 0.866 . . . . 0.0 111.795 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.08 175.58 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.56 1.171 . . . . 0.0 113.13 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.81 153.39 50.82 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.795 -1.191 . . . . 0.0 112.203 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.35 138.68 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.586 0.708 . . . . 0.0 109.254 169.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 t -107.82 -41.98 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.712 1.605 . . . . 0.0 110.557 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -145.58 151.07 37.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.344 1.458 . . . . 0.0 110.031 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.93 11.78 19.86 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.953 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.9 mmm -53.39 -37.42 62.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.928 1.864 . . . . 0.0 112.544 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.92 -31.76 72.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.039 0.936 . . . . 0.0 112.377 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.93 -43.75 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.174 1.39 . . . . 0.0 110.282 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.95 -38.01 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.217 -0.927 . . . . 0.0 111.031 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -71.93 -26.31 62.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.246 1.418 . . . . 0.0 112.558 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -77.89 -41.52 36.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.865 1.266 . . . . 0.0 110.886 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.89 -30.23 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.061 1.744 . . . . 0.0 112.726 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -89.43 -12.39 40.38 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -111.42 -12.88 14.08 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.542 1.544 . . . . 0.0 114.471 -171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 m -61.29 -58.07 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.733 1.266 . . . . 0.0 112.678 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.23 145.0 1.26 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.964 1.305 . . . . 0.0 112.073 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -122.5 149.37 44.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.629 1.572 . . . . 0.0 112.564 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.825 0 C-N-CA 124.33 0.967 . . . . 0.0 112.053 175.277 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.93 132.87 31.57 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.372 1.381 . . . . 0.0 109.397 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 -26.14 28.82 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.14 142.56 45.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.581 0.753 . . . . 0.0 109.644 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -81.42 112.05 18.34 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.328 0.651 . . . . 0.0 110.803 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.13 103.99 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.45 143.65 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.772 1.229 . . . . 0.0 111.57 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.4 mt -86.78 102.7 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.04 -28.31 43.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.389 1.076 . . . . 0.0 112.109 -174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -153.66 161.78 41.84 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.21 140.09 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.967 1.707 . . . . 0.0 109.875 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -136.37 126.52 26.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.747 1.219 . . . . 0.0 110.343 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.5 121.77 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 t -111.75 150.45 30.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.386 1.474 . . . . 0.0 112.316 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.706 1.602 . . . . 0.0 113.502 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.84 130.36 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.0 m -103.97 124.78 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.47 1.508 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -101.08 120.04 39.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.674 1.19 . . . . 0.0 109.756 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -93.9 114.38 26.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -125.31 159.39 31.84 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -68.94 -7.99 40.22 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -106.77 -28.26 10.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.645 1.578 . . . . 0.0 113.276 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.88 146.91 4.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.323 1.916 . . . . 0.0 113.094 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.69 133.15 31.26 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.533 1.133 . . . . 0.0 112.863 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.3 mt -128.39 142.96 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.845 1.658 . . . . 0.0 109.28 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -129.27 138.6 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.165 0.986 . . . . 0.0 110.269 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 mt -128.89 138.32 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.551 1.94 . . . . 0.0 109.801 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -107.38 122.28 46.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.725 2.01 . . . . 0.0 109.419 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 p -86.74 149.3 24.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.128 0.971 . . . . 0.0 112.414 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.03 72.49 0.89 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 123.025 1.393 . . . . 0.0 111.924 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.85 -26.07 64.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.544 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.06 -29.1 54.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.241 1.016 . . . . 0.0 111.481 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -99.42 -23.18 15.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.88 1.272 . . . . 0.0 113.23 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.22 55.42 1.39 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.33 1.052 . . . . 0.0 113.41 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.77 -44.34 31.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.368 2.712 . . . . 0.0 112.99 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -69.37 -39.94 77.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.725 0.693 . . . . 0.0 111.291 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.2 m -64.86 -47.67 77.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.451 0.7 . . . . 0.0 111.245 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.7 -38.03 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.121 0.968 . . . . 0.0 112.275 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -54.21 -45.08 72.16 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.849 1.204 . . . . 0.0 112.035 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.41 HD21 HD11 ' A' ' 68' ' ' ILE . 62.5 t30 -68.26 -41.53 80.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.282 0.633 . . . . 0.0 111.467 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.6 -47.05 85.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.109 0.963 . . . . 0.0 111.611 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.55 -36.37 68.23 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.381 -0.825 . . . . 0.0 112.209 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.59 -39.15 76.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.819 0.448 . . . . 0.0 111.74 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -68.29 -43.38 77.83 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.55 -0.719 . . . . 0.0 111.932 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.8 m -60.33 -40.3 90.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.065 0.546 . . . . 0.0 111.32 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -68.78 -33.79 74.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.968 1.707 . . . . 0.0 112.821 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.35 -18.44 42.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.162 0.985 . . . . 0.0 112.994 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.87 25.91 43.63 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.919 -0.488 . . . . 0.0 112.561 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -69.78 -42.49 73.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.273 1.037 . . . . 0.0 113.156 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -81.22 -13.4 58.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.769 0.828 . . . . 0.0 111.732 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -63.14 124.96 22.5 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.684 0.794 . . . . 0.0 108.87 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.252 61.1 t30 59.1 45.52 14.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.592 1.557 . . . . 0.0 114.886 -169.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -111.66 164.3 13.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.466 1.106 . . . . 0.0 111.067 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.36 163.05 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 85.05 7.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.197 1.399 . . . . 0.0 107.978 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -75.59 -7.25 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -135.45 140.9 45.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.854 1.661 . . . . 0.0 112.252 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.53 136.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.961 2.104 . . . . 0.0 110.526 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.4 mt -140.33 130.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 108.363 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -66.93 137.21 56.37 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.099 0.96 . . . . 0.0 112.067 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 11.95 66.43 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.816 0.722 . . . . 0.0 114.492 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -146.3 -176.99 5.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.91 2.084 . . . . 0.0 110.216 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -90.51 -180.0 5.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.107 1.763 . . . . 0.0 114.45 -171.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.14 140.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.882 1.273 . . . . 0.0 111.971 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -112.49 149.03 33.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.021 1.329 . . . . 0.0 110.789 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.35 175.72 32.43 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 3.51 90.0 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.311 1.434 . . . . 0.0 115.392 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.12 -26.32 37.36 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.002 1.401 . . . . 0.0 115.031 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -143.78 160.53 40.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.2 164.31 39.05 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.319 1.447 . . . . 0.0 110.59 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.92 -14.47 37.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.381 2.721 . . . . 0.0 117.943 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.87 21.08 47.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.344 0.973 . . . . 0.0 114.451 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.78 33.68 17.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.941 1.696 . . . . 0.0 113.011 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.06 130.48 36.96 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.057 1.343 . . . . 0.0 109.772 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.62 128.92 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 123.943 1.83 . . . . 0.0 111.357 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -76.79 178.48 6.78 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 110.615 -2.993 . . . . 0.0 114.379 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.18 54.43 3.1 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.821 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.2 p -71.11 117.36 12.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.509 1.124 . . . . 0.0 111.402 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.34 -178.07 4.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.062 1.745 . . . . 0.0 111.818 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 45.95 64.19 8.43 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.649 1.58 . . . . 0.0 114.344 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -54.51 129.3 34.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.097 2.531 . . . . 0.0 110.703 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -109.68 148.65 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.152 1.381 . . . . 0.0 109.044 -174.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 151.71 38.55 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.31 0.576 . . . . 0.0 110.787 169.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -80.11 125.17 29.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.575 0.75 . . . . 0.0 110.851 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.82 12.67 34.22 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.804 1.241 . . . . 0.0 113.152 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -16.49 49.22 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.64 -1.287 . . . . 0.0 114.409 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.89 1.11 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.437 1.495 . . . . 0.0 114.02 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -71.98 -11.6 60.85 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.878 1.271 . . . . 0.0 113.076 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 10.67 77.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.1 1.333 . . . . 0.0 114.383 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.55 154.96 34.04 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.582 1.191 . . . . 0.0 112.48 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -130.01 151.85 50.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.77 103.21 15.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.14 2.176 . . . . 0.0 109.668 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 p -134.65 170.59 15.57 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.096 1.358 . . . . 0.0 110.822 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -49.65 119.79 3.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.773 1.229 . . . . 0.0 111.116 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.08 33.31 26.77 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.832 1.206 . . . . 0.0 114.923 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -119.6 159.57 24.13 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.727 1.263 . . . . 0.0 113.09 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.75 136.37 54.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -135.07 156.31 49.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.03 0.532 . . . . 0.0 111.467 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -85.13 134.5 34.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.71 153.44 22.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.374 1.07 . . . . 0.0 111.122 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -105.26 158.24 16.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.071 1.349 . . . . 0.0 111.969 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.9 m -78.01 -51.6 10.09 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.987 0.915 . . . . 0.0 110.776 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -161.85 -53.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.899 1.28 . . . . 0.0 111.334 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.8 162.99 68.36 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.058 1.343 . . . . 0.0 112.315 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.5 -17.07 58.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.217 2.611 . . . . 0.0 114.263 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -122.17 50.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.569 1.547 . . . . 0.0 111.681 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.9 p -132.78 33.5 3.72 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.65 57.76 0.76 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.114 1.366 . . . . 0.0 113.475 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p -60.17 -47.67 84.97 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -169.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.12 -30.72 0.13 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -174.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -70.81 142.82 51.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.317 1.047 . . . . 0.0 111.434 -170.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -137.21 168.39 19.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.196 1.798 . . . . 0.0 110.524 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 24.3 p90 -148.27 160.53 42.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 112.071 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.02 115.9 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 108.903 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.7 95.97 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.175 0.99 . . . . 0.0 110.697 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.91 -24.73 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.167 -0.958 . . . . 0.0 113.388 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.9 168.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.501 . . . . 0.0 111.492 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.79 118.04 21.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.201 1.0 . . . . 0.0 110.531 169.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -141.88 68.49 1.32 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.938 1.352 . . . . 0.0 113.004 -169.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.52 -35.31 39.95 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.309 2.244 . . . . 0.0 114.538 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -58.8 -13.79 7.08 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.08 -10.45 59.2 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.58 -177.35 3.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.511 1.524 . . . . 0.0 114.814 -171.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -79.35 155.59 28.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.098 1.359 . . . . 0.0 111.64 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.5 t -136.11 -55.05 0.76 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -178.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.28 4.0 p-90 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.74 -89.52 1.9 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.719 1.628 . . . . 0.0 114.802 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -140.56 146.73 38.44 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.169 1.387 . . . . 0.0 112.139 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.08 129.51 34.82 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.34 94.48 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.762 1.225 . . . . 0.0 108.585 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -79.28 -16.0 57.09 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.648 0.779 . . . . 0.0 111.976 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.96 177.8 8.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.663 1.221 . . . . 0.0 113.111 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.06 153.78 51.93 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.89 -1.131 . . . . 0.0 112.027 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.61 143.98 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.744 0.783 . . . . 0.0 109.315 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.83 -38.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 110.854 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -146.37 149.12 33.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.274 1.43 . . . . 0.0 110.906 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.48 6.09 18.03 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.65 1.119 . . . . 0.0 115.793 170.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.4 mmm -56.3 -37.14 69.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.169 1.484 . . . . 0.0 113.103 -176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.81 -30.93 71.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.724 0.809 . . . . 0.0 112.207 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.06 -41.73 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.037 1.735 . . . . 0.0 110.696 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.27 -38.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 111.05 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 6.8 t70 -75.77 -19.18 59.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.02 1.328 . . . . 0.0 113.19 175.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -79.75 -41.94 25.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.108 1.363 . . . . 0.0 111.081 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.5 mt -55.51 -35.56 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.06 1.344 . . . . 0.0 112.158 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.49 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.9 pttp -83.78 -12.36 55.81 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.87 -24.49 9.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.151 1.358 . . . . 0.0 114.197 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 m -74.16 -59.5 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.718 1.259 . . . . 0.0 114.379 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.05 154.48 9.07 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.8 p -141.94 153.63 44.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.943 1.697 . . . . 0.0 112.143 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 123.343 0.497 . . . . 0.0 113.176 171.845 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 119.581 -0.247 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.98 136.39 41.03 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.515 1.476 . . . . 0.0 110.259 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -30.11 40.76 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.88 152.28 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.078 0.951 . . . . 0.0 110.849 169.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.64 109.65 17.61 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.837 0.827 . . . . 0.0 110.799 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.1 t -105.03 93.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.54 144.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.14 103.97 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.224 1.81 . . . . 0.0 107.09 169.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.32 -29.17 42.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.254 1.021 . . . . 0.0 112.504 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -156.28 165.7 35.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.17 139.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.901 1.681 . . . . 0.0 110.741 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 m -136.58 132.71 35.51 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.004 1.322 . . . . 0.0 110.712 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.75 123.33 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -117.41 150.39 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.611 1.564 . . . . 0.0 112.41 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 125.365 1.466 . . . . 0.0 113.611 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.78 128.59 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.979 0.912 . . . . 0.0 108.742 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -104.26 124.45 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.022 1.329 . . . . 0.0 109.958 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.0 123.54 40.74 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.173 0.989 . . . . 0.0 109.74 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -99.32 105.98 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.563 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.22 159.66 20.69 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.966 -0.459 . . . . 0.0 111.555 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -70.78 -6.05 34.78 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -110.37 -24.66 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.528 1.531 . . . . 0.0 113.759 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.77 145.17 4.14 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.258 1.885 . . . . 0.0 113.665 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.27 135.45 38.5 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.676 1.19 . . . . 0.0 112.836 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -132.66 142.62 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.313 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.18 136.91 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.321 1.048 . . . . 0.0 110.672 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 139.33 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.778 2.031 . . . . 0.0 110.255 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -105.94 123.51 48.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.694 1.998 . . . . 0.0 108.807 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -87.63 148.6 24.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.266 1.026 . . . . 0.0 112.183 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.15 74.17 1.03 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.684 1.23 . . . . 0.0 111.684 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.75 -27.07 64.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.499 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.122 0.969 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.73 -22.65 15.77 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 113.106 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.98 2.75 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.754 1.222 . . . . 0.0 112.816 -171.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.55 -44.88 19.96 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.249 2.633 . . . . 0.0 112.708 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -70.55 -41.26 72.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.777 -0.577 . . . . 0.0 110.996 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -63.06 -47.34 83.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.907 0.483 . . . . 0.0 111.71 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.87 -38.79 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.635 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -57.46 -44.47 84.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.002 1.274 . . . . 0.0 111.484 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -68.17 -39.22 82.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.455 0.702 . . . . 0.0 111.624 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.02 -50.61 73.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.705 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.31 -37.0 77.56 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.448 0.699 . . . . 0.0 111.422 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -56.93 -37.47 71.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.824 0.85 . . . . 0.0 111.965 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -74.15 -43.53 57.05 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.416 -0.803 . . . . 0.0 112.226 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.42 -37.96 76.44 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.84 -0.537 . . . . 0.0 111.808 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -32.76 72.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.257 1.823 . . . . 0.0 112.858 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.63 -15.62 54.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.973 0.909 . . . . 0.0 113.124 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.31 19.85 65.79 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.276 0.941 . . . . 0.0 113.149 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.09 -37.03 73.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.391 1.096 . . . . 0.0 113.068 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.889 0.476 . . . . 0.0 112.139 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -63.74 132.57 51.39 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.221 -0.924 . . . . 0.0 109.112 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.253 13.9 t30 59.42 25.14 13.83 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.722 2.009 . . . . 0.0 116.118 -171.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.2 p -83.27 142.32 31.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.933 -1.105 . . . . 0.0 113.212 170.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.9 pt -95.45 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -83.6 79.16 9.53 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 168.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -73.57 4.71 4.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -148.06 135.6 20.7 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.269 1.395 . . . . 0.0 112.439 171.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.45 131.04 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 110.676 170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -137.34 128.37 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.572 1.549 . . . . 0.0 108.399 -172.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -64.25 136.68 57.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.589 0.755 . . . . 0.0 111.97 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.29 9.66 61.25 Favored Glycine 0 CA--C 1.541 1.668 0 N-CA-C 115.091 0.797 . . . . 0.0 115.091 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.25 -177.16 5.32 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.558 1.943 . . . . 0.0 110.496 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -179.34 6.77 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.674 1.589 . . . . 0.0 115.139 -170.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.0 pt -116.76 134.88 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.78 1.232 . . . . 0.0 112.303 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -108.72 153.52 23.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.659 1.183 . . . . 0.0 111.684 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.38 -179.96 34.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.228 0.918 . . . . 0.0 114.957 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.79 84.39 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.699 1.04 . . . . 0.0 115.699 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -21.4 35.96 Favored Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.115 1.458 . . . . 0.0 115.917 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.3 162.82 35.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.269 1.034 . . . . 0.0 113.45 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -90.27 158.98 42.9 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.851 1.66 . . . . 0.0 109.804 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.98 -8.99 13.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.668 3.578 . . . . 0.0 116.113 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.74 14.63 64.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.08 0.848 . . . . 0.0 114.534 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.37 26.94 16.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.913 1.685 . . . . 0.0 113.163 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.15 131.6 36.6 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.093 1.357 . . . . 0.0 109.842 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -75.9 129.35 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.086 1.898 . . . . 0.0 111.204 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -72.2 179.54 3.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 110.447 -3.07 . . . . 0.0 114.127 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.24 51.21 2.08 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.258 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.2 p -72.28 117.17 13.59 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.594 1.158 . . . . 0.0 111.944 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -138.0 178.87 6.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.176 2.191 . . . . 0.0 111.857 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 51.13 71.4 1.54 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.324 1.45 . . . . 0.0 113.728 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.08 147.95 94.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.3 2.667 . . . . 0.0 111.889 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 147.96 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.135 1.374 . . . . 0.0 110.64 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -64.76 153.27 40.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.919 0.888 . . . . 0.0 111.107 169.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.96 -54.89 40.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.256 8.6 mt-10 71.62 1.66 3.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.422 2.289 . . . . 0.0 117.029 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -14.21 59.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.478 1.944 . . . . 0.0 113.972 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -62.72 2.28 0.31 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.728 1.611 . . . . 0.0 114.126 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -74.18 -12.49 60.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.244 1.418 . . . . 0.0 113.543 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.76 77.56 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.075 1.321 . . . . 0.0 114.6 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.5 157.35 30.47 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.517 1.159 . . . . 0.0 112.16 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.6 148.11 52.36 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.67 113.38 18.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.972 2.509 . . . . 0.0 109.653 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -139.44 167.43 22.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.932 1.293 . . . . 0.0 110.569 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -56.45 122.83 12.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.851 0.834 . . . . 0.0 110.9 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.45 51.74 5.48 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.926 1.25 . . . . 0.0 113.74 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 p -138.89 162.96 33.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.176 0.991 . . . . 0.0 112.156 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.5 138.12 53.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.833 0.825 . . . . 0.0 113.176 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -137.32 160.83 37.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.143 0.577 . . . . 0.0 111.459 171.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.7 mmt -82.4 142.71 31.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.898 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.03 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.519 1.127 . . . . 0.0 110.054 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -106.06 155.79 19.05 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.225 1.01 . . . . 0.0 113.117 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -75.01 -51.61 13.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.685 0.794 . . . . 0.0 111.099 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -156.97 -40.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.139 1.375 . . . . 0.0 113.119 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.97 32.86 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.173 1.389 . . . . 0.0 111.879 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.59 -20.52 65.06 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.303 2.669 . . . . 0.0 114.295 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -108.23 39.38 1.98 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.165 1.786 . . . . 0.0 112.244 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.9 p -128.43 31.04 5.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.059 1.344 . . . . 0.0 113.475 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.33 56.76 3.36 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.826 1.651 . . . . 0.0 113.595 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.1 p -49.69 -70.76 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.767 2.027 . . . . 0.0 115.197 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.18 -21.87 0.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.717 1.207 . . . . 0.0 113.89 -169.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.66 139.87 49.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.411 -0.806 . . . . 0.0 110.568 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.3 168.49 19.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.75 2.02 . . . . 0.0 110.837 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 20.9 p90 -144.36 160.86 40.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.593 0.757 . . . . 0.0 111.887 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.3 mt -111.46 117.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -72.76 103.02 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.071 0.549 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.04 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.08 168.18 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 127.277 2.231 . . . . 0.0 112.212 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.75 122.98 25.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.877 1.271 . . . . 0.0 111.457 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -145.32 73.13 1.34 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.68 1.229 . . . . 0.0 112.403 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.47 -34.24 68.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.675 1.59 . . . . 0.0 114.365 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -56.92 -13.69 2.88 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.82 -12.74 58.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.14 169.51 17.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.99 155.35 40.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.738 1.615 . . . . 0.0 113.133 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.7 p -134.45 -56.77 0.85 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.614 1.166 . . . . 0.0 113.197 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 C-N-CA 123.947 0.784 . . . . 0.0 113.983 -177.681 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.27 1.7 p-90 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.97 -82.89 0.82 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.051 1.31 . . . . 0.0 115.165 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -128.93 123.55 32.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 112.548 -169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -83.06 131.77 35.15 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -75.64 99.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.011 0.924 . . . . 0.0 108.845 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -80.96 -16.78 52.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.712 0.805 . . . . 0.0 111.591 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 175.88 9.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.194 0.997 . . . . 0.0 113.624 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.51 149.65 48.27 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.481 -1.387 . . . . 0.0 112.144 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.26 135.1 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-O 121.481 0.658 . . . . 0.0 110.405 172.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.56 -41.09 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.499 1.92 . . . . 0.0 110.581 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -142.51 149.27 38.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.186 1.395 . . . . 0.0 110.313 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.32 8.54 28.89 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.342 0.972 . . . . 0.0 115.275 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 79.9 mmm -55.98 -37.68 69.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.176 1.488 . . . . 0.0 112.759 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.71 -29.96 71.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.84 . . . . 0.0 112.49 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.23 -45.26 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.021 1.728 . . . . 0.0 110.492 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.9 t -57.8 -40.11 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.392 1.077 . . . . 0.0 111.38 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 -19.47 61.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.47 1.508 . . . . 0.0 112.905 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -86.85 -39.84 15.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.1 mt -50.92 -41.72 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.499 1.52 . . . . 0.0 111.495 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -73.01 -17.71 61.42 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.34 -10.46 36.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.373 1.939 . . . . 0.0 114.796 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.62 -63.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.305 1.553 . . . . 0.0 110.471 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 156.07 2.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.907 1.283 . . . . 0.0 112.008 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.6 p -139.94 149.46 43.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.701 1.2 . . . . 0.0 112.181 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 C-N-CA 123.323 0.487 . . . . 0.0 112.464 170.941 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -68.26 134.88 32.61 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.73 1.62 . . . . 0.0 109.03 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -29.53 61.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -86.86 159.55 19.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.593 1.157 . . . . 0.0 110.303 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -82.79 109.89 17.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.41 1.084 . . . . 0.0 111.794 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.61 94.0 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.563 1.545 . . . . 0.0 106.913 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.79 149.01 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.239 1.495 . . . . 0.0 113.342 -169.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.72 103.9 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.03 -40.14 65.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.744 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -149.52 164.26 35.56 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.57 142.05 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.888 1.675 . . . . 0.0 110.929 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 m -136.24 134.0 37.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.629 1.171 . . . . 0.0 110.983 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.58 120.52 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.0 t -117.98 150.23 39.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.537 1.535 . . . . 0.0 112.723 -171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.388 1.475 . . . . 0.0 113.907 -170.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 120.27 0.081 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.98 129.99 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.936 0.894 . . . . 0.0 109.905 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.1 m -104.12 124.44 49.08 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.371 1.468 . . . . 0.0 109.766 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -99.47 123.54 43.84 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.464 1.106 . . . . 0.0 110.346 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -97.61 108.09 20.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.623 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -119.14 159.08 24.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 112.223 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -68.59 -6.77 27.52 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -110.67 -25.13 10.11 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.466 1.506 . . . . 0.0 113.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.38 145.85 4.3 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.123 1.82 . . . . 0.0 113.583 173.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.32 133.81 39.88 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.474 1.109 . . . . 0.0 112.535 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.4 mt -131.1 144.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.943 1.697 . . . . 0.0 109.499 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.26 137.76 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.387 1.075 . . . . 0.0 110.463 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -124.07 138.75 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.987 2.115 . . . . 0.0 110.087 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -106.83 125.37 50.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.109 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.5 p -87.75 149.49 24.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 112.075 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -108.59 74.5 0.92 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.766 1.27 . . . . 0.0 111.726 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.76 -25.9 64.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.548 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -77.57 -26.78 51.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.619 1.168 . . . . 0.0 111.675 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -101.84 -22.39 14.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.231 1.412 . . . . 0.0 112.972 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.73 56.41 1.59 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.891 1.276 . . . . 0.0 113.103 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.09 -44.36 29.94 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.496 2.797 . . . . 0.0 112.914 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.2 -41.45 77.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.793 0.724 . . . . 0.0 111.084 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -64.77 -48.59 73.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.725 0.41 . . . . 0.0 111.549 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.7 -41.46 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.573 . . . . 0.0 111.349 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.17 -45.59 87.22 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.571 1.078 . . . . 0.0 111.623 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.1 -34.31 70.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.682 0.674 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.84 -49.68 75.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.257 1.023 . . . . 0.0 111.733 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.358 -0.839 . . . . 0.0 111.658 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -56.52 -33.05 65.67 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.183 0.993 . . . . 0.0 112.628 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -77.61 -46.43 22.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 171.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.3 m -57.72 -40.1 78.8 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.967 0.907 . . . . 0.0 112.201 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -52.86 -46.68 67.99 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.659 1.984 . . . . 0.0 112.872 173.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -83.2 -14.55 53.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.055 0.942 . . . . 0.0 112.133 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.47 52.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.289 0.947 . . . . 0.0 113.046 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.29 -37.15 69.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.402 1.101 . . . . 0.0 113.241 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -83.33 -6.44 59.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.396 0.679 . . . . 0.0 112.132 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -64.41 132.35 49.82 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.1 t30 53.82 49.91 18.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.319 1.448 . . . . 0.0 113.998 -171.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.8 p -114.44 157.14 23.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.304 1.042 . . . . 0.0 112.393 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.41 155.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -86.4 75.97 9.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.863 1.265 . . . . 0.0 107.855 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -53.16 -38.23 62.58 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.0 1.72 . . . . 0.0 114.76 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -123.64 135.53 53.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.56 1.144 . . . . 0.0 111.495 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.2 132.69 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.408 2.283 . . . . 0.0 110.578 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.44 128.9 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.622 1.569 . . . . 0.0 107.989 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 133.49 55.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 111.631 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.97 9.32 66.14 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 123.898 0.761 . . . . 0.0 114.871 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -141.52 -177.28 5.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.153 1.781 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.21 -179.55 5.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.7 136.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.054 1.342 . . . . 0.0 112.399 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.92 146.63 46.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.194 1.398 . . . . 0.0 111.094 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.92 31.03 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.18 -8.73 72.56 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.647 1.594 . . . . 0.0 115.944 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.76 -20.65 70.53 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 118.961 1.381 . . . . 0.0 115.479 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.2 164.9 28.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.482 1.113 . . . . 0.0 113.652 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -101.29 163.65 17.52 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.028 1.731 . . . . 0.0 110.629 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.01 -12.12 28.12 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.384 2.723 . . . . 0.0 118.0 -169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.08 14.59 60.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 123.452 0.549 . . . . 0.0 114.426 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.6 mmt 59.49 28.74 18.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.582 1.953 . . . . 0.0 112.757 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.81 123.01 28.95 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.1 1.36 . . . . 0.0 109.555 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.82 126.62 30.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 124.365 2.031 . . . . 0.0 110.887 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.0 179.74 2.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 110.077 -3.238 . . . . 0.0 114.408 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.06 64.11 3.27 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.372 -2.195 . . . . 0.0 112.147 -174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 p -70.22 107.29 3.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.146 1.379 . . . . 0.0 110.838 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -140.9 168.03 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.133 2.173 . . . . 0.0 112.401 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 50.13 66.94 4.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 0.0 112.487 171.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.62 145.97 97.21 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.469 2.779 . . . . 0.0 113.664 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.85 146.05 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.515 1.926 . . . . 0.0 109.053 -176.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 158.74 16.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.553 1.141 . . . . 0.0 111.143 170.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -73.44 134.55 43.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 111.614 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.04 13.63 12.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.086 1.354 . . . . 0.0 112.675 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -11.85 56.43 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.565 -1.334 . . . . 0.0 114.128 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -62.24 5.27 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.309 1.444 . . . . 0.0 114.553 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -76.53 -11.35 59.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.773 1.629 . . . . 0.0 112.826 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 6.47 85.39 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.256 1.407 . . . . 0.0 115.071 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.53 154.85 38.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.361 1.081 . . . . 0.0 112.25 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.55 149.21 51.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -86.03 64.24 8.47 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.44 1.896 . . . . 0.0 112.528 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.8 p -98.57 166.24 11.44 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.735 0.814 . . . . 0.0 112.235 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.05 123.25 11.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.878 1.671 . . . . 0.0 111.019 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.25 56.37 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.315 1.436 . . . . 0.0 114.945 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.2 p -110.51 161.36 15.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.591 1.695 . . . . 0.0 113.266 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -118.98 135.34 54.66 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.031 0.932 . . . . 0.0 112.734 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -135.43 159.39 41.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.652 174.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -81.7 143.04 32.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 111.204 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 153.99 18.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.953 0.901 . . . . 0.0 110.617 169.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -133.9 152.94 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.134 1.374 . . . . 0.0 111.923 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -65.32 -55.08 20.23 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.837 1.255 . . . . 0.0 112.708 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.71 -55.48 0.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.758 1.223 . . . . 0.0 111.366 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.47 159.04 86.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.574 1.15 . . . . 0.0 111.5 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.37 -26.28 81.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.005 2.47 . . . . 0.0 113.703 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -114.28 42.15 2.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.317 1.447 . . . . 0.0 111.947 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -122.61 30.64 6.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.309 1.444 . . . . 0.0 114.124 -173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.06 22.67 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.268 1.427 . . . . 0.0 107.465 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -132.51 -59.48 0.91 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.23 1.412 . . . . 0.0 112.739 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.57 -11.85 1.58 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 0.0 112.677 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -78.96 134.37 36.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.551 1.14 . . . . 0.0 110.383 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -141.32 168.1 20.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.082 1.753 . . . . 0.0 111.635 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 9.6 p90 -149.96 163.12 38.94 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.856 0.862 . . . . 0.0 111.751 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.0 mt -117.26 119.19 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.922 1.289 . . . . 0.0 108.538 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -72.59 97.57 2.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.564 0.745 . . . . 0.0 110.037 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 m -76.14 -15.54 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.8 167.01 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 128.724 2.809 . . . . 0.0 110.296 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.22 116.54 13.88 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.204 0.526 . . . . 0.0 111.525 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.9 57.25 1.28 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 111.921 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -64.82 -15.59 61.97 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -66.08 -15.12 62.8 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.779 -1.201 . . . . 0.0 113.383 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.37 -8.73 59.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.37 1.068 . . . . 0.0 113.452 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.28 179.83 3.73 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -79.08 141.09 37.66 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.561 1.544 . . . . 0.0 112.483 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.6 p -104.17 -60.31 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.638 1.175 . . . . 0.0 113.591 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 123.818 0.723 . . . . 0.0 114.732 -172.176 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.299 8.0 p-90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 122.044 0.926 . . . . 0.0 113.36 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.84 -96.45 0.69 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.339 1.447 . . . . 0.0 115.618 -169.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.51 137.64 48.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 111.805 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.8 129.31 34.87 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.27 94.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.794 1.238 . . . . 0.0 108.455 169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -80.64 -15.38 56.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.401 0.681 . . . . 0.0 111.821 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.03 177.97 8.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.46 1.124 . . . . 0.0 113.554 -171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -137.14 153.6 50.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 120.811 -1.181 . . . . 0.0 112.105 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.84 138.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.509 0.671 . . . . 0.0 110.443 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.33 -41.95 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.993 1.717 . . . . 0.0 111.187 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -143.48 153.84 43.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.141 1.377 . . . . 0.0 110.584 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.31 39.15 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.526 1.06 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.9 mtp -60.66 -35.17 75.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.895 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -65.12 -29.07 69.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.865 0.866 . . . . 0.0 112.142 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.05 -43.6 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.491 1.517 . . . . 0.0 110.307 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.59 -38.95 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.488 1.115 . . . . 0.0 111.253 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.13 -20.09 60.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.419 1.488 . . . . 0.0 113.0 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -86.22 -40.55 15.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.761 1.624 . . . . 0.0 111.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.7 -34.44 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.487 1.515 . . . . 0.0 112.065 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -83.82 -16.58 44.06 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.0 13.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.182 1.372 . . . . 0.0 114.091 -173.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.84 -62.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.405 1.102 . . . . 0.0 113.312 -174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.79 157.27 5.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.013 0.925 . . . . 0.0 113.458 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -139.47 155.14 47.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 111.772 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.612 0 CA-C-O 123.329 1.516 . . . . 0.0 115.137 170.266 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.0 135.84 28.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.703 1.602 . . . . 0.0 110.059 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.8 51.63 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -84.72 157.69 20.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 110.058 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -79.91 125.86 30.28 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.01 -1.057 . . . . 0.0 111.207 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.92 93.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.354 1.861 . . . . 0.0 107.732 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 144.27 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.98 110.51 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.96 -41.58 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.689 0.677 . . . . 0.0 110.389 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.77 165.6 33.0 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.18 142.51 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.06 1.744 . . . . 0.0 111.446 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -136.37 136.29 39.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.987 1.315 . . . . 0.0 110.683 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.71 123.95 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.2 t -122.51 143.61 49.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 112.087 -169.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.31 1.844 . . . . 0.0 112.082 178.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.08 128.34 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.988 1.267 . . . . 0.0 110.423 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.9 m -100.37 125.6 46.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.277 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -101.44 128.02 47.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.999 1.319 . . . . 0.0 110.518 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.19 95.79 6.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -99.9 152.36 20.25 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.901 -0.5 . . . . 0.0 110.829 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -60.31 -13.84 15.05 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -97.97 -11.14 23.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 113.624 171.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.87 167.84 13.72 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.651 1.596 . . . . 0.0 113.408 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.3 137.25 41.02 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.754 1.622 . . . . 0.0 112.821 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -133.2 140.48 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.752 2.021 . . . . 0.0 108.561 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.96 134.18 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.464 1.105 . . . . 0.0 110.266 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.02 133.88 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.483 1.913 . . . . 0.0 110.039 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -99.64 126.86 45.72 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.898 1.679 . . . . 0.0 108.44 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -89.08 146.77 24.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.24 1.016 . . . . 0.0 110.999 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -103.65 73.73 1.2 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 122.669 1.224 . . . . 0.0 111.458 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.86 -26.28 64.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.77 -1.104 . . . . 0.0 112.48 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.87 -27.97 49.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.253 1.021 . . . . 0.0 111.672 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.72 -18.87 15.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.104 1.362 . . . . 0.0 113.222 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.0 55.39 1.19 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.665 1.186 . . . . 0.0 113.123 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.72 -44.97 27.6 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.47 2.78 . . . . 0.0 112.952 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.27 -41.82 80.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.108 0.563 . . . . 0.0 110.971 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -65.42 -45.43 83.94 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.175 0.59 . . . . 0.0 111.789 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.97 -43.09 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.583 0.753 . . . . 0.0 111.761 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.66 -42.48 79.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.96 1.254 . . . . 0.0 111.797 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -70.2 -37.95 75.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.733 0.813 . . . . 0.0 111.626 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.91 -48.96 79.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.432 1.093 . . . . 0.0 111.713 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.98 -37.97 79.07 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.593 0.757 . . . . 0.0 111.456 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -57.25 -33.88 68.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.361 1.065 . . . . 0.0 112.808 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 18.5 m-85 -76.84 -44.73 31.13 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.462 -0.774 . . . . 0.0 112.493 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -59.98 -35.98 76.16 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.63 -0.669 . . . . 0.0 111.658 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.78 -34.28 77.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.026 2.13 . . . . 0.0 112.945 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.43 -14.48 52.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.029 0.932 . . . . 0.0 113.372 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.51 19.23 60.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.553 1.073 . . . . 0.0 113.885 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 54.4 t80 -68.27 -17.72 64.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.13 -3.63 44.19 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.269 -0.894 . . . . 0.0 113.137 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.5 135.29 54.97 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.135 -0.978 . . . . 0.0 108.952 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 54.16 47.17 23.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.531 1.533 . . . . 0.0 113.689 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.3 p -114.37 151.23 33.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.836 0.855 . . . . 0.0 112.532 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 pt -103.3 162.05 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.45 86.41 6.77 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -80.05 2.63 23.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -169.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -144.25 143.16 30.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.967 2.167 . . . . 0.0 113.46 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.14 131.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 110.271 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.2 mt -137.65 129.64 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.613 1.565 . . . . 0.0 108.15 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.84 133.5 54.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.756 0.822 . . . . 0.0 111.782 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 9.37 65.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 123.895 0.759 . . . . 0.0 114.947 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -141.89 -177.3 5.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 110.872 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -179.25 5.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.869 1.667 . . . . 0.0 115.379 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.9 pt -114.31 135.91 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.885 1.274 . . . . 0.0 112.446 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.31 150.77 25.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.434 1.094 . . . . 0.0 110.653 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.87 34.66 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.05 -2.32 61.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.811 1.672 . . . . 0.0 115.662 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.31 -14.94 65.29 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 118.921 1.361 . . . . 0.0 115.833 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.38 167.09 23.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.744 1.217 . . . . 0.0 112.782 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.55 164.5 18.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.729 1.612 . . . . 0.0 110.711 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.38 -11.91 28.02 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.514 2.809 . . . . 0.0 116.811 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.59 15.94 62.23 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.088 0.851 . . . . 0.0 114.477 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.1 mmt 61.42 26.46 16.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.058 1.743 . . . . 0.0 113.221 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -83.22 127.18 33.4 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.834 1.254 . . . . 0.0 109.357 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -73.57 119.24 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.966 0.906 . . . . 0.0 110.145 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -69.43 164.83 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.136 0.974 . . . . 0.0 113.472 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 66.04 9.47 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.814 1.645 . . . . 0.0 111.494 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.4 p -69.18 134.47 49.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.932 1.293 . . . . 0.0 112.219 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -137.71 174.05 10.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.022 2.129 . . . . 0.0 111.965 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.12 66.24 5.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.451 1.5 . . . . 0.0 113.605 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.62 135.76 62.66 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.284 2.656 . . . . 0.0 111.067 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.08 151.61 7.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 125.849 1.66 . . . . 0.0 108.166 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 157.11 27.45 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.638 0.732 . . . . 0.0 111.565 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -81.81 103.68 11.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.33 1.052 . . . . 0.0 111.198 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.75 23.83 1.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.529 1.132 . . . . 0.0 113.289 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.6 -19.86 66.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 119.863 -1.773 . . . . 0.0 113.784 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -65.44 8.82 0.14 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.344 1.458 . . . . 0.0 114.516 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -77.97 -10.06 59.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.144 1.378 . . . . 0.0 113.426 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.66 81.62 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.101 1.334 . . . . 0.0 114.83 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.77 158.61 26.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.498 1.149 . . . . 0.0 112.706 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -130.69 155.07 47.23 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.18 111.56 23.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.489 2.316 . . . . 0.0 110.478 -174.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -142.3 170.38 15.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.327 1.451 . . . . 0.0 111.175 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -38.88 117.13 0.63 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.979 1.712 . . . . 0.0 111.948 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.86 33.29 30.46 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 124.352 0.977 . . . . 0.0 114.787 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.1 p -123.39 157.68 32.82 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.897 1.348 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.78 136.7 54.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -138.27 160.77 38.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.982 171.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.6 mtt -84.04 143.22 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.39 147.89 22.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.641 1.176 . . . . 0.0 111.766 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 165.62 14.03 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.27 1.028 . . . . 0.0 113.518 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -81.56 -57.14 3.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.136 0.974 . . . . 0.0 110.873 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -151.47 -38.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.082 1.353 . . . . 0.0 113.68 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.89 156.46 35.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.014 1.326 . . . . 0.0 111.48 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.91 -23.91 76.44 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.63 2.22 . . . . 0.0 114.324 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -103.37 33.0 3.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.539 1.536 . . . . 0.0 112.746 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.3 p -118.2 26.09 9.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.42 1.488 . . . . 0.0 113.158 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.13 98.8 2.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.676 1.191 . . . . 0.0 108.574 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.2 p -90.04 -68.64 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.519 1.128 . . . . 0.0 111.691 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.32 20.07 1.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.731 1.212 . . . . 0.0 113.445 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -110.41 142.7 41.76 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.805 -1.185 . . . . 0.0 111.145 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -143.77 168.16 20.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.48 1.512 . . . . 0.0 111.036 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 24.0 p90 -142.86 158.3 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.353 0.661 . . . . 0.0 111.878 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 mt -111.12 118.38 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -75.27 108.78 8.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.08 0.552 . . . . 0.0 110.137 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.03 -11.02 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.42 165.15 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.985 2.514 . . . . 0.0 111.274 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.25 120.99 25.07 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.843 0.457 . . . . 0.0 109.843 169.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -140.93 74.81 1.48 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.711 1.243 . . . . 0.0 112.459 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.62 -34.57 62.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.153 1.781 . . . . 0.0 114.406 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -59.41 -13.71 9.53 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.89 -8.51 59.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -80.92 177.04 9.31 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.464 . . . . 0.0 114.174 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -89.77 140.76 29.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.877 1.271 . . . . 0.0 112.695 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.2 p -109.34 -61.02 1.69 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.761 1.224 . . . . 0.0 113.351 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 163.89 69.43 0.02 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.459 1.028 . . . . 0.0 113.65 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.59 26.01 5.35 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.133 1.773 . . . . 0.0 115.089 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -111.09 116.62 31.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.164 . . . . 0.0 110.106 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.1 -36.19 62.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -74.68 -10.96 60.03 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.57 -71.06 0.97 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 127.24 2.352 . . . . 0.0 114.0 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -73.49 135.09 44.02 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.31 -113.33 2.47 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.153 1.835 . . . . 0.0 114.877 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.98 148.02 50.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 113.067 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.39 126.62 31.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.05 94.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -80.46 -15.36 56.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.63 176.65 8.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.557 1.17 . . . . 0.0 113.951 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.17 154.18 48.03 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.854 -1.154 . . . . 0.0 112.335 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.49 139.49 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.651 0.739 . . . . 0.0 109.865 170.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 t -111.18 -42.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.765 1.626 . . . . 0.0 110.99 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.88 154.76 42.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.469 1.508 . . . . 0.0 109.997 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.21 16.3 25.62 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 123.849 0.737 . . . . 0.0 114.217 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -34.78 67.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.891 1.345 . . . . 0.0 112.256 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.15 -30.44 70.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.1 t -76.27 -40.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.943 1.297 . . . . 0.0 110.408 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.61 -41.89 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.277 -0.889 . . . . 0.0 110.867 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.54 -25.37 63.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.131 1.372 . . . . 0.0 112.355 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -74.57 -52.6 11.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.384 1.074 . . . . 0.0 110.208 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -53.65 -35.56 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.327 1.851 . . . . 0.0 112.793 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.47 -11.46 32.0 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.68 -15.82 10.69 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.718 1.628 . . . . 0.0 114.165 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.53 -63.33 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.45 1.125 . . . . 0.0 112.707 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -176.83 153.64 1.07 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.752 1.621 . . . . 0.0 111.499 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.4 p -125.9 148.67 49.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.985 1.314 . . . . 0.0 112.842 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.37 125.04 0.92 Allowed Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.263 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -73.5 151.36 41.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.4 p -111.28 168.93 9.14 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.599 1.56 . . . . 0.0 112.689 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.9 -21.95 75.46 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.144 0.818 . . . . 0.0 115.144 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.5 mtp -105.61 -34.89 7.6 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.48 1.14 . . . . 0.0 113.558 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.14 127.41 32.0 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.664 1.586 . . . . 0.0 111.223 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.94 161.93 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.332 1.053 . . . . 0.0 112.142 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 55.93 55.64 6.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.846 1.658 . . . . 0.0 112.34 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.05 152.46 54.31 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.083 2.153 . . . . 0.0 111.795 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.07 138.89 49.05 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.798 1.665 . . . . 0.0 109.559 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -30.74 54.51 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.856 -0.527 . . . . 0.0 112.152 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.15 149.04 32.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.879 0.872 . . . . 0.0 109.848 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -84.03 119.74 25.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 111.313 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.99 108.69 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.318 1.047 . . . . 0.0 109.242 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 148.28 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.884 1.326 . . . . 0.0 111.574 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.1 mt -87.24 103.35 13.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.16 -38.37 60.93 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.71 -0.619 . . . . 0.0 110.197 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 p -151.61 166.96 29.61 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.03 142.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 110.629 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -135.42 128.4 31.47 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.061 1.344 . . . . 0.0 110.205 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.74 124.04 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.518 -0.739 . . . . 0.0 109.02 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -113.36 150.5 32.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.253 1.421 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.753 1.621 . . . . 0.0 113.323 -169.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.2 t -124.68 132.45 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m -104.86 124.89 50.25 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.812 1.245 . . . . 0.0 110.152 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -98.34 132.14 44.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.659 1.184 . . . . 0.0 110.45 169.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -104.22 98.39 8.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -103.77 151.95 22.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.068 -0.395 . . . . 0.0 111.267 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -60.53 -9.36 3.65 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.27 -8.15 18.47 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.815 1.246 . . . . 0.0 114.014 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.51 163.96 10.93 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.411 1.482 . . . . 0.0 113.617 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.43 137.99 44.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.812 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.52 140.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.352 1.861 . . . . 0.0 108.886 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 t -122.34 137.66 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.566 1.147 . . . . 0.0 110.326 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.59 138.43 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.587 1.955 . . . . 0.0 110.409 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -100.5 128.76 46.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.013 2.125 . . . . 0.0 107.713 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 p -88.45 146.46 25.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.303 1.041 . . . . 0.0 111.201 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -102.85 73.79 1.29 Allowed 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 122.614 1.197 . . . . 0.0 111.293 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.59 -27.65 65.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.352 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.15 -29.19 57.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.426 1.09 . . . . 0.0 111.53 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.85 -27.56 14.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.835 1.254 . . . . 0.0 112.835 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.89 61.72 4.33 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.8 0.84 . . . . 0.0 113.188 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.11 -43.7 23.07 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.32 2.68 . . . . 0.0 112.906 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -69.2 -40.54 77.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.484 0.583 . . . . 0.0 110.852 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -64.86 -47.54 77.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.315 0.646 . . . . 0.0 111.593 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.63 -44.51 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 111.342 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -55.95 -48.26 76.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.55 1.068 . . . . 0.0 112.039 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -68.12 -38.32 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.572 0.624 . . . . 0.0 111.878 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.13 -49.04 79.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.329 1.051 . . . . 0.0 111.673 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.35 -38.18 81.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.555 0.742 . . . . 0.0 111.554 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -59.1 -33.36 70.76 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.847 0.859 . . . . 0.0 112.665 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 -43.95 50.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.909 0.777 . . . . 0.0 112.285 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.33 -36.15 79.36 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.578 -0.701 . . . . 0.0 111.687 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.71 -34.1 77.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.087 2.155 . . . . 0.0 112.86 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.71 -13.34 56.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.963 0.905 . . . . 0.0 113.267 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.97 18.61 62.83 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.628 1.109 . . . . 0.0 113.939 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.65 -17.56 64.12 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -96.7 -5.42 38.82 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.414 -0.804 . . . . 0.0 113.022 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -67.67 136.07 53.78 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.59 44.46 29.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.353 1.461 . . . . 0.0 113.828 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -109.32 164.4 12.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.865 0.866 . . . . 0.0 111.742 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.3 pt -124.75 159.05 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -91.14 96.59 10.66 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -88.39 -11.46 46.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -143.27 136.15 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.939 1.245 . . . . 0.0 113.374 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -135.4 145.11 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 128.145 2.578 . . . . 0.0 109.018 169.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -133.14 131.18 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.734 1.614 . . . . 0.0 108.188 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.62 126.77 28.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.111 0.964 . . . . 0.0 112.594 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.1 11.81 70.97 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 123.81 0.719 . . . . 0.0 114.81 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.15 -176.98 4.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.495 1.918 . . . . 0.0 110.979 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.72 -179.25 7.26 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.2 pt -118.95 134.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.485 1.514 . . . . 0.0 112.91 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -112.18 146.47 38.03 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.746 1.219 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.23 35.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.693 1.437 . . . . 0.0 116.693 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.94 -4.69 85.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.952 1.739 . . . . 0.0 115.602 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -15.84 64.84 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -169.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -146.61 164.71 31.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.746 1.273 . . . . 0.0 112.939 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.19 161.82 31.95 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.502 1.521 . . . . 0.0 110.003 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -63.29 -13.0 33.18 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.298 2.665 . . . . 0.0 117.729 -169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.44 14.96 64.08 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 123.908 0.766 . . . . 0.0 114.496 171.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.1 mmm 58.1 39.44 26.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.343 1.857 . . . . 0.0 112.988 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -92.28 127.95 37.95 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.369 1.467 . . . . 0.0 109.53 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -75.37 123.67 25.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.423 1.089 . . . . 0.0 111.166 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -73.44 162.75 28.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.72 73.51 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.561 1.544 . . . . 0.0 111.538 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 p -72.0 131.58 43.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.299 1.039 . . . . 0.0 112.118 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -137.37 175.04 9.96 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.463 1.905 . . . . 0.0 112.527 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 50.62 69.49 2.57 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.746 1.619 . . . . 0.0 113.996 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.49 135.68 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.189 2.592 . . . . 0.0 111.515 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.88 154.04 7.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.298 1.839 . . . . 0.0 108.535 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 158.07 18.47 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.23 0.612 . . . . 0.0 111.829 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -72.54 127.64 33.16 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.198 0.599 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -113.03 12.05 19.13 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.022 1.329 . . . . 0.0 112.73 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 -11.71 46.67 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.197 -1.565 . . . . 0.0 113.762 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -58.62 -1.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.95 0.83 29.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.122 1.369 . . . . 0.0 111.569 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.71 10.14 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.708 1.623 . . . . 0.0 114.094 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.8 mt -78.64 157.07 28.75 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.78 158.44 36.55 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -117.68 109.84 17.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.786 2.034 . . . . 0.0 110.717 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -136.0 169.87 16.91 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.703 1.201 . . . . 0.0 111.537 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.1 126.27 24.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.988 0.899 . . . . 0.0 111.079 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.7 24.45 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.923 1.249 . . . . 0.0 114.651 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.5 p -123.86 159.11 30.33 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.172 1.486 . . . . 0.0 113.096 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.69 137.78 54.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.3 159.0 42.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.007 0.523 . . . . 0.0 111.923 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 94.7 mmm -78.34 138.21 38.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.089 -0.382 . . . . 0.0 110.518 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.94 150.31 25.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.106 0.562 . . . . 0.0 110.66 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -115.3 160.77 19.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.536 1.134 . . . . 0.0 112.896 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.8 m -75.56 -52.46 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.054 0.942 . . . . 0.0 111.285 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.27 -57.39 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.559 1.544 . . . . 0.0 110.716 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.99 157.47 78.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.946 1.298 . . . . 0.0 112.115 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.25 -23.09 73.03 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.48 2.787 . . . . 0.0 114.068 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -111.52 36.78 3.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.739 1.615 . . . . 0.0 112.41 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 p -121.15 26.52 8.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.388 1.475 . . . . 0.0 113.843 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.62 99.67 10.34 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.364 1.466 . . . . 0.0 109.447 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -87.07 -71.55 0.55 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.186 . . . . 0.0 112.618 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.9 38.73 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -129.36 152.3 49.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.374 1.07 . . . . 0.0 111.903 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.18 168.41 19.81 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.504 1.522 . . . . 0.0 110.716 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 84' ' ' ALA . 8.1 p90 -144.03 159.49 42.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.16 0.584 . . . . 0.0 111.055 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 mt -116.42 120.12 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.44 102.8 5.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.167 0.587 . . . . 0.0 109.525 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.28 -18.05 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.88 165.69 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.592 1.557 . . . . 0.0 111.663 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -78.48 119.4 21.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.792 0.437 . . . . 0.0 110.03 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -143.03 63.02 1.39 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 123.009 1.385 . . . . 0.0 111.758 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.27 -11.9 53.15 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -172.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -64.42 -13.68 52.6 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.579 -1.325 . . . . 0.0 113.573 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.06 -13.88 58.96 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.529 1.132 . . . . 0.0 113.431 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -69.32 167.06 17.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.39 1.476 . . . . 0.0 114.904 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -70.2 138.3 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -143.77 21.9 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.5 63.02 0.66 Allowed Glycine 0 N--CA 1.476 1.364 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.33 26.35 10.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.56 1.544 . . . . 0.0 114.916 169.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -127.2 136.85 52.61 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.601 1.16 . . . . 0.0 112.353 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.902 1.281 . . . . 0.0 113.916 -170.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -72.93 -17.26 61.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.836 0.454 . . . . 0.0 112.209 172.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.26 -94.82 1.09 Allowed Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.194 2.33 . . . . 0.0 111.72 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.94 126.2 29.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.09 -54.88 0.83 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.853 1.216 . . . . 0.0 114.259 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -143.82 158.96 43.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.429 1.492 . . . . 0.0 111.72 -169.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 35.0 t -93.66 119.19 32.36 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.646 -0.658 . . . . 0.0 112.657 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.2 82.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.218 1.407 . . . . 0.0 108.66 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -77.5 -13.25 59.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.914 0.886 . . . . 0.0 112.309 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.08 177.56 8.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 122.751 1.262 . . . . 0.0 114.278 -169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -141.96 154.29 44.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.511 1.124 . . . . 0.0 112.792 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.36 143.49 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.68 0.753 . . . . 0.0 110.394 172.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.8 t -117.11 -40.99 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.79 1.636 . . . . 0.0 111.122 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -145.19 155.12 43.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.869 1.667 . . . . 0.0 109.75 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.92 16.37 23.89 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.817 0.723 . . . . 0.0 114.327 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -33.55 66.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.834 1.317 . . . . 0.0 112.33 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.52 -29.14 69.16 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.545 0.738 . . . . 0.0 112.551 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.01 -41.52 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.256 1.423 . . . . 0.0 110.238 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.24 -39.89 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.879 -1.138 . . . . 0.0 111.042 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.0 -30.47 68.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.112 1.365 . . . . 0.0 111.953 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.09 -42.89 62.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.986 0.914 . . . . 0.0 111.168 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.13 -25.12 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.494 1.517 . . . . 0.0 112.409 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -86.39 -23.3 26.18 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.39 -7.61 69.32 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.986 1.755 . . . . 0.0 114.779 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.79 -27.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 84.55 163.54 0.1 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.522 2.329 . . . . 0.0 114.057 -169.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 p -118.92 143.98 46.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.196 1.398 . . . . 0.0 113.668 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.16 128.84 1.85 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.034 1.302 . . . . 0.0 111.426 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -62.61 146.01 53.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.52 1.128 . . . . 0.0 113.344 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.3 p -98.42 169.62 9.42 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.392 1.477 . . . . 0.0 111.755 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -5.66 12.55 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.043 -0.865 . . . . 0.0 115.064 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -119.82 -37.99 3.03 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.986 1.314 . . . . 0.0 113.574 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -141.55 137.38 31.95 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.98 1.712 . . . . 0.0 110.767 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -95.08 156.04 16.48 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.373 1.069 . . . . 0.0 113.443 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 t70 58.22 31.59 20.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 114.523 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m -86.61 156.37 56.08 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.317 1.447 . . . . 0.0 111.429 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.54 137.57 70.17 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.709 1.606 . . . . 0.0 110.512 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -32.17 61.89 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -84.91 147.38 26.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.184 0.593 . . . . 0.0 110.544 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.18 116.73 23.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.196 0.998 . . . . 0.0 111.071 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 91.0 t -114.85 108.06 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.316 1.047 . . . . 0.0 108.483 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.52 141.34 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.439 1.114 . . . . 0.0 111.932 -169.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.2 mt -83.61 103.44 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.38 -36.87 66.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.186 0.594 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.6 t -154.37 165.22 37.04 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -133.76 141.07 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.791 2.037 . . . . 0.0 110.431 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -135.76 131.75 35.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 110.187 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.62 124.07 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.309 -0.869 . . . . 0.0 108.82 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.7 t -117.36 150.3 39.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.077 1.351 . . . . 0.0 112.749 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.93 1.692 . . . . 0.0 113.629 -169.707 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 120.318 0.104 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.9 t -123.46 129.97 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.4 m -104.36 123.68 47.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.98 1.312 . . . . 0.0 110.205 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.36 132.31 42.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.568 1.147 . . . . 0.0 110.688 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -103.18 103.13 13.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -106.48 151.49 24.89 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.966 -0.459 . . . . 0.0 111.126 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -60.57 -7.63 2.3 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -108.28 -8.71 15.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.005 1.322 . . . . 0.0 114.094 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.96 163.5 11.17 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.505 1.526 . . . . 0.0 113.859 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.04 138.82 44.29 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.034 1.734 . . . . 0.0 112.957 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.82 141.51 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.512 1.925 . . . . 0.0 109.062 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -124.62 135.66 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 110.805 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 139.72 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.743 2.017 . . . . 0.0 110.389 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -105.07 125.77 51.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.638 1.975 . . . . 0.0 108.844 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -88.96 147.5 24.28 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.379 1.072 . . . . 0.0 111.553 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -104.94 74.52 1.13 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.792 1.282 . . . . 0.0 111.202 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.76 -26.3 64.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.618 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.81 -28.0 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 111.386 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -95.83 -29.13 14.39 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.388 1.475 . . . . 0.0 112.398 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.74 58.55 3.32 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 0.0 113.003 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -60.87 -43.19 32.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.493 2.795 . . . . 0.0 112.932 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -68.33 -40.38 81.63 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.741 0.7 . . . . 0.0 110.893 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 m -63.91 -51.33 64.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.641 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.57 -38.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -56.33 -49.58 73.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.601 1.091 . . . . 0.0 111.484 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -68.81 -36.74 78.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.412 0.551 . . . . 0.0 112.19 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.59 -49.63 77.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.763 1.225 . . . . 0.0 111.426 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.71 -34.71 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.368 -0.833 . . . . 0.0 112.449 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -45.2 77.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.573 0.349 . . . . 0.0 110.261 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.45 -40.68 81.0 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.593 -0.692 . . . . 0.0 111.456 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.77 -40.06 86.95 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.878 -0.514 . . . . 0.0 111.397 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -72.67 -30.07 63.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.376 1.47 . . . . 0.0 113.385 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -79.41 -16.54 56.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.631 0.65 . . . . 0.0 112.372 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.66 17.39 56.81 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.497 1.046 . . . . 0.0 113.298 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.04 -41.66 97.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.438 1.095 . . . . 0.0 113.121 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -81.49 -15.21 55.67 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.27 5.31 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.87 17.49 1.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.064 1.346 . . . . 0.0 112.986 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.7 p -81.67 163.17 22.7 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.126 -0.984 . . . . 0.0 112.345 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -119.26 165.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.08 89.45 6.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.412 1.485 . . . . 0.0 108.573 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -85.68 -3.06 58.78 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.92 134.6 45.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.822 1.646 . . . . 0.0 111.173 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.42 135.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.504 1.522 . . . . 0.0 110.807 169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.79 128.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.61 1.564 . . . . 0.0 108.429 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.26 132.2 49.57 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.611 0.764 . . . . 0.0 111.691 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.05 10.99 66.21 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 123.956 0.789 . . . . 0.0 115.029 -174.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.01 -177.23 5.34 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.121 1.769 . . . . 0.0 111.019 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -83.75 177.41 8.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.44 140.0 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.61 1.564 . . . . 0.0 111.857 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -123.41 148.5 46.06 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 0.0 111.287 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.16 -178.1 27.39 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.557 1.075 . . . . 0.0 114.51 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 -1.09 89.27 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.31 0.957 . . . . 0.0 115.342 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.94 -27.06 32.56 Favored Glycine 0 N--CA 1.473 1.102 0 CA-C-N 118.931 1.366 . . . . 0.0 115.391 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.22 161.86 37.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -88.62 164.46 31.96 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 126.048 1.739 . . . . 0.0 109.69 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.31 -11.49 30.42 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.337 2.692 . . . . 0.0 117.518 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 17.16 59.81 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.273 0.94 . . . . 0.0 114.61 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.7 mmm 59.46 37.83 22.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.152 1.781 . . . . 0.0 113.31 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.074 1.349 . . . . 0.0 109.468 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -74.19 131.92 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 124.143 1.925 . . . . 0.0 111.792 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -75.93 -179.29 4.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 110.322 -3.127 . . . . 0.0 114.519 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.65 56.49 3.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 112.869 -1.968 . . . . 0.0 112.066 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 p -69.41 106.25 2.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.084 1.354 . . . . 0.0 110.824 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -137.87 169.25 18.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 111.947 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 48.49 62.89 11.3 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.486 1.514 . . . . 0.0 113.183 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -58.11 134.79 64.34 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.539 2.826 . . . . 0.0 111.749 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.24 152.55 4.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.356 1.862 . . . . 0.0 107.837 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 158.67 17.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.192 0.597 . . . . 0.0 110.67 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -71.43 134.6 46.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.179 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.38 14.09 12.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.765 1.226 . . . . 0.0 112.627 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.49 59.93 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.434 -1.416 . . . . 0.0 113.93 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.93 0.21 0.24 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.629 1.972 . . . . 0.0 115.822 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -81.37 -3.45 52.79 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.036 1.334 . . . . 0.0 112.556 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.44 24.77 49.77 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.578 1.085 . . . . 0.0 114.942 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 159.1 28.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 117.707 0.753 . . . . 0.0 112.616 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -131.39 154.47 48.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -98.65 100.02 11.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.669 1.987 . . . . 0.0 110.118 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.1 p -130.68 165.24 23.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.306 1.042 . . . . 0.0 111.603 -175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -55.34 121.97 10.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.64 1.176 . . . . 0.0 110.771 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 49.82 6.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.72 1.153 . . . . 0.0 113.923 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -136.21 163.51 30.21 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.16 0.98 . . . . 0.0 112.523 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.79 140.81 51.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.725 0.81 . . . . 0.0 112.709 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -137.91 157.82 45.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.894 -0.504 . . . . 0.0 112.019 169.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -82.37 140.6 33.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.498 0.319 . . . . 0.0 111.303 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.64 144.68 25.08 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.575 0.75 . . . . 0.0 111.469 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -114.58 159.81 20.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.026 1.33 . . . . 0.0 112.978 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.3 m -77.67 -54.86 5.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.068 1.347 . . . . 0.0 112.051 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -153.65 -40.38 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.696 1.199 . . . . 0.0 113.078 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.04 157.18 35.41 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.868 1.267 . . . . 0.0 111.267 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.73 -26.13 64.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 114.429 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -105.77 33.9 3.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.58 1.552 . . . . 0.0 112.779 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.9 p -123.07 35.71 4.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.379 1.472 . . . . 0.0 113.161 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.66 107.93 20.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.086 1.754 . . . . 0.0 109.826 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 p -91.65 -67.82 0.83 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.393 1.077 . . . . 0.0 112.584 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.87 -17.15 1.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -78.34 143.53 36.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 122.116 0.96 . . . . 0.0 112.194 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.03 167.97 20.89 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.316 1.847 . . . . 0.0 110.816 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 5.6 p90 -145.34 161.44 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.577 0.751 . . . . 0.0 111.726 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.39 115.45 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 108.16 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -73.4 101.23 3.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.713 0.805 . . . . 0.0 110.193 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 -16.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.1 167.28 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 128.129 2.572 . . . . 0.0 111.057 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -78.31 121.84 24.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.124 0.57 . . . . 0.0 110.667 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -145.85 68.98 1.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 123.266 1.508 . . . . 0.0 111.306 -170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.59 -13.02 61.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -64.4 -12.83 46.98 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.614 -1.304 . . . . 0.0 113.224 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.98 -7.16 59.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.626 1.171 . . . . 0.0 113.972 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.18 179.6 5.61 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -79.82 142.1 35.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.361 1.465 . . . . 0.0 112.171 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -107.71 -59.45 1.83 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.459 1.104 . . . . 0.0 113.682 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.18 60.21 0.02 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.859 0.742 . . . . 0.0 114.363 -172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.2 21.33 9.43 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.216 1.806 . . . . 0.0 115.303 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -98.61 126.23 44.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.357 1.063 . . . . 0.0 112.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.8 tp -54.78 -37.21 65.74 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.669 1.188 . . . . 0.0 113.81 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -88.34 -3.92 58.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.058 0.943 . . . . 0.0 113.14 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.69 -72.77 1.07 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.547 2.022 . . . . 0.0 114.026 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 5.5 p-90 -69.73 127.58 33.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.05 -108.17 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.617 1.58 . . . . 0.0 116.013 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.69 142.8 46.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.419 1.488 . . . . 0.0 111.554 -169.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.21 118.45 25.67 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -170.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.38 84.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.691 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -78.19 -13.75 59.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.004 0.922 . . . . 0.0 112.083 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.96 177.2 8.71 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.496 1.141 . . . . 0.0 113.672 -170.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.98 149.81 43.72 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.845 -1.159 . . . . 0.0 111.928 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.07 136.69 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.605 -0.684 . . . . 0.0 110.414 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.72 -42.29 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.356 1.862 . . . . 0.0 110.834 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -143.26 154.86 44.25 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.466 1.506 . . . . 0.0 109.862 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.36 13.9 37.24 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.911 0.767 . . . . 0.0 114.754 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.5 mmm -54.19 -35.95 62.89 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.43 1.615 . . . . 0.0 112.381 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.95 -33.43 75.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.693 0.797 . . . . 0.0 112.385 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.59 -42.64 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.925 1.29 . . . . 0.0 110.39 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.71 -40.29 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.23 1.012 . . . . 0.0 111.237 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.38 -26.01 60.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.892 1.277 . . . . 0.0 112.78 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.39 -41.51 27.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.914 1.286 . . . . 0.0 111.18 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.7 mt -54.87 -31.79 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.899 1.679 . . . . 0.0 112.771 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -90.59 -15.27 30.86 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.3 -16.24 18.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.707 1.623 . . . . 0.0 114.475 -172.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.18 -59.5 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.834 1.317 . . . . 0.0 112.29 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.96 153.53 2.61 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.471 1.508 . . . . 0.0 111.587 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.3 p -133.67 147.75 51.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.96 1.304 . . . . 0.0 112.366 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.96 136.44 2.22 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.247 0.451 . . . . 0.0 113.201 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -62.97 153.35 33.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.493 1.117 . . . . 0.0 113.291 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.7 t -134.73 169.28 17.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.408 1.883 . . . . 0.0 111.645 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.03 121.39 15.76 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.295 -0.878 . . . . 0.0 112.471 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.8 mtt 59.93 3.07 0.44 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.36 2.264 . . . . 0.0 116.659 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -141.38 111.39 6.69 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.838 1.199 . . . . 0.0 111.757 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -99.65 158.05 16.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.029 0.931 . . . . 0.0 112.364 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 57.49 56.04 5.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.69 1.233 . . . . 0.0 112.699 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.65 154.55 57.16 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 125.71 1.604 . . . . 0.0 111.179 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.02 131.79 24.7 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 N-CA-C 108.027 -1.566 . . . . 0.0 108.027 169.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -31.15 63.44 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.67 -0.644 . . . . 0.0 111.797 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -83.26 150.3 26.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 109.103 168.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.25 117.75 23.17 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.102 -0.999 . . . . 0.0 110.651 -170.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.3 102.82 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.04 143.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 112.287 -169.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.0 mt -82.64 103.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.04 -27.34 57.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.557 1.143 . . . . 0.0 111.697 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -163.38 169.33 19.13 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.52 140.82 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.287 1.835 . . . . 0.0 110.477 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.3 m -133.84 135.0 43.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.271 1.428 . . . . 0.0 110.073 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.68 125.73 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.6 t -122.6 150.78 42.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.763 1.625 . . . . 0.0 111.927 -171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.73 1.212 . . . . 0.0 113.246 -179.629 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -125.7 129.56 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.077 0.951 . . . . 0.0 109.41 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -104.71 123.28 47.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.589 1.156 . . . . 0.0 110.055 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.56 134.59 38.25 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 110.598 169.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -105.9 101.78 11.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -106.21 151.13 25.17 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.041 -0.412 . . . . 0.0 110.949 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -60.78 -7.8 2.57 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -108.14 -8.33 15.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.954 1.302 . . . . 0.0 114.101 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.24 160.9 9.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.046 1.307 . . . . 0.0 114.124 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.15 138.08 43.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.852 1.661 . . . . 0.0 112.702 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -134.21 141.01 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.111 1.764 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.7 t -123.16 136.65 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.736 1.214 . . . . 0.0 110.68 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mt -127.12 138.75 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.495 1.918 . . . . 0.0 110.323 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.84 122.21 45.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.492 1.917 . . . . 0.0 109.142 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 p -85.91 148.18 25.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.312 1.045 . . . . 0.0 111.83 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -104.22 73.82 1.15 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.702 1.239 . . . . 0.0 111.359 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.75 -26.85 64.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.502 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.15 -30.87 58.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.262 1.025 . . . . 0.0 111.53 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.29 -26.43 15.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.833 1.253 . . . . 0.0 112.991 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.03 59.0 3.46 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.99 0.916 . . . . 0.0 112.833 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.63 -43.77 25.22 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.251 2.634 . . . . 0.0 112.72 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -69.77 -41.15 75.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.513 0.597 . . . . 0.0 110.957 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 24.8 m -62.73 -49.9 73.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.482 0.713 . . . . 0.0 111.265 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.63 -44.32 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.307 0.643 . . . . 0.0 111.477 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -55.72 -47.7 76.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.771 1.168 . . . . 0.0 112.014 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -68.0 -39.13 83.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.43 0.559 . . . . 0.0 111.667 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.7 -48.47 81.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.683 1.193 . . . . 0.0 111.542 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.96 -38.31 79.34 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 111.653 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.86 -33.73 70.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.956 0.902 . . . . 0.0 112.529 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.392 -0.817 . . . . 0.0 112.287 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.03 -35.2 76.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.791 -0.568 . . . . 0.0 111.596 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -64.99 -34.19 77.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.909 2.084 . . . . 0.0 113.006 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -81.78 -15.74 53.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.831 0.852 . . . . 0.0 113.086 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.89 15.18 56.83 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.121 1.344 . . . . 0.0 113.979 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -65.48 -31.58 72.73 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.198 0.999 . . . . 0.0 113.678 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -87.64 -15.47 37.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.19 0.7 5.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.435 1.494 . . . . 0.0 114.574 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -144.85 50.35 1.26 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.129 1.772 . . . . 0.0 110.252 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.5 p -119.81 169.83 9.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.466 1.106 . . . . 0.0 111.945 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.0 pt -129.72 167.14 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -169.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -95.3 93.92 7.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.378 1.471 . . . . 0.0 107.764 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -86.46 -0.86 56.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -140.39 141.17 35.61 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.089 1.768 . . . . 0.0 112.67 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.87 132.73 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.187 1.795 . . . . 0.0 111.152 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.98 128.72 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.022 1.729 . . . . 0.0 108.292 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -68.97 139.42 55.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.782 -0.574 . . . . 0.0 111.249 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.59 9.12 68.71 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -144.79 -177.12 5.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.788 2.035 . . . . 0.0 110.55 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.87 178.1 6.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.016 1.726 . . . . 0.0 114.501 -171.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -114.21 136.94 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.016 1.326 . . . . 0.0 111.765 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -103.62 147.26 27.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.137 0.975 . . . . 0.0 110.761 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.05 31.38 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 122.637 1.132 . . . . 0.0 114.849 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.92 72.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.668 -1.073 . . . . 0.0 114.434 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.49 -22.87 41.96 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-N 119.624 1.712 . . . . 0.0 114.729 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.35 166.07 26.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.799 1.24 . . . . 0.0 112.912 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.83 162.19 27.85 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.956 1.702 . . . . 0.0 110.402 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -60.77 -13.2 25.21 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.696 2.93 . . . . 0.0 118.505 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.26 17.23 59.7 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.122 0.867 . . . . 0.0 114.592 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mmm 58.46 36.46 25.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.072 1.749 . . . . 0.0 113.114 -173.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -92.07 131.32 37.43 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.296 1.438 . . . . 0.0 109.386 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -71.04 124.43 24.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.495 1.118 . . . . 0.0 110.107 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.38 159.14 32.1 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.3 75.27 8.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.245 1.418 . . . . 0.0 111.484 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.2 p -69.0 127.53 33.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.546 1.139 . . . . 0.0 112.409 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.5 177.32 7.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.62 1.968 . . . . 0.0 111.484 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 50.42 68.33 3.52 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.593 1.557 . . . . 0.0 113.617 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.81 147.46 88.48 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.252 2.635 . . . . 0.0 111.597 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.68 149.6 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.813 1.645 . . . . 0.0 109.155 -174.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 155.49 29.0 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.581 0.705 . . . . 0.0 110.419 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -78.71 134.45 37.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.397 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.69 14.39 12.61 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.941 0.896 . . . . 0.0 112.11 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.53 -17.03 64.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.569 -1.332 . . . . 0.0 113.764 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -63.5 -0.97 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.388 1.875 . . . . 0.0 115.482 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -79.77 -5.63 55.7 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.701 1.2 . . . . 0.0 113.017 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.65 21.06 49.03 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.531 1.063 . . . . 0.0 114.942 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.05 155.47 39.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.911 0.855 . . . . 0.0 111.75 170.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -133.63 155.38 49.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -90.31 107.11 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.428 2.291 . . . . 0.0 109.439 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -137.67 169.43 17.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.918 1.287 . . . . 0.0 110.869 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -49.63 124.82 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.798 1.239 . . . . 0.0 111.458 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.78 41.14 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.274 1.416 . . . . 0.0 115.048 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.9 p -121.95 160.86 23.96 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.536 1.668 . . . . 0.0 113.584 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.91 137.91 54.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.659 0.784 . . . . 0.0 112.965 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.47 160.49 38.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.817 0.447 . . . . 0.0 112.143 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 96.7 mmm -79.1 139.74 38.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.158 0.583 . . . . 0.0 111.341 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.45 112.22 23.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.502 0.721 . . . . 0.0 110.292 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -75.48 157.26 34.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 0.0 112.709 -174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.0 m -70.81 -51.09 28.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.873 0.869 . . . . 0.0 110.934 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -160.12 -58.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.322 1.449 . . . . 0.0 110.373 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.24 79.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.61 1.164 . . . . 0.0 111.889 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.77 -31.48 88.39 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.825 2.35 . . . . 0.0 113.459 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -101.62 46.46 0.93 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.346 1.858 . . . . 0.0 112.294 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.6 p -133.99 32.2 3.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.96 54.66 1.33 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.989 1.716 . . . . 0.0 113.643 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -54.42 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -154.74 36.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -135.27 151.54 50.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.311 1.444 . . . . 0.0 110.097 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.58 172.21 13.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.061 1.344 . . . . 0.0 111.667 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -147.2 161.56 40.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.402 -0.811 . . . . 0.0 111.524 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 mt -115.5 115.84 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -76.69 102.68 6.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.903 0.881 . . . . 0.0 110.156 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.81 -21.93 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.268 -0.895 . . . . 0.0 112.968 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.01 168.55 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.813 1.645 . . . . 0.0 111.959 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.22 123.44 29.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.323 0.649 . . . . 0.0 110.291 169.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -144.79 76.82 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.828 1.299 . . . . 0.0 112.707 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.07 -34.88 66.37 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.209 1.804 . . . . 0.0 114.583 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -59.88 -12.58 7.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.84 -9.57 59.26 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.48 -177.08 5.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -169.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -77.05 141.21 40.39 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.289 1.836 . . . . 0.0 112.473 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.2 p -107.79 -57.16 2.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.24 1.016 . . . . 0.0 113.59 173.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.19 68.96 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.428 1.013 . . . . 0.0 113.427 -171.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 54.15 24.3 4.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.311 1.844 . . . . 0.0 115.289 171.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.0 m -110.2 119.32 38.89 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.639 1.176 . . . . 0.0 111.188 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.9 mt -49.81 -39.68 39.26 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -86.91 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.51 -62.47 1.09 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.567 2.032 . . . . 0.0 113.966 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.353 2.8 p-90 -73.02 126.79 30.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.581 1.191 . . . . 0.0 112.634 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.93 -95.35 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.387 1.47 . . . . 0.0 115.948 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -129.19 138.22 51.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.513 1.125 . . . . 0.0 112.11 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.92 121.82 26.97 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.76 87.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.013 1.325 . . . . 0.0 108.178 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -77.81 -15.61 58.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.431 0.692 . . . . 0.0 111.88 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.4 178.69 7.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.572 1.177 . . . . 0.0 113.942 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -138.93 154.38 48.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.659 1.183 . . . . 0.0 112.325 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 140.44 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.624 0.726 . . . . 0.0 110.271 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.79 -42.52 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.715 1.606 . . . . 0.0 111.213 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.49 152.86 41.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.591 1.556 . . . . 0.0 109.791 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.89 13.97 22.26 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.85 0.738 . . . . 0.0 114.67 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -34.94 68.81 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.125 1.462 . . . . 0.0 112.301 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.94 -30.7 71.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.8 0.84 . . . . 0.0 112.486 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.27 -41.38 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.416 1.087 . . . . 0.0 110.131 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.89 -40.23 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.489 -0.757 . . . . 0.0 111.091 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.58 -28.56 63.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.776 1.23 . . . . 0.0 112.349 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -74.65 -44.16 51.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.473 1.109 . . . . 0.0 110.699 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.61 -29.25 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.641 1.576 . . . . 0.0 112.633 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -94.48 -11.42 29.69 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.54 -14.65 13.77 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.631 1.586 . . . . 0.0 114.5 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.6 m -62.11 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.86 1.33 . . . . 0.0 112.428 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -175.07 156.59 2.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.658 1.583 . . . . 0.0 111.645 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 p -123.72 150.04 44.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.293 1.437 . . . . 0.0 112.281 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.75 142.91 3.65 Favored Glycine 0 N--CA 1.465 0.572 0 CA-C-O 122.835 1.242 . . . . 0.0 113.252 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -65.78 153.62 41.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.209 2.204 . . . . 0.0 113.693 -169.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.9 p -117.91 169.16 9.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.05 1.34 . . . . 0.0 112.089 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.1 -14.78 66.54 Favored Glycine 0 CA--C 1.54 1.601 0 N-CA-C 115.663 1.025 . . . . 0.0 115.663 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 37.8 ttp -133.3 -19.53 2.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -133.45 134.05 43.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.601 1.56 . . . . 0.0 110.947 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -105.55 163.68 12.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.032 1.733 . . . . 0.0 111.393 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 58.14 46.7 15.61 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.17 1.388 . . . . 0.0 113.208 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.07 152.43 54.3 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.764 1.625 . . . . 0.0 112.574 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.23 142.61 46.3 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.96 1.773 . . . . 0.0 109.412 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -30.83 61.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.601 -0.687 . . . . 0.0 112.63 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.97 145.24 32.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.905 0.882 . . . . 0.0 110.078 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.64 120.59 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.383 1.073 . . . . 0.0 110.436 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.64 99.93 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.175 0.99 . . . . 0.0 108.358 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.32 143.0 36.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.79 1.236 . . . . 0.0 112.216 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.3 mt -83.13 103.86 10.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.89 -28.89 60.82 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.381 1.073 . . . . 0.0 111.18 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.7 t -164.02 169.54 17.8 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.0 139.85 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.716 2.007 . . . . 0.0 110.055 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -133.06 133.11 42.58 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.291 1.437 . . . . 0.0 110.134 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.73 125.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.274 -0.891 . . . . 0.0 108.864 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 t -121.55 140.44 52.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.07 1.348 . . . . 0.0 112.024 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 112.217 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.46 131.25 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.544 -1.347 . . . . 0.0 110.624 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.2 m -102.67 126.38 49.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.631 1.172 . . . . 0.0 110.184 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.1 123.34 44.23 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.875 1.27 . . . . 0.0 109.753 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -98.79 109.64 22.37 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 p -121.88 158.82 28.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 112.147 -169.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -7.2 34.94 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.62 -26.39 10.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.579 1.552 . . . . 0.0 113.392 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.68 145.52 4.24 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.311 1.91 . . . . 0.0 113.282 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.0 132.8 32.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.302 1.041 . . . . 0.0 112.277 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.43 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.828 1.651 . . . . 0.0 109.199 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.21 138.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.099 0.96 . . . . 0.0 110.506 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -131.79 135.67 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.671 1.989 . . . . 0.0 110.13 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -104.18 125.73 50.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.116 1.766 . . . . 0.0 108.946 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -88.28 146.97 25.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.108 0.963 . . . . 0.0 112.036 -175.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -104.67 74.36 1.14 Allowed 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 122.887 1.327 . . . . 0.0 110.973 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.66 -25.48 63.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.35 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.25 -31.78 60.91 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.5 1.12 . . . . 0.0 111.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -94.02 -27.28 16.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.625 1.17 . . . . 0.0 113.027 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.62 59.43 3.87 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.546 0.738 . . . . 0.0 112.919 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -61.72 -43.98 23.7 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.328 2.686 . . . . 0.0 112.723 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -67.51 -40.54 85.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.283 0.492 . . . . 0.0 110.708 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -49.16 74.74 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.597 0.759 . . . . 0.0 111.948 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.4 -40.8 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.33 -48.31 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.789 1.177 . . . . 0.0 111.718 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.51 -36.03 78.31 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.56 0.744 . . . . 0.0 112.128 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -60.4 -51.4 69.66 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.38 -34.8 73.0 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.639 -0.663 . . . . 0.0 111.558 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -55.8 -36.44 67.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.978 0.911 . . . . 0.0 112.351 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -76.35 -42.53 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.602 -0.686 . . . . 0.0 112.586 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.6 m -60.78 -35.31 76.12 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.589 -0.694 . . . . 0.0 111.779 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -32.32 73.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 112.694 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -81.7 -13.28 58.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.96 18.25 65.66 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.616 1.103 . . . . 0.0 114.14 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.58 -17.37 64.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.41 -7.22 48.26 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.459 -0.776 . . . . 0.0 112.998 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -69.17 135.41 50.61 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 51.93 45.21 28.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.992 1.717 . . . . 0.0 114.253 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -104.05 160.05 15.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.504 0.722 . . . . 0.0 110.907 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.9 pt -123.42 162.31 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -91.42 115.76 28.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -116.7 -3.63 11.73 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -139.18 132.68 30.3 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.424 1.011 . . . . 0.0 111.291 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.18 146.48 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.91 2.084 . . . . 0.0 108.913 169.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -142.56 135.16 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.446 1.898 . . . . 0.0 107.415 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -64.21 134.8 55.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.324 0.65 . . . . 0.0 111.86 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.17 13.5 67.28 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.848 0.737 . . . . 0.0 114.848 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.15 -177.28 5.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.311 1.844 . . . . 0.0 111.033 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.24 -178.71 5.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.584 1.954 . . . . 0.0 115.16 -169.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 pt -120.01 142.47 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.022 1.329 . . . . 0.0 113.113 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -113.93 148.4 36.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.058 1.343 . . . . 0.0 112.083 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.41 178.79 32.71 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 -14.91 37.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 115.815 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.6 -10.67 76.15 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 116.738 1.455 . . . . 0.0 116.738 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -144.09 168.88 18.96 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.161 1.481 . . . . 0.0 113.359 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.83 162.85 18.7 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 126.895 2.078 . . . . 0.0 110.737 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -58.9 -15.22 25.98 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.019 3.146 . . . . 0.0 118.807 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 18.42 57.48 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.051 0.834 . . . . 0.0 114.715 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.0 mmt 59.4 27.3 16.37 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.588 1.555 . . . . 0.0 112.696 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.07 123.09 29.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.867 1.267 . . . . 0.0 109.169 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -73.17 121.2 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.005 0.922 . . . . 0.0 110.331 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -69.19 164.83 21.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.11 67.08 7.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.83 1.652 . . . . 0.0 111.704 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -66.17 125.93 27.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.781 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -133.09 173.66 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.827 2.051 . . . . 0.0 111.96 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 46.24 66.32 5.62 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.478 1.511 . . . . 0.0 113.711 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.55 137.52 74.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.337 2.691 . . . . 0.0 111.172 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.5 150.78 7.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.689 1.596 . . . . 0.0 108.655 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 151.92 29.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.259 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -87.37 101.59 13.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.697 1.599 . . . . 0.0 110.438 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.43 18.69 3.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.801 1.24 . . . . 0.0 113.836 -169.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.74 -21.5 63.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.432 1.493 . . . . 0.0 114.18 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.52 -2.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.846 2.058 . . . . 0.0 115.536 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -77.11 0.9 19.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.187 0.995 . . . . 0.0 112.282 169.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 35.74 27.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.905 1.24 . . . . 0.0 112.888 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.0 144.59 43.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.421 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.84 154.46 49.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.71 114.78 26.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.065 2.146 . . . . 0.0 110.572 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.5 p -138.8 171.98 13.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.933 1.293 . . . . 0.0 111.009 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -51.78 125.89 16.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.805 1.242 . . . . 0.0 110.959 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.4 36.43 39.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.848 1.213 . . . . 0.0 114.803 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.7 p -120.72 158.81 26.67 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.892 1.346 . . . . 0.0 112.89 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.44 136.3 54.54 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.61 158.23 44.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.291 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.7 mmt -81.38 132.49 35.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.69 0.396 . . . . 0.0 110.902 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.11 161.13 24.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.5 0.72 . . . . 0.0 110.573 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -133.02 158.42 42.76 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 m -74.01 -57.08 4.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.895 1.278 . . . . 0.0 112.777 -169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -158.61 -47.67 0.06 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.079 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.65 157.9 71.62 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.543 1.137 . . . . 0.0 111.359 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.84 -21.3 71.94 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.182 2.588 . . . . 0.0 114.584 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.74 42.2 2.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.604 1.962 . . . . 0.0 112.337 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.6 p -117.45 33.59 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.837 1.255 . . . . 0.0 113.861 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.63 14.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.277 1.431 . . . . 0.0 108.943 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -91.91 -60.09 1.95 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.49 33.33 0.32 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.79 140.08 53.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.216 1.406 . . . . 0.0 110.657 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -142.04 168.2 20.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.088 1.355 . . . . 0.0 111.354 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 84' ' ' ALA . 18.6 p90 -144.12 160.3 41.15 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.538 0.735 . . . . 0.0 111.849 172.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.9 mt -114.26 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.211 1.004 . . . . 0.0 108.419 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.32 100.32 2.61 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.8 0.84 . . . . 0.0 110.217 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.23 -25.99 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 121.199 -0.938 . . . . 0.0 113.188 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 m -114.97 166.56 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.998 1.719 . . . . 0.0 111.633 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.69 122.84 27.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.02 0.528 . . . . 0.0 110.11 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -141.95 71.77 1.36 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.927 1.346 . . . . 0.0 112.596 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -52.29 -35.71 51.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.235 2.214 . . . . 0.0 114.445 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -59.88 -12.77 8.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.73 -14.18 55.01 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -73.16 161.91 30.04 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.284 1.434 . . . . 0.0 114.462 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -69.71 144.41 52.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.216 0.606 . . . . 0.0 112.312 173.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.8 p -126.22 -59.29 1.32 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.797 1.239 . . . . 0.0 113.089 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.81 70.31 0.03 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.987 0.803 . . . . 0.0 113.974 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.17 25.25 7.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.797 1.639 . . . . 0.0 114.826 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 m -113.95 123.15 49.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.907 1.283 . . . . 0.0 111.364 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.01 -33.71 67.44 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.72 -10.28 59.3 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.88 -88.52 1.95 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.178 2.323 . . . . 0.0 113.053 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -65.96 135.27 54.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.42 -82.3 1.36 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.564 1.078 . . . . 0.0 115.139 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -137.36 154.63 49.98 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.199 1.4 . . . . 0.0 112.176 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -84.67 117.17 23.61 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.928 -0.482 . . . . 0.0 111.801 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.1 81.0 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.842 1.257 . . . . 0.0 108.755 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.74 -13.99 60.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 0.0 112.258 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.86 178.09 8.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.74 1.257 . . . . 0.0 113.648 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -137.25 154.09 50.21 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.918 -1.113 . . . . 0.0 112.339 171.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.12 143.94 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.772 0.796 . . . . 0.0 109.697 171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.79 -39.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.734 1.614 . . . . 0.0 110.861 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -146.46 148.89 32.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.52 1.528 . . . . 0.0 110.549 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 116.98 7.45 12.79 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 77.1 mmm -56.62 -36.21 69.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.584 1.692 . . . . 0.0 113.099 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -62.87 -30.3 71.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.631 0.773 . . . . 0.0 112.202 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.98 -40.93 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.044 1.738 . . . . 0.0 110.673 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.64 -39.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.034 0.934 . . . . 0.0 110.946 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.89 -25.57 61.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.993 1.317 . . . . 0.0 112.717 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -76.55 -42.86 41.45 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.12 1.368 . . . . 0.0 110.975 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.24 -34.45 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.877 1.271 . . . . 0.0 112.111 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -91.49 -14.68 30.03 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.57 -20.64 14.42 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.106 1.336 . . . . 0.0 114.332 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.92 -63.88 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 118.598 1.199 . . . . 0.0 112.172 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.42 155.79 5.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -137.19 152.17 49.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.993 1.317 . . . . 0.0 112.135 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.78 137.76 4.67 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.199 1.381 . . . . 0.0 111.404 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.57 145.18 55.89 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -169.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.0 p -98.97 169.7 9.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.439 1.896 . . . . 0.0 111.149 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.15 -4.44 8.08 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.301 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 49.7 tpp -123.17 -33.19 3.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.958 1.379 . . . . 0.0 114.057 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -141.43 133.67 27.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 110.723 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.05 152.97 18.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.7 t0 50.41 38.04 17.1 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.857 2.063 . . . . 0.0 114.564 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.97 161.24 44.6 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 125.472 1.509 . . . . 0.0 111.187 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -57.74 128.79 30.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 120.759 1.307 . . . . 0.0 110.248 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.74 45.28 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.55 159.45 26.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.615 0.766 . . . . 0.0 110.467 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.49 109.67 16.17 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.612 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.17 94.0 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.74 144.32 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -168.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.4 104.4 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 106.25 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.45 -41.02 61.53 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.811 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -151.21 166.26 31.4 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.48 141.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.052 1.741 . . . . 0.0 110.764 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.5 m -133.88 129.66 36.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.006 1.322 . . . . 0.0 110.243 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.04 120.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -109.64 137.98 46.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.706 1.202 . . . . 0.0 111.752 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.571 1.948 . . . . 0.0 112.151 -178.454 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.92 130.52 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 121.13 -0.981 . . . . 0.0 109.597 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 m -103.67 120.95 41.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.039 0.936 . . . . 0.0 110.087 172.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -92.4 119.51 32.01 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -93.88 119.07 32.31 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -121.82 160.54 24.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.976 0.893 . . . . 0.0 113.125 -169.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -73.06 -4.64 33.81 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -120.5 -20.07 7.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.441 1.497 . . . . 0.0 114.412 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.67 117.32 1.08 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.001 1.762 . . . . 0.0 110.771 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.88 145.7 55.35 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.531 0.732 . . . . 0.0 111.763 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.7 141.88 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.772 1.629 . . . . 0.0 109.664 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.08 134.09 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.465 1.106 . . . . 0.0 110.072 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.79 137.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.345 1.858 . . . . 0.0 110.102 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -105.57 123.36 47.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.446 1.898 . . . . 0.0 109.259 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.9 p -87.1 148.61 25.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.158 0.983 . . . . 0.0 112.005 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.13 72.9 0.9 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.888 1.328 . . . . 0.0 111.856 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.64 -25.58 64.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.536 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -77.25 -28.99 53.79 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.379 1.071 . . . . 0.0 111.566 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -99.29 -21.11 16.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.081 1.352 . . . . 0.0 113.406 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.52 56.22 1.31 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.274 1.029 . . . . 0.0 113.244 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.01 -45.07 25.72 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.478 2.785 . . . . 0.0 113.088 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.94 -41.29 74.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.646 0.657 . . . . 0.0 111.245 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.9 m -63.9 -48.27 77.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.551 0.74 . . . . 0.0 111.281 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.67 -43.41 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.717 0.807 . . . . 0.0 111.463 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -57.17 -45.32 83.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.816 1.189 . . . . 0.0 112.019 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -69.36 -36.8 77.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.512 0.596 . . . . 0.0 111.821 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.09 -48.91 79.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.342 1.057 . . . . 0.0 111.728 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.18 -36.84 80.24 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.269 -0.894 . . . . 0.0 111.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -58.45 -34.8 71.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 112.499 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -73.63 -43.34 59.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 112.161 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.8 m -58.38 -38.44 77.31 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.735 -0.603 . . . . 0.0 111.762 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -65.39 -35.77 81.94 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.327 2.251 . . . . 0.0 112.691 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -81.17 -16.03 54.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 0.0 113.046 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.69 19.36 63.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.962 0.792 . . . . 0.0 113.052 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.26 -37.61 75.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 113.036 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -78.37 -9.84 59.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.714 0.406 . . . . 0.0 111.892 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.27 131.04 48.05 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.297 -0.877 . . . . 0.0 108.844 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.5 t30 62.38 20.86 12.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.054 2.142 . . . . 0.0 116.7 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -82.05 144.54 30.75 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.741 -1.224 . . . . 0.0 113.414 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -101.14 155.92 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -86.41 72.97 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.87 2.068 . . . . 0.0 108.402 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -69.45 -9.61 54.41 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.62 125.26 45.29 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.572 1.149 . . . . 0.0 110.508 -172.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.95 131.01 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.767 1.227 . . . . 0.0 112.042 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.42 131.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.697 1.999 . . . . 0.0 108.182 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.06 138.14 54.13 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.624 0.77 . . . . 0.0 112.008 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.02 67.74 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.702 0.668 . . . . 0.0 114.641 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.12 -177.22 5.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.607 1.963 . . . . 0.0 110.316 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.29 177.86 6.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.218 1.807 . . . . 0.0 114.196 -171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 pt -116.39 140.82 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.896 1.278 . . . . 0.0 111.937 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -118.4 149.04 41.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.954 1.301 . . . . 0.0 111.372 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.6 -176.61 29.85 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.052 0.834 . . . . 0.0 114.978 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 -11.41 70.47 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.054 1.312 . . . . 0.0 115.632 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.32 60.06 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 118.879 1.34 . . . . 0.0 115.839 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.0 157.05 44.25 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -83.66 164.74 43.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 126.306 1.842 . . . . 0.0 109.32 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.04 -14.61 44.49 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.509 2.806 . . . . 0.0 117.087 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.71 18.83 56.81 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.438 1.018 . . . . 0.0 114.44 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.5 34.11 15.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.2 1.8 . . . . 0.0 112.94 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.32 131.22 37.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.389 1.476 . . . . 0.0 109.448 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.41 130.81 42.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 124.172 1.939 . . . . 0.0 111.603 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.85 -176.9 1.45 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 110.212 -3.176 . . . . 0.0 113.761 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.91 54.47 2.74 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.897 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 p -73.56 104.11 4.4 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.865 1.266 . . . . 0.0 111.571 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -133.47 178.44 6.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.872 2.069 . . . . 0.0 112.067 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.93 68.11 3.86 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.417 1.487 . . . . 0.0 113.798 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -61.95 138.31 72.73 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.168 2.579 . . . . 0.0 111.338 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.39 152.83 5.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 126.268 1.827 . . . . 0.0 108.024 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 155.05 27.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.153 0.502 . . . . 0.0 111.032 169.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.9 128.98 34.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.609 0.764 . . . . 0.0 111.124 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -111.12 15.13 21.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.942 1.297 . . . . 0.0 112.867 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -11.68 28.1 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -75.19 39.24 0.14 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -113.37 -6.49 13.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.21 . . . . 0.0 114.191 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.18 3.66 65.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.444 1.497 . . . . 0.0 115.2 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.19 158.24 19.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.606 1.203 . . . . 0.0 112.878 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.49 156.8 48.09 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.7 1.2 . . . . 0.0 113.521 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -90.25 93.21 9.25 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.496 1.918 . . . . 0.0 109.755 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.7 p -122.86 166.02 15.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.261 1.025 . . . . 0.0 111.319 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -55.37 114.38 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.265 1.826 . . . . 0.0 110.26 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 43.04 5.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.904 1.24 . . . . 0.0 114.633 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.7 p -134.91 165.46 25.26 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.842 1.321 . . . . 0.0 113.512 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mp -124.35 142.84 50.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 112.775 174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.6 156.72 47.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.724 -0.61 . . . . 0.0 111.853 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -83.94 136.93 33.89 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.175 -0.328 . . . . 0.0 111.258 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.66 155.25 20.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.717 0.807 . . . . 0.0 111.608 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -118.91 159.22 24.19 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.677 1.191 . . . . 0.0 112.674 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.3 m -72.25 -52.23 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.011 0.924 . . . . 0.0 110.805 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -159.56 -58.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.458 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.24 157.4 85.0 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 111.75 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -55.81 -34.69 92.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.841 2.36 . . . . 0.0 113.118 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -99.59 35.3 2.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.25 1.42 . . . . 0.0 112.917 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -123.35 27.53 7.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.506 1.522 . . . . 0.0 113.491 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 103.92 16.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.623 1.569 . . . . 0.0 109.638 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.5 p -88.41 -74.78 0.45 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.851 1.26 . . . . 0.0 112.519 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.71 -20.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.042 1.337 . . . . 0.0 113.643 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -71.04 145.32 50.0 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 121.029 -1.044 . . . . 0.0 112.441 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -141.81 168.06 20.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.32 1.848 . . . . 0.0 110.402 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -146.05 160.14 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.576 0.75 . . . . 0.0 111.753 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.5 mt -113.27 113.9 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.226 1.01 . . . . 0.0 108.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.78 93.88 2.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.989 . . . . 0.0 110.418 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.15 -23.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 163.67 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.483 1.513 . . . . 0.0 111.223 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -77.78 117.56 19.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.174 0.59 . . . . 0.0 109.8 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -143.64 64.95 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 123.113 1.435 . . . . 0.0 112.268 -169.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -66.31 -13.24 60.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -172.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.83 -13.82 38.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.654 -1.279 . . . . 0.0 113.453 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.02 -9.81 59.72 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.45 1.1 . . . . 0.0 113.949 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.12 -177.81 3.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -81.39 145.01 31.03 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.731 1.612 . . . . 0.0 111.785 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.4 p -111.75 -59.08 2.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.478 1.111 . . . . 0.0 113.468 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.16 61.49 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.068 0.842 . . . . 0.0 113.865 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.28 24.9 12.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.839 1.656 . . . . 0.0 114.791 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.6 t -104.56 121.22 43.04 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.165 . . . . 0.0 111.743 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -33.59 71.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -169.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -78.77 -9.16 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 -70.65 0.93 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.61 2.052 . . . . 0.0 113.94 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.327 7.0 p-90 -70.6 124.81 25.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.33 -91.31 1.36 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.427 1.489 . . . . 0.0 115.458 -169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -134.57 144.79 48.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.579 1.151 . . . . 0.0 112.041 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.5 t -83.67 124.06 30.45 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.978 -0.451 . . . . 0.0 112.066 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.29 88.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -78.09 -15.44 58.88 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.626 0.77 . . . . 0.0 112.14 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.23 177.87 8.68 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.599 1.19 . . . . 0.0 113.341 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -136.13 151.45 49.79 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.98 -1.075 . . . . 0.0 112.247 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.36 135.64 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.76 -40.95 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.9 1.68 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -144.28 144.71 31.62 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.19 1.396 . . . . 0.0 110.677 174.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.06 -0.09 10.69 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 124.737 1.161 . . . . 0.0 115.629 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -55.92 -37.59 69.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.435 1.618 . . . . 0.0 113.17 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.99 -34.14 75.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.703 0.801 . . . . 0.0 111.936 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.03 -39.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.16 1.784 . . . . 0.0 110.905 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.34 -39.32 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 121.204 -0.935 . . . . 0.0 111.121 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 8.8 t70 -74.3 -22.86 59.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.066 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.8 -43.2 47.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.939 1.295 . . . . 0.0 111.082 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.8 mt -54.69 -35.12 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.221 1.408 . . . . 0.0 112.195 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.2 pttp -90.31 -18.93 24.7 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -96.49 -22.06 20.13 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.977 1.275 . . . . 0.0 114.225 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.8 t -81.41 -63.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 118.378 1.089 . . . . 0.0 112.055 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -162.63 152.72 16.31 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 51.8 p -140.36 152.83 46.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.944 1.697 . . . . 0.0 111.619 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.16 132.34 1.75 Allowed Glycine 0 CA--C 1.53 1.004 0 N-CA-C 114.386 0.515 . . . . 0.0 114.386 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -61.85 152.61 31.22 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.452 1.501 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.4 t -141.99 102.18 4.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.708 1.203 . . . . 0.0 111.184 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.6 -120.8 23.13 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.165 0.888 . . . . 0.0 113.139 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.3 ttm -69.17 -21.15 64.0 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.876 1.27 . . . . 0.0 113.675 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -108.9 111.65 23.47 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.697 1.199 . . . . 0.0 110.917 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -96.84 156.21 16.45 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.325 1.05 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 57.76 38.62 27.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 113.76 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.3 156.92 43.25 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.335 1.454 . . . . 0.0 110.385 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.24 140.24 52.8 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -28.06 60.52 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.99 153.96 27.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.429 1.091 . . . . 0.0 110.257 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.2 109.68 11.26 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.007 -1.058 . . . . 0.0 110.788 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.24 94.28 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.828 1.251 . . . . 0.0 107.709 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.68 152.05 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.405 1.574 . . . . 0.0 113.756 -169.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.81 104.16 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.79 -39.77 66.43 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.116 -0.99 . . . . 0.0 111.01 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -152.3 170.88 18.97 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.16 143.15 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.505 1.522 . . . . 0.0 111.458 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.8 m -135.23 130.61 35.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 110.534 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.9 121.31 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -113.65 150.2 33.52 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.308 1.443 . . . . 0.0 112.525 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.317 1.447 . . . . 0.0 114.091 -169.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.72 129.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.889 0.876 . . . . 0.0 108.992 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.3 m -103.68 123.65 47.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.674 1.19 . . . . 0.0 109.891 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -97.35 132.01 43.48 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.562 1.145 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -104.99 98.71 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p -103.67 152.06 22.24 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.052 -0.405 . . . . 0.0 111.192 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -60.54 -10.35 4.95 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -103.62 -8.08 20.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.834 1.253 . . . . 0.0 113.748 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.8 165.98 12.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.921 1.724 . . . . 0.0 113.485 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.94 138.49 42.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.813 1.645 . . . . 0.0 112.949 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.93 139.26 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.271 1.828 . . . . 0.0 108.886 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -120.22 135.53 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.452 1.101 . . . . 0.0 110.002 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 138.51 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.499 1.919 . . . . 0.0 110.106 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -103.77 126.32 50.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.566 1.946 . . . . 0.0 108.912 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 p -90.29 147.96 23.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.34 1.056 . . . . 0.0 111.527 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.11 72.89 1.02 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.794 1.283 . . . . 0.0 111.35 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.56 -25.5 64.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.603 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -77.24 -24.84 51.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.464 1.105 . . . . 0.0 111.547 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -99.9 -28.1 13.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 112.381 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.68 57.9 3.0 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.803 0.841 . . . . 0.0 112.718 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -60.93 -43.42 30.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.593 2.862 . . . . 0.0 112.711 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -68.88 -40.83 79.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.819 0.736 . . . . 0.0 110.715 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.9 m -62.37 -50.37 71.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.691 0.796 . . . . 0.0 111.813 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.3 t -67.21 -38.89 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.131 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.49 -46.63 86.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.673 1.124 . . . . 0.0 111.422 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.88 -42.73 97.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.189 0.996 . . . . 0.0 111.977 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -59.27 -50.46 73.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.283 1.033 . . . . 0.0 111.619 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.22 -36.24 71.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.788 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.64 -38.07 71.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.728 0.811 . . . . 0.0 111.864 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.93 -40.77 60.64 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.727 -0.608 . . . . 0.0 112.339 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.3 m -61.34 -36.05 79.1 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.277 -0.89 . . . . 0.0 111.607 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -31.76 72.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.16 1.784 . . . . 0.0 112.93 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -81.61 -13.54 57.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.282 1.033 . . . . 0.0 113.476 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.77 18.3 61.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.51 1.052 . . . . 0.0 114.006 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.63 -17.53 62.87 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.34 -7.29 35.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.66 136.49 54.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.292 0.951 . . . . 0.0 109.154 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.5 t30 53.82 41.68 31.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.813 1.645 . . . . 0.0 114.586 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.9 p -102.11 167.31 10.1 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.908 0.883 . . . . 0.0 110.643 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 pt -125.56 160.71 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -83.95 80.54 9.13 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -66.41 -14.21 61.82 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -169.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -150.96 143.74 24.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.275 1.852 . . . . 0.0 113.877 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.44 147.44 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 128.064 2.546 . . . . 0.0 108.201 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.5 mt -130.76 130.71 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.862 1.665 . . . . 0.0 107.493 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -61.63 134.95 57.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.852 0.461 . . . . 0.0 111.087 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 8.6 65.02 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.44 -176.89 5.22 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.481 1.913 . . . . 0.0 111.341 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -179.39 7.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -169.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.2 pt -115.4 135.35 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.703 1.601 . . . . 0.0 112.364 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -112.64 149.0 33.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.491 1.516 . . . . 0.0 111.351 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.55 175.76 36.39 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.11 66.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.145 1.831 . . . . 0.0 115.443 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.79 -15.02 62.1 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 118.745 1.272 . . . . 0.0 115.819 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.68 164.83 31.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.659 1.229 . . . . 0.0 113.331 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.91 164.46 28.42 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.858 1.663 . . . . 0.0 110.703 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -61.78 -14.91 39.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.451 2.767 . . . . 0.0 117.927 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.22 17.89 58.38 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.169 0.89 . . . . 0.0 114.563 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 32.7 18.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.845 1.658 . . . . 0.0 112.569 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -88.87 130.96 35.31 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.751 1.62 . . . . 0.0 109.537 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.96 124.98 27.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.322 1.049 . . . . 0.0 111.511 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -76.3 167.7 21.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.698 1.199 . . . . 0.0 113.485 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.68 77.84 3.33 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.345 1.458 . . . . 0.0 111.361 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.7 p -72.41 95.01 1.7 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.852 1.261 . . . . 0.0 111.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -110.95 171.46 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.169 1.788 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 51.45 64.48 7.88 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.548 1.539 . . . . 0.0 114.088 169.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -60.15 139.17 85.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.237 2.625 . . . . 0.0 111.808 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -102.83 150.41 6.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.348 1.459 . . . . 0.0 108.519 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.0 161.67 22.92 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.766 0.827 . . . . 0.0 111.369 169.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -73.22 121.37 20.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.403 0.681 . . . . 0.0 111.664 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -105.02 15.88 26.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.837 1.255 . . . . 0.0 113.215 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -14.09 49.75 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.307 -1.496 . . . . 0.0 114.568 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.45 2.64 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.913 2.085 . . . . 0.0 116.139 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.31 -3.39 58.22 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.421 1.489 . . . . 0.0 112.866 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 26.85 49.47 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.229 0.919 . . . . 0.0 114.976 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.75 160.54 27.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.571 0.748 . . . . 0.0 112.861 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -127.48 155.24 44.04 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -103.73 73.5 1.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.942 2.097 . . . . 0.0 111.6 -170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.9 p -103.31 167.65 9.68 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.473 0.709 . . . . 0.0 111.46 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -57.45 127.14 30.5 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.923 0.868 . . . . 0.0 111.282 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.39 26.72 42.22 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.086 1.327 . . . . 0.0 114.828 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.3 p -115.43 159.62 20.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.456 1.628 . . . . 0.0 112.777 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.53 136.32 53.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -136.64 161.03 37.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.273 0.559 . . . . 0.0 111.706 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -81.06 139.29 35.79 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.962 -0.461 . . . . 0.0 111.457 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 168.89 11.36 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.884 1.274 . . . . 0.0 110.905 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -105.08 160.24 15.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.164 1.385 . . . . 0.0 112.452 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.1 m -83.64 -52.16 6.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 0.0 110.719 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -161.25 -50.21 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.277 1.431 . . . . 0.0 112.217 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -85.46 160.47 53.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.943 1.297 . . . . 0.0 112.501 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.07 -16.52 55.4 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.245 2.63 . . . . 0.0 115.217 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -124.78 47.28 2.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.708 1.603 . . . . 0.0 111.141 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.9 p -119.46 25.78 9.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.26 1.424 . . . . 0.0 114.393 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.32 93.68 0.87 Allowed 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.936 -1.103 . . . . 0.0 108.907 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.5 p -89.04 -52.21 5.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.626 0.77 . . . . 0.0 111.779 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.36 -5.04 0.19 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -80.43 134.32 35.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.984 -1.072 . . . . 0.0 110.07 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.79 168.4 19.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.486 1.914 . . . . 0.0 110.673 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 12.5 p90 -147.1 161.82 40.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 111.842 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.83 119.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -69.76 100.15 1.46 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.22 -17.91 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.403 -0.81 . . . . 0.0 113.146 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.06 168.14 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 127.923 2.489 . . . . 0.0 111.256 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -68.92 113.47 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.706 1.202 . . . . 0.0 112.138 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.41 54.18 1.49 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.966 1.706 . . . . 0.0 111.58 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.0 -26.27 65.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -62.54 -13.73 34.21 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -85.8 -6.42 59.11 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.653 1.181 . . . . 0.0 114.069 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -71.73 179.48 3.09 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.184 1.394 . . . . 0.0 114.425 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -85.72 143.9 28.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.821 1.248 . . . . 0.0 111.991 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.8 p -112.7 -60.15 1.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 113.419 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.61 61.26 0.03 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.797 0.713 . . . . 0.0 114.378 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.72 23.48 11.15 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.743 1.617 . . . . 0.0 115.02 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.6 t -105.36 123.05 47.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.399 1.08 . . . . 0.0 111.971 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.96 -31.2 66.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -81.23 -8.82 59.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.27 -73.22 0.98 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.732 2.11 . . . . 0.0 114.289 -173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 7.5 p-90 -70.23 127.77 33.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.32 -100.3 1.52 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.549 1.547 . . . . 0.0 115.688 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -126.3 150.6 48.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.667 1.587 . . . . 0.0 111.483 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.2 t -82.95 118.44 23.48 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.3 87.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.685 1.194 . . . . 0.0 108.227 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -78.71 -14.28 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.545 0.738 . . . . 0.0 112.234 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.89 177.62 7.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.626 1.203 . . . . 0.0 113.96 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -140.77 152.23 45.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.689 1.196 . . . . 0.0 112.345 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.91 142.89 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.598 0.713 . . . . 0.0 110.152 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.3 -41.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.86 1.664 . . . . 0.0 110.852 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -145.09 155.7 43.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.895 1.678 . . . . 0.0 109.682 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.31 23.13 Favored Glycine 0 N--CA 1.467 0.765 0 C-N-CA 123.867 0.746 . . . . 0.0 114.407 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -32.57 66.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.766 1.283 . . . . 0.0 112.325 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.83 -29.01 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 112.658 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.0 -40.05 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.315 1.446 . . . . 0.0 110.48 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.31 -39.41 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.803 -1.185 . . . . 0.0 110.982 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.35 -30.54 69.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -73.11 -44.51 60.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.829 1.252 . . . . 0.0 111.126 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.05 -25.03 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.432 1.493 . . . . 0.0 112.409 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -84.24 -25.45 29.41 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.16 -8.68 64.37 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.784 1.659 . . . . 0.0 114.747 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.3 -26.15 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 82.83 163.46 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.313 2.245 . . . . 0.0 114.376 -169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 68.3 p -111.8 151.05 29.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.135 1.374 . . . . 0.0 113.632 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -166.22 149.92 16.54 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 123.333 1.518 . . . . 0.0 112.537 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -64.78 144.55 57.17 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.067 2.147 . . . . 0.0 114.133 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.1 t -137.46 74.77 1.5 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.843 1.657 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.72 -113.09 5.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.015 0.817 . . . . 0.0 112.374 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 66.0 mtt -72.78 -13.63 61.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.573 1.149 . . . . 0.0 113.746 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -104.18 111.76 24.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.474 1.51 . . . . 0.0 110.127 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.21 148.0 28.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.266 1.427 . . . . 0.0 112.714 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 52.25 30.19 7.59 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.116 1.766 . . . . 0.0 114.847 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 m -79.97 156.1 74.81 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.708 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -59.36 135.74 67.3 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 120.756 1.306 . . . . 0.0 111.033 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -31.51 60.24 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.35 0.66 . . . . 0.0 112.687 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.48 147.87 35.65 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.486 0.714 . . . . 0.0 110.435 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.26 109.78 16.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.426 0.631 . . . . 0.0 110.027 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.41 100.14 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.85 141.22 42.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.525 1.13 . . . . 0.0 111.726 -169.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.3 103.41 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.39 -35.61 58.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.015 0.926 . . . . 0.0 110.859 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.56 165.01 34.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.12 139.59 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.205 1.802 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -135.39 130.31 34.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.775 1.23 . . . . 0.0 110.198 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.6 t -86.81 120.13 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t -114.18 147.3 39.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.027 1.331 . . . . 0.0 112.426 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.539 1.536 . . . . 0.0 113.46 -169.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 119.925 -0.083 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.76 128.2 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.979 0.912 . . . . 0.0 109.37 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.4 m -102.51 126.23 49.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 109.917 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -100.93 117.72 35.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.54 1.136 . . . . 0.0 109.329 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.25 112.53 24.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -118.81 163.89 16.21 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.479 0.656 . . . . 0.0 112.239 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -69.7 -6.29 30.72 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -118.65 -20.63 8.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 114.16 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.14 142.52 3.47 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 126.982 2.23 . . . . 0.0 113.64 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.88 136.26 47.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.65 1.18 . . . . 0.0 113.303 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.26 141.14 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.35 1.46 . . . . 0.0 109.596 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -124.92 136.34 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.912 1.285 . . . . 0.0 110.257 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -126.5 139.96 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 126.725 2.01 . . . . 0.0 110.1 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -107.14 124.72 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.587 1.955 . . . . 0.0 109.245 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -85.85 147.99 26.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.205 1.002 . . . . 0.0 111.555 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.93 74.85 1.01 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 122.651 1.215 . . . . 0.0 111.404 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.77 -26.23 64.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.503 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -77.75 -26.61 50.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.327 1.051 . . . . 0.0 111.712 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.85 -21.37 15.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.905 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.69 55.44 1.6 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.915 1.286 . . . . 0.0 113.069 -172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -60.63 -43.39 32.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.554 2.836 . . . . 0.0 112.953 -172.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -70.34 -41.11 73.62 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.553 0.615 . . . . 0.0 110.671 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.2 m -62.85 -52.37 63.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.676 0.39 . . . . 0.0 111.474 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.33 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 118.801 -0.618 . . . . 0.0 111.24 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -57.66 -48.16 80.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.569 1.077 . . . . 0.0 111.359 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.1 -41.17 82.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.954 0.902 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.18 -48.1 82.86 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.695 1.198 . . . . 0.0 111.682 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.96 -37.47 72.79 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.361 0.664 . . . . 0.0 111.415 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -59.08 -33.79 71.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.352 0.661 . . . . 0.0 112.607 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -73.77 -43.82 57.85 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.469 -0.77 . . . . 0.0 112.205 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.52 -37.19 82.83 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.33 -0.856 . . . . 0.0 111.503 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -62.61 -33.54 75.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.814 2.046 . . . . 0.0 112.883 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -83.79 -14.85 50.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.084 0.953 . . . . 0.0 113.503 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 17.5 53.5 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.082 0.849 . . . . 0.0 114.15 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -73.73 -18.47 60.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.196 1.498 . . . . 0.0 114.832 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -98.26 -6.6 30.79 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.2 -0.938 . . . . 0.0 112.35 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -71.57 129.33 38.48 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.934 -1.103 . . . . 0.0 108.792 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.7 43.99 17.95 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.089 1.355 . . . . 0.0 113.752 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.3 p -109.32 167.26 10.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.435 1.094 . . . . 0.0 111.829 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.8 pt -120.45 161.58 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.82 83.42 7.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.773 1.229 . . . . 0.0 108.177 168.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -60.8 -28.63 68.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.684 1.993 . . . . 0.0 115.025 -169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 149' ' ' ASP . 40.1 mmm-85 -132.0 136.55 47.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.787 1.176 . . . . 0.0 111.378 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.57 130.03 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.643 1.977 . . . . 0.0 110.944 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.3 mt -137.19 126.78 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 108.276 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.1 136.54 57.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.298 0.639 . . . . 0.0 111.628 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.24 9.23 63.61 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -142.54 -177.23 5.18 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.948 1.699 . . . . 0.0 111.025 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.93 179.89 6.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.835 1.654 . . . . 0.0 114.393 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.26 136.64 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.807 1.243 . . . . 0.0 112.364 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.55 141.96 34.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.661 1.184 . . . . 0.0 110.489 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.09 165.97 27.23 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 123.033 1.352 . . . . 0.0 115.801 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.62 -8.48 65.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.439 1.495 . . . . 0.0 115.831 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.54 -20.87 76.15 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.061 1.431 . . . . 0.0 116.065 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -143.68 170.06 16.56 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.757 1.278 . . . . 0.0 113.067 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -100.08 162.61 20.45 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 111.147 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.9 -13.26 29.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.838 3.025 . . . . 0.0 117.886 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 17.17 59.83 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.768 0.699 . . . . 0.0 114.389 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt 60.44 25.5 15.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.711 1.604 . . . . 0.0 112.967 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -82.77 125.17 30.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.58 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -76.08 120.28 21.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 110.952 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -72.15 163.85 27.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.226 1.011 . . . . 0.0 113.632 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.27 69.23 8.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.968 1.707 . . . . 0.0 111.542 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -72.84 130.3 40.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.514 1.526 . . . . 0.0 112.706 -173.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -133.56 174.87 9.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.467 1.907 . . . . 0.0 112.641 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 49.39 68.21 3.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.654 1.582 . . . . 0.0 114.009 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -61.14 133.93 49.72 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.171 2.581 . . . . 0.0 111.418 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.61 153.26 4.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.949 1.7 . . . . 0.0 108.012 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -74.83 161.2 29.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.54 0.336 . . . . 0.0 110.156 169.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.0 -42.88 69.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -168.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 61.34 -0.21 0.38 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.205 2.602 . . . . 0.0 117.717 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.39 -12.29 61.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.763 -1.836 . . . . 0.0 113.897 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -62.74 8.05 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.969 1.708 . . . . 0.0 115.101 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -79.21 -10.94 59.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.384 1.473 . . . . 0.0 112.832 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.6 81.35 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.055 1.312 . . . . 0.0 115.193 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.13 158.58 29.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.555 1.177 . . . . 0.0 112.535 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -128.53 150.3 50.23 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -87.15 65.44 8.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.477 1.911 . . . . 0.0 112.029 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.3 p -100.39 166.99 10.68 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.812 0.845 . . . . 0.0 112.424 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -52.27 123.22 10.2 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.699 1.599 . . . . 0.0 111.09 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.0 43.65 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 114.926 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.2 p -116.25 159.28 22.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.364 1.582 . . . . 0.0 113.682 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.95 134.72 55.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.826 0.85 . . . . 0.0 112.454 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.411 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -132.45 157.32 44.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 173.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -80.9 140.64 35.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.327 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.14 162.19 15.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.66 0.784 . . . . 0.0 111.231 172.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -129.75 164.65 23.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.461 1.104 . . . . 0.0 112.893 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.6 m -72.4 -54.54 9.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.67 0.788 . . . . 0.0 110.905 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.11 -52.13 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.627 1.571 . . . . 0.0 112.193 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.04 157.19 76.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.751 1.221 . . . . 0.0 111.776 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.2 -24.98 76.44 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.122 2.548 . . . . 0.0 114.296 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -109.12 33.64 4.17 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.478 1.511 . . . . 0.0 112.649 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.7 p -118.84 26.3 9.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.34 1.456 . . . . 0.0 113.88 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.51 100.85 13.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.209 1.404 . . . . 0.0 109.51 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.0 p -89.15 -57.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.065 0.946 . . . . 0.0 113.201 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -162.39 48.44 0.17 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -136.71 147.5 46.8 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.832 -1.167 . . . . 0.0 111.381 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.82 168.22 20.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.114 1.366 . . . . 0.0 111.78 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -147.61 162.44 39.12 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.239 0.616 . . . . 0.0 111.371 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.1 mt -116.05 115.85 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.053 0.941 . . . . 0.0 108.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -73.6 96.12 2.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.379 0.671 . . . . 0.0 110.062 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.42 -22.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.06 -1.025 . . . . 0.0 113.189 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.55 166.66 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.633 . . . . 0.0 110.862 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.71 114.73 13.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.326 0.584 . . . . 0.0 111.629 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -124.94 59.44 1.22 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.063 1.745 . . . . 0.0 111.554 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.09 -14.89 63.32 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.15 -14.05 62.53 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.849 -1.157 . . . . 0.0 113.266 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.2 -8.27 59.64 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.379 1.072 . . . . 0.0 113.695 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.36 -176.94 2.4 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -74.69 147.51 41.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.05 1.74 . . . . 0.0 113.034 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.4 p -103.15 -61.19 1.44 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.652 1.581 . . . . 0.0 113.107 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.27 56.2 0.01 OUTLIER Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.142 1.353 . . . . 0.0 112.618 -170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.61 28.26 15.41 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.209 1.804 . . . . 0.0 114.421 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.8 p -106.82 114.43 28.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.225 . . . . 0.0 111.222 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.22 -32.31 68.18 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.64 -14.89 60.38 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.05 -68.24 1.1 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.578 2.513 . . . . 0.0 113.604 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.348 2.4 p-90 -66.1 121.97 16.37 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.237 1.518 . . . . 0.0 112.958 -171.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.88 -85.72 1.26 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.371 1.463 . . . . 0.0 115.905 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -137.1 132.97 34.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.957 1.303 . . . . 0.0 111.79 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.59 128.78 34.79 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.58 90.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.574 1.15 . . . . 0.0 107.935 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -78.94 -14.86 58.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.716 0.806 . . . . 0.0 111.904 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.01 177.33 9.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.579 1.18 . . . . 0.0 112.929 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -136.31 153.99 50.99 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.592 -1.317 . . . . 0.0 112.232 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.33 140.01 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.591 0.71 . . . . 0.0 109.403 169.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.99 -42.24 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.704 1.602 . . . . 0.0 110.519 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.43 147.0 32.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.563 1.545 . . . . 0.0 109.902 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.12 7.15 10.4 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.523 0.969 . . . . 0.0 115.523 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -56.32 -37.51 70.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.695 1.747 . . . . 0.0 112.716 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.47 -29.03 70.23 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.84 0.856 . . . . 0.0 112.431 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.11 -44.98 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.423 1.489 . . . . 0.0 110.443 172.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.84 -38.52 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.165 -0.959 . . . . 0.0 111.25 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.84 -23.51 60.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 112.457 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -78.92 -42.4 27.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.191 1.396 . . . . 0.0 111.182 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -54.37 -35.52 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.558 1.143 . . . . 0.0 111.87 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -84.98 -18.14 35.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.1 15.41 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.179 1.371 . . . . 0.0 114.422 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.42 -57.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.806 1.303 . . . . 0.0 113.106 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.33 5.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 112.024 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.2 p -142.84 153.52 43.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.2 1.4 . . . . 0.0 112.119 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.84 121.93 0.72 Allowed Glycine 0 CA--C 1.532 1.136 0 O-C-N 122.135 -0.353 . . . . 0.0 113.234 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -65.5 158.99 25.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.816 1.246 . . . . 0.0 113.483 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.3 p -116.0 168.58 9.95 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 112.173 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.06 -21.56 75.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 123.578 0.609 . . . . 0.0 114.546 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.3 mmt -99.48 -35.61 9.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.31 1.044 . . . . 0.0 113.386 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.37 129.6 22.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.107 1.763 . . . . 0.0 110.482 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -96.81 158.12 15.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.273 1.029 . . . . 0.0 113.026 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.403 ' HB2' ' HE ' ' A' ' 43' ' ' ARG . 5.7 m-20 59.74 18.24 7.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.063 1.745 . . . . 0.0 114.697 -171.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m -70.69 149.14 95.28 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.966 -1.084 . . . . 0.0 111.597 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.08 143.79 55.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 121.711 1.607 . . . . 0.0 109.324 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.46 58.17 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.44 159.11 16.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.211 1.405 . . . . 0.0 110.216 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.51 112.57 17.98 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.854 -1.154 . . . . 0.0 111.477 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.6 94.21 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.15 147.49 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -168.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 63.8 mt -85.76 104.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.992 1.717 . . . . 0.0 107.988 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -78.94 -30.47 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.081 1.353 . . . . 0.0 112.612 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 t -155.29 162.43 40.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.06 0.944 . . . . 0.0 113.119 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.03 139.6 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.69 1.596 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.7 m -136.39 128.61 29.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.594 1.157 . . . . 0.0 110.779 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.79 118.08 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.2 t -112.63 150.19 31.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.635 1.574 . . . . 0.0 112.295 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.346 1.458 . . . . 0.0 113.627 -170.081 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.865 -0.588 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.39 130.27 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 120.684 1.584 . . . . 0.0 110.394 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -101.24 123.16 44.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.446 1.098 . . . . 0.0 110.346 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -97.83 130.73 44.73 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.977 1.311 . . . . 0.0 110.286 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -103.6 97.84 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -101.51 152.35 20.87 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.064 -0.398 . . . . 0.0 111.269 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -60.85 -9.09 3.62 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -107.49 -8.44 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 114.147 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.45 162.23 10.61 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 123.109 1.394 . . . . 0.0 113.653 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.13 137.72 45.34 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.452 1.501 . . . . 0.0 112.651 172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.91 140.77 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.392 1.877 . . . . 0.0 108.685 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.47 135.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.384 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.13 134.55 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.559 1.944 . . . . 0.0 110.473 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -101.73 127.64 48.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.138 1.775 . . . . 0.0 108.796 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.4 p -88.28 149.27 23.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.386 1.075 . . . . 0.0 111.25 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.81 73.26 0.94 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.898 1.332 . . . . 0.0 111.656 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.76 -26.14 64.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.518 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -78.14 -26.2 47.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.333 1.053 . . . . 0.0 111.638 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.77 -22.02 14.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 113.183 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.85 55.31 1.19 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.855 1.262 . . . . 0.0 113.674 -171.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.63 -42.98 35.38 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.532 2.821 . . . . 0.0 113.147 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.31 -38.04 78.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 111.043 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.3 m -68.28 -47.99 66.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.153 0.581 . . . . 0.0 111.904 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.48 -39.43 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.337 0.655 . . . . 0.0 111.6 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -52.64 -49.36 65.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.543 1.065 . . . . 0.0 112.104 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.6 -38.05 77.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.459 0.704 . . . . 0.0 111.562 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.01 -50.34 74.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.472 1.109 . . . . 0.0 111.82 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.31 -35.18 73.5 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.51 -0.744 . . . . 0.0 111.638 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.07 -33.19 70.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 112.694 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.54 -43.42 39.22 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.378 -0.826 . . . . 0.0 112.376 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -58.84 -40.36 84.01 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.731 -0.605 . . . . 0.0 111.706 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -61.03 -39.66 90.65 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.362 1.865 . . . . 0.0 113.387 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -77.48 -16.23 58.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.031 0.933 . . . . 0.0 112.632 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.9 62.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.988 0.804 . . . . 0.0 112.836 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.95 -35.76 75.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.53 1.165 . . . . 0.0 113.122 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.72 -8.61 59.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.733 0.413 . . . . 0.0 112.089 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.04 132.12 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.15 -0.969 . . . . 0.0 108.809 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 56.1 t30 58.17 30.82 19.95 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -170.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -88.61 167.24 13.54 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.6 162.58 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -89.11 82.72 6.57 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -70.95 -12.85 61.77 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -168.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -147.54 135.09 20.88 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.649 1.568 . . . . 0.0 112.679 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -135.45 147.61 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 127.235 2.214 . . . . 0.0 109.516 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.87 132.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.139 1.776 . . . . 0.0 107.376 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.34 133.41 55.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.355 0.662 . . . . 0.0 111.897 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.53 11.1 61.7 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.989 0.804 . . . . 0.0 115.039 -172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.63 -177.12 4.91 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 111.164 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -83.65 179.9 7.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -169.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.0 pt -115.24 136.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.075 1.75 . . . . 0.0 112.168 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -115.8 149.38 38.64 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.142 1.377 . . . . 0.0 111.413 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.49 179.99 30.2 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 122.164 0.869 . . . . 0.0 115.235 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.12 -2.14 87.47 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.627 1.108 . . . . 0.0 115.493 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -25.17 43.73 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 118.965 1.383 . . . . 0.0 115.095 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -143.5 164.83 29.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.89 164.34 16.68 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.469 1.908 . . . . 0.0 110.441 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.32 -11.53 25.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.468 2.778 . . . . 0.0 117.492 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.15 16.1 60.47 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.042 0.829 . . . . 0.0 114.575 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mmt 60.8 27.1 16.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.394 1.877 . . . . 0.0 113.16 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.49 126.92 33.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.915 1.286 . . . . 0.0 109.561 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.49 127.55 33.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 124.017 1.865 . . . . 0.0 111.002 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -71.23 174.83 5.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 110.494 -3.048 . . . . 0.0 114.95 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 47.79 1.55 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.649 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.5 p -69.75 119.56 14.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.493 1.117 . . . . 0.0 112.308 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -132.82 173.41 11.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.748 2.419 . . . . 0.0 111.377 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 44.61 73.43 0.97 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.829 1.652 . . . . 0.0 114.359 169.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.83 144.5 26.68 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.78 2.987 . . . . 0.0 113.523 171.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.18 150.96 6.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.197 1.799 . . . . 0.0 107.993 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 151.93 26.96 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.269 0.627 . . . . 0.0 110.049 169.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -74.7 116.48 15.45 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.89 -77.87 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.088 0.555 . . . . 0.0 110.08 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.66 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.934 3.293 . . . . 0.0 118.202 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -75.05 27.51 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.395 2.278 . . . . 0.0 114.327 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.33 -5.57 18.99 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.379 2.272 . . . . 0.0 113.961 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.04 82.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 115.379 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.47 155.65 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.354 1.077 . . . . 0.0 112.527 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.01 154.0 51.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -90.79 62.05 4.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.083 1.753 . . . . 0.0 112.059 -169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.6 p -96.72 169.07 10.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.75 0.82 . . . . 0.0 111.768 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -54.02 127.42 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.667 1.187 . . . . 0.0 111.268 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.84 29.23 55.17 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.78 1.181 . . . . 0.0 114.66 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.5 p -115.35 159.16 21.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.472 1.636 . . . . 0.0 112.912 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.87 137.22 52.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.976 0.893 . . . . 0.0 113.152 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -137.53 161.57 36.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.973 0.892 . . . . 0.0 111.693 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 138.48 31.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.242 1.417 . . . . 0.0 111.71 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.73 137.34 35.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.984 0.914 . . . . 0.0 112.45 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -81.15 155.93 25.97 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.431 1.492 . . . . 0.0 112.264 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -80.41 -55.15 5.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.191 0.996 . . . . 0.0 111.065 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -154.55 -54.87 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.475 1.51 . . . . 0.0 110.975 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.5 79.88 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.9 0.88 . . . . 0.0 111.318 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.29 -22.81 74.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.552 2.168 . . . . 0.0 114.292 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.72 37.05 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.692 1.597 . . . . 0.0 112.303 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.4 p -114.42 23.96 12.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.462 1.505 . . . . 0.0 113.691 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.25 97.79 9.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 109.173 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -83.57 -69.34 0.64 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.735 1.214 . . . . 0.0 111.868 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.44 -14.1 1.98 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 113.249 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -74.06 141.56 45.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.228 1.013 . . . . 0.0 111.821 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -141.75 168.17 20.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.093 2.157 . . . . 0.0 111.047 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 13.1 p90 -145.96 162.65 37.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.055 0.942 . . . . 0.0 111.638 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -116.57 118.85 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.583 1.153 . . . . 0.0 108.311 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -71.71 98.89 2.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.414 0.686 . . . . 0.0 109.737 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -75.2 -17.47 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 113.318 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.6 167.19 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 128.537 2.735 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -75.65 115.5 15.39 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.712 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -125.0 55.65 1.36 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.116 1.766 . . . . 0.0 111.991 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.08 -16.01 60.82 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -66.54 -14.45 62.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.83 -1.169 . . . . 0.0 113.45 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.4 mt -82.23 -9.07 59.63 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.621 1.169 . . . . 0.0 113.607 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -71.64 -178.74 2.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.155 1.382 . . . . 0.0 114.363 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -83.65 144.31 29.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.145 1.378 . . . . 0.0 113.107 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.3 p -104.46 -63.06 1.25 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.833 1.653 . . . . 0.0 112.911 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.83 55.32 0.01 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.316 1.436 . . . . 0.0 112.836 -170.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 57.95 26.51 13.49 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.934 1.693 . . . . 0.0 114.999 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 p -100.66 116.69 33.17 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.88 1.272 . . . . 0.0 110.939 174.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 tp -57.14 -34.89 68.86 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -79.87 -10.9 59.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.74 -72.74 1.21 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.132 2.301 . . . . 0.0 113.151 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.469 ' HB3' ' H ' ' A' ' 111' ' ' SER . 17.7 p-90 -71.88 131.42 42.98 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.13 -100.5 2.01 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.224 1.392 . . . . 0.0 114.857 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.32 141.65 51.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.116 1.366 . . . . 0.0 111.643 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 36.3 t -79.49 126.98 31.56 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.944 -0.473 . . . . 0.0 112.159 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.88 94.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -81.88 -14.41 56.24 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.301 0.64 . . . . 0.0 111.939 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 176.88 8.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.41 1.1 . . . . 0.0 113.88 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -139.76 153.78 47.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.447 1.099 . . . . 0.0 112.647 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.03 140.18 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.599 0.714 . . . . 0.0 110.132 170.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.62 -42.28 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.091 1.756 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -144.72 155.26 43.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.552 1.541 . . . . 0.0 109.771 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.67 15.78 28.33 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 123.878 0.752 . . . . 0.0 113.964 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -34.95 67.87 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.761 1.28 . . . . 0.0 112.319 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.69 -29.41 69.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.581 0.753 . . . . 0.0 112.657 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.37 -42.63 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.229 1.412 . . . . 0.0 110.278 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.96 -39.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.957 . . . . 0.0 111.357 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.42 -21.24 61.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.689 1.596 . . . . 0.0 112.71 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -86.32 -43.72 12.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.769 1.628 . . . . 0.0 111.447 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.16 -29.1 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.416 1.486 . . . . 0.0 112.585 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -81.29 -16.49 52.34 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.91 -2.35 11.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.311 1.434 . . . . 0.0 114.544 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.82 -55.07 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.039 1.419 . . . . 0.0 112.012 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 177.93 148.4 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.686 1.995 . . . . 0.0 111.258 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 p -121.66 149.86 42.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.348 1.459 . . . . 0.0 112.947 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.18 134.84 1.78 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.875 1.226 . . . . 0.0 112.141 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -61.97 144.78 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.034 0.934 . . . . 0.0 113.323 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.8 p -98.32 169.49 9.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.959 1.704 . . . . 0.0 111.519 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.71 -7.89 30.72 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.002 -0.888 . . . . 0.0 115.221 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 62.6 mtm -125.51 -24.09 3.96 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.918 1.359 . . . . 0.0 114.536 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -141.42 129.22 21.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.388 1.475 . . . . 0.0 110.6 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -96.0 153.3 17.84 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.6 t0 55.6 54.55 8.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.473 1.509 . . . . 0.0 112.972 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.89 159.17 45.67 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.495 1.918 . . . . 0.0 111.515 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.4 130.49 23.93 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.088 1.192 . . . . 0.0 109.364 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -26.6 30.7 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.87 140.8 42.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.62 0.768 . . . . 0.0 109.418 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.38 109.83 17.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.419 0.628 . . . . 0.0 110.78 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.95 107.51 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.63 142.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 124.417 1.087 . . . . 0.0 111.446 -170.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.25 103.41 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.68 -37.72 62.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.21 0.604 . . . . 0.0 110.831 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 t -152.32 165.77 33.91 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 t -138.86 141.6 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.945 1.698 . . . . 0.0 110.641 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -134.0 126.1 29.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.022 1.329 . . . . 0.0 110.087 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.84 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -115.4 150.23 36.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.299 1.44 . . . . 0.0 112.412 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.429 1.492 . . . . 0.0 113.614 -169.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.17 126.39 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -97.97 124.91 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.939 1.296 . . . . 0.0 109.892 173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.95 121.69 42.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 109.974 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -97.2 108.76 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -120.16 159.61 24.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -68.54 -8.57 42.67 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -109.17 -25.28 10.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 113.677 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.74 145.16 4.12 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.479 1.99 . . . . 0.0 113.402 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.7 133.74 36.54 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.268 -1.136 . . . . 0.0 112.672 172.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.12 143.38 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.95 1.7 . . . . 0.0 109.252 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.8 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.308 1.043 . . . . 0.0 110.239 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.71 139.56 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.698 1.999 . . . . 0.0 110.265 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -104.09 124.55 49.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 108.132 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -85.87 148.81 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 111.547 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -106.89 73.41 0.94 Allowed 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.78 1.276 . . . . 0.0 111.608 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.72 -26.49 64.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.413 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.5 -27.14 51.75 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.327 1.051 . . . . 0.0 111.412 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -99.31 -24.64 14.76 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.213 1.405 . . . . 0.0 112.922 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.48 57.77 2.26 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.404 1.082 . . . . 0.0 113.162 -169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.66 -44.38 26.76 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.232 2.621 . . . . 0.0 112.906 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -71.95 -39.78 69.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.756 0.707 . . . . 0.0 111.38 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -64.04 -47.54 79.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 111.215 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.26 -42.37 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.612 0.765 . . . . 0.0 111.595 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -54.89 -47.42 74.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.764 1.166 . . . . 0.0 111.967 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -71.18 -36.01 71.82 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.339 0.518 . . . . 0.0 112.032 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.63 -48.88 79.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.134 0.974 . . . . 0.0 111.611 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.64 -36.05 73.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.4 -0.812 . . . . 0.0 111.826 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -58.67 -35.32 72.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.586 0.755 . . . . 0.0 112.338 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.394 -0.816 . . . . 0.0 111.958 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -58.84 -38.11 77.97 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.665 -0.647 . . . . 0.0 111.808 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -65.69 -35.83 81.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.053 2.141 . . . . 0.0 112.703 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -81.63 -16.02 52.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.704 0.802 . . . . 0.0 113.107 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.29 20.24 60.92 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.295 0.95 . . . . 0.0 113.215 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.12 -38.47 76.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.371 1.068 . . . . 0.0 113.179 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -82.12 -7.75 59.63 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.044 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.53 130.35 42.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.2 t30 55.08 46.78 23.39 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 114.262 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.6 p -110.62 162.51 14.66 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.301 1.04 . . . . 0.0 111.489 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.2 pt -122.72 161.85 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -86.45 81.85 8.16 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.843 1.257 . . . . 0.0 107.609 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -71.96 -7.96 51.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -146.0 135.22 22.83 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.55 1.523 . . . . 0.0 112.183 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.61 143.48 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.784 2.034 . . . . 0.0 110.556 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.35 129.72 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.853 1.661 . . . . 0.0 108.135 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -62.96 129.35 39.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.538 0.735 . . . . 0.0 111.65 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.61 10.48 67.14 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -142.49 -177.19 5.16 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.152 1.781 . . . . 0.0 110.765 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -81.71 178.82 8.11 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -169.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.29 135.81 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.679 1.591 . . . . 0.0 112.17 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -110.29 150.85 28.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.728 1.211 . . . . 0.0 111.206 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.68 175.79 33.42 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.33 2.9 85.06 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.329 1.442 . . . . 0.0 115.411 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.14 -26.14 49.45 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 118.953 1.377 . . . . 0.0 114.509 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.11 164.62 30.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.256 1.022 . . . . 0.0 113.396 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -97.41 164.59 17.36 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.768 1.627 . . . . 0.0 110.145 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -61.27 -15.26 39.1 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.51 2.807 . . . . 0.0 118.196 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.22 16.68 58.23 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.887 0.756 . . . . 0.0 114.284 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.6 mmm 58.1 37.85 26.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.818 2.047 . . . . 0.0 113.331 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -83.25 123.06 29.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.919 1.288 . . . . 0.0 109.122 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.41 119.94 17.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 124.196 1.951 . . . . 0.0 110.337 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.62 179.7 1.64 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 110.332 -3.122 . . . . 0.0 114.513 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 61.66 6.75 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.166 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -69.48 106.43 2.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.179 1.392 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.65 168.27 20.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.806 2.043 . . . . 0.0 111.995 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 49.12 61.35 14.17 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 113.007 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.4 129.85 36.88 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.731 2.954 . . . . 0.0 111.507 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.95 153.23 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.209 1.804 . . . . 0.0 108.154 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 162.66 18.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 112.19 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -76.5 123.07 25.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.796 0.838 . . . . 0.0 110.943 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.13 15.22 22.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.0 112.89 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -12.38 58.52 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.618 -1.301 . . . . 0.0 114.288 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -62.88 6.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 114.438 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -77.46 -11.54 59.86 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.134 1.774 . . . . 0.0 113.211 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.92 69.34 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.737 1.161 . . . . 0.0 114.891 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.39 156.93 26.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.882 1.341 . . . . 0.0 112.936 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -125.51 149.65 48.11 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -89.31 66.5 7.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 111.417 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.0 p -95.07 163.87 13.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.537 0.735 . . . . 0.0 111.514 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 124.88 15.74 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.765 0.793 . . . . 0.0 111.33 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.11 46.32 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.374 1.464 . . . . 0.0 115.391 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.0 p -115.17 160.37 19.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.627 1.713 . . . . 0.0 113.536 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.31 134.64 55.1 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -131.68 157.41 43.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.346 0.658 . . . . 0.0 111.381 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 35.7 mtp -84.23 138.1 33.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.223 -0.298 . . . . 0.0 111.061 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.52 155.83 17.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.161 0.985 . . . . 0.0 111.381 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -117.17 164.42 14.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.491 1.116 . . . . 0.0 113.2 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.8 m -76.66 -58.33 3.34 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.195 0.998 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -152.89 -58.31 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.991 1.716 . . . . 0.0 110.879 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.12 156.87 79.07 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.864 1.265 . . . . 0.0 112.047 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.66 -26.09 71.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.48 2.787 . . . . 0.0 114.249 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -108.18 33.37 4.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.507 1.523 . . . . 0.0 112.758 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -118.55 28.82 8.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.452 1.501 . . . . 0.0 113.693 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.13 106.28 18.26 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.732 1.613 . . . . 0.0 109.427 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.5 p -94.0 -69.02 0.77 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 0.0 113.139 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.81 -24.84 2.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.5 mp0 -67.06 140.58 57.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.528 1.131 . . . . 0.0 111.27 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -136.83 168.39 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.123 1.769 . . . . 0.0 110.358 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.442 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 10.9 p90 -143.23 162.04 36.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.247 0.619 . . . . 0.0 111.552 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.3 mt -114.38 118.89 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -70.12 96.76 1.1 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -73.71 -17.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.299 -0.876 . . . . 0.0 113.117 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -134.47 165.72 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 128.259 2.624 . . . . 0.0 110.78 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.57 116.58 14.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.758 0.823 . . . . 0.0 111.549 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -123.42 63.41 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.371 1.468 . . . . 0.0 112.535 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -52.34 -35.16 50.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.342 1.457 . . . . 0.0 114.327 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -65.61 -13.72 59.67 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.85 -9.05 58.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -74.01 -178.86 3.48 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -171.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -78.89 150.82 32.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.34 1.456 . . . . 0.0 112.839 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -127.48 -39.92 1.82 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.99 63.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.944 0.793 . . . . 0.0 114.205 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 53.66 24.0 3.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.142 1.777 . . . . 0.0 115.151 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.3 m -116.19 119.84 37.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.054 1.342 . . . . 0.0 110.573 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.37 -32.61 62.73 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -75.41 -12.26 60.21 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.24 -78.7 1.42 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.116 2.293 . . . . 0.0 113.743 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.286 5.4 p-90 -66.43 128.61 36.84 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.55 -105.98 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.928 1.728 . . . . 0.0 114.86 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.24 141.06 51.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.533 1.533 . . . . 0.0 111.672 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -85.15 124.58 31.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -73.59 97.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 108.414 170.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -79.76 -15.94 56.52 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.544 0.737 . . . . 0.0 111.656 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.83 8.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.567 1.175 . . . . 0.0 113.843 -170.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -139.95 153.71 46.99 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.563 -1.335 . . . . 0.0 112.466 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.46 137.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.723 0.773 . . . . 0.0 109.924 170.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.13 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.331 1.852 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -141.74 148.65 39.35 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.521 1.528 . . . . 0.0 110.031 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.89 13.2 20.63 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.944 0.783 . . . . 0.0 114.87 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 69.5 mmm -54.69 -38.06 66.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.405 1.602 . . . . 0.0 112.377 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.76 -29.04 70.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.049 0.94 . . . . 0.0 112.439 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.98 -43.55 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.689 1.596 . . . . 0.0 110.336 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.18 -38.4 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.218 1.007 . . . . 0.0 111.198 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.9 -22.26 60.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.585 1.554 . . . . 0.0 112.857 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -81.39 -43.86 18.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.368 1.467 . . . . 0.0 111.395 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.5 mt -55.18 -33.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.097 1.359 . . . . 0.0 112.045 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -85.17 -16.59 39.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.35 12.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.166 1.365 . . . . 0.0 114.268 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.5 m -72.81 -57.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.607 1.203 . . . . 0.0 113.613 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.68 156.51 7.89 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.994 0.917 . . . . 0.0 113.324 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.9 p -141.71 152.13 43.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.392 1.477 . . . . 0.0 111.972 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.25 133.27 1.65 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.114 0.387 . . . . 0.0 113.263 171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -61.82 149.29 40.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.876 1.27 . . . . 0.0 112.99 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.3 p -110.47 168.89 9.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.193 1.397 . . . . 0.0 111.742 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.21 -22.2 72.51 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.699 0.639 . . . . 0.0 114.699 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.8 ttm -105.49 -34.32 7.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.517 1.127 . . . . 0.0 113.375 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -136.72 124.47 22.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.881 1.672 . . . . 0.0 110.598 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -92.23 156.75 17.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.492 1.117 . . . . 0.0 112.452 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 56.35 54.62 7.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.521 1.528 . . . . 0.0 113.481 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.14 159.49 49.29 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 127.203 2.201 . . . . 0.0 111.354 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.0 135.36 34.71 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 121.378 1.385 . . . . 0.0 109.548 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -29.59 48.76 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 154.23 22.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 110.636 169.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -84.53 109.61 18.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.998 0.904 . . . . 0.0 111.312 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.19 94.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.5 141.67 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -168.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.48 103.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.596 1.958 . . . . 0.0 106.786 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.02 -39.8 60.88 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.614 -0.679 . . . . 0.0 111.119 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -150.07 165.99 31.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -137.97 142.1 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.745 1.618 . . . . 0.0 111.001 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.7 m -136.33 129.59 31.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.766 1.227 . . . . 0.0 110.384 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.74 122.55 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -118.88 150.45 39.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.705 1.602 . . . . 0.0 112.044 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.628 1.171 . . . . 0.0 113.699 -172.331 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.31 124.75 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.97 0.908 . . . . 0.0 109.575 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 125.19 45.95 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.967 0.907 . . . . 0.0 110.314 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -96.87 135.34 38.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.674 1.19 . . . . 0.0 110.6 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -105.82 101.43 10.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -106.36 151.96 24.2 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.075 -0.39 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.83 -8.09 2.82 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -105.38 -10.46 16.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.781 1.232 . . . . 0.0 114.03 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.59 162.16 10.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.124 1.345 . . . . 0.0 113.592 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.21 138.1 45.42 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.667 1.587 . . . . 0.0 112.401 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.6 mt -135.61 140.36 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.299 1.84 . . . . 0.0 108.9 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.77 133.26 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.583 1.153 . . . . 0.0 110.682 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.54 139.16 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.551 1.94 . . . . 0.0 109.909 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -101.5 129.45 47.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.884 2.074 . . . . 0.0 108.452 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -93.43 145.98 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.412 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -103.96 72.08 1.08 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.897 1.332 . . . . 0.0 111.699 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.97 -26.13 63.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.502 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -77.58 -29.43 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.201 1.001 . . . . 0.0 111.698 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.7 -20.74 16.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.943 1.297 . . . . 0.0 113.285 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.65 56.79 1.55 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.516 1.126 . . . . 0.0 113.224 -171.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.18 -45.3 23.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.433 2.756 . . . . 0.0 113.116 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -69.48 -39.73 77.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.784 0.72 . . . . 0.0 111.449 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -63.44 -48.26 78.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.723 0.809 . . . . 0.0 111.24 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.17 -41.23 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.408 0.683 . . . . 0.0 111.512 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -54.42 -48.47 71.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.705 1.139 . . . . 0.0 112.329 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -70.56 -35.99 73.38 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.608 0.64 . . . . 0.0 111.922 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.84 -50.92 71.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.447 1.099 . . . . 0.0 111.418 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 -36.35 73.17 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.697 0.799 . . . . 0.0 111.959 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.89 -34.8 70.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -76.27 -39.19 54.97 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.519 -0.738 . . . . 0.0 112.442 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.45 -35.77 76.64 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.11 -0.994 . . . . 0.0 111.565 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -31.08 71.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.105 1.762 . . . . 0.0 112.763 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.21 -14.31 57.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.225 1.01 . . . . 0.0 113.345 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.52 15.38 62.0 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.69 1.138 . . . . 0.0 114.04 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -68.17 -18.96 64.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.438 1.495 . . . . 0.0 114.689 -171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.78 -13.5 21.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.23 1.71 8.81 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -145.24 49.38 1.26 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.28 1.432 . . . . 0.0 111.055 170.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.9 p -113.57 170.39 8.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.36 162.2 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -103.15 130.93 50.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.647 1.579 . . . . 0.0 107.368 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.96 -40.39 1.51 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -87.66 116.81 26.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.609 1.095 . . . . 0.0 109.627 -175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.03 129.75 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.489 1.516 . . . . 0.0 110.413 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.7 mt -141.47 129.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.021 1.728 . . . . 0.0 107.856 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -65.96 134.94 54.01 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.697 0.799 . . . . 0.0 111.819 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.5 13.5 68.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.811 0.72 . . . . 0.0 114.79 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -142.98 -177.32 5.28 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.903 1.681 . . . . 0.0 111.542 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.58 179.93 6.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.12 1.768 . . . . 0.0 114.975 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.0 pt -120.83 142.63 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -118.19 147.7 43.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 112.225 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.34 -177.6 30.61 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 122.151 0.862 . . . . 0.0 115.216 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.74 -5.82 82.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.362 1.458 . . . . 0.0 115.622 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.01 -16.08 63.8 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 -169.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.05 163.76 34.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.805 1.302 . . . . 0.0 112.366 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.13 163.0 30.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.303 1.041 . . . . 0.0 111.11 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.54 -12.9 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.187 3.258 . . . . 0.0 117.33 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.47 13.55 67.0 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.074 0.845 . . . . 0.0 114.833 172.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.8 mmt 59.71 29.64 19.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.374 1.87 . . . . 0.0 112.868 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -81.24 124.08 29.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.827 1.251 . . . . 0.0 109.197 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -72.97 114.72 11.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.535 0.734 . . . . 0.0 109.88 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -71.99 165.2 24.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.59 73.29 10.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.798 1.639 . . . . 0.0 111.033 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -70.41 129.31 38.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.864 0.866 . . . . 0.0 111.09 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -140.29 172.09 13.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.545 1.938 . . . . 0.0 111.513 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 48.42 62.66 11.71 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.396 1.478 . . . . 0.0 113.127 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -55.87 129.23 33.84 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.125 2.55 . . . . 0.0 110.339 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.63 149.18 4.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 107.536 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 158.45 27.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.691 0.758 . . . . 0.0 111.133 171.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -85.24 131.06 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.334 1.054 . . . . 0.0 111.217 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.36 15.92 17.92 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.224 1.01 . . . . 0.0 112.715 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.01 -11.36 28.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -74.43 40.41 0.13 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.932 1.693 . . . . 0.0 112.173 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -117.88 -3.48 11.18 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.419 2.287 . . . . 0.0 114.006 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.63 4.55 72.96 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.48 1.514 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.91 157.64 20.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.614 1.207 . . . . 0.0 113.124 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.04 158.85 43.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.616 1.166 . . . . 0.0 113.754 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -94.78 102.25 14.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.983 1.713 . . . . 0.0 110.563 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.4 p -133.5 168.03 19.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.787 1.235 . . . . 0.0 111.663 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.95 121.49 7.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.848 1.259 . . . . 0.0 110.692 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.91 24.54 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.503 1.525 . . . . 0.0 114.992 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.4 p -122.31 159.96 26.34 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.38 1.59 . . . . 0.0 113.734 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -122.24 139.49 53.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.836 0.854 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -138.46 159.24 42.57 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.843 -0.536 . . . . 0.0 111.881 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.9 mmm -78.75 137.7 37.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.919 0.488 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.69 148.85 29.99 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.122 0.569 . . . . 0.0 110.978 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.19 162.55 18.48 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.995 1.318 . . . . 0.0 112.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.6 m -77.37 -55.48 5.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.872 0.869 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.3 -56.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.977 1.311 . . . . 0.0 111.069 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.66 157.27 86.17 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 111.556 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.96 -35.53 94.49 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.869 2.379 . . . . 0.0 113.671 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -98.82 32.62 2.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.965 1.706 . . . . 0.0 113.359 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.5 p -117.24 33.91 5.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.006 1.322 . . . . 0.0 113.426 -173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.12 109.79 21.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.793 1.637 . . . . 0.0 110.186 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 p -94.94 -66.94 0.88 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.264 1.425 . . . . 0.0 113.449 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.67 -22.64 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.52 145.18 47.66 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 120.574 -1.329 . . . . 0.0 112.088 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -140.32 168.22 20.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 127.409 2.283 . . . . 0.0 109.611 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 11.9 p90 -144.81 159.9 42.13 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.125 0.57 . . . . 0.0 111.703 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.52 117.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 0.0 108.273 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.78 111.44 14.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.642 0.777 . . . . 0.0 110.707 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.13 -6.32 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 m -129.11 165.06 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.895 1.678 . . . . 0.0 111.154 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -80.27 117.4 21.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.89 0.476 . . . . 0.0 109.917 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -142.14 63.92 1.4 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.019 1.39 . . . . 0.0 111.822 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.31 -13.52 60.64 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -172.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.88 -14.03 41.41 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.689 -1.257 . . . . 0.0 113.427 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.01 -10.51 59.78 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.53 1.132 . . . . 0.0 113.729 173.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -75.44 -176.45 3.18 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -82.1 143.7 31.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.693 1.597 . . . . 0.0 112.288 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.4 p -108.62 -59.28 1.89 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.499 1.119 . . . . 0.0 113.631 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.6 60.94 0.02 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.081 0.848 . . . . 0.0 114.161 -172.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 58.39 23.51 10.67 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.012 1.725 . . . . 0.0 115.05 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 t -101.78 122.18 43.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.857 1.263 . . . . 0.0 111.848 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.1 tp -52.43 -43.46 64.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.907 1.283 . . . . 0.0 114.152 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -81.92 -6.61 59.25 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 113.785 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.49 -69.9 1.08 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.705 2.098 . . . . 0.0 113.893 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.288 8.3 p-90 -72.07 130.53 41.14 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -171.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.7 -98.54 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.629 1.585 . . . . 0.0 116.506 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -126.31 139.83 53.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.957 1.303 . . . . 0.0 111.809 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.94 122.85 28.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.878 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.75 89.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.551 1.14 . . . . 0.0 108.182 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.43 -15.22 59.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.369 0.667 . . . . 0.0 112.36 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.72 175.8 9.39 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -138.11 152.65 48.96 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.965 -1.085 . . . . 0.0 112.458 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.37 139.63 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.542 0.687 . . . . 0.0 110.476 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.95 -43.34 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.388 1.475 . . . . 0.0 111.165 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -145.96 154.02 41.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.379 1.472 . . . . 0.0 110.339 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.88 15.06 29.8 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.009 0.814 . . . . 0.0 113.395 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 23.0 mtp -57.84 -34.64 69.93 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.65 1.18 . . . . 0.0 111.938 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.55 -31.44 72.5 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.921 0.888 . . . . 0.0 112.407 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t -72.16 -43.12 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.444 1.097 . . . . 0.0 109.89 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.585 -0.697 . . . . 0.0 111.001 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.44 -26.38 61.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.82 1.248 . . . . 0.0 112.644 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -78.32 -41.39 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.054 1.342 . . . . 0.0 110.978 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mt -55.7 -30.1 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.447 1.899 . . . . 0.0 112.772 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -92.76 -11.1 34.71 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.04 -11.95 13.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.509 1.528 . . . . 0.0 114.413 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.16 -59.32 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.572 1.186 . . . . 0.0 112.799 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.94 143.22 0.93 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 112.431 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.0 p -112.07 148.75 33.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.435 1.494 . . . . 0.0 112.587 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.97 144.1 3.97 Favored Glycine 0 N--CA 1.464 0.526 0 CA-C-O 123.198 1.444 . . . . 0.0 113.7 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -61.83 144.25 55.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.405 2.282 . . . . 0.0 113.347 -169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.4 t -107.43 158.72 16.96 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.053 1.741 . . . . 0.0 110.936 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.7 -16.02 62.87 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.578 -0.702 . . . . 0.0 114.069 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.11 -22.26 10.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.025 1.33 . . . . 0.0 114.407 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -141.56 140.77 33.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.176 1.39 . . . . 0.0 111.519 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.65 154.37 22.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.392 1.477 . . . . 0.0 111.778 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 56.81 49.2 14.65 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.907 1.683 . . . . 0.0 113.558 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.17 158.77 54.49 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 126.239 1.816 . . . . 0.0 112.414 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.87 137.66 45.83 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 121.66 1.573 . . . . 0.0 109.858 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -27.64 43.04 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.768 -0.582 . . . . 0.0 112.281 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.72 140.71 44.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 109.635 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -84.22 130.44 34.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.67 0.748 . . . . 0.0 109.836 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.15 109.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.329 1.452 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.89 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.384 1.074 . . . . 0.0 111.566 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 mt -84.07 103.83 11.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.75 -28.35 60.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.2 t -163.89 169.53 18.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.38 140.07 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.496 1.919 . . . . 0.0 110.416 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.8 m -130.04 124.96 34.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 109.891 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.68 123.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -115.58 150.39 36.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.808 1.243 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.775 1.63 . . . . 0.0 113.413 -169.812 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.69 127.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.236 -0.915 . . . . 0.0 109.545 169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -102.35 120.92 41.3 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 110.119 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.7 132.12 41.23 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 110.843 169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -104.51 101.42 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -106.42 152.21 23.91 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.066 -0.396 . . . . 0.0 111.193 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.48 -9.77 4.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.93 -7.55 19.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 0.0 114.027 170.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.29 166.69 12.26 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.864 1.697 . . . . 0.0 113.683 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.09 137.6 41.53 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.097 1.759 . . . . 0.0 113.044 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -133.09 141.15 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.586 1.954 . . . . 0.0 108.971 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.49 135.78 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.457 1.103 . . . . 0.0 110.359 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 mt -122.98 139.84 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 126.339 1.855 . . . . 0.0 110.162 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -107.21 123.57 48.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.168 1.787 . . . . 0.0 109.113 172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.0 p -87.85 148.1 24.81 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.486 1.115 . . . . 0.0 111.914 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -105.73 73.66 1.02 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 122.655 1.217 . . . . 0.0 111.209 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.31 -26.06 64.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.581 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.99 -24.45 47.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.327 1.051 . . . . 0.0 111.595 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.2 -21.98 13.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.342 1.457 . . . . 0.0 112.862 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.65 55.59 1.81 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.199 1.4 . . . . 0.0 112.982 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.64 -43.77 30.53 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.509 2.806 . . . . 0.0 112.762 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -69.54 -40.09 77.08 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.006 0.821 . . . . 0.0 111.055 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -63.57 -49.37 73.68 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.947 0.499 . . . . 0.0 111.423 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.23 -38.05 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.399 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -55.74 -50.43 70.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.503 1.047 . . . . 0.0 111.433 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.6 -48.28 82.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.914 1.286 . . . . 0.0 111.199 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.17 -50.52 73.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 111.171 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -73.12 -36.07 66.67 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.524 0.73 . . . . 0.0 111.654 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -58.8 -36.33 74.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.949 0.5 . . . . 0.0 111.601 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 2.9 m-85 -77.75 -39.36 44.58 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 76.1 m -61.48 -36.33 80.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.967 . . . . 0.0 111.46 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -34.2 77.07 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 112.765 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.21 -14.06 57.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.367 1.067 . . . . 0.0 113.404 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.09 16.91 62.04 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.871 1.224 . . . . 0.0 114.258 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 45.9 t80 -71.81 -17.59 62.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -93.74 -12.81 28.36 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.98 2.94 7.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -146.12 43.92 1.23 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.229 1.412 . . . . 0.0 111.357 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 p -104.8 169.45 8.44 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.262 -0.899 . . . . 0.0 112.923 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.8 pt -127.85 163.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -89.29 119.16 29.51 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -93.08 -30.52 15.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.46 1.504 . . . . 0.0 114.289 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -133.99 138.93 45.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.997 0.919 . . . . 0.0 112.389 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.83 133.6 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 127.292 2.237 . . . . 0.0 109.699 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.2 mt -138.65 130.15 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.169 1.788 . . . . 0.0 107.891 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -63.58 135.6 56.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.439 0.696 . . . . 0.0 111.875 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.56 9.97 62.74 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -141.85 -177.09 5.03 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.439 1.896 . . . . 0.0 110.975 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.13 -178.16 5.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.961 1.704 . . . . 0.0 115.42 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 pt -121.3 136.05 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 112.559 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -116.5 149.92 38.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.429 1.092 . . . . 0.0 112.124 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.6 -179.77 36.5 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.42 1.328 . . . . 0.0 116.42 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.08 -12.16 68.58 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.668 1.604 . . . . 0.0 115.979 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.5 -15.17 69.19 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.881 1.513 . . . . 0.0 116.881 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.04 166.22 25.23 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.033 1.417 . . . . 0.0 112.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.13 163.17 20.51 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.87 1.668 . . . . 0.0 111.239 169.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.49 -13.89 27.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.051 3.167 . . . . 0.0 118.301 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.37 14.46 65.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.936 0.779 . . . . 0.0 114.677 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 mmm 57.77 38.66 27.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.776 1.63 . . . . 0.0 112.733 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.55 126.44 36.64 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.433 1.493 . . . . 0.0 109.493 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -73.44 118.46 16.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.848 0.859 . . . . 0.0 110.346 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -73.36 166.5 23.08 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.32 73.96 5.94 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.945 1.698 . . . . 0.0 111.671 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 p -68.76 122.72 19.16 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.621 1.168 . . . . 0.0 111.71 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -137.81 170.12 16.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 111.226 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 48.23 61.15 14.39 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.327 1.451 . . . . 0.0 113.386 169.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.08 139.29 89.93 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.698 2.932 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.41 148.24 6.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.457 1.503 . . . . 0.0 107.968 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 155.99 19.63 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.771 0.828 . . . . 0.0 110.843 170.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -71.71 126.1 28.83 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -107.47 11.38 28.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.79 1.236 . . . . 0.0 113.013 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -12.62 45.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -171.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.56 0.94 0.26 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.406 1.482 . . . . 0.0 113.944 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -72.25 -11.26 60.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.791 1.236 . . . . 0.0 112.939 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.61 7.59 85.91 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.305 1.431 . . . . 0.0 114.695 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.69 153.25 38.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.464 1.132 . . . . 0.0 112.226 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -130.63 151.57 50.94 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -93.45 99.52 11.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 110.921 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.2 p -129.96 168.21 17.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.555 1.142 . . . . 0.0 111.496 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 124.9 18.57 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.71 1.204 . . . . 0.0 110.976 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.61 46.99 8.27 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.537 1.065 . . . . 0.0 113.807 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.8 p -134.75 163.36 29.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 118.304 1.052 . . . . 0.0 112.942 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.36 139.08 54.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.817 . . . . 0.0 112.997 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -136.7 159.86 40.56 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.086 0.47 . . . . 0.0 111.731 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -82.88 141.13 32.45 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.687 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.01 162.0 14.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.188 0.995 . . . . 0.0 111.025 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -137.4 158.74 43.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.212 1.405 . . . . 0.0 112.274 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 m -72.35 -54.94 8.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.46 1.104 . . . . 0.0 111.661 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.87 -49.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.113 1.365 . . . . 0.0 112.425 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 156.1 77.77 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.594 1.158 . . . . 0.0 111.21 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.01 -27.72 80.44 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.081 2.521 . . . . 0.0 113.653 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -109.34 35.63 3.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.514 1.526 . . . . 0.0 112.515 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -118.07 31.82 6.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.517 1.527 . . . . 0.0 113.671 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.54 105.14 17.22 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.009 1.724 . . . . 0.0 109.038 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.2 p -97.57 -45.39 6.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.37 12.59 0.23 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -104.96 139.72 39.25 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.358 -1.464 . . . . 0.0 111.489 -169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -141.51 168.42 19.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.051 1.74 . . . . 0.0 111.527 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 10.7 p90 -147.79 162.08 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.97 117.79 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.744 1.218 . . . . 0.0 108.783 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -76.57 100.8 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.861 0.864 . . . . 0.0 110.596 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.78 -19.27 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.81 167.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.812 1.645 . . . . 0.0 111.761 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.81 120.7 24.44 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.964 -0.46 . . . . 0.0 110.092 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -146.2 62.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 123.001 1.381 . . . . 0.0 111.937 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.64 -13.23 58.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -62.76 -13.91 38.55 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.507 -1.371 . . . . 0.0 113.381 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.25 -9.26 59.72 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.583 1.153 . . . . 0.0 113.821 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -73.8 179.91 3.99 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -81.0 145.89 30.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.348 1.459 . . . . 0.0 112.257 169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.3 p -115.8 -59.34 2.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.581 1.152 . . . . 0.0 113.613 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.04 66.21 0.03 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.17 0.891 . . . . 0.0 114.028 -172.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.29 23.54 5.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.055 1.742 . . . . 0.0 115.05 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.6 m -111.46 119.0 37.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.999 1.319 . . . . 0.0 110.342 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.93 -32.17 63.56 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -79.25 -9.9 59.69 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.04 -72.23 1.03 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.125 2.298 . . . . 0.0 113.97 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.282 7.2 p-90 -70.68 122.29 19.52 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.33 -93.42 1.13 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.316 1.436 . . . . 0.0 114.834 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.21 142.27 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.259 1.424 . . . . 0.0 111.721 -169.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.22 127.41 34.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.2 92.27 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.597 1.159 . . . . 0.0 108.22 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -80.38 -14.92 57.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.857 0.863 . . . . 0.0 112.031 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.98 8.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.335 1.064 . . . . 0.0 113.252 -170.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -138.94 149.98 45.38 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.842 -1.161 . . . . 0.0 112.041 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 p -78.8 134.99 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.424 0.63 . . . . 0.0 110.464 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.96 -41.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.326 1.85 . . . . 0.0 110.736 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -143.98 155.81 44.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.667 1.587 . . . . 0.0 109.853 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.21 16.79 26.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.754 0.692 . . . . 0.0 114.734 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.05 -32.91 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.371 1.585 . . . . 0.0 112.437 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.66 -29.06 68.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.574 0.75 . . . . 0.0 112.684 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.06 -38.55 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.533 1.533 . . . . 0.0 110.463 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.6 -41.4 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.8 -1.188 . . . . 0.0 110.658 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.7 -30.6 70.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.134 1.373 . . . . 0.0 111.652 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.98 -46.89 61.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.51 0.724 . . . . 0.0 111.12 173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 98.6 mt -68.73 -25.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.993 1.317 . . . . 0.0 112.142 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -85.13 -17.62 36.69 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.883 -1.136 . . . . 0.0 113.864 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.67 -8.73 54.14 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.058 1.79 . . . . 0.0 115.181 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -26.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 83.55 164.59 0.12 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.357 2.263 . . . . 0.0 114.663 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.2 p -114.27 151.5 32.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.909 1.683 . . . . 0.0 113.599 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.05 117.85 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.032 1.301 . . . . 0.0 110.688 169.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -63.77 150.82 43.75 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.218 1.007 . . . . 0.0 113.411 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.7 p -115.08 168.26 10.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.303 1.441 . . . . 0.0 111.958 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.59 -21.81 72.97 Favored Glycine 0 CA--C 1.539 1.582 0 O-C-N 121.811 -0.556 . . . . 0.0 114.252 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 98.1 mmm -92.65 -43.9 8.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.361 1.065 . . . . 0.0 112.821 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -141.73 131.61 24.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.037 1.735 . . . . 0.0 111.129 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.37 163.27 20.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.754 0.822 . . . . 0.0 112.825 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . 0.324 3.4 p30 54.82 18.14 2.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.09 154.66 93.56 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.319 1.447 . . . . 0.0 112.246 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -60.3 140.04 89.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.887 1.725 . . . . 0.0 110.761 169.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -32.38 62.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.62 150.18 31.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.726 0.774 . . . . 0.0 111.198 169.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.95 110.01 16.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 110.617 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.38 106.24 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.143 0.977 . . . . 0.0 108.372 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.74 142.2 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.652 1.181 . . . . 0.0 112.176 -169.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mt -84.36 103.87 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.78 -30.96 59.29 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.536 1.134 . . . . 0.0 111.533 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 p -162.76 171.47 16.73 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -135.52 143.75 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.329 1.452 . . . . 0.0 110.786 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -132.79 130.28 39.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.351 1.46 . . . . 0.0 109.764 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.66 125.46 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.1 t -121.15 150.5 41.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.588 1.555 . . . . 0.0 111.838 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.356 1.062 . . . . 0.0 112.999 -179.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.504 2.258 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -129.75 130.47 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 120.846 -1.159 . . . . 0.0 110.273 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.1 m -101.07 127.11 47.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.493 1.117 . . . . 0.0 110.235 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -101.66 124.03 46.63 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.778 1.231 . . . . 0.0 110.054 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.53 106.64 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.5 p -117.55 160.12 21.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.303 0.573 . . . . 0.0 112.114 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -68.5 -7.88 36.14 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -111.24 -25.69 9.56 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.522 . . . . 0.0 113.591 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.48 144.95 4.09 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.164 1.84 . . . . 0.0 113.538 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.96 133.6 38.06 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.383 1.073 . . . . 0.0 112.38 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -130.86 144.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.788 1.635 . . . . 0.0 109.379 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.4 136.79 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.274 1.03 . . . . 0.0 110.517 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -126.38 139.83 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.888 2.075 . . . . 0.0 110.189 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -102.46 127.69 49.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.69 1.996 . . . . 0.0 107.753 171.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -88.79 147.63 24.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.162 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -104.48 74.11 1.15 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.695 1.236 . . . . 0.0 111.391 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.69 -27.52 65.08 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.212 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.87 -31.37 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.528 1.131 . . . . 0.0 111.529 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -96.39 -24.51 16.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.6 1.16 . . . . 0.0 113.066 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.1 61.36 4.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.662 0.785 . . . . 0.0 112.971 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.37 -45.07 15.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.201 2.601 . . . . 0.0 112.583 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -69.48 -39.97 77.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.858 0.754 . . . . 0.0 111.13 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.4 m -63.23 -48.19 79.29 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.739 0.816 . . . . 0.0 111.249 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.26 -41.81 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.409 0.684 . . . . 0.0 111.803 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.26 -47.87 74.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.72 1.146 . . . . 0.0 112.129 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -37.11 73.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.097 0.559 . . . . 0.0 111.813 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.75 -49.0 79.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.333 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.78 -37.09 70.5 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.591 0.757 . . . . 0.0 111.821 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.094 0.558 . . . . 0.0 112.436 172.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.81 -41.83 59.2 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.438 -0.789 . . . . 0.0 112.522 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.21 -37.33 79.95 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.424 -0.797 . . . . 0.0 111.51 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.82 -35.04 78.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.803 2.041 . . . . 0.0 112.788 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -82.65 -13.15 56.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.023 0.929 . . . . 0.0 113.39 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.49 19.43 64.12 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.481 1.039 . . . . 0.0 114.154 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.53 -17.61 64.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.073 1.349 . . . . 0.0 114.524 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.49 -4.28 45.22 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.342 -0.848 . . . . 0.0 113.211 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -67.85 136.7 54.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 109.405 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.7 t30 49.29 46.35 23.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.829 1.652 . . . . 0.0 114.211 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -103.77 161.6 13.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.506 0.722 . . . . 0.0 111.921 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.7 pt -122.48 162.2 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -169.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -94.79 114.92 26.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.071 1.349 . . . . 0.0 107.945 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.96 1.11 14.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -134.22 133.55 41.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.333 1.424 . . . . 0.0 110.43 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.13 133.64 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.127 1.371 . . . . 0.0 111.125 170.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.41 130.48 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.988 1.715 . . . . 0.0 108.186 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -63.83 134.62 55.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.712 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.45 68.86 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.741 0.686 . . . . 0.0 114.667 -173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.07 -177.19 5.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.234 1.813 . . . . 0.0 111.266 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.76 179.73 6.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.384 1.874 . . . . 0.0 114.974 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 pt -119.58 139.52 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.106 1.363 . . . . 0.0 112.317 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.4 148.74 33.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.874 1.27 . . . . 0.0 111.121 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.01 -176.41 33.09 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 115.259 0.864 . . . . 0.0 115.259 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.52 24.15 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.44 1.495 . . . . 0.0 115.252 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.56 -14.61 75.61 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.1 1.333 . . . . 0.0 115.689 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -141.5 167.66 21.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.721 1.208 . . . . 0.0 112.944 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -107.87 156.07 38.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.267 2.227 . . . . 0.0 109.329 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.83 128.8 31.44 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.102 2.535 . . . . 0.0 112.956 -170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.31 15.94 36.53 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.598 1.57 . . . . 0.0 113.505 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmm 61.66 37.44 15.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.241 1.416 . . . . 0.0 112.26 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.77 118.3 21.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.695 1.198 . . . . 0.0 108.882 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.59 126.35 29.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.491 0.663 . . . . 0.0 111.213 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -78.74 167.45 21.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.217 1.007 . . . . 0.0 113.366 171.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.47 75.1 5.19 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.833 1.653 . . . . 0.0 110.768 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.8 p -73.4 134.95 44.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.134 0.974 . . . . 0.0 111.842 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -138.68 171.93 13.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.941 2.096 . . . . 0.0 112.0 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 51.88 66.48 5.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.616 1.566 . . . . 0.0 113.365 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.27 136.06 69.75 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.297 2.665 . . . . 0.0 111.405 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -111.74 150.69 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.475 1.51 . . . . 0.0 109.413 -170.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 157.66 21.77 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.915 0.486 . . . . 0.0 111.969 175.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -71.54 131.24 42.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.472 0.709 . . . . 0.0 110.131 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -117.44 13.58 14.47 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.054 1.342 . . . . 0.0 111.961 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.8 63.37 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.571 -1.331 . . . . 0.0 113.739 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -60.72 4.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.613 1.965 . . . . 0.0 115.914 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -84.67 4.23 33.49 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.876 1.67 . . . . 0.0 111.808 168.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.65 28.04 27.88 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.204 1.383 . . . . 0.0 113.961 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.58 143.43 40.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.002 0.921 . . . . 0.0 112.771 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.51 156.3 48.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.747 1.219 . . . . 0.0 113.702 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -110.83 110.78 21.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.598 2.359 . . . . 0.0 109.778 -171.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 p -137.65 171.65 14.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.43 1.092 . . . . 0.0 110.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -47.85 120.26 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.54 1.136 . . . . 0.0 111.362 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.03 21.5 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.717 1.151 . . . . 0.0 114.949 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.1 p -121.95 160.51 24.68 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.669 1.235 . . . . 0.0 112.937 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.15 136.49 54.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.686 0.794 . . . . 0.0 112.828 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.61 159.15 42.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.886 -0.509 . . . . 0.0 111.948 172.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 97.5 mmm -82.39 134.8 35.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.852 0.461 . . . . 0.0 110.86 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.12 154.51 21.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.244 1.018 . . . . 0.0 110.3 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -120.74 158.25 27.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.363 1.065 . . . . 0.0 113.034 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.8 m -69.27 -56.49 7.4 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.905 0.882 . . . . 0.0 110.73 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -150.69 -56.09 0.16 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.806 1.642 . . . . 0.0 110.23 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.51 157.34 72.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.947 1.299 . . . . 0.0 112.401 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -56.54 -25.77 60.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.683 2.922 . . . . 0.0 113.999 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -107.53 36.62 2.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.57 1.548 . . . . 0.0 112.687 -177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -126.74 28.03 5.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.27 1.428 . . . . 0.0 113.905 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.7 76.51 4.95 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.423 1.489 . . . . 0.0 112.469 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -70.19 -60.38 2.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.816 1.247 . . . . 0.0 114.233 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.21 -8.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -169.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -81.21 140.52 34.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.729 -1.232 . . . . 0.0 109.694 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -140.47 168.33 20.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.88 1.672 . . . . 0.0 111.251 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 19.7 p90 -146.81 161.73 40.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.657 0.783 . . . . 0.0 111.966 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.34 116.94 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.49 1.116 . . . . 0.0 108.537 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.72 98.15 4.02 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 110.689 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 -24.86 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 113.066 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.71 168.94 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.479 1.512 . . . . 0.0 112.024 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.41 120.51 23.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.732 1.213 . . . . 0.0 110.371 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -142.22 74.73 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.204 1.478 . . . . 0.0 112.209 -170.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.77 -34.93 70.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.894 2.077 . . . . 0.0 114.094 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.46 -13.17 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.46 -11.62 58.39 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -72.64 172.23 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.71 155.45 40.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.588 1.155 . . . . 0.0 112.107 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -139.65 -55.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 177.22 53.16 0.07 OUTLIER Glycine 0 N--CA 1.476 1.317 0 N-CA-C 116.769 1.467 . . . . 0.0 116.769 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 55.12 25.92 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.96 1.704 . . . . 0.0 114.099 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 m -125.29 136.37 53.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.126 1.37 . . . . 0.0 111.685 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 mp -56.14 -30.63 62.42 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -169.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -82.42 -8.88 59.62 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.51 -71.42 1.1 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.256 1.884 . . . . 0.0 113.746 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.1 136.06 33.22 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -169.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.92 -72.68 0.9 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.112 1.339 . . . . 0.0 115.378 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -139.68 150.1 44.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.04 1.336 . . . . 0.0 111.843 -169.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.6 t -87.98 120.35 29.23 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.647 -0.658 . . . . 0.0 112.543 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -77.52 82.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.253 1.421 . . . . 0.0 108.537 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -74.38 -14.52 60.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.024 0.929 . . . . 0.0 112.419 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.99 177.84 8.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.567 1.175 . . . . 0.0 113.904 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.79 153.9 47.24 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.888 -1.132 . . . . 0.0 112.606 172.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.09 141.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.711 0.767 . . . . 0.0 110.201 172.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.81 -40.2 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.786 1.634 . . . . 0.0 111.107 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -144.81 148.89 34.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.345 1.458 . . . . 0.0 110.674 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.88 10.11 21.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.579 1.085 . . . . 0.0 114.899 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -38.2 72.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.85 1.325 . . . . 0.0 112.433 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.961 0.904 . . . . 0.0 112.107 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.1 t -77.52 -43.71 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.518 . . . . 0.0 110.283 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.59 -38.16 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.291 -0.881 . . . . 0.0 111.099 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.43 -19.74 60.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.173 1.389 . . . . 0.0 113.044 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -86.19 -39.11 16.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.745 1.618 . . . . 0.0 111.669 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 66.0 mt -53.13 -36.02 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.622 1.569 . . . . 0.0 112.09 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -84.61 -17.71 37.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.89 -20.36 16.77 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.291 1.424 . . . . 0.0 114.296 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.23 -59.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.614 1.207 . . . . 0.0 113.155 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.98 148.21 4.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 112.359 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.4 p -138.03 151.11 47.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.214 1.406 . . . . 0.0 111.861 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.2 131.38 1.74 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.163 0.411 . . . . 0.0 112.639 169.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -63.84 149.98 45.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.345 1.058 . . . . 0.0 113.494 -174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.5 t -113.04 160.82 17.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.08 -23.32 71.24 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 113.818 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 tpt -87.55 -42.58 12.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.09 0.945 . . . . 0.0 112.57 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -141.28 132.35 26.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.085 1.754 . . . . 0.0 110.863 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -87.02 160.41 18.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.687 0.795 . . . . 0.0 111.714 171.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 57.39 62.05 2.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.177 . . . . 0.0 112.724 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 m -127.63 154.18 77.69 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 125.76 1.624 . . . . 0.0 111.749 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.84 134.55 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 121.386 1.391 . . . . 0.0 108.932 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -27.95 51.43 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.3 157.7 22.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.582 1.153 . . . . 0.0 110.369 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.13 111.48 18.29 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.135 -0.978 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.67 94.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.646 1.578 . . . . 0.0 107.071 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.42 143.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -169.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.1 mt -86.43 103.98 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.815 2.046 . . . . 0.0 106.728 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.76 -41.77 61.99 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.673 -0.642 . . . . 0.0 110.863 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.5 t -150.2 165.82 31.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.78 142.46 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.112 1.765 . . . . 0.0 111.178 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.2 m -135.21 128.58 32.24 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.89 1.276 . . . . 0.0 110.245 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.73 122.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -113.59 150.4 33.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.137 1.375 . . . . 0.0 112.275 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.061 1.344 . . . . 0.0 113.622 -170.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.94 127.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.909 0.884 . . . . 0.0 109.364 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.4 m -102.31 124.17 47.41 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.815 1.246 . . . . 0.0 109.901 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -101.46 125.3 48.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.588 1.155 . . . . 0.0 110.474 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -96.9 94.47 7.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 172.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -96.67 152.33 18.76 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.833 -0.542 . . . . 0.0 110.765 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -59.35 -14.34 11.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.96 -13.57 21.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.739 1.215 . . . . 0.0 113.655 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 167.74 14.94 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 123.242 1.468 . . . . 0.0 113.125 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.91 136.9 38.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.341 1.457 . . . . 0.0 112.835 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.2 mt -133.97 139.3 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.663 1.985 . . . . 0.0 108.643 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.1 t -123.56 134.93 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.594 1.158 . . . . 0.0 110.385 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -121.0 139.0 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.655 1.982 . . . . 0.0 110.094 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -103.79 125.78 50.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.56 1.944 . . . . 0.0 108.823 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -87.77 147.24 25.27 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.407 1.083 . . . . 0.0 111.361 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.52 74.41 1.25 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.692 1.234 . . . . 0.0 111.251 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.71 -25.9 64.09 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.607 1.163 . . . . 0.0 112.674 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.33 -28.01 56.72 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.559 1.144 . . . . 0.0 111.346 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -96.82 -30.6 13.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 112.725 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.61 58.59 3.38 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.761 0.824 . . . . 0.0 113.194 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -60.53 -42.71 38.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.583 2.855 . . . . 0.0 112.928 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -69.37 -41.43 76.54 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.655 0.661 . . . . 0.0 110.793 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.1 m -62.23 -49.86 74.05 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.393 0.677 . . . . 0.0 111.481 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -42.64 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.447 0.699 . . . . 0.0 111.401 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.2 -44.59 88.19 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.646 1.112 . . . . 0.0 111.567 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -65.45 -42.28 92.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.305 1.042 . . . . 0.0 111.868 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.9 -48.55 81.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.182 0.993 . . . . 0.0 111.731 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -38.49 81.49 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.91 0.884 . . . . 0.0 111.675 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -56.3 -36.24 68.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.172 0.989 . . . . 0.0 112.094 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -75.51 -43.56 48.35 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.526 -0.734 . . . . 0.0 112.626 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.7 m -61.69 -36.82 81.97 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.61 -0.681 . . . . 0.0 111.877 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.29 71.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.135 1.774 . . . . 0.0 112.824 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.42 -15.48 49.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.337 1.055 . . . . 0.0 113.378 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.66 51.57 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.524 0.583 . . . . 0.0 113.849 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -73.02 -18.11 61.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.117 1.459 . . . . 0.0 114.688 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -100.83 -5.2 26.54 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.143 -0.973 . . . . 0.0 112.273 169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -69.58 130.66 43.05 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.913 -1.117 . . . . 0.0 108.484 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t30 57.08 46.2 19.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.252 1.421 . . . . 0.0 113.698 -169.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -116.23 153.26 32.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.809 0.844 . . . . 0.0 112.449 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -104.93 163.44 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -95.7 94.81 7.92 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -89.08 -2.16 58.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -168.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -138.99 139.85 38.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.114 1.779 . . . . 0.0 112.304 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 132.0 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 126.624 1.97 . . . . 0.0 111.019 169.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.06 129.46 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.058 1.743 . . . . 0.0 108.027 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.71 133.41 55.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.387 0.675 . . . . 0.0 111.574 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.78 10.29 64.02 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -141.34 -177.34 5.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.008 1.723 . . . . 0.0 111.266 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.4 -178.9 5.72 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -169.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.6 pt -116.93 137.2 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.143 1.377 . . . . 0.0 112.275 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -109.15 149.29 29.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.685 1.194 . . . . 0.0 110.625 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.25 174.21 34.1 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 122.473 1.041 . . . . 0.0 115.381 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.72 0.74 75.3 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.932 1.253 . . . . 0.0 115.253 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 -19.27 62.74 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.255 1.527 . . . . 0.0 115.678 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -147.87 165.29 31.08 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.508 1.123 . . . . 0.0 113.193 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.69 163.88 28.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.19 1.396 . . . . 0.0 109.926 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -60.29 -15.63 36.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.551 2.834 . . . . 0.0 118.325 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.27 19.79 53.08 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.179 0.895 . . . . 0.0 114.558 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.05 32.35 19.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.92 126.7 35.2 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.321 1.448 . . . . 0.0 109.162 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.16 127.98 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.717 0.807 . . . . 0.0 110.829 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -72.69 165.52 24.62 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.268 170.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.52 74.48 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.736 1.614 . . . . 0.0 111.088 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 p -73.0 140.76 47.55 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.596 1.158 . . . . 0.0 112.703 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -141.76 178.06 7.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.991 2.116 . . . . 0.0 111.887 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 51.68 65.17 6.76 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 125.784 1.634 . . . . 0.0 114.346 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -57.12 133.26 56.54 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.316 2.677 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.16 150.87 7.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 126.101 1.76 . . . . 0.0 108.72 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 157.85 23.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 169.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -76.52 126.14 30.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.597 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -108.18 14.39 25.06 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.233 1.413 . . . . 0.0 112.915 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -15.79 62.73 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.325 -1.485 . . . . 0.0 114.111 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.94 0.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.123 1.769 . . . . 0.0 115.77 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -79.39 -3.87 48.41 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.883 1.273 . . . . 0.0 112.126 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.39 31.55 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.891 1.234 . . . . 0.0 114.619 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.3 mt -80.43 159.3 25.69 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -131.43 156.34 45.76 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -103.82 115.41 30.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.232 2.213 . . . . 0.0 110.302 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -139.94 167.91 21.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.685 1.194 . . . . 0.0 111.442 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -51.72 119.79 4.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.388 1.475 . . . . 0.0 110.715 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.16 28.87 21.69 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.922 1.249 . . . . 0.0 114.977 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.4 p -122.58 158.94 28.82 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.169 1.484 . . . . 0.0 112.897 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.69 139.28 53.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.681 0.753 . . . . 0.0 112.756 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -137.49 159.7 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.738 170.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -80.28 141.21 35.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.101 0.56 . . . . 0.0 111.641 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 154.18 19.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.27 0.628 . . . . 0.0 111.516 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -141.0 158.1 44.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.292 1.437 . . . . 0.0 112.713 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 m -72.25 -55.5 7.09 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.881 0.872 . . . . 0.0 113.006 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -159.47 -54.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.276 1.031 . . . . 0.0 111.57 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.71 158.84 86.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.2 1.0 . . . . 0.0 111.365 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.01 -27.69 85.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.832 2.355 . . . . 0.0 113.358 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -109.21 36.15 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.499 1.52 . . . . 0.0 112.511 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.0 p -115.58 30.56 7.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.456 1.502 . . . . 0.0 113.318 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 101.91 14.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.015 1.326 . . . . 0.0 110.092 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 p -91.52 -64.35 1.13 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.187 0.995 . . . . 0.0 113.001 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.81 42.37 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -133.87 153.91 51.42 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.069 -1.02 . . . . 0.0 112.955 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -145.54 168.21 21.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.749 2.02 . . . . 0.0 110.958 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 11.0 p90 -144.63 159.69 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 111.208 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.6 mt -113.0 118.07 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.19 108.22 6.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.192 0.597 . . . . 0.0 109.798 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.94 -14.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.35 168.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.376 2.271 . . . . 0.0 111.226 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.69 119.24 24.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.469 0.708 . . . . 0.0 109.525 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -141.07 77.17 1.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.975 1.369 . . . . 0.0 113.15 -169.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.24 -34.73 61.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.024 2.13 . . . . 0.0 114.514 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -61.79 -12.7 18.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.09 -10.64 57.66 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.41 178.14 6.12 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -83.94 142.38 30.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.971 1.308 . . . . 0.0 111.814 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -111.35 -58.74 2.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.599 1.159 . . . . 0.0 113.42 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 163.45 67.87 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.241 0.924 . . . . 0.0 113.346 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 54.23 25.51 5.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.107 1.763 . . . . 0.0 114.801 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.3 m -111.93 117.72 33.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.702 1.201 . . . . 0.0 110.752 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.2 -37.19 54.17 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -78.05 -14.3 59.55 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.74 -72.76 1.21 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.509 2.48 . . . . 0.0 114.261 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.306 6.6 p-90 -71.15 127.23 31.88 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.2 -86.9 1.26 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.362 1.458 . . . . 0.0 115.758 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -139.54 149.94 44.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.883 1.273 . . . . 0.0 111.796 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.9 t -81.27 119.53 23.76 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.732 -0.605 . . . . 0.0 112.408 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.44 84.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -77.06 -14.81 59.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.64 0.776 . . . . 0.0 111.942 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 177.42 8.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.622 1.201 . . . . 0.0 113.783 -170.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -140.64 154.56 46.47 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.768 -1.208 . . . . 0.0 112.333 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.48 140.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.64 0.733 . . . . 0.0 110.084 170.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.97 -42.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 111.008 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -144.5 153.54 41.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 109.93 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 103.47 15.03 24.19 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 123.878 0.751 . . . . 0.0 114.289 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.1 68.54 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.028 1.414 . . . . 0.0 112.263 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -65.74 -30.07 70.68 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.746 0.818 . . . . 0.0 112.466 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.49 -43.13 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.8 1.24 . . . . 0.0 110.092 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.25 -40.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.816 0.846 . . . . 0.0 111.332 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.83 -27.29 62.81 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.93 1.292 . . . . 0.0 112.367 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.13 -42.27 32.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.463 1.105 . . . . 0.0 111.205 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.11 -30.14 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.935 1.694 . . . . 0.0 112.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -91.82 -20.11 21.83 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.78 -17.53 27.88 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.498 1.523 . . . . 0.0 114.738 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.44 -51.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 118.887 1.344 . . . . 0.0 112.722 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.97 155.77 5.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.189 1.396 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.8 p -135.87 150.96 49.56 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 0.0 112.312 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.48 128.4 1.03 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.032 0.348 . . . . 0.0 112.819 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -67.17 147.25 53.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 0.0 113.228 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -99.28 157.47 16.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.074 1.75 . . . . 0.0 110.875 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.96 -18.99 69.38 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 121.586 -0.697 . . . . 0.0 113.917 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.77 -31.68 11.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 0.0 113.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -140.72 124.96 17.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.171 1.388 . . . . 0.0 110.709 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.39 160.13 14.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.485 0.714 . . . . 0.0 112.718 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.32 52.76 8.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.345 1.458 . . . . 0.0 113.205 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.24 151.37 53.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.129 1.372 . . . . 0.0 112.002 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.2 135.03 24.1 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.766 1.644 . . . . 0.0 109.375 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -24.98 39.83 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.28 150.24 35.32 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.431 1.092 . . . . 0.0 110.738 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.19 116.94 21.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.798 0.839 . . . . 0.0 111.249 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.03 110.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.573 1.149 . . . . 0.0 108.579 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.08 152.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.415 1.486 . . . . 0.0 110.871 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.96 103.25 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.4 -25.02 36.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.691 0.797 . . . . 0.0 112.113 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -154.35 161.76 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.513 0.725 . . . . 0.0 112.714 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.5 t -134.41 139.2 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.696 1.598 . . . . 0.0 110.157 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.8 m -136.54 131.01 33.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.739 1.216 . . . . 0.0 110.588 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.85 122.95 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -119.31 150.25 40.44 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.079 1.352 . . . . 0.0 112.277 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.294 1.438 . . . . 0.0 113.753 -170.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 131.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.989 -1.694 . . . . 0.0 111.514 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.0 m -102.32 123.93 46.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.022 0.929 . . . . 0.0 110.091 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -98.98 132.83 44.0 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.95 1.3 . . . . 0.0 110.677 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -104.83 98.89 8.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -104.6 152.51 22.36 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.962 -0.461 . . . . 0.0 110.835 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.413 HD21 HG12 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -59.44 -20.43 55.02 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -89.8 -15.92 31.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.845 1.258 . . . . 0.0 113.187 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.06 165.3 12.44 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.741 1.639 . . . . 0.0 113.191 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -72.98 137.69 45.61 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.519 1.528 . . . . 0.0 112.534 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.7 mt -134.47 140.71 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.256 1.822 . . . . 0.0 108.764 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.31 132.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 110.479 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.92 135.75 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 110.04 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -98.19 130.46 44.93 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.928 1.691 . . . . 0.0 107.224 171.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -92.13 146.57 23.62 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.22 1.008 . . . . 0.0 110.505 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -102.14 73.9 1.4 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.843 1.306 . . . . 0.0 111.006 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.97 -25.5 64.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.209 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.77 1.228 . . . . 0.0 111.508 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.08 -27.54 15.04 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.861 1.264 . . . . 0.0 112.801 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.25 58.13 3.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -61.11 -42.64 34.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.519 2.813 . . . . 0.0 113.146 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.16 -40.55 78.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.8 m -61.05 -53.57 55.58 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.541 0.736 . . . . 0.0 111.845 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.1 -41.73 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.839 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -54.14 -49.22 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.918 1.236 . . . . 0.0 111.969 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.52 -38.88 81.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.376 0.67 . . . . 0.0 111.935 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.67 -49.52 77.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 0.0 111.767 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.58 -34.31 67.36 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.56 0.744 . . . . 0.0 111.811 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -57.78 -33.45 68.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.69 0.796 . . . . 0.0 112.556 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -75.4 -44.21 45.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.437 -0.79 . . . . 0.0 112.333 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.2 -35.81 78.17 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.6 -0.688 . . . . 0.0 111.765 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.84 -34.54 78.15 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.353 2.261 . . . . 0.0 112.789 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -82.11 -14.12 56.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.882 0.873 . . . . 0.0 113.152 171.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.7 18.58 61.45 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.562 1.077 . . . . 0.0 113.814 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.55 -24.04 67.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.72 1.26 . . . . 0.0 114.19 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -89.21 -7.7 55.02 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.304 0.642 . . . . 0.0 112.687 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -64.36 135.67 56.38 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.938 -1.101 . . . . 0.0 108.793 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.25 22.98 12.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.5 p -88.73 162.48 16.23 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.116 -0.99 . . . . 0.0 111.392 169.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 pt -122.38 164.76 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -97.99 96.75 8.37 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -90.24 -8.27 51.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -134.37 138.49 44.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.37 1.441 . . . . 0.0 113.471 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.48 134.37 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.961 2.505 . . . . 0.0 109.272 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 90.1 mt -138.07 129.28 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.733 1.613 . . . . 0.0 108.029 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -61.63 132.77 54.34 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.25 0.62 . . . . 0.0 111.849 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.01 10.17 61.28 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.15 -177.16 5.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.892 1.677 . . . . 0.0 111.314 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -178.66 6.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.083 1.753 . . . . 0.0 115.558 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.7 pt -115.96 138.06 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.186 1.394 . . . . 0.0 112.563 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -108.68 149.35 29.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.516 1.126 . . . . 0.0 111.056 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.89 175.9 32.78 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.454 1.03 . . . . 0.0 114.965 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 6.78 83.6 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.627 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.71 -25.53 35.02 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 119.717 1.758 . . . . 0.0 115.71 -172.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -149.73 169.78 20.26 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.663 1.185 . . . . 0.0 113.054 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.46 164.47 16.58 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.892 1.677 . . . . 0.0 110.064 168.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.87 -12.88 33.98 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.877 3.051 . . . . 0.0 117.437 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.19 14.65 61.71 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.786 0.708 . . . . 0.0 114.449 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.0 mmt 59.71 29.77 19.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.396 1.878 . . . . 0.0 112.879 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.03 125.49 32.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.961 1.304 . . . . 0.0 109.367 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -71.57 121.94 19.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.412 1.085 . . . . 0.0 110.231 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -66.68 159.2 28.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.35 73.38 8.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.409 1.483 . . . . 0.0 111.57 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 p -68.03 121.27 15.74 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.507 1.123 . . . . 0.0 112.596 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -130.93 176.66 8.05 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.098 1.759 . . . . 0.0 111.954 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 49.25 67.27 4.65 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.674 1.59 . . . . 0.0 113.99 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.66 140.1 91.99 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.38 2.72 . . . . 0.0 111.765 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -111.76 152.59 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.038 1.735 . . . . 0.0 109.046 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.27 0.1 OUTLIER -76.23 158.93 31.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.237 0.615 . . . . 0.0 110.355 169.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.27 -56.58 20.0 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 70.95 3.68 4.74 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.46 -15.09 63.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 119.919 -1.738 . . . . 0.0 114.126 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -59.94 3.8 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.118 2.567 . . . . 0.0 116.151 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -84.22 5.72 25.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.421 1.489 . . . . 0.0 112.257 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.71 32.71 32.6 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.816 1.198 . . . . 0.0 113.299 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.11 140.56 39.05 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.417 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -131.69 147.74 52.53 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -99.13 85.87 3.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 111.642 -169.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.5 p -112.57 168.32 9.75 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.506 0.723 . . . . 0.0 112.109 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -55.89 130.16 42.5 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.667 1.187 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.24 35.41 33.95 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.179 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.9 p -125.92 161.91 26.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.78 1.29 . . . . 0.0 113.354 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 mp -120.49 136.09 54.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.792 0.837 . . . . 0.0 112.896 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -132.09 159.19 39.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.468 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -84.64 141.12 30.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.62 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.31 154.02 19.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.467 0.707 . . . . 0.0 111.112 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -133.39 162.92 30.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.827 1.251 . . . . 0.0 113.572 -171.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -76.95 -56.23 4.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.617 1.167 . . . . 0.0 113.109 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -159.09 -54.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.543 1.137 . . . . 0.0 111.76 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.28 161.82 71.45 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.509 1.124 . . . . 0.0 111.53 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.31 -20.14 69.78 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.147 2.565 . . . . 0.0 114.071 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.28 42.13 2.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.356 1.862 . . . . 0.0 111.983 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.5 p -125.79 30.79 5.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.186 1.394 . . . . 0.0 113.638 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.0 104.48 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.816 1.647 . . . . 0.0 109.527 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.2 p -89.73 -72.73 0.54 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.455 1.102 . . . . 0.0 113.204 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.27 36.43 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.32 149.8 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.03 1.332 . . . . 0.0 111.621 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.18 168.41 21.06 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.476 1.511 . . . . 0.0 111.673 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 14.7 p90 -146.37 162.1 38.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 30.4 mt -115.01 116.03 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.539 1.136 . . . . 0.0 108.181 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -71.31 99.09 1.87 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.72 0.808 . . . . 0.0 109.772 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.4 m -77.83 -16.36 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 113.212 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.55 166.28 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 128.292 2.637 . . . . 0.0 110.968 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.0 119.66 19.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.226 0.536 . . . . 0.0 111.331 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -126.85 55.37 1.56 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.015 1.726 . . . . 0.0 111.641 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.56 -12.14 50.37 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -69.51 -14.92 63.12 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.819 -1.176 . . . . 0.0 113.349 169.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.37 -14.91 56.69 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -66.79 172.48 4.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.071 2.148 . . . . 0.0 116.595 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.05 155.81 40.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.871 1.268 . . . . 0.0 112.402 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.7 t -140.92 -53.78 0.48 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.71 56.29 0.05 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.17 23.63 12.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.106 1.362 . . . . 0.0 114.617 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -123.85 140.58 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.414 1.486 . . . . 0.0 112.963 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.89 -39.56 81.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.467 1.107 . . . . 0.0 112.891 -169.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.98 -17.43 64.67 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.63 -90.3 1.51 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.191 2.329 . . . . 0.0 112.859 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.252 0.4 OUTLIER -71.49 128.11 34.77 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.54 -71.37 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.991 1.282 . . . . 0.0 114.048 -174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -133.73 131.85 39.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.939 0.896 . . . . 0.0 111.899 -169.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.3 t -93.04 126.16 37.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.425 0.69 . . . . 0.0 112.523 -172.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.82 89.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.189 0.995 . . . . 0.0 109.225 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -75.23 -15.18 60.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.354 1.062 . . . . 0.0 112.015 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.66 176.36 10.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.315 1.055 . . . . 0.0 113.828 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -140.37 151.19 44.78 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 112.264 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.04 133.6 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.575 0.702 . . . . 0.0 110.349 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.67 -43.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.339 1.856 . . . . 0.0 110.812 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -143.07 154.77 44.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.546 1.538 . . . . 0.0 109.964 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.75 14.92 33.05 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.787 0.708 . . . . 0.0 114.478 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 81.9 mmm -54.89 -36.11 64.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.27 1.535 . . . . 0.0 112.275 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.36 -30.48 71.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.849 0.86 . . . . 0.0 112.612 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.49 -40.77 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.978 1.311 . . . . 0.0 110.377 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.65 -42.56 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.272 -0.892 . . . . 0.0 110.93 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.08 -25.08 63.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.314 1.445 . . . . 0.0 112.22 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -75.76 -52.19 11.0 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.049 0.94 . . . . 0.0 110.398 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 53.6 mt -53.01 -36.41 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.364 1.865 . . . . 0.0 112.686 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.02 -14.44 31.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.88 -18.23 11.83 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.828 1.68 . . . . 0.0 113.882 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.31 -59.41 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.412 1.106 . . . . 0.0 113.051 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.56 162.39 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.768 1.227 . . . . 0.0 112.677 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.0 p -136.07 151.4 49.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.496 1.518 . . . . 0.0 112.389 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.43 133.71 1.64 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.146 0.403 . . . . 0.0 113.436 170.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.92 151.91 33.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.874 1.269 . . . . 0.0 113.111 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.2 p -115.29 168.75 9.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.073 1.349 . . . . 0.0 112.239 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.82 -21.27 74.99 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 121.714 -0.616 . . . . 0.0 114.576 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.18 -38.18 9.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.67 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.13 126.96 22.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.086 1.754 . . . . 0.0 110.541 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -85.28 160.42 19.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.354 0.662 . . . . 0.0 110.971 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.55 58.85 2.77 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.025 1.33 . . . . 0.0 113.581 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.93 157.8 77.45 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 126.271 1.828 . . . . 0.0 111.835 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -69.95 138.64 37.68 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.14 1.893 . . . . 0.0 109.852 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -31.18 38.0 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -79.17 149.42 31.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.83 0.852 . . . . 0.0 111.398 169.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.0 114.38 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.495 1.118 . . . . 0.0 111.229 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.24 105.67 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 108.402 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG12 HD21 ' A' ' 7' ' ' ASN . 1.4 pt -128.12 143.82 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.558 0.743 . . . . 0.0 111.565 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.16 103.34 11.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.17 -36.66 66.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.294 0.637 . . . . 0.0 110.476 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 t -153.92 166.0 34.35 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.21 141.38 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.642 1.977 . . . . 0.0 110.58 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 125.09 30.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.184 1.394 . . . . 0.0 109.909 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.67 125.47 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.205 0.602 . . . . 0.0 109.878 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.2 t -111.49 150.77 29.45 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.33 1.452 . . . . 0.0 112.138 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.676 1.19 . . . . 0.0 113.241 -172.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.15 130.75 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.045 0.938 . . . . 0.0 109.265 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -106.19 121.69 44.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.795 1.238 . . . . 0.0 110.148 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.68 135.61 33.94 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.495 1.118 . . . . 0.0 110.72 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -107.25 101.1 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -103.92 152.75 21.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.895 -0.503 . . . . 0.0 111.016 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -60.1 -7.49 1.87 Allowed 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -109.31 -8.04 15.15 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.074 1.35 . . . . 0.0 114.215 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.52 165.89 12.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.374 1.464 . . . . 0.0 113.742 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.78 138.82 39.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.364 1.866 . . . . 0.0 112.838 174.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -135.4 140.9 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.303 1.841 . . . . 0.0 109.066 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.04 136.87 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.553 1.141 . . . . 0.0 110.562 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.22 139.43 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.73 2.012 . . . . 0.0 110.465 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -101.81 126.91 48.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.862 2.065 . . . . 0.0 107.659 171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 p -88.62 147.58 24.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.171 0.989 . . . . 0.0 111.085 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.02 74.33 1.3 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.688 1.232 . . . . 0.0 111.156 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.74 -26.92 64.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.547 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -75.73 -30.87 59.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.291 1.036 . . . . 0.0 111.437 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 -28.7 14.53 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 113.011 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.8 56.99 3.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -60.1 -43.63 34.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 112.758 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -68.08 -40.17 82.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.756 0.707 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.6 m -65.14 -48.12 74.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.569 0.748 . . . . 0.0 111.6 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -68.38 -39.51 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.921 0.888 . . . . 0.0 112.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.16 -47.16 75.53 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.677 1.126 . . . . 0.0 111.816 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -69.3 -38.66 78.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.339 0.655 . . . . 0.0 111.88 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.09 -47.6 84.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 0.0 111.539 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.56 -38.57 74.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.25 0.62 . . . . 0.0 111.374 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -63.14 -29.66 70.97 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -73.62 -42.84 60.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.302 -0.874 . . . . 0.0 111.967 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.16 -37.61 85.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.541 -0.725 . . . . 0.0 111.463 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -58.42 -37.87 76.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.468 2.307 . . . . 0.0 113.438 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -81.73 -15.0 55.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.707 1.203 . . . . 0.0 113.531 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.8 61.03 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.872 1.225 . . . . 0.0 114.362 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -69.58 -17.72 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.542 1.537 . . . . 0.0 114.963 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.92 -13.03 21.42 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.55 1.23 8.53 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -147.19 53.59 1.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.206 1.402 . . . . 0.0 110.606 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.4 p -114.36 171.94 7.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.185 0.994 . . . . 0.0 113.121 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 pt -127.65 166.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -98.93 110.44 23.05 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -109.15 0.81 19.97 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -152.66 129.94 11.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.53 1.513 . . . . 0.0 111.591 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.66 141.21 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.664 1.986 . . . . 0.0 111.168 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.61 127.62 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.142 1.377 . . . . 0.0 108.66 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -64.63 132.88 50.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 0.0 111.659 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 10.74 66.01 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.01 0.814 . . . . 0.0 114.908 -173.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -144.56 -174.84 4.43 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.82 2.048 . . . . 0.0 110.412 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.58 -179.93 7.46 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.7 pt -123.34 142.73 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.169 1.387 . . . . 0.0 113.8 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -122.79 147.81 46.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.826 1.65 . . . . 0.0 112.363 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.68 -175.74 32.02 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.73 73.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.148 1.832 . . . . 0.0 115.641 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.86 -16.05 60.33 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.79 164.87 28.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.583 1.192 . . . . 0.0 112.705 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -94.92 161.94 26.76 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.926 1.691 . . . . 0.0 110.806 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -60.75 -8.84 10.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.007 3.138 . . . . 0.0 117.613 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.68 12.96 67.08 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.151 0.882 . . . . 0.0 115.039 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mmt 59.68 29.12 18.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.282 1.833 . . . . 0.0 112.822 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.01 131.22 34.15 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.303 1.441 . . . . 0.0 109.403 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -73.53 121.02 19.93 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.094 0.958 . . . . 0.0 110.339 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -72.34 164.77 25.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.86 71.85 7.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.513 1.525 . . . . 0.0 111.332 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 p -70.86 107.92 4.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 111.824 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -111.28 175.98 5.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.454 1.902 . . . . 0.0 111.808 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.08 65.8 5.46 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.464 1.505 . . . . 0.0 113.576 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -58.03 132.12 47.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.998 2.465 . . . . 0.0 110.364 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.85 147.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.607 1.163 . . . . 0.0 109.656 -173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 155.31 29.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.991 0.917 . . . . 0.0 112.145 172.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -75.14 129.56 37.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.987 0.915 . . . . 0.0 110.828 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -112.29 14.33 20.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.207 1.403 . . . . 0.0 113.124 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.99 -15.45 59.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.247 -1.533 . . . . 0.0 113.477 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -59.25 -0.97 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -80.39 -3.03 48.11 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.117 1.367 . . . . 0.0 112.095 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.8 27.19 27.31 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.099 1.333 . . . . 0.0 114.495 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.61 158.57 28.42 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.962 0.881 . . . . 0.0 112.999 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -130.58 159.24 37.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.684 1.194 . . . . 0.0 114.024 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -106.9 115.15 29.69 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.068 2.147 . . . . 0.0 109.927 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.3 p -140.95 168.41 19.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.81 1.244 . . . . 0.0 111.241 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -54.49 125.15 18.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.117 0.967 . . . . 0.0 110.91 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.84 31.97 25.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.26 1.41 . . . . 0.0 115.075 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.1 p -123.79 159.77 28.78 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.31 1.555 . . . . 0.0 113.342 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -123.68 138.47 54.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 0.0 113.191 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -135.9 157.78 46.0 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.823 -0.548 . . . . 0.0 112.184 169.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.0 mmm -79.6 136.17 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.865 0.466 . . . . 0.0 110.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.58 142.19 27.9 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.798 0.839 . . . . 0.0 110.749 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -85.83 154.03 21.84 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.413 1.085 . . . . 0.0 112.677 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -70.14 -51.99 27.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.801 0.841 . . . . 0.0 110.178 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -157.56 -57.96 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.424 1.489 . . . . 0.0 110.451 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.41 154.73 83.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.18 0.992 . . . . 0.0 111.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.69 -19.27 64.53 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.93 2.42 . . . . 0.0 114.45 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -112.69 38.21 2.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.845 1.658 . . . . 0.0 112.332 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -122.17 30.26 6.66 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.319 1.447 . . . . 0.0 113.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.08 61.55 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.446 1.499 . . . . 0.0 113.035 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -58.82 -65.33 0.68 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.904 1.681 . . . . 0.0 113.946 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.83 0.55 0.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.7 146.43 24.52 Favored 'General case' 0 N--CA 1.462 0.175 0 O-C-N 120.515 -1.366 . . . . 0.0 110.51 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -141.14 168.28 20.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.758 1.623 . . . . 0.0 110.479 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.413 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 7.1 p90 -145.33 159.27 43.31 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.103 0.561 . . . . 0.0 111.87 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.82 119.49 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.101 1.36 . . . . 0.0 108.267 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -78.28 119.74 22.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.55 0.74 . . . . 0.0 110.774 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -98.74 -8.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.9 164.51 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.689 1.596 . . . . 0.0 111.32 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -80.8 119.1 22.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.996 0.518 . . . . 0.0 109.993 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -137.58 70.67 1.4 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.955 1.359 . . . . 0.0 112.149 -169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.57 -35.79 54.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.251 2.22 . . . . 0.0 114.404 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -59.72 -14.24 13.41 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.27 -13.33 57.19 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -73.6 169.83 16.45 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.25 145.63 55.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.625 0.77 . . . . 0.0 112.981 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -115.05 -59.54 2.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.522 1.529 . . . . 0.0 113.09 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.44 55.83 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.32 1.438 . . . . 0.0 112.077 -171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.14 26.75 15.55 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.81 1.644 . . . . 0.0 114.474 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.9 p -107.93 125.34 51.38 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.0 tp -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -78.51 -10.33 59.67 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.39 -96.91 1.93 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 127.366 2.412 . . . . 0.0 112.423 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -60.56 125.45 23.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.58 -58.94 0.64 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 116.559 1.383 . . . . 0.0 116.559 -169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -141.65 151.11 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.365 1.066 . . . . 0.0 112.215 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.2 t -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.835 -0.541 . . . . 0.0 112.456 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.3 83.38 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.766 1.226 . . . . 0.0 108.594 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -77.6 -14.03 59.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.021 0.928 . . . . 0.0 112.129 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.45 177.83 7.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.771 1.272 . . . . 0.0 114.343 -169.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -141.43 153.63 45.12 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.65 1.18 . . . . 0.0 112.417 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 143.7 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.688 0.756 . . . . 0.0 110.323 173.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.45 -41.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.736 1.614 . . . . 0.0 110.936 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -147.03 154.52 41.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.678 1.591 . . . . 0.0 110.108 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.25 14.21 24.79 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 123.866 0.746 . . . . 0.0 114.603 172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -34.62 63.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.055 1.427 . . . . 0.0 112.305 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.15 -30.02 71.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.687 0.795 . . . . 0.0 112.577 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.2 t -75.97 -43.22 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.052 1.341 . . . . 0.0 110.271 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.62 -38.42 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.362 -0.836 . . . . 0.0 110.973 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -26.42 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.339 1.456 . . . . 0.0 112.6 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -76.91 -42.27 40.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.724 1.21 . . . . 0.0 110.821 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.6 mt -57.61 -29.26 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.568 1.547 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -89.82 -14.04 35.3 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.15 -14.0 17.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.745 1.64 . . . . 0.0 114.627 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 -57.74 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 118.778 1.289 . . . . 0.0 112.445 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.61 144.95 0.89 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.7 1.6 . . . . 0.0 111.157 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -129.05 150.07 50.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.043 1.337 . . . . 0.0 112.946 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 174.99 130.57 1.32 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.343 0.973 . . . . 0.0 112.256 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -66.74 150.15 49.51 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.6 t -115.8 166.85 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.554 1.942 . . . . 0.0 111.451 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.0 -30.84 72.13 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 114.285 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.4 mmt -95.11 -28.03 15.28 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -140.92 129.14 22.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.786 1.634 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -95.92 154.73 17.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.681 0.792 . . . . 0.0 112.627 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 49.86 75.1 0.18 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.627 2.371 . . . . 0.0 112.219 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.7 m -128.67 152.18 78.25 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.06 1.344 . . . . 0.0 110.912 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.47 129.29 18.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.245 1.296 . . . . 0.0 108.897 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -25.21 32.31 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.709 0.403 . . . . 0.0 111.857 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.9 146.7 37.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.004 0.922 . . . . 0.0 109.155 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.32 109.99 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.403 0.621 . . . . 0.0 111.326 -171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.88 109.1 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.218 1.007 . . . . 0.0 108.589 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.9 142.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -172.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -84.01 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -76.95 -27.07 54.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.801 1.24 . . . . 0.0 111.794 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.4 t -163.17 168.66 20.46 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.67 140.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.276 1.831 . . . . 0.0 110.488 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -131.53 133.12 44.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.355 1.462 . . . . 0.0 110.001 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.69 123.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.4 t -118.21 150.35 39.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.254 1.421 . . . . 0.0 112.533 -173.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.542 1.537 . . . . 0.0 113.649 -170.029 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.04 128.28 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.921 1.237 . . . . 0.0 110.387 174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -99.9 126.53 46.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.514 1.125 . . . . 0.0 110.262 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -102.52 127.62 49.51 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.091 1.356 . . . . 0.0 110.29 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -101.16 99.43 9.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -103.77 152.27 22.06 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.842 -0.536 . . . . 0.0 111.293 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -60.39 -9.52 3.68 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -106.99 -9.56 16.2 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.805 1.242 . . . . 0.0 114.189 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.02 163.23 11.55 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.046 1.359 . . . . 0.0 113.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.28 138.18 43.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.636 1.574 . . . . 0.0 112.736 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.18 139.85 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.521 1.928 . . . . 0.0 108.43 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.63 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 110.352 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -125.03 134.11 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.357 1.863 . . . . 0.0 110.04 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.14 127.75 47.55 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.678 . . . . 0.0 108.605 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 p -88.92 146.48 24.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -104.31 73.94 1.15 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.701 1.239 . . . . 0.0 111.434 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.19 -25.06 64.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.503 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 -24.04 46.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.593 1.157 . . . . 0.0 111.873 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -107.4 -16.74 14.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.501 1.521 . . . . 0.0 113.29 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 50.6 0.52 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.841 1.256 . . . . 0.0 114.352 -172.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.22 -40.82 56.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.568 2.845 . . . . 0.0 113.859 -170.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -71.68 -35.17 70.2 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.646 -0.659 . . . . 0.0 110.851 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.4 m -70.49 -47.95 58.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.56 -43.5 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.089 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -58.77 -45.54 89.56 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.672 1.123 . . . . 0.0 111.619 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.98 -43.78 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.342 1.057 . . . . 0.0 111.937 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.51 -47.7 84.51 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 111.693 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.98 -37.72 72.74 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.565 0.746 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.64 -29.49 70.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.92 0.888 . . . . 0.0 112.937 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -77.01 -43.14 35.82 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.512 -0.743 . . . . 0.0 112.536 170.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.0 m -62.09 -37.53 85.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.206 -0.934 . . . . 0.0 111.515 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -57.2 -37.37 72.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.127 2.571 . . . . 0.0 113.581 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.3 -15.25 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.766 1.226 . . . . 0.0 113.381 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.88 18.12 56.78 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.988 0.804 . . . . 0.0 113.935 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.2 -17.96 60.83 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -99.47 -8.37 24.76 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.147 -0.97 . . . . 0.0 112.068 169.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.35 130.24 41.43 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.01 44.37 22.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 114.226 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 p -109.9 167.7 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.214 1.006 . . . . 0.0 110.926 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.0 162.16 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.68 85.06 6.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.499 1.12 . . . . 0.0 108.033 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -74.88 -10.81 59.85 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -146.72 138.22 24.38 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.237 1.835 . . . . 0.0 114.182 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.76 146.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.155 2.582 . . . . 0.0 110.46 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.7 mt -137.94 131.86 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.183 1.793 . . . . 0.0 107.85 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.47 137.22 57.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.553 0.741 . . . . 0.0 112.049 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 12.73 62.21 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.864 0.745 . . . . 0.0 114.644 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -142.54 -177.13 5.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.169 1.788 . . . . 0.0 111.412 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -178.79 7.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.971 1.709 . . . . 0.0 114.576 -173.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.7 pt -119.49 142.62 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.417 1.087 . . . . 0.0 113.237 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -110.89 150.2 29.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.944 1.297 . . . . 0.0 111.512 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.78 176.13 35.7 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.35 0.57 67.05 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.085 1.802 . . . . 0.0 115.354 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -16.93 65.12 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.013 1.407 . . . . 0.0 115.494 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -145.38 166.4 25.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.824 1.25 . . . . 0.0 112.987 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.91 162.26 24.62 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.841 1.657 . . . . 0.0 110.493 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.96 -13.17 29.6 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.655 2.903 . . . . 0.0 117.709 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.12 16.62 60.56 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.053 0.835 . . . . 0.0 114.5 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.8 30.19 19.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 112.575 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.04 126.12 33.93 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.037 1.335 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.25 119.96 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.362 1.065 . . . . 0.0 110.675 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.86 162.78 28.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.17 70.35 3.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.769 1.628 . . . . 0.0 111.591 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -73.35 142.71 47.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.927 1.291 . . . . 0.0 113.049 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -141.76 175.46 9.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.982 2.113 . . . . 0.0 111.943 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 52.55 67.87 3.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.689 1.595 . . . . 0.0 114.09 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -60.59 134.49 54.82 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.204 2.603 . . . . 0.0 111.51 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.1 152.13 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.811 1.644 . . . . 0.0 107.999 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 160.49 19.89 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.098 0.559 . . . . 0.0 111.757 170.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.16 132.98 41.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.164 0.586 . . . . 0.0 110.998 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -118.42 15.42 13.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.425 1.49 . . . . 0.0 112.674 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -15.96 46.13 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 119.957 -1.714 . . . . 0.0 114.179 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.28 4.48 0.5 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.13 1.372 . . . . 0.0 113.568 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -75.7 -9.68 58.79 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.775 1.23 . . . . 0.0 112.898 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.62 1.67 82.89 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.754 1.645 . . . . 0.0 114.822 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.09 153.58 32.08 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.259 1.029 . . . . 0.0 112.13 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -130.98 150.85 51.94 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -87.97 77.66 8.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.625 1.97 . . . . 0.0 111.629 -169.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 p -110.34 168.07 9.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -46.19 121.82 3.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 111.372 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.6 36.78 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.23 1.395 . . . . 0.0 114.823 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -118.66 157.72 26.89 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.121 1.46 . . . . 0.0 113.586 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -117.96 135.08 54.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 112.831 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . . . -134.47 159.7 40.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.485 0.659 . . . . 0.0 111.962 172.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ptp -70.12 145.12 51.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.536 0.734 . . . . 0.0 111.233 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 150.56 20.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.265 0.626 . . . . 0.0 110.066 169.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -127.68 160.5 31.45 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.519 1.127 . . . . 0.0 112.856 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -87.78 58.27 4.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.996 1.718 . . . . 0.0 110.213 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.341 18.1 pt20 54.49 -38.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 130.186 3.395 . . . . 0.0 117.648 -169.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.34 149.29 84.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.347 1.43 . . . . 0.0 111.3 173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.13 -35.18 66.03 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.471 2.114 . . . . 0.0 113.715 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -106.09 41.18 1.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 0.0 112.406 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -130.05 27.74 5.1 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.22 1.408 . . . . 0.0 113.839 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.58 104.69 16.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.47 1.508 . . . . 0.0 108.644 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -91.08 -52.31 4.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.282 1.033 . . . . 0.0 112.949 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -161.08 41.41 0.16 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.311 1.044 . . . . 0.0 113.064 -170.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -131.17 145.24 51.88 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.974 -1.078 . . . . 0.0 111.602 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.59 168.32 21.56 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.398 1.879 . . . . 0.0 111.594 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -146.5 163.78 34.62 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.029 0.932 . . . . 0.0 111.566 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.18 118.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.587 1.155 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.04 108.24 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.675 0.79 . . . . 0.0 110.915 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.74 -12.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 113.725 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.55 167.19 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.44 1.496 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.51 113.15 4.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.731 1.612 . . . . 0.0 112.115 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.7 62.34 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.309 1.443 . . . . 0.0 111.643 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.81 -35.69 66.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.343 1.457 . . . . 0.0 114.106 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -65.18 -12.98 56.94 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.51 -8.05 59.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.342 1.057 . . . . 0.0 113.443 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -77.71 -172.35 2.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.683 1.193 . . . . 0.0 113.84 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -81.87 146.43 29.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.36 1.464 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.9 p -107.58 -61.87 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.658 1.583 . . . . 0.0 113.349 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.99 56.64 0.01 OUTLIER Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.515 1.531 . . . . 0.0 112.335 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.41 24.77 13.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.114 1.766 . . . . 0.0 114.862 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.9 p -102.34 122.11 43.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.876 1.27 . . . . 0.0 112.781 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.76 -40.56 63.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.01 1.324 . . . . 0.0 114.558 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -83.08 -10.36 58.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.773 0.829 . . . . 0.0 113.047 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.87 -71.44 1.17 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.323 1.916 . . . . 0.0 113.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.404 ' HB3' ' H ' ' A' ' 111' ' ' SER 0.31 5.6 p-90 -71.87 123.51 22.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.433 1.117 . . . . 0.0 113.542 -169.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.77 -99.18 1.31 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.221 1.391 . . . . 0.0 115.388 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.5 132.92 45.88 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.306 1.042 . . . . 0.0 112.328 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.52 126.46 30.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.17 94.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.402 1.081 . . . . 0.0 108.242 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -82.05 -14.7 55.5 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.866 0.866 . . . . 0.0 111.795 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.08 175.58 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.56 1.171 . . . . 0.0 113.13 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.81 153.39 50.82 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.795 -1.191 . . . . 0.0 112.203 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.35 138.68 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.586 0.708 . . . . 0.0 109.254 169.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 t -107.82 -41.98 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.712 1.605 . . . . 0.0 110.557 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -145.58 151.07 37.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.344 1.458 . . . . 0.0 110.031 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.93 11.78 19.86 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.953 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.9 mmm -53.39 -37.42 62.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.928 1.864 . . . . 0.0 112.544 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.92 -31.76 72.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.039 0.936 . . . . 0.0 112.377 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.93 -43.75 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.174 1.39 . . . . 0.0 110.282 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.95 -38.01 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.217 -0.927 . . . . 0.0 111.031 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -71.93 -26.31 62.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.246 1.418 . . . . 0.0 112.558 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -77.89 -41.52 36.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.865 1.266 . . . . 0.0 110.886 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.89 -30.23 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.061 1.744 . . . . 0.0 112.726 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -89.43 -12.39 40.38 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -111.42 -12.88 14.08 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.542 1.544 . . . . 0.0 114.471 -171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 m -61.29 -58.07 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.733 1.266 . . . . 0.0 112.678 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.23 145.0 1.26 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.964 1.305 . . . . 0.0 112.073 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -122.5 149.37 44.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.629 1.572 . . . . 0.0 112.564 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.82 130.55 1.27 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.33 0.967 . . . . 0.0 112.053 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -68.3 145.78 53.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.441 1.096 . . . . 0.0 113.119 -173.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.3 p -114.69 167.97 10.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.213 1.405 . . . . 0.0 112.277 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.27 76.72 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.535 0.588 . . . . 0.0 114.517 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.3 mmm -95.76 -41.53 8.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.525 1.13 . . . . 0.0 112.765 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -141.31 130.11 22.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.393 1.877 . . . . 0.0 110.174 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -90.3 153.78 20.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.579 0.751 . . . . 0.0 112.681 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 53.3 65.4 1.53 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.225 2.21 . . . . 0.0 112.624 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.44 160.27 63.28 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 127.58 2.352 . . . . 0.0 111.816 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.93 132.87 31.57 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.372 1.381 . . . . 0.0 109.397 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 -26.14 28.82 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.14 142.56 45.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.581 0.753 . . . . 0.0 109.644 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -81.42 112.05 18.34 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.328 0.651 . . . . 0.0 110.803 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.13 103.99 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.45 143.65 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.772 1.229 . . . . 0.0 111.57 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.4 mt -86.78 102.7 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.04 -28.31 43.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.389 1.076 . . . . 0.0 112.109 -174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -153.66 161.78 41.84 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.21 140.09 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.967 1.707 . . . . 0.0 109.875 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -136.37 126.52 26.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.747 1.219 . . . . 0.0 110.343 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.5 121.77 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 t -111.75 150.45 30.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.386 1.474 . . . . 0.0 112.316 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.706 1.602 . . . . 0.0 113.502 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.84 130.36 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.0 m -103.97 124.78 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.47 1.508 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -101.08 120.04 39.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.674 1.19 . . . . 0.0 109.756 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -93.9 114.38 26.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -125.31 159.39 31.84 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -68.94 -7.99 40.22 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -106.77 -28.26 10.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.645 1.578 . . . . 0.0 113.276 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.88 146.91 4.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.323 1.916 . . . . 0.0 113.094 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.69 133.15 31.26 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.533 1.133 . . . . 0.0 112.863 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.3 mt -128.39 142.96 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.845 1.658 . . . . 0.0 109.28 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -129.27 138.6 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.165 0.986 . . . . 0.0 110.269 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 mt -128.89 138.32 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.551 1.94 . . . . 0.0 109.801 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -107.38 122.28 46.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.725 2.01 . . . . 0.0 109.419 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 p -86.74 149.3 24.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.128 0.971 . . . . 0.0 112.414 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.03 72.49 0.89 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 123.025 1.393 . . . . 0.0 111.924 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.85 -26.07 64.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.544 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.06 -29.1 54.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.241 1.016 . . . . 0.0 111.481 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -99.42 -23.18 15.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.88 1.272 . . . . 0.0 113.23 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.22 55.42 1.39 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.33 1.052 . . . . 0.0 113.41 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.77 -44.34 31.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.368 2.712 . . . . 0.0 112.99 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -69.37 -39.94 77.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.725 0.693 . . . . 0.0 111.291 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.2 m -64.86 -47.67 77.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.451 0.7 . . . . 0.0 111.245 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.7 -38.03 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.121 0.968 . . . . 0.0 112.275 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -54.21 -45.08 72.16 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.849 1.204 . . . . 0.0 112.035 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.41 HD21 HD11 ' A' ' 68' ' ' ILE . 62.5 t30 -68.26 -41.53 80.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.282 0.633 . . . . 0.0 111.467 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.6 -47.05 85.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.109 0.963 . . . . 0.0 111.611 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.55 -36.37 68.23 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.381 -0.825 . . . . 0.0 112.209 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.59 -39.15 76.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.819 0.448 . . . . 0.0 111.74 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -68.29 -43.38 77.83 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.55 -0.719 . . . . 0.0 111.932 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.8 m -60.33 -40.3 90.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.065 0.546 . . . . 0.0 111.32 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -68.78 -33.79 74.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.968 1.707 . . . . 0.0 112.821 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.35 -18.44 42.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.162 0.985 . . . . 0.0 112.994 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.87 25.91 43.63 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.919 -0.488 . . . . 0.0 112.561 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -69.78 -42.49 73.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.273 1.037 . . . . 0.0 113.156 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -81.22 -13.4 58.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.769 0.828 . . . . 0.0 111.732 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -63.14 124.96 22.5 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.684 0.794 . . . . 0.0 108.87 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.252 61.1 t30 59.1 45.52 14.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.592 1.557 . . . . 0.0 114.886 -169.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -111.66 164.3 13.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.466 1.106 . . . . 0.0 111.067 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.5 pt -121.36 163.05 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 85.05 7.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.197 1.399 . . . . 0.0 107.978 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -75.59 -7.25 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -135.45 140.9 45.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.854 1.661 . . . . 0.0 112.252 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.53 136.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.961 2.104 . . . . 0.0 110.526 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.4 mt -140.33 130.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 108.363 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -66.93 137.21 56.37 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.099 0.96 . . . . 0.0 112.067 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 11.95 66.43 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.816 0.722 . . . . 0.0 114.492 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -146.3 -176.99 5.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.91 2.084 . . . . 0.0 110.216 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -90.51 -180.0 5.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.107 1.763 . . . . 0.0 114.45 -171.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.14 140.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.882 1.273 . . . . 0.0 111.971 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -112.49 149.03 33.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.021 1.329 . . . . 0.0 110.789 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.35 175.72 32.43 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 3.51 90.0 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.311 1.434 . . . . 0.0 115.392 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.12 -26.32 37.36 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.002 1.401 . . . . 0.0 115.031 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -143.78 160.53 40.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.2 164.31 39.05 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.319 1.447 . . . . 0.0 110.59 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.92 -14.47 37.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.381 2.721 . . . . 0.0 117.943 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.87 21.08 47.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.344 0.973 . . . . 0.0 114.451 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.78 33.68 17.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.941 1.696 . . . . 0.0 113.011 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.06 130.48 36.96 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.057 1.343 . . . . 0.0 109.772 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.62 128.92 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 123.943 1.83 . . . . 0.0 111.357 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -76.79 178.48 6.78 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 110.615 -2.993 . . . . 0.0 114.379 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.18 54.43 3.1 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.821 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.2 p -71.11 117.36 12.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.509 1.124 . . . . 0.0 111.402 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.34 -178.07 4.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.062 1.745 . . . . 0.0 111.818 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 45.95 64.19 8.43 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.649 1.58 . . . . 0.0 114.344 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -54.51 129.3 34.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.097 2.531 . . . . 0.0 110.703 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -109.68 148.65 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.152 1.381 . . . . 0.0 109.044 -174.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 151.71 38.55 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.31 0.576 . . . . 0.0 110.787 169.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -80.11 125.17 29.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.575 0.75 . . . . 0.0 110.851 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.82 12.67 34.22 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.804 1.241 . . . . 0.0 113.152 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -16.49 49.22 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.64 -1.287 . . . . 0.0 114.409 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.89 1.11 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.437 1.495 . . . . 0.0 114.02 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -71.98 -11.6 60.85 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.878 1.271 . . . . 0.0 113.076 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 10.67 77.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.1 1.333 . . . . 0.0 114.383 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.55 154.96 34.04 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.582 1.191 . . . . 0.0 112.48 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -130.01 151.85 50.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.77 103.21 15.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.14 2.176 . . . . 0.0 109.668 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 p -134.65 170.59 15.57 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.096 1.358 . . . . 0.0 110.822 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -49.65 119.79 3.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.773 1.229 . . . . 0.0 111.116 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.08 33.31 26.77 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.832 1.206 . . . . 0.0 114.923 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -119.6 159.57 24.13 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.727 1.263 . . . . 0.0 113.09 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.75 136.37 54.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -135.07 156.31 49.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.03 0.532 . . . . 0.0 111.467 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -85.13 134.5 34.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.71 153.44 22.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.374 1.07 . . . . 0.0 111.122 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -105.26 158.24 16.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.071 1.349 . . . . 0.0 111.969 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.9 m -78.01 -51.6 10.09 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.987 0.915 . . . . 0.0 110.776 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -161.85 -53.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.899 1.28 . . . . 0.0 111.334 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.8 162.99 68.36 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.058 1.343 . . . . 0.0 112.315 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.5 -17.07 58.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.217 2.611 . . . . 0.0 114.263 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -122.17 50.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.569 1.547 . . . . 0.0 111.681 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.9 p -132.78 33.5 3.72 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.65 57.76 0.76 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.114 1.366 . . . . 0.0 113.475 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p -60.17 -47.67 84.97 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -169.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.12 -30.72 0.13 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -174.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -70.81 142.82 51.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.317 1.047 . . . . 0.0 111.434 -170.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -137.21 168.39 19.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.196 1.798 . . . . 0.0 110.524 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 24.3 p90 -148.27 160.53 42.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 112.071 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.02 115.9 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 108.903 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.7 95.97 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.175 0.99 . . . . 0.0 110.697 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.91 -24.73 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.167 -0.958 . . . . 0.0 113.388 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.9 168.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.501 . . . . 0.0 111.492 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.79 118.04 21.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.201 1.0 . . . . 0.0 110.531 169.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -141.88 68.49 1.32 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.938 1.352 . . . . 0.0 113.004 -169.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.52 -35.31 39.95 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.309 2.244 . . . . 0.0 114.538 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -58.8 -13.79 7.08 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.08 -10.45 59.2 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.58 -177.35 3.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.511 1.524 . . . . 0.0 114.814 -171.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -79.35 155.59 28.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.098 1.359 . . . . 0.0 111.64 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.5 t -136.11 -55.05 0.76 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 169.13 61.65 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.85 23.48 9.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.586 1.554 . . . . 0.0 114.847 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -114.13 137.17 52.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.023 1.329 . . . . 0.0 112.883 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.14 -31.65 71.36 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.515 1.126 . . . . 0.0 113.39 -170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -85.63 -7.29 58.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.075 0.95 . . . . 0.0 113.085 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.88 -67.86 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.43 1.967 . . . . 0.0 114.19 -174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.28 4.0 p-90 -90.2 129.85 36.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.74 -89.52 1.9 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.719 1.628 . . . . 0.0 114.802 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -140.56 146.73 38.44 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.169 1.387 . . . . 0.0 112.139 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.08 129.51 34.82 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.34 94.48 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.762 1.225 . . . . 0.0 108.585 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -79.28 -16.0 57.09 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.648 0.779 . . . . 0.0 111.976 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.96 177.8 8.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.663 1.221 . . . . 0.0 113.111 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.06 153.78 51.93 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.89 -1.131 . . . . 0.0 112.027 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.61 143.98 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.744 0.783 . . . . 0.0 109.315 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.83 -38.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 110.854 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -146.37 149.12 33.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.274 1.43 . . . . 0.0 110.906 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.48 6.09 18.03 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.65 1.119 . . . . 0.0 115.793 170.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.4 mmm -56.3 -37.14 69.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.169 1.484 . . . . 0.0 113.103 -176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.81 -30.93 71.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.724 0.809 . . . . 0.0 112.207 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.06 -41.73 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.037 1.735 . . . . 0.0 110.696 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.27 -38.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 111.05 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 6.8 t70 -75.77 -19.18 59.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.02 1.328 . . . . 0.0 113.19 175.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -79.75 -41.94 25.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.108 1.363 . . . . 0.0 111.081 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.5 mt -55.51 -35.56 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.06 1.344 . . . . 0.0 112.158 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.49 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.9 pttp -83.78 -12.36 55.81 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.87 -24.49 9.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.151 1.358 . . . . 0.0 114.197 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 m -74.16 -59.5 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.718 1.259 . . . . 0.0 114.379 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.05 154.48 9.07 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.8 p -141.94 153.63 44.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.943 1.697 . . . . 0.0 112.143 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.81 131.33 1.38 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.343 0.497 . . . . 0.0 113.176 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.97 149.71 39.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.397 1.479 . . . . 0.0 113.055 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 28.7 p -116.55 168.9 9.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.354 1.461 . . . . 0.0 112.451 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.24 -19.45 70.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.569 0.604 . . . . 0.0 114.557 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.01 -41.97 7.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.645 1.178 . . . . 0.0 112.655 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -141.45 132.91 26.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.379 1.871 . . . . 0.0 110.471 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -94.83 158.34 15.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.321 1.048 . . . . 0.0 111.813 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.52 58.15 4.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.271 1.428 . . . . 0.0 113.299 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.67 160.66 59.62 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 0.0 111.64 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.98 136.39 41.03 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.515 1.476 . . . . 0.0 110.259 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -30.11 40.76 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.88 152.28 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.078 0.951 . . . . 0.0 110.849 169.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.64 109.65 17.61 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.837 0.827 . . . . 0.0 110.799 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.1 t -105.03 93.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.54 144.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.14 103.97 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.224 1.81 . . . . 0.0 107.09 169.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.32 -29.17 42.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.254 1.021 . . . . 0.0 112.504 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -156.28 165.7 35.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.17 139.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.901 1.681 . . . . 0.0 110.741 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 m -136.58 132.71 35.51 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.004 1.322 . . . . 0.0 110.712 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.75 123.33 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -117.41 150.39 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.611 1.564 . . . . 0.0 112.41 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 125.365 1.466 . . . . 0.0 113.611 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.78 128.59 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.979 0.912 . . . . 0.0 108.742 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -104.26 124.45 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.022 1.329 . . . . 0.0 109.958 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.0 123.54 40.74 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.173 0.989 . . . . 0.0 109.74 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -99.32 105.98 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.563 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.22 159.66 20.69 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.966 -0.459 . . . . 0.0 111.555 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -70.78 -6.05 34.78 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -110.37 -24.66 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.528 1.531 . . . . 0.0 113.759 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.77 145.17 4.14 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.258 1.885 . . . . 0.0 113.665 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.27 135.45 38.5 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.676 1.19 . . . . 0.0 112.836 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -132.66 142.62 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.313 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.18 136.91 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.321 1.048 . . . . 0.0 110.672 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 139.33 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.778 2.031 . . . . 0.0 110.255 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -105.94 123.51 48.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.694 1.998 . . . . 0.0 108.807 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -87.63 148.6 24.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.266 1.026 . . . . 0.0 112.183 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.15 74.17 1.03 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.684 1.23 . . . . 0.0 111.684 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.75 -27.07 64.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.499 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.122 0.969 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.73 -22.65 15.77 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 113.106 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.98 2.75 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.754 1.222 . . . . 0.0 112.816 -171.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.55 -44.88 19.96 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.249 2.633 . . . . 0.0 112.708 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -70.55 -41.26 72.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.777 -0.577 . . . . 0.0 110.996 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -63.06 -47.34 83.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.907 0.483 . . . . 0.0 111.71 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.87 -38.79 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.635 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -57.46 -44.47 84.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.002 1.274 . . . . 0.0 111.484 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -68.17 -39.22 82.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.455 0.702 . . . . 0.0 111.624 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.02 -50.61 73.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.705 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.31 -37.0 77.56 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.448 0.699 . . . . 0.0 111.422 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -56.93 -37.47 71.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.824 0.85 . . . . 0.0 111.965 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -74.15 -43.53 57.05 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.416 -0.803 . . . . 0.0 112.226 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.42 -37.96 76.44 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.84 -0.537 . . . . 0.0 111.808 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -32.76 72.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.257 1.823 . . . . 0.0 112.858 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.63 -15.62 54.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.973 0.909 . . . . 0.0 113.124 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.31 19.85 65.79 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.276 0.941 . . . . 0.0 113.149 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.09 -37.03 73.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.391 1.096 . . . . 0.0 113.068 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.889 0.476 . . . . 0.0 112.139 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -63.74 132.57 51.39 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.221 -0.924 . . . . 0.0 109.112 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.253 13.9 t30 59.42 25.14 13.83 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.722 2.009 . . . . 0.0 116.118 -171.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.2 p -83.27 142.32 31.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.933 -1.105 . . . . 0.0 113.212 170.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.9 pt -95.45 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -83.6 79.16 9.53 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 168.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -73.57 4.71 4.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.553 ' HE ' ' HB2' ' A' ' 149' ' ' ASP . 9.7 tpt180 -148.06 135.6 20.7 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.269 1.395 . . . . 0.0 112.439 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.45 131.04 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 110.676 170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -137.34 128.37 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.572 1.549 . . . . 0.0 108.399 -172.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -64.25 136.68 57.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.589 0.755 . . . . 0.0 111.97 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.29 9.66 61.25 Favored Glycine 0 CA--C 1.541 1.668 0 N-CA-C 115.091 0.797 . . . . 0.0 115.091 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.25 -177.16 5.32 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.558 1.943 . . . . 0.0 110.496 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.97 -179.34 6.77 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.674 1.589 . . . . 0.0 115.139 -170.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.0 pt -116.76 134.88 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.78 1.232 . . . . 0.0 112.303 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -108.72 153.52 23.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.659 1.183 . . . . 0.0 111.684 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.38 -179.96 34.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.228 0.918 . . . . 0.0 114.957 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.79 84.39 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.699 1.04 . . . . 0.0 115.699 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -21.4 35.96 Favored Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.115 1.458 . . . . 0.0 115.917 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.3 162.82 35.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.269 1.034 . . . . 0.0 113.45 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -90.27 158.98 42.9 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.851 1.66 . . . . 0.0 109.804 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.98 -8.99 13.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.668 3.578 . . . . 0.0 116.113 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.74 14.63 64.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.08 0.848 . . . . 0.0 114.534 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.37 26.94 16.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.913 1.685 . . . . 0.0 113.163 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.15 131.6 36.6 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.093 1.357 . . . . 0.0 109.842 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -75.9 129.35 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.086 1.898 . . . . 0.0 111.204 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -72.2 179.54 3.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 110.447 -3.07 . . . . 0.0 114.127 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.24 51.21 2.08 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.258 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.2 p -72.28 117.17 13.59 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.594 1.158 . . . . 0.0 111.944 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -138.0 178.87 6.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.176 2.191 . . . . 0.0 111.857 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 51.13 71.4 1.54 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.324 1.45 . . . . 0.0 113.728 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.08 147.95 94.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.3 2.667 . . . . 0.0 111.889 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.74 147.96 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.135 1.374 . . . . 0.0 110.64 -172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -64.76 153.27 40.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.919 0.888 . . . . 0.0 111.107 169.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.96 -54.89 40.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.256 8.6 mt-10 71.62 1.66 3.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.422 2.289 . . . . 0.0 117.029 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -14.21 59.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.478 1.944 . . . . 0.0 113.972 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -62.72 2.28 0.31 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.728 1.611 . . . . 0.0 114.126 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -74.18 -12.49 60.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.244 1.418 . . . . 0.0 113.543 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.76 77.56 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.075 1.321 . . . . 0.0 114.6 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.5 157.35 30.47 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.517 1.159 . . . . 0.0 112.16 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.6 148.11 52.36 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.67 113.38 18.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.972 2.509 . . . . 0.0 109.653 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -139.44 167.43 22.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.932 1.293 . . . . 0.0 110.569 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -56.45 122.83 12.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.851 0.834 . . . . 0.0 110.9 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.45 51.74 5.48 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.926 1.25 . . . . 0.0 113.74 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 p -138.89 162.96 33.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.176 0.991 . . . . 0.0 112.156 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.5 138.12 53.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.833 0.825 . . . . 0.0 113.176 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -137.32 160.83 37.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.143 0.577 . . . . 0.0 111.459 171.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.7 mmt -82.4 142.71 31.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.898 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.03 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.519 1.127 . . . . 0.0 110.054 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -106.06 155.79 19.05 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.225 1.01 . . . . 0.0 113.117 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -75.01 -51.61 13.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.685 0.794 . . . . 0.0 111.099 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -156.97 -40.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.139 1.375 . . . . 0.0 113.119 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.97 32.86 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.173 1.389 . . . . 0.0 111.879 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.59 -20.52 65.06 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.303 2.669 . . . . 0.0 114.295 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -108.23 39.38 1.98 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.165 1.786 . . . . 0.0 112.244 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.9 p -128.43 31.04 5.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.059 1.344 . . . . 0.0 113.475 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.33 56.76 3.36 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.826 1.651 . . . . 0.0 113.595 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.1 p -49.69 -70.76 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.767 2.027 . . . . 0.0 115.197 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.18 -21.87 0.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.717 1.207 . . . . 0.0 113.89 -169.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.66 139.87 49.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.411 -0.806 . . . . 0.0 110.568 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.3 168.49 19.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.75 2.02 . . . . 0.0 110.837 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 20.9 p90 -144.36 160.86 40.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.593 0.757 . . . . 0.0 111.887 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.3 mt -111.46 117.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -72.76 103.02 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.071 0.549 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.04 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.08 168.18 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 127.277 2.231 . . . . 0.0 112.212 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.75 122.98 25.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.877 1.271 . . . . 0.0 111.457 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -145.32 73.13 1.34 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.68 1.229 . . . . 0.0 112.403 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.47 -34.24 68.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.675 1.59 . . . . 0.0 114.365 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -56.92 -13.69 2.88 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.82 -12.74 58.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.14 169.51 17.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.99 155.35 40.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.738 1.615 . . . . 0.0 113.133 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.7 p -134.45 -56.77 0.85 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.614 1.166 . . . . 0.0 113.197 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 169.24 70.48 0.03 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.947 0.784 . . . . 0.0 113.983 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 55.34 26.42 8.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.549 1.54 . . . . 0.0 114.52 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -119.42 123.07 43.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.719 1.208 . . . . 0.0 111.695 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.85 -32.36 67.58 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -73.0 -12.02 60.78 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.86 -88.38 1.98 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 127.627 2.537 . . . . 0.0 113.066 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.27 1.7 p-90 -62.21 129.65 41.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -169.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.97 -82.89 0.82 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.051 1.31 . . . . 0.0 115.165 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -128.93 123.55 32.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 112.548 -169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -83.06 131.77 35.15 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -75.64 99.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.011 0.924 . . . . 0.0 108.845 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -80.96 -16.78 52.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.712 0.805 . . . . 0.0 111.591 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 175.88 9.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.194 0.997 . . . . 0.0 113.624 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.51 149.65 48.27 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.481 -1.387 . . . . 0.0 112.144 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.26 135.1 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-O 121.481 0.658 . . . . 0.0 110.405 172.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.56 -41.09 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.499 1.92 . . . . 0.0 110.581 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -142.51 149.27 38.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.186 1.395 . . . . 0.0 110.313 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.32 8.54 28.89 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.342 0.972 . . . . 0.0 115.275 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 79.9 mmm -55.98 -37.68 69.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.176 1.488 . . . . 0.0 112.759 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.71 -29.96 71.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.84 . . . . 0.0 112.49 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.23 -45.26 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.021 1.728 . . . . 0.0 110.492 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.9 t -57.8 -40.11 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.392 1.077 . . . . 0.0 111.38 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 -19.47 61.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.47 1.508 . . . . 0.0 112.905 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -86.85 -39.84 15.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 54.1 mt -50.92 -41.72 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.499 1.52 . . . . 0.0 111.495 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -73.01 -17.71 61.42 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.34 -10.46 36.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.373 1.939 . . . . 0.0 114.796 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.62 -63.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.305 1.553 . . . . 0.0 110.471 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 156.07 2.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.907 1.283 . . . . 0.0 112.008 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.6 p -139.94 149.46 43.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.701 1.2 . . . . 0.0 112.181 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.07 118.75 0.58 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.323 0.487 . . . . 0.0 112.464 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -64.0 146.71 53.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.608 1.563 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.2 p -113.57 168.97 9.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.179 1.392 . . . . 0.0 112.584 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.42 -17.03 70.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.842 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.3 mtp -105.86 -38.06 6.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.581 1.19 . . . . 0.0 113.436 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -141.49 138.08 32.55 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.241 1.817 . . . . 0.0 110.732 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -105.33 160.46 15.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.053 1.341 . . . . 0.0 113.4 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.553 ' HB2' ' HE ' ' A' ' 43' ' ' ARG . 2.8 m-20 55.69 51.35 12.62 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.883 1.673 . . . . 0.0 112.032 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 m -117.45 152.56 49.58 Favored Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 126.161 1.785 . . . . 0.0 111.959 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -68.26 134.88 32.61 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.73 1.62 . . . . 0.0 109.03 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -29.53 61.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -86.86 159.55 19.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.593 1.157 . . . . 0.0 110.303 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -82.79 109.89 17.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.41 1.084 . . . . 0.0 111.794 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.61 94.0 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.563 1.545 . . . . 0.0 106.913 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.79 149.01 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.239 1.495 . . . . 0.0 113.342 -169.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.72 103.9 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.03 -40.14 65.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.744 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -149.52 164.26 35.56 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.57 142.05 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.888 1.675 . . . . 0.0 110.929 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 m -136.24 134.0 37.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.629 1.171 . . . . 0.0 110.983 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.58 120.52 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.0 t -117.98 150.23 39.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.537 1.535 . . . . 0.0 112.723 -171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.388 1.475 . . . . 0.0 113.907 -170.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 120.27 0.081 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.98 129.99 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.936 0.894 . . . . 0.0 109.905 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.1 m -104.12 124.44 49.08 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.371 1.468 . . . . 0.0 109.766 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -99.47 123.54 43.84 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.464 1.106 . . . . 0.0 110.346 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -97.61 108.09 20.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.623 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -119.14 159.08 24.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 112.223 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -68.59 -6.77 27.52 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -110.67 -25.13 10.11 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.466 1.506 . . . . 0.0 113.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.38 145.85 4.3 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.123 1.82 . . . . 0.0 113.583 173.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.32 133.81 39.88 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.474 1.109 . . . . 0.0 112.535 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.4 mt -131.1 144.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.943 1.697 . . . . 0.0 109.499 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.26 137.76 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.387 1.075 . . . . 0.0 110.463 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -124.07 138.75 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.987 2.115 . . . . 0.0 110.087 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -106.83 125.37 50.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.109 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.5 p -87.75 149.49 24.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 112.075 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -108.59 74.5 0.92 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.766 1.27 . . . . 0.0 111.726 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.76 -25.9 64.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.548 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -77.57 -26.78 51.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.619 1.168 . . . . 0.0 111.675 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -101.84 -22.39 14.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.231 1.412 . . . . 0.0 112.972 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.73 56.41 1.59 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.891 1.276 . . . . 0.0 113.103 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.09 -44.36 29.94 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.496 2.797 . . . . 0.0 112.914 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.2 -41.45 77.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.793 0.724 . . . . 0.0 111.084 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -64.77 -48.59 73.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.725 0.41 . . . . 0.0 111.549 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.7 -41.46 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.573 . . . . 0.0 111.349 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.17 -45.59 87.22 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.571 1.078 . . . . 0.0 111.623 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.1 -34.31 70.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.682 0.674 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.84 -49.68 75.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.257 1.023 . . . . 0.0 111.733 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.358 -0.839 . . . . 0.0 111.658 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -56.52 -33.05 65.67 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.183 0.993 . . . . 0.0 112.628 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -77.61 -46.43 22.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 171.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.3 m -57.72 -40.1 78.8 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.967 0.907 . . . . 0.0 112.201 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -52.86 -46.68 67.99 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.659 1.984 . . . . 0.0 112.872 173.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -83.2 -14.55 53.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.055 0.942 . . . . 0.0 112.133 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.47 52.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.289 0.947 . . . . 0.0 113.046 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.29 -37.15 69.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.402 1.101 . . . . 0.0 113.241 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -83.33 -6.44 59.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.396 0.679 . . . . 0.0 112.132 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -64.41 132.35 49.82 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.1 t30 53.82 49.91 18.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.319 1.448 . . . . 0.0 113.998 -171.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.8 p -114.44 157.14 23.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.304 1.042 . . . . 0.0 112.393 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.41 155.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -86.4 75.97 9.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.863 1.265 . . . . 0.0 107.855 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -53.16 -38.23 62.58 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.0 1.72 . . . . 0.0 114.76 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -123.64 135.53 53.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.56 1.144 . . . . 0.0 111.495 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.2 132.69 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.408 2.283 . . . . 0.0 110.578 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.44 128.9 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.622 1.569 . . . . 0.0 107.989 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 133.49 55.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 111.631 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.97 9.32 66.14 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 123.898 0.761 . . . . 0.0 114.871 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -141.52 -177.28 5.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.153 1.781 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.21 -179.55 5.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.7 136.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.054 1.342 . . . . 0.0 112.399 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.92 146.63 46.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.194 1.398 . . . . 0.0 111.094 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.92 31.03 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.18 -8.73 72.56 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.647 1.594 . . . . 0.0 115.944 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.76 -20.65 70.53 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 118.961 1.381 . . . . 0.0 115.479 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.2 164.9 28.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.482 1.113 . . . . 0.0 113.652 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -101.29 163.65 17.52 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.028 1.731 . . . . 0.0 110.629 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.01 -12.12 28.12 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.384 2.723 . . . . 0.0 118.0 -169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.08 14.59 60.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 123.452 0.549 . . . . 0.0 114.426 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.6 mmt 59.49 28.74 18.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.582 1.953 . . . . 0.0 112.757 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.81 123.01 28.95 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.1 1.36 . . . . 0.0 109.555 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.82 126.62 30.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 124.365 2.031 . . . . 0.0 110.887 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.0 179.74 2.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 110.077 -3.238 . . . . 0.0 114.408 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.06 64.11 3.27 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.372 -2.195 . . . . 0.0 112.147 -174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 p -70.22 107.29 3.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.146 1.379 . . . . 0.0 110.838 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -140.9 168.03 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.133 2.173 . . . . 0.0 112.401 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 50.13 66.94 4.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 0.0 112.487 171.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.62 145.97 97.21 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.469 2.779 . . . . 0.0 113.664 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.85 146.05 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.515 1.926 . . . . 0.0 109.053 -176.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 158.74 16.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.553 1.141 . . . . 0.0 111.143 170.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -73.44 134.55 43.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 111.614 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.04 13.63 12.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.086 1.354 . . . . 0.0 112.675 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -11.85 56.43 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.565 -1.334 . . . . 0.0 114.128 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -62.24 5.27 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.309 1.444 . . . . 0.0 114.553 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -76.53 -11.35 59.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.773 1.629 . . . . 0.0 112.826 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 6.47 85.39 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.256 1.407 . . . . 0.0 115.071 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.53 154.85 38.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.361 1.081 . . . . 0.0 112.25 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.55 149.21 51.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -86.03 64.24 8.47 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.44 1.896 . . . . 0.0 112.528 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.8 p -98.57 166.24 11.44 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.735 0.814 . . . . 0.0 112.235 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.05 123.25 11.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.878 1.671 . . . . 0.0 111.019 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.25 56.37 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.315 1.436 . . . . 0.0 114.945 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.2 p -110.51 161.36 15.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.591 1.695 . . . . 0.0 113.266 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -118.98 135.34 54.66 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.031 0.932 . . . . 0.0 112.734 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . . . -135.43 159.39 41.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.652 174.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -81.7 143.04 32.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 111.204 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 153.99 18.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.953 0.901 . . . . 0.0 110.617 169.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -133.9 152.94 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.134 1.374 . . . . 0.0 111.923 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -65.32 -55.08 20.23 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.837 1.255 . . . . 0.0 112.708 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.71 -55.48 0.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.758 1.223 . . . . 0.0 111.366 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.47 159.04 86.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.574 1.15 . . . . 0.0 111.5 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.37 -26.28 81.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.005 2.47 . . . . 0.0 113.703 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -114.28 42.15 2.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.317 1.447 . . . . 0.0 111.947 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -122.61 30.64 6.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.309 1.444 . . . . 0.0 114.124 -173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.06 22.67 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.268 1.427 . . . . 0.0 107.465 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -132.51 -59.48 0.91 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.23 1.412 . . . . 0.0 112.739 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.57 -11.85 1.58 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 0.0 112.677 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -78.96 134.37 36.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.551 1.14 . . . . 0.0 110.383 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -141.32 168.1 20.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.082 1.753 . . . . 0.0 111.635 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 9.6 p90 -149.96 163.12 38.94 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.856 0.862 . . . . 0.0 111.751 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.0 mt -117.26 119.19 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.922 1.289 . . . . 0.0 108.538 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -72.59 97.57 2.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.564 0.745 . . . . 0.0 110.037 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 m -76.14 -15.54 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.8 167.01 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 128.724 2.809 . . . . 0.0 110.296 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.22 116.54 13.88 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.204 0.526 . . . . 0.0 111.525 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.9 57.25 1.28 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 111.921 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -64.82 -15.59 61.97 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -66.08 -15.12 62.8 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.779 -1.201 . . . . 0.0 113.383 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.37 -8.73 59.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.37 1.068 . . . . 0.0 113.452 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.28 179.83 3.73 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -79.08 141.09 37.66 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.561 1.544 . . . . 0.0 112.483 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.6 p -104.17 -60.31 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.638 1.175 . . . . 0.0 113.591 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.64 58.73 0.03 OUTLIER Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.818 0.723 . . . . 0.0 114.732 -172.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 57.13 26.17 11.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.756 1.622 . . . . 0.0 114.943 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.3 t -104.94 112.51 25.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.188 0.995 . . . . 0.0 109.417 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.39 -32.19 64.57 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -76.89 -15.55 59.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.43 -64.97 1.26 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 127.487 2.47 . . . . 0.0 113.512 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.299 8.0 p-90 -69.07 122.24 18.34 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.888 1.344 . . . . 0.0 113.36 -174.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.84 -96.45 0.69 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.339 1.447 . . . . 0.0 115.618 -169.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.51 137.64 48.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 111.805 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.8 129.31 34.87 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.27 94.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.794 1.238 . . . . 0.0 108.455 169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -80.64 -15.38 56.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.401 0.681 . . . . 0.0 111.821 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.03 177.97 8.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.46 1.124 . . . . 0.0 113.554 -171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -137.14 153.6 50.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 120.811 -1.181 . . . . 0.0 112.105 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.84 138.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.509 0.671 . . . . 0.0 110.443 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.33 -41.95 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.993 1.717 . . . . 0.0 111.187 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -143.48 153.84 43.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.141 1.377 . . . . 0.0 110.584 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.31 39.15 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.526 1.06 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.9 mtp -60.66 -35.17 75.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.895 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -65.12 -29.07 69.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.865 0.866 . . . . 0.0 112.142 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.05 -43.6 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.491 1.517 . . . . 0.0 110.307 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.59 -38.95 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.488 1.115 . . . . 0.0 111.253 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.13 -20.09 60.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.419 1.488 . . . . 0.0 113.0 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -86.22 -40.55 15.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.761 1.624 . . . . 0.0 111.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.4 mt -54.7 -34.44 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.487 1.515 . . . . 0.0 112.065 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -83.82 -16.58 44.06 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.0 13.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.182 1.372 . . . . 0.0 114.091 -173.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.84 -62.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.405 1.102 . . . . 0.0 113.312 -174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.79 157.27 5.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.013 0.925 . . . . 0.0 113.458 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -139.47 155.14 47.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 111.772 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.75 149.42 7.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-O 123.329 1.516 . . . . 0.0 115.137 170.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -61.74 148.65 42.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.716 2.806 . . . . 0.0 112.589 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 p -120.21 169.41 10.27 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.659 1.183 . . . . 0.0 112.146 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -9.44 35.36 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 118.777 -1.013 . . . . 0.0 115.217 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 ptp -144.68 -9.28 0.63 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -134.39 159.06 42.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.701 1.6 . . . . 0.0 111.667 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -129.3 159.62 35.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.247 2.219 . . . . 0.0 111.156 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.09 39.73 28.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.97 1.308 . . . . 0.0 113.374 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.12 154.05 42.24 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.303 1.441 . . . . 0.0 111.781 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.0 135.84 28.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.703 1.602 . . . . 0.0 110.059 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.8 51.63 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -84.72 157.69 20.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 110.058 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -79.91 125.86 30.28 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.01 -1.057 . . . . 0.0 111.207 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.92 93.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.354 1.861 . . . . 0.0 107.732 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 144.27 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.98 110.51 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.96 -41.58 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.689 0.677 . . . . 0.0 110.389 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.77 165.6 33.0 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.18 142.51 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.06 1.744 . . . . 0.0 111.446 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -136.37 136.29 39.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.987 1.315 . . . . 0.0 110.683 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.71 123.95 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.2 t -122.51 143.61 49.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 112.087 -169.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.31 1.844 . . . . 0.0 112.082 178.783 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.08 128.34 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.988 1.267 . . . . 0.0 110.423 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.9 m -100.37 125.6 46.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.277 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -101.44 128.02 47.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.999 1.319 . . . . 0.0 110.518 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.19 95.79 6.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -99.9 152.36 20.25 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.901 -0.5 . . . . 0.0 110.829 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -60.31 -13.84 15.05 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -97.97 -11.14 23.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 113.624 171.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.87 167.84 13.72 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.651 1.596 . . . . 0.0 113.408 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.3 137.25 41.02 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.754 1.622 . . . . 0.0 112.821 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -133.2 140.48 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.752 2.021 . . . . 0.0 108.561 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.96 134.18 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.464 1.105 . . . . 0.0 110.266 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.02 133.88 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.483 1.913 . . . . 0.0 110.039 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -99.64 126.86 45.72 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.898 1.679 . . . . 0.0 108.44 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -89.08 146.77 24.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.24 1.016 . . . . 0.0 110.999 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -103.65 73.73 1.2 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 122.669 1.224 . . . . 0.0 111.458 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.86 -26.28 64.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.77 -1.104 . . . . 0.0 112.48 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.87 -27.97 49.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.253 1.021 . . . . 0.0 111.672 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.72 -18.87 15.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.104 1.362 . . . . 0.0 113.222 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.0 55.39 1.19 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.665 1.186 . . . . 0.0 113.123 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.72 -44.97 27.6 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.47 2.78 . . . . 0.0 112.952 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.27 -41.82 80.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.108 0.563 . . . . 0.0 110.971 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -65.42 -45.43 83.94 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.175 0.59 . . . . 0.0 111.789 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.97 -43.09 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.583 0.753 . . . . 0.0 111.761 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.66 -42.48 79.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.96 1.254 . . . . 0.0 111.797 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -70.2 -37.95 75.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.733 0.813 . . . . 0.0 111.626 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.91 -48.96 79.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.432 1.093 . . . . 0.0 111.713 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.98 -37.97 79.07 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.593 0.757 . . . . 0.0 111.456 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -57.25 -33.88 68.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.361 1.065 . . . . 0.0 112.808 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 18.5 m-85 -76.84 -44.73 31.13 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.462 -0.774 . . . . 0.0 112.493 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -59.98 -35.98 76.16 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.63 -0.669 . . . . 0.0 111.658 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.78 -34.28 77.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.026 2.13 . . . . 0.0 112.945 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.43 -14.48 52.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.029 0.932 . . . . 0.0 113.372 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.51 19.23 60.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.553 1.073 . . . . 0.0 113.885 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 54.4 t80 -68.27 -17.72 64.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.13 -3.63 44.19 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.269 -0.894 . . . . 0.0 113.137 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.5 135.29 54.97 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.135 -0.978 . . . . 0.0 108.952 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 54.16 47.17 23.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.531 1.533 . . . . 0.0 113.689 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.3 p -114.37 151.23 33.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.836 0.855 . . . . 0.0 112.532 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 pt -103.3 162.05 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.45 86.41 6.77 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -80.05 2.63 23.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -169.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -144.25 143.16 30.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.967 2.167 . . . . 0.0 113.46 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.14 131.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 110.271 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.2 mt -137.65 129.64 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.613 1.565 . . . . 0.0 108.15 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.84 133.5 54.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.756 0.822 . . . . 0.0 111.782 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 9.37 65.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 123.895 0.759 . . . . 0.0 114.947 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -141.89 -177.3 5.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 110.872 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -179.25 5.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.869 1.667 . . . . 0.0 115.379 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.9 pt -114.31 135.91 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.885 1.274 . . . . 0.0 112.446 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.31 150.77 25.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.434 1.094 . . . . 0.0 110.653 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.87 34.66 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.05 -2.32 61.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.811 1.672 . . . . 0.0 115.662 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.31 -14.94 65.29 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 118.921 1.361 . . . . 0.0 115.833 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.38 167.09 23.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.744 1.217 . . . . 0.0 112.782 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.55 164.5 18.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.729 1.612 . . . . 0.0 110.711 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.38 -11.91 28.02 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.514 2.809 . . . . 0.0 116.811 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.59 15.94 62.23 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.088 0.851 . . . . 0.0 114.477 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.1 mmt 61.42 26.46 16.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.058 1.743 . . . . 0.0 113.221 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -83.22 127.18 33.4 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.834 1.254 . . . . 0.0 109.357 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -73.57 119.24 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.966 0.906 . . . . 0.0 110.145 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -69.43 164.83 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.136 0.974 . . . . 0.0 113.472 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 66.04 9.47 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.814 1.645 . . . . 0.0 111.494 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.4 p -69.18 134.47 49.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.932 1.293 . . . . 0.0 112.219 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -137.71 174.05 10.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.022 2.129 . . . . 0.0 111.965 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.12 66.24 5.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.451 1.5 . . . . 0.0 113.605 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.62 135.76 62.66 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.284 2.656 . . . . 0.0 111.067 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.08 151.61 7.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 125.849 1.66 . . . . 0.0 108.166 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 157.11 27.45 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.638 0.732 . . . . 0.0 111.565 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -81.81 103.68 11.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.33 1.052 . . . . 0.0 111.198 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.75 23.83 1.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.529 1.132 . . . . 0.0 113.289 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.6 -19.86 66.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 119.863 -1.773 . . . . 0.0 113.784 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -65.44 8.82 0.14 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.344 1.458 . . . . 0.0 114.516 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -77.97 -10.06 59.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.144 1.378 . . . . 0.0 113.426 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.66 81.62 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.101 1.334 . . . . 0.0 114.83 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.77 158.61 26.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.498 1.149 . . . . 0.0 112.706 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -130.69 155.07 47.23 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.18 111.56 23.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.489 2.316 . . . . 0.0 110.478 -174.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -142.3 170.38 15.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.327 1.451 . . . . 0.0 111.175 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -38.88 117.13 0.63 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.979 1.712 . . . . 0.0 111.948 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.86 33.29 30.46 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 124.352 0.977 . . . . 0.0 114.787 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.1 p -123.39 157.68 32.82 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.897 1.348 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.78 136.7 54.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.27 160.77 38.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.982 171.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.6 mtt -84.04 143.22 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.39 147.89 22.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.641 1.176 . . . . 0.0 111.766 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 165.62 14.03 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.27 1.028 . . . . 0.0 113.518 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -81.56 -57.14 3.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.136 0.974 . . . . 0.0 110.873 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -151.47 -38.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.082 1.353 . . . . 0.0 113.68 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.89 156.46 35.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.014 1.326 . . . . 0.0 111.48 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.91 -23.91 76.44 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.63 2.22 . . . . 0.0 114.324 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -103.37 33.0 3.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.539 1.536 . . . . 0.0 112.746 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.3 p -118.2 26.09 9.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.42 1.488 . . . . 0.0 113.158 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.13 98.8 2.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.676 1.191 . . . . 0.0 108.574 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.2 p -90.04 -68.64 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.519 1.128 . . . . 0.0 111.691 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.32 20.07 1.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.731 1.212 . . . . 0.0 113.445 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -110.41 142.7 41.76 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.805 -1.185 . . . . 0.0 111.145 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -143.77 168.16 20.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.48 1.512 . . . . 0.0 111.036 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.0 p90 -142.86 158.3 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.353 0.661 . . . . 0.0 111.878 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 mt -111.12 118.38 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -75.27 108.78 8.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.08 0.552 . . . . 0.0 110.137 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.03 -11.02 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.42 165.15 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.985 2.514 . . . . 0.0 111.274 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.25 120.99 25.07 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.843 0.457 . . . . 0.0 109.843 169.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -140.93 74.81 1.48 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.711 1.243 . . . . 0.0 112.459 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.62 -34.57 62.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.153 1.781 . . . . 0.0 114.406 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -59.41 -13.71 9.53 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.89 -8.51 59.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -80.92 177.04 9.31 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.464 . . . . 0.0 114.174 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -89.77 140.76 29.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.877 1.271 . . . . 0.0 112.695 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.2 p -109.34 -61.02 1.69 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.761 1.224 . . . . 0.0 113.351 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.975 0 C-N-CA 124.459 1.028 . . . . 0.0 113.65 -173.846 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.31 -113.33 2.47 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.153 1.835 . . . . 0.0 114.877 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.98 148.02 50.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 113.067 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.39 126.62 31.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.05 94.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -80.46 -15.36 56.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.63 176.65 8.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.557 1.17 . . . . 0.0 113.951 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.17 154.18 48.03 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.854 -1.154 . . . . 0.0 112.335 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.49 139.49 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.651 0.739 . . . . 0.0 109.865 170.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 t -111.18 -42.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.765 1.626 . . . . 0.0 110.99 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.88 154.76 42.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.469 1.508 . . . . 0.0 109.997 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.21 16.3 25.62 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 123.849 0.737 . . . . 0.0 114.217 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -34.78 67.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.891 1.345 . . . . 0.0 112.256 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.15 -30.44 70.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.1 t -76.27 -40.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.943 1.297 . . . . 0.0 110.408 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.61 -41.89 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.277 -0.889 . . . . 0.0 110.867 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.54 -25.37 63.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.131 1.372 . . . . 0.0 112.355 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -74.57 -52.6 11.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.384 1.074 . . . . 0.0 110.208 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -53.65 -35.56 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.327 1.851 . . . . 0.0 112.793 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.47 -11.46 32.0 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.68 -15.82 10.69 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.718 1.628 . . . . 0.0 114.165 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.53 -63.33 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.45 1.125 . . . . 0.0 112.707 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -176.83 153.64 1.07 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.752 1.621 . . . . 0.0 111.499 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.4 p -125.9 148.67 49.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.985 1.314 . . . . 0.0 112.842 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.263 169.903 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.07 138.89 49.05 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.798 1.665 . . . . 0.0 109.559 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -30.74 54.51 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.856 -0.527 . . . . 0.0 112.152 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.15 149.04 32.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.879 0.872 . . . . 0.0 109.848 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -84.03 119.74 25.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 111.313 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.99 108.69 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.318 1.047 . . . . 0.0 109.242 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 148.28 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.884 1.326 . . . . 0.0 111.574 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.1 mt -87.24 103.35 13.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.16 -38.37 60.93 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.71 -0.619 . . . . 0.0 110.197 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 p -151.61 166.96 29.61 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.03 142.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 110.629 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -135.42 128.4 31.47 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.061 1.344 . . . . 0.0 110.205 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.74 124.04 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.518 -0.739 . . . . 0.0 109.02 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -113.36 150.5 32.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.253 1.421 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.753 1.621 . . . . 0.0 113.323 -169.814 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.2 t -124.68 132.45 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m -104.86 124.89 50.25 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.812 1.245 . . . . 0.0 110.152 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -98.34 132.14 44.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.659 1.184 . . . . 0.0 110.45 169.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -104.22 98.39 8.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -103.77 151.95 22.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.068 -0.395 . . . . 0.0 111.267 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -60.53 -9.36 3.65 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.27 -8.15 18.47 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.815 1.246 . . . . 0.0 114.014 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.51 163.96 10.93 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.411 1.482 . . . . 0.0 113.617 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.43 137.99 44.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.812 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.52 140.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.352 1.861 . . . . 0.0 108.886 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 t -122.34 137.66 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.566 1.147 . . . . 0.0 110.326 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.59 138.43 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.587 1.955 . . . . 0.0 110.409 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -100.5 128.76 46.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.013 2.125 . . . . 0.0 107.713 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 p -88.45 146.46 25.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.303 1.041 . . . . 0.0 111.201 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -102.85 73.79 1.29 Allowed 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 122.614 1.197 . . . . 0.0 111.293 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.59 -27.65 65.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.352 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.15 -29.19 57.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.426 1.09 . . . . 0.0 111.53 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.85 -27.56 14.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.835 1.254 . . . . 0.0 112.835 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.89 61.72 4.33 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.8 0.84 . . . . 0.0 113.188 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.11 -43.7 23.07 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.32 2.68 . . . . 0.0 112.906 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -69.2 -40.54 77.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.484 0.583 . . . . 0.0 110.852 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -64.86 -47.54 77.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.315 0.646 . . . . 0.0 111.593 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.63 -44.51 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 111.342 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -55.95 -48.26 76.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.55 1.068 . . . . 0.0 112.039 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -68.12 -38.32 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.572 0.624 . . . . 0.0 111.878 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.13 -49.04 79.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.329 1.051 . . . . 0.0 111.673 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.35 -38.18 81.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.555 0.742 . . . . 0.0 111.554 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -59.1 -33.36 70.76 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.847 0.859 . . . . 0.0 112.665 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 -43.95 50.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.909 0.777 . . . . 0.0 112.285 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.33 -36.15 79.36 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.578 -0.701 . . . . 0.0 111.687 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.71 -34.1 77.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.087 2.155 . . . . 0.0 112.86 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.71 -13.34 56.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.963 0.905 . . . . 0.0 113.267 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.97 18.61 62.83 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.628 1.109 . . . . 0.0 113.939 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.65 -17.56 64.12 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -96.7 -5.42 38.82 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.414 -0.804 . . . . 0.0 113.022 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -67.67 136.07 53.78 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.59 44.46 29.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.353 1.461 . . . . 0.0 113.828 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -109.32 164.4 12.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.865 0.866 . . . . 0.0 111.742 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 11.3 pt -124.75 159.05 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -169.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -91.14 96.59 10.66 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -88.39 -11.46 46.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -143.27 136.15 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.939 1.245 . . . . 0.0 113.374 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -135.4 145.11 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 128.145 2.578 . . . . 0.0 109.018 169.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -133.14 131.18 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.734 1.614 . . . . 0.0 108.188 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.62 126.77 28.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.111 0.964 . . . . 0.0 112.594 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.1 11.81 70.97 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 123.81 0.719 . . . . 0.0 114.81 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.15 -176.98 4.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.495 1.918 . . . . 0.0 110.979 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.72 -179.25 7.26 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.2 pt -118.95 134.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.485 1.514 . . . . 0.0 112.91 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -112.18 146.47 38.03 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.746 1.219 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.23 35.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.693 1.437 . . . . 0.0 116.693 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.94 -4.69 85.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.952 1.739 . . . . 0.0 115.602 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -15.84 64.84 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -169.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -146.61 164.71 31.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.746 1.273 . . . . 0.0 112.939 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.19 161.82 31.95 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.502 1.521 . . . . 0.0 110.003 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -63.29 -13.0 33.18 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.298 2.665 . . . . 0.0 117.729 -169.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.44 14.96 64.08 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 123.908 0.766 . . . . 0.0 114.496 171.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.1 mmm 58.1 39.44 26.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.343 1.857 . . . . 0.0 112.988 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -92.28 127.95 37.95 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.369 1.467 . . . . 0.0 109.53 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -75.37 123.67 25.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.423 1.089 . . . . 0.0 111.166 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -73.44 162.75 28.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.72 73.51 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.561 1.544 . . . . 0.0 111.538 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 p -72.0 131.58 43.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.299 1.039 . . . . 0.0 112.118 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -137.37 175.04 9.96 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.463 1.905 . . . . 0.0 112.527 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 50.62 69.49 2.57 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.746 1.619 . . . . 0.0 113.996 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.49 135.68 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.189 2.592 . . . . 0.0 111.515 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.88 154.04 7.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.298 1.839 . . . . 0.0 108.535 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 158.07 18.47 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.23 0.612 . . . . 0.0 111.829 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -72.54 127.64 33.16 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.198 0.599 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -113.03 12.05 19.13 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.022 1.329 . . . . 0.0 112.73 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 -11.71 46.67 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.197 -1.565 . . . . 0.0 113.762 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -58.62 -1.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.95 0.83 29.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.122 1.369 . . . . 0.0 111.569 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.71 10.14 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.708 1.623 . . . . 0.0 114.094 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.8 mt -78.64 157.07 28.75 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.78 158.44 36.55 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -117.68 109.84 17.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.786 2.034 . . . . 0.0 110.717 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -136.0 169.87 16.91 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.703 1.201 . . . . 0.0 111.537 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.1 126.27 24.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.988 0.899 . . . . 0.0 111.079 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.7 24.45 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.923 1.249 . . . . 0.0 114.651 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.5 p -123.86 159.11 30.33 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.172 1.486 . . . . 0.0 113.096 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.69 137.78 54.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.3 159.0 42.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.007 0.523 . . . . 0.0 111.923 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 94.7 mmm -78.34 138.21 38.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.089 -0.382 . . . . 0.0 110.518 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.94 150.31 25.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.106 0.562 . . . . 0.0 110.66 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -115.3 160.77 19.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.536 1.134 . . . . 0.0 112.896 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.8 m -75.56 -52.46 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.054 0.942 . . . . 0.0 111.285 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.27 -57.39 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.559 1.544 . . . . 0.0 110.716 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.99 157.47 78.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.946 1.298 . . . . 0.0 112.115 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.25 -23.09 73.03 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.48 2.787 . . . . 0.0 114.068 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -111.52 36.78 3.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.739 1.615 . . . . 0.0 112.41 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 p -121.15 26.52 8.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.388 1.475 . . . . 0.0 113.843 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.62 99.67 10.34 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.364 1.466 . . . . 0.0 109.447 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -87.07 -71.55 0.55 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.186 . . . . 0.0 112.618 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.9 38.73 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -129.36 152.3 49.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.374 1.07 . . . . 0.0 111.903 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.18 168.41 19.81 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.504 1.522 . . . . 0.0 110.716 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 8.1 p90 -144.03 159.49 42.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.16 0.584 . . . . 0.0 111.055 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 mt -116.42 120.12 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.44 102.8 5.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.167 0.587 . . . . 0.0 109.525 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.28 -18.05 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.88 165.69 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.592 1.557 . . . . 0.0 111.663 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -78.48 119.4 21.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.792 0.437 . . . . 0.0 110.03 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -143.03 63.02 1.39 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 123.009 1.385 . . . . 0.0 111.758 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.27 -11.9 53.15 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -172.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -64.42 -13.68 52.6 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.579 -1.325 . . . . 0.0 113.573 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.06 -13.88 58.96 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.529 1.132 . . . . 0.0 113.431 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -69.32 167.06 17.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.39 1.476 . . . . 0.0 114.904 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -70.2 138.3 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -143.77 21.9 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.343 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.09 -54.88 0.83 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.853 1.216 . . . . 0.0 114.259 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -143.82 158.96 43.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.429 1.492 . . . . 0.0 111.72 -169.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 35.0 t -93.66 119.19 32.36 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.646 -0.658 . . . . 0.0 112.657 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.2 82.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.218 1.407 . . . . 0.0 108.66 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -77.5 -13.25 59.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.914 0.886 . . . . 0.0 112.309 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.08 177.56 8.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 122.751 1.262 . . . . 0.0 114.278 -169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -141.96 154.29 44.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.511 1.124 . . . . 0.0 112.792 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.36 143.49 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.68 0.753 . . . . 0.0 110.394 172.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.8 t -117.11 -40.99 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.79 1.636 . . . . 0.0 111.122 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -145.19 155.12 43.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.869 1.667 . . . . 0.0 109.75 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.92 16.37 23.89 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.817 0.723 . . . . 0.0 114.327 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -33.55 66.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.834 1.317 . . . . 0.0 112.33 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.52 -29.14 69.16 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.545 0.738 . . . . 0.0 112.551 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.01 -41.52 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.256 1.423 . . . . 0.0 110.238 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.24 -39.89 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.879 -1.138 . . . . 0.0 111.042 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.0 -30.47 68.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.112 1.365 . . . . 0.0 111.953 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.09 -42.89 62.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.986 0.914 . . . . 0.0 111.168 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.13 -25.12 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.494 1.517 . . . . 0.0 112.409 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -86.39 -23.3 26.18 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.39 -7.61 69.32 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.986 1.755 . . . . 0.0 114.779 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.79 -27.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 84.55 163.54 0.1 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.522 2.329 . . . . 0.0 114.057 -169.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 p -118.92 143.98 46.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.196 1.398 . . . . 0.0 113.668 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 125.034 1.302 . . . . 0.0 111.426 169.835 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 119.529 -0.272 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.54 137.57 70.17 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.709 1.606 . . . . 0.0 110.512 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -32.17 61.89 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -84.91 147.38 26.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.184 0.593 . . . . 0.0 110.544 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.18 116.73 23.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.196 0.998 . . . . 0.0 111.071 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 91.0 t -114.85 108.06 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.316 1.047 . . . . 0.0 108.483 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -129.52 141.34 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.439 1.114 . . . . 0.0 111.932 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.2 mt -83.61 103.44 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.38 -36.87 66.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.186 0.594 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.6 t -154.37 165.22 37.04 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -133.76 141.07 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.791 2.037 . . . . 0.0 110.431 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -135.76 131.75 35.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 110.187 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.62 124.07 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.309 -0.869 . . . . 0.0 108.82 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.7 t -117.36 150.3 39.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.077 1.351 . . . . 0.0 112.749 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.93 1.692 . . . . 0.0 113.629 -169.707 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 120.318 0.104 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.9 t -123.46 129.97 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.4 m -104.36 123.68 47.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.98 1.312 . . . . 0.0 110.205 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.36 132.31 42.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.568 1.147 . . . . 0.0 110.688 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -103.18 103.13 13.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -106.48 151.49 24.89 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.966 -0.459 . . . . 0.0 111.126 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -60.57 -7.63 2.3 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -108.28 -8.71 15.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.005 1.322 . . . . 0.0 114.094 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.96 163.5 11.17 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.505 1.526 . . . . 0.0 113.859 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.04 138.82 44.29 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.034 1.734 . . . . 0.0 112.957 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.82 141.51 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.512 1.925 . . . . 0.0 109.062 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -124.62 135.66 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 110.805 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 139.72 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.743 2.017 . . . . 0.0 110.389 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -105.07 125.77 51.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.638 1.975 . . . . 0.0 108.844 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -88.96 147.5 24.28 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.379 1.072 . . . . 0.0 111.553 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -104.94 74.52 1.13 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.792 1.282 . . . . 0.0 111.202 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.76 -26.3 64.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.618 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.81 -28.0 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 111.386 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -95.83 -29.13 14.39 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.388 1.475 . . . . 0.0 112.398 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.74 58.55 3.32 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 0.0 113.003 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -60.87 -43.19 32.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.493 2.795 . . . . 0.0 112.932 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -68.33 -40.38 81.63 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.741 0.7 . . . . 0.0 110.893 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 m -63.91 -51.33 64.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.641 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.57 -38.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -56.33 -49.58 73.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.601 1.091 . . . . 0.0 111.484 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -68.81 -36.74 78.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.412 0.551 . . . . 0.0 112.19 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.59 -49.63 77.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.763 1.225 . . . . 0.0 111.426 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.71 -34.71 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.368 -0.833 . . . . 0.0 112.449 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -45.2 77.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.573 0.349 . . . . 0.0 110.261 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.45 -40.68 81.0 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.593 -0.692 . . . . 0.0 111.456 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.77 -40.06 86.95 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.878 -0.514 . . . . 0.0 111.397 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -72.67 -30.07 63.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.376 1.47 . . . . 0.0 113.385 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -79.41 -16.54 56.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.631 0.65 . . . . 0.0 112.372 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.66 17.39 56.81 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.497 1.046 . . . . 0.0 113.298 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.04 -41.66 97.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.438 1.095 . . . . 0.0 113.121 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -81.49 -15.21 55.67 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.27 5.31 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.87 17.49 1.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.064 1.346 . . . . 0.0 112.986 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.7 p -81.67 163.17 22.7 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.126 -0.984 . . . . 0.0 112.345 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 156' ' ' ILE . 12.0 pt -119.26 165.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.08 89.45 6.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.412 1.485 . . . . 0.0 108.573 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -85.68 -3.06 58.78 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.92 134.6 45.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.822 1.646 . . . . 0.0 111.173 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.42 135.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.504 1.522 . . . . 0.0 110.807 169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.79 128.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.61 1.564 . . . . 0.0 108.429 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.26 132.2 49.57 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.611 0.764 . . . . 0.0 111.691 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.05 10.99 66.21 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 123.956 0.789 . . . . 0.0 115.029 -174.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.01 -177.23 5.34 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.121 1.769 . . . . 0.0 111.019 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -83.75 177.41 8.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.44 140.0 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.61 1.564 . . . . 0.0 111.857 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -123.41 148.5 46.06 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 0.0 111.287 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.16 -178.1 27.39 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.557 1.075 . . . . 0.0 114.51 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 -1.09 89.27 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.31 0.957 . . . . 0.0 115.342 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.94 -27.06 32.56 Favored Glycine 0 N--CA 1.473 1.102 0 CA-C-N 118.931 1.366 . . . . 0.0 115.391 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.22 161.86 37.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -88.62 164.46 31.96 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 126.048 1.739 . . . . 0.0 109.69 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.31 -11.49 30.42 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.337 2.692 . . . . 0.0 117.518 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 17.16 59.81 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.273 0.94 . . . . 0.0 114.61 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.7 mmm 59.46 37.83 22.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.152 1.781 . . . . 0.0 113.31 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.074 1.349 . . . . 0.0 109.468 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -74.19 131.92 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 124.143 1.925 . . . . 0.0 111.792 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -75.93 -179.29 4.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 110.322 -3.127 . . . . 0.0 114.519 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.65 56.49 3.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 112.869 -1.968 . . . . 0.0 112.066 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 p -69.41 106.25 2.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.084 1.354 . . . . 0.0 110.824 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -137.87 169.25 18.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 111.947 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 48.49 62.89 11.3 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.486 1.514 . . . . 0.0 113.183 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -58.11 134.79 64.34 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.539 2.826 . . . . 0.0 111.749 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.24 152.55 4.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.356 1.862 . . . . 0.0 107.837 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 158.67 17.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.192 0.597 . . . . 0.0 110.67 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -71.43 134.6 46.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.179 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.38 14.09 12.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.765 1.226 . . . . 0.0 112.627 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.49 59.93 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.434 -1.416 . . . . 0.0 113.93 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.93 0.21 0.24 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.629 1.972 . . . . 0.0 115.822 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -81.37 -3.45 52.79 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.036 1.334 . . . . 0.0 112.556 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.44 24.77 49.77 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.578 1.085 . . . . 0.0 114.942 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 159.1 28.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 117.707 0.753 . . . . 0.0 112.616 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -131.39 154.47 48.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -98.65 100.02 11.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.669 1.987 . . . . 0.0 110.118 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.1 p -130.68 165.24 23.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.306 1.042 . . . . 0.0 111.603 -175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -55.34 121.97 10.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.64 1.176 . . . . 0.0 110.771 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 49.82 6.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.72 1.153 . . . . 0.0 113.923 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -136.21 163.51 30.21 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.16 0.98 . . . . 0.0 112.523 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.79 140.81 51.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.725 0.81 . . . . 0.0 112.709 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.91 157.82 45.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.894 -0.504 . . . . 0.0 112.019 169.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -82.37 140.6 33.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.498 0.319 . . . . 0.0 111.303 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.64 144.68 25.08 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.575 0.75 . . . . 0.0 111.469 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -114.58 159.81 20.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.026 1.33 . . . . 0.0 112.978 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.3 m -77.67 -54.86 5.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.068 1.347 . . . . 0.0 112.051 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -153.65 -40.38 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.696 1.199 . . . . 0.0 113.078 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.04 157.18 35.41 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.868 1.267 . . . . 0.0 111.267 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.73 -26.13 64.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 114.429 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -105.77 33.9 3.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.58 1.552 . . . . 0.0 112.779 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.9 p -123.07 35.71 4.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.379 1.472 . . . . 0.0 113.161 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.66 107.93 20.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.086 1.754 . . . . 0.0 109.826 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 p -91.65 -67.82 0.83 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.393 1.077 . . . . 0.0 112.584 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.87 -17.15 1.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -78.34 143.53 36.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 122.116 0.96 . . . . 0.0 112.194 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.03 167.97 20.89 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.316 1.847 . . . . 0.0 110.816 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 5.6 p90 -145.34 161.44 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.577 0.751 . . . . 0.0 111.726 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.39 115.45 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 108.16 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -73.4 101.23 3.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.713 0.805 . . . . 0.0 110.193 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 -16.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.1 167.28 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 128.129 2.572 . . . . 0.0 111.057 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -78.31 121.84 24.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.124 0.57 . . . . 0.0 110.667 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -145.85 68.98 1.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 123.266 1.508 . . . . 0.0 111.306 -170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.59 -13.02 61.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -64.4 -12.83 46.98 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.614 -1.304 . . . . 0.0 113.224 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.98 -7.16 59.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.626 1.171 . . . . 0.0 113.972 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.18 179.6 5.61 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -79.82 142.1 35.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.361 1.465 . . . . 0.0 112.171 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -107.71 -59.45 1.83 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.459 1.104 . . . . 0.0 113.682 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.132 0 C-N-CA 123.859 0.742 . . . . 0.0 114.363 -172.439 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 5.5 p-90 . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.05 -108.17 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.617 1.58 . . . . 0.0 116.013 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.69 142.8 46.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.419 1.488 . . . . 0.0 111.554 -169.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.21 118.45 25.67 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -170.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.38 84.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.691 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -78.19 -13.75 59.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.004 0.922 . . . . 0.0 112.083 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.96 177.2 8.71 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.496 1.141 . . . . 0.0 113.672 -170.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.98 149.81 43.72 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.845 -1.159 . . . . 0.0 111.928 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.07 136.69 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.605 -0.684 . . . . 0.0 110.414 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.72 -42.29 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.356 1.862 . . . . 0.0 110.834 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -143.26 154.86 44.25 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.466 1.506 . . . . 0.0 109.862 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.36 13.9 37.24 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.911 0.767 . . . . 0.0 114.754 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.5 mmm -54.19 -35.95 62.89 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.43 1.615 . . . . 0.0 112.381 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.95 -33.43 75.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.693 0.797 . . . . 0.0 112.385 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.59 -42.64 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.925 1.29 . . . . 0.0 110.39 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.71 -40.29 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.23 1.012 . . . . 0.0 111.237 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.38 -26.01 60.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.892 1.277 . . . . 0.0 112.78 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.39 -41.51 27.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.914 1.286 . . . . 0.0 111.18 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.7 mt -54.87 -31.79 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.899 1.679 . . . . 0.0 112.771 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -90.59 -15.27 30.86 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.3 -16.24 18.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.707 1.623 . . . . 0.0 114.475 -172.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.18 -59.5 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.834 1.317 . . . . 0.0 112.29 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.96 153.53 2.61 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.471 1.508 . . . . 0.0 111.587 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.3 p -133.67 147.75 51.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.96 1.304 . . . . 0.0 112.366 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.054 0 C-N-CA 123.247 0.451 . . . . 0.0 113.201 169.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.02 131.79 24.7 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 N-CA-C 108.027 -1.566 . . . . 0.0 108.027 169.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -31.15 63.44 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.67 -0.644 . . . . 0.0 111.797 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -83.26 150.3 26.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 109.103 168.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.25 117.75 23.17 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.102 -0.999 . . . . 0.0 110.651 -170.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.3 102.82 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.04 143.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 112.287 -169.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.0 mt -82.64 103.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.04 -27.34 57.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.557 1.143 . . . . 0.0 111.697 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -163.38 169.33 19.13 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.52 140.82 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.287 1.835 . . . . 0.0 110.477 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.3 m -133.84 135.0 43.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.271 1.428 . . . . 0.0 110.073 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.68 125.73 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.6 t -122.6 150.78 42.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.763 1.625 . . . . 0.0 111.927 -171.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.73 1.212 . . . . 0.0 113.246 -179.629 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -125.7 129.56 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.077 0.951 . . . . 0.0 109.41 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -104.71 123.28 47.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.589 1.156 . . . . 0.0 110.055 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.56 134.59 38.25 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 110.598 169.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -105.9 101.78 11.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -106.21 151.13 25.17 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.041 -0.412 . . . . 0.0 110.949 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -60.78 -7.8 2.57 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -108.14 -8.33 15.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.954 1.302 . . . . 0.0 114.101 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.24 160.9 9.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.046 1.307 . . . . 0.0 114.124 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.15 138.08 43.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.852 1.661 . . . . 0.0 112.702 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -134.21 141.01 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.111 1.764 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.7 t -123.16 136.65 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.736 1.214 . . . . 0.0 110.68 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mt -127.12 138.75 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.495 1.918 . . . . 0.0 110.323 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.84 122.21 45.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.492 1.917 . . . . 0.0 109.142 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 p -85.91 148.18 25.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.312 1.045 . . . . 0.0 111.83 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -104.22 73.82 1.15 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.702 1.239 . . . . 0.0 111.359 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.75 -26.85 64.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.502 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.15 -30.87 58.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.262 1.025 . . . . 0.0 111.53 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.29 -26.43 15.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.833 1.253 . . . . 0.0 112.991 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.03 59.0 3.46 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.99 0.916 . . . . 0.0 112.833 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.63 -43.77 25.22 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.251 2.634 . . . . 0.0 112.72 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -69.77 -41.15 75.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.513 0.597 . . . . 0.0 110.957 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' ILE . 24.8 m -62.73 -49.9 73.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.482 0.713 . . . . 0.0 111.265 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.63 -44.32 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.307 0.643 . . . . 0.0 111.477 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -55.72 -47.7 76.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.771 1.168 . . . . 0.0 112.014 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -68.0 -39.13 83.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.43 0.559 . . . . 0.0 111.667 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.7 -48.47 81.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.683 1.193 . . . . 0.0 111.542 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.96 -38.31 79.34 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 111.653 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.86 -33.73 70.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.956 0.902 . . . . 0.0 112.529 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.392 -0.817 . . . . 0.0 112.287 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.03 -35.2 76.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.791 -0.568 . . . . 0.0 111.596 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -64.99 -34.19 77.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.909 2.084 . . . . 0.0 113.006 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -81.78 -15.74 53.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.831 0.852 . . . . 0.0 113.086 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.89 15.18 56.83 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.121 1.344 . . . . 0.0 113.979 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -65.48 -31.58 72.73 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.198 0.999 . . . . 0.0 113.678 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -87.64 -15.47 37.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.19 0.7 5.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.435 1.494 . . . . 0.0 114.574 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -144.85 50.35 1.26 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.129 1.772 . . . . 0.0 110.252 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.5 p -119.81 169.83 9.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.466 1.106 . . . . 0.0 111.945 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 156' ' ' ILE . 19.0 pt -129.72 167.14 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -169.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -95.3 93.92 7.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.378 1.471 . . . . 0.0 107.764 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -86.46 -0.86 56.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -140.39 141.17 35.61 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.089 1.768 . . . . 0.0 112.67 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.87 132.73 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.187 1.795 . . . . 0.0 111.152 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.98 128.72 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.022 1.729 . . . . 0.0 108.292 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -68.97 139.42 55.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.782 -0.574 . . . . 0.0 111.249 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.59 9.12 68.71 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -144.79 -177.12 5.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.788 2.035 . . . . 0.0 110.55 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.87 178.1 6.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.016 1.726 . . . . 0.0 114.501 -171.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -114.21 136.94 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.016 1.326 . . . . 0.0 111.765 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -103.62 147.26 27.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.137 0.975 . . . . 0.0 110.761 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.05 31.38 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 122.637 1.132 . . . . 0.0 114.849 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.92 72.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.668 -1.073 . . . . 0.0 114.434 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.49 -22.87 41.96 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-N 119.624 1.712 . . . . 0.0 114.729 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.35 166.07 26.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.799 1.24 . . . . 0.0 112.912 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.83 162.19 27.85 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.956 1.702 . . . . 0.0 110.402 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -60.77 -13.2 25.21 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.696 2.93 . . . . 0.0 118.505 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.26 17.23 59.7 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.122 0.867 . . . . 0.0 114.592 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mmm 58.46 36.46 25.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.072 1.749 . . . . 0.0 113.114 -173.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -92.07 131.32 37.43 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.296 1.438 . . . . 0.0 109.386 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -71.04 124.43 24.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.495 1.118 . . . . 0.0 110.107 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.38 159.14 32.1 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.3 75.27 8.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.245 1.418 . . . . 0.0 111.484 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.2 p -69.0 127.53 33.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.546 1.139 . . . . 0.0 112.409 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.5 177.32 7.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.62 1.968 . . . . 0.0 111.484 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 50.42 68.33 3.52 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.593 1.557 . . . . 0.0 113.617 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.81 147.46 88.48 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.252 2.635 . . . . 0.0 111.597 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.0 OUTLIER -124.68 149.6 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.813 1.645 . . . . 0.0 109.155 -174.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 155.49 29.0 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.581 0.705 . . . . 0.0 110.419 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -78.71 134.45 37.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.397 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.69 14.39 12.61 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.941 0.896 . . . . 0.0 112.11 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.53 -17.03 64.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.569 -1.332 . . . . 0.0 113.764 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -63.5 -0.97 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.388 1.875 . . . . 0.0 115.482 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -79.77 -5.63 55.7 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.701 1.2 . . . . 0.0 113.017 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.65 21.06 49.03 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.531 1.063 . . . . 0.0 114.942 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.05 155.47 39.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.911 0.855 . . . . 0.0 111.75 170.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -133.63 155.38 49.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -90.31 107.11 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.428 2.291 . . . . 0.0 109.439 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -137.67 169.43 17.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.918 1.287 . . . . 0.0 110.869 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -49.63 124.82 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.798 1.239 . . . . 0.0 111.458 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.78 41.14 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.274 1.416 . . . . 0.0 115.048 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.9 p -121.95 160.86 23.96 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.536 1.668 . . . . 0.0 113.584 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.91 137.91 54.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.659 0.784 . . . . 0.0 112.965 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.47 160.49 38.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.817 0.447 . . . . 0.0 112.143 170.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 96.7 mmm -79.1 139.74 38.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.158 0.583 . . . . 0.0 111.341 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.45 112.22 23.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.502 0.721 . . . . 0.0 110.292 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -75.48 157.26 34.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 0.0 112.709 -174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.0 m -70.81 -51.09 28.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.873 0.869 . . . . 0.0 110.934 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -160.12 -58.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.322 1.449 . . . . 0.0 110.373 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.24 79.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.61 1.164 . . . . 0.0 111.889 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.77 -31.48 88.39 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.825 2.35 . . . . 0.0 113.459 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -101.62 46.46 0.93 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.346 1.858 . . . . 0.0 112.294 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.6 p -133.99 32.2 3.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.96 54.66 1.33 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.989 1.716 . . . . 0.0 113.643 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -54.42 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -154.74 36.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -135.27 151.54 50.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.311 1.444 . . . . 0.0 110.097 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.58 172.21 13.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.061 1.344 . . . . 0.0 111.667 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.2 p90 -147.2 161.56 40.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.402 -0.811 . . . . 0.0 111.524 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 mt -115.5 115.84 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -76.69 102.68 6.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.903 0.881 . . . . 0.0 110.156 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.81 -21.93 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.268 -0.895 . . . . 0.0 112.968 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.01 168.55 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.813 1.645 . . . . 0.0 111.959 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.22 123.44 29.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.323 0.649 . . . . 0.0 110.291 169.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -144.79 76.82 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.828 1.299 . . . . 0.0 112.707 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.07 -34.88 66.37 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.209 1.804 . . . . 0.0 114.583 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -59.88 -12.58 7.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.84 -9.57 59.26 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.48 -177.08 5.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -169.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -77.05 141.21 40.39 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.289 1.836 . . . . 0.0 112.473 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.2 p -107.79 -57.16 2.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.24 1.016 . . . . 0.0 113.59 173.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 C-N-CA 124.428 1.013 . . . . 0.0 113.427 -171.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.353 2.8 p-90 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.93 -95.35 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.387 1.47 . . . . 0.0 115.948 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -129.19 138.22 51.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.513 1.125 . . . . 0.0 112.11 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.92 121.82 26.97 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.76 87.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.013 1.325 . . . . 0.0 108.178 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -77.81 -15.61 58.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.431 0.692 . . . . 0.0 111.88 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.4 178.69 7.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.572 1.177 . . . . 0.0 113.942 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -138.93 154.38 48.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.659 1.183 . . . . 0.0 112.325 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 140.44 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.624 0.726 . . . . 0.0 110.271 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.79 -42.52 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.715 1.606 . . . . 0.0 111.213 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.49 152.86 41.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.591 1.556 . . . . 0.0 109.791 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.89 13.97 22.26 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.85 0.738 . . . . 0.0 114.67 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -34.94 68.81 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.125 1.462 . . . . 0.0 112.301 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.94 -30.7 71.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.8 0.84 . . . . 0.0 112.486 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.27 -41.38 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.416 1.087 . . . . 0.0 110.131 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.89 -40.23 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.489 -0.757 . . . . 0.0 111.091 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.58 -28.56 63.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.776 1.23 . . . . 0.0 112.349 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -74.65 -44.16 51.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.473 1.109 . . . . 0.0 110.699 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.61 -29.25 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.641 1.576 . . . . 0.0 112.633 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -94.48 -11.42 29.69 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.54 -14.65 13.77 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.631 1.586 . . . . 0.0 114.5 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.6 m -62.11 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.86 1.33 . . . . 0.0 112.428 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -175.07 156.59 2.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.658 1.583 . . . . 0.0 111.645 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 p -123.72 150.04 44.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.293 1.437 . . . . 0.0 112.281 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 CA-C-O 122.835 1.242 . . . . 0.0 113.252 172.282 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.23 142.61 46.3 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.96 1.773 . . . . 0.0 109.412 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -30.83 61.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.601 -0.687 . . . . 0.0 112.63 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.97 145.24 32.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.905 0.882 . . . . 0.0 110.078 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.64 120.59 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.383 1.073 . . . . 0.0 110.436 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.64 99.93 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.175 0.99 . . . . 0.0 108.358 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -122.32 143.0 36.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.79 1.236 . . . . 0.0 112.216 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.3 mt -83.13 103.86 10.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.89 -28.89 60.82 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.381 1.073 . . . . 0.0 111.18 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.7 t -164.02 169.54 17.8 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.0 139.85 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.716 2.007 . . . . 0.0 110.055 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -133.06 133.11 42.58 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.291 1.437 . . . . 0.0 110.134 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.73 125.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.274 -0.891 . . . . 0.0 108.864 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 t -121.55 140.44 52.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.07 1.348 . . . . 0.0 112.024 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 112.217 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.46 131.25 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.544 -1.347 . . . . 0.0 110.624 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.2 m -102.67 126.38 49.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.631 1.172 . . . . 0.0 110.184 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.1 123.34 44.23 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.875 1.27 . . . . 0.0 109.753 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -98.79 109.64 22.37 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 p -121.88 158.82 28.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 112.147 -169.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -7.2 34.94 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.62 -26.39 10.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.579 1.552 . . . . 0.0 113.392 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.68 145.52 4.24 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.311 1.91 . . . . 0.0 113.282 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.0 132.8 32.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.302 1.041 . . . . 0.0 112.277 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.43 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.828 1.651 . . . . 0.0 109.199 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.21 138.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.099 0.96 . . . . 0.0 110.506 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -131.79 135.67 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.671 1.989 . . . . 0.0 110.13 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -104.18 125.73 50.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.116 1.766 . . . . 0.0 108.946 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -88.28 146.97 25.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.108 0.963 . . . . 0.0 112.036 -175.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -104.67 74.36 1.14 Allowed 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 122.887 1.327 . . . . 0.0 110.973 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.66 -25.48 63.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.35 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.25 -31.78 60.91 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.5 1.12 . . . . 0.0 111.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -94.02 -27.28 16.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.625 1.17 . . . . 0.0 113.027 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.62 59.43 3.87 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.546 0.738 . . . . 0.0 112.919 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -61.72 -43.98 23.7 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.328 2.686 . . . . 0.0 112.723 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -67.51 -40.54 85.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.283 0.492 . . . . 0.0 110.708 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -49.16 74.74 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.597 0.759 . . . . 0.0 111.948 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.4 -40.8 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.33 -48.31 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.789 1.177 . . . . 0.0 111.718 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -68.51 -36.03 78.31 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.56 0.744 . . . . 0.0 112.128 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -60.4 -51.4 69.66 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.38 -34.8 73.0 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.639 -0.663 . . . . 0.0 111.558 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -55.8 -36.44 67.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.978 0.911 . . . . 0.0 112.351 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -76.35 -42.53 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.602 -0.686 . . . . 0.0 112.586 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.6 m -60.78 -35.31 76.12 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.589 -0.694 . . . . 0.0 111.779 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -32.32 73.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 112.694 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -81.7 -13.28 58.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.96 18.25 65.66 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.616 1.103 . . . . 0.0 114.14 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.58 -17.37 64.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.41 -7.22 48.26 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.459 -0.776 . . . . 0.0 112.998 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -69.17 135.41 50.61 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 51.93 45.21 28.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.992 1.717 . . . . 0.0 114.253 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -104.05 160.05 15.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.504 0.722 . . . . 0.0 110.907 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 156' ' ' ILE . 15.9 pt -123.42 162.31 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -91.42 115.76 28.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -116.7 -3.63 11.73 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -139.18 132.68 30.3 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.424 1.011 . . . . 0.0 111.291 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.18 146.48 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.91 2.084 . . . . 0.0 108.913 169.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -142.56 135.16 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.446 1.898 . . . . 0.0 107.415 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -64.21 134.8 55.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.324 0.65 . . . . 0.0 111.86 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.17 13.5 67.28 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.848 0.737 . . . . 0.0 114.848 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.15 -177.28 5.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.311 1.844 . . . . 0.0 111.033 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -88.24 -178.71 5.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.584 1.954 . . . . 0.0 115.16 -169.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 pt -120.01 142.47 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.022 1.329 . . . . 0.0 113.113 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -113.93 148.4 36.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.058 1.343 . . . . 0.0 112.083 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.41 178.79 32.71 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 -14.91 37.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 115.815 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.6 -10.67 76.15 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 116.738 1.455 . . . . 0.0 116.738 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -144.09 168.88 18.96 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.161 1.481 . . . . 0.0 113.359 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.83 162.85 18.7 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 126.895 2.078 . . . . 0.0 110.737 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -58.9 -15.22 25.98 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.019 3.146 . . . . 0.0 118.807 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 18.42 57.48 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.051 0.834 . . . . 0.0 114.715 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.0 mmt 59.4 27.3 16.37 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.588 1.555 . . . . 0.0 112.696 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.07 123.09 29.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.867 1.267 . . . . 0.0 109.169 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -73.17 121.2 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.005 0.922 . . . . 0.0 110.331 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -69.19 164.83 21.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.11 67.08 7.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.83 1.652 . . . . 0.0 111.704 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -66.17 125.93 27.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.781 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -133.09 173.66 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.827 2.051 . . . . 0.0 111.96 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 46.24 66.32 5.62 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.478 1.511 . . . . 0.0 113.711 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.55 137.52 74.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.337 2.691 . . . . 0.0 111.172 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.5 150.78 7.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.689 1.596 . . . . 0.0 108.655 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 151.92 29.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.259 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -87.37 101.59 13.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.697 1.599 . . . . 0.0 110.438 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.43 18.69 3.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.801 1.24 . . . . 0.0 113.836 -169.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.74 -21.5 63.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.432 1.493 . . . . 0.0 114.18 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.52 -2.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.846 2.058 . . . . 0.0 115.536 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -77.11 0.9 19.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.187 0.995 . . . . 0.0 112.282 169.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 35.74 27.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.905 1.24 . . . . 0.0 112.888 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.0 144.59 43.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.421 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.84 154.46 49.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.71 114.78 26.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.065 2.146 . . . . 0.0 110.572 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.5 p -138.8 171.98 13.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.933 1.293 . . . . 0.0 111.009 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -51.78 125.89 16.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.805 1.242 . . . . 0.0 110.959 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.4 36.43 39.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.848 1.213 . . . . 0.0 114.803 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.7 p -120.72 158.81 26.67 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.892 1.346 . . . . 0.0 112.89 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.44 136.3 54.54 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.61 158.23 44.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.291 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.7 mmt -81.38 132.49 35.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.69 0.396 . . . . 0.0 110.902 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.11 161.13 24.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.5 0.72 . . . . 0.0 110.573 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -133.02 158.42 42.76 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 m -74.01 -57.08 4.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.895 1.278 . . . . 0.0 112.777 -169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -158.61 -47.67 0.06 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.079 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.65 157.9 71.62 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.543 1.137 . . . . 0.0 111.359 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.84 -21.3 71.94 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.182 2.588 . . . . 0.0 114.584 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.74 42.2 2.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.604 1.962 . . . . 0.0 112.337 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.6 p -117.45 33.59 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.837 1.255 . . . . 0.0 113.861 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.63 14.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.277 1.431 . . . . 0.0 108.943 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -91.91 -60.09 1.95 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.49 33.33 0.32 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.79 140.08 53.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.216 1.406 . . . . 0.0 110.657 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -142.04 168.2 20.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.088 1.355 . . . . 0.0 111.354 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 18.6 p90 -144.12 160.3 41.15 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.538 0.735 . . . . 0.0 111.849 172.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.9 mt -114.26 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.211 1.004 . . . . 0.0 108.419 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.32 100.32 2.61 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.8 0.84 . . . . 0.0 110.217 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.23 -25.99 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 121.199 -0.938 . . . . 0.0 113.188 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 m -114.97 166.56 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.998 1.719 . . . . 0.0 111.633 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.69 122.84 27.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.02 0.528 . . . . 0.0 110.11 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -141.95 71.77 1.36 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.927 1.346 . . . . 0.0 112.596 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -52.29 -35.71 51.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.235 2.214 . . . . 0.0 114.445 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -59.88 -12.77 8.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.73 -14.18 55.01 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -73.16 161.91 30.04 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.284 1.434 . . . . 0.0 114.462 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -69.71 144.41 52.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.216 0.606 . . . . 0.0 112.312 173.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.8 p -126.22 -59.29 1.32 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.797 1.239 . . . . 0.0 113.089 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 C-N-CA 123.987 0.803 . . . . 0.0 113.974 -176.941 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.42 -82.3 1.36 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.564 1.078 . . . . 0.0 115.139 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -137.36 154.63 49.98 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.199 1.4 . . . . 0.0 112.176 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -84.67 117.17 23.61 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.928 -0.482 . . . . 0.0 111.801 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.1 81.0 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.842 1.257 . . . . 0.0 108.755 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.74 -13.99 60.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 0.0 112.258 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.86 178.09 8.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.74 1.257 . . . . 0.0 113.648 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -137.25 154.09 50.21 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.918 -1.113 . . . . 0.0 112.339 171.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.12 143.94 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.772 0.796 . . . . 0.0 109.697 171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.79 -39.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.734 1.614 . . . . 0.0 110.861 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -146.46 148.89 32.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.52 1.528 . . . . 0.0 110.549 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 116.98 7.45 12.79 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 77.1 mmm -56.62 -36.21 69.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.584 1.692 . . . . 0.0 113.099 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -62.87 -30.3 71.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.631 0.773 . . . . 0.0 112.202 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.98 -40.93 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.044 1.738 . . . . 0.0 110.673 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.64 -39.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.034 0.934 . . . . 0.0 110.946 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.89 -25.57 61.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.993 1.317 . . . . 0.0 112.717 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -76.55 -42.86 41.45 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.12 1.368 . . . . 0.0 110.975 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.24 -34.45 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.877 1.271 . . . . 0.0 112.111 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -91.49 -14.68 30.03 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.57 -20.64 14.42 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.106 1.336 . . . . 0.0 114.332 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.92 -63.88 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 118.598 1.199 . . . . 0.0 112.172 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.42 155.79 5.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -137.19 152.17 49.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.993 1.317 . . . . 0.0 112.135 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.857 0 C-N-CA 125.199 1.381 . . . . 0.0 111.404 170.382 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -57.74 128.79 30.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 120.759 1.307 . . . . 0.0 110.248 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.74 45.28 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.55 159.45 26.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.615 0.766 . . . . 0.0 110.467 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.49 109.67 16.17 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.612 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.17 94.0 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -122.74 144.32 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -168.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.4 104.4 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 106.25 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.45 -41.02 61.53 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.811 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -151.21 166.26 31.4 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.48 141.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.052 1.741 . . . . 0.0 110.764 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.5 m -133.88 129.66 36.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.006 1.322 . . . . 0.0 110.243 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.04 120.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -109.64 137.98 46.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.706 1.202 . . . . 0.0 111.752 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.571 1.948 . . . . 0.0 112.151 -178.454 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.92 130.52 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 121.13 -0.981 . . . . 0.0 109.597 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 m -103.67 120.95 41.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.039 0.936 . . . . 0.0 110.087 172.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -92.4 119.51 32.01 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -93.88 119.07 32.31 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -121.82 160.54 24.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.976 0.893 . . . . 0.0 113.125 -169.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -73.06 -4.64 33.81 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -120.5 -20.07 7.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.441 1.497 . . . . 0.0 114.412 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.67 117.32 1.08 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.001 1.762 . . . . 0.0 110.771 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.88 145.7 55.35 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.531 0.732 . . . . 0.0 111.763 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.7 141.88 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.772 1.629 . . . . 0.0 109.664 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.08 134.09 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.465 1.106 . . . . 0.0 110.072 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.79 137.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.345 1.858 . . . . 0.0 110.102 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -105.57 123.36 47.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.446 1.898 . . . . 0.0 109.259 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.9 p -87.1 148.61 25.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.158 0.983 . . . . 0.0 112.005 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.13 72.9 0.9 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.888 1.328 . . . . 0.0 111.856 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.64 -25.58 64.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.536 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -77.25 -28.99 53.79 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.379 1.071 . . . . 0.0 111.566 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -99.29 -21.11 16.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.081 1.352 . . . . 0.0 113.406 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.52 56.22 1.31 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.274 1.029 . . . . 0.0 113.244 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.01 -45.07 25.72 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.478 2.785 . . . . 0.0 113.088 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.94 -41.29 74.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.646 0.657 . . . . 0.0 111.245 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.9 m -63.9 -48.27 77.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.551 0.74 . . . . 0.0 111.281 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.67 -43.41 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.717 0.807 . . . . 0.0 111.463 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -57.17 -45.32 83.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.816 1.189 . . . . 0.0 112.019 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -69.36 -36.8 77.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.512 0.596 . . . . 0.0 111.821 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.09 -48.91 79.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.342 1.057 . . . . 0.0 111.728 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.18 -36.84 80.24 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.269 -0.894 . . . . 0.0 111.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -58.45 -34.8 71.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 112.499 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -73.63 -43.34 59.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 112.161 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.8 m -58.38 -38.44 77.31 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.735 -0.603 . . . . 0.0 111.762 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -65.39 -35.77 81.94 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.327 2.251 . . . . 0.0 112.691 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -81.17 -16.03 54.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 0.0 113.046 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.69 19.36 63.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.962 0.792 . . . . 0.0 113.052 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.26 -37.61 75.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 113.036 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -78.37 -9.84 59.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.714 0.406 . . . . 0.0 111.892 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.27 131.04 48.05 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.297 -0.877 . . . . 0.0 108.844 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.5 t30 62.38 20.86 12.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.054 2.142 . . . . 0.0 116.7 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -82.05 144.54 30.75 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.741 -1.224 . . . . 0.0 113.414 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -101.14 155.92 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -86.41 72.97 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.87 2.068 . . . . 0.0 108.402 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -69.45 -9.61 54.41 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.62 125.26 45.29 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.572 1.149 . . . . 0.0 110.508 -172.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.95 131.01 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.767 1.227 . . . . 0.0 112.042 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.42 131.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.697 1.999 . . . . 0.0 108.182 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.06 138.14 54.13 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.624 0.77 . . . . 0.0 112.008 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.02 67.74 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.702 0.668 . . . . 0.0 114.641 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.12 -177.22 5.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.607 1.963 . . . . 0.0 110.316 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.29 177.86 6.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.218 1.807 . . . . 0.0 114.196 -171.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 pt -116.39 140.82 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.896 1.278 . . . . 0.0 111.937 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -118.4 149.04 41.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.954 1.301 . . . . 0.0 111.372 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.6 -176.61 29.85 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.052 0.834 . . . . 0.0 114.978 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 -11.41 70.47 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.054 1.312 . . . . 0.0 115.632 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.32 60.06 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 118.879 1.34 . . . . 0.0 115.839 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.0 157.05 44.25 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -83.66 164.74 43.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 126.306 1.842 . . . . 0.0 109.32 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.04 -14.61 44.49 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.509 2.806 . . . . 0.0 117.087 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.71 18.83 56.81 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.438 1.018 . . . . 0.0 114.44 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.5 34.11 15.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.2 1.8 . . . . 0.0 112.94 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.32 131.22 37.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.389 1.476 . . . . 0.0 109.448 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.41 130.81 42.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 124.172 1.939 . . . . 0.0 111.603 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.85 -176.9 1.45 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 110.212 -3.176 . . . . 0.0 113.761 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.91 54.47 2.74 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.897 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 p -73.56 104.11 4.4 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.865 1.266 . . . . 0.0 111.571 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -133.47 178.44 6.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.872 2.069 . . . . 0.0 112.067 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.93 68.11 3.86 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.417 1.487 . . . . 0.0 113.798 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -61.95 138.31 72.73 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.168 2.579 . . . . 0.0 111.338 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.39 152.83 5.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 126.268 1.827 . . . . 0.0 108.024 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 155.05 27.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.153 0.502 . . . . 0.0 111.032 169.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.9 128.98 34.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.609 0.764 . . . . 0.0 111.124 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -111.12 15.13 21.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.942 1.297 . . . . 0.0 112.867 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -11.68 28.1 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -75.19 39.24 0.14 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -113.37 -6.49 13.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.21 . . . . 0.0 114.191 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.18 3.66 65.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.444 1.497 . . . . 0.0 115.2 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.19 158.24 19.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.606 1.203 . . . . 0.0 112.878 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.49 156.8 48.09 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.7 1.2 . . . . 0.0 113.521 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -90.25 93.21 9.25 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.496 1.918 . . . . 0.0 109.755 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.7 p -122.86 166.02 15.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.261 1.025 . . . . 0.0 111.319 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -55.37 114.38 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.265 1.826 . . . . 0.0 110.26 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 43.04 5.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.904 1.24 . . . . 0.0 114.633 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.7 p -134.91 165.46 25.26 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.842 1.321 . . . . 0.0 113.512 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mp -124.35 142.84 50.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 112.775 174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.6 156.72 47.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.724 -0.61 . . . . 0.0 111.853 169.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -83.94 136.93 33.89 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.175 -0.328 . . . . 0.0 111.258 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.66 155.25 20.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.717 0.807 . . . . 0.0 111.608 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -118.91 159.22 24.19 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.677 1.191 . . . . 0.0 112.674 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.3 m -72.25 -52.23 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.011 0.924 . . . . 0.0 110.805 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -159.56 -58.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.458 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.24 157.4 85.0 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 111.75 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -55.81 -34.69 92.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.841 2.36 . . . . 0.0 113.118 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -99.59 35.3 2.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.25 1.42 . . . . 0.0 112.917 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -123.35 27.53 7.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.506 1.522 . . . . 0.0 113.491 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 103.92 16.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.623 1.569 . . . . 0.0 109.638 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.5 p -88.41 -74.78 0.45 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.851 1.26 . . . . 0.0 112.519 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.71 -20.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.042 1.337 . . . . 0.0 113.643 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -71.04 145.32 50.0 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 121.029 -1.044 . . . . 0.0 112.441 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -141.81 168.06 20.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.32 1.848 . . . . 0.0 110.402 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.7 p90 -146.05 160.14 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.576 0.75 . . . . 0.0 111.753 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.5 mt -113.27 113.9 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.226 1.01 . . . . 0.0 108.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.78 93.88 2.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.989 . . . . 0.0 110.418 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.15 -23.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 163.67 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.483 1.513 . . . . 0.0 111.223 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -77.78 117.56 19.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.174 0.59 . . . . 0.0 109.8 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -143.64 64.95 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 123.113 1.435 . . . . 0.0 112.268 -169.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -66.31 -13.24 60.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.83 -13.82 38.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.654 -1.279 . . . . 0.0 113.453 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.02 -9.81 59.72 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.45 1.1 . . . . 0.0 113.949 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.12 -177.81 3.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -81.39 145.01 31.03 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.731 1.612 . . . . 0.0 111.785 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.4 p -111.75 -59.08 2.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.478 1.111 . . . . 0.0 113.468 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.051 0 C-N-CA 124.068 0.842 . . . . 0.0 113.865 -173.296 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.327 7.0 p-90 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.33 -91.31 1.36 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.427 1.489 . . . . 0.0 115.458 -169.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -134.57 144.79 48.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.579 1.151 . . . . 0.0 112.041 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.5 t -83.67 124.06 30.45 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.978 -0.451 . . . . 0.0 112.066 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.29 88.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -78.09 -15.44 58.88 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.626 0.77 . . . . 0.0 112.14 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.23 177.87 8.68 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.599 1.19 . . . . 0.0 113.341 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -136.13 151.45 49.79 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.98 -1.075 . . . . 0.0 112.247 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.36 135.64 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.76 -40.95 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.9 1.68 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -144.28 144.71 31.62 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.19 1.396 . . . . 0.0 110.677 174.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.06 -0.09 10.69 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 124.737 1.161 . . . . 0.0 115.629 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -55.92 -37.59 69.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.435 1.618 . . . . 0.0 113.17 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.99 -34.14 75.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.703 0.801 . . . . 0.0 111.936 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.03 -39.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.16 1.784 . . . . 0.0 110.905 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.34 -39.32 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 121.204 -0.935 . . . . 0.0 111.121 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 8.8 t70 -74.3 -22.86 59.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.066 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.8 -43.2 47.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.939 1.295 . . . . 0.0 111.082 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.8 mt -54.69 -35.12 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.221 1.408 . . . . 0.0 112.195 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.2 pttp -90.31 -18.93 24.7 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -96.49 -22.06 20.13 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.977 1.275 . . . . 0.0 114.225 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.8 t -81.41 -63.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 118.378 1.089 . . . . 0.0 112.055 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -162.63 152.72 16.31 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 51.8 p -140.36 152.83 46.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.944 1.697 . . . . 0.0 111.619 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 114.386 0.515 . . . . 0.0 114.386 169.757 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.24 140.24 52.8 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -28.06 60.52 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.99 153.96 27.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.429 1.091 . . . . 0.0 110.257 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.2 109.68 11.26 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.007 -1.058 . . . . 0.0 110.788 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.24 94.28 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.828 1.251 . . . . 0.0 107.709 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.68 152.05 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.405 1.574 . . . . 0.0 113.756 -169.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.81 104.16 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.79 -39.77 66.43 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.116 -0.99 . . . . 0.0 111.01 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -152.3 170.88 18.97 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.16 143.15 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.505 1.522 . . . . 0.0 111.458 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.8 m -135.23 130.61 35.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 110.534 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.9 121.31 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -113.65 150.2 33.52 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.308 1.443 . . . . 0.0 112.525 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.317 1.447 . . . . 0.0 114.091 -169.969 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.72 129.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.889 0.876 . . . . 0.0 108.992 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.3 m -103.68 123.65 47.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.674 1.19 . . . . 0.0 109.891 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -97.35 132.01 43.48 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.562 1.145 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -104.99 98.71 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p -103.67 152.06 22.24 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.052 -0.405 . . . . 0.0 111.192 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -60.54 -10.35 4.95 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -103.62 -8.08 20.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.834 1.253 . . . . 0.0 113.748 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.8 165.98 12.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.921 1.724 . . . . 0.0 113.485 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.94 138.49 42.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.813 1.645 . . . . 0.0 112.949 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.93 139.26 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.271 1.828 . . . . 0.0 108.886 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -120.22 135.53 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.452 1.101 . . . . 0.0 110.002 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 138.51 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.499 1.919 . . . . 0.0 110.106 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -103.77 126.32 50.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.566 1.946 . . . . 0.0 108.912 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 p -90.29 147.96 23.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.34 1.056 . . . . 0.0 111.527 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.11 72.89 1.02 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.794 1.283 . . . . 0.0 111.35 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.56 -25.5 64.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.603 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -77.24 -24.84 51.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.464 1.105 . . . . 0.0 111.547 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -99.9 -28.1 13.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 112.381 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.68 57.9 3.0 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.803 0.841 . . . . 0.0 112.718 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -60.93 -43.42 30.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.593 2.862 . . . . 0.0 112.711 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -68.88 -40.83 79.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.819 0.736 . . . . 0.0 110.715 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' HD13 ' A' ' 68' ' ' ILE . 66.9 m -62.37 -50.37 71.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.691 0.796 . . . . 0.0 111.813 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.3 t -67.21 -38.89 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.131 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.49 -46.63 86.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.673 1.124 . . . . 0.0 111.422 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.88 -42.73 97.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.189 0.996 . . . . 0.0 111.977 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -59.27 -50.46 73.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.283 1.033 . . . . 0.0 111.619 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.22 -36.24 71.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.788 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.64 -38.07 71.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.728 0.811 . . . . 0.0 111.864 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.93 -40.77 60.64 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.727 -0.608 . . . . 0.0 112.339 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.3 m -61.34 -36.05 79.1 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.277 -0.89 . . . . 0.0 111.607 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -31.76 72.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.16 1.784 . . . . 0.0 112.93 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -81.61 -13.54 57.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.282 1.033 . . . . 0.0 113.476 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.77 18.3 61.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.51 1.052 . . . . 0.0 114.006 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.63 -17.53 62.87 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.34 -7.29 35.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.66 136.49 54.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.292 0.951 . . . . 0.0 109.154 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.5 t30 53.82 41.68 31.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.813 1.645 . . . . 0.0 114.586 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.9 p -102.11 167.31 10.1 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.908 0.883 . . . . 0.0 110.643 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 156' ' ' ILE . 24.4 pt -125.56 160.71 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -83.95 80.54 9.13 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -66.41 -14.21 61.82 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -169.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -150.96 143.74 24.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.275 1.852 . . . . 0.0 113.877 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.44 147.44 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 128.064 2.546 . . . . 0.0 108.201 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.5 mt -130.76 130.71 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.862 1.665 . . . . 0.0 107.493 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -61.63 134.95 57.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.852 0.461 . . . . 0.0 111.087 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 8.6 65.02 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.44 -176.89 5.22 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.481 1.913 . . . . 0.0 111.341 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -179.39 7.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -169.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.2 pt -115.4 135.35 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.703 1.601 . . . . 0.0 112.364 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -112.64 149.0 33.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.491 1.516 . . . . 0.0 111.351 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.55 175.76 36.39 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.11 66.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.145 1.831 . . . . 0.0 115.443 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.79 -15.02 62.1 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 118.745 1.272 . . . . 0.0 115.819 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.68 164.83 31.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.659 1.229 . . . . 0.0 113.331 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.91 164.46 28.42 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.858 1.663 . . . . 0.0 110.703 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' HG21 ' A' ' 40' ' ' ILE . 50.8 Cg_exo -61.78 -14.91 39.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.451 2.767 . . . . 0.0 117.927 -170.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.22 17.89 58.38 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.169 0.89 . . . . 0.0 114.563 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 32.7 18.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.845 1.658 . . . . 0.0 112.569 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -88.87 130.96 35.31 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.751 1.62 . . . . 0.0 109.537 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.96 124.98 27.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.322 1.049 . . . . 0.0 111.511 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -76.3 167.7 21.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.698 1.199 . . . . 0.0 113.485 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.68 77.84 3.33 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.345 1.458 . . . . 0.0 111.361 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.7 p -72.41 95.01 1.7 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.852 1.261 . . . . 0.0 111.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -110.95 171.46 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.169 1.788 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 51.45 64.48 7.88 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.548 1.539 . . . . 0.0 114.088 169.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -60.15 139.17 85.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.237 2.625 . . . . 0.0 111.808 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -102.83 150.41 6.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.348 1.459 . . . . 0.0 108.519 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.0 161.67 22.92 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.766 0.827 . . . . 0.0 111.369 169.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -73.22 121.37 20.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.403 0.681 . . . . 0.0 111.664 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -105.02 15.88 26.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.837 1.255 . . . . 0.0 113.215 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -14.09 49.75 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.307 -1.496 . . . . 0.0 114.568 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.45 2.64 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.913 2.085 . . . . 0.0 116.139 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.31 -3.39 58.22 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.421 1.489 . . . . 0.0 112.866 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 26.85 49.47 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.229 0.919 . . . . 0.0 114.976 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.75 160.54 27.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.571 0.748 . . . . 0.0 112.861 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -127.48 155.24 44.04 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -103.73 73.5 1.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.942 2.097 . . . . 0.0 111.6 -170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.9 p -103.31 167.65 9.68 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.473 0.709 . . . . 0.0 111.46 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -57.45 127.14 30.5 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.923 0.868 . . . . 0.0 111.282 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.39 26.72 42.22 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.086 1.327 . . . . 0.0 114.828 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.3 p -115.43 159.62 20.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.456 1.628 . . . . 0.0 112.777 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.53 136.32 53.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.64 161.03 37.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.273 0.559 . . . . 0.0 111.706 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -81.06 139.29 35.79 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.962 -0.461 . . . . 0.0 111.457 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 168.89 11.36 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.884 1.274 . . . . 0.0 110.905 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -105.08 160.24 15.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.164 1.385 . . . . 0.0 112.452 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.1 m -83.64 -52.16 6.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 0.0 110.719 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -161.25 -50.21 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.277 1.431 . . . . 0.0 112.217 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -85.46 160.47 53.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.943 1.297 . . . . 0.0 112.501 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.07 -16.52 55.4 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.245 2.63 . . . . 0.0 115.217 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -124.78 47.28 2.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.708 1.603 . . . . 0.0 111.141 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.9 p -119.46 25.78 9.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.26 1.424 . . . . 0.0 114.393 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.32 93.68 0.87 Allowed 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.936 -1.103 . . . . 0.0 108.907 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.5 p -89.04 -52.21 5.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.626 0.77 . . . . 0.0 111.779 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.36 -5.04 0.19 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -80.43 134.32 35.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.984 -1.072 . . . . 0.0 110.07 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.79 168.4 19.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.486 1.914 . . . . 0.0 110.673 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.5 p90 -147.1 161.82 40.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 111.842 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.83 119.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -69.76 100.15 1.46 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.22 -17.91 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.403 -0.81 . . . . 0.0 113.146 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.06 168.14 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 127.923 2.489 . . . . 0.0 111.256 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -68.92 113.47 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.706 1.202 . . . . 0.0 112.138 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.41 54.18 1.49 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.966 1.706 . . . . 0.0 111.58 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.0 -26.27 65.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -62.54 -13.73 34.21 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -85.8 -6.42 59.11 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.653 1.181 . . . . 0.0 114.069 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -71.73 179.48 3.09 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.184 1.394 . . . . 0.0 114.425 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -85.72 143.9 28.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.821 1.248 . . . . 0.0 111.991 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.8 p -112.7 -60.15 1.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 113.419 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 C-N-CA 123.797 0.713 . . . . 0.0 114.378 -173.294 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 7.5 p-90 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.32 -100.3 1.52 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.549 1.547 . . . . 0.0 115.688 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -126.3 150.6 48.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.667 1.587 . . . . 0.0 111.483 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.2 t -82.95 118.44 23.48 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.3 87.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.685 1.194 . . . . 0.0 108.227 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -78.71 -14.28 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.545 0.738 . . . . 0.0 112.234 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.89 177.62 7.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.626 1.203 . . . . 0.0 113.96 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -140.77 152.23 45.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.689 1.196 . . . . 0.0 112.345 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.91 142.89 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.598 0.713 . . . . 0.0 110.152 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.3 -41.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.86 1.664 . . . . 0.0 110.852 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -145.09 155.7 43.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.895 1.678 . . . . 0.0 109.682 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.31 23.13 Favored Glycine 0 N--CA 1.467 0.765 0 C-N-CA 123.867 0.746 . . . . 0.0 114.407 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -32.57 66.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.766 1.283 . . . . 0.0 112.325 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.83 -29.01 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 112.658 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.0 -40.05 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.315 1.446 . . . . 0.0 110.48 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.31 -39.41 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.803 -1.185 . . . . 0.0 110.982 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.35 -30.54 69.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -73.11 -44.51 60.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.829 1.252 . . . . 0.0 111.126 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.05 -25.03 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.432 1.493 . . . . 0.0 112.409 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -84.24 -25.45 29.41 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.16 -8.68 64.37 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.784 1.659 . . . . 0.0 114.747 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -60.3 -26.15 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . . . 82.83 163.46 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.313 2.245 . . . . 0.0 114.376 -169.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 68.3 p -111.8 151.05 29.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.135 1.374 . . . . 0.0 113.632 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 123.333 1.518 . . . . 0.0 112.537 169.875 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -59.36 135.74 67.3 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 120.756 1.306 . . . . 0.0 111.033 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -31.51 60.24 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.35 0.66 . . . . 0.0 112.687 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.48 147.87 35.65 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.486 0.714 . . . . 0.0 110.435 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.26 109.78 16.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.426 0.631 . . . . 0.0 110.027 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.41 100.14 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -120.85 141.22 42.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.525 1.13 . . . . 0.0 111.726 -169.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.3 103.41 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.39 -35.61 58.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.015 0.926 . . . . 0.0 110.859 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.56 165.01 34.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.12 139.59 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.205 1.802 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -135.39 130.31 34.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.775 1.23 . . . . 0.0 110.198 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.6 t -86.81 120.13 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t -114.18 147.3 39.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.027 1.331 . . . . 0.0 112.426 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.539 1.536 . . . . 0.0 113.46 -169.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 119.925 -0.083 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.76 128.2 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.979 0.912 . . . . 0.0 109.37 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.4 m -102.51 126.23 49.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 109.917 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -100.93 117.72 35.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.54 1.136 . . . . 0.0 109.329 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.25 112.53 24.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -118.81 163.89 16.21 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.479 0.656 . . . . 0.0 112.239 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -69.7 -6.29 30.72 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.638 ' CE1' HD11 ' A' ' 136' ' ' ILE . 29.9 p80 -118.65 -20.63 8.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 114.16 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.14 142.52 3.47 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 126.982 2.23 . . . . 0.0 113.64 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.88 136.26 47.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.65 1.18 . . . . 0.0 113.303 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.26 141.14 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.35 1.46 . . . . 0.0 109.596 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -124.92 136.34 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.912 1.285 . . . . 0.0 110.257 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -126.5 139.96 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 126.725 2.01 . . . . 0.0 110.1 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -107.14 124.72 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.587 1.955 . . . . 0.0 109.245 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -85.85 147.99 26.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.205 1.002 . . . . 0.0 111.555 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.93 74.85 1.01 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 122.651 1.215 . . . . 0.0 111.404 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.77 -26.23 64.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.503 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -77.75 -26.61 50.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.327 1.051 . . . . 0.0 111.712 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.85 -21.37 15.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.905 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.69 55.44 1.6 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.915 1.286 . . . . 0.0 113.069 -172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -60.63 -43.39 32.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.554 2.836 . . . . 0.0 112.953 -172.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -70.34 -41.11 73.62 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.553 0.615 . . . . 0.0 110.671 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' ' 68' ' ' ILE . 38.2 m -62.85 -52.37 63.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.676 0.39 . . . . 0.0 111.474 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.33 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 118.801 -0.618 . . . . 0.0 111.24 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -57.66 -48.16 80.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.569 1.077 . . . . 0.0 111.359 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.1 -41.17 82.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.954 0.902 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.18 -48.1 82.86 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.695 1.198 . . . . 0.0 111.682 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.96 -37.47 72.79 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.361 0.664 . . . . 0.0 111.415 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -59.08 -33.79 71.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.352 0.661 . . . . 0.0 112.607 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -73.77 -43.82 57.85 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.469 -0.77 . . . . 0.0 112.205 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.52 -37.19 82.83 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.33 -0.856 . . . . 0.0 111.503 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -62.61 -33.54 75.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.814 2.046 . . . . 0.0 112.883 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -83.79 -14.85 50.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.084 0.953 . . . . 0.0 113.503 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 17.5 53.5 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.082 0.849 . . . . 0.0 114.15 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -73.73 -18.47 60.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.196 1.498 . . . . 0.0 114.832 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -98.26 -6.6 30.79 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.2 -0.938 . . . . 0.0 112.35 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -71.57 129.33 38.48 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.934 -1.103 . . . . 0.0 108.792 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.7 43.99 17.95 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.089 1.355 . . . . 0.0 113.752 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.3 p -109.32 167.26 10.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.435 1.094 . . . . 0.0 111.829 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 15.8 pt -120.45 161.58 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.82 83.42 7.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.773 1.229 . . . . 0.0 108.177 168.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -60.8 -28.63 68.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.684 1.993 . . . . 0.0 115.025 -169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -132.0 136.55 47.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.787 1.176 . . . . 0.0 111.378 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.57 130.03 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.643 1.977 . . . . 0.0 110.944 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.3 mt -137.19 126.78 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 108.276 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.1 136.54 57.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.298 0.639 . . . . 0.0 111.628 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.24 9.23 63.61 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -142.54 -177.23 5.18 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.948 1.699 . . . . 0.0 111.025 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.93 179.89 6.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.835 1.654 . . . . 0.0 114.393 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.26 136.64 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.807 1.243 . . . . 0.0 112.364 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.55 141.96 34.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.661 1.184 . . . . 0.0 110.489 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.09 165.97 27.23 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 123.033 1.352 . . . . 0.0 115.801 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.62 -8.48 65.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.439 1.495 . . . . 0.0 115.831 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.54 -20.87 76.15 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.061 1.431 . . . . 0.0 116.065 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -143.68 170.06 16.56 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.757 1.278 . . . . 0.0 113.067 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -100.08 162.61 20.45 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 111.147 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.9 -13.26 29.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.838 3.025 . . . . 0.0 117.886 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 17.17 59.83 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.768 0.699 . . . . 0.0 114.389 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt 60.44 25.5 15.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.711 1.604 . . . . 0.0 112.967 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -82.77 125.17 30.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.58 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -76.08 120.28 21.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 110.952 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -72.15 163.85 27.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.226 1.011 . . . . 0.0 113.632 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.27 69.23 8.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.968 1.707 . . . . 0.0 111.542 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -72.84 130.3 40.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.514 1.526 . . . . 0.0 112.706 -173.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -133.56 174.87 9.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.467 1.907 . . . . 0.0 112.641 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 49.39 68.21 3.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.654 1.582 . . . . 0.0 114.009 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -61.14 133.93 49.72 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.171 2.581 . . . . 0.0 111.418 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.7 mt -98.61 153.26 4.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.949 1.7 . . . . 0.0 108.012 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -74.83 161.2 29.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.54 0.336 . . . . 0.0 110.156 169.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.0 -42.88 69.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -168.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 61.34 -0.21 0.38 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.205 2.602 . . . . 0.0 117.717 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.39 -12.29 61.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.763 -1.836 . . . . 0.0 113.897 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -62.74 8.05 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.969 1.708 . . . . 0.0 115.101 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -79.21 -10.94 59.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.384 1.473 . . . . 0.0 112.832 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.6 81.35 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.055 1.312 . . . . 0.0 115.193 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.13 158.58 29.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.555 1.177 . . . . 0.0 112.535 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -128.53 150.3 50.23 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -87.15 65.44 8.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.477 1.911 . . . . 0.0 112.029 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.3 p -100.39 166.99 10.68 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.812 0.845 . . . . 0.0 112.424 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -52.27 123.22 10.2 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.699 1.599 . . . . 0.0 111.09 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.0 43.65 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 114.926 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.2 p -116.25 159.28 22.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.364 1.582 . . . . 0.0 113.682 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.95 134.72 55.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.826 0.85 . . . . 0.0 112.454 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.45 157.32 44.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 173.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -80.9 140.64 35.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.327 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.14 162.19 15.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.66 0.784 . . . . 0.0 111.231 172.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -129.75 164.65 23.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.461 1.104 . . . . 0.0 112.893 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.6 m -72.4 -54.54 9.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.67 0.788 . . . . 0.0 110.905 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.11 -52.13 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.627 1.571 . . . . 0.0 112.193 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.04 157.19 76.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.751 1.221 . . . . 0.0 111.776 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.2 -24.98 76.44 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.122 2.548 . . . . 0.0 114.296 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -109.12 33.64 4.17 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.478 1.511 . . . . 0.0 112.649 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.7 p -118.84 26.3 9.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.34 1.456 . . . . 0.0 113.88 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.51 100.85 13.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.209 1.404 . . . . 0.0 109.51 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.0 p -89.15 -57.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.065 0.946 . . . . 0.0 113.201 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -162.39 48.44 0.17 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -136.71 147.5 46.8 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.832 -1.167 . . . . 0.0 111.381 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.82 168.22 20.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.114 1.366 . . . . 0.0 111.78 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -147.61 162.44 39.12 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.239 0.616 . . . . 0.0 111.371 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.1 mt -116.05 115.85 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.053 0.941 . . . . 0.0 108.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -73.6 96.12 2.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.379 0.671 . . . . 0.0 110.062 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.42 -22.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.06 -1.025 . . . . 0.0 113.189 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.55 166.66 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.633 . . . . 0.0 110.862 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.71 114.73 13.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.326 0.584 . . . . 0.0 111.629 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -124.94 59.44 1.22 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.063 1.745 . . . . 0.0 111.554 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.09 -14.89 63.32 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.15 -14.05 62.53 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.849 -1.157 . . . . 0.0 113.266 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.2 -8.27 59.64 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.379 1.072 . . . . 0.0 113.695 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.36 -176.94 2.4 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -74.69 147.51 41.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.05 1.74 . . . . 0.0 113.034 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.513 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 53.4 p -103.15 -61.19 1.44 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.652 1.581 . . . . 0.0 113.107 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 C-N-CA 125.142 1.353 . . . . 0.0 112.618 -170.016 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.513 ' N ' ' HG ' ' A' ' 111' ' ' SER 0.348 2.4 p-90 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.913 0.863 . . . . 0.0 112.958 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.88 -85.72 1.26 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.371 1.463 . . . . 0.0 115.905 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -137.1 132.97 34.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.957 1.303 . . . . 0.0 111.79 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.59 128.78 34.79 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.58 90.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.574 1.15 . . . . 0.0 107.935 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -78.94 -14.86 58.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.716 0.806 . . . . 0.0 111.904 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.01 177.33 9.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.579 1.18 . . . . 0.0 112.929 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -136.31 153.99 50.99 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.592 -1.317 . . . . 0.0 112.232 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.33 140.01 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.591 0.71 . . . . 0.0 109.403 169.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.99 -42.24 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.704 1.602 . . . . 0.0 110.519 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.43 147.0 32.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.563 1.545 . . . . 0.0 109.902 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.12 7.15 10.4 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.523 0.969 . . . . 0.0 115.523 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -56.32 -37.51 70.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.695 1.747 . . . . 0.0 112.716 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.47 -29.03 70.23 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.84 0.856 . . . . 0.0 112.431 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.11 -44.98 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.423 1.489 . . . . 0.0 110.443 172.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.84 -38.52 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.165 -0.959 . . . . 0.0 111.25 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.84 -23.51 60.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 112.457 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -78.92 -42.4 27.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.191 1.396 . . . . 0.0 111.182 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.8 mt -54.37 -35.52 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.558 1.143 . . . . 0.0 111.87 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -84.98 -18.14 35.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.1 15.41 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.179 1.371 . . . . 0.0 114.422 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.42 -57.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.806 1.303 . . . . 0.0 113.106 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.33 5.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 112.024 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.2 p -142.84 153.52 43.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.2 1.4 . . . . 0.0 112.119 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.136 0 O-C-N 122.135 -0.353 . . . . 0.0 113.234 169.744 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.08 143.79 55.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 121.711 1.607 . . . . 0.0 109.324 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.46 58.17 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.44 159.11 16.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.211 1.405 . . . . 0.0 110.216 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.51 112.57 17.98 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.854 -1.154 . . . . 0.0 111.477 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.6 94.21 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -128.15 147.49 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -168.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 63.8 mt -85.76 104.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.992 1.717 . . . . 0.0 107.988 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -78.94 -30.47 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.081 1.353 . . . . 0.0 112.612 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 t -155.29 162.43 40.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.06 0.944 . . . . 0.0 113.119 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.03 139.6 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.69 1.596 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.7 m -136.39 128.61 29.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.594 1.157 . . . . 0.0 110.779 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.79 118.08 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.2 t -112.63 150.19 31.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.635 1.574 . . . . 0.0 112.295 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.346 1.458 . . . . 0.0 113.627 -170.081 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.865 -0.588 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.39 130.27 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 120.684 1.584 . . . . 0.0 110.394 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -101.24 123.16 44.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.446 1.098 . . . . 0.0 110.346 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -97.83 130.73 44.73 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.977 1.311 . . . . 0.0 110.286 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -103.6 97.84 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -101.51 152.35 20.87 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.064 -0.398 . . . . 0.0 111.269 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -60.85 -9.09 3.62 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -107.49 -8.44 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 114.147 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.45 162.23 10.61 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 123.109 1.394 . . . . 0.0 113.653 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.13 137.72 45.34 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.452 1.501 . . . . 0.0 112.651 172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.91 140.77 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.392 1.877 . . . . 0.0 108.685 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.47 135.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.384 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.13 134.55 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.559 1.944 . . . . 0.0 110.473 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -101.73 127.64 48.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.138 1.775 . . . . 0.0 108.796 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.4 p -88.28 149.27 23.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.386 1.075 . . . . 0.0 111.25 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.81 73.26 0.94 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.898 1.332 . . . . 0.0 111.656 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.76 -26.14 64.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.518 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -78.14 -26.2 47.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.333 1.053 . . . . 0.0 111.638 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.77 -22.02 14.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 113.183 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.85 55.31 1.19 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.855 1.262 . . . . 0.0 113.674 -171.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.63 -42.98 35.38 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.532 2.821 . . . . 0.0 113.147 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.31 -38.04 78.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 111.043 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.3 m -68.28 -47.99 66.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.153 0.581 . . . . 0.0 111.904 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.48 -39.43 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.337 0.655 . . . . 0.0 111.6 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -52.64 -49.36 65.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.543 1.065 . . . . 0.0 112.104 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.6 -38.05 77.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.459 0.704 . . . . 0.0 111.562 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.01 -50.34 74.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.472 1.109 . . . . 0.0 111.82 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.31 -35.18 73.5 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.51 -0.744 . . . . 0.0 111.638 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.07 -33.19 70.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 112.694 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.54 -43.42 39.22 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.378 -0.826 . . . . 0.0 112.376 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -58.84 -40.36 84.01 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.731 -0.605 . . . . 0.0 111.706 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -61.03 -39.66 90.65 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.362 1.865 . . . . 0.0 113.387 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -77.48 -16.23 58.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.031 0.933 . . . . 0.0 112.632 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.9 62.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.988 0.804 . . . . 0.0 112.836 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.95 -35.76 75.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.53 1.165 . . . . 0.0 113.122 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.72 -8.61 59.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.733 0.413 . . . . 0.0 112.089 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.04 132.12 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.15 -0.969 . . . . 0.0 108.809 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 56.1 t30 58.17 30.82 19.95 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -170.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -88.61 167.24 13.54 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 156' ' ' ILE . 12.1 pt -124.6 162.58 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -89.11 82.72 6.57 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -70.95 -12.85 61.77 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -168.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -147.54 135.09 20.88 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.649 1.568 . . . . 0.0 112.679 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -135.45 147.61 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 127.235 2.214 . . . . 0.0 109.516 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.87 132.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.139 1.776 . . . . 0.0 107.376 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.34 133.41 55.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.355 0.662 . . . . 0.0 111.897 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.53 11.1 61.7 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.989 0.804 . . . . 0.0 115.039 -172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.63 -177.12 4.91 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 111.164 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -83.65 179.9 7.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -169.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.0 pt -115.24 136.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.075 1.75 . . . . 0.0 112.168 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -115.8 149.38 38.64 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.142 1.377 . . . . 0.0 111.413 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.49 179.99 30.2 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 122.164 0.869 . . . . 0.0 115.235 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.12 -2.14 87.47 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.627 1.108 . . . . 0.0 115.493 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -25.17 43.73 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 118.965 1.383 . . . . 0.0 115.095 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -143.5 164.83 29.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.89 164.34 16.68 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.469 1.908 . . . . 0.0 110.441 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.32 -11.53 25.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.468 2.778 . . . . 0.0 117.492 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.15 16.1 60.47 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.042 0.829 . . . . 0.0 114.575 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mmt 60.8 27.1 16.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.394 1.877 . . . . 0.0 113.16 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.49 126.92 33.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.915 1.286 . . . . 0.0 109.561 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.49 127.55 33.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 124.017 1.865 . . . . 0.0 111.002 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -71.23 174.83 5.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 110.494 -3.048 . . . . 0.0 114.95 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 47.79 1.55 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.649 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.5 p -69.75 119.56 14.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.493 1.117 . . . . 0.0 112.308 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -132.82 173.41 11.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.748 2.419 . . . . 0.0 111.377 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 44.61 73.43 0.97 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.829 1.652 . . . . 0.0 114.359 169.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.83 144.5 26.68 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.78 2.987 . . . . 0.0 113.523 171.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.18 150.96 6.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.197 1.799 . . . . 0.0 107.993 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 151.93 26.96 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.269 0.627 . . . . 0.0 110.049 169.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -74.7 116.48 15.45 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.89 -77.87 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.088 0.555 . . . . 0.0 110.08 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.66 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.934 3.293 . . . . 0.0 118.202 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -75.05 27.51 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.395 2.278 . . . . 0.0 114.327 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.33 -5.57 18.99 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.379 2.272 . . . . 0.0 113.961 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.04 82.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 115.379 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.47 155.65 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.354 1.077 . . . . 0.0 112.527 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.01 154.0 51.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -90.79 62.05 4.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.083 1.753 . . . . 0.0 112.059 -169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.6 p -96.72 169.07 10.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.75 0.82 . . . . 0.0 111.768 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -54.02 127.42 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.667 1.187 . . . . 0.0 111.268 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.84 29.23 55.17 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.78 1.181 . . . . 0.0 114.66 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.5 p -115.35 159.16 21.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.472 1.636 . . . . 0.0 112.912 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.87 137.22 52.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.976 0.893 . . . . 0.0 113.152 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.53 161.57 36.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.973 0.892 . . . . 0.0 111.693 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 138.48 31.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.242 1.417 . . . . 0.0 111.71 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.73 137.34 35.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.984 0.914 . . . . 0.0 112.45 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -81.15 155.93 25.97 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.431 1.492 . . . . 0.0 112.264 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -80.41 -55.15 5.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.191 0.996 . . . . 0.0 111.065 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -154.55 -54.87 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.475 1.51 . . . . 0.0 110.975 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.5 79.88 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.9 0.88 . . . . 0.0 111.318 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.29 -22.81 74.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.552 2.168 . . . . 0.0 114.292 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.72 37.05 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.692 1.597 . . . . 0.0 112.303 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.4 p -114.42 23.96 12.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.462 1.505 . . . . 0.0 113.691 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.25 97.79 9.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 109.173 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -83.57 -69.34 0.64 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.735 1.214 . . . . 0.0 111.868 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.44 -14.1 1.98 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 113.249 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -74.06 141.56 45.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.228 1.013 . . . . 0.0 111.821 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -141.75 168.17 20.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.093 2.157 . . . . 0.0 111.047 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 13.1 p90 -145.96 162.65 37.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.055 0.942 . . . . 0.0 111.638 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -116.57 118.85 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.583 1.153 . . . . 0.0 108.311 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -71.71 98.89 2.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.414 0.686 . . . . 0.0 109.737 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -75.2 -17.47 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 113.318 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.6 167.19 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 128.537 2.735 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -75.65 115.5 15.39 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.712 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -125.0 55.65 1.36 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.116 1.766 . . . . 0.0 111.991 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.08 -16.01 60.82 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -66.54 -14.45 62.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.83 -1.169 . . . . 0.0 113.45 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.4 mt -82.23 -9.07 59.63 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.621 1.169 . . . . 0.0 113.607 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -71.64 -178.74 2.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.155 1.382 . . . . 0.0 114.363 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -83.65 144.31 29.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.145 1.378 . . . . 0.0 113.107 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.526 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 61.3 p -104.46 -63.06 1.25 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.833 1.653 . . . . 0.0 112.911 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.016 0 C-N-CA 125.316 1.436 . . . . 0.0 112.836 -170.229 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.526 ' N ' ' HG ' ' A' ' 111' ' ' SER . 17.7 p-90 . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.13 -100.5 2.01 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.224 1.392 . . . . 0.0 114.857 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.32 141.65 51.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.116 1.366 . . . . 0.0 111.643 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 36.3 t -79.49 126.98 31.56 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.944 -0.473 . . . . 0.0 112.159 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.88 94.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -81.88 -14.41 56.24 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.301 0.64 . . . . 0.0 111.939 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 176.88 8.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.41 1.1 . . . . 0.0 113.88 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -139.76 153.78 47.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.447 1.099 . . . . 0.0 112.647 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.03 140.18 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.599 0.714 . . . . 0.0 110.132 170.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.62 -42.28 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.091 1.756 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -144.72 155.26 43.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.552 1.541 . . . . 0.0 109.771 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.67 15.78 28.33 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 123.878 0.752 . . . . 0.0 113.964 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -34.95 67.87 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.761 1.28 . . . . 0.0 112.319 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.69 -29.41 69.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.581 0.753 . . . . 0.0 112.657 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.37 -42.63 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.229 1.412 . . . . 0.0 110.278 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.96 -39.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.957 . . . . 0.0 111.357 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.42 -21.24 61.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.689 1.596 . . . . 0.0 112.71 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -86.32 -43.72 12.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.769 1.628 . . . . 0.0 111.447 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.16 -29.1 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.416 1.486 . . . . 0.0 112.585 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -81.29 -16.49 52.34 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.91 -2.35 11.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.311 1.434 . . . . 0.0 114.544 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.82 -55.07 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.039 1.419 . . . . 0.0 112.012 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 177.93 148.4 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.686 1.995 . . . . 0.0 111.258 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 p -121.66 149.86 42.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.348 1.459 . . . . 0.0 112.947 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 C-N-CA 124.875 1.226 . . . . 0.0 112.141 175.511 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.4 130.49 23.93 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.088 1.192 . . . . 0.0 109.364 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -26.6 30.7 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.87 140.8 42.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.62 0.768 . . . . 0.0 109.418 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.38 109.83 17.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.419 0.628 . . . . 0.0 110.78 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.95 107.51 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.63 142.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 124.417 1.087 . . . . 0.0 111.446 -170.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.25 103.41 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.68 -37.72 62.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.21 0.604 . . . . 0.0 110.831 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 t -152.32 165.77 33.91 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 t -138.86 141.6 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.945 1.698 . . . . 0.0 110.641 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -134.0 126.1 29.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.022 1.329 . . . . 0.0 110.087 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.84 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -115.4 150.23 36.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.299 1.44 . . . . 0.0 112.412 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.429 1.492 . . . . 0.0 113.614 -169.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.17 126.39 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -97.97 124.91 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.939 1.296 . . . . 0.0 109.892 173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.95 121.69 42.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 109.974 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -97.2 108.76 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -120.16 159.61 24.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -68.54 -8.57 42.67 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.9 p80 -109.17 -25.28 10.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 113.677 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.74 145.16 4.12 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.479 1.99 . . . . 0.0 113.402 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.7 133.74 36.54 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.268 -1.136 . . . . 0.0 112.672 172.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.12 143.38 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.95 1.7 . . . . 0.0 109.252 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.8 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.308 1.043 . . . . 0.0 110.239 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.71 139.56 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.698 1.999 . . . . 0.0 110.265 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -104.09 124.55 49.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 108.132 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -85.87 148.81 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 111.547 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -106.89 73.41 0.94 Allowed 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.78 1.276 . . . . 0.0 111.608 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.72 -26.49 64.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.413 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.5 -27.14 51.75 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.327 1.051 . . . . 0.0 111.412 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -99.31 -24.64 14.76 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.213 1.405 . . . . 0.0 112.922 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.48 57.77 2.26 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.404 1.082 . . . . 0.0 113.162 -169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.66 -44.38 26.76 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.232 2.621 . . . . 0.0 112.906 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -71.95 -39.78 69.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.756 0.707 . . . . 0.0 111.38 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -64.04 -47.54 79.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 111.215 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.26 -42.37 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.612 0.765 . . . . 0.0 111.595 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -54.89 -47.42 74.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.764 1.166 . . . . 0.0 111.967 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -71.18 -36.01 71.82 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.339 0.518 . . . . 0.0 112.032 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.63 -48.88 79.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.134 0.974 . . . . 0.0 111.611 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.64 -36.05 73.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.4 -0.812 . . . . 0.0 111.826 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -58.67 -35.32 72.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.586 0.755 . . . . 0.0 112.338 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.394 -0.816 . . . . 0.0 111.958 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -58.84 -38.11 77.97 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.665 -0.647 . . . . 0.0 111.808 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -65.69 -35.83 81.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.053 2.141 . . . . 0.0 112.703 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -81.63 -16.02 52.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.704 0.802 . . . . 0.0 113.107 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.29 20.24 60.92 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.295 0.95 . . . . 0.0 113.215 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.12 -38.47 76.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.371 1.068 . . . . 0.0 113.179 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -82.12 -7.75 59.63 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.044 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.53 130.35 42.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.2 t30 55.08 46.78 23.39 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 114.262 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.6 p -110.62 162.51 14.66 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.301 1.04 . . . . 0.0 111.489 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 9.2 pt -122.72 161.85 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -86.45 81.85 8.16 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.843 1.257 . . . . 0.0 107.609 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -71.96 -7.96 51.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -146.0 135.22 22.83 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.55 1.523 . . . . 0.0 112.183 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.61 143.48 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.784 2.034 . . . . 0.0 110.556 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.35 129.72 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.853 1.661 . . . . 0.0 108.135 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -62.96 129.35 39.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.538 0.735 . . . . 0.0 111.65 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.61 10.48 67.14 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -142.49 -177.19 5.16 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.152 1.781 . . . . 0.0 110.765 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -81.71 178.82 8.11 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -169.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.29 135.81 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.679 1.591 . . . . 0.0 112.17 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -110.29 150.85 28.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.728 1.211 . . . . 0.0 111.206 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.68 175.79 33.42 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.33 2.9 85.06 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.329 1.442 . . . . 0.0 115.411 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.14 -26.14 49.45 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 118.953 1.377 . . . . 0.0 114.509 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.11 164.62 30.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.256 1.022 . . . . 0.0 113.396 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -97.41 164.59 17.36 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.768 1.627 . . . . 0.0 110.145 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -61.27 -15.26 39.1 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.51 2.807 . . . . 0.0 118.196 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.22 16.68 58.23 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.887 0.756 . . . . 0.0 114.284 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.6 mmm 58.1 37.85 26.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.818 2.047 . . . . 0.0 113.331 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -83.25 123.06 29.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.919 1.288 . . . . 0.0 109.122 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.41 119.94 17.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 124.196 1.951 . . . . 0.0 110.337 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.62 179.7 1.64 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 110.332 -3.122 . . . . 0.0 114.513 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 61.66 6.75 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.166 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -69.48 106.43 2.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.179 1.392 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.65 168.27 20.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.806 2.043 . . . . 0.0 111.995 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 49.12 61.35 14.17 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 113.007 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.4 129.85 36.88 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.731 2.954 . . . . 0.0 111.507 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.95 153.23 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.209 1.804 . . . . 0.0 108.154 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 162.66 18.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 112.19 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -76.5 123.07 25.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.796 0.838 . . . . 0.0 110.943 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.13 15.22 22.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.0 112.89 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -12.38 58.52 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.618 -1.301 . . . . 0.0 114.288 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -62.88 6.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 114.438 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -77.46 -11.54 59.86 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.134 1.774 . . . . 0.0 113.211 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.92 69.34 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.737 1.161 . . . . 0.0 114.891 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.39 156.93 26.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.882 1.341 . . . . 0.0 112.936 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -125.51 149.65 48.11 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -89.31 66.5 7.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 111.417 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.0 p -95.07 163.87 13.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.537 0.735 . . . . 0.0 111.514 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 124.88 15.74 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.765 0.793 . . . . 0.0 111.33 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.11 46.32 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.374 1.464 . . . . 0.0 115.391 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.0 p -115.17 160.37 19.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.627 1.713 . . . . 0.0 113.536 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.31 134.64 55.1 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -131.68 157.41 43.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.346 0.658 . . . . 0.0 111.381 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 35.7 mtp -84.23 138.1 33.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.223 -0.298 . . . . 0.0 111.061 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.52 155.83 17.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.161 0.985 . . . . 0.0 111.381 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -117.17 164.42 14.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.491 1.116 . . . . 0.0 113.2 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.8 m -76.66 -58.33 3.34 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.195 0.998 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -152.89 -58.31 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.991 1.716 . . . . 0.0 110.879 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.12 156.87 79.07 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.864 1.265 . . . . 0.0 112.047 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.66 -26.09 71.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.48 2.787 . . . . 0.0 114.249 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -108.18 33.37 4.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.507 1.523 . . . . 0.0 112.758 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -118.55 28.82 8.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.452 1.501 . . . . 0.0 113.693 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.13 106.28 18.26 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.732 1.613 . . . . 0.0 109.427 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.5 p -94.0 -69.02 0.77 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 0.0 113.139 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.81 -24.84 2.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.5 mp0 -67.06 140.58 57.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.528 1.131 . . . . 0.0 111.27 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -136.83 168.39 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.123 1.769 . . . . 0.0 110.358 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.9 p90 -143.23 162.04 36.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.247 0.619 . . . . 0.0 111.552 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.3 mt -114.38 118.89 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -70.12 96.76 1.1 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -73.71 -17.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.299 -0.876 . . . . 0.0 113.117 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -134.47 165.72 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 128.259 2.624 . . . . 0.0 110.78 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.57 116.58 14.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.758 0.823 . . . . 0.0 111.549 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -123.42 63.41 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.371 1.468 . . . . 0.0 112.535 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -52.34 -35.16 50.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.342 1.457 . . . . 0.0 114.327 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -65.61 -13.72 59.67 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.85 -9.05 58.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -74.01 -178.86 3.48 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -171.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -78.89 150.82 32.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.34 1.456 . . . . 0.0 112.839 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -127.48 -39.92 1.82 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.244 0 CA-C-N 118.944 0.793 . . . . 0.0 114.205 -177.683 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.286 5.4 p-90 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.55 -105.98 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.928 1.728 . . . . 0.0 114.86 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.24 141.06 51.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.533 1.533 . . . . 0.0 111.672 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -85.15 124.58 31.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -73.59 97.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 108.414 170.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -79.76 -15.94 56.52 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.544 0.737 . . . . 0.0 111.656 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.83 8.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.567 1.175 . . . . 0.0 113.843 -170.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -139.95 153.71 46.99 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.563 -1.335 . . . . 0.0 112.466 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.46 137.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.723 0.773 . . . . 0.0 109.924 170.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.13 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.331 1.852 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -141.74 148.65 39.35 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.521 1.528 . . . . 0.0 110.031 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.89 13.2 20.63 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.944 0.783 . . . . 0.0 114.87 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 69.5 mmm -54.69 -38.06 66.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.405 1.602 . . . . 0.0 112.377 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.76 -29.04 70.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.049 0.94 . . . . 0.0 112.439 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.98 -43.55 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.689 1.596 . . . . 0.0 110.336 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.18 -38.4 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.218 1.007 . . . . 0.0 111.198 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.9 -22.26 60.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.585 1.554 . . . . 0.0 112.857 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -81.39 -43.86 18.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.368 1.467 . . . . 0.0 111.395 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.5 mt -55.18 -33.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.097 1.359 . . . . 0.0 112.045 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -85.17 -16.59 39.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.35 12.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.166 1.365 . . . . 0.0 114.268 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.5 m -72.81 -57.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.607 1.203 . . . . 0.0 113.613 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.68 156.51 7.89 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.994 0.917 . . . . 0.0 113.324 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.9 p -141.71 152.13 43.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.392 1.477 . . . . 0.0 111.972 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 C-N-CA 123.114 0.387 . . . . 0.0 113.263 171.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.0 135.36 34.71 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 121.378 1.385 . . . . 0.0 109.548 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -29.59 48.76 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 154.23 22.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 110.636 169.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -84.53 109.61 18.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.998 0.904 . . . . 0.0 111.312 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.19 94.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -123.5 141.67 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -168.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.48 103.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.596 1.958 . . . . 0.0 106.786 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.02 -39.8 60.88 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.614 -0.679 . . . . 0.0 111.119 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -150.07 165.99 31.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -137.97 142.1 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.745 1.618 . . . . 0.0 111.001 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.7 m -136.33 129.59 31.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.766 1.227 . . . . 0.0 110.384 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.74 122.55 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -118.88 150.45 39.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.705 1.602 . . . . 0.0 112.044 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.628 1.171 . . . . 0.0 113.699 -172.331 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.31 124.75 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.97 0.908 . . . . 0.0 109.575 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 125.19 45.95 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.967 0.907 . . . . 0.0 110.314 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -96.87 135.34 38.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.674 1.19 . . . . 0.0 110.6 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -105.82 101.43 10.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -106.36 151.96 24.2 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.075 -0.39 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.83 -8.09 2.82 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -105.38 -10.46 16.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.781 1.232 . . . . 0.0 114.03 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.59 162.16 10.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.124 1.345 . . . . 0.0 113.592 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.21 138.1 45.42 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.667 1.587 . . . . 0.0 112.401 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.6 mt -135.61 140.36 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.299 1.84 . . . . 0.0 108.9 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.77 133.26 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.583 1.153 . . . . 0.0 110.682 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.54 139.16 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.551 1.94 . . . . 0.0 109.909 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -101.5 129.45 47.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.884 2.074 . . . . 0.0 108.452 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -93.43 145.98 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.412 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -103.96 72.08 1.08 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.897 1.332 . . . . 0.0 111.699 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.97 -26.13 63.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.502 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -77.58 -29.43 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.201 1.001 . . . . 0.0 111.698 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.7 -20.74 16.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.943 1.297 . . . . 0.0 113.285 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.65 56.79 1.55 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.516 1.126 . . . . 0.0 113.224 -171.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.18 -45.3 23.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.433 2.756 . . . . 0.0 113.116 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -69.48 -39.73 77.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.784 0.72 . . . . 0.0 111.449 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -63.44 -48.26 78.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.723 0.809 . . . . 0.0 111.24 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.17 -41.23 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.408 0.683 . . . . 0.0 111.512 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -54.42 -48.47 71.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.705 1.139 . . . . 0.0 112.329 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -70.56 -35.99 73.38 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.608 0.64 . . . . 0.0 111.922 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.84 -50.92 71.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.447 1.099 . . . . 0.0 111.418 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 -36.35 73.17 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.697 0.799 . . . . 0.0 111.959 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.89 -34.8 70.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -76.27 -39.19 54.97 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.519 -0.738 . . . . 0.0 112.442 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.45 -35.77 76.64 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.11 -0.994 . . . . 0.0 111.565 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -31.08 71.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.105 1.762 . . . . 0.0 112.763 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.21 -14.31 57.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.225 1.01 . . . . 0.0 113.345 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.52 15.38 62.0 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.69 1.138 . . . . 0.0 114.04 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -68.17 -18.96 64.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.438 1.495 . . . . 0.0 114.689 -171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.78 -13.5 21.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.23 1.71 8.81 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -145.24 49.38 1.26 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.28 1.432 . . . . 0.0 111.055 170.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.9 p -113.57 170.39 8.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.36 162.2 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -103.15 130.93 50.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.647 1.579 . . . . 0.0 107.368 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.96 -40.39 1.51 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -87.66 116.81 26.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.609 1.095 . . . . 0.0 109.627 -175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.03 129.75 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.489 1.516 . . . . 0.0 110.413 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.7 mt -141.47 129.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.021 1.728 . . . . 0.0 107.856 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -65.96 134.94 54.01 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.697 0.799 . . . . 0.0 111.819 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.5 13.5 68.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.811 0.72 . . . . 0.0 114.79 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -142.98 -177.32 5.28 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.903 1.681 . . . . 0.0 111.542 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.58 179.93 6.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.12 1.768 . . . . 0.0 114.975 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.0 pt -120.83 142.63 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -118.19 147.7 43.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 112.225 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.34 -177.6 30.61 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 122.151 0.862 . . . . 0.0 115.216 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.74 -5.82 82.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.362 1.458 . . . . 0.0 115.622 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.01 -16.08 63.8 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 -169.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.05 163.76 34.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.805 1.302 . . . . 0.0 112.366 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.13 163.0 30.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.303 1.041 . . . . 0.0 111.11 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.54 -12.9 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.187 3.258 . . . . 0.0 117.33 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.47 13.55 67.0 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.074 0.845 . . . . 0.0 114.833 172.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.8 mmt 59.71 29.64 19.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.374 1.87 . . . . 0.0 112.868 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -81.24 124.08 29.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.827 1.251 . . . . 0.0 109.197 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -72.97 114.72 11.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.535 0.734 . . . . 0.0 109.88 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -71.99 165.2 24.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.59 73.29 10.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.798 1.639 . . . . 0.0 111.033 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -70.41 129.31 38.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.864 0.866 . . . . 0.0 111.09 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -140.29 172.09 13.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.545 1.938 . . . . 0.0 111.513 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 48.42 62.66 11.71 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.396 1.478 . . . . 0.0 113.127 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -55.87 129.23 33.84 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.125 2.55 . . . . 0.0 110.339 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.63 149.18 4.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 107.536 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 158.45 27.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.691 0.758 . . . . 0.0 111.133 171.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -85.24 131.06 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.334 1.054 . . . . 0.0 111.217 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.36 15.92 17.92 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.224 1.01 . . . . 0.0 112.715 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.01 -11.36 28.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -74.43 40.41 0.13 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.932 1.693 . . . . 0.0 112.173 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -117.88 -3.48 11.18 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.419 2.287 . . . . 0.0 114.006 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.63 4.55 72.96 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.48 1.514 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.91 157.64 20.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.614 1.207 . . . . 0.0 113.124 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.04 158.85 43.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.616 1.166 . . . . 0.0 113.754 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -94.78 102.25 14.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.983 1.713 . . . . 0.0 110.563 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.4 p -133.5 168.03 19.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.787 1.235 . . . . 0.0 111.663 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.95 121.49 7.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.848 1.259 . . . . 0.0 110.692 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.91 24.54 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.503 1.525 . . . . 0.0 114.992 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.4 p -122.31 159.96 26.34 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.38 1.59 . . . . 0.0 113.734 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -122.24 139.49 53.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.836 0.854 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.46 159.24 42.57 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.843 -0.536 . . . . 0.0 111.881 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.9 mmm -78.75 137.7 37.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.919 0.488 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.69 148.85 29.99 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.122 0.569 . . . . 0.0 110.978 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.19 162.55 18.48 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.995 1.318 . . . . 0.0 112.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.6 m -77.37 -55.48 5.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.872 0.869 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.3 -56.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.977 1.311 . . . . 0.0 111.069 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.66 157.27 86.17 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 111.556 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.96 -35.53 94.49 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.869 2.379 . . . . 0.0 113.671 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -98.82 32.62 2.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.965 1.706 . . . . 0.0 113.359 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.5 p -117.24 33.91 5.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.006 1.322 . . . . 0.0 113.426 -173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.12 109.79 21.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.793 1.637 . . . . 0.0 110.186 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 p -94.94 -66.94 0.88 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.264 1.425 . . . . 0.0 113.449 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.67 -22.64 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.52 145.18 47.66 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 120.574 -1.329 . . . . 0.0 112.088 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -140.32 168.22 20.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 127.409 2.283 . . . . 0.0 109.611 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.9 p90 -144.81 159.9 42.13 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.125 0.57 . . . . 0.0 111.703 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.52 117.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 0.0 108.273 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.78 111.44 14.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.642 0.777 . . . . 0.0 110.707 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.13 -6.32 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 m -129.11 165.06 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.895 1.678 . . . . 0.0 111.154 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -80.27 117.4 21.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.89 0.476 . . . . 0.0 109.917 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -142.14 63.92 1.4 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.019 1.39 . . . . 0.0 111.822 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.31 -13.52 60.64 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -172.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.88 -14.03 41.41 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.689 -1.257 . . . . 0.0 113.427 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.01 -10.51 59.78 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.53 1.132 . . . . 0.0 113.729 173.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -75.44 -176.45 3.18 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -82.1 143.7 31.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.693 1.597 . . . . 0.0 112.288 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.4 p -108.62 -59.28 1.89 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.499 1.119 . . . . 0.0 113.631 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.238 0 C-N-CA 124.081 0.848 . . . . 0.0 114.161 -172.708 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.288 8.3 p-90 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.7 -98.54 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.629 1.585 . . . . 0.0 116.506 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -126.31 139.83 53.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.957 1.303 . . . . 0.0 111.809 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.94 122.85 28.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.878 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.75 89.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.551 1.14 . . . . 0.0 108.182 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.43 -15.22 59.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.369 0.667 . . . . 0.0 112.36 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.72 175.8 9.39 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -138.11 152.65 48.96 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.965 -1.085 . . . . 0.0 112.458 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.37 139.63 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.542 0.687 . . . . 0.0 110.476 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.95 -43.34 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.388 1.475 . . . . 0.0 111.165 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -145.96 154.02 41.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.379 1.472 . . . . 0.0 110.339 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.88 15.06 29.8 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.009 0.814 . . . . 0.0 113.395 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 23.0 mtp -57.84 -34.64 69.93 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.65 1.18 . . . . 0.0 111.938 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.55 -31.44 72.5 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.921 0.888 . . . . 0.0 112.407 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t -72.16 -43.12 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.444 1.097 . . . . 0.0 109.89 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.585 -0.697 . . . . 0.0 111.001 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.44 -26.38 61.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.82 1.248 . . . . 0.0 112.644 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -78.32 -41.39 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.054 1.342 . . . . 0.0 110.978 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mt -55.7 -30.1 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.447 1.899 . . . . 0.0 112.772 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -92.76 -11.1 34.71 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.04 -11.95 13.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.509 1.528 . . . . 0.0 114.413 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.16 -59.32 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.572 1.186 . . . . 0.0 112.799 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.94 143.22 0.93 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 112.431 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.0 p -112.07 148.75 33.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.435 1.494 . . . . 0.0 112.587 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 CA-C-O 123.198 1.444 . . . . 0.0 113.7 174.035 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.87 137.66 45.83 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 121.66 1.573 . . . . 0.0 109.858 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -27.64 43.04 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.768 -0.582 . . . . 0.0 112.281 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.72 140.71 44.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 109.635 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -84.22 130.44 34.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.67 0.748 . . . . 0.0 109.836 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.15 109.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.329 1.452 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.89 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.384 1.074 . . . . 0.0 111.566 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 mt -84.07 103.83 11.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.75 -28.35 60.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.2 t -163.89 169.53 18.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.38 140.07 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.496 1.919 . . . . 0.0 110.416 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.8 m -130.04 124.96 34.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 109.891 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.68 123.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -115.58 150.39 36.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.808 1.243 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.775 1.63 . . . . 0.0 113.413 -169.812 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.69 127.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.236 -0.915 . . . . 0.0 109.545 169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -102.35 120.92 41.3 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 110.119 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.7 132.12 41.23 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 110.843 169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -104.51 101.42 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -106.42 152.21 23.91 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.066 -0.396 . . . . 0.0 111.193 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.48 -9.77 4.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.93 -7.55 19.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 0.0 114.027 170.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.29 166.69 12.26 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.864 1.697 . . . . 0.0 113.683 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.09 137.6 41.53 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.097 1.759 . . . . 0.0 113.044 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -133.09 141.15 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.586 1.954 . . . . 0.0 108.971 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.49 135.78 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.457 1.103 . . . . 0.0 110.359 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 mt -122.98 139.84 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 126.339 1.855 . . . . 0.0 110.162 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -107.21 123.57 48.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.168 1.787 . . . . 0.0 109.113 172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.0 p -87.85 148.1 24.81 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.486 1.115 . . . . 0.0 111.914 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -105.73 73.66 1.02 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 122.655 1.217 . . . . 0.0 111.209 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.31 -26.06 64.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.581 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.99 -24.45 47.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.327 1.051 . . . . 0.0 111.595 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.2 -21.98 13.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.342 1.457 . . . . 0.0 112.862 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.65 55.59 1.81 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.199 1.4 . . . . 0.0 112.982 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.64 -43.77 30.53 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.509 2.806 . . . . 0.0 112.762 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -69.54 -40.09 77.08 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.006 0.821 . . . . 0.0 111.055 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -63.57 -49.37 73.68 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.947 0.499 . . . . 0.0 111.423 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.23 -38.05 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.399 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -55.74 -50.43 70.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.503 1.047 . . . . 0.0 111.433 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.6 -48.28 82.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.914 1.286 . . . . 0.0 111.199 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.17 -50.52 73.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 111.171 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -73.12 -36.07 66.67 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.524 0.73 . . . . 0.0 111.654 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -58.8 -36.33 74.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.949 0.5 . . . . 0.0 111.601 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 2.9 m-85 -77.75 -39.36 44.58 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 76.1 m -61.48 -36.33 80.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.967 . . . . 0.0 111.46 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -34.2 77.07 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 112.765 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.21 -14.06 57.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.367 1.067 . . . . 0.0 113.404 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.09 16.91 62.04 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.871 1.224 . . . . 0.0 114.258 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 45.9 t80 -71.81 -17.59 62.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -93.74 -12.81 28.36 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.98 2.94 7.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -146.12 43.92 1.23 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.229 1.412 . . . . 0.0 111.357 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 p -104.8 169.45 8.44 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.262 -0.899 . . . . 0.0 112.923 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 156' ' ' ILE . 20.8 pt -127.85 163.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -89.29 119.16 29.51 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -93.08 -30.52 15.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.46 1.504 . . . . 0.0 114.289 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -133.99 138.93 45.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.997 0.919 . . . . 0.0 112.389 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.83 133.6 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 127.292 2.237 . . . . 0.0 109.699 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.2 mt -138.65 130.15 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.169 1.788 . . . . 0.0 107.891 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -63.58 135.6 56.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.439 0.696 . . . . 0.0 111.875 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.56 9.97 62.74 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -141.85 -177.09 5.03 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.439 1.896 . . . . 0.0 110.975 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.13 -178.16 5.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.961 1.704 . . . . 0.0 115.42 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 pt -121.3 136.05 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 112.559 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -116.5 149.92 38.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.429 1.092 . . . . 0.0 112.124 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.6 -179.77 36.5 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.42 1.328 . . . . 0.0 116.42 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.08 -12.16 68.58 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.668 1.604 . . . . 0.0 115.979 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.5 -15.17 69.19 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.881 1.513 . . . . 0.0 116.881 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.04 166.22 25.23 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.033 1.417 . . . . 0.0 112.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.13 163.17 20.51 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.87 1.668 . . . . 0.0 111.239 169.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.49 -13.89 27.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.051 3.167 . . . . 0.0 118.301 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.37 14.46 65.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.936 0.779 . . . . 0.0 114.677 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 mmm 57.77 38.66 27.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.776 1.63 . . . . 0.0 112.733 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.55 126.44 36.64 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.433 1.493 . . . . 0.0 109.493 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -73.44 118.46 16.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.848 0.859 . . . . 0.0 110.346 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -73.36 166.5 23.08 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.32 73.96 5.94 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.945 1.698 . . . . 0.0 111.671 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 p -68.76 122.72 19.16 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.621 1.168 . . . . 0.0 111.71 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -137.81 170.12 16.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 111.226 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 48.23 61.15 14.39 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.327 1.451 . . . . 0.0 113.386 169.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.08 139.29 89.93 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.698 2.932 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.41 148.24 6.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.457 1.503 . . . . 0.0 107.968 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 155.99 19.63 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.771 0.828 . . . . 0.0 110.843 170.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -71.71 126.1 28.83 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -107.47 11.38 28.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.79 1.236 . . . . 0.0 113.013 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -12.62 45.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -171.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.56 0.94 0.26 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.406 1.482 . . . . 0.0 113.944 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -72.25 -11.26 60.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.791 1.236 . . . . 0.0 112.939 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.61 7.59 85.91 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.305 1.431 . . . . 0.0 114.695 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.69 153.25 38.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.464 1.132 . . . . 0.0 112.226 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -130.63 151.57 50.94 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -93.45 99.52 11.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 110.921 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.2 p -129.96 168.21 17.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.555 1.142 . . . . 0.0 111.496 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 124.9 18.57 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.71 1.204 . . . . 0.0 110.976 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.61 46.99 8.27 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.537 1.065 . . . . 0.0 113.807 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.8 p -134.75 163.36 29.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 118.304 1.052 . . . . 0.0 112.942 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.36 139.08 54.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.817 . . . . 0.0 112.997 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.7 159.86 40.56 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.086 0.47 . . . . 0.0 111.731 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -82.88 141.13 32.45 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.687 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.01 162.0 14.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.188 0.995 . . . . 0.0 111.025 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -137.4 158.74 43.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.212 1.405 . . . . 0.0 112.274 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 m -72.35 -54.94 8.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.46 1.104 . . . . 0.0 111.661 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.87 -49.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.113 1.365 . . . . 0.0 112.425 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 156.1 77.77 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.594 1.158 . . . . 0.0 111.21 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.01 -27.72 80.44 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.081 2.521 . . . . 0.0 113.653 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -109.34 35.63 3.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.514 1.526 . . . . 0.0 112.515 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -118.07 31.82 6.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.517 1.527 . . . . 0.0 113.671 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.54 105.14 17.22 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.009 1.724 . . . . 0.0 109.038 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.2 p -97.57 -45.39 6.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.37 12.59 0.23 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -104.96 139.72 39.25 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.358 -1.464 . . . . 0.0 111.489 -169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -141.51 168.42 19.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.051 1.74 . . . . 0.0 111.527 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.7 p90 -147.79 162.08 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.97 117.79 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.744 1.218 . . . . 0.0 108.783 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -76.57 100.8 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.861 0.864 . . . . 0.0 110.596 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.78 -19.27 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.81 167.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.812 1.645 . . . . 0.0 111.761 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.81 120.7 24.44 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.964 -0.46 . . . . 0.0 110.092 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -146.2 62.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 123.001 1.381 . . . . 0.0 111.937 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.64 -13.23 58.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -62.76 -13.91 38.55 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.507 -1.371 . . . . 0.0 113.381 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.25 -9.26 59.72 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.583 1.153 . . . . 0.0 113.821 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -73.8 179.91 3.99 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -81.0 145.89 30.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.348 1.459 . . . . 0.0 112.257 169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.3 p -115.8 -59.34 2.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.581 1.152 . . . . 0.0 113.613 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.008 0 C-N-CA 124.17 0.891 . . . . 0.0 114.028 -172.875 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.282 7.2 p-90 . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.33 -93.42 1.13 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.316 1.436 . . . . 0.0 114.834 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.21 142.27 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.259 1.424 . . . . 0.0 111.721 -169.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.22 127.41 34.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.2 92.27 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.597 1.159 . . . . 0.0 108.22 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -80.38 -14.92 57.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.857 0.863 . . . . 0.0 112.031 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.98 8.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.335 1.064 . . . . 0.0 113.252 -170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -138.94 149.98 45.38 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.842 -1.161 . . . . 0.0 112.041 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 p -78.8 134.99 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.424 0.63 . . . . 0.0 110.464 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.96 -41.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.326 1.85 . . . . 0.0 110.736 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -143.98 155.81 44.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.667 1.587 . . . . 0.0 109.853 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.21 16.79 26.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.754 0.692 . . . . 0.0 114.734 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.05 -32.91 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.371 1.585 . . . . 0.0 112.437 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.66 -29.06 68.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.574 0.75 . . . . 0.0 112.684 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.06 -38.55 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.533 1.533 . . . . 0.0 110.463 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.6 -41.4 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.8 -1.188 . . . . 0.0 110.658 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.7 -30.6 70.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.134 1.373 . . . . 0.0 111.652 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.98 -46.89 61.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.51 0.724 . . . . 0.0 111.12 173.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 98.6 mt -68.73 -25.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.993 1.317 . . . . 0.0 112.142 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -85.13 -17.62 36.69 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.883 -1.136 . . . . 0.0 113.864 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.67 -8.73 54.14 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.058 1.79 . . . . 0.0 115.181 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -26.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 83.55 164.59 0.12 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.357 2.263 . . . . 0.0 114.663 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.2 p -114.27 151.5 32.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.909 1.683 . . . . 0.0 113.599 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.905 0 C-N-CA 125.032 1.301 . . . . 0.0 110.688 169.575 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -60.3 140.04 89.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.887 1.725 . . . . 0.0 110.761 169.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -32.38 62.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.62 150.18 31.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.726 0.774 . . . . 0.0 111.198 169.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.95 110.01 16.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 110.617 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.38 106.24 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.143 0.977 . . . . 0.0 108.372 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.74 142.2 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.652 1.181 . . . . 0.0 112.176 -169.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mt -84.36 103.87 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.78 -30.96 59.29 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.536 1.134 . . . . 0.0 111.533 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 p -162.76 171.47 16.73 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -135.52 143.75 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.329 1.452 . . . . 0.0 110.786 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -132.79 130.28 39.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.351 1.46 . . . . 0.0 109.764 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.66 125.46 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.1 t -121.15 150.5 41.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.588 1.555 . . . . 0.0 111.838 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.356 1.062 . . . . 0.0 112.999 -179.872 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.504 2.258 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -129.75 130.47 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 120.846 -1.159 . . . . 0.0 110.273 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.1 m -101.07 127.11 47.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.493 1.117 . . . . 0.0 110.235 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -101.66 124.03 46.63 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.778 1.231 . . . . 0.0 110.054 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.53 106.64 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.5 p -117.55 160.12 21.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.303 0.573 . . . . 0.0 112.114 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -68.5 -7.88 36.14 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.474 ' CE1' HD11 ' A' ' 136' ' ' ILE . 21.2 p80 -111.24 -25.69 9.56 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.522 . . . . 0.0 113.591 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.48 144.95 4.09 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.164 1.84 . . . . 0.0 113.538 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.96 133.6 38.06 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.383 1.073 . . . . 0.0 112.38 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -130.86 144.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.788 1.635 . . . . 0.0 109.379 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.4 136.79 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.274 1.03 . . . . 0.0 110.517 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -126.38 139.83 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.888 2.075 . . . . 0.0 110.189 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -102.46 127.69 49.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.69 1.996 . . . . 0.0 107.753 171.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -88.79 147.63 24.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.162 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -104.48 74.11 1.15 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.695 1.236 . . . . 0.0 111.391 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.69 -27.52 65.08 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.212 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.87 -31.37 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.528 1.131 . . . . 0.0 111.529 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -96.39 -24.51 16.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.6 1.16 . . . . 0.0 113.066 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.1 61.36 4.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.662 0.785 . . . . 0.0 112.971 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.37 -45.07 15.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.201 2.601 . . . . 0.0 112.583 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -69.48 -39.97 77.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.858 0.754 . . . . 0.0 111.13 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.482 ' HA ' HD13 ' A' ' 68' ' ' ILE . 20.4 m -63.23 -48.19 79.29 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.739 0.816 . . . . 0.0 111.249 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.26 -41.81 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.409 0.684 . . . . 0.0 111.803 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.26 -47.87 74.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.72 1.146 . . . . 0.0 112.129 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -37.11 73.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.097 0.559 . . . . 0.0 111.813 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.75 -49.0 79.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.333 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.78 -37.09 70.5 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.591 0.757 . . . . 0.0 111.821 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.094 0.558 . . . . 0.0 112.436 172.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.81 -41.83 59.2 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.438 -0.789 . . . . 0.0 112.522 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.21 -37.33 79.95 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.424 -0.797 . . . . 0.0 111.51 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.82 -35.04 78.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.803 2.041 . . . . 0.0 112.788 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -82.65 -13.15 56.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.023 0.929 . . . . 0.0 113.39 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.49 19.43 64.12 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.481 1.039 . . . . 0.0 114.154 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.53 -17.61 64.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.073 1.349 . . . . 0.0 114.524 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.49 -4.28 45.22 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.342 -0.848 . . . . 0.0 113.211 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -67.85 136.7 54.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 109.405 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.7 t30 49.29 46.35 23.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.829 1.652 . . . . 0.0 114.211 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -103.77 161.6 13.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.506 0.722 . . . . 0.0 111.921 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 13.7 pt -122.48 162.2 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -169.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -94.79 114.92 26.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.071 1.349 . . . . 0.0 107.945 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.96 1.11 14.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -134.22 133.55 41.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.333 1.424 . . . . 0.0 110.43 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.13 133.64 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.127 1.371 . . . . 0.0 111.125 170.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.41 130.48 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.988 1.715 . . . . 0.0 108.186 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -63.83 134.62 55.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.712 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.45 68.86 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.741 0.686 . . . . 0.0 114.667 -173.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.07 -177.19 5.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.234 1.813 . . . . 0.0 111.266 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.76 179.73 6.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.384 1.874 . . . . 0.0 114.974 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 pt -119.58 139.52 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.106 1.363 . . . . 0.0 112.317 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.4 148.74 33.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.874 1.27 . . . . 0.0 111.121 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.01 -176.41 33.09 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 115.259 0.864 . . . . 0.0 115.259 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.52 24.15 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.44 1.495 . . . . 0.0 115.252 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.56 -14.61 75.61 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.1 1.333 . . . . 0.0 115.689 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -141.5 167.66 21.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.721 1.208 . . . . 0.0 112.944 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -107.87 156.07 38.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.267 2.227 . . . . 0.0 109.329 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.83 128.8 31.44 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.102 2.535 . . . . 0.0 112.956 -170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.31 15.94 36.53 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.598 1.57 . . . . 0.0 113.505 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmm 61.66 37.44 15.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.241 1.416 . . . . 0.0 112.26 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.77 118.3 21.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.695 1.198 . . . . 0.0 108.882 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.59 126.35 29.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.491 0.663 . . . . 0.0 111.213 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -78.74 167.45 21.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.217 1.007 . . . . 0.0 113.366 171.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.47 75.1 5.19 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.833 1.653 . . . . 0.0 110.768 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.8 p -73.4 134.95 44.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.134 0.974 . . . . 0.0 111.842 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -138.68 171.93 13.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.941 2.096 . . . . 0.0 112.0 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 51.88 66.48 5.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.616 1.566 . . . . 0.0 113.365 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.27 136.06 69.75 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.297 2.665 . . . . 0.0 111.405 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -111.74 150.69 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.475 1.51 . . . . 0.0 109.413 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 157.66 21.77 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.915 0.486 . . . . 0.0 111.969 175.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -71.54 131.24 42.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.472 0.709 . . . . 0.0 110.131 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -117.44 13.58 14.47 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.054 1.342 . . . . 0.0 111.961 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.8 63.37 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.571 -1.331 . . . . 0.0 113.739 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -60.72 4.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.613 1.965 . . . . 0.0 115.914 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -84.67 4.23 33.49 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.876 1.67 . . . . 0.0 111.808 168.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.65 28.04 27.88 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.204 1.383 . . . . 0.0 113.961 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.58 143.43 40.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.002 0.921 . . . . 0.0 112.771 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.51 156.3 48.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.747 1.219 . . . . 0.0 113.702 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -110.83 110.78 21.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.598 2.359 . . . . 0.0 109.778 -171.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 p -137.65 171.65 14.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.43 1.092 . . . . 0.0 110.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -47.85 120.26 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.54 1.136 . . . . 0.0 111.362 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.03 21.5 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.717 1.151 . . . . 0.0 114.949 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.1 p -121.95 160.51 24.68 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.669 1.235 . . . . 0.0 112.937 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.15 136.49 54.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.686 0.794 . . . . 0.0 112.828 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.61 159.15 42.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.886 -0.509 . . . . 0.0 111.948 172.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 97.5 mmm -82.39 134.8 35.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.852 0.461 . . . . 0.0 110.86 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.12 154.51 21.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.244 1.018 . . . . 0.0 110.3 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -120.74 158.25 27.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.363 1.065 . . . . 0.0 113.034 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.8 m -69.27 -56.49 7.4 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.905 0.882 . . . . 0.0 110.73 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -150.69 -56.09 0.16 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.806 1.642 . . . . 0.0 110.23 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.51 157.34 72.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.947 1.299 . . . . 0.0 112.401 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -56.54 -25.77 60.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.683 2.922 . . . . 0.0 113.999 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -107.53 36.62 2.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.57 1.548 . . . . 0.0 112.687 -177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -126.74 28.03 5.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.27 1.428 . . . . 0.0 113.905 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.7 76.51 4.95 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.423 1.489 . . . . 0.0 112.469 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -70.19 -60.38 2.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.816 1.247 . . . . 0.0 114.233 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.21 -8.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -169.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -81.21 140.52 34.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.729 -1.232 . . . . 0.0 109.694 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -140.47 168.33 20.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.88 1.672 . . . . 0.0 111.251 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 19.7 p90 -146.81 161.73 40.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.657 0.783 . . . . 0.0 111.966 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.34 116.94 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.49 1.116 . . . . 0.0 108.537 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.72 98.15 4.02 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 110.689 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 -24.86 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 113.066 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.71 168.94 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.479 1.512 . . . . 0.0 112.024 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.41 120.51 23.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.732 1.213 . . . . 0.0 110.371 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -142.22 74.73 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.204 1.478 . . . . 0.0 112.209 -170.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.77 -34.93 70.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.894 2.077 . . . . 0.0 114.094 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.46 -13.17 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.46 -11.62 58.39 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -72.64 172.23 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.71 155.45 40.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.588 1.155 . . . . 0.0 112.107 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -139.65 -55.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.317 0 N-CA-C 116.769 1.467 . . . . 0.0 116.769 -177.191 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.258 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.92 -72.68 0.9 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.112 1.339 . . . . 0.0 115.378 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -139.68 150.1 44.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.04 1.336 . . . . 0.0 111.843 -169.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.6 t -87.98 120.35 29.23 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.647 -0.658 . . . . 0.0 112.543 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -77.52 82.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.253 1.421 . . . . 0.0 108.537 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -74.38 -14.52 60.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.024 0.929 . . . . 0.0 112.419 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.99 177.84 8.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.567 1.175 . . . . 0.0 113.904 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.79 153.9 47.24 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.888 -1.132 . . . . 0.0 112.606 172.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.09 141.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.711 0.767 . . . . 0.0 110.201 172.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.81 -40.2 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.786 1.634 . . . . 0.0 111.107 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -144.81 148.89 34.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.345 1.458 . . . . 0.0 110.674 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.88 10.11 21.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.579 1.085 . . . . 0.0 114.899 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -38.2 72.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.85 1.325 . . . . 0.0 112.433 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.961 0.904 . . . . 0.0 112.107 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.1 t -77.52 -43.71 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.518 . . . . 0.0 110.283 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.59 -38.16 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.291 -0.881 . . . . 0.0 111.099 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.43 -19.74 60.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.173 1.389 . . . . 0.0 113.044 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -86.19 -39.11 16.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.745 1.618 . . . . 0.0 111.669 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 8' ' ' HIS . 66.0 mt -53.13 -36.02 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.622 1.569 . . . . 0.0 112.09 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -84.61 -17.71 37.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.89 -20.36 16.77 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.291 1.424 . . . . 0.0 114.296 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.23 -59.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.614 1.207 . . . . 0.0 113.155 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.98 148.21 4.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 112.359 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.4 p -138.03 151.11 47.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.214 1.406 . . . . 0.0 111.861 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.955 0 C-N-CA 123.163 0.411 . . . . 0.0 112.639 169.974 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.84 134.55 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 121.386 1.391 . . . . 0.0 108.932 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -27.95 51.43 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.3 157.7 22.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.582 1.153 . . . . 0.0 110.369 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.13 111.48 18.29 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.135 -0.978 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.67 94.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.646 1.578 . . . . 0.0 107.071 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -127.42 143.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -169.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.1 mt -86.43 103.98 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.815 2.046 . . . . 0.0 106.728 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.76 -41.77 61.99 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.673 -0.642 . . . . 0.0 110.863 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.5 t -150.2 165.82 31.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.78 142.46 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.112 1.765 . . . . 0.0 111.178 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.2 m -135.21 128.58 32.24 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.89 1.276 . . . . 0.0 110.245 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.73 122.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -113.59 150.4 33.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.137 1.375 . . . . 0.0 112.275 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.061 1.344 . . . . 0.0 113.622 -170.803 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.94 127.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.909 0.884 . . . . 0.0 109.364 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.4 m -102.31 124.17 47.41 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.815 1.246 . . . . 0.0 109.901 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -101.46 125.3 48.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.588 1.155 . . . . 0.0 110.474 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -96.9 94.47 7.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 172.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -96.67 152.33 18.76 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.833 -0.542 . . . . 0.0 110.765 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -59.35 -14.34 11.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.96 -13.57 21.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.739 1.215 . . . . 0.0 113.655 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 167.74 14.94 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 123.242 1.468 . . . . 0.0 113.125 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.91 136.9 38.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.341 1.457 . . . . 0.0 112.835 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.2 mt -133.97 139.3 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.663 1.985 . . . . 0.0 108.643 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.1 t -123.56 134.93 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.594 1.158 . . . . 0.0 110.385 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -121.0 139.0 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.655 1.982 . . . . 0.0 110.094 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -103.79 125.78 50.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.56 1.944 . . . . 0.0 108.823 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -87.77 147.24 25.27 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.407 1.083 . . . . 0.0 111.361 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.52 74.41 1.25 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.692 1.234 . . . . 0.0 111.251 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.71 -25.9 64.09 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.607 1.163 . . . . 0.0 112.674 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.33 -28.01 56.72 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.559 1.144 . . . . 0.0 111.346 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -96.82 -30.6 13.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 112.725 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.61 58.59 3.38 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.761 0.824 . . . . 0.0 113.194 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -60.53 -42.71 38.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.583 2.855 . . . . 0.0 112.928 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -69.37 -41.43 76.54 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.655 0.661 . . . . 0.0 110.793 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.1 m -62.23 -49.86 74.05 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.393 0.677 . . . . 0.0 111.481 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -42.64 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.447 0.699 . . . . 0.0 111.401 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.2 -44.59 88.19 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.646 1.112 . . . . 0.0 111.567 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -65.45 -42.28 92.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.305 1.042 . . . . 0.0 111.868 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.9 -48.55 81.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.182 0.993 . . . . 0.0 111.731 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -38.49 81.49 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.91 0.884 . . . . 0.0 111.675 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -56.3 -36.24 68.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.172 0.989 . . . . 0.0 112.094 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -75.51 -43.56 48.35 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.526 -0.734 . . . . 0.0 112.626 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.7 m -61.69 -36.82 81.97 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.61 -0.681 . . . . 0.0 111.877 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.29 71.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.135 1.774 . . . . 0.0 112.824 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.42 -15.48 49.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.337 1.055 . . . . 0.0 113.378 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.66 51.57 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.524 0.583 . . . . 0.0 113.849 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -73.02 -18.11 61.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.117 1.459 . . . . 0.0 114.688 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -100.83 -5.2 26.54 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.143 -0.973 . . . . 0.0 112.273 169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -69.58 130.66 43.05 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.913 -1.117 . . . . 0.0 108.484 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t30 57.08 46.2 19.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.252 1.421 . . . . 0.0 113.698 -169.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -116.23 153.26 32.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.809 0.844 . . . . 0.0 112.449 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -104.93 163.44 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -95.7 94.81 7.92 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -89.08 -2.16 58.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -168.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -138.99 139.85 38.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.114 1.779 . . . . 0.0 112.304 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 132.0 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 126.624 1.97 . . . . 0.0 111.019 169.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.06 129.46 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.058 1.743 . . . . 0.0 108.027 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.71 133.41 55.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.387 0.675 . . . . 0.0 111.574 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.78 10.29 64.02 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -141.34 -177.34 5.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.008 1.723 . . . . 0.0 111.266 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.4 -178.9 5.72 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -169.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.6 pt -116.93 137.2 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.143 1.377 . . . . 0.0 112.275 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -109.15 149.29 29.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.685 1.194 . . . . 0.0 110.625 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.25 174.21 34.1 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 122.473 1.041 . . . . 0.0 115.381 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.72 0.74 75.3 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.932 1.253 . . . . 0.0 115.253 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 -19.27 62.74 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.255 1.527 . . . . 0.0 115.678 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -147.87 165.29 31.08 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.508 1.123 . . . . 0.0 113.193 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.69 163.88 28.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.19 1.396 . . . . 0.0 109.926 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -60.29 -15.63 36.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.551 2.834 . . . . 0.0 118.325 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.27 19.79 53.08 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.179 0.895 . . . . 0.0 114.558 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.05 32.35 19.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.92 126.7 35.2 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.321 1.448 . . . . 0.0 109.162 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.16 127.98 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.717 0.807 . . . . 0.0 110.829 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -72.69 165.52 24.62 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.268 170.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.52 74.48 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.736 1.614 . . . . 0.0 111.088 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 p -73.0 140.76 47.55 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.596 1.158 . . . . 0.0 112.703 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -141.76 178.06 7.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.991 2.116 . . . . 0.0 111.887 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 51.68 65.17 6.76 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 125.784 1.634 . . . . 0.0 114.346 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -57.12 133.26 56.54 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.316 2.677 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.16 150.87 7.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 126.101 1.76 . . . . 0.0 108.72 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 157.85 23.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 169.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -76.52 126.14 30.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.597 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -108.18 14.39 25.06 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.233 1.413 . . . . 0.0 112.915 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -15.79 62.73 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.325 -1.485 . . . . 0.0 114.111 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.94 0.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.123 1.769 . . . . 0.0 115.77 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -79.39 -3.87 48.41 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.883 1.273 . . . . 0.0 112.126 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.39 31.55 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.891 1.234 . . . . 0.0 114.619 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.3 mt -80.43 159.3 25.69 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -131.43 156.34 45.76 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -103.82 115.41 30.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.232 2.213 . . . . 0.0 110.302 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -139.94 167.91 21.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.685 1.194 . . . . 0.0 111.442 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -51.72 119.79 4.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.388 1.475 . . . . 0.0 110.715 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.16 28.87 21.69 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.922 1.249 . . . . 0.0 114.977 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.4 p -122.58 158.94 28.82 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.169 1.484 . . . . 0.0 112.897 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.69 139.28 53.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.681 0.753 . . . . 0.0 112.756 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.49 159.7 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.738 170.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -80.28 141.21 35.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.101 0.56 . . . . 0.0 111.641 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 154.18 19.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.27 0.628 . . . . 0.0 111.516 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -141.0 158.1 44.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.292 1.437 . . . . 0.0 112.713 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 m -72.25 -55.5 7.09 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.881 0.872 . . . . 0.0 113.006 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -159.47 -54.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.276 1.031 . . . . 0.0 111.57 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.71 158.84 86.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.2 1.0 . . . . 0.0 111.365 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.01 -27.69 85.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.832 2.355 . . . . 0.0 113.358 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -109.21 36.15 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.499 1.52 . . . . 0.0 112.511 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.0 p -115.58 30.56 7.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.456 1.502 . . . . 0.0 113.318 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 101.91 14.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.015 1.326 . . . . 0.0 110.092 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 p -91.52 -64.35 1.13 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.187 0.995 . . . . 0.0 113.001 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.81 42.37 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -133.87 153.91 51.42 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.069 -1.02 . . . . 0.0 112.955 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -145.54 168.21 21.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.749 2.02 . . . . 0.0 110.958 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.0 p90 -144.63 159.69 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 111.208 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.6 mt -113.0 118.07 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.19 108.22 6.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.192 0.597 . . . . 0.0 109.798 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.94 -14.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.35 168.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.376 2.271 . . . . 0.0 111.226 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.69 119.24 24.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.469 0.708 . . . . 0.0 109.525 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -141.07 77.17 1.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.975 1.369 . . . . 0.0 113.15 -169.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.24 -34.73 61.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.024 2.13 . . . . 0.0 114.514 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -61.79 -12.7 18.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.09 -10.64 57.66 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.41 178.14 6.12 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -83.94 142.38 30.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.971 1.308 . . . . 0.0 111.814 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -111.35 -58.74 2.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.599 1.159 . . . . 0.0 113.42 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 C-N-CA 124.241 0.924 . . . . 0.0 113.346 -173.187 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.306 6.6 p-90 . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.2 -86.9 1.26 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.362 1.458 . . . . 0.0 115.758 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -139.54 149.94 44.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.883 1.273 . . . . 0.0 111.796 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.9 t -81.27 119.53 23.76 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.732 -0.605 . . . . 0.0 112.408 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.44 84.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -77.06 -14.81 59.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.64 0.776 . . . . 0.0 111.942 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 177.42 8.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.622 1.201 . . . . 0.0 113.783 -170.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -140.64 154.56 46.47 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.768 -1.208 . . . . 0.0 112.333 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.48 140.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.64 0.733 . . . . 0.0 110.084 170.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.97 -42.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 111.008 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -144.5 153.54 41.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 109.93 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 103.47 15.03 24.19 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 123.878 0.751 . . . . 0.0 114.289 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.1 68.54 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.028 1.414 . . . . 0.0 112.263 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -65.74 -30.07 70.68 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.746 0.818 . . . . 0.0 112.466 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.49 -43.13 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.8 1.24 . . . . 0.0 110.092 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.25 -40.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.816 0.846 . . . . 0.0 111.332 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.83 -27.29 62.81 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.93 1.292 . . . . 0.0 112.367 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.13 -42.27 32.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.463 1.105 . . . . 0.0 111.205 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.11 -30.14 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.935 1.694 . . . . 0.0 112.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -91.82 -20.11 21.83 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.78 -17.53 27.88 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.498 1.523 . . . . 0.0 114.738 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.44 -51.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 118.887 1.344 . . . . 0.0 112.722 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.97 155.77 5.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.189 1.396 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.8 p -135.87 150.96 49.56 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 0.0 112.312 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.111 0 C-N-CA 123.032 0.348 . . . . 0.0 112.819 169.93 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.2 135.03 24.1 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.766 1.644 . . . . 0.0 109.375 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -24.98 39.83 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.28 150.24 35.32 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.431 1.092 . . . . 0.0 110.738 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.19 116.94 21.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.798 0.839 . . . . 0.0 111.249 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.03 110.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.573 1.149 . . . . 0.0 108.579 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.08 152.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.415 1.486 . . . . 0.0 110.871 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.96 103.25 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.4 -25.02 36.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.691 0.797 . . . . 0.0 112.113 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -154.35 161.76 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.513 0.725 . . . . 0.0 112.714 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.5 t -134.41 139.2 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.696 1.598 . . . . 0.0 110.157 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.8 m -136.54 131.01 33.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.739 1.216 . . . . 0.0 110.588 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.85 122.95 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -119.31 150.25 40.44 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.079 1.352 . . . . 0.0 112.277 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.294 1.438 . . . . 0.0 113.753 -170.37 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 131.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.989 -1.694 . . . . 0.0 111.514 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.0 m -102.32 123.93 46.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.022 0.929 . . . . 0.0 110.091 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -98.98 132.83 44.0 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.95 1.3 . . . . 0.0 110.677 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -104.83 98.89 8.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -104.6 152.51 22.36 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.962 -0.461 . . . . 0.0 110.835 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.448 HD22 HG12 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -59.44 -20.43 55.02 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -89.8 -15.92 31.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.845 1.258 . . . . 0.0 113.187 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.06 165.3 12.44 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.741 1.639 . . . . 0.0 113.191 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -72.98 137.69 45.61 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.519 1.528 . . . . 0.0 112.534 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.7 mt -134.47 140.71 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.256 1.822 . . . . 0.0 108.764 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.31 132.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 110.479 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.92 135.75 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 110.04 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -98.19 130.46 44.93 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.928 1.691 . . . . 0.0 107.224 171.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -92.13 146.57 23.62 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.22 1.008 . . . . 0.0 110.505 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -102.14 73.9 1.4 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.843 1.306 . . . . 0.0 111.006 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.97 -25.5 64.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.209 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.77 1.228 . . . . 0.0 111.508 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.08 -27.54 15.04 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.861 1.264 . . . . 0.0 112.801 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.25 58.13 3.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -61.11 -42.64 34.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.519 2.813 . . . . 0.0 113.146 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.16 -40.55 78.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.8 m -61.05 -53.57 55.58 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.541 0.736 . . . . 0.0 111.845 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.1 -41.73 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.839 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -54.14 -49.22 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.918 1.236 . . . . 0.0 111.969 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -68.52 -38.88 81.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.376 0.67 . . . . 0.0 111.935 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.67 -49.52 77.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 0.0 111.767 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.58 -34.31 67.36 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.56 0.744 . . . . 0.0 111.811 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -57.78 -33.45 68.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.69 0.796 . . . . 0.0 112.556 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -75.4 -44.21 45.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.437 -0.79 . . . . 0.0 112.333 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.2 -35.81 78.17 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.6 -0.688 . . . . 0.0 111.765 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.84 -34.54 78.15 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.353 2.261 . . . . 0.0 112.789 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -82.11 -14.12 56.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.882 0.873 . . . . 0.0 113.152 171.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.7 18.58 61.45 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.562 1.077 . . . . 0.0 113.814 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.55 -24.04 67.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.72 1.26 . . . . 0.0 114.19 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -89.21 -7.7 55.02 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.304 0.642 . . . . 0.0 112.687 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -64.36 135.67 56.38 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.938 -1.101 . . . . 0.0 108.793 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.25 22.98 12.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.5 p -88.73 162.48 16.23 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.116 -0.99 . . . . 0.0 111.392 169.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.44 HG22 HG22 ' A' ' 156' ' ' ILE . 9.0 pt -122.38 164.76 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -169.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -97.99 96.75 8.37 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -90.24 -8.27 51.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -134.37 138.49 44.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.37 1.441 . . . . 0.0 113.471 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.48 134.37 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.961 2.505 . . . . 0.0 109.272 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 90.1 mt -138.07 129.28 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.733 1.613 . . . . 0.0 108.029 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -61.63 132.77 54.34 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.25 0.62 . . . . 0.0 111.849 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.01 10.17 61.28 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.15 -177.16 5.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.892 1.677 . . . . 0.0 111.314 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -178.66 6.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.083 1.753 . . . . 0.0 115.558 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.7 pt -115.96 138.06 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.186 1.394 . . . . 0.0 112.563 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -108.68 149.35 29.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.516 1.126 . . . . 0.0 111.056 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.89 175.9 32.78 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.454 1.03 . . . . 0.0 114.965 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 6.78 83.6 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.627 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.71 -25.53 35.02 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 119.717 1.758 . . . . 0.0 115.71 -172.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -149.73 169.78 20.26 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.663 1.185 . . . . 0.0 113.054 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.46 164.47 16.58 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.892 1.677 . . . . 0.0 110.064 168.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.87 -12.88 33.98 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.877 3.051 . . . . 0.0 117.437 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.19 14.65 61.71 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.786 0.708 . . . . 0.0 114.449 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.0 mmt 59.71 29.77 19.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.396 1.878 . . . . 0.0 112.879 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.03 125.49 32.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.961 1.304 . . . . 0.0 109.367 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -71.57 121.94 19.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.412 1.085 . . . . 0.0 110.231 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -66.68 159.2 28.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.35 73.38 8.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.409 1.483 . . . . 0.0 111.57 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 p -68.03 121.27 15.74 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.507 1.123 . . . . 0.0 112.596 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -130.93 176.66 8.05 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.098 1.759 . . . . 0.0 111.954 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 49.25 67.27 4.65 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.674 1.59 . . . . 0.0 113.99 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.66 140.1 91.99 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.38 2.72 . . . . 0.0 111.765 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -111.76 152.59 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.038 1.735 . . . . 0.0 109.046 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.27 0.1 OUTLIER -76.23 158.93 31.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.237 0.615 . . . . 0.0 110.355 169.5 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.27 -56.58 20.0 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 70.95 3.68 4.74 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.46 -15.09 63.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 119.919 -1.738 . . . . 0.0 114.126 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -59.94 3.8 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.118 2.567 . . . . 0.0 116.151 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -84.22 5.72 25.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.421 1.489 . . . . 0.0 112.257 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.71 32.71 32.6 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.816 1.198 . . . . 0.0 113.299 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.11 140.56 39.05 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.417 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -131.69 147.74 52.53 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -99.13 85.87 3.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 111.642 -169.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.5 p -112.57 168.32 9.75 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.506 0.723 . . . . 0.0 112.109 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -55.89 130.16 42.5 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.667 1.187 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.24 35.41 33.95 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.179 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.9 p -125.92 161.91 26.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.78 1.29 . . . . 0.0 113.354 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 mp -120.49 136.09 54.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.792 0.837 . . . . 0.0 112.896 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.09 159.19 39.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.468 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -84.64 141.12 30.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.62 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.31 154.02 19.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.467 0.707 . . . . 0.0 111.112 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -133.39 162.92 30.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.827 1.251 . . . . 0.0 113.572 -171.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -76.95 -56.23 4.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.617 1.167 . . . . 0.0 113.109 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -159.09 -54.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.543 1.137 . . . . 0.0 111.76 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.28 161.82 71.45 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.509 1.124 . . . . 0.0 111.53 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.31 -20.14 69.78 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.147 2.565 . . . . 0.0 114.071 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.28 42.13 2.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.356 1.862 . . . . 0.0 111.983 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.5 p -125.79 30.79 5.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.186 1.394 . . . . 0.0 113.638 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.0 104.48 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.816 1.647 . . . . 0.0 109.527 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.2 p -89.73 -72.73 0.54 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.455 1.102 . . . . 0.0 113.204 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.27 36.43 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.32 149.8 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.03 1.332 . . . . 0.0 111.621 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.18 168.41 21.06 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.476 1.511 . . . . 0.0 111.673 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.7 p90 -146.37 162.1 38.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 30.4 mt -115.01 116.03 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.539 1.136 . . . . 0.0 108.181 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -71.31 99.09 1.87 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.72 0.808 . . . . 0.0 109.772 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.4 m -77.83 -16.36 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 113.212 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.55 166.28 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 128.292 2.637 . . . . 0.0 110.968 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.0 119.66 19.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.226 0.536 . . . . 0.0 111.331 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -126.85 55.37 1.56 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.015 1.726 . . . . 0.0 111.641 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.56 -12.14 50.37 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -69.51 -14.92 63.12 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.819 -1.176 . . . . 0.0 113.349 169.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.37 -14.91 56.69 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -66.79 172.48 4.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.071 2.148 . . . . 0.0 116.595 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.05 155.81 40.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.871 1.268 . . . . 0.0 112.402 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.7 t -140.92 -53.78 0.48 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -178.169 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.252 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.54 -71.37 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.991 1.282 . . . . 0.0 114.048 -174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -133.73 131.85 39.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.939 0.896 . . . . 0.0 111.899 -169.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.3 t -93.04 126.16 37.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.425 0.69 . . . . 0.0 112.523 -172.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.82 89.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.189 0.995 . . . . 0.0 109.225 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -75.23 -15.18 60.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.354 1.062 . . . . 0.0 112.015 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.66 176.36 10.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.315 1.055 . . . . 0.0 113.828 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -140.37 151.19 44.78 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 112.264 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.04 133.6 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.575 0.702 . . . . 0.0 110.349 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.67 -43.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.339 1.856 . . . . 0.0 110.812 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -143.07 154.77 44.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.546 1.538 . . . . 0.0 109.964 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.75 14.92 33.05 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.787 0.708 . . . . 0.0 114.478 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 81.9 mmm -54.89 -36.11 64.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.27 1.535 . . . . 0.0 112.275 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.36 -30.48 71.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.849 0.86 . . . . 0.0 112.612 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.49 -40.77 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.978 1.311 . . . . 0.0 110.377 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.65 -42.56 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.272 -0.892 . . . . 0.0 110.93 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.08 -25.08 63.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.314 1.445 . . . . 0.0 112.22 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -75.76 -52.19 11.0 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.049 0.94 . . . . 0.0 110.398 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 53.6 mt -53.01 -36.41 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.364 1.865 . . . . 0.0 112.686 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.02 -14.44 31.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.88 -18.23 11.83 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.828 1.68 . . . . 0.0 113.882 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.31 -59.41 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.412 1.106 . . . . 0.0 113.051 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.56 162.39 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.768 1.227 . . . . 0.0 112.677 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.0 p -136.07 151.4 49.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.496 1.518 . . . . 0.0 112.389 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.175 0 C-N-CA 123.146 0.403 . . . . 0.0 113.436 170.063 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -69.95 138.64 37.68 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.14 1.893 . . . . 0.0 109.852 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -31.18 38.0 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -79.17 149.42 31.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.83 0.852 . . . . 0.0 111.398 169.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.0 114.38 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.495 1.118 . . . . 0.0 111.229 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.24 105.67 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 108.402 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 7' ' ' ASN . 1.4 pt -128.12 143.82 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.558 0.743 . . . . 0.0 111.565 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.16 103.34 11.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.17 -36.66 66.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.294 0.637 . . . . 0.0 110.476 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 t -153.92 166.0 34.35 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.21 141.38 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.642 1.977 . . . . 0.0 110.58 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 125.09 30.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.184 1.394 . . . . 0.0 109.909 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.67 125.47 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.205 0.602 . . . . 0.0 109.878 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.2 t -111.49 150.77 29.45 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.33 1.452 . . . . 0.0 112.138 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.676 1.19 . . . . 0.0 113.241 -172.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.15 130.75 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.045 0.938 . . . . 0.0 109.265 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -106.19 121.69 44.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.795 1.238 . . . . 0.0 110.148 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.68 135.61 33.94 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.495 1.118 . . . . 0.0 110.72 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -107.25 101.1 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -103.92 152.75 21.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.895 -0.503 . . . . 0.0 111.016 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -60.1 -7.49 1.87 Allowed 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -109.31 -8.04 15.15 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.074 1.35 . . . . 0.0 114.215 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.52 165.89 12.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.374 1.464 . . . . 0.0 113.742 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.78 138.82 39.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.364 1.866 . . . . 0.0 112.838 174.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -135.4 140.9 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.303 1.841 . . . . 0.0 109.066 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.04 136.87 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.553 1.141 . . . . 0.0 110.562 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.22 139.43 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.73 2.012 . . . . 0.0 110.465 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -101.81 126.91 48.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.862 2.065 . . . . 0.0 107.659 171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 p -88.62 147.58 24.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.171 0.989 . . . . 0.0 111.085 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.02 74.33 1.3 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.688 1.232 . . . . 0.0 111.156 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.74 -26.92 64.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.547 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -75.73 -30.87 59.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.291 1.036 . . . . 0.0 111.437 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 -28.7 14.53 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 113.011 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.8 56.99 3.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -60.1 -43.63 34.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 112.758 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -68.08 -40.17 82.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.756 0.707 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 68' ' ' ILE . 26.6 m -65.14 -48.12 74.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.569 0.748 . . . . 0.0 111.6 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -68.38 -39.51 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.921 0.888 . . . . 0.0 112.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.16 -47.16 75.53 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.677 1.126 . . . . 0.0 111.816 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -69.3 -38.66 78.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.339 0.655 . . . . 0.0 111.88 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.09 -47.6 84.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 0.0 111.539 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.56 -38.57 74.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.25 0.62 . . . . 0.0 111.374 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -63.14 -29.66 70.97 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -73.62 -42.84 60.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.302 -0.874 . . . . 0.0 111.967 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.16 -37.61 85.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.541 -0.725 . . . . 0.0 111.463 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -58.42 -37.87 76.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.468 2.307 . . . . 0.0 113.438 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -81.73 -15.0 55.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.707 1.203 . . . . 0.0 113.531 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.8 61.03 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.872 1.225 . . . . 0.0 114.362 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -69.58 -17.72 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.542 1.537 . . . . 0.0 114.963 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.92 -13.03 21.42 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.55 1.23 8.53 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -147.19 53.59 1.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.206 1.402 . . . . 0.0 110.606 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.4 p -114.36 171.94 7.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.185 0.994 . . . . 0.0 113.121 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 156' ' ' ILE . 12.9 pt -127.65 166.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -98.93 110.44 23.05 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -109.15 0.81 19.97 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -152.66 129.94 11.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.53 1.513 . . . . 0.0 111.591 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.66 141.21 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.664 1.986 . . . . 0.0 111.168 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.61 127.62 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.142 1.377 . . . . 0.0 108.66 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -64.63 132.88 50.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 0.0 111.659 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 10.74 66.01 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.01 0.814 . . . . 0.0 114.908 -173.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -144.56 -174.84 4.43 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.82 2.048 . . . . 0.0 110.412 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.58 -179.93 7.46 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.7 pt -123.34 142.73 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.169 1.387 . . . . 0.0 113.8 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -122.79 147.81 46.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.826 1.65 . . . . 0.0 112.363 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.68 -175.74 32.02 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.73 73.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.148 1.832 . . . . 0.0 115.641 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.86 -16.05 60.33 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.79 164.87 28.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.583 1.192 . . . . 0.0 112.705 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -94.92 161.94 26.76 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.926 1.691 . . . . 0.0 110.806 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -60.75 -8.84 10.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.007 3.138 . . . . 0.0 117.613 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.68 12.96 67.08 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.151 0.882 . . . . 0.0 115.039 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mmt 59.68 29.12 18.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.282 1.833 . . . . 0.0 112.822 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.01 131.22 34.15 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.303 1.441 . . . . 0.0 109.403 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -73.53 121.02 19.93 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.094 0.958 . . . . 0.0 110.339 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -72.34 164.77 25.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.86 71.85 7.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.513 1.525 . . . . 0.0 111.332 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 p -70.86 107.92 4.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 111.824 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -111.28 175.98 5.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.454 1.902 . . . . 0.0 111.808 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.08 65.8 5.46 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.464 1.505 . . . . 0.0 113.576 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -58.03 132.12 47.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.998 2.465 . . . . 0.0 110.364 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -114.85 147.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.607 1.163 . . . . 0.0 109.656 -173.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 155.31 29.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.991 0.917 . . . . 0.0 112.145 172.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -75.14 129.56 37.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.987 0.915 . . . . 0.0 110.828 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -112.29 14.33 20.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.207 1.403 . . . . 0.0 113.124 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.99 -15.45 59.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.247 -1.533 . . . . 0.0 113.477 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -59.25 -0.97 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -80.39 -3.03 48.11 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.117 1.367 . . . . 0.0 112.095 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.8 27.19 27.31 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.099 1.333 . . . . 0.0 114.495 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.61 158.57 28.42 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.962 0.881 . . . . 0.0 112.999 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -130.58 159.24 37.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.684 1.194 . . . . 0.0 114.024 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -106.9 115.15 29.69 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.068 2.147 . . . . 0.0 109.927 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.3 p -140.95 168.41 19.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.81 1.244 . . . . 0.0 111.241 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -54.49 125.15 18.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.117 0.967 . . . . 0.0 110.91 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.84 31.97 25.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.26 1.41 . . . . 0.0 115.075 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.1 p -123.79 159.77 28.78 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.31 1.555 . . . . 0.0 113.342 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -123.68 138.47 54.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 0.0 113.191 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.9 157.78 46.0 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.823 -0.548 . . . . 0.0 112.184 169.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.0 mmm -79.6 136.17 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.865 0.466 . . . . 0.0 110.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.58 142.19 27.9 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.798 0.839 . . . . 0.0 110.749 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -85.83 154.03 21.84 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.413 1.085 . . . . 0.0 112.677 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -70.14 -51.99 27.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.801 0.841 . . . . 0.0 110.178 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -157.56 -57.96 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.424 1.489 . . . . 0.0 110.451 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.41 154.73 83.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.18 0.992 . . . . 0.0 111.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.69 -19.27 64.53 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.93 2.42 . . . . 0.0 114.45 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -112.69 38.21 2.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.845 1.658 . . . . 0.0 112.332 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -122.17 30.26 6.66 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.319 1.447 . . . . 0.0 113.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.08 61.55 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.446 1.499 . . . . 0.0 113.035 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -58.82 -65.33 0.68 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.904 1.681 . . . . 0.0 113.946 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.83 0.55 0.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.7 146.43 24.52 Favored 'General case' 0 N--CA 1.462 0.175 0 O-C-N 120.515 -1.366 . . . . 0.0 110.51 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -141.14 168.28 20.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.758 1.623 . . . . 0.0 110.479 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.1 p90 -145.33 159.27 43.31 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.103 0.561 . . . . 0.0 111.87 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.82 119.49 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.101 1.36 . . . . 0.0 108.267 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -78.28 119.74 22.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.55 0.74 . . . . 0.0 110.774 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -98.74 -8.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.9 164.51 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.689 1.596 . . . . 0.0 111.32 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -80.8 119.1 22.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.996 0.518 . . . . 0.0 109.993 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -137.58 70.67 1.4 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.955 1.359 . . . . 0.0 112.149 -169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.57 -35.79 54.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.251 2.22 . . . . 0.0 114.404 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -59.72 -14.24 13.41 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.27 -13.33 57.19 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -73.6 169.83 16.45 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.25 145.63 55.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.625 0.77 . . . . 0.0 112.981 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 61.0 p -115.05 -59.54 2.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.522 1.529 . . . . 0.0 113.09 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 C-N-CA 125.32 1.438 . . . . 0.0 112.077 -171.098 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.489 ' N ' ' HG ' ' A' ' 111' ' ' SER . 1.6 p-90 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.58 -58.94 0.64 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 116.559 1.383 . . . . 0.0 116.559 -169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -141.65 151.11 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.365 1.066 . . . . 0.0 112.215 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.2 t -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.835 -0.541 . . . . 0.0 112.456 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.3 83.38 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.766 1.226 . . . . 0.0 108.594 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -77.6 -14.03 59.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.021 0.928 . . . . 0.0 112.129 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.45 177.83 7.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.771 1.272 . . . . 0.0 114.343 -169.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -141.43 153.63 45.12 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.65 1.18 . . . . 0.0 112.417 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 143.7 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.688 0.756 . . . . 0.0 110.323 173.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.45 -41.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.736 1.614 . . . . 0.0 110.936 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -147.03 154.52 41.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.678 1.591 . . . . 0.0 110.108 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.25 14.21 24.79 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 123.866 0.746 . . . . 0.0 114.603 172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -34.62 63.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.055 1.427 . . . . 0.0 112.305 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.15 -30.02 71.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.687 0.795 . . . . 0.0 112.577 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.2 t -75.97 -43.22 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.052 1.341 . . . . 0.0 110.271 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.62 -38.42 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.362 -0.836 . . . . 0.0 110.973 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -26.42 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.339 1.456 . . . . 0.0 112.6 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -76.91 -42.27 40.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.724 1.21 . . . . 0.0 110.821 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.6 mt -57.61 -29.26 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.568 1.547 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -89.82 -14.04 35.3 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.15 -14.0 17.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.745 1.64 . . . . 0.0 114.627 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 -57.74 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 118.778 1.289 . . . . 0.0 112.445 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.61 144.95 0.89 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.7 1.6 . . . . 0.0 111.157 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -129.05 150.07 50.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.043 1.337 . . . . 0.0 112.946 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 C-N-CA 124.343 0.973 . . . . 0.0 112.256 170.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.47 129.29 18.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.245 1.296 . . . . 0.0 108.897 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -25.21 32.31 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.709 0.403 . . . . 0.0 111.857 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.9 146.7 37.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.004 0.922 . . . . 0.0 109.155 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.32 109.99 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.403 0.621 . . . . 0.0 111.326 -171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.88 109.1 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.218 1.007 . . . . 0.0 108.589 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.9 142.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -172.233 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -84.01 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -76.95 -27.07 54.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.801 1.24 . . . . 0.0 111.794 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.4 t -163.17 168.66 20.46 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.67 140.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.276 1.831 . . . . 0.0 110.488 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -131.53 133.12 44.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.355 1.462 . . . . 0.0 110.001 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.69 123.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.4 t -118.21 150.35 39.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.254 1.421 . . . . 0.0 112.533 -173.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.542 1.537 . . . . 0.0 113.649 -170.029 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.04 128.28 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.921 1.237 . . . . 0.0 110.387 174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -99.9 126.53 46.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.514 1.125 . . . . 0.0 110.262 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -102.52 127.62 49.51 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.091 1.356 . . . . 0.0 110.29 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -101.16 99.43 9.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -103.77 152.27 22.06 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.842 -0.536 . . . . 0.0 111.293 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -60.39 -9.52 3.68 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -106.99 -9.56 16.2 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.805 1.242 . . . . 0.0 114.189 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.02 163.23 11.55 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.046 1.359 . . . . 0.0 113.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.28 138.18 43.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.636 1.574 . . . . 0.0 112.736 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.18 139.85 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.521 1.928 . . . . 0.0 108.43 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.63 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 110.352 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -125.03 134.11 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.357 1.863 . . . . 0.0 110.04 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.14 127.75 47.55 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.678 . . . . 0.0 108.605 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 p -88.92 146.48 24.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -104.31 73.94 1.15 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.701 1.239 . . . . 0.0 111.434 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.19 -25.06 64.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.503 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 -24.04 46.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.593 1.157 . . . . 0.0 111.873 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -107.4 -16.74 14.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.501 1.521 . . . . 0.0 113.29 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 50.6 0.52 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.841 1.256 . . . . 0.0 114.352 -172.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.22 -40.82 56.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.568 2.845 . . . . 0.0 113.859 -170.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -71.68 -35.17 70.2 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.646 -0.659 . . . . 0.0 110.851 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.4 m -70.49 -47.95 58.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.56 -43.5 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.089 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -58.77 -45.54 89.56 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.672 1.123 . . . . 0.0 111.619 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.98 -43.78 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.342 1.057 . . . . 0.0 111.937 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.51 -47.7 84.51 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 111.693 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.98 -37.72 72.74 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.565 0.746 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.64 -29.49 70.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.92 0.888 . . . . 0.0 112.937 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -77.01 -43.14 35.82 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.512 -0.743 . . . . 0.0 112.536 170.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.0 m -62.09 -37.53 85.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.206 -0.934 . . . . 0.0 111.515 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -57.2 -37.37 72.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.127 2.571 . . . . 0.0 113.581 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.3 -15.25 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.766 1.226 . . . . 0.0 113.381 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.88 18.12 56.78 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.988 0.804 . . . . 0.0 113.935 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.2 -17.96 60.83 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -99.47 -8.37 24.76 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.147 -0.97 . . . . 0.0 112.068 169.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.35 130.24 41.43 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.01 44.37 22.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 114.226 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 p -109.9 167.7 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.214 1.006 . . . . 0.0 110.926 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 156' ' ' ILE . 15.0 pt -124.0 162.16 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.68 85.06 6.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.499 1.12 . . . . 0.0 108.033 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -74.88 -10.81 59.85 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -146.72 138.22 24.38 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.237 1.835 . . . . 0.0 114.182 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.76 146.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.155 2.582 . . . . 0.0 110.46 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.7 mt -137.94 131.86 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.183 1.793 . . . . 0.0 107.85 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.47 137.22 57.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.553 0.741 . . . . 0.0 112.049 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 12.73 62.21 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.864 0.745 . . . . 0.0 114.644 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -142.54 -177.13 5.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.169 1.788 . . . . 0.0 111.412 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -178.79 7.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.971 1.709 . . . . 0.0 114.576 -173.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.7 pt -119.49 142.62 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.417 1.087 . . . . 0.0 113.237 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -110.89 150.2 29.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.944 1.297 . . . . 0.0 111.512 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.78 176.13 35.7 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.35 0.57 67.05 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.085 1.802 . . . . 0.0 115.354 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -16.93 65.12 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.013 1.407 . . . . 0.0 115.494 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -145.38 166.4 25.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.824 1.25 . . . . 0.0 112.987 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.91 162.26 24.62 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.841 1.657 . . . . 0.0 110.493 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.96 -13.17 29.6 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.655 2.903 . . . . 0.0 117.709 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.12 16.62 60.56 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.053 0.835 . . . . 0.0 114.5 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.8 30.19 19.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 112.575 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.04 126.12 33.93 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.037 1.335 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.25 119.96 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.362 1.065 . . . . 0.0 110.675 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.86 162.78 28.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.17 70.35 3.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.769 1.628 . . . . 0.0 111.591 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -73.35 142.71 47.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.927 1.291 . . . . 0.0 113.049 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -141.76 175.46 9.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.982 2.113 . . . . 0.0 111.943 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 52.55 67.87 3.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.689 1.595 . . . . 0.0 114.09 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -60.59 134.49 54.82 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.204 2.603 . . . . 0.0 111.51 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.1 152.13 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.811 1.644 . . . . 0.0 107.999 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 160.49 19.89 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.098 0.559 . . . . 0.0 111.757 170.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.16 132.98 41.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.164 0.586 . . . . 0.0 110.998 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -118.42 15.42 13.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.425 1.49 . . . . 0.0 112.674 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -15.96 46.13 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 119.957 -1.714 . . . . 0.0 114.179 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.28 4.48 0.5 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.13 1.372 . . . . 0.0 113.568 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -75.7 -9.68 58.79 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.775 1.23 . . . . 0.0 112.898 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.62 1.67 82.89 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.754 1.645 . . . . 0.0 114.822 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.09 153.58 32.08 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.259 1.029 . . . . 0.0 112.13 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -130.98 150.85 51.94 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -87.97 77.66 8.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.625 1.97 . . . . 0.0 111.629 -169.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 p -110.34 168.07 9.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -46.19 121.82 3.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 111.372 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.6 36.78 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.23 1.395 . . . . 0.0 114.823 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -118.66 157.72 26.89 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.121 1.46 . . . . 0.0 113.586 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -117.96 135.08 54.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 112.831 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.47 159.7 40.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.485 0.659 . . . . 0.0 111.962 172.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ptp -70.12 145.12 51.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.536 0.734 . . . . 0.0 111.233 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 150.56 20.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.265 0.626 . . . . 0.0 110.066 169.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -127.68 160.5 31.45 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.519 1.127 . . . . 0.0 112.856 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -87.78 58.27 4.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.996 1.718 . . . . 0.0 110.213 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.341 18.1 pt20 54.49 -38.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 130.186 3.395 . . . . 0.0 117.648 -169.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.34 149.29 84.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.347 1.43 . . . . 0.0 111.3 173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.13 -35.18 66.03 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.471 2.114 . . . . 0.0 113.715 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -106.09 41.18 1.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 0.0 112.406 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -130.05 27.74 5.1 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.22 1.408 . . . . 0.0 113.839 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.58 104.69 16.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.47 1.508 . . . . 0.0 108.644 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -91.08 -52.31 4.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.282 1.033 . . . . 0.0 112.949 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -161.08 41.41 0.16 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.311 1.044 . . . . 0.0 113.064 -170.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -131.17 145.24 51.88 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.974 -1.078 . . . . 0.0 111.602 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.59 168.32 21.56 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.398 1.879 . . . . 0.0 111.594 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -146.5 163.78 34.62 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.029 0.932 . . . . 0.0 111.566 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.18 118.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.587 1.155 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.04 108.24 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.675 0.79 . . . . 0.0 110.915 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.74 -12.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 113.725 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.55 167.19 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.44 1.496 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.51 113.15 4.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.731 1.612 . . . . 0.0 112.115 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.7 62.34 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.309 1.443 . . . . 0.0 111.643 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.81 -35.69 66.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.343 1.457 . . . . 0.0 114.106 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -65.18 -12.98 56.94 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.51 -8.05 59.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.342 1.057 . . . . 0.0 113.443 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -77.71 -172.35 2.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.683 1.193 . . . . 0.0 113.84 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -81.87 146.43 29.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.36 1.464 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.522 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 61.9 p -107.58 -61.87 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.658 1.583 . . . . 0.0 113.349 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 C-N-CA 125.515 1.531 . . . . 0.0 112.335 -169.884 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.522 ' N ' ' HG ' ' A' ' 111' ' ' SER 0.31 5.6 p-90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 122.246 1.022 . . . . 0.0 113.542 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.77 -99.18 1.31 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.221 1.391 . . . . 0.0 115.388 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.5 132.92 45.88 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.306 1.042 . . . . 0.0 112.328 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.52 126.46 30.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.17 94.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.402 1.081 . . . . 0.0 108.242 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -82.05 -14.7 55.5 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.866 0.866 . . . . 0.0 111.795 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.08 175.58 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.56 1.171 . . . . 0.0 113.13 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.81 153.39 50.82 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.795 -1.191 . . . . 0.0 112.203 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.35 138.68 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.586 0.708 . . . . 0.0 109.254 169.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 t -107.82 -41.98 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.712 1.605 . . . . 0.0 110.557 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -145.58 151.07 37.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.344 1.458 . . . . 0.0 110.031 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.93 11.78 19.86 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.953 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.9 mmm -53.39 -37.42 62.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.928 1.864 . . . . 0.0 112.544 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.92 -31.76 72.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.039 0.936 . . . . 0.0 112.377 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.93 -43.75 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.174 1.39 . . . . 0.0 110.282 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.95 -38.01 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.217 -0.927 . . . . 0.0 111.031 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -71.93 -26.31 62.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.246 1.418 . . . . 0.0 112.558 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -77.89 -41.52 36.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.865 1.266 . . . . 0.0 110.886 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.89 -30.23 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.061 1.744 . . . . 0.0 112.726 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -89.43 -12.39 40.38 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -111.42 -12.88 14.08 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.542 1.544 . . . . 0.0 114.471 -171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 m -61.29 -58.07 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.733 1.266 . . . . 0.0 112.678 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.23 145.0 1.26 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.964 1.305 . . . . 0.0 112.073 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -122.5 149.37 44.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.629 1.572 . . . . 0.0 112.564 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.825 0 C-N-CA 124.33 0.967 . . . . 0.0 112.053 175.277 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.93 132.87 31.57 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.372 1.381 . . . . 0.0 109.397 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 -26.14 28.82 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.14 142.56 45.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.581 0.753 . . . . 0.0 109.644 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -81.42 112.05 18.34 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.328 0.651 . . . . 0.0 110.803 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.13 103.99 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -126.45 143.65 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.772 1.229 . . . . 0.0 111.57 -170.009 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.4 mt -86.78 102.7 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.04 -28.31 43.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.389 1.076 . . . . 0.0 112.109 -174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -153.66 161.78 41.84 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.21 140.09 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.967 1.707 . . . . 0.0 109.875 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -136.37 126.52 26.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.747 1.219 . . . . 0.0 110.343 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.5 121.77 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 t -111.75 150.45 30.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.386 1.474 . . . . 0.0 112.316 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.706 1.602 . . . . 0.0 113.502 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.84 130.36 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.0 m -103.97 124.78 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.47 1.508 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -101.08 120.04 39.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.674 1.19 . . . . 0.0 109.756 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -93.9 114.38 26.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -125.31 159.39 31.84 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -68.94 -7.99 40.22 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -106.77 -28.26 10.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.645 1.578 . . . . 0.0 113.276 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.88 146.91 4.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.323 1.916 . . . . 0.0 113.094 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.69 133.15 31.26 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.533 1.133 . . . . 0.0 112.863 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.3 mt -128.39 142.96 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.845 1.658 . . . . 0.0 109.28 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -129.27 138.6 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.165 0.986 . . . . 0.0 110.269 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 mt -128.89 138.32 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.551 1.94 . . . . 0.0 109.801 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -107.38 122.28 46.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.725 2.01 . . . . 0.0 109.419 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 p -86.74 149.3 24.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.128 0.971 . . . . 0.0 112.414 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.03 72.49 0.89 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 123.025 1.393 . . . . 0.0 111.924 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.85 -26.07 64.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.544 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.06 -29.1 54.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.241 1.016 . . . . 0.0 111.481 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -99.42 -23.18 15.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.88 1.272 . . . . 0.0 113.23 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.22 55.42 1.39 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.33 1.052 . . . . 0.0 113.41 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.77 -44.34 31.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.368 2.712 . . . . 0.0 112.99 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -69.37 -39.94 77.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.725 0.693 . . . . 0.0 111.291 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.483 ' HA ' HD13 ' A' ' 68' ' ' ILE . 18.2 m -64.86 -47.67 77.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.451 0.7 . . . . 0.0 111.245 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.7 -38.03 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.121 0.968 . . . . 0.0 112.275 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -54.21 -45.08 72.16 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.849 1.204 . . . . 0.0 112.035 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -68.26 -41.53 80.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.282 0.633 . . . . 0.0 111.467 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.6 -47.05 85.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.109 0.963 . . . . 0.0 111.611 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.55 -36.37 68.23 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.381 -0.825 . . . . 0.0 112.209 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.59 -39.15 76.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.819 0.448 . . . . 0.0 111.74 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -68.29 -43.38 77.83 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.55 -0.719 . . . . 0.0 111.932 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.8 m -60.33 -40.3 90.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.065 0.546 . . . . 0.0 111.32 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -68.78 -33.79 74.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.968 1.707 . . . . 0.0 112.821 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.35 -18.44 42.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.162 0.985 . . . . 0.0 112.994 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.87 25.91 43.63 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.919 -0.488 . . . . 0.0 112.561 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -69.78 -42.49 73.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.273 1.037 . . . . 0.0 113.156 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -81.22 -13.4 58.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.769 0.828 . . . . 0.0 111.732 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -63.14 124.96 22.5 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.684 0.794 . . . . 0.0 108.87 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.252 61.1 t30 59.1 45.52 14.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.592 1.557 . . . . 0.0 114.886 -169.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -111.66 164.3 13.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.466 1.106 . . . . 0.0 111.067 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 156' ' ' ILE . 11.5 pt -121.36 163.05 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 85.05 7.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.197 1.399 . . . . 0.0 107.978 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -75.59 -7.25 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -135.45 140.9 45.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.854 1.661 . . . . 0.0 112.252 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.53 136.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.961 2.104 . . . . 0.0 110.526 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.4 mt -140.33 130.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 108.363 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -66.93 137.21 56.37 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.099 0.96 . . . . 0.0 112.067 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 11.95 66.43 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.816 0.722 . . . . 0.0 114.492 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -146.3 -176.99 5.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.91 2.084 . . . . 0.0 110.216 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -90.51 -180.0 5.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.107 1.763 . . . . 0.0 114.45 -171.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.14 140.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.882 1.273 . . . . 0.0 111.971 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -112.49 149.03 33.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.021 1.329 . . . . 0.0 110.789 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.35 175.72 32.43 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 3.51 90.0 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.311 1.434 . . . . 0.0 115.392 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.12 -26.32 37.36 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.002 1.401 . . . . 0.0 115.031 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -143.78 160.53 40.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.2 164.31 39.05 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.319 1.447 . . . . 0.0 110.59 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.92 -14.47 37.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.381 2.721 . . . . 0.0 117.943 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.87 21.08 47.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.344 0.973 . . . . 0.0 114.451 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.78 33.68 17.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.941 1.696 . . . . 0.0 113.011 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.06 130.48 36.96 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.057 1.343 . . . . 0.0 109.772 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.62 128.92 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 123.943 1.83 . . . . 0.0 111.357 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -76.79 178.48 6.78 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 110.615 -2.993 . . . . 0.0 114.379 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.18 54.43 3.1 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.821 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.2 p -71.11 117.36 12.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.509 1.124 . . . . 0.0 111.402 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.34 -178.07 4.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.062 1.745 . . . . 0.0 111.818 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 45.95 64.19 8.43 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.649 1.58 . . . . 0.0 114.344 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -54.51 129.3 34.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.097 2.531 . . . . 0.0 110.703 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.0 OUTLIER -109.68 148.65 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.152 1.381 . . . . 0.0 109.044 -174.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 151.71 38.55 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.31 0.576 . . . . 0.0 110.787 169.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -80.11 125.17 29.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.575 0.75 . . . . 0.0 110.851 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.82 12.67 34.22 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.804 1.241 . . . . 0.0 113.152 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -16.49 49.22 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.64 -1.287 . . . . 0.0 114.409 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.89 1.11 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.437 1.495 . . . . 0.0 114.02 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -71.98 -11.6 60.85 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.878 1.271 . . . . 0.0 113.076 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 10.67 77.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.1 1.333 . . . . 0.0 114.383 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.55 154.96 34.04 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.582 1.191 . . . . 0.0 112.48 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -130.01 151.85 50.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.77 103.21 15.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.14 2.176 . . . . 0.0 109.668 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 p -134.65 170.59 15.57 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.096 1.358 . . . . 0.0 110.822 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -49.65 119.79 3.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.773 1.229 . . . . 0.0 111.116 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.08 33.31 26.77 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.832 1.206 . . . . 0.0 114.923 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -119.6 159.57 24.13 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.727 1.263 . . . . 0.0 113.09 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.75 136.37 54.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.07 156.31 49.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.03 0.532 . . . . 0.0 111.467 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -85.13 134.5 34.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.71 153.44 22.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.374 1.07 . . . . 0.0 111.122 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -105.26 158.24 16.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.071 1.349 . . . . 0.0 111.969 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.9 m -78.01 -51.6 10.09 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.987 0.915 . . . . 0.0 110.776 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -161.85 -53.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.899 1.28 . . . . 0.0 111.334 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.8 162.99 68.36 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.058 1.343 . . . . 0.0 112.315 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.5 -17.07 58.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.217 2.611 . . . . 0.0 114.263 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -122.17 50.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.569 1.547 . . . . 0.0 111.681 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.9 p -132.78 33.5 3.72 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.65 57.76 0.76 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.114 1.366 . . . . 0.0 113.475 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p -60.17 -47.67 84.97 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -169.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.12 -30.72 0.13 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -174.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -70.81 142.82 51.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.317 1.047 . . . . 0.0 111.434 -170.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -137.21 168.39 19.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.196 1.798 . . . . 0.0 110.524 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.3 p90 -148.27 160.53 42.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 112.071 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.02 115.9 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 108.903 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.7 95.97 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.175 0.99 . . . . 0.0 110.697 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.91 -24.73 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.167 -0.958 . . . . 0.0 113.388 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.9 168.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.501 . . . . 0.0 111.492 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.79 118.04 21.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.201 1.0 . . . . 0.0 110.531 169.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -141.88 68.49 1.32 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.938 1.352 . . . . 0.0 113.004 -169.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.52 -35.31 39.95 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.309 2.244 . . . . 0.0 114.538 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -58.8 -13.79 7.08 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.08 -10.45 59.2 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.58 -177.35 3.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.511 1.524 . . . . 0.0 114.814 -171.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -79.35 155.59 28.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.098 1.359 . . . . 0.0 111.64 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.5 t -136.11 -55.05 0.76 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -178.925 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.28 4.0 p-90 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.74 -89.52 1.9 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.719 1.628 . . . . 0.0 114.802 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -140.56 146.73 38.44 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.169 1.387 . . . . 0.0 112.139 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.08 129.51 34.82 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.34 94.48 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.762 1.225 . . . . 0.0 108.585 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -79.28 -16.0 57.09 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.648 0.779 . . . . 0.0 111.976 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.96 177.8 8.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.663 1.221 . . . . 0.0 113.111 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.06 153.78 51.93 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.89 -1.131 . . . . 0.0 112.027 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.61 143.98 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.744 0.783 . . . . 0.0 109.315 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.83 -38.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 110.854 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -146.37 149.12 33.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.274 1.43 . . . . 0.0 110.906 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.48 6.09 18.03 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.65 1.119 . . . . 0.0 115.793 170.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.4 mmm -56.3 -37.14 69.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.169 1.484 . . . . 0.0 113.103 -176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.81 -30.93 71.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.724 0.809 . . . . 0.0 112.207 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.06 -41.73 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.037 1.735 . . . . 0.0 110.696 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.27 -38.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 111.05 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 6.8 t70 -75.77 -19.18 59.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.02 1.328 . . . . 0.0 113.19 175.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -79.75 -41.94 25.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.108 1.363 . . . . 0.0 111.081 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.5 mt -55.51 -35.56 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.06 1.344 . . . . 0.0 112.158 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.9 pttp -83.78 -12.36 55.81 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.87 -24.49 9.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.151 1.358 . . . . 0.0 114.197 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 m -74.16 -59.5 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.718 1.259 . . . . 0.0 114.379 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.05 154.48 9.07 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.8 p -141.94 153.63 44.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.943 1.697 . . . . 0.0 112.143 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 123.343 0.497 . . . . 0.0 113.176 171.845 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 119.581 -0.247 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.98 136.39 41.03 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.515 1.476 . . . . 0.0 110.259 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -30.11 40.76 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.88 152.28 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.078 0.951 . . . . 0.0 110.849 169.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.64 109.65 17.61 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.837 0.827 . . . . 0.0 110.799 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.1 t -105.03 93.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.54 144.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.14 103.97 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.224 1.81 . . . . 0.0 107.09 169.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.32 -29.17 42.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.254 1.021 . . . . 0.0 112.504 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -156.28 165.7 35.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.17 139.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.901 1.681 . . . . 0.0 110.741 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 m -136.58 132.71 35.51 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.004 1.322 . . . . 0.0 110.712 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.75 123.33 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -117.41 150.39 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.611 1.564 . . . . 0.0 112.41 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 125.365 1.466 . . . . 0.0 113.611 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.78 128.59 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.979 0.912 . . . . 0.0 108.742 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -104.26 124.45 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.022 1.329 . . . . 0.0 109.958 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.0 123.54 40.74 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.173 0.989 . . . . 0.0 109.74 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -99.32 105.98 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.563 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.22 159.66 20.69 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.966 -0.459 . . . . 0.0 111.555 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -70.78 -6.05 34.78 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.67 ' CE1' HD11 ' A' ' 136' ' ' ILE . 20.1 p80 -110.37 -24.66 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.528 1.531 . . . . 0.0 113.759 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.77 145.17 4.14 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.258 1.885 . . . . 0.0 113.665 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.27 135.45 38.5 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.676 1.19 . . . . 0.0 112.836 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -132.66 142.62 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.313 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.18 136.91 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.321 1.048 . . . . 0.0 110.672 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 139.33 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.778 2.031 . . . . 0.0 110.255 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -105.94 123.51 48.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.694 1.998 . . . . 0.0 108.807 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -87.63 148.6 24.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.266 1.026 . . . . 0.0 112.183 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.15 74.17 1.03 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.684 1.23 . . . . 0.0 111.684 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.75 -27.07 64.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.499 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.122 0.969 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.73 -22.65 15.77 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 113.106 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.98 2.75 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.754 1.222 . . . . 0.0 112.816 -171.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.55 -44.88 19.96 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.249 2.633 . . . . 0.0 112.708 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -70.55 -41.26 72.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.777 -0.577 . . . . 0.0 110.996 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.432 ' HA ' HD13 ' A' ' 68' ' ' ILE . 23.1 m -63.06 -47.34 83.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.907 0.483 . . . . 0.0 111.71 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.87 -38.79 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.635 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -57.46 -44.47 84.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.002 1.274 . . . . 0.0 111.484 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -68.17 -39.22 82.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.455 0.702 . . . . 0.0 111.624 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.02 -50.61 73.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.705 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.31 -37.0 77.56 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.448 0.699 . . . . 0.0 111.422 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -56.93 -37.47 71.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.824 0.85 . . . . 0.0 111.965 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -74.15 -43.53 57.05 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.416 -0.803 . . . . 0.0 112.226 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.42 -37.96 76.44 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.84 -0.537 . . . . 0.0 111.808 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -32.76 72.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.257 1.823 . . . . 0.0 112.858 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.63 -15.62 54.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.973 0.909 . . . . 0.0 113.124 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.31 19.85 65.79 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.276 0.941 . . . . 0.0 113.149 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.09 -37.03 73.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.391 1.096 . . . . 0.0 113.068 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.889 0.476 . . . . 0.0 112.139 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -63.74 132.57 51.39 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.221 -0.924 . . . . 0.0 109.112 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.253 13.9 t30 59.42 25.14 13.83 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.722 2.009 . . . . 0.0 116.118 -171.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.2 p -83.27 142.32 31.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.933 -1.105 . . . . 0.0 113.212 170.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.9 pt -95.45 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -83.6 79.16 9.53 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 168.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -73.57 4.71 4.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -148.06 135.6 20.7 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.269 1.395 . . . . 0.0 112.439 171.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.45 131.04 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 110.676 170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -137.34 128.37 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.572 1.549 . . . . 0.0 108.399 -172.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -64.25 136.68 57.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.589 0.755 . . . . 0.0 111.97 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.29 9.66 61.25 Favored Glycine 0 CA--C 1.541 1.668 0 N-CA-C 115.091 0.797 . . . . 0.0 115.091 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.25 -177.16 5.32 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.558 1.943 . . . . 0.0 110.496 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.422 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -85.97 -179.34 6.77 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.674 1.589 . . . . 0.0 115.139 -170.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.0 pt -116.76 134.88 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.78 1.232 . . . . 0.0 112.303 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -108.72 153.52 23.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.659 1.183 . . . . 0.0 111.684 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.38 -179.96 34.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.228 0.918 . . . . 0.0 114.957 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.79 84.39 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.699 1.04 . . . . 0.0 115.699 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -21.4 35.96 Favored Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.115 1.458 . . . . 0.0 115.917 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.3 162.82 35.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.269 1.034 . . . . 0.0 113.45 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -90.27 158.98 42.9 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.851 1.66 . . . . 0.0 109.804 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.98 -8.99 13.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.668 3.578 . . . . 0.0 116.113 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.74 14.63 64.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.08 0.848 . . . . 0.0 114.534 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.37 26.94 16.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.913 1.685 . . . . 0.0 113.163 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.15 131.6 36.6 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.093 1.357 . . . . 0.0 109.842 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -75.9 129.35 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.086 1.898 . . . . 0.0 111.204 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -72.2 179.54 3.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 110.447 -3.07 . . . . 0.0 114.127 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.24 51.21 2.08 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.258 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.2 p -72.28 117.17 13.59 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.594 1.158 . . . . 0.0 111.944 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -138.0 178.87 6.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.176 2.191 . . . . 0.0 111.857 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 51.13 71.4 1.54 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.324 1.45 . . . . 0.0 113.728 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.08 147.95 94.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.3 2.667 . . . . 0.0 111.889 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -126.74 147.96 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.135 1.374 . . . . 0.0 110.64 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -64.76 153.27 40.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.919 0.888 . . . . 0.0 111.107 169.433 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.96 -54.89 40.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.256 8.6 mt-10 71.62 1.66 3.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.422 2.289 . . . . 0.0 117.029 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -14.21 59.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.478 1.944 . . . . 0.0 113.972 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -62.72 2.28 0.31 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.728 1.611 . . . . 0.0 114.126 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -74.18 -12.49 60.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.244 1.418 . . . . 0.0 113.543 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.76 77.56 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.075 1.321 . . . . 0.0 114.6 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.5 157.35 30.47 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.517 1.159 . . . . 0.0 112.16 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.6 148.11 52.36 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.67 113.38 18.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.972 2.509 . . . . 0.0 109.653 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -139.44 167.43 22.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.932 1.293 . . . . 0.0 110.569 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -56.45 122.83 12.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.851 0.834 . . . . 0.0 110.9 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.45 51.74 5.48 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.926 1.25 . . . . 0.0 113.74 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 p -138.89 162.96 33.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.176 0.991 . . . . 0.0 112.156 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.5 138.12 53.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.833 0.825 . . . . 0.0 113.176 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.32 160.83 37.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.143 0.577 . . . . 0.0 111.459 171.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.7 mmt -82.4 142.71 31.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.898 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.03 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.519 1.127 . . . . 0.0 110.054 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -106.06 155.79 19.05 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.225 1.01 . . . . 0.0 113.117 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -75.01 -51.61 13.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.685 0.794 . . . . 0.0 111.099 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -156.97 -40.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.139 1.375 . . . . 0.0 113.119 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.97 32.86 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.173 1.389 . . . . 0.0 111.879 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.59 -20.52 65.06 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.303 2.669 . . . . 0.0 114.295 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -108.23 39.38 1.98 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.165 1.786 . . . . 0.0 112.244 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.9 p -128.43 31.04 5.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.059 1.344 . . . . 0.0 113.475 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.33 56.76 3.36 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.826 1.651 . . . . 0.0 113.595 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.1 p -49.69 -70.76 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.767 2.027 . . . . 0.0 115.197 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.18 -21.87 0.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.717 1.207 . . . . 0.0 113.89 -169.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.66 139.87 49.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.411 -0.806 . . . . 0.0 110.568 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.3 168.49 19.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.75 2.02 . . . . 0.0 110.837 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 20.9 p90 -144.36 160.86 40.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.593 0.757 . . . . 0.0 111.887 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.3 mt -111.46 117.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -72.76 103.02 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.071 0.549 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.04 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.08 168.18 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 127.277 2.231 . . . . 0.0 112.212 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.75 122.98 25.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.877 1.271 . . . . 0.0 111.457 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -145.32 73.13 1.34 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.68 1.229 . . . . 0.0 112.403 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.47 -34.24 68.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.675 1.59 . . . . 0.0 114.365 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -56.92 -13.69 2.88 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.82 -12.74 58.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.14 169.51 17.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.99 155.35 40.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.738 1.615 . . . . 0.0 113.133 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.7 p -134.45 -56.77 0.85 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.614 1.166 . . . . 0.0 113.197 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 C-N-CA 123.947 0.784 . . . . 0.0 113.983 -177.681 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.27 1.7 p-90 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.97 -82.89 0.82 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.051 1.31 . . . . 0.0 115.165 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -128.93 123.55 32.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 112.548 -169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -83.06 131.77 35.15 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -75.64 99.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.011 0.924 . . . . 0.0 108.845 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -80.96 -16.78 52.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.712 0.805 . . . . 0.0 111.591 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 175.88 9.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.194 0.997 . . . . 0.0 113.624 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.51 149.65 48.27 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.481 -1.387 . . . . 0.0 112.144 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.26 135.1 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-O 121.481 0.658 . . . . 0.0 110.405 172.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.56 -41.09 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.499 1.92 . . . . 0.0 110.581 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -142.51 149.27 38.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.186 1.395 . . . . 0.0 110.313 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.32 8.54 28.89 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.342 0.972 . . . . 0.0 115.275 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 79.9 mmm -55.98 -37.68 69.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.176 1.488 . . . . 0.0 112.759 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.71 -29.96 71.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.84 . . . . 0.0 112.49 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.23 -45.26 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.021 1.728 . . . . 0.0 110.492 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.9 t -57.8 -40.11 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.392 1.077 . . . . 0.0 111.38 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 -19.47 61.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.47 1.508 . . . . 0.0 112.905 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -86.85 -39.84 15.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.67 HD11 ' CE1' ' A' ' 8' ' ' HIS . 54.1 mt -50.92 -41.72 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.499 1.52 . . . . 0.0 111.495 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -73.01 -17.71 61.42 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.34 -10.46 36.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.373 1.939 . . . . 0.0 114.796 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.62 -63.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.305 1.553 . . . . 0.0 110.471 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 156.07 2.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.907 1.283 . . . . 0.0 112.008 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.6 p -139.94 149.46 43.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.701 1.2 . . . . 0.0 112.181 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 C-N-CA 123.323 0.487 . . . . 0.0 112.464 170.941 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -68.26 134.88 32.61 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.73 1.62 . . . . 0.0 109.03 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -29.53 61.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -86.86 159.55 19.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.593 1.157 . . . . 0.0 110.303 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -82.79 109.89 17.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.41 1.084 . . . . 0.0 111.794 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.61 94.0 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.563 1.545 . . . . 0.0 106.913 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.79 149.01 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.239 1.495 . . . . 0.0 113.342 -169.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.72 103.9 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.03 -40.14 65.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.744 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -149.52 164.26 35.56 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.57 142.05 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.888 1.675 . . . . 0.0 110.929 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 m -136.24 134.0 37.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.629 1.171 . . . . 0.0 110.983 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.58 120.52 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.0 t -117.98 150.23 39.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.537 1.535 . . . . 0.0 112.723 -171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.388 1.475 . . . . 0.0 113.907 -170.869 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 120.27 0.081 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.98 129.99 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.936 0.894 . . . . 0.0 109.905 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.1 m -104.12 124.44 49.08 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.371 1.468 . . . . 0.0 109.766 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -99.47 123.54 43.84 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.464 1.106 . . . . 0.0 110.346 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -97.61 108.09 20.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.623 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -119.14 159.08 24.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 112.223 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -68.59 -6.77 27.52 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.499 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.2 p80 -110.67 -25.13 10.11 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.466 1.506 . . . . 0.0 113.634 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.38 145.85 4.3 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.123 1.82 . . . . 0.0 113.583 173.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.32 133.81 39.88 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.474 1.109 . . . . 0.0 112.535 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.4 mt -131.1 144.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.943 1.697 . . . . 0.0 109.499 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.26 137.76 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.387 1.075 . . . . 0.0 110.463 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -124.07 138.75 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.987 2.115 . . . . 0.0 110.087 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -106.83 125.37 50.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.109 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.5 p -87.75 149.49 24.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 112.075 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -108.59 74.5 0.92 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.766 1.27 . . . . 0.0 111.726 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.76 -25.9 64.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.548 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -77.57 -26.78 51.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.619 1.168 . . . . 0.0 111.675 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -101.84 -22.39 14.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.231 1.412 . . . . 0.0 112.972 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.73 56.41 1.59 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.891 1.276 . . . . 0.0 113.103 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.09 -44.36 29.94 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.496 2.797 . . . . 0.0 112.914 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.2 -41.45 77.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.793 0.724 . . . . 0.0 111.084 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -64.77 -48.59 73.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.725 0.41 . . . . 0.0 111.549 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.7 -41.46 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.573 . . . . 0.0 111.349 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.17 -45.59 87.22 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.571 1.078 . . . . 0.0 111.623 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.1 -34.31 70.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.682 0.674 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.84 -49.68 75.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.257 1.023 . . . . 0.0 111.733 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.358 -0.839 . . . . 0.0 111.658 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -56.52 -33.05 65.67 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.183 0.993 . . . . 0.0 112.628 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -77.61 -46.43 22.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 171.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.3 m -57.72 -40.1 78.8 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.967 0.907 . . . . 0.0 112.201 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -52.86 -46.68 67.99 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.659 1.984 . . . . 0.0 112.872 173.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -83.2 -14.55 53.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.055 0.942 . . . . 0.0 112.133 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.47 52.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.289 0.947 . . . . 0.0 113.046 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.29 -37.15 69.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.402 1.101 . . . . 0.0 113.241 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -83.33 -6.44 59.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.396 0.679 . . . . 0.0 112.132 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -64.41 132.35 49.82 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.1 t30 53.82 49.91 18.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.319 1.448 . . . . 0.0 113.998 -171.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.8 p -114.44 157.14 23.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.304 1.042 . . . . 0.0 112.393 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.41 155.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -86.4 75.97 9.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.863 1.265 . . . . 0.0 107.855 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -53.16 -38.23 62.58 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.0 1.72 . . . . 0.0 114.76 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -123.64 135.53 53.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.56 1.144 . . . . 0.0 111.495 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.2 132.69 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.408 2.283 . . . . 0.0 110.578 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.44 128.9 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.622 1.569 . . . . 0.0 107.989 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 133.49 55.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 111.631 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.97 9.32 66.14 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 123.898 0.761 . . . . 0.0 114.871 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -141.52 -177.28 5.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.153 1.781 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.21 -179.55 5.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.7 136.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.054 1.342 . . . . 0.0 112.399 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.92 146.63 46.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.194 1.398 . . . . 0.0 111.094 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.92 31.03 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.18 -8.73 72.56 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.647 1.594 . . . . 0.0 115.944 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.76 -20.65 70.53 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 118.961 1.381 . . . . 0.0 115.479 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.2 164.9 28.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.482 1.113 . . . . 0.0 113.652 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -101.29 163.65 17.52 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.028 1.731 . . . . 0.0 110.629 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.01 -12.12 28.12 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.384 2.723 . . . . 0.0 118.0 -169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.08 14.59 60.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 123.452 0.549 . . . . 0.0 114.426 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.6 mmt 59.49 28.74 18.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.582 1.953 . . . . 0.0 112.757 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.81 123.01 28.95 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.1 1.36 . . . . 0.0 109.555 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.82 126.62 30.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 124.365 2.031 . . . . 0.0 110.887 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.0 179.74 2.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 110.077 -3.238 . . . . 0.0 114.408 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.06 64.11 3.27 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.372 -2.195 . . . . 0.0 112.147 -174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 p -70.22 107.29 3.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.146 1.379 . . . . 0.0 110.838 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -140.9 168.03 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.133 2.173 . . . . 0.0 112.401 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 50.13 66.94 4.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 0.0 112.487 171.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.62 145.97 97.21 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.469 2.779 . . . . 0.0 113.664 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.85 146.05 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.515 1.926 . . . . 0.0 109.053 -176.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 158.74 16.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.553 1.141 . . . . 0.0 111.143 170.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -73.44 134.55 43.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 111.614 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.04 13.63 12.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.086 1.354 . . . . 0.0 112.675 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -11.85 56.43 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.565 -1.334 . . . . 0.0 114.128 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -62.24 5.27 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.309 1.444 . . . . 0.0 114.553 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -76.53 -11.35 59.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.773 1.629 . . . . 0.0 112.826 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 6.47 85.39 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.256 1.407 . . . . 0.0 115.071 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.53 154.85 38.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.361 1.081 . . . . 0.0 112.25 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.55 149.21 51.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -86.03 64.24 8.47 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.44 1.896 . . . . 0.0 112.528 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.8 p -98.57 166.24 11.44 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.735 0.814 . . . . 0.0 112.235 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.05 123.25 11.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.878 1.671 . . . . 0.0 111.019 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.25 56.37 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.315 1.436 . . . . 0.0 114.945 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.2 p -110.51 161.36 15.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.591 1.695 . . . . 0.0 113.266 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -118.98 135.34 54.66 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.031 0.932 . . . . 0.0 112.734 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.43 159.39 41.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.652 174.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -81.7 143.04 32.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 111.204 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 153.99 18.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.953 0.901 . . . . 0.0 110.617 169.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -133.9 152.94 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.134 1.374 . . . . 0.0 111.923 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -65.32 -55.08 20.23 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.837 1.255 . . . . 0.0 112.708 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.71 -55.48 0.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.758 1.223 . . . . 0.0 111.366 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.47 159.04 86.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.574 1.15 . . . . 0.0 111.5 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.37 -26.28 81.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.005 2.47 . . . . 0.0 113.703 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -114.28 42.15 2.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.317 1.447 . . . . 0.0 111.947 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -122.61 30.64 6.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.309 1.444 . . . . 0.0 114.124 -173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.06 22.67 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.268 1.427 . . . . 0.0 107.465 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -132.51 -59.48 0.91 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.23 1.412 . . . . 0.0 112.739 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.57 -11.85 1.58 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 0.0 112.677 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -78.96 134.37 36.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.551 1.14 . . . . 0.0 110.383 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -141.32 168.1 20.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.082 1.753 . . . . 0.0 111.635 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 9.6 p90 -149.96 163.12 38.94 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.856 0.862 . . . . 0.0 111.751 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.0 mt -117.26 119.19 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.922 1.289 . . . . 0.0 108.538 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -72.59 97.57 2.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.564 0.745 . . . . 0.0 110.037 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 m -76.14 -15.54 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.8 167.01 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 128.724 2.809 . . . . 0.0 110.296 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.22 116.54 13.88 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.204 0.526 . . . . 0.0 111.525 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.9 57.25 1.28 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 111.921 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -64.82 -15.59 61.97 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -66.08 -15.12 62.8 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.779 -1.201 . . . . 0.0 113.383 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.37 -8.73 59.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.37 1.068 . . . . 0.0 113.452 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.28 179.83 3.73 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -79.08 141.09 37.66 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.561 1.544 . . . . 0.0 112.483 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.6 p -104.17 -60.31 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.638 1.175 . . . . 0.0 113.591 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 123.818 0.723 . . . . 0.0 114.732 -172.176 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.299 8.0 p-90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 122.044 0.926 . . . . 0.0 113.36 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.84 -96.45 0.69 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.339 1.447 . . . . 0.0 115.618 -169.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.51 137.64 48.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 111.805 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.8 129.31 34.87 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.27 94.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.794 1.238 . . . . 0.0 108.455 169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -80.64 -15.38 56.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.401 0.681 . . . . 0.0 111.821 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.03 177.97 8.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.46 1.124 . . . . 0.0 113.554 -171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -137.14 153.6 50.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 120.811 -1.181 . . . . 0.0 112.105 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.84 138.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.509 0.671 . . . . 0.0 110.443 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.33 -41.95 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.993 1.717 . . . . 0.0 111.187 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -143.48 153.84 43.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.141 1.377 . . . . 0.0 110.584 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.31 39.15 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.526 1.06 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.9 mtp -60.66 -35.17 75.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.895 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -65.12 -29.07 69.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.865 0.866 . . . . 0.0 112.142 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.05 -43.6 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.491 1.517 . . . . 0.0 110.307 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.59 -38.95 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.488 1.115 . . . . 0.0 111.253 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.13 -20.09 60.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.419 1.488 . . . . 0.0 113.0 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -86.22 -40.55 15.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.761 1.624 . . . . 0.0 111.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.4 mt -54.7 -34.44 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.487 1.515 . . . . 0.0 112.065 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -83.82 -16.58 44.06 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.0 13.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.182 1.372 . . . . 0.0 114.091 -173.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.84 -62.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.405 1.102 . . . . 0.0 113.312 -174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.79 157.27 5.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.013 0.925 . . . . 0.0 113.458 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -139.47 155.14 47.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 111.772 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.612 0 CA-C-O 123.329 1.516 . . . . 0.0 115.137 170.266 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.0 135.84 28.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.703 1.602 . . . . 0.0 110.059 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.8 51.63 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -84.72 157.69 20.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 110.058 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -79.91 125.86 30.28 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.01 -1.057 . . . . 0.0 111.207 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.92 93.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.354 1.861 . . . . 0.0 107.732 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 144.27 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.98 110.51 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.96 -41.58 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.689 0.677 . . . . 0.0 110.389 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.77 165.6 33.0 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.18 142.51 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.06 1.744 . . . . 0.0 111.446 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -136.37 136.29 39.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.987 1.315 . . . . 0.0 110.683 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.71 123.95 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.2 t -122.51 143.61 49.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 112.087 -169.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.31 1.844 . . . . 0.0 112.082 178.783 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.08 128.34 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.988 1.267 . . . . 0.0 110.423 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.9 m -100.37 125.6 46.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.277 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -101.44 128.02 47.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.999 1.319 . . . . 0.0 110.518 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.19 95.79 6.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -99.9 152.36 20.25 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.901 -0.5 . . . . 0.0 110.829 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -60.31 -13.84 15.05 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -97.97 -11.14 23.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 113.624 171.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.87 167.84 13.72 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.651 1.596 . . . . 0.0 113.408 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.3 137.25 41.02 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.754 1.622 . . . . 0.0 112.821 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -133.2 140.48 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.752 2.021 . . . . 0.0 108.561 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.96 134.18 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.464 1.105 . . . . 0.0 110.266 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.02 133.88 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.483 1.913 . . . . 0.0 110.039 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -99.64 126.86 45.72 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.898 1.679 . . . . 0.0 108.44 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -89.08 146.77 24.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.24 1.016 . . . . 0.0 110.999 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -103.65 73.73 1.2 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 122.669 1.224 . . . . 0.0 111.458 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.86 -26.28 64.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.77 -1.104 . . . . 0.0 112.48 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.87 -27.97 49.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.253 1.021 . . . . 0.0 111.672 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.72 -18.87 15.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.104 1.362 . . . . 0.0 113.222 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.0 55.39 1.19 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.665 1.186 . . . . 0.0 113.123 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.72 -44.97 27.6 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.47 2.78 . . . . 0.0 112.952 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.27 -41.82 80.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.108 0.563 . . . . 0.0 110.971 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -65.42 -45.43 83.94 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.175 0.59 . . . . 0.0 111.789 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.97 -43.09 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.583 0.753 . . . . 0.0 111.761 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.66 -42.48 79.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.96 1.254 . . . . 0.0 111.797 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -70.2 -37.95 75.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.733 0.813 . . . . 0.0 111.626 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.91 -48.96 79.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.432 1.093 . . . . 0.0 111.713 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.98 -37.97 79.07 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.593 0.757 . . . . 0.0 111.456 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -57.25 -33.88 68.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.361 1.065 . . . . 0.0 112.808 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 18.5 m-85 -76.84 -44.73 31.13 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.462 -0.774 . . . . 0.0 112.493 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -59.98 -35.98 76.16 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.63 -0.669 . . . . 0.0 111.658 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.78 -34.28 77.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.026 2.13 . . . . 0.0 112.945 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.43 -14.48 52.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.029 0.932 . . . . 0.0 113.372 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.51 19.23 60.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.553 1.073 . . . . 0.0 113.885 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 54.4 t80 -68.27 -17.72 64.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.13 -3.63 44.19 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.269 -0.894 . . . . 0.0 113.137 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.5 135.29 54.97 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.135 -0.978 . . . . 0.0 108.952 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 54.16 47.17 23.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.531 1.533 . . . . 0.0 113.689 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.3 p -114.37 151.23 33.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.836 0.855 . . . . 0.0 112.532 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 pt -103.3 162.05 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.45 86.41 6.77 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -80.05 2.63 23.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -169.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -144.25 143.16 30.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.967 2.167 . . . . 0.0 113.46 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.14 131.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 110.271 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.2 mt -137.65 129.64 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.613 1.565 . . . . 0.0 108.15 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.84 133.5 54.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.756 0.822 . . . . 0.0 111.782 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 9.37 65.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 123.895 0.759 . . . . 0.0 114.947 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -141.89 -177.3 5.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 110.872 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -179.25 5.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.869 1.667 . . . . 0.0 115.379 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.9 pt -114.31 135.91 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.885 1.274 . . . . 0.0 112.446 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.31 150.77 25.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.434 1.094 . . . . 0.0 110.653 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.87 34.66 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.05 -2.32 61.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.811 1.672 . . . . 0.0 115.662 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.31 -14.94 65.29 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 118.921 1.361 . . . . 0.0 115.833 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.38 167.09 23.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.744 1.217 . . . . 0.0 112.782 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.55 164.5 18.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.729 1.612 . . . . 0.0 110.711 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.38 -11.91 28.02 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.514 2.809 . . . . 0.0 116.811 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.59 15.94 62.23 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.088 0.851 . . . . 0.0 114.477 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.1 mmt 61.42 26.46 16.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.058 1.743 . . . . 0.0 113.221 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -83.22 127.18 33.4 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.834 1.254 . . . . 0.0 109.357 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -73.57 119.24 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.966 0.906 . . . . 0.0 110.145 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -69.43 164.83 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.136 0.974 . . . . 0.0 113.472 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 66.04 9.47 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.814 1.645 . . . . 0.0 111.494 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.4 p -69.18 134.47 49.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.932 1.293 . . . . 0.0 112.219 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -137.71 174.05 10.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.022 2.129 . . . . 0.0 111.965 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.12 66.24 5.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.451 1.5 . . . . 0.0 113.605 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.62 135.76 62.66 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.284 2.656 . . . . 0.0 111.067 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.08 151.61 7.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 125.849 1.66 . . . . 0.0 108.166 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 157.11 27.45 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.638 0.732 . . . . 0.0 111.565 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -81.81 103.68 11.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.33 1.052 . . . . 0.0 111.198 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.75 23.83 1.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.529 1.132 . . . . 0.0 113.289 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.6 -19.86 66.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 119.863 -1.773 . . . . 0.0 113.784 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -65.44 8.82 0.14 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.344 1.458 . . . . 0.0 114.516 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -77.97 -10.06 59.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.144 1.378 . . . . 0.0 113.426 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.66 81.62 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.101 1.334 . . . . 0.0 114.83 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.77 158.61 26.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.498 1.149 . . . . 0.0 112.706 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -130.69 155.07 47.23 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.18 111.56 23.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.489 2.316 . . . . 0.0 110.478 -174.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -142.3 170.38 15.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.327 1.451 . . . . 0.0 111.175 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -38.88 117.13 0.63 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.979 1.712 . . . . 0.0 111.948 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.86 33.29 30.46 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 124.352 0.977 . . . . 0.0 114.787 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.1 p -123.39 157.68 32.82 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.897 1.348 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.78 136.7 54.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.27 160.77 38.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.982 171.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.6 mtt -84.04 143.22 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.39 147.89 22.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.641 1.176 . . . . 0.0 111.766 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 165.62 14.03 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.27 1.028 . . . . 0.0 113.518 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -81.56 -57.14 3.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.136 0.974 . . . . 0.0 110.873 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -151.47 -38.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.082 1.353 . . . . 0.0 113.68 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.89 156.46 35.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.014 1.326 . . . . 0.0 111.48 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.91 -23.91 76.44 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.63 2.22 . . . . 0.0 114.324 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -103.37 33.0 3.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.539 1.536 . . . . 0.0 112.746 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.3 p -118.2 26.09 9.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.42 1.488 . . . . 0.0 113.158 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.13 98.8 2.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.676 1.191 . . . . 0.0 108.574 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.2 p -90.04 -68.64 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.519 1.128 . . . . 0.0 111.691 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.32 20.07 1.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.731 1.212 . . . . 0.0 113.445 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -110.41 142.7 41.76 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.805 -1.185 . . . . 0.0 111.145 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -143.77 168.16 20.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.48 1.512 . . . . 0.0 111.036 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.0 p90 -142.86 158.3 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.353 0.661 . . . . 0.0 111.878 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 mt -111.12 118.38 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -75.27 108.78 8.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.08 0.552 . . . . 0.0 110.137 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.03 -11.02 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.42 165.15 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.985 2.514 . . . . 0.0 111.274 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.25 120.99 25.07 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.843 0.457 . . . . 0.0 109.843 169.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -140.93 74.81 1.48 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.711 1.243 . . . . 0.0 112.459 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.62 -34.57 62.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.153 1.781 . . . . 0.0 114.406 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -59.41 -13.71 9.53 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.89 -8.51 59.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -80.92 177.04 9.31 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.464 . . . . 0.0 114.174 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -89.77 140.76 29.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.877 1.271 . . . . 0.0 112.695 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.2 p -109.34 -61.02 1.69 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.761 1.224 . . . . 0.0 113.351 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 163.89 69.43 0.02 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.459 1.028 . . . . 0.0 113.65 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.59 26.01 5.35 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.133 1.773 . . . . 0.0 115.089 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -111.09 116.62 31.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.164 . . . . 0.0 110.106 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.1 -36.19 62.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -74.68 -10.96 60.03 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.57 -71.06 0.97 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 127.24 2.352 . . . . 0.0 114.0 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -73.49 135.09 44.02 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.31 -113.33 2.47 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.153 1.835 . . . . 0.0 114.877 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.98 148.02 50.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 113.067 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.39 126.62 31.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.05 94.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -80.46 -15.36 56.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.63 176.65 8.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.557 1.17 . . . . 0.0 113.951 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.17 154.18 48.03 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.854 -1.154 . . . . 0.0 112.335 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.49 139.49 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.651 0.739 . . . . 0.0 109.865 170.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 t -111.18 -42.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.765 1.626 . . . . 0.0 110.99 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.88 154.76 42.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.469 1.508 . . . . 0.0 109.997 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.21 16.3 25.62 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 123.849 0.737 . . . . 0.0 114.217 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -34.78 67.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.891 1.345 . . . . 0.0 112.256 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.15 -30.44 70.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.1 t -76.27 -40.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.943 1.297 . . . . 0.0 110.408 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.61 -41.89 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.277 -0.889 . . . . 0.0 110.867 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.54 -25.37 63.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.131 1.372 . . . . 0.0 112.355 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -74.57 -52.6 11.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.384 1.074 . . . . 0.0 110.208 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -53.65 -35.56 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.327 1.851 . . . . 0.0 112.793 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.47 -11.46 32.0 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.68 -15.82 10.69 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.718 1.628 . . . . 0.0 114.165 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.53 -63.33 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.45 1.125 . . . . 0.0 112.707 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -176.83 153.64 1.07 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.752 1.621 . . . . 0.0 111.499 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.4 p -125.9 148.67 49.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.985 1.314 . . . . 0.0 112.842 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.37 125.04 0.92 Allowed Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.263 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -73.5 151.36 41.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.4 p -111.28 168.93 9.14 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.599 1.56 . . . . 0.0 112.689 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.9 -21.95 75.46 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.144 0.818 . . . . 0.0 115.144 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.5 mtp -105.61 -34.89 7.6 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.48 1.14 . . . . 0.0 113.558 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.14 127.41 32.0 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.664 1.586 . . . . 0.0 111.223 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.94 161.93 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.332 1.053 . . . . 0.0 112.142 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 55.93 55.64 6.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.846 1.658 . . . . 0.0 112.34 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.05 152.46 54.31 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.083 2.153 . . . . 0.0 111.795 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.07 138.89 49.05 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.798 1.665 . . . . 0.0 109.559 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -30.74 54.51 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.856 -0.527 . . . . 0.0 112.152 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.15 149.04 32.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.879 0.872 . . . . 0.0 109.848 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -84.03 119.74 25.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 111.313 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.99 108.69 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.318 1.047 . . . . 0.0 109.242 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 148.28 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.884 1.326 . . . . 0.0 111.574 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.1 mt -87.24 103.35 13.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.16 -38.37 60.93 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.71 -0.619 . . . . 0.0 110.197 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 p -151.61 166.96 29.61 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.03 142.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 110.629 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -135.42 128.4 31.47 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.061 1.344 . . . . 0.0 110.205 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.74 124.04 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.518 -0.739 . . . . 0.0 109.02 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -113.36 150.5 32.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.253 1.421 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.753 1.621 . . . . 0.0 113.323 -169.814 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.2 t -124.68 132.45 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m -104.86 124.89 50.25 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.812 1.245 . . . . 0.0 110.152 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -98.34 132.14 44.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.659 1.184 . . . . 0.0 110.45 169.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -104.22 98.39 8.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -103.77 151.95 22.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.068 -0.395 . . . . 0.0 111.267 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -60.53 -9.36 3.65 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.27 -8.15 18.47 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.815 1.246 . . . . 0.0 114.014 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.51 163.96 10.93 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.411 1.482 . . . . 0.0 113.617 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.43 137.99 44.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.812 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.52 140.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.352 1.861 . . . . 0.0 108.886 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 t -122.34 137.66 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.566 1.147 . . . . 0.0 110.326 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.59 138.43 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.587 1.955 . . . . 0.0 110.409 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -100.5 128.76 46.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.013 2.125 . . . . 0.0 107.713 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 p -88.45 146.46 25.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.303 1.041 . . . . 0.0 111.201 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -102.85 73.79 1.29 Allowed 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 122.614 1.197 . . . . 0.0 111.293 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.59 -27.65 65.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.352 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.15 -29.19 57.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.426 1.09 . . . . 0.0 111.53 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.85 -27.56 14.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.835 1.254 . . . . 0.0 112.835 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.89 61.72 4.33 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.8 0.84 . . . . 0.0 113.188 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.11 -43.7 23.07 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.32 2.68 . . . . 0.0 112.906 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -69.2 -40.54 77.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.484 0.583 . . . . 0.0 110.852 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -64.86 -47.54 77.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.315 0.646 . . . . 0.0 111.593 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.63 -44.51 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 111.342 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -55.95 -48.26 76.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.55 1.068 . . . . 0.0 112.039 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -68.12 -38.32 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.572 0.624 . . . . 0.0 111.878 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.13 -49.04 79.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.329 1.051 . . . . 0.0 111.673 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.35 -38.18 81.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.555 0.742 . . . . 0.0 111.554 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -59.1 -33.36 70.76 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.847 0.859 . . . . 0.0 112.665 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 -43.95 50.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.909 0.777 . . . . 0.0 112.285 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.33 -36.15 79.36 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.578 -0.701 . . . . 0.0 111.687 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.71 -34.1 77.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.087 2.155 . . . . 0.0 112.86 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.71 -13.34 56.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.963 0.905 . . . . 0.0 113.267 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.97 18.61 62.83 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.628 1.109 . . . . 0.0 113.939 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.65 -17.56 64.12 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -96.7 -5.42 38.82 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.414 -0.804 . . . . 0.0 113.022 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -67.67 136.07 53.78 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.59 44.46 29.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.353 1.461 . . . . 0.0 113.828 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -109.32 164.4 12.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.865 0.866 . . . . 0.0 111.742 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 11.3 pt -124.75 159.05 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -169.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -91.14 96.59 10.66 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -88.39 -11.46 46.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -143.27 136.15 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.939 1.245 . . . . 0.0 113.374 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -135.4 145.11 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 128.145 2.578 . . . . 0.0 109.018 169.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -133.14 131.18 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.734 1.614 . . . . 0.0 108.188 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.62 126.77 28.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.111 0.964 . . . . 0.0 112.594 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.1 11.81 70.97 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 123.81 0.719 . . . . 0.0 114.81 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.15 -176.98 4.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.495 1.918 . . . . 0.0 110.979 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.72 -179.25 7.26 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.2 pt -118.95 134.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.485 1.514 . . . . 0.0 112.91 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -112.18 146.47 38.03 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.746 1.219 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.23 35.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.693 1.437 . . . . 0.0 116.693 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.94 -4.69 85.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.952 1.739 . . . . 0.0 115.602 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -15.84 64.84 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -169.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -146.61 164.71 31.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.746 1.273 . . . . 0.0 112.939 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.19 161.82 31.95 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.502 1.521 . . . . 0.0 110.003 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -63.29 -13.0 33.18 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.298 2.665 . . . . 0.0 117.729 -169.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.44 14.96 64.08 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 123.908 0.766 . . . . 0.0 114.496 171.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.1 mmm 58.1 39.44 26.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.343 1.857 . . . . 0.0 112.988 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -92.28 127.95 37.95 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.369 1.467 . . . . 0.0 109.53 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -75.37 123.67 25.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.423 1.089 . . . . 0.0 111.166 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -73.44 162.75 28.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.72 73.51 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.561 1.544 . . . . 0.0 111.538 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 p -72.0 131.58 43.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.299 1.039 . . . . 0.0 112.118 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -137.37 175.04 9.96 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.463 1.905 . . . . 0.0 112.527 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 50.62 69.49 2.57 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.746 1.619 . . . . 0.0 113.996 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.49 135.68 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.189 2.592 . . . . 0.0 111.515 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.88 154.04 7.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.298 1.839 . . . . 0.0 108.535 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 158.07 18.47 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.23 0.612 . . . . 0.0 111.829 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -72.54 127.64 33.16 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.198 0.599 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -113.03 12.05 19.13 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.022 1.329 . . . . 0.0 112.73 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 -11.71 46.67 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.197 -1.565 . . . . 0.0 113.762 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -58.62 -1.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.95 0.83 29.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.122 1.369 . . . . 0.0 111.569 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.71 10.14 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.708 1.623 . . . . 0.0 114.094 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.8 mt -78.64 157.07 28.75 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.78 158.44 36.55 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -117.68 109.84 17.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.786 2.034 . . . . 0.0 110.717 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -136.0 169.87 16.91 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.703 1.201 . . . . 0.0 111.537 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.1 126.27 24.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.988 0.899 . . . . 0.0 111.079 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.7 24.45 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.923 1.249 . . . . 0.0 114.651 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.5 p -123.86 159.11 30.33 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.172 1.486 . . . . 0.0 113.096 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.69 137.78 54.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.3 159.0 42.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.007 0.523 . . . . 0.0 111.923 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 94.7 mmm -78.34 138.21 38.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.089 -0.382 . . . . 0.0 110.518 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.94 150.31 25.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.106 0.562 . . . . 0.0 110.66 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -115.3 160.77 19.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.536 1.134 . . . . 0.0 112.896 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.8 m -75.56 -52.46 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.054 0.942 . . . . 0.0 111.285 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.27 -57.39 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.559 1.544 . . . . 0.0 110.716 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.99 157.47 78.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.946 1.298 . . . . 0.0 112.115 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.25 -23.09 73.03 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.48 2.787 . . . . 0.0 114.068 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -111.52 36.78 3.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.739 1.615 . . . . 0.0 112.41 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 p -121.15 26.52 8.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.388 1.475 . . . . 0.0 113.843 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.62 99.67 10.34 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.364 1.466 . . . . 0.0 109.447 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -87.07 -71.55 0.55 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.186 . . . . 0.0 112.618 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.9 38.73 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -129.36 152.3 49.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.374 1.07 . . . . 0.0 111.903 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.18 168.41 19.81 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.504 1.522 . . . . 0.0 110.716 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 8.1 p90 -144.03 159.49 42.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.16 0.584 . . . . 0.0 111.055 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 mt -116.42 120.12 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.44 102.8 5.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.167 0.587 . . . . 0.0 109.525 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.28 -18.05 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.88 165.69 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.592 1.557 . . . . 0.0 111.663 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -78.48 119.4 21.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.792 0.437 . . . . 0.0 110.03 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -143.03 63.02 1.39 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 123.009 1.385 . . . . 0.0 111.758 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.27 -11.9 53.15 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -172.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -64.42 -13.68 52.6 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.579 -1.325 . . . . 0.0 113.573 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.06 -13.88 58.96 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.529 1.132 . . . . 0.0 113.431 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -69.32 167.06 17.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.39 1.476 . . . . 0.0 114.904 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -70.2 138.3 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -143.77 21.9 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.5 63.02 0.66 Allowed Glycine 0 N--CA 1.476 1.364 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.33 26.35 10.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.56 1.544 . . . . 0.0 114.916 169.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -127.2 136.85 52.61 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.601 1.16 . . . . 0.0 112.353 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.902 1.281 . . . . 0.0 113.916 -170.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -72.93 -17.26 61.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.836 0.454 . . . . 0.0 112.209 172.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.26 -94.82 1.09 Allowed Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.194 2.33 . . . . 0.0 111.72 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.94 126.2 29.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.09 -54.88 0.83 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.853 1.216 . . . . 0.0 114.259 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -143.82 158.96 43.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.429 1.492 . . . . 0.0 111.72 -169.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 35.0 t -93.66 119.19 32.36 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.646 -0.658 . . . . 0.0 112.657 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.2 82.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.218 1.407 . . . . 0.0 108.66 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -77.5 -13.25 59.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.914 0.886 . . . . 0.0 112.309 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.08 177.56 8.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 122.751 1.262 . . . . 0.0 114.278 -169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -141.96 154.29 44.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.511 1.124 . . . . 0.0 112.792 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.36 143.49 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.68 0.753 . . . . 0.0 110.394 172.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.8 t -117.11 -40.99 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.79 1.636 . . . . 0.0 111.122 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -145.19 155.12 43.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.869 1.667 . . . . 0.0 109.75 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.92 16.37 23.89 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.817 0.723 . . . . 0.0 114.327 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -33.55 66.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.834 1.317 . . . . 0.0 112.33 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.52 -29.14 69.16 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.545 0.738 . . . . 0.0 112.551 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.01 -41.52 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.256 1.423 . . . . 0.0 110.238 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.24 -39.89 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.879 -1.138 . . . . 0.0 111.042 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.0 -30.47 68.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.112 1.365 . . . . 0.0 111.953 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.09 -42.89 62.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.986 0.914 . . . . 0.0 111.168 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.13 -25.12 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.494 1.517 . . . . 0.0 112.409 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -86.39 -23.3 26.18 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.39 -7.61 69.32 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.986 1.755 . . . . 0.0 114.779 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.79 -27.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 84.55 163.54 0.1 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.522 2.329 . . . . 0.0 114.057 -169.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 p -118.92 143.98 46.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.196 1.398 . . . . 0.0 113.668 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.16 128.84 1.85 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.034 1.302 . . . . 0.0 111.426 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -62.61 146.01 53.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.52 1.128 . . . . 0.0 113.344 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.3 p -98.42 169.62 9.42 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.392 1.477 . . . . 0.0 111.755 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -5.66 12.55 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.043 -0.865 . . . . 0.0 115.064 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -119.82 -37.99 3.03 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.986 1.314 . . . . 0.0 113.574 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -141.55 137.38 31.95 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.98 1.712 . . . . 0.0 110.767 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -95.08 156.04 16.48 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.373 1.069 . . . . 0.0 113.443 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 t70 58.22 31.59 20.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 114.523 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m -86.61 156.37 56.08 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.317 1.447 . . . . 0.0 111.429 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.54 137.57 70.17 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.709 1.606 . . . . 0.0 110.512 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -32.17 61.89 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -84.91 147.38 26.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.184 0.593 . . . . 0.0 110.544 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.18 116.73 23.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.196 0.998 . . . . 0.0 111.071 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 91.0 t -114.85 108.06 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.316 1.047 . . . . 0.0 108.483 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -129.52 141.34 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.439 1.114 . . . . 0.0 111.932 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.2 mt -83.61 103.44 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.38 -36.87 66.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.186 0.594 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.6 t -154.37 165.22 37.04 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -133.76 141.07 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.791 2.037 . . . . 0.0 110.431 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -135.76 131.75 35.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 110.187 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.62 124.07 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.309 -0.869 . . . . 0.0 108.82 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.7 t -117.36 150.3 39.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.077 1.351 . . . . 0.0 112.749 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.93 1.692 . . . . 0.0 113.629 -169.707 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 120.318 0.104 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.9 t -123.46 129.97 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.4 m -104.36 123.68 47.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.98 1.312 . . . . 0.0 110.205 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.36 132.31 42.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.568 1.147 . . . . 0.0 110.688 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -103.18 103.13 13.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -106.48 151.49 24.89 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.966 -0.459 . . . . 0.0 111.126 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -60.57 -7.63 2.3 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -108.28 -8.71 15.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.005 1.322 . . . . 0.0 114.094 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.96 163.5 11.17 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.505 1.526 . . . . 0.0 113.859 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.04 138.82 44.29 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.034 1.734 . . . . 0.0 112.957 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.82 141.51 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.512 1.925 . . . . 0.0 109.062 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -124.62 135.66 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 110.805 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 139.72 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.743 2.017 . . . . 0.0 110.389 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -105.07 125.77 51.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.638 1.975 . . . . 0.0 108.844 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -88.96 147.5 24.28 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.379 1.072 . . . . 0.0 111.553 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -104.94 74.52 1.13 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.792 1.282 . . . . 0.0 111.202 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.76 -26.3 64.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.618 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.81 -28.0 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 111.386 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -95.83 -29.13 14.39 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.388 1.475 . . . . 0.0 112.398 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.74 58.55 3.32 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 0.0 113.003 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -60.87 -43.19 32.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.493 2.795 . . . . 0.0 112.932 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -68.33 -40.38 81.63 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.741 0.7 . . . . 0.0 110.893 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 m -63.91 -51.33 64.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.641 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.57 -38.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -56.33 -49.58 73.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.601 1.091 . . . . 0.0 111.484 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -68.81 -36.74 78.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.412 0.551 . . . . 0.0 112.19 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.59 -49.63 77.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.763 1.225 . . . . 0.0 111.426 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.71 -34.71 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.368 -0.833 . . . . 0.0 112.449 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -45.2 77.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.573 0.349 . . . . 0.0 110.261 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.45 -40.68 81.0 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.593 -0.692 . . . . 0.0 111.456 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.77 -40.06 86.95 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.878 -0.514 . . . . 0.0 111.397 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -72.67 -30.07 63.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.376 1.47 . . . . 0.0 113.385 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -79.41 -16.54 56.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.631 0.65 . . . . 0.0 112.372 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.66 17.39 56.81 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.497 1.046 . . . . 0.0 113.298 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.04 -41.66 97.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.438 1.095 . . . . 0.0 113.121 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -81.49 -15.21 55.67 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.27 5.31 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.87 17.49 1.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.064 1.346 . . . . 0.0 112.986 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.7 p -81.67 163.17 22.7 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.126 -0.984 . . . . 0.0 112.345 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 156' ' ' ILE . 12.0 pt -119.26 165.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.08 89.45 6.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.412 1.485 . . . . 0.0 108.573 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -85.68 -3.06 58.78 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.92 134.6 45.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.822 1.646 . . . . 0.0 111.173 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.42 135.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.504 1.522 . . . . 0.0 110.807 169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.79 128.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.61 1.564 . . . . 0.0 108.429 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.26 132.2 49.57 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.611 0.764 . . . . 0.0 111.691 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.05 10.99 66.21 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 123.956 0.789 . . . . 0.0 115.029 -174.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.01 -177.23 5.34 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.121 1.769 . . . . 0.0 111.019 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -83.75 177.41 8.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.44 140.0 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.61 1.564 . . . . 0.0 111.857 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -123.41 148.5 46.06 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 0.0 111.287 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.16 -178.1 27.39 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.557 1.075 . . . . 0.0 114.51 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 -1.09 89.27 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.31 0.957 . . . . 0.0 115.342 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.94 -27.06 32.56 Favored Glycine 0 N--CA 1.473 1.102 0 CA-C-N 118.931 1.366 . . . . 0.0 115.391 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.22 161.86 37.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -88.62 164.46 31.96 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 126.048 1.739 . . . . 0.0 109.69 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.31 -11.49 30.42 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.337 2.692 . . . . 0.0 117.518 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 17.16 59.81 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.273 0.94 . . . . 0.0 114.61 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.7 mmm 59.46 37.83 22.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.152 1.781 . . . . 0.0 113.31 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.074 1.349 . . . . 0.0 109.468 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -74.19 131.92 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 124.143 1.925 . . . . 0.0 111.792 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -75.93 -179.29 4.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 110.322 -3.127 . . . . 0.0 114.519 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.65 56.49 3.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 112.869 -1.968 . . . . 0.0 112.066 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 p -69.41 106.25 2.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.084 1.354 . . . . 0.0 110.824 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -137.87 169.25 18.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 111.947 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 48.49 62.89 11.3 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.486 1.514 . . . . 0.0 113.183 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -58.11 134.79 64.34 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.539 2.826 . . . . 0.0 111.749 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.24 152.55 4.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.356 1.862 . . . . 0.0 107.837 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 158.67 17.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.192 0.597 . . . . 0.0 110.67 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -71.43 134.6 46.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.179 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.38 14.09 12.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.765 1.226 . . . . 0.0 112.627 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.49 59.93 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.434 -1.416 . . . . 0.0 113.93 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.93 0.21 0.24 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.629 1.972 . . . . 0.0 115.822 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -81.37 -3.45 52.79 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.036 1.334 . . . . 0.0 112.556 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.44 24.77 49.77 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.578 1.085 . . . . 0.0 114.942 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 159.1 28.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 117.707 0.753 . . . . 0.0 112.616 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -131.39 154.47 48.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -98.65 100.02 11.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.669 1.987 . . . . 0.0 110.118 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.1 p -130.68 165.24 23.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.306 1.042 . . . . 0.0 111.603 -175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -55.34 121.97 10.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.64 1.176 . . . . 0.0 110.771 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 49.82 6.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.72 1.153 . . . . 0.0 113.923 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -136.21 163.51 30.21 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.16 0.98 . . . . 0.0 112.523 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.79 140.81 51.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.725 0.81 . . . . 0.0 112.709 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.91 157.82 45.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.894 -0.504 . . . . 0.0 112.019 169.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -82.37 140.6 33.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.498 0.319 . . . . 0.0 111.303 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.64 144.68 25.08 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.575 0.75 . . . . 0.0 111.469 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -114.58 159.81 20.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.026 1.33 . . . . 0.0 112.978 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.3 m -77.67 -54.86 5.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.068 1.347 . . . . 0.0 112.051 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -153.65 -40.38 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.696 1.199 . . . . 0.0 113.078 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.04 157.18 35.41 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.868 1.267 . . . . 0.0 111.267 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.73 -26.13 64.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 114.429 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -105.77 33.9 3.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.58 1.552 . . . . 0.0 112.779 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.9 p -123.07 35.71 4.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.379 1.472 . . . . 0.0 113.161 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.66 107.93 20.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.086 1.754 . . . . 0.0 109.826 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 p -91.65 -67.82 0.83 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.393 1.077 . . . . 0.0 112.584 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.87 -17.15 1.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -78.34 143.53 36.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 122.116 0.96 . . . . 0.0 112.194 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.03 167.97 20.89 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.316 1.847 . . . . 0.0 110.816 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 5.6 p90 -145.34 161.44 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.577 0.751 . . . . 0.0 111.726 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.39 115.45 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 108.16 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -73.4 101.23 3.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.713 0.805 . . . . 0.0 110.193 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 -16.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.1 167.28 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 128.129 2.572 . . . . 0.0 111.057 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -78.31 121.84 24.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.124 0.57 . . . . 0.0 110.667 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -145.85 68.98 1.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 123.266 1.508 . . . . 0.0 111.306 -170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.59 -13.02 61.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -64.4 -12.83 46.98 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.614 -1.304 . . . . 0.0 113.224 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.98 -7.16 59.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.626 1.171 . . . . 0.0 113.972 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.18 179.6 5.61 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -79.82 142.1 35.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.361 1.465 . . . . 0.0 112.171 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -107.71 -59.45 1.83 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.459 1.104 . . . . 0.0 113.682 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.18 60.21 0.02 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.859 0.742 . . . . 0.0 114.363 -172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.2 21.33 9.43 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.216 1.806 . . . . 0.0 115.303 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -98.61 126.23 44.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.357 1.063 . . . . 0.0 112.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.8 tp -54.78 -37.21 65.74 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.669 1.188 . . . . 0.0 113.81 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -88.34 -3.92 58.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.058 0.943 . . . . 0.0 113.14 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.69 -72.77 1.07 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.547 2.022 . . . . 0.0 114.026 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 5.5 p-90 -69.73 127.58 33.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.05 -108.17 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.617 1.58 . . . . 0.0 116.013 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.69 142.8 46.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.419 1.488 . . . . 0.0 111.554 -169.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.21 118.45 25.67 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -170.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.38 84.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.691 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -78.19 -13.75 59.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.004 0.922 . . . . 0.0 112.083 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.96 177.2 8.71 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.496 1.141 . . . . 0.0 113.672 -170.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.98 149.81 43.72 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.845 -1.159 . . . . 0.0 111.928 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.07 136.69 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.605 -0.684 . . . . 0.0 110.414 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.72 -42.29 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.356 1.862 . . . . 0.0 110.834 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -143.26 154.86 44.25 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.466 1.506 . . . . 0.0 109.862 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.36 13.9 37.24 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.911 0.767 . . . . 0.0 114.754 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.5 mmm -54.19 -35.95 62.89 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.43 1.615 . . . . 0.0 112.381 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.95 -33.43 75.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.693 0.797 . . . . 0.0 112.385 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.59 -42.64 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.925 1.29 . . . . 0.0 110.39 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.71 -40.29 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.23 1.012 . . . . 0.0 111.237 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.38 -26.01 60.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.892 1.277 . . . . 0.0 112.78 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.39 -41.51 27.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.914 1.286 . . . . 0.0 111.18 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.7 mt -54.87 -31.79 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.899 1.679 . . . . 0.0 112.771 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -90.59 -15.27 30.86 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.3 -16.24 18.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.707 1.623 . . . . 0.0 114.475 -172.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.18 -59.5 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.834 1.317 . . . . 0.0 112.29 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.96 153.53 2.61 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.471 1.508 . . . . 0.0 111.587 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.3 p -133.67 147.75 51.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.96 1.304 . . . . 0.0 112.366 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.96 136.44 2.22 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.247 0.451 . . . . 0.0 113.201 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -62.97 153.35 33.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.493 1.117 . . . . 0.0 113.291 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.7 t -134.73 169.28 17.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.408 1.883 . . . . 0.0 111.645 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.03 121.39 15.76 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.295 -0.878 . . . . 0.0 112.471 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.8 mtt 59.93 3.07 0.44 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.36 2.264 . . . . 0.0 116.659 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -141.38 111.39 6.69 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.838 1.199 . . . . 0.0 111.757 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -99.65 158.05 16.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.029 0.931 . . . . 0.0 112.364 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 57.49 56.04 5.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.69 1.233 . . . . 0.0 112.699 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.65 154.55 57.16 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 125.71 1.604 . . . . 0.0 111.179 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.02 131.79 24.7 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 N-CA-C 108.027 -1.566 . . . . 0.0 108.027 169.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -31.15 63.44 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.67 -0.644 . . . . 0.0 111.797 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -83.26 150.3 26.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 109.103 168.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.25 117.75 23.17 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.102 -0.999 . . . . 0.0 110.651 -170.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.3 102.82 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.04 143.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 112.287 -169.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.0 mt -82.64 103.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.04 -27.34 57.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.557 1.143 . . . . 0.0 111.697 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -163.38 169.33 19.13 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.52 140.82 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.287 1.835 . . . . 0.0 110.477 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.3 m -133.84 135.0 43.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.271 1.428 . . . . 0.0 110.073 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.68 125.73 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.6 t -122.6 150.78 42.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.763 1.625 . . . . 0.0 111.927 -171.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.73 1.212 . . . . 0.0 113.246 -179.629 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -125.7 129.56 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.077 0.951 . . . . 0.0 109.41 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -104.71 123.28 47.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.589 1.156 . . . . 0.0 110.055 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.56 134.59 38.25 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 110.598 169.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -105.9 101.78 11.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -106.21 151.13 25.17 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.041 -0.412 . . . . 0.0 110.949 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -60.78 -7.8 2.57 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -108.14 -8.33 15.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.954 1.302 . . . . 0.0 114.101 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.24 160.9 9.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.046 1.307 . . . . 0.0 114.124 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.15 138.08 43.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.852 1.661 . . . . 0.0 112.702 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -134.21 141.01 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.111 1.764 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.7 t -123.16 136.65 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.736 1.214 . . . . 0.0 110.68 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mt -127.12 138.75 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.495 1.918 . . . . 0.0 110.323 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.84 122.21 45.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.492 1.917 . . . . 0.0 109.142 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 p -85.91 148.18 25.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.312 1.045 . . . . 0.0 111.83 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -104.22 73.82 1.15 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.702 1.239 . . . . 0.0 111.359 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.75 -26.85 64.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.502 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.15 -30.87 58.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.262 1.025 . . . . 0.0 111.53 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.29 -26.43 15.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.833 1.253 . . . . 0.0 112.991 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.03 59.0 3.46 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.99 0.916 . . . . 0.0 112.833 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.63 -43.77 25.22 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.251 2.634 . . . . 0.0 112.72 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -69.77 -41.15 75.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.513 0.597 . . . . 0.0 110.957 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' ILE . 24.8 m -62.73 -49.9 73.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.482 0.713 . . . . 0.0 111.265 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.63 -44.32 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.307 0.643 . . . . 0.0 111.477 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -55.72 -47.7 76.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.771 1.168 . . . . 0.0 112.014 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -68.0 -39.13 83.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.43 0.559 . . . . 0.0 111.667 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.7 -48.47 81.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.683 1.193 . . . . 0.0 111.542 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.96 -38.31 79.34 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 111.653 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.86 -33.73 70.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.956 0.902 . . . . 0.0 112.529 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.392 -0.817 . . . . 0.0 112.287 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.03 -35.2 76.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.791 -0.568 . . . . 0.0 111.596 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -64.99 -34.19 77.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.909 2.084 . . . . 0.0 113.006 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -81.78 -15.74 53.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.831 0.852 . . . . 0.0 113.086 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.89 15.18 56.83 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.121 1.344 . . . . 0.0 113.979 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -65.48 -31.58 72.73 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.198 0.999 . . . . 0.0 113.678 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -87.64 -15.47 37.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.19 0.7 5.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.435 1.494 . . . . 0.0 114.574 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -144.85 50.35 1.26 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.129 1.772 . . . . 0.0 110.252 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.5 p -119.81 169.83 9.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.466 1.106 . . . . 0.0 111.945 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 156' ' ' ILE . 19.0 pt -129.72 167.14 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -169.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -95.3 93.92 7.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.378 1.471 . . . . 0.0 107.764 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -86.46 -0.86 56.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -140.39 141.17 35.61 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.089 1.768 . . . . 0.0 112.67 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.87 132.73 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.187 1.795 . . . . 0.0 111.152 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.98 128.72 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.022 1.729 . . . . 0.0 108.292 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -68.97 139.42 55.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.782 -0.574 . . . . 0.0 111.249 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.59 9.12 68.71 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -144.79 -177.12 5.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.788 2.035 . . . . 0.0 110.55 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.87 178.1 6.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.016 1.726 . . . . 0.0 114.501 -171.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -114.21 136.94 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.016 1.326 . . . . 0.0 111.765 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -103.62 147.26 27.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.137 0.975 . . . . 0.0 110.761 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.05 31.38 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 122.637 1.132 . . . . 0.0 114.849 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.92 72.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.668 -1.073 . . . . 0.0 114.434 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.49 -22.87 41.96 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-N 119.624 1.712 . . . . 0.0 114.729 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.35 166.07 26.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.799 1.24 . . . . 0.0 112.912 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.83 162.19 27.85 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.956 1.702 . . . . 0.0 110.402 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -60.77 -13.2 25.21 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.696 2.93 . . . . 0.0 118.505 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.26 17.23 59.7 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.122 0.867 . . . . 0.0 114.592 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mmm 58.46 36.46 25.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.072 1.749 . . . . 0.0 113.114 -173.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -92.07 131.32 37.43 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.296 1.438 . . . . 0.0 109.386 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -71.04 124.43 24.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.495 1.118 . . . . 0.0 110.107 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.38 159.14 32.1 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.3 75.27 8.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.245 1.418 . . . . 0.0 111.484 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.2 p -69.0 127.53 33.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.546 1.139 . . . . 0.0 112.409 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.5 177.32 7.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.62 1.968 . . . . 0.0 111.484 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 50.42 68.33 3.52 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.593 1.557 . . . . 0.0 113.617 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.81 147.46 88.48 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.252 2.635 . . . . 0.0 111.597 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.0 OUTLIER -124.68 149.6 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.813 1.645 . . . . 0.0 109.155 -174.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 155.49 29.0 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.581 0.705 . . . . 0.0 110.419 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -78.71 134.45 37.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.397 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.69 14.39 12.61 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.941 0.896 . . . . 0.0 112.11 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.53 -17.03 64.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.569 -1.332 . . . . 0.0 113.764 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -63.5 -0.97 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.388 1.875 . . . . 0.0 115.482 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -79.77 -5.63 55.7 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.701 1.2 . . . . 0.0 113.017 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.65 21.06 49.03 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.531 1.063 . . . . 0.0 114.942 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.05 155.47 39.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.911 0.855 . . . . 0.0 111.75 170.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -133.63 155.38 49.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -90.31 107.11 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.428 2.291 . . . . 0.0 109.439 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -137.67 169.43 17.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.918 1.287 . . . . 0.0 110.869 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -49.63 124.82 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.798 1.239 . . . . 0.0 111.458 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.78 41.14 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.274 1.416 . . . . 0.0 115.048 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.9 p -121.95 160.86 23.96 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.536 1.668 . . . . 0.0 113.584 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.91 137.91 54.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.659 0.784 . . . . 0.0 112.965 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.47 160.49 38.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.817 0.447 . . . . 0.0 112.143 170.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 96.7 mmm -79.1 139.74 38.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.158 0.583 . . . . 0.0 111.341 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.45 112.22 23.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.502 0.721 . . . . 0.0 110.292 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -75.48 157.26 34.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 0.0 112.709 -174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.0 m -70.81 -51.09 28.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.873 0.869 . . . . 0.0 110.934 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -160.12 -58.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.322 1.449 . . . . 0.0 110.373 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.24 79.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.61 1.164 . . . . 0.0 111.889 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.77 -31.48 88.39 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.825 2.35 . . . . 0.0 113.459 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -101.62 46.46 0.93 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.346 1.858 . . . . 0.0 112.294 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.6 p -133.99 32.2 3.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.96 54.66 1.33 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.989 1.716 . . . . 0.0 113.643 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -54.42 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -154.74 36.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -135.27 151.54 50.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.311 1.444 . . . . 0.0 110.097 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.58 172.21 13.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.061 1.344 . . . . 0.0 111.667 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.2 p90 -147.2 161.56 40.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.402 -0.811 . . . . 0.0 111.524 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 mt -115.5 115.84 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -76.69 102.68 6.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.903 0.881 . . . . 0.0 110.156 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.81 -21.93 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.268 -0.895 . . . . 0.0 112.968 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.01 168.55 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.813 1.645 . . . . 0.0 111.959 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.22 123.44 29.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.323 0.649 . . . . 0.0 110.291 169.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -144.79 76.82 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.828 1.299 . . . . 0.0 112.707 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.07 -34.88 66.37 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.209 1.804 . . . . 0.0 114.583 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -59.88 -12.58 7.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.84 -9.57 59.26 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.48 -177.08 5.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -169.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -77.05 141.21 40.39 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.289 1.836 . . . . 0.0 112.473 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.2 p -107.79 -57.16 2.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.24 1.016 . . . . 0.0 113.59 173.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.19 68.96 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.428 1.013 . . . . 0.0 113.427 -171.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 54.15 24.3 4.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.311 1.844 . . . . 0.0 115.289 171.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.0 m -110.2 119.32 38.89 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.639 1.176 . . . . 0.0 111.188 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.9 mt -49.81 -39.68 39.26 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -86.91 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.51 -62.47 1.09 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.567 2.032 . . . . 0.0 113.966 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.353 2.8 p-90 -73.02 126.79 30.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.581 1.191 . . . . 0.0 112.634 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.93 -95.35 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.387 1.47 . . . . 0.0 115.948 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -129.19 138.22 51.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.513 1.125 . . . . 0.0 112.11 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.92 121.82 26.97 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.76 87.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.013 1.325 . . . . 0.0 108.178 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -77.81 -15.61 58.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.431 0.692 . . . . 0.0 111.88 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.4 178.69 7.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.572 1.177 . . . . 0.0 113.942 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -138.93 154.38 48.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.659 1.183 . . . . 0.0 112.325 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 140.44 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.624 0.726 . . . . 0.0 110.271 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.79 -42.52 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.715 1.606 . . . . 0.0 111.213 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.49 152.86 41.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.591 1.556 . . . . 0.0 109.791 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.89 13.97 22.26 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.85 0.738 . . . . 0.0 114.67 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -34.94 68.81 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.125 1.462 . . . . 0.0 112.301 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.94 -30.7 71.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.8 0.84 . . . . 0.0 112.486 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.27 -41.38 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.416 1.087 . . . . 0.0 110.131 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.89 -40.23 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.489 -0.757 . . . . 0.0 111.091 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.58 -28.56 63.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.776 1.23 . . . . 0.0 112.349 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -74.65 -44.16 51.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.473 1.109 . . . . 0.0 110.699 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.61 -29.25 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.641 1.576 . . . . 0.0 112.633 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -94.48 -11.42 29.69 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.54 -14.65 13.77 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.631 1.586 . . . . 0.0 114.5 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.6 m -62.11 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.86 1.33 . . . . 0.0 112.428 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -175.07 156.59 2.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.658 1.583 . . . . 0.0 111.645 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 p -123.72 150.04 44.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.293 1.437 . . . . 0.0 112.281 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.75 142.91 3.65 Favored Glycine 0 N--CA 1.465 0.572 0 CA-C-O 122.835 1.242 . . . . 0.0 113.252 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -65.78 153.62 41.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.209 2.204 . . . . 0.0 113.693 -169.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.9 p -117.91 169.16 9.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.05 1.34 . . . . 0.0 112.089 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.1 -14.78 66.54 Favored Glycine 0 CA--C 1.54 1.601 0 N-CA-C 115.663 1.025 . . . . 0.0 115.663 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 37.8 ttp -133.3 -19.53 2.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -133.45 134.05 43.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.601 1.56 . . . . 0.0 110.947 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -105.55 163.68 12.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.032 1.733 . . . . 0.0 111.393 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 58.14 46.7 15.61 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.17 1.388 . . . . 0.0 113.208 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.07 152.43 54.3 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.764 1.625 . . . . 0.0 112.574 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.23 142.61 46.3 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.96 1.773 . . . . 0.0 109.412 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -30.83 61.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.601 -0.687 . . . . 0.0 112.63 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.97 145.24 32.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.905 0.882 . . . . 0.0 110.078 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.64 120.59 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.383 1.073 . . . . 0.0 110.436 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.64 99.93 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.175 0.99 . . . . 0.0 108.358 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -122.32 143.0 36.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.79 1.236 . . . . 0.0 112.216 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.3 mt -83.13 103.86 10.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.89 -28.89 60.82 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.381 1.073 . . . . 0.0 111.18 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.7 t -164.02 169.54 17.8 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.0 139.85 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.716 2.007 . . . . 0.0 110.055 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -133.06 133.11 42.58 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.291 1.437 . . . . 0.0 110.134 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.73 125.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.274 -0.891 . . . . 0.0 108.864 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 t -121.55 140.44 52.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.07 1.348 . . . . 0.0 112.024 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 112.217 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.46 131.25 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.544 -1.347 . . . . 0.0 110.624 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.2 m -102.67 126.38 49.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.631 1.172 . . . . 0.0 110.184 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.1 123.34 44.23 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.875 1.27 . . . . 0.0 109.753 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -98.79 109.64 22.37 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 p -121.88 158.82 28.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 112.147 -169.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -7.2 34.94 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.62 -26.39 10.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.579 1.552 . . . . 0.0 113.392 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.68 145.52 4.24 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.311 1.91 . . . . 0.0 113.282 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.0 132.8 32.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.302 1.041 . . . . 0.0 112.277 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.43 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.828 1.651 . . . . 0.0 109.199 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.21 138.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.099 0.96 . . . . 0.0 110.506 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -131.79 135.67 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.671 1.989 . . . . 0.0 110.13 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -104.18 125.73 50.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.116 1.766 . . . . 0.0 108.946 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -88.28 146.97 25.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.108 0.963 . . . . 0.0 112.036 -175.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -104.67 74.36 1.14 Allowed 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 122.887 1.327 . . . . 0.0 110.973 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.66 -25.48 63.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.35 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.25 -31.78 60.91 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.5 1.12 . . . . 0.0 111.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -94.02 -27.28 16.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.625 1.17 . . . . 0.0 113.027 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.62 59.43 3.87 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.546 0.738 . . . . 0.0 112.919 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -61.72 -43.98 23.7 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.328 2.686 . . . . 0.0 112.723 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -67.51 -40.54 85.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.283 0.492 . . . . 0.0 110.708 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -49.16 74.74 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.597 0.759 . . . . 0.0 111.948 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.4 -40.8 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.33 -48.31 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.789 1.177 . . . . 0.0 111.718 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -68.51 -36.03 78.31 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.56 0.744 . . . . 0.0 112.128 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -60.4 -51.4 69.66 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.38 -34.8 73.0 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.639 -0.663 . . . . 0.0 111.558 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -55.8 -36.44 67.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.978 0.911 . . . . 0.0 112.351 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -76.35 -42.53 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.602 -0.686 . . . . 0.0 112.586 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.6 m -60.78 -35.31 76.12 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.589 -0.694 . . . . 0.0 111.779 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -32.32 73.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 112.694 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -81.7 -13.28 58.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.96 18.25 65.66 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.616 1.103 . . . . 0.0 114.14 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.58 -17.37 64.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.41 -7.22 48.26 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.459 -0.776 . . . . 0.0 112.998 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -69.17 135.41 50.61 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 51.93 45.21 28.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.992 1.717 . . . . 0.0 114.253 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -104.05 160.05 15.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.504 0.722 . . . . 0.0 110.907 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 156' ' ' ILE . 15.9 pt -123.42 162.31 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -91.42 115.76 28.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -116.7 -3.63 11.73 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -139.18 132.68 30.3 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.424 1.011 . . . . 0.0 111.291 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.18 146.48 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.91 2.084 . . . . 0.0 108.913 169.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -142.56 135.16 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.446 1.898 . . . . 0.0 107.415 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -64.21 134.8 55.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.324 0.65 . . . . 0.0 111.86 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.17 13.5 67.28 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.848 0.737 . . . . 0.0 114.848 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.15 -177.28 5.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.311 1.844 . . . . 0.0 111.033 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -88.24 -178.71 5.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.584 1.954 . . . . 0.0 115.16 -169.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 pt -120.01 142.47 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.022 1.329 . . . . 0.0 113.113 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -113.93 148.4 36.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.058 1.343 . . . . 0.0 112.083 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.41 178.79 32.71 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 -14.91 37.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 115.815 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.6 -10.67 76.15 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 116.738 1.455 . . . . 0.0 116.738 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -144.09 168.88 18.96 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.161 1.481 . . . . 0.0 113.359 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.83 162.85 18.7 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 126.895 2.078 . . . . 0.0 110.737 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -58.9 -15.22 25.98 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.019 3.146 . . . . 0.0 118.807 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 18.42 57.48 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.051 0.834 . . . . 0.0 114.715 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.0 mmt 59.4 27.3 16.37 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.588 1.555 . . . . 0.0 112.696 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.07 123.09 29.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.867 1.267 . . . . 0.0 109.169 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -73.17 121.2 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.005 0.922 . . . . 0.0 110.331 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -69.19 164.83 21.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.11 67.08 7.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.83 1.652 . . . . 0.0 111.704 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -66.17 125.93 27.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.781 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -133.09 173.66 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.827 2.051 . . . . 0.0 111.96 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 46.24 66.32 5.62 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.478 1.511 . . . . 0.0 113.711 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.55 137.52 74.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.337 2.691 . . . . 0.0 111.172 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.5 150.78 7.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.689 1.596 . . . . 0.0 108.655 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 151.92 29.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.259 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -87.37 101.59 13.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.697 1.599 . . . . 0.0 110.438 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.43 18.69 3.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.801 1.24 . . . . 0.0 113.836 -169.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.74 -21.5 63.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.432 1.493 . . . . 0.0 114.18 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.52 -2.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.846 2.058 . . . . 0.0 115.536 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -77.11 0.9 19.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.187 0.995 . . . . 0.0 112.282 169.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 35.74 27.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.905 1.24 . . . . 0.0 112.888 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.0 144.59 43.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.421 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.84 154.46 49.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.71 114.78 26.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.065 2.146 . . . . 0.0 110.572 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.5 p -138.8 171.98 13.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.933 1.293 . . . . 0.0 111.009 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -51.78 125.89 16.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.805 1.242 . . . . 0.0 110.959 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.4 36.43 39.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.848 1.213 . . . . 0.0 114.803 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.7 p -120.72 158.81 26.67 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.892 1.346 . . . . 0.0 112.89 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.44 136.3 54.54 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.61 158.23 44.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.291 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.7 mmt -81.38 132.49 35.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.69 0.396 . . . . 0.0 110.902 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.11 161.13 24.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.5 0.72 . . . . 0.0 110.573 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -133.02 158.42 42.76 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 m -74.01 -57.08 4.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.895 1.278 . . . . 0.0 112.777 -169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -158.61 -47.67 0.06 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.079 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.65 157.9 71.62 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.543 1.137 . . . . 0.0 111.359 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.84 -21.3 71.94 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.182 2.588 . . . . 0.0 114.584 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.74 42.2 2.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.604 1.962 . . . . 0.0 112.337 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.6 p -117.45 33.59 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.837 1.255 . . . . 0.0 113.861 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.63 14.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.277 1.431 . . . . 0.0 108.943 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -91.91 -60.09 1.95 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.49 33.33 0.32 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.79 140.08 53.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.216 1.406 . . . . 0.0 110.657 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -142.04 168.2 20.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.088 1.355 . . . . 0.0 111.354 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 18.6 p90 -144.12 160.3 41.15 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.538 0.735 . . . . 0.0 111.849 172.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.9 mt -114.26 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.211 1.004 . . . . 0.0 108.419 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.32 100.32 2.61 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.8 0.84 . . . . 0.0 110.217 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.23 -25.99 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 121.199 -0.938 . . . . 0.0 113.188 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 m -114.97 166.56 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.998 1.719 . . . . 0.0 111.633 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.69 122.84 27.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.02 0.528 . . . . 0.0 110.11 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -141.95 71.77 1.36 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.927 1.346 . . . . 0.0 112.596 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -52.29 -35.71 51.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.235 2.214 . . . . 0.0 114.445 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -59.88 -12.77 8.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.73 -14.18 55.01 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -73.16 161.91 30.04 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.284 1.434 . . . . 0.0 114.462 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -69.71 144.41 52.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.216 0.606 . . . . 0.0 112.312 173.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.8 p -126.22 -59.29 1.32 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.797 1.239 . . . . 0.0 113.089 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.81 70.31 0.03 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.987 0.803 . . . . 0.0 113.974 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.17 25.25 7.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.797 1.639 . . . . 0.0 114.826 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 m -113.95 123.15 49.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.907 1.283 . . . . 0.0 111.364 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.01 -33.71 67.44 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.72 -10.28 59.3 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.88 -88.52 1.95 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.178 2.323 . . . . 0.0 113.053 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -65.96 135.27 54.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.42 -82.3 1.36 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.564 1.078 . . . . 0.0 115.139 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -137.36 154.63 49.98 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.199 1.4 . . . . 0.0 112.176 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -84.67 117.17 23.61 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.928 -0.482 . . . . 0.0 111.801 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.1 81.0 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.842 1.257 . . . . 0.0 108.755 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.74 -13.99 60.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 0.0 112.258 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.86 178.09 8.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.74 1.257 . . . . 0.0 113.648 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -137.25 154.09 50.21 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.918 -1.113 . . . . 0.0 112.339 171.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.12 143.94 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.772 0.796 . . . . 0.0 109.697 171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.79 -39.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.734 1.614 . . . . 0.0 110.861 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -146.46 148.89 32.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.52 1.528 . . . . 0.0 110.549 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 116.98 7.45 12.79 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 77.1 mmm -56.62 -36.21 69.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.584 1.692 . . . . 0.0 113.099 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -62.87 -30.3 71.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.631 0.773 . . . . 0.0 112.202 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.98 -40.93 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.044 1.738 . . . . 0.0 110.673 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.64 -39.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.034 0.934 . . . . 0.0 110.946 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.89 -25.57 61.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.993 1.317 . . . . 0.0 112.717 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -76.55 -42.86 41.45 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.12 1.368 . . . . 0.0 110.975 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.24 -34.45 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.877 1.271 . . . . 0.0 112.111 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -91.49 -14.68 30.03 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.57 -20.64 14.42 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.106 1.336 . . . . 0.0 114.332 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.92 -63.88 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 118.598 1.199 . . . . 0.0 112.172 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.42 155.79 5.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -137.19 152.17 49.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.993 1.317 . . . . 0.0 112.135 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.78 137.76 4.67 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.199 1.381 . . . . 0.0 111.404 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.57 145.18 55.89 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -169.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.0 p -98.97 169.7 9.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.439 1.896 . . . . 0.0 111.149 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.15 -4.44 8.08 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.301 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 49.7 tpp -123.17 -33.19 3.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.958 1.379 . . . . 0.0 114.057 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -141.43 133.67 27.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 110.723 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.05 152.97 18.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.7 t0 50.41 38.04 17.1 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.857 2.063 . . . . 0.0 114.564 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.97 161.24 44.6 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 125.472 1.509 . . . . 0.0 111.187 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -57.74 128.79 30.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 120.759 1.307 . . . . 0.0 110.248 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.74 45.28 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.55 159.45 26.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.615 0.766 . . . . 0.0 110.467 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.49 109.67 16.17 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.612 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.17 94.0 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -122.74 144.32 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -168.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.4 104.4 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 106.25 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.45 -41.02 61.53 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.811 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -151.21 166.26 31.4 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.48 141.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.052 1.741 . . . . 0.0 110.764 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.5 m -133.88 129.66 36.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.006 1.322 . . . . 0.0 110.243 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.04 120.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -109.64 137.98 46.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.706 1.202 . . . . 0.0 111.752 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.571 1.948 . . . . 0.0 112.151 -178.454 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.92 130.52 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 121.13 -0.981 . . . . 0.0 109.597 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 m -103.67 120.95 41.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.039 0.936 . . . . 0.0 110.087 172.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -92.4 119.51 32.01 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -93.88 119.07 32.31 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -121.82 160.54 24.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.976 0.893 . . . . 0.0 113.125 -169.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -73.06 -4.64 33.81 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -120.5 -20.07 7.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.441 1.497 . . . . 0.0 114.412 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.67 117.32 1.08 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.001 1.762 . . . . 0.0 110.771 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.88 145.7 55.35 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.531 0.732 . . . . 0.0 111.763 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.7 141.88 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.772 1.629 . . . . 0.0 109.664 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.08 134.09 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.465 1.106 . . . . 0.0 110.072 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.79 137.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.345 1.858 . . . . 0.0 110.102 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -105.57 123.36 47.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.446 1.898 . . . . 0.0 109.259 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.9 p -87.1 148.61 25.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.158 0.983 . . . . 0.0 112.005 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.13 72.9 0.9 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.888 1.328 . . . . 0.0 111.856 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.64 -25.58 64.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.536 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -77.25 -28.99 53.79 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.379 1.071 . . . . 0.0 111.566 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -99.29 -21.11 16.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.081 1.352 . . . . 0.0 113.406 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.52 56.22 1.31 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.274 1.029 . . . . 0.0 113.244 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.01 -45.07 25.72 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.478 2.785 . . . . 0.0 113.088 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.94 -41.29 74.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.646 0.657 . . . . 0.0 111.245 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.9 m -63.9 -48.27 77.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.551 0.74 . . . . 0.0 111.281 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.67 -43.41 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.717 0.807 . . . . 0.0 111.463 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -57.17 -45.32 83.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.816 1.189 . . . . 0.0 112.019 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -69.36 -36.8 77.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.512 0.596 . . . . 0.0 111.821 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.09 -48.91 79.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.342 1.057 . . . . 0.0 111.728 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.18 -36.84 80.24 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.269 -0.894 . . . . 0.0 111.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -58.45 -34.8 71.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 112.499 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -73.63 -43.34 59.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 112.161 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.8 m -58.38 -38.44 77.31 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.735 -0.603 . . . . 0.0 111.762 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -65.39 -35.77 81.94 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.327 2.251 . . . . 0.0 112.691 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -81.17 -16.03 54.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 0.0 113.046 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.69 19.36 63.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.962 0.792 . . . . 0.0 113.052 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.26 -37.61 75.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 113.036 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -78.37 -9.84 59.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.714 0.406 . . . . 0.0 111.892 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.27 131.04 48.05 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.297 -0.877 . . . . 0.0 108.844 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.5 t30 62.38 20.86 12.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.054 2.142 . . . . 0.0 116.7 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -82.05 144.54 30.75 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.741 -1.224 . . . . 0.0 113.414 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -101.14 155.92 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -86.41 72.97 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.87 2.068 . . . . 0.0 108.402 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -69.45 -9.61 54.41 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.62 125.26 45.29 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.572 1.149 . . . . 0.0 110.508 -172.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.95 131.01 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.767 1.227 . . . . 0.0 112.042 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.42 131.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.697 1.999 . . . . 0.0 108.182 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.06 138.14 54.13 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.624 0.77 . . . . 0.0 112.008 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.02 67.74 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.702 0.668 . . . . 0.0 114.641 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.12 -177.22 5.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.607 1.963 . . . . 0.0 110.316 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.29 177.86 6.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.218 1.807 . . . . 0.0 114.196 -171.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 pt -116.39 140.82 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.896 1.278 . . . . 0.0 111.937 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -118.4 149.04 41.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.954 1.301 . . . . 0.0 111.372 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.6 -176.61 29.85 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.052 0.834 . . . . 0.0 114.978 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 -11.41 70.47 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.054 1.312 . . . . 0.0 115.632 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.32 60.06 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 118.879 1.34 . . . . 0.0 115.839 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.0 157.05 44.25 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -83.66 164.74 43.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 126.306 1.842 . . . . 0.0 109.32 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.04 -14.61 44.49 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.509 2.806 . . . . 0.0 117.087 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.71 18.83 56.81 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.438 1.018 . . . . 0.0 114.44 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.5 34.11 15.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.2 1.8 . . . . 0.0 112.94 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.32 131.22 37.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.389 1.476 . . . . 0.0 109.448 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.41 130.81 42.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 124.172 1.939 . . . . 0.0 111.603 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.85 -176.9 1.45 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 110.212 -3.176 . . . . 0.0 113.761 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.91 54.47 2.74 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.897 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 p -73.56 104.11 4.4 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.865 1.266 . . . . 0.0 111.571 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -133.47 178.44 6.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.872 2.069 . . . . 0.0 112.067 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.93 68.11 3.86 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.417 1.487 . . . . 0.0 113.798 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -61.95 138.31 72.73 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.168 2.579 . . . . 0.0 111.338 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.39 152.83 5.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 126.268 1.827 . . . . 0.0 108.024 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 155.05 27.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.153 0.502 . . . . 0.0 111.032 169.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.9 128.98 34.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.609 0.764 . . . . 0.0 111.124 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -111.12 15.13 21.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.942 1.297 . . . . 0.0 112.867 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -11.68 28.1 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -75.19 39.24 0.14 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -113.37 -6.49 13.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.21 . . . . 0.0 114.191 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.18 3.66 65.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.444 1.497 . . . . 0.0 115.2 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.19 158.24 19.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.606 1.203 . . . . 0.0 112.878 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.49 156.8 48.09 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.7 1.2 . . . . 0.0 113.521 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -90.25 93.21 9.25 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.496 1.918 . . . . 0.0 109.755 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.7 p -122.86 166.02 15.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.261 1.025 . . . . 0.0 111.319 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -55.37 114.38 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.265 1.826 . . . . 0.0 110.26 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 43.04 5.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.904 1.24 . . . . 0.0 114.633 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.7 p -134.91 165.46 25.26 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.842 1.321 . . . . 0.0 113.512 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mp -124.35 142.84 50.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 112.775 174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.6 156.72 47.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.724 -0.61 . . . . 0.0 111.853 169.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -83.94 136.93 33.89 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.175 -0.328 . . . . 0.0 111.258 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.66 155.25 20.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.717 0.807 . . . . 0.0 111.608 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -118.91 159.22 24.19 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.677 1.191 . . . . 0.0 112.674 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.3 m -72.25 -52.23 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.011 0.924 . . . . 0.0 110.805 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -159.56 -58.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.458 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.24 157.4 85.0 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 111.75 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -55.81 -34.69 92.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.841 2.36 . . . . 0.0 113.118 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -99.59 35.3 2.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.25 1.42 . . . . 0.0 112.917 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -123.35 27.53 7.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.506 1.522 . . . . 0.0 113.491 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 103.92 16.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.623 1.569 . . . . 0.0 109.638 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.5 p -88.41 -74.78 0.45 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.851 1.26 . . . . 0.0 112.519 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.71 -20.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.042 1.337 . . . . 0.0 113.643 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -71.04 145.32 50.0 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 121.029 -1.044 . . . . 0.0 112.441 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -141.81 168.06 20.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.32 1.848 . . . . 0.0 110.402 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.7 p90 -146.05 160.14 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.576 0.75 . . . . 0.0 111.753 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.5 mt -113.27 113.9 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.226 1.01 . . . . 0.0 108.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.78 93.88 2.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.989 . . . . 0.0 110.418 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.15 -23.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 163.67 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.483 1.513 . . . . 0.0 111.223 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -77.78 117.56 19.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.174 0.59 . . . . 0.0 109.8 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -143.64 64.95 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 123.113 1.435 . . . . 0.0 112.268 -169.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -66.31 -13.24 60.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -172.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.83 -13.82 38.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.654 -1.279 . . . . 0.0 113.453 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.02 -9.81 59.72 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.45 1.1 . . . . 0.0 113.949 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.12 -177.81 3.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -81.39 145.01 31.03 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.731 1.612 . . . . 0.0 111.785 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.4 p -111.75 -59.08 2.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.478 1.111 . . . . 0.0 113.468 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.16 61.49 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.068 0.842 . . . . 0.0 113.865 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.28 24.9 12.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.839 1.656 . . . . 0.0 114.791 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.6 t -104.56 121.22 43.04 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.165 . . . . 0.0 111.743 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -33.59 71.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -169.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -78.77 -9.16 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 -70.65 0.93 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.61 2.052 . . . . 0.0 113.94 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.327 7.0 p-90 -70.6 124.81 25.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.33 -91.31 1.36 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.427 1.489 . . . . 0.0 115.458 -169.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -134.57 144.79 48.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.579 1.151 . . . . 0.0 112.041 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.5 t -83.67 124.06 30.45 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.978 -0.451 . . . . 0.0 112.066 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.29 88.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -78.09 -15.44 58.88 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.626 0.77 . . . . 0.0 112.14 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.23 177.87 8.68 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.599 1.19 . . . . 0.0 113.341 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -136.13 151.45 49.79 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.98 -1.075 . . . . 0.0 112.247 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.36 135.64 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.76 -40.95 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.9 1.68 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -144.28 144.71 31.62 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.19 1.396 . . . . 0.0 110.677 174.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.06 -0.09 10.69 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 124.737 1.161 . . . . 0.0 115.629 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -55.92 -37.59 69.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.435 1.618 . . . . 0.0 113.17 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.99 -34.14 75.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.703 0.801 . . . . 0.0 111.936 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.03 -39.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.16 1.784 . . . . 0.0 110.905 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.34 -39.32 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 121.204 -0.935 . . . . 0.0 111.121 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 8.8 t70 -74.3 -22.86 59.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.066 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.8 -43.2 47.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.939 1.295 . . . . 0.0 111.082 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.8 mt -54.69 -35.12 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.221 1.408 . . . . 0.0 112.195 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.2 pttp -90.31 -18.93 24.7 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -96.49 -22.06 20.13 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.977 1.275 . . . . 0.0 114.225 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.8 t -81.41 -63.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 118.378 1.089 . . . . 0.0 112.055 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -162.63 152.72 16.31 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 51.8 p -140.36 152.83 46.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.944 1.697 . . . . 0.0 111.619 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.16 132.34 1.75 Allowed Glycine 0 CA--C 1.53 1.004 0 N-CA-C 114.386 0.515 . . . . 0.0 114.386 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -61.85 152.61 31.22 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.452 1.501 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.4 t -141.99 102.18 4.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.708 1.203 . . . . 0.0 111.184 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.6 -120.8 23.13 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.165 0.888 . . . . 0.0 113.139 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.3 ttm -69.17 -21.15 64.0 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.876 1.27 . . . . 0.0 113.675 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -108.9 111.65 23.47 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.697 1.199 . . . . 0.0 110.917 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -96.84 156.21 16.45 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.325 1.05 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 57.76 38.62 27.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 113.76 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.3 156.92 43.25 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.335 1.454 . . . . 0.0 110.385 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.24 140.24 52.8 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -28.06 60.52 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.99 153.96 27.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.429 1.091 . . . . 0.0 110.257 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.2 109.68 11.26 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.007 -1.058 . . . . 0.0 110.788 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.24 94.28 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.828 1.251 . . . . 0.0 107.709 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.68 152.05 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.405 1.574 . . . . 0.0 113.756 -169.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.81 104.16 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.79 -39.77 66.43 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.116 -0.99 . . . . 0.0 111.01 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -152.3 170.88 18.97 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.16 143.15 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.505 1.522 . . . . 0.0 111.458 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.8 m -135.23 130.61 35.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 110.534 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.9 121.31 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -113.65 150.2 33.52 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.308 1.443 . . . . 0.0 112.525 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.317 1.447 . . . . 0.0 114.091 -169.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.72 129.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.889 0.876 . . . . 0.0 108.992 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.3 m -103.68 123.65 47.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.674 1.19 . . . . 0.0 109.891 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -97.35 132.01 43.48 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.562 1.145 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -104.99 98.71 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p -103.67 152.06 22.24 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.052 -0.405 . . . . 0.0 111.192 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -60.54 -10.35 4.95 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -103.62 -8.08 20.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.834 1.253 . . . . 0.0 113.748 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.8 165.98 12.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.921 1.724 . . . . 0.0 113.485 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.94 138.49 42.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.813 1.645 . . . . 0.0 112.949 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.93 139.26 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.271 1.828 . . . . 0.0 108.886 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -120.22 135.53 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.452 1.101 . . . . 0.0 110.002 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 138.51 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.499 1.919 . . . . 0.0 110.106 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -103.77 126.32 50.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.566 1.946 . . . . 0.0 108.912 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 p -90.29 147.96 23.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.34 1.056 . . . . 0.0 111.527 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.11 72.89 1.02 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.794 1.283 . . . . 0.0 111.35 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.56 -25.5 64.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.603 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -77.24 -24.84 51.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.464 1.105 . . . . 0.0 111.547 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -99.9 -28.1 13.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 112.381 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.68 57.9 3.0 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.803 0.841 . . . . 0.0 112.718 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -60.93 -43.42 30.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.593 2.862 . . . . 0.0 112.711 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -68.88 -40.83 79.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.819 0.736 . . . . 0.0 110.715 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' HD13 ' A' ' 68' ' ' ILE . 66.9 m -62.37 -50.37 71.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.691 0.796 . . . . 0.0 111.813 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.3 t -67.21 -38.89 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.131 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.49 -46.63 86.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.673 1.124 . . . . 0.0 111.422 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -63.88 -42.73 97.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.189 0.996 . . . . 0.0 111.977 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -59.27 -50.46 73.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.283 1.033 . . . . 0.0 111.619 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.22 -36.24 71.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.788 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.64 -38.07 71.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.728 0.811 . . . . 0.0 111.864 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.93 -40.77 60.64 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.727 -0.608 . . . . 0.0 112.339 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.3 m -61.34 -36.05 79.1 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.277 -0.89 . . . . 0.0 111.607 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -31.76 72.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.16 1.784 . . . . 0.0 112.93 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -81.61 -13.54 57.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.282 1.033 . . . . 0.0 113.476 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.77 18.3 61.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.51 1.052 . . . . 0.0 114.006 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.63 -17.53 62.87 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.34 -7.29 35.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.66 136.49 54.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.292 0.951 . . . . 0.0 109.154 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.5 t30 53.82 41.68 31.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.813 1.645 . . . . 0.0 114.586 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.9 p -102.11 167.31 10.1 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.908 0.883 . . . . 0.0 110.643 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 156' ' ' ILE . 24.4 pt -125.56 160.71 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -83.95 80.54 9.13 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -66.41 -14.21 61.82 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -169.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -150.96 143.74 24.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.275 1.852 . . . . 0.0 113.877 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.44 147.44 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 128.064 2.546 . . . . 0.0 108.201 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.5 mt -130.76 130.71 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.862 1.665 . . . . 0.0 107.493 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -61.63 134.95 57.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.852 0.461 . . . . 0.0 111.087 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 8.6 65.02 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.44 -176.89 5.22 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.481 1.913 . . . . 0.0 111.341 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -179.39 7.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -169.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.2 pt -115.4 135.35 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.703 1.601 . . . . 0.0 112.364 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -112.64 149.0 33.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.491 1.516 . . . . 0.0 111.351 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.55 175.76 36.39 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.11 66.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.145 1.831 . . . . 0.0 115.443 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.79 -15.02 62.1 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 118.745 1.272 . . . . 0.0 115.819 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.68 164.83 31.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.659 1.229 . . . . 0.0 113.331 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.91 164.46 28.42 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.858 1.663 . . . . 0.0 110.703 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' HG21 ' A' ' 40' ' ' ILE . 50.8 Cg_exo -61.78 -14.91 39.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.451 2.767 . . . . 0.0 117.927 -170.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.22 17.89 58.38 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.169 0.89 . . . . 0.0 114.563 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 32.7 18.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.845 1.658 . . . . 0.0 112.569 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -88.87 130.96 35.31 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.751 1.62 . . . . 0.0 109.537 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.96 124.98 27.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.322 1.049 . . . . 0.0 111.511 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -76.3 167.7 21.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.698 1.199 . . . . 0.0 113.485 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.68 77.84 3.33 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.345 1.458 . . . . 0.0 111.361 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.7 p -72.41 95.01 1.7 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.852 1.261 . . . . 0.0 111.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -110.95 171.46 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.169 1.788 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 51.45 64.48 7.88 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.548 1.539 . . . . 0.0 114.088 169.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -60.15 139.17 85.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.237 2.625 . . . . 0.0 111.808 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -102.83 150.41 6.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.348 1.459 . . . . 0.0 108.519 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.0 161.67 22.92 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.766 0.827 . . . . 0.0 111.369 169.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -73.22 121.37 20.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.403 0.681 . . . . 0.0 111.664 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -105.02 15.88 26.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.837 1.255 . . . . 0.0 113.215 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -14.09 49.75 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.307 -1.496 . . . . 0.0 114.568 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.45 2.64 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.913 2.085 . . . . 0.0 116.139 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.31 -3.39 58.22 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.421 1.489 . . . . 0.0 112.866 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 26.85 49.47 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.229 0.919 . . . . 0.0 114.976 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.75 160.54 27.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.571 0.748 . . . . 0.0 112.861 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -127.48 155.24 44.04 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -103.73 73.5 1.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.942 2.097 . . . . 0.0 111.6 -170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.9 p -103.31 167.65 9.68 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.473 0.709 . . . . 0.0 111.46 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -57.45 127.14 30.5 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.923 0.868 . . . . 0.0 111.282 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.39 26.72 42.22 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.086 1.327 . . . . 0.0 114.828 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.3 p -115.43 159.62 20.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.456 1.628 . . . . 0.0 112.777 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.53 136.32 53.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.64 161.03 37.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.273 0.559 . . . . 0.0 111.706 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -81.06 139.29 35.79 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.962 -0.461 . . . . 0.0 111.457 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 168.89 11.36 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.884 1.274 . . . . 0.0 110.905 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -105.08 160.24 15.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.164 1.385 . . . . 0.0 112.452 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.1 m -83.64 -52.16 6.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 0.0 110.719 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -161.25 -50.21 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.277 1.431 . . . . 0.0 112.217 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -85.46 160.47 53.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.943 1.297 . . . . 0.0 112.501 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.07 -16.52 55.4 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.245 2.63 . . . . 0.0 115.217 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -124.78 47.28 2.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.708 1.603 . . . . 0.0 111.141 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.9 p -119.46 25.78 9.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.26 1.424 . . . . 0.0 114.393 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.32 93.68 0.87 Allowed 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.936 -1.103 . . . . 0.0 108.907 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.5 p -89.04 -52.21 5.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.626 0.77 . . . . 0.0 111.779 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.36 -5.04 0.19 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -80.43 134.32 35.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.984 -1.072 . . . . 0.0 110.07 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.79 168.4 19.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.486 1.914 . . . . 0.0 110.673 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.5 p90 -147.1 161.82 40.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 111.842 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.83 119.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -69.76 100.15 1.46 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.22 -17.91 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.403 -0.81 . . . . 0.0 113.146 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.06 168.14 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 127.923 2.489 . . . . 0.0 111.256 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -68.92 113.47 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.706 1.202 . . . . 0.0 112.138 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.41 54.18 1.49 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.966 1.706 . . . . 0.0 111.58 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.0 -26.27 65.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -62.54 -13.73 34.21 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -85.8 -6.42 59.11 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.653 1.181 . . . . 0.0 114.069 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -71.73 179.48 3.09 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.184 1.394 . . . . 0.0 114.425 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -85.72 143.9 28.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.821 1.248 . . . . 0.0 111.991 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.8 p -112.7 -60.15 1.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 113.419 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.61 61.26 0.03 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.797 0.713 . . . . 0.0 114.378 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.72 23.48 11.15 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.743 1.617 . . . . 0.0 115.02 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.6 t -105.36 123.05 47.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.399 1.08 . . . . 0.0 111.971 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.96 -31.2 66.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -81.23 -8.82 59.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.27 -73.22 0.98 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.732 2.11 . . . . 0.0 114.289 -173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 7.5 p-90 -70.23 127.77 33.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.32 -100.3 1.52 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.549 1.547 . . . . 0.0 115.688 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -126.3 150.6 48.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.667 1.587 . . . . 0.0 111.483 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.2 t -82.95 118.44 23.48 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.3 87.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.685 1.194 . . . . 0.0 108.227 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -78.71 -14.28 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.545 0.738 . . . . 0.0 112.234 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.89 177.62 7.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.626 1.203 . . . . 0.0 113.96 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -140.77 152.23 45.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.689 1.196 . . . . 0.0 112.345 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.91 142.89 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.598 0.713 . . . . 0.0 110.152 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.3 -41.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.86 1.664 . . . . 0.0 110.852 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -145.09 155.7 43.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.895 1.678 . . . . 0.0 109.682 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.31 23.13 Favored Glycine 0 N--CA 1.467 0.765 0 C-N-CA 123.867 0.746 . . . . 0.0 114.407 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -32.57 66.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.766 1.283 . . . . 0.0 112.325 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.83 -29.01 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 112.658 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.0 -40.05 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.315 1.446 . . . . 0.0 110.48 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.31 -39.41 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.803 -1.185 . . . . 0.0 110.982 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.35 -30.54 69.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -73.11 -44.51 60.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.829 1.252 . . . . 0.0 111.126 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.05 -25.03 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.432 1.493 . . . . 0.0 112.409 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -84.24 -25.45 29.41 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.16 -8.68 64.37 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.784 1.659 . . . . 0.0 114.747 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -60.3 -26.15 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . . . 82.83 163.46 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.313 2.245 . . . . 0.0 114.376 -169.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 68.3 p -111.8 151.05 29.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.135 1.374 . . . . 0.0 113.632 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -166.22 149.92 16.54 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 123.333 1.518 . . . . 0.0 112.537 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -64.78 144.55 57.17 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.067 2.147 . . . . 0.0 114.133 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.1 t -137.46 74.77 1.5 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.843 1.657 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.72 -113.09 5.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.015 0.817 . . . . 0.0 112.374 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 66.0 mtt -72.78 -13.63 61.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.573 1.149 . . . . 0.0 113.746 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -104.18 111.76 24.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.474 1.51 . . . . 0.0 110.127 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.21 148.0 28.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.266 1.427 . . . . 0.0 112.714 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 52.25 30.19 7.59 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.116 1.766 . . . . 0.0 114.847 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 m -79.97 156.1 74.81 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.708 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -59.36 135.74 67.3 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 120.756 1.306 . . . . 0.0 111.033 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -31.51 60.24 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.35 0.66 . . . . 0.0 112.687 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.48 147.87 35.65 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.486 0.714 . . . . 0.0 110.435 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.26 109.78 16.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.426 0.631 . . . . 0.0 110.027 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.41 100.14 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -120.85 141.22 42.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.525 1.13 . . . . 0.0 111.726 -169.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.3 103.41 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.39 -35.61 58.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.015 0.926 . . . . 0.0 110.859 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.56 165.01 34.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.12 139.59 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.205 1.802 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -135.39 130.31 34.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.775 1.23 . . . . 0.0 110.198 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.6 t -86.81 120.13 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t -114.18 147.3 39.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.027 1.331 . . . . 0.0 112.426 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.539 1.536 . . . . 0.0 113.46 -169.754 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 119.925 -0.083 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.76 128.2 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.979 0.912 . . . . 0.0 109.37 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.4 m -102.51 126.23 49.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 109.917 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -100.93 117.72 35.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.54 1.136 . . . . 0.0 109.329 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.25 112.53 24.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -118.81 163.89 16.21 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.479 0.656 . . . . 0.0 112.239 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -69.7 -6.29 30.72 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.638 ' CE1' HD11 ' A' ' 136' ' ' ILE . 29.9 p80 -118.65 -20.63 8.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 114.16 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.14 142.52 3.47 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 126.982 2.23 . . . . 0.0 113.64 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.88 136.26 47.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.65 1.18 . . . . 0.0 113.303 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.26 141.14 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.35 1.46 . . . . 0.0 109.596 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -124.92 136.34 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.912 1.285 . . . . 0.0 110.257 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -126.5 139.96 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 126.725 2.01 . . . . 0.0 110.1 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -107.14 124.72 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.587 1.955 . . . . 0.0 109.245 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -85.85 147.99 26.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.205 1.002 . . . . 0.0 111.555 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.93 74.85 1.01 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 122.651 1.215 . . . . 0.0 111.404 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.77 -26.23 64.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.503 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -77.75 -26.61 50.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.327 1.051 . . . . 0.0 111.712 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.85 -21.37 15.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.905 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.69 55.44 1.6 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.915 1.286 . . . . 0.0 113.069 -172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -60.63 -43.39 32.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.554 2.836 . . . . 0.0 112.953 -172.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -70.34 -41.11 73.62 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.553 0.615 . . . . 0.0 110.671 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' ' 68' ' ' ILE . 38.2 m -62.85 -52.37 63.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.676 0.39 . . . . 0.0 111.474 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.33 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 118.801 -0.618 . . . . 0.0 111.24 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -57.66 -48.16 80.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.569 1.077 . . . . 0.0 111.359 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.1 -41.17 82.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.954 0.902 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.18 -48.1 82.86 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.695 1.198 . . . . 0.0 111.682 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.96 -37.47 72.79 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.361 0.664 . . . . 0.0 111.415 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -59.08 -33.79 71.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.352 0.661 . . . . 0.0 112.607 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -73.77 -43.82 57.85 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.469 -0.77 . . . . 0.0 112.205 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.52 -37.19 82.83 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.33 -0.856 . . . . 0.0 111.503 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -62.61 -33.54 75.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.814 2.046 . . . . 0.0 112.883 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -83.79 -14.85 50.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.084 0.953 . . . . 0.0 113.503 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 17.5 53.5 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.082 0.849 . . . . 0.0 114.15 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -73.73 -18.47 60.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.196 1.498 . . . . 0.0 114.832 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -98.26 -6.6 30.79 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.2 -0.938 . . . . 0.0 112.35 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -71.57 129.33 38.48 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.934 -1.103 . . . . 0.0 108.792 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.7 43.99 17.95 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.089 1.355 . . . . 0.0 113.752 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.3 p -109.32 167.26 10.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.435 1.094 . . . . 0.0 111.829 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 15.8 pt -120.45 161.58 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.82 83.42 7.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.773 1.229 . . . . 0.0 108.177 168.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -60.8 -28.63 68.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.684 1.993 . . . . 0.0 115.025 -169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HE ' ' HB2' ' A' ' 149' ' ' ASP . 40.1 mmm-85 -132.0 136.55 47.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.787 1.176 . . . . 0.0 111.378 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.57 130.03 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.643 1.977 . . . . 0.0 110.944 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.3 mt -137.19 126.78 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 108.276 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.1 136.54 57.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.298 0.639 . . . . 0.0 111.628 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.24 9.23 63.61 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -142.54 -177.23 5.18 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.948 1.699 . . . . 0.0 111.025 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.93 179.89 6.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.835 1.654 . . . . 0.0 114.393 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.26 136.64 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.807 1.243 . . . . 0.0 112.364 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.55 141.96 34.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.661 1.184 . . . . 0.0 110.489 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.09 165.97 27.23 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 123.033 1.352 . . . . 0.0 115.801 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.62 -8.48 65.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.439 1.495 . . . . 0.0 115.831 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.54 -20.87 76.15 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.061 1.431 . . . . 0.0 116.065 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -143.68 170.06 16.56 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.757 1.278 . . . . 0.0 113.067 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -100.08 162.61 20.45 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 111.147 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.9 -13.26 29.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.838 3.025 . . . . 0.0 117.886 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 17.17 59.83 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.768 0.699 . . . . 0.0 114.389 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt 60.44 25.5 15.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.711 1.604 . . . . 0.0 112.967 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -82.77 125.17 30.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.58 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -76.08 120.28 21.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 110.952 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -72.15 163.85 27.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.226 1.011 . . . . 0.0 113.632 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.27 69.23 8.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.968 1.707 . . . . 0.0 111.542 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -72.84 130.3 40.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.514 1.526 . . . . 0.0 112.706 -173.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -133.56 174.87 9.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.467 1.907 . . . . 0.0 112.641 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 49.39 68.21 3.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.654 1.582 . . . . 0.0 114.009 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -61.14 133.93 49.72 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.171 2.581 . . . . 0.0 111.418 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.7 mt -98.61 153.26 4.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.949 1.7 . . . . 0.0 108.012 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -74.83 161.2 29.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.54 0.336 . . . . 0.0 110.156 169.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.0 -42.88 69.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -168.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 61.34 -0.21 0.38 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.205 2.602 . . . . 0.0 117.717 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.39 -12.29 61.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.763 -1.836 . . . . 0.0 113.897 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -62.74 8.05 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.969 1.708 . . . . 0.0 115.101 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -79.21 -10.94 59.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.384 1.473 . . . . 0.0 112.832 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.6 81.35 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.055 1.312 . . . . 0.0 115.193 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.13 158.58 29.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.555 1.177 . . . . 0.0 112.535 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -128.53 150.3 50.23 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -87.15 65.44 8.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.477 1.911 . . . . 0.0 112.029 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.3 p -100.39 166.99 10.68 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.812 0.845 . . . . 0.0 112.424 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -52.27 123.22 10.2 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.699 1.599 . . . . 0.0 111.09 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.0 43.65 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 114.926 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.2 p -116.25 159.28 22.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.364 1.582 . . . . 0.0 113.682 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.95 134.72 55.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.826 0.85 . . . . 0.0 112.454 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.45 157.32 44.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 173.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -80.9 140.64 35.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.327 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.14 162.19 15.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.66 0.784 . . . . 0.0 111.231 172.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -129.75 164.65 23.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.461 1.104 . . . . 0.0 112.893 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.6 m -72.4 -54.54 9.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.67 0.788 . . . . 0.0 110.905 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.11 -52.13 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.627 1.571 . . . . 0.0 112.193 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.04 157.19 76.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.751 1.221 . . . . 0.0 111.776 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.2 -24.98 76.44 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.122 2.548 . . . . 0.0 114.296 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -109.12 33.64 4.17 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.478 1.511 . . . . 0.0 112.649 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.7 p -118.84 26.3 9.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.34 1.456 . . . . 0.0 113.88 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.51 100.85 13.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.209 1.404 . . . . 0.0 109.51 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.0 p -89.15 -57.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.065 0.946 . . . . 0.0 113.201 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -162.39 48.44 0.17 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -136.71 147.5 46.8 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.832 -1.167 . . . . 0.0 111.381 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.82 168.22 20.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.114 1.366 . . . . 0.0 111.78 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -147.61 162.44 39.12 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.239 0.616 . . . . 0.0 111.371 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.1 mt -116.05 115.85 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.053 0.941 . . . . 0.0 108.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -73.6 96.12 2.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.379 0.671 . . . . 0.0 110.062 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.42 -22.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.06 -1.025 . . . . 0.0 113.189 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.55 166.66 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.633 . . . . 0.0 110.862 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.71 114.73 13.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.326 0.584 . . . . 0.0 111.629 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -124.94 59.44 1.22 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.063 1.745 . . . . 0.0 111.554 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.09 -14.89 63.32 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.15 -14.05 62.53 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.849 -1.157 . . . . 0.0 113.266 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.2 -8.27 59.64 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.379 1.072 . . . . 0.0 113.695 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.36 -176.94 2.4 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -74.69 147.51 41.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.05 1.74 . . . . 0.0 113.034 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.4 p -103.15 -61.19 1.44 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.652 1.581 . . . . 0.0 113.107 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.27 56.2 0.01 OUTLIER Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.142 1.353 . . . . 0.0 112.618 -170.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.61 28.26 15.41 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.209 1.804 . . . . 0.0 114.421 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.8 p -106.82 114.43 28.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.225 . . . . 0.0 111.222 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.22 -32.31 68.18 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.64 -14.89 60.38 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.05 -68.24 1.1 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.578 2.513 . . . . 0.0 113.604 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.348 2.4 p-90 -66.1 121.97 16.37 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.237 1.518 . . . . 0.0 112.958 -171.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.88 -85.72 1.26 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.371 1.463 . . . . 0.0 115.905 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -137.1 132.97 34.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.957 1.303 . . . . 0.0 111.79 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.59 128.78 34.79 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.58 90.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.574 1.15 . . . . 0.0 107.935 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -78.94 -14.86 58.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.716 0.806 . . . . 0.0 111.904 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.01 177.33 9.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.579 1.18 . . . . 0.0 112.929 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -136.31 153.99 50.99 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.592 -1.317 . . . . 0.0 112.232 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.33 140.01 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.591 0.71 . . . . 0.0 109.403 169.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.99 -42.24 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.704 1.602 . . . . 0.0 110.519 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.43 147.0 32.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.563 1.545 . . . . 0.0 109.902 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.12 7.15 10.4 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.523 0.969 . . . . 0.0 115.523 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -56.32 -37.51 70.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.695 1.747 . . . . 0.0 112.716 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.47 -29.03 70.23 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.84 0.856 . . . . 0.0 112.431 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.11 -44.98 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.423 1.489 . . . . 0.0 110.443 172.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.84 -38.52 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.165 -0.959 . . . . 0.0 111.25 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.84 -23.51 60.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 112.457 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -78.92 -42.4 27.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.191 1.396 . . . . 0.0 111.182 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.8 mt -54.37 -35.52 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.558 1.143 . . . . 0.0 111.87 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -84.98 -18.14 35.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.1 15.41 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.179 1.371 . . . . 0.0 114.422 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.42 -57.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.806 1.303 . . . . 0.0 113.106 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.33 5.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 112.024 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.2 p -142.84 153.52 43.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.2 1.4 . . . . 0.0 112.119 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.84 121.93 0.72 Allowed Glycine 0 CA--C 1.532 1.136 0 O-C-N 122.135 -0.353 . . . . 0.0 113.234 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -65.5 158.99 25.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.816 1.246 . . . . 0.0 113.483 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.3 p -116.0 168.58 9.95 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 112.173 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.06 -21.56 75.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 123.578 0.609 . . . . 0.0 114.546 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.3 mmt -99.48 -35.61 9.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.31 1.044 . . . . 0.0 113.386 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.37 129.6 22.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.107 1.763 . . . . 0.0 110.482 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -96.81 158.12 15.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.273 1.029 . . . . 0.0 113.026 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.478 ' HB2' ' HE ' ' A' ' 43' ' ' ARG . 5.7 m-20 59.74 18.24 7.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.063 1.745 . . . . 0.0 114.697 -171.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m -70.69 149.14 95.28 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.966 -1.084 . . . . 0.0 111.597 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.08 143.79 55.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 121.711 1.607 . . . . 0.0 109.324 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.46 58.17 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.44 159.11 16.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.211 1.405 . . . . 0.0 110.216 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.51 112.57 17.98 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.854 -1.154 . . . . 0.0 111.477 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.6 94.21 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -128.15 147.49 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -168.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 63.8 mt -85.76 104.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.992 1.717 . . . . 0.0 107.988 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -78.94 -30.47 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.081 1.353 . . . . 0.0 112.612 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 t -155.29 162.43 40.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.06 0.944 . . . . 0.0 113.119 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.03 139.6 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.69 1.596 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.7 m -136.39 128.61 29.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.594 1.157 . . . . 0.0 110.779 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.79 118.08 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.2 t -112.63 150.19 31.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.635 1.574 . . . . 0.0 112.295 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.346 1.458 . . . . 0.0 113.627 -170.081 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.865 -0.588 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.39 130.27 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 120.684 1.584 . . . . 0.0 110.394 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -101.24 123.16 44.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.446 1.098 . . . . 0.0 110.346 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -97.83 130.73 44.73 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.977 1.311 . . . . 0.0 110.286 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -103.6 97.84 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -101.51 152.35 20.87 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.064 -0.398 . . . . 0.0 111.269 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -60.85 -9.09 3.62 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -107.49 -8.44 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 114.147 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.45 162.23 10.61 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 123.109 1.394 . . . . 0.0 113.653 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.13 137.72 45.34 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.452 1.501 . . . . 0.0 112.651 172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.91 140.77 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.392 1.877 . . . . 0.0 108.685 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.47 135.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.384 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.13 134.55 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.559 1.944 . . . . 0.0 110.473 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -101.73 127.64 48.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.138 1.775 . . . . 0.0 108.796 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.4 p -88.28 149.27 23.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.386 1.075 . . . . 0.0 111.25 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.81 73.26 0.94 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.898 1.332 . . . . 0.0 111.656 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.76 -26.14 64.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.518 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -78.14 -26.2 47.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.333 1.053 . . . . 0.0 111.638 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.77 -22.02 14.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 113.183 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.85 55.31 1.19 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.855 1.262 . . . . 0.0 113.674 -171.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.63 -42.98 35.38 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.532 2.821 . . . . 0.0 113.147 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.31 -38.04 78.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 111.043 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.3 m -68.28 -47.99 66.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.153 0.581 . . . . 0.0 111.904 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.48 -39.43 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.337 0.655 . . . . 0.0 111.6 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -52.64 -49.36 65.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.543 1.065 . . . . 0.0 112.104 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.6 -38.05 77.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.459 0.704 . . . . 0.0 111.562 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.01 -50.34 74.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.472 1.109 . . . . 0.0 111.82 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.31 -35.18 73.5 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.51 -0.744 . . . . 0.0 111.638 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.07 -33.19 70.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 112.694 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.54 -43.42 39.22 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.378 -0.826 . . . . 0.0 112.376 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -58.84 -40.36 84.01 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.731 -0.605 . . . . 0.0 111.706 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -61.03 -39.66 90.65 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.362 1.865 . . . . 0.0 113.387 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -77.48 -16.23 58.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.031 0.933 . . . . 0.0 112.632 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.9 62.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.988 0.804 . . . . 0.0 112.836 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.95 -35.76 75.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.53 1.165 . . . . 0.0 113.122 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.72 -8.61 59.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.733 0.413 . . . . 0.0 112.089 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.04 132.12 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.15 -0.969 . . . . 0.0 108.809 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 56.1 t30 58.17 30.82 19.95 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -170.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -88.61 167.24 13.54 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 156' ' ' ILE . 12.1 pt -124.6 162.58 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -89.11 82.72 6.57 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -70.95 -12.85 61.77 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -168.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -147.54 135.09 20.88 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.649 1.568 . . . . 0.0 112.679 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -135.45 147.61 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 127.235 2.214 . . . . 0.0 109.516 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.87 132.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.139 1.776 . . . . 0.0 107.376 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.34 133.41 55.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.355 0.662 . . . . 0.0 111.897 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.53 11.1 61.7 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.989 0.804 . . . . 0.0 115.039 -172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.63 -177.12 4.91 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 111.164 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -83.65 179.9 7.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -169.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.0 pt -115.24 136.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.075 1.75 . . . . 0.0 112.168 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -115.8 149.38 38.64 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.142 1.377 . . . . 0.0 111.413 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.49 179.99 30.2 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 122.164 0.869 . . . . 0.0 115.235 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.12 -2.14 87.47 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.627 1.108 . . . . 0.0 115.493 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -25.17 43.73 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 118.965 1.383 . . . . 0.0 115.095 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -143.5 164.83 29.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.89 164.34 16.68 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.469 1.908 . . . . 0.0 110.441 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.32 -11.53 25.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.468 2.778 . . . . 0.0 117.492 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.15 16.1 60.47 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.042 0.829 . . . . 0.0 114.575 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mmt 60.8 27.1 16.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.394 1.877 . . . . 0.0 113.16 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.49 126.92 33.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.915 1.286 . . . . 0.0 109.561 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.49 127.55 33.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 124.017 1.865 . . . . 0.0 111.002 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -71.23 174.83 5.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 110.494 -3.048 . . . . 0.0 114.95 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 47.79 1.55 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.649 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.5 p -69.75 119.56 14.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.493 1.117 . . . . 0.0 112.308 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -132.82 173.41 11.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.748 2.419 . . . . 0.0 111.377 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 44.61 73.43 0.97 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.829 1.652 . . . . 0.0 114.359 169.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.83 144.5 26.68 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.78 2.987 . . . . 0.0 113.523 171.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.18 150.96 6.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.197 1.799 . . . . 0.0 107.993 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 151.93 26.96 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.269 0.627 . . . . 0.0 110.049 169.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -74.7 116.48 15.45 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.89 -77.87 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.088 0.555 . . . . 0.0 110.08 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.66 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.934 3.293 . . . . 0.0 118.202 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -75.05 27.51 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.395 2.278 . . . . 0.0 114.327 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.33 -5.57 18.99 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.379 2.272 . . . . 0.0 113.961 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.04 82.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 115.379 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.47 155.65 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.354 1.077 . . . . 0.0 112.527 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.01 154.0 51.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -90.79 62.05 4.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.083 1.753 . . . . 0.0 112.059 -169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.6 p -96.72 169.07 10.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.75 0.82 . . . . 0.0 111.768 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -54.02 127.42 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.667 1.187 . . . . 0.0 111.268 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.84 29.23 55.17 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.78 1.181 . . . . 0.0 114.66 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.5 p -115.35 159.16 21.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.472 1.636 . . . . 0.0 112.912 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.87 137.22 52.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.976 0.893 . . . . 0.0 113.152 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.53 161.57 36.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.973 0.892 . . . . 0.0 111.693 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 138.48 31.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.242 1.417 . . . . 0.0 111.71 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.73 137.34 35.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.984 0.914 . . . . 0.0 112.45 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -81.15 155.93 25.97 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.431 1.492 . . . . 0.0 112.264 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -80.41 -55.15 5.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.191 0.996 . . . . 0.0 111.065 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -154.55 -54.87 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.475 1.51 . . . . 0.0 110.975 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.5 79.88 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.9 0.88 . . . . 0.0 111.318 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.29 -22.81 74.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.552 2.168 . . . . 0.0 114.292 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.72 37.05 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.692 1.597 . . . . 0.0 112.303 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.4 p -114.42 23.96 12.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.462 1.505 . . . . 0.0 113.691 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.25 97.79 9.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 109.173 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -83.57 -69.34 0.64 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.735 1.214 . . . . 0.0 111.868 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.44 -14.1 1.98 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 113.249 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -74.06 141.56 45.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.228 1.013 . . . . 0.0 111.821 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -141.75 168.17 20.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.093 2.157 . . . . 0.0 111.047 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 13.1 p90 -145.96 162.65 37.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.055 0.942 . . . . 0.0 111.638 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -116.57 118.85 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.583 1.153 . . . . 0.0 108.311 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -71.71 98.89 2.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.414 0.686 . . . . 0.0 109.737 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -75.2 -17.47 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 113.318 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.6 167.19 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 128.537 2.735 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -75.65 115.5 15.39 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.712 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -125.0 55.65 1.36 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.116 1.766 . . . . 0.0 111.991 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.08 -16.01 60.82 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -66.54 -14.45 62.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.83 -1.169 . . . . 0.0 113.45 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.4 mt -82.23 -9.07 59.63 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.621 1.169 . . . . 0.0 113.607 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -71.64 -178.74 2.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.155 1.382 . . . . 0.0 114.363 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -83.65 144.31 29.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.145 1.378 . . . . 0.0 113.107 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.485 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.3 p -104.46 -63.06 1.25 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.833 1.653 . . . . 0.0 112.911 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.83 55.32 0.01 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.316 1.436 . . . . 0.0 112.836 -170.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 57.95 26.51 13.49 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.934 1.693 . . . . 0.0 114.999 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 p -100.66 116.69 33.17 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.88 1.272 . . . . 0.0 110.939 174.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 tp -57.14 -34.89 68.86 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -79.87 -10.9 59.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.74 -72.74 1.21 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.132 2.301 . . . . 0.0 113.151 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.485 ' HB3' ' H ' ' A' ' 111' ' ' SER . 17.7 p-90 -71.88 131.42 42.98 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.13 -100.5 2.01 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.224 1.392 . . . . 0.0 114.857 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.32 141.65 51.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.116 1.366 . . . . 0.0 111.643 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 36.3 t -79.49 126.98 31.56 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.944 -0.473 . . . . 0.0 112.159 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.88 94.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -81.88 -14.41 56.24 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.301 0.64 . . . . 0.0 111.939 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 176.88 8.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.41 1.1 . . . . 0.0 113.88 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -139.76 153.78 47.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.447 1.099 . . . . 0.0 112.647 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.03 140.18 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.599 0.714 . . . . 0.0 110.132 170.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.62 -42.28 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.091 1.756 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -144.72 155.26 43.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.552 1.541 . . . . 0.0 109.771 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.67 15.78 28.33 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 123.878 0.752 . . . . 0.0 113.964 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -34.95 67.87 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.761 1.28 . . . . 0.0 112.319 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.69 -29.41 69.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.581 0.753 . . . . 0.0 112.657 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.37 -42.63 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.229 1.412 . . . . 0.0 110.278 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.96 -39.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.957 . . . . 0.0 111.357 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.42 -21.24 61.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.689 1.596 . . . . 0.0 112.71 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -86.32 -43.72 12.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.769 1.628 . . . . 0.0 111.447 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.16 -29.1 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.416 1.486 . . . . 0.0 112.585 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -81.29 -16.49 52.34 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.91 -2.35 11.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.311 1.434 . . . . 0.0 114.544 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.82 -55.07 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.039 1.419 . . . . 0.0 112.012 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 177.93 148.4 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.686 1.995 . . . . 0.0 111.258 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 p -121.66 149.86 42.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.348 1.459 . . . . 0.0 112.947 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.18 134.84 1.78 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.875 1.226 . . . . 0.0 112.141 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -61.97 144.78 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.034 0.934 . . . . 0.0 113.323 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.8 p -98.32 169.49 9.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.959 1.704 . . . . 0.0 111.519 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.71 -7.89 30.72 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.002 -0.888 . . . . 0.0 115.221 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 62.6 mtm -125.51 -24.09 3.96 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.918 1.359 . . . . 0.0 114.536 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -141.42 129.22 21.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.388 1.475 . . . . 0.0 110.6 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -96.0 153.3 17.84 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.6 t0 55.6 54.55 8.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.473 1.509 . . . . 0.0 112.972 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.89 159.17 45.67 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.495 1.918 . . . . 0.0 111.515 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.4 130.49 23.93 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.088 1.192 . . . . 0.0 109.364 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -26.6 30.7 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.87 140.8 42.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.62 0.768 . . . . 0.0 109.418 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.38 109.83 17.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.419 0.628 . . . . 0.0 110.78 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.95 107.51 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.63 142.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 124.417 1.087 . . . . 0.0 111.446 -170.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.25 103.41 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.68 -37.72 62.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.21 0.604 . . . . 0.0 110.831 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 t -152.32 165.77 33.91 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 t -138.86 141.6 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.945 1.698 . . . . 0.0 110.641 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -134.0 126.1 29.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.022 1.329 . . . . 0.0 110.087 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.84 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -115.4 150.23 36.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.299 1.44 . . . . 0.0 112.412 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.429 1.492 . . . . 0.0 113.614 -169.946 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.17 126.39 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -97.97 124.91 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.939 1.296 . . . . 0.0 109.892 173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.95 121.69 42.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 109.974 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -97.2 108.76 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -120.16 159.61 24.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -68.54 -8.57 42.67 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.9 p80 -109.17 -25.28 10.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 113.677 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.74 145.16 4.12 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.479 1.99 . . . . 0.0 113.402 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.7 133.74 36.54 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.268 -1.136 . . . . 0.0 112.672 172.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.12 143.38 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.95 1.7 . . . . 0.0 109.252 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.8 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.308 1.043 . . . . 0.0 110.239 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.71 139.56 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.698 1.999 . . . . 0.0 110.265 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -104.09 124.55 49.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 108.132 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -85.87 148.81 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 111.547 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -106.89 73.41 0.94 Allowed 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.78 1.276 . . . . 0.0 111.608 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.72 -26.49 64.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.413 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.5 -27.14 51.75 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.327 1.051 . . . . 0.0 111.412 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -99.31 -24.64 14.76 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.213 1.405 . . . . 0.0 112.922 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.48 57.77 2.26 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.404 1.082 . . . . 0.0 113.162 -169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.66 -44.38 26.76 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.232 2.621 . . . . 0.0 112.906 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -71.95 -39.78 69.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.756 0.707 . . . . 0.0 111.38 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -64.04 -47.54 79.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 111.215 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.26 -42.37 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.612 0.765 . . . . 0.0 111.595 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -54.89 -47.42 74.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.764 1.166 . . . . 0.0 111.967 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -71.18 -36.01 71.82 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.339 0.518 . . . . 0.0 112.032 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.63 -48.88 79.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.134 0.974 . . . . 0.0 111.611 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.64 -36.05 73.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.4 -0.812 . . . . 0.0 111.826 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -58.67 -35.32 72.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.586 0.755 . . . . 0.0 112.338 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.394 -0.816 . . . . 0.0 111.958 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -58.84 -38.11 77.97 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.665 -0.647 . . . . 0.0 111.808 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -65.69 -35.83 81.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.053 2.141 . . . . 0.0 112.703 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -81.63 -16.02 52.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.704 0.802 . . . . 0.0 113.107 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.29 20.24 60.92 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.295 0.95 . . . . 0.0 113.215 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.12 -38.47 76.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.371 1.068 . . . . 0.0 113.179 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -82.12 -7.75 59.63 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.044 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.53 130.35 42.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.2 t30 55.08 46.78 23.39 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 114.262 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.6 p -110.62 162.51 14.66 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.301 1.04 . . . . 0.0 111.489 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 9.2 pt -122.72 161.85 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -86.45 81.85 8.16 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.843 1.257 . . . . 0.0 107.609 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -71.96 -7.96 51.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -146.0 135.22 22.83 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.55 1.523 . . . . 0.0 112.183 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.61 143.48 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.784 2.034 . . . . 0.0 110.556 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.35 129.72 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.853 1.661 . . . . 0.0 108.135 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -62.96 129.35 39.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.538 0.735 . . . . 0.0 111.65 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.61 10.48 67.14 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -142.49 -177.19 5.16 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.152 1.781 . . . . 0.0 110.765 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -81.71 178.82 8.11 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -169.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.29 135.81 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.679 1.591 . . . . 0.0 112.17 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -110.29 150.85 28.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.728 1.211 . . . . 0.0 111.206 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.68 175.79 33.42 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.33 2.9 85.06 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.329 1.442 . . . . 0.0 115.411 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.14 -26.14 49.45 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 118.953 1.377 . . . . 0.0 114.509 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.11 164.62 30.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.256 1.022 . . . . 0.0 113.396 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -97.41 164.59 17.36 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.768 1.627 . . . . 0.0 110.145 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -61.27 -15.26 39.1 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.51 2.807 . . . . 0.0 118.196 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.22 16.68 58.23 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.887 0.756 . . . . 0.0 114.284 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.6 mmm 58.1 37.85 26.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.818 2.047 . . . . 0.0 113.331 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -83.25 123.06 29.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.919 1.288 . . . . 0.0 109.122 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.41 119.94 17.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 124.196 1.951 . . . . 0.0 110.337 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.62 179.7 1.64 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 110.332 -3.122 . . . . 0.0 114.513 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 61.66 6.75 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.166 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -69.48 106.43 2.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.179 1.392 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.65 168.27 20.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.806 2.043 . . . . 0.0 111.995 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 49.12 61.35 14.17 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 113.007 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.4 129.85 36.88 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.731 2.954 . . . . 0.0 111.507 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.95 153.23 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.209 1.804 . . . . 0.0 108.154 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 162.66 18.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 112.19 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -76.5 123.07 25.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.796 0.838 . . . . 0.0 110.943 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.13 15.22 22.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.0 112.89 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -12.38 58.52 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.618 -1.301 . . . . 0.0 114.288 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -62.88 6.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 114.438 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -77.46 -11.54 59.86 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.134 1.774 . . . . 0.0 113.211 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.92 69.34 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.737 1.161 . . . . 0.0 114.891 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.39 156.93 26.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.882 1.341 . . . . 0.0 112.936 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -125.51 149.65 48.11 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -89.31 66.5 7.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 111.417 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.0 p -95.07 163.87 13.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.537 0.735 . . . . 0.0 111.514 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 124.88 15.74 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.765 0.793 . . . . 0.0 111.33 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.11 46.32 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.374 1.464 . . . . 0.0 115.391 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.0 p -115.17 160.37 19.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.627 1.713 . . . . 0.0 113.536 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.31 134.64 55.1 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -131.68 157.41 43.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.346 0.658 . . . . 0.0 111.381 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 35.7 mtp -84.23 138.1 33.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.223 -0.298 . . . . 0.0 111.061 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.52 155.83 17.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.161 0.985 . . . . 0.0 111.381 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -117.17 164.42 14.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.491 1.116 . . . . 0.0 113.2 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.8 m -76.66 -58.33 3.34 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.195 0.998 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -152.89 -58.31 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.991 1.716 . . . . 0.0 110.879 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.12 156.87 79.07 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.864 1.265 . . . . 0.0 112.047 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.66 -26.09 71.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.48 2.787 . . . . 0.0 114.249 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -108.18 33.37 4.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.507 1.523 . . . . 0.0 112.758 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -118.55 28.82 8.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.452 1.501 . . . . 0.0 113.693 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.13 106.28 18.26 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.732 1.613 . . . . 0.0 109.427 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.5 p -94.0 -69.02 0.77 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 0.0 113.139 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.81 -24.84 2.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.5 mp0 -67.06 140.58 57.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.528 1.131 . . . . 0.0 111.27 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -136.83 168.39 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.123 1.769 . . . . 0.0 110.358 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.9 p90 -143.23 162.04 36.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.247 0.619 . . . . 0.0 111.552 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.3 mt -114.38 118.89 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -70.12 96.76 1.1 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -73.71 -17.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.299 -0.876 . . . . 0.0 113.117 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -134.47 165.72 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 128.259 2.624 . . . . 0.0 110.78 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.57 116.58 14.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.758 0.823 . . . . 0.0 111.549 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -123.42 63.41 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.371 1.468 . . . . 0.0 112.535 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -52.34 -35.16 50.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.342 1.457 . . . . 0.0 114.327 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -65.61 -13.72 59.67 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.85 -9.05 58.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -74.01 -178.86 3.48 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -171.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -78.89 150.82 32.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.34 1.456 . . . . 0.0 112.839 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -127.48 -39.92 1.82 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.99 63.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.944 0.793 . . . . 0.0 114.205 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 53.66 24.0 3.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.142 1.777 . . . . 0.0 115.151 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.3 m -116.19 119.84 37.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.054 1.342 . . . . 0.0 110.573 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.37 -32.61 62.73 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -75.41 -12.26 60.21 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.24 -78.7 1.42 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.116 2.293 . . . . 0.0 113.743 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.286 5.4 p-90 -66.43 128.61 36.84 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.55 -105.98 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.928 1.728 . . . . 0.0 114.86 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.24 141.06 51.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.533 1.533 . . . . 0.0 111.672 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -85.15 124.58 31.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -73.59 97.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 108.414 170.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -79.76 -15.94 56.52 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.544 0.737 . . . . 0.0 111.656 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.83 8.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.567 1.175 . . . . 0.0 113.843 -170.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -139.95 153.71 46.99 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.563 -1.335 . . . . 0.0 112.466 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.46 137.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.723 0.773 . . . . 0.0 109.924 170.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.13 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.331 1.852 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -141.74 148.65 39.35 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.521 1.528 . . . . 0.0 110.031 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.89 13.2 20.63 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.944 0.783 . . . . 0.0 114.87 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 69.5 mmm -54.69 -38.06 66.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.405 1.602 . . . . 0.0 112.377 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.76 -29.04 70.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.049 0.94 . . . . 0.0 112.439 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.98 -43.55 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.689 1.596 . . . . 0.0 110.336 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.18 -38.4 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.218 1.007 . . . . 0.0 111.198 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.9 -22.26 60.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.585 1.554 . . . . 0.0 112.857 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -81.39 -43.86 18.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.368 1.467 . . . . 0.0 111.395 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.5 mt -55.18 -33.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.097 1.359 . . . . 0.0 112.045 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -85.17 -16.59 39.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.35 12.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.166 1.365 . . . . 0.0 114.268 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.5 m -72.81 -57.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.607 1.203 . . . . 0.0 113.613 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.68 156.51 7.89 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.994 0.917 . . . . 0.0 113.324 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.9 p -141.71 152.13 43.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.392 1.477 . . . . 0.0 111.972 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.25 133.27 1.65 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.114 0.387 . . . . 0.0 113.263 171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -61.82 149.29 40.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.876 1.27 . . . . 0.0 112.99 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.3 p -110.47 168.89 9.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.193 1.397 . . . . 0.0 111.742 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.21 -22.2 72.51 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.699 0.639 . . . . 0.0 114.699 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.8 ttm -105.49 -34.32 7.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.517 1.127 . . . . 0.0 113.375 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -136.72 124.47 22.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.881 1.672 . . . . 0.0 110.598 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -92.23 156.75 17.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.492 1.117 . . . . 0.0 112.452 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 56.35 54.62 7.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.521 1.528 . . . . 0.0 113.481 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.14 159.49 49.29 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 127.203 2.201 . . . . 0.0 111.354 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.0 135.36 34.71 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 121.378 1.385 . . . . 0.0 109.548 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -29.59 48.76 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 154.23 22.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 110.636 169.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -84.53 109.61 18.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.998 0.904 . . . . 0.0 111.312 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.19 94.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -123.5 141.67 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -168.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.48 103.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.596 1.958 . . . . 0.0 106.786 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.02 -39.8 60.88 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.614 -0.679 . . . . 0.0 111.119 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -150.07 165.99 31.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -137.97 142.1 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.745 1.618 . . . . 0.0 111.001 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.7 m -136.33 129.59 31.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.766 1.227 . . . . 0.0 110.384 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.74 122.55 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -118.88 150.45 39.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.705 1.602 . . . . 0.0 112.044 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.628 1.171 . . . . 0.0 113.699 -172.331 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.31 124.75 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.97 0.908 . . . . 0.0 109.575 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 125.19 45.95 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.967 0.907 . . . . 0.0 110.314 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -96.87 135.34 38.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.674 1.19 . . . . 0.0 110.6 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -105.82 101.43 10.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -106.36 151.96 24.2 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.075 -0.39 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.83 -8.09 2.82 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -105.38 -10.46 16.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.781 1.232 . . . . 0.0 114.03 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.59 162.16 10.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.124 1.345 . . . . 0.0 113.592 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.21 138.1 45.42 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.667 1.587 . . . . 0.0 112.401 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.6 mt -135.61 140.36 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.299 1.84 . . . . 0.0 108.9 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.77 133.26 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.583 1.153 . . . . 0.0 110.682 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.54 139.16 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.551 1.94 . . . . 0.0 109.909 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -101.5 129.45 47.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.884 2.074 . . . . 0.0 108.452 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -93.43 145.98 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.412 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -103.96 72.08 1.08 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.897 1.332 . . . . 0.0 111.699 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.97 -26.13 63.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.502 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -77.58 -29.43 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.201 1.001 . . . . 0.0 111.698 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.7 -20.74 16.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.943 1.297 . . . . 0.0 113.285 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.65 56.79 1.55 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.516 1.126 . . . . 0.0 113.224 -171.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.18 -45.3 23.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.433 2.756 . . . . 0.0 113.116 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -69.48 -39.73 77.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.784 0.72 . . . . 0.0 111.449 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -63.44 -48.26 78.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.723 0.809 . . . . 0.0 111.24 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.17 -41.23 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.408 0.683 . . . . 0.0 111.512 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -54.42 -48.47 71.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.705 1.139 . . . . 0.0 112.329 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -70.56 -35.99 73.38 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.608 0.64 . . . . 0.0 111.922 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.84 -50.92 71.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.447 1.099 . . . . 0.0 111.418 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 -36.35 73.17 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.697 0.799 . . . . 0.0 111.959 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.89 -34.8 70.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -76.27 -39.19 54.97 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.519 -0.738 . . . . 0.0 112.442 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.45 -35.77 76.64 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.11 -0.994 . . . . 0.0 111.565 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -31.08 71.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.105 1.762 . . . . 0.0 112.763 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.21 -14.31 57.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.225 1.01 . . . . 0.0 113.345 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.52 15.38 62.0 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.69 1.138 . . . . 0.0 114.04 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -68.17 -18.96 64.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.438 1.495 . . . . 0.0 114.689 -171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.78 -13.5 21.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.23 1.71 8.81 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -145.24 49.38 1.26 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.28 1.432 . . . . 0.0 111.055 170.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.9 p -113.57 170.39 8.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.36 162.2 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -103.15 130.93 50.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.647 1.579 . . . . 0.0 107.368 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.96 -40.39 1.51 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -87.66 116.81 26.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.609 1.095 . . . . 0.0 109.627 -175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.03 129.75 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.489 1.516 . . . . 0.0 110.413 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.7 mt -141.47 129.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.021 1.728 . . . . 0.0 107.856 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -65.96 134.94 54.01 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.697 0.799 . . . . 0.0 111.819 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.5 13.5 68.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.811 0.72 . . . . 0.0 114.79 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -142.98 -177.32 5.28 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.903 1.681 . . . . 0.0 111.542 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.58 179.93 6.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.12 1.768 . . . . 0.0 114.975 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.0 pt -120.83 142.63 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -118.19 147.7 43.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 112.225 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.34 -177.6 30.61 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 122.151 0.862 . . . . 0.0 115.216 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.74 -5.82 82.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.362 1.458 . . . . 0.0 115.622 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.01 -16.08 63.8 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 -169.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.05 163.76 34.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.805 1.302 . . . . 0.0 112.366 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.13 163.0 30.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.303 1.041 . . . . 0.0 111.11 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.54 -12.9 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.187 3.258 . . . . 0.0 117.33 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.47 13.55 67.0 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.074 0.845 . . . . 0.0 114.833 172.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.8 mmt 59.71 29.64 19.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.374 1.87 . . . . 0.0 112.868 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -81.24 124.08 29.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.827 1.251 . . . . 0.0 109.197 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -72.97 114.72 11.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.535 0.734 . . . . 0.0 109.88 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -71.99 165.2 24.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.59 73.29 10.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.798 1.639 . . . . 0.0 111.033 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -70.41 129.31 38.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.864 0.866 . . . . 0.0 111.09 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -140.29 172.09 13.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.545 1.938 . . . . 0.0 111.513 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 48.42 62.66 11.71 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.396 1.478 . . . . 0.0 113.127 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -55.87 129.23 33.84 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.125 2.55 . . . . 0.0 110.339 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.63 149.18 4.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 107.536 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 158.45 27.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.691 0.758 . . . . 0.0 111.133 171.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -85.24 131.06 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.334 1.054 . . . . 0.0 111.217 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.36 15.92 17.92 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.224 1.01 . . . . 0.0 112.715 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.01 -11.36 28.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -74.43 40.41 0.13 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.932 1.693 . . . . 0.0 112.173 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -117.88 -3.48 11.18 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.419 2.287 . . . . 0.0 114.006 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.63 4.55 72.96 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.48 1.514 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.91 157.64 20.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.614 1.207 . . . . 0.0 113.124 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.04 158.85 43.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.616 1.166 . . . . 0.0 113.754 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -94.78 102.25 14.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.983 1.713 . . . . 0.0 110.563 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.4 p -133.5 168.03 19.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.787 1.235 . . . . 0.0 111.663 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.95 121.49 7.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.848 1.259 . . . . 0.0 110.692 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.91 24.54 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.503 1.525 . . . . 0.0 114.992 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.4 p -122.31 159.96 26.34 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.38 1.59 . . . . 0.0 113.734 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -122.24 139.49 53.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.836 0.854 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.46 159.24 42.57 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.843 -0.536 . . . . 0.0 111.881 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.9 mmm -78.75 137.7 37.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.919 0.488 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.69 148.85 29.99 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.122 0.569 . . . . 0.0 110.978 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.19 162.55 18.48 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.995 1.318 . . . . 0.0 112.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.6 m -77.37 -55.48 5.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.872 0.869 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.3 -56.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.977 1.311 . . . . 0.0 111.069 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.66 157.27 86.17 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 111.556 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.96 -35.53 94.49 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.869 2.379 . . . . 0.0 113.671 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -98.82 32.62 2.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.965 1.706 . . . . 0.0 113.359 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.5 p -117.24 33.91 5.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.006 1.322 . . . . 0.0 113.426 -173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.12 109.79 21.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.793 1.637 . . . . 0.0 110.186 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 p -94.94 -66.94 0.88 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.264 1.425 . . . . 0.0 113.449 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.67 -22.64 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.52 145.18 47.66 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 120.574 -1.329 . . . . 0.0 112.088 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -140.32 168.22 20.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 127.409 2.283 . . . . 0.0 109.611 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.9 p90 -144.81 159.9 42.13 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.125 0.57 . . . . 0.0 111.703 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.52 117.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 0.0 108.273 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.78 111.44 14.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.642 0.777 . . . . 0.0 110.707 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.13 -6.32 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 m -129.11 165.06 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.895 1.678 . . . . 0.0 111.154 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -80.27 117.4 21.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.89 0.476 . . . . 0.0 109.917 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -142.14 63.92 1.4 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.019 1.39 . . . . 0.0 111.822 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.31 -13.52 60.64 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -172.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.88 -14.03 41.41 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.689 -1.257 . . . . 0.0 113.427 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.01 -10.51 59.78 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.53 1.132 . . . . 0.0 113.729 173.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -75.44 -176.45 3.18 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -82.1 143.7 31.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.693 1.597 . . . . 0.0 112.288 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.4 p -108.62 -59.28 1.89 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.499 1.119 . . . . 0.0 113.631 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.6 60.94 0.02 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.081 0.848 . . . . 0.0 114.161 -172.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 58.39 23.51 10.67 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.012 1.725 . . . . 0.0 115.05 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 t -101.78 122.18 43.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.857 1.263 . . . . 0.0 111.848 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.1 tp -52.43 -43.46 64.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.907 1.283 . . . . 0.0 114.152 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -81.92 -6.61 59.25 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 113.785 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.49 -69.9 1.08 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.705 2.098 . . . . 0.0 113.893 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.288 8.3 p-90 -72.07 130.53 41.14 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -171.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.7 -98.54 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.629 1.585 . . . . 0.0 116.506 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -126.31 139.83 53.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.957 1.303 . . . . 0.0 111.809 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.94 122.85 28.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.878 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.75 89.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.551 1.14 . . . . 0.0 108.182 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.43 -15.22 59.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.369 0.667 . . . . 0.0 112.36 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.72 175.8 9.39 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -138.11 152.65 48.96 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.965 -1.085 . . . . 0.0 112.458 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.37 139.63 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.542 0.687 . . . . 0.0 110.476 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.95 -43.34 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.388 1.475 . . . . 0.0 111.165 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -145.96 154.02 41.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.379 1.472 . . . . 0.0 110.339 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.88 15.06 29.8 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.009 0.814 . . . . 0.0 113.395 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 23.0 mtp -57.84 -34.64 69.93 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.65 1.18 . . . . 0.0 111.938 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.55 -31.44 72.5 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.921 0.888 . . . . 0.0 112.407 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t -72.16 -43.12 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.444 1.097 . . . . 0.0 109.89 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.585 -0.697 . . . . 0.0 111.001 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.44 -26.38 61.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.82 1.248 . . . . 0.0 112.644 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -78.32 -41.39 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.054 1.342 . . . . 0.0 110.978 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mt -55.7 -30.1 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.447 1.899 . . . . 0.0 112.772 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -92.76 -11.1 34.71 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.04 -11.95 13.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.509 1.528 . . . . 0.0 114.413 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.16 -59.32 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.572 1.186 . . . . 0.0 112.799 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.94 143.22 0.93 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 112.431 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.0 p -112.07 148.75 33.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.435 1.494 . . . . 0.0 112.587 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.97 144.1 3.97 Favored Glycine 0 N--CA 1.464 0.526 0 CA-C-O 123.198 1.444 . . . . 0.0 113.7 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -61.83 144.25 55.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.405 2.282 . . . . 0.0 113.347 -169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.4 t -107.43 158.72 16.96 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.053 1.741 . . . . 0.0 110.936 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.7 -16.02 62.87 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.578 -0.702 . . . . 0.0 114.069 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.11 -22.26 10.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.025 1.33 . . . . 0.0 114.407 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -141.56 140.77 33.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.176 1.39 . . . . 0.0 111.519 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.65 154.37 22.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.392 1.477 . . . . 0.0 111.778 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 56.81 49.2 14.65 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.907 1.683 . . . . 0.0 113.558 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.17 158.77 54.49 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 126.239 1.816 . . . . 0.0 112.414 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.87 137.66 45.83 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 121.66 1.573 . . . . 0.0 109.858 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -27.64 43.04 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.768 -0.582 . . . . 0.0 112.281 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.72 140.71 44.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 109.635 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -84.22 130.44 34.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.67 0.748 . . . . 0.0 109.836 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.15 109.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.329 1.452 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.89 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.384 1.074 . . . . 0.0 111.566 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 mt -84.07 103.83 11.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.75 -28.35 60.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.2 t -163.89 169.53 18.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.38 140.07 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.496 1.919 . . . . 0.0 110.416 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.8 m -130.04 124.96 34.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 109.891 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.68 123.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -115.58 150.39 36.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.808 1.243 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.775 1.63 . . . . 0.0 113.413 -169.812 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.69 127.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.236 -0.915 . . . . 0.0 109.545 169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -102.35 120.92 41.3 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 110.119 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.7 132.12 41.23 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 110.843 169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -104.51 101.42 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -106.42 152.21 23.91 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.066 -0.396 . . . . 0.0 111.193 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.48 -9.77 4.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.93 -7.55 19.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 0.0 114.027 170.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.29 166.69 12.26 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.864 1.697 . . . . 0.0 113.683 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.09 137.6 41.53 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.097 1.759 . . . . 0.0 113.044 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -133.09 141.15 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.586 1.954 . . . . 0.0 108.971 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.49 135.78 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.457 1.103 . . . . 0.0 110.359 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 mt -122.98 139.84 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 126.339 1.855 . . . . 0.0 110.162 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -107.21 123.57 48.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.168 1.787 . . . . 0.0 109.113 172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.0 p -87.85 148.1 24.81 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.486 1.115 . . . . 0.0 111.914 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -105.73 73.66 1.02 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 122.655 1.217 . . . . 0.0 111.209 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.31 -26.06 64.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.581 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.99 -24.45 47.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.327 1.051 . . . . 0.0 111.595 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.2 -21.98 13.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.342 1.457 . . . . 0.0 112.862 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.65 55.59 1.81 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.199 1.4 . . . . 0.0 112.982 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.64 -43.77 30.53 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.509 2.806 . . . . 0.0 112.762 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -69.54 -40.09 77.08 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.006 0.821 . . . . 0.0 111.055 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -63.57 -49.37 73.68 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.947 0.499 . . . . 0.0 111.423 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.23 -38.05 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.399 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -55.74 -50.43 70.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.503 1.047 . . . . 0.0 111.433 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.6 -48.28 82.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.914 1.286 . . . . 0.0 111.199 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.17 -50.52 73.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 111.171 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -73.12 -36.07 66.67 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.524 0.73 . . . . 0.0 111.654 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -58.8 -36.33 74.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.949 0.5 . . . . 0.0 111.601 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 2.9 m-85 -77.75 -39.36 44.58 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 76.1 m -61.48 -36.33 80.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.967 . . . . 0.0 111.46 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -34.2 77.07 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 112.765 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.21 -14.06 57.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.367 1.067 . . . . 0.0 113.404 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.09 16.91 62.04 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.871 1.224 . . . . 0.0 114.258 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 45.9 t80 -71.81 -17.59 62.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -93.74 -12.81 28.36 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.98 2.94 7.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -146.12 43.92 1.23 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.229 1.412 . . . . 0.0 111.357 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 p -104.8 169.45 8.44 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.262 -0.899 . . . . 0.0 112.923 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 156' ' ' ILE . 20.8 pt -127.85 163.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -89.29 119.16 29.51 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -93.08 -30.52 15.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.46 1.504 . . . . 0.0 114.289 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -133.99 138.93 45.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.997 0.919 . . . . 0.0 112.389 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.83 133.6 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 127.292 2.237 . . . . 0.0 109.699 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.2 mt -138.65 130.15 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.169 1.788 . . . . 0.0 107.891 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -63.58 135.6 56.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.439 0.696 . . . . 0.0 111.875 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.56 9.97 62.74 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -141.85 -177.09 5.03 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.439 1.896 . . . . 0.0 110.975 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.13 -178.16 5.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.961 1.704 . . . . 0.0 115.42 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 pt -121.3 136.05 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 112.559 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -116.5 149.92 38.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.429 1.092 . . . . 0.0 112.124 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.6 -179.77 36.5 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.42 1.328 . . . . 0.0 116.42 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.08 -12.16 68.58 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.668 1.604 . . . . 0.0 115.979 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.5 -15.17 69.19 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.881 1.513 . . . . 0.0 116.881 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.04 166.22 25.23 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.033 1.417 . . . . 0.0 112.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.13 163.17 20.51 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.87 1.668 . . . . 0.0 111.239 169.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.49 -13.89 27.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.051 3.167 . . . . 0.0 118.301 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.37 14.46 65.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.936 0.779 . . . . 0.0 114.677 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 mmm 57.77 38.66 27.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.776 1.63 . . . . 0.0 112.733 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.55 126.44 36.64 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.433 1.493 . . . . 0.0 109.493 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -73.44 118.46 16.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.848 0.859 . . . . 0.0 110.346 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -73.36 166.5 23.08 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.32 73.96 5.94 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.945 1.698 . . . . 0.0 111.671 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 p -68.76 122.72 19.16 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.621 1.168 . . . . 0.0 111.71 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -137.81 170.12 16.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 111.226 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 48.23 61.15 14.39 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.327 1.451 . . . . 0.0 113.386 169.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.08 139.29 89.93 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.698 2.932 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.41 148.24 6.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.457 1.503 . . . . 0.0 107.968 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 155.99 19.63 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.771 0.828 . . . . 0.0 110.843 170.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -71.71 126.1 28.83 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -107.47 11.38 28.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.79 1.236 . . . . 0.0 113.013 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -12.62 45.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -171.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.56 0.94 0.26 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.406 1.482 . . . . 0.0 113.944 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -72.25 -11.26 60.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.791 1.236 . . . . 0.0 112.939 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.61 7.59 85.91 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.305 1.431 . . . . 0.0 114.695 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.69 153.25 38.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.464 1.132 . . . . 0.0 112.226 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -130.63 151.57 50.94 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -93.45 99.52 11.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 110.921 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.2 p -129.96 168.21 17.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.555 1.142 . . . . 0.0 111.496 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 124.9 18.57 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.71 1.204 . . . . 0.0 110.976 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.61 46.99 8.27 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.537 1.065 . . . . 0.0 113.807 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.8 p -134.75 163.36 29.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 118.304 1.052 . . . . 0.0 112.942 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.36 139.08 54.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.817 . . . . 0.0 112.997 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.7 159.86 40.56 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.086 0.47 . . . . 0.0 111.731 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -82.88 141.13 32.45 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.687 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.01 162.0 14.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.188 0.995 . . . . 0.0 111.025 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -137.4 158.74 43.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.212 1.405 . . . . 0.0 112.274 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 m -72.35 -54.94 8.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.46 1.104 . . . . 0.0 111.661 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.87 -49.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.113 1.365 . . . . 0.0 112.425 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 156.1 77.77 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.594 1.158 . . . . 0.0 111.21 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.01 -27.72 80.44 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.081 2.521 . . . . 0.0 113.653 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -109.34 35.63 3.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.514 1.526 . . . . 0.0 112.515 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -118.07 31.82 6.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.517 1.527 . . . . 0.0 113.671 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.54 105.14 17.22 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.009 1.724 . . . . 0.0 109.038 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.2 p -97.57 -45.39 6.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.37 12.59 0.23 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -104.96 139.72 39.25 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.358 -1.464 . . . . 0.0 111.489 -169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -141.51 168.42 19.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.051 1.74 . . . . 0.0 111.527 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.7 p90 -147.79 162.08 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.97 117.79 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.744 1.218 . . . . 0.0 108.783 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -76.57 100.8 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.861 0.864 . . . . 0.0 110.596 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.78 -19.27 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.81 167.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.812 1.645 . . . . 0.0 111.761 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.81 120.7 24.44 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.964 -0.46 . . . . 0.0 110.092 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -146.2 62.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 123.001 1.381 . . . . 0.0 111.937 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.64 -13.23 58.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -62.76 -13.91 38.55 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.507 -1.371 . . . . 0.0 113.381 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.25 -9.26 59.72 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.583 1.153 . . . . 0.0 113.821 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -73.8 179.91 3.99 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -81.0 145.89 30.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.348 1.459 . . . . 0.0 112.257 169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.3 p -115.8 -59.34 2.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.581 1.152 . . . . 0.0 113.613 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.04 66.21 0.03 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.17 0.891 . . . . 0.0 114.028 -172.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.29 23.54 5.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.055 1.742 . . . . 0.0 115.05 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.6 m -111.46 119.0 37.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.999 1.319 . . . . 0.0 110.342 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.93 -32.17 63.56 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -79.25 -9.9 59.69 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.04 -72.23 1.03 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.125 2.298 . . . . 0.0 113.97 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.282 7.2 p-90 -70.68 122.29 19.52 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.33 -93.42 1.13 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.316 1.436 . . . . 0.0 114.834 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.21 142.27 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.259 1.424 . . . . 0.0 111.721 -169.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.22 127.41 34.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.2 92.27 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.597 1.159 . . . . 0.0 108.22 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -80.38 -14.92 57.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.857 0.863 . . . . 0.0 112.031 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.98 8.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.335 1.064 . . . . 0.0 113.252 -170.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -138.94 149.98 45.38 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.842 -1.161 . . . . 0.0 112.041 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 p -78.8 134.99 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.424 0.63 . . . . 0.0 110.464 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.96 -41.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.326 1.85 . . . . 0.0 110.736 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -143.98 155.81 44.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.667 1.587 . . . . 0.0 109.853 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.21 16.79 26.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.754 0.692 . . . . 0.0 114.734 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.05 -32.91 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.371 1.585 . . . . 0.0 112.437 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.66 -29.06 68.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.574 0.75 . . . . 0.0 112.684 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.06 -38.55 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.533 1.533 . . . . 0.0 110.463 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.6 -41.4 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.8 -1.188 . . . . 0.0 110.658 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.7 -30.6 70.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.134 1.373 . . . . 0.0 111.652 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.98 -46.89 61.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.51 0.724 . . . . 0.0 111.12 173.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 98.6 mt -68.73 -25.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.993 1.317 . . . . 0.0 112.142 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -85.13 -17.62 36.69 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.883 -1.136 . . . . 0.0 113.864 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.67 -8.73 54.14 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.058 1.79 . . . . 0.0 115.181 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -26.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 83.55 164.59 0.12 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.357 2.263 . . . . 0.0 114.663 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.2 p -114.27 151.5 32.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.909 1.683 . . . . 0.0 113.599 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.05 117.85 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.032 1.301 . . . . 0.0 110.688 169.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -63.77 150.82 43.75 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.218 1.007 . . . . 0.0 113.411 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.7 p -115.08 168.26 10.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.303 1.441 . . . . 0.0 111.958 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.59 -21.81 72.97 Favored Glycine 0 CA--C 1.539 1.582 0 O-C-N 121.811 -0.556 . . . . 0.0 114.252 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 98.1 mmm -92.65 -43.9 8.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.361 1.065 . . . . 0.0 112.821 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -141.73 131.61 24.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.037 1.735 . . . . 0.0 111.129 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.37 163.27 20.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.754 0.822 . . . . 0.0 112.825 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . 0.324 3.4 p30 54.82 18.14 2.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.09 154.66 93.56 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.319 1.447 . . . . 0.0 112.246 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -60.3 140.04 89.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.887 1.725 . . . . 0.0 110.761 169.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -32.38 62.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.62 150.18 31.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.726 0.774 . . . . 0.0 111.198 169.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.95 110.01 16.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 110.617 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.38 106.24 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.143 0.977 . . . . 0.0 108.372 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.74 142.2 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.652 1.181 . . . . 0.0 112.176 -169.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mt -84.36 103.87 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.78 -30.96 59.29 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.536 1.134 . . . . 0.0 111.533 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 p -162.76 171.47 16.73 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -135.52 143.75 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.329 1.452 . . . . 0.0 110.786 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -132.79 130.28 39.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.351 1.46 . . . . 0.0 109.764 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.66 125.46 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.1 t -121.15 150.5 41.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.588 1.555 . . . . 0.0 111.838 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.356 1.062 . . . . 0.0 112.999 -179.872 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.504 2.258 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -129.75 130.47 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 120.846 -1.159 . . . . 0.0 110.273 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.1 m -101.07 127.11 47.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.493 1.117 . . . . 0.0 110.235 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -101.66 124.03 46.63 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.778 1.231 . . . . 0.0 110.054 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.53 106.64 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.5 p -117.55 160.12 21.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.303 0.573 . . . . 0.0 112.114 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -68.5 -7.88 36.14 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.474 ' CE1' HD11 ' A' ' 136' ' ' ILE . 21.2 p80 -111.24 -25.69 9.56 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.522 . . . . 0.0 113.591 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.48 144.95 4.09 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.164 1.84 . . . . 0.0 113.538 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.96 133.6 38.06 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.383 1.073 . . . . 0.0 112.38 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -130.86 144.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.788 1.635 . . . . 0.0 109.379 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.4 136.79 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.274 1.03 . . . . 0.0 110.517 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -126.38 139.83 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.888 2.075 . . . . 0.0 110.189 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -102.46 127.69 49.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.69 1.996 . . . . 0.0 107.753 171.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -88.79 147.63 24.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.162 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -104.48 74.11 1.15 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.695 1.236 . . . . 0.0 111.391 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.69 -27.52 65.08 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.212 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.87 -31.37 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.528 1.131 . . . . 0.0 111.529 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -96.39 -24.51 16.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.6 1.16 . . . . 0.0 113.066 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.1 61.36 4.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.662 0.785 . . . . 0.0 112.971 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.37 -45.07 15.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.201 2.601 . . . . 0.0 112.583 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -69.48 -39.97 77.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.858 0.754 . . . . 0.0 111.13 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.482 ' HA ' HD13 ' A' ' 68' ' ' ILE . 20.4 m -63.23 -48.19 79.29 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.739 0.816 . . . . 0.0 111.249 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.26 -41.81 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.409 0.684 . . . . 0.0 111.803 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.26 -47.87 74.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.72 1.146 . . . . 0.0 112.129 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -37.11 73.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.097 0.559 . . . . 0.0 111.813 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.75 -49.0 79.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.333 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.78 -37.09 70.5 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.591 0.757 . . . . 0.0 111.821 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.094 0.558 . . . . 0.0 112.436 172.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.81 -41.83 59.2 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.438 -0.789 . . . . 0.0 112.522 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.21 -37.33 79.95 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.424 -0.797 . . . . 0.0 111.51 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.82 -35.04 78.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.803 2.041 . . . . 0.0 112.788 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -82.65 -13.15 56.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.023 0.929 . . . . 0.0 113.39 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.49 19.43 64.12 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.481 1.039 . . . . 0.0 114.154 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.53 -17.61 64.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.073 1.349 . . . . 0.0 114.524 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.49 -4.28 45.22 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.342 -0.848 . . . . 0.0 113.211 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -67.85 136.7 54.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 109.405 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.7 t30 49.29 46.35 23.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.829 1.652 . . . . 0.0 114.211 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -103.77 161.6 13.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.506 0.722 . . . . 0.0 111.921 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 13.7 pt -122.48 162.2 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -169.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -94.79 114.92 26.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.071 1.349 . . . . 0.0 107.945 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.96 1.11 14.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -134.22 133.55 41.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.333 1.424 . . . . 0.0 110.43 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.13 133.64 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.127 1.371 . . . . 0.0 111.125 170.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.41 130.48 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.988 1.715 . . . . 0.0 108.186 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -63.83 134.62 55.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.712 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.45 68.86 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.741 0.686 . . . . 0.0 114.667 -173.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.07 -177.19 5.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.234 1.813 . . . . 0.0 111.266 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.76 179.73 6.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.384 1.874 . . . . 0.0 114.974 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 pt -119.58 139.52 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.106 1.363 . . . . 0.0 112.317 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.4 148.74 33.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.874 1.27 . . . . 0.0 111.121 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.01 -176.41 33.09 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 115.259 0.864 . . . . 0.0 115.259 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.52 24.15 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.44 1.495 . . . . 0.0 115.252 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.56 -14.61 75.61 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.1 1.333 . . . . 0.0 115.689 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -141.5 167.66 21.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.721 1.208 . . . . 0.0 112.944 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -107.87 156.07 38.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.267 2.227 . . . . 0.0 109.329 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.83 128.8 31.44 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.102 2.535 . . . . 0.0 112.956 -170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.31 15.94 36.53 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.598 1.57 . . . . 0.0 113.505 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmm 61.66 37.44 15.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.241 1.416 . . . . 0.0 112.26 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.77 118.3 21.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.695 1.198 . . . . 0.0 108.882 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.59 126.35 29.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.491 0.663 . . . . 0.0 111.213 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -78.74 167.45 21.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.217 1.007 . . . . 0.0 113.366 171.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.47 75.1 5.19 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.833 1.653 . . . . 0.0 110.768 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.8 p -73.4 134.95 44.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.134 0.974 . . . . 0.0 111.842 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -138.68 171.93 13.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.941 2.096 . . . . 0.0 112.0 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 51.88 66.48 5.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.616 1.566 . . . . 0.0 113.365 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.27 136.06 69.75 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.297 2.665 . . . . 0.0 111.405 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -111.74 150.69 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.475 1.51 . . . . 0.0 109.413 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 157.66 21.77 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.915 0.486 . . . . 0.0 111.969 175.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -71.54 131.24 42.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.472 0.709 . . . . 0.0 110.131 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -117.44 13.58 14.47 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.054 1.342 . . . . 0.0 111.961 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.8 63.37 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.571 -1.331 . . . . 0.0 113.739 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -60.72 4.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.613 1.965 . . . . 0.0 115.914 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -84.67 4.23 33.49 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.876 1.67 . . . . 0.0 111.808 168.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.65 28.04 27.88 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.204 1.383 . . . . 0.0 113.961 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.58 143.43 40.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.002 0.921 . . . . 0.0 112.771 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.51 156.3 48.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.747 1.219 . . . . 0.0 113.702 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -110.83 110.78 21.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.598 2.359 . . . . 0.0 109.778 -171.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 p -137.65 171.65 14.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.43 1.092 . . . . 0.0 110.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -47.85 120.26 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.54 1.136 . . . . 0.0 111.362 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.03 21.5 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.717 1.151 . . . . 0.0 114.949 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.1 p -121.95 160.51 24.68 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.669 1.235 . . . . 0.0 112.937 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.15 136.49 54.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.686 0.794 . . . . 0.0 112.828 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.61 159.15 42.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.886 -0.509 . . . . 0.0 111.948 172.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 97.5 mmm -82.39 134.8 35.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.852 0.461 . . . . 0.0 110.86 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.12 154.51 21.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.244 1.018 . . . . 0.0 110.3 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -120.74 158.25 27.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.363 1.065 . . . . 0.0 113.034 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.8 m -69.27 -56.49 7.4 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.905 0.882 . . . . 0.0 110.73 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -150.69 -56.09 0.16 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.806 1.642 . . . . 0.0 110.23 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.51 157.34 72.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.947 1.299 . . . . 0.0 112.401 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -56.54 -25.77 60.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.683 2.922 . . . . 0.0 113.999 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -107.53 36.62 2.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.57 1.548 . . . . 0.0 112.687 -177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -126.74 28.03 5.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.27 1.428 . . . . 0.0 113.905 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.7 76.51 4.95 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.423 1.489 . . . . 0.0 112.469 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -70.19 -60.38 2.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.816 1.247 . . . . 0.0 114.233 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.21 -8.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -169.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -81.21 140.52 34.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.729 -1.232 . . . . 0.0 109.694 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -140.47 168.33 20.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.88 1.672 . . . . 0.0 111.251 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 19.7 p90 -146.81 161.73 40.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.657 0.783 . . . . 0.0 111.966 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.34 116.94 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.49 1.116 . . . . 0.0 108.537 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.72 98.15 4.02 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 110.689 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 -24.86 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 113.066 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.71 168.94 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.479 1.512 . . . . 0.0 112.024 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.41 120.51 23.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.732 1.213 . . . . 0.0 110.371 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -142.22 74.73 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.204 1.478 . . . . 0.0 112.209 -170.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.77 -34.93 70.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.894 2.077 . . . . 0.0 114.094 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.46 -13.17 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.46 -11.62 58.39 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -72.64 172.23 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.71 155.45 40.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.588 1.155 . . . . 0.0 112.107 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -139.65 -55.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 177.22 53.16 0.07 OUTLIER Glycine 0 N--CA 1.476 1.317 0 N-CA-C 116.769 1.467 . . . . 0.0 116.769 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 55.12 25.92 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.96 1.704 . . . . 0.0 114.099 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 m -125.29 136.37 53.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.126 1.37 . . . . 0.0 111.685 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 mp -56.14 -30.63 62.42 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -82.42 -8.88 59.62 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.51 -71.42 1.1 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.256 1.884 . . . . 0.0 113.746 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.1 136.06 33.22 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -169.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.92 -72.68 0.9 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.112 1.339 . . . . 0.0 115.378 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -139.68 150.1 44.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.04 1.336 . . . . 0.0 111.843 -169.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.6 t -87.98 120.35 29.23 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.647 -0.658 . . . . 0.0 112.543 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -77.52 82.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.253 1.421 . . . . 0.0 108.537 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -74.38 -14.52 60.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.024 0.929 . . . . 0.0 112.419 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.99 177.84 8.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.567 1.175 . . . . 0.0 113.904 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.79 153.9 47.24 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.888 -1.132 . . . . 0.0 112.606 172.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.09 141.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.711 0.767 . . . . 0.0 110.201 172.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.81 -40.2 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.786 1.634 . . . . 0.0 111.107 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -144.81 148.89 34.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.345 1.458 . . . . 0.0 110.674 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.88 10.11 21.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.579 1.085 . . . . 0.0 114.899 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -38.2 72.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.85 1.325 . . . . 0.0 112.433 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.961 0.904 . . . . 0.0 112.107 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.1 t -77.52 -43.71 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.518 . . . . 0.0 110.283 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.59 -38.16 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.291 -0.881 . . . . 0.0 111.099 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.43 -19.74 60.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.173 1.389 . . . . 0.0 113.044 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -86.19 -39.11 16.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.745 1.618 . . . . 0.0 111.669 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 8' ' ' HIS . 66.0 mt -53.13 -36.02 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.622 1.569 . . . . 0.0 112.09 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -84.61 -17.71 37.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.89 -20.36 16.77 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.291 1.424 . . . . 0.0 114.296 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.23 -59.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.614 1.207 . . . . 0.0 113.155 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.98 148.21 4.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 112.359 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.4 p -138.03 151.11 47.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.214 1.406 . . . . 0.0 111.861 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.2 131.38 1.74 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.163 0.411 . . . . 0.0 112.639 169.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -63.84 149.98 45.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.345 1.058 . . . . 0.0 113.494 -174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.5 t -113.04 160.82 17.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.08 -23.32 71.24 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 113.818 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 tpt -87.55 -42.58 12.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.09 0.945 . . . . 0.0 112.57 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -141.28 132.35 26.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.085 1.754 . . . . 0.0 110.863 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -87.02 160.41 18.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.687 0.795 . . . . 0.0 111.714 171.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 57.39 62.05 2.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.177 . . . . 0.0 112.724 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 m -127.63 154.18 77.69 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 125.76 1.624 . . . . 0.0 111.749 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.84 134.55 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 121.386 1.391 . . . . 0.0 108.932 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -27.95 51.43 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.3 157.7 22.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.582 1.153 . . . . 0.0 110.369 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.13 111.48 18.29 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.135 -0.978 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.67 94.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.646 1.578 . . . . 0.0 107.071 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -127.42 143.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -169.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.1 mt -86.43 103.98 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.815 2.046 . . . . 0.0 106.728 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.76 -41.77 61.99 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.673 -0.642 . . . . 0.0 110.863 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.5 t -150.2 165.82 31.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.78 142.46 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.112 1.765 . . . . 0.0 111.178 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.2 m -135.21 128.58 32.24 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.89 1.276 . . . . 0.0 110.245 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.73 122.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -113.59 150.4 33.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.137 1.375 . . . . 0.0 112.275 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.061 1.344 . . . . 0.0 113.622 -170.803 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.94 127.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.909 0.884 . . . . 0.0 109.364 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.4 m -102.31 124.17 47.41 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.815 1.246 . . . . 0.0 109.901 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -101.46 125.3 48.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.588 1.155 . . . . 0.0 110.474 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -96.9 94.47 7.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 172.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -96.67 152.33 18.76 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.833 -0.542 . . . . 0.0 110.765 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -59.35 -14.34 11.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.96 -13.57 21.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.739 1.215 . . . . 0.0 113.655 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 167.74 14.94 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 123.242 1.468 . . . . 0.0 113.125 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.91 136.9 38.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.341 1.457 . . . . 0.0 112.835 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.2 mt -133.97 139.3 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.663 1.985 . . . . 0.0 108.643 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.1 t -123.56 134.93 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.594 1.158 . . . . 0.0 110.385 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -121.0 139.0 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.655 1.982 . . . . 0.0 110.094 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -103.79 125.78 50.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.56 1.944 . . . . 0.0 108.823 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -87.77 147.24 25.27 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.407 1.083 . . . . 0.0 111.361 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.52 74.41 1.25 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.692 1.234 . . . . 0.0 111.251 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.71 -25.9 64.09 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.607 1.163 . . . . 0.0 112.674 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.33 -28.01 56.72 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.559 1.144 . . . . 0.0 111.346 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -96.82 -30.6 13.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 112.725 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.61 58.59 3.38 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.761 0.824 . . . . 0.0 113.194 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -60.53 -42.71 38.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.583 2.855 . . . . 0.0 112.928 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -69.37 -41.43 76.54 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.655 0.661 . . . . 0.0 110.793 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.1 m -62.23 -49.86 74.05 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.393 0.677 . . . . 0.0 111.481 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -42.64 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.447 0.699 . . . . 0.0 111.401 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.2 -44.59 88.19 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.646 1.112 . . . . 0.0 111.567 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -65.45 -42.28 92.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.305 1.042 . . . . 0.0 111.868 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.9 -48.55 81.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.182 0.993 . . . . 0.0 111.731 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -38.49 81.49 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.91 0.884 . . . . 0.0 111.675 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -56.3 -36.24 68.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.172 0.989 . . . . 0.0 112.094 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -75.51 -43.56 48.35 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.526 -0.734 . . . . 0.0 112.626 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.7 m -61.69 -36.82 81.97 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.61 -0.681 . . . . 0.0 111.877 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.29 71.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.135 1.774 . . . . 0.0 112.824 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.42 -15.48 49.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.337 1.055 . . . . 0.0 113.378 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.66 51.57 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.524 0.583 . . . . 0.0 113.849 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -73.02 -18.11 61.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.117 1.459 . . . . 0.0 114.688 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -100.83 -5.2 26.54 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.143 -0.973 . . . . 0.0 112.273 169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -69.58 130.66 43.05 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.913 -1.117 . . . . 0.0 108.484 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t30 57.08 46.2 19.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.252 1.421 . . . . 0.0 113.698 -169.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -116.23 153.26 32.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.809 0.844 . . . . 0.0 112.449 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -104.93 163.44 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -95.7 94.81 7.92 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -89.08 -2.16 58.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -168.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -138.99 139.85 38.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.114 1.779 . . . . 0.0 112.304 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 132.0 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 126.624 1.97 . . . . 0.0 111.019 169.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.06 129.46 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.058 1.743 . . . . 0.0 108.027 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.71 133.41 55.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.387 0.675 . . . . 0.0 111.574 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.78 10.29 64.02 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -141.34 -177.34 5.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.008 1.723 . . . . 0.0 111.266 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.4 -178.9 5.72 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -169.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.6 pt -116.93 137.2 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.143 1.377 . . . . 0.0 112.275 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -109.15 149.29 29.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.685 1.194 . . . . 0.0 110.625 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.25 174.21 34.1 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 122.473 1.041 . . . . 0.0 115.381 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.72 0.74 75.3 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.932 1.253 . . . . 0.0 115.253 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 -19.27 62.74 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.255 1.527 . . . . 0.0 115.678 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -147.87 165.29 31.08 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.508 1.123 . . . . 0.0 113.193 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.69 163.88 28.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.19 1.396 . . . . 0.0 109.926 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -60.29 -15.63 36.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.551 2.834 . . . . 0.0 118.325 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.27 19.79 53.08 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.179 0.895 . . . . 0.0 114.558 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.05 32.35 19.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.92 126.7 35.2 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.321 1.448 . . . . 0.0 109.162 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.16 127.98 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.717 0.807 . . . . 0.0 110.829 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -72.69 165.52 24.62 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.268 170.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.52 74.48 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.736 1.614 . . . . 0.0 111.088 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 p -73.0 140.76 47.55 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.596 1.158 . . . . 0.0 112.703 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -141.76 178.06 7.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.991 2.116 . . . . 0.0 111.887 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 51.68 65.17 6.76 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 125.784 1.634 . . . . 0.0 114.346 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -57.12 133.26 56.54 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.316 2.677 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.16 150.87 7.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 126.101 1.76 . . . . 0.0 108.72 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 157.85 23.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 169.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -76.52 126.14 30.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.597 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -108.18 14.39 25.06 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.233 1.413 . . . . 0.0 112.915 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -15.79 62.73 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.325 -1.485 . . . . 0.0 114.111 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.94 0.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.123 1.769 . . . . 0.0 115.77 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -79.39 -3.87 48.41 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.883 1.273 . . . . 0.0 112.126 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.39 31.55 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.891 1.234 . . . . 0.0 114.619 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.3 mt -80.43 159.3 25.69 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -131.43 156.34 45.76 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -103.82 115.41 30.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.232 2.213 . . . . 0.0 110.302 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -139.94 167.91 21.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.685 1.194 . . . . 0.0 111.442 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -51.72 119.79 4.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.388 1.475 . . . . 0.0 110.715 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.16 28.87 21.69 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.922 1.249 . . . . 0.0 114.977 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.4 p -122.58 158.94 28.82 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.169 1.484 . . . . 0.0 112.897 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.69 139.28 53.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.681 0.753 . . . . 0.0 112.756 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.49 159.7 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.738 170.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -80.28 141.21 35.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.101 0.56 . . . . 0.0 111.641 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 154.18 19.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.27 0.628 . . . . 0.0 111.516 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -141.0 158.1 44.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.292 1.437 . . . . 0.0 112.713 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 m -72.25 -55.5 7.09 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.881 0.872 . . . . 0.0 113.006 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -159.47 -54.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.276 1.031 . . . . 0.0 111.57 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.71 158.84 86.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.2 1.0 . . . . 0.0 111.365 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.01 -27.69 85.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.832 2.355 . . . . 0.0 113.358 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -109.21 36.15 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.499 1.52 . . . . 0.0 112.511 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.0 p -115.58 30.56 7.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.456 1.502 . . . . 0.0 113.318 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 101.91 14.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.015 1.326 . . . . 0.0 110.092 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 p -91.52 -64.35 1.13 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.187 0.995 . . . . 0.0 113.001 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.81 42.37 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -133.87 153.91 51.42 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.069 -1.02 . . . . 0.0 112.955 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -145.54 168.21 21.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.749 2.02 . . . . 0.0 110.958 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.0 p90 -144.63 159.69 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 111.208 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.6 mt -113.0 118.07 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.19 108.22 6.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.192 0.597 . . . . 0.0 109.798 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.94 -14.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.35 168.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.376 2.271 . . . . 0.0 111.226 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.69 119.24 24.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.469 0.708 . . . . 0.0 109.525 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -141.07 77.17 1.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.975 1.369 . . . . 0.0 113.15 -169.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.24 -34.73 61.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.024 2.13 . . . . 0.0 114.514 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -61.79 -12.7 18.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.09 -10.64 57.66 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.41 178.14 6.12 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -83.94 142.38 30.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.971 1.308 . . . . 0.0 111.814 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -111.35 -58.74 2.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.599 1.159 . . . . 0.0 113.42 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 163.45 67.87 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.241 0.924 . . . . 0.0 113.346 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 54.23 25.51 5.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.107 1.763 . . . . 0.0 114.801 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.3 m -111.93 117.72 33.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.702 1.201 . . . . 0.0 110.752 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.2 -37.19 54.17 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -78.05 -14.3 59.55 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.74 -72.76 1.21 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.509 2.48 . . . . 0.0 114.261 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.306 6.6 p-90 -71.15 127.23 31.88 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.2 -86.9 1.26 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.362 1.458 . . . . 0.0 115.758 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -139.54 149.94 44.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.883 1.273 . . . . 0.0 111.796 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.9 t -81.27 119.53 23.76 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.732 -0.605 . . . . 0.0 112.408 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.44 84.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -77.06 -14.81 59.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.64 0.776 . . . . 0.0 111.942 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 177.42 8.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.622 1.201 . . . . 0.0 113.783 -170.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -140.64 154.56 46.47 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.768 -1.208 . . . . 0.0 112.333 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.48 140.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.64 0.733 . . . . 0.0 110.084 170.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.97 -42.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 111.008 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -144.5 153.54 41.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 109.93 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 103.47 15.03 24.19 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 123.878 0.751 . . . . 0.0 114.289 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.1 68.54 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.028 1.414 . . . . 0.0 112.263 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -65.74 -30.07 70.68 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.746 0.818 . . . . 0.0 112.466 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.49 -43.13 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.8 1.24 . . . . 0.0 110.092 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.25 -40.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.816 0.846 . . . . 0.0 111.332 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.83 -27.29 62.81 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.93 1.292 . . . . 0.0 112.367 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.13 -42.27 32.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.463 1.105 . . . . 0.0 111.205 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.11 -30.14 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.935 1.694 . . . . 0.0 112.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -91.82 -20.11 21.83 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.78 -17.53 27.88 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.498 1.523 . . . . 0.0 114.738 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.44 -51.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 118.887 1.344 . . . . 0.0 112.722 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.97 155.77 5.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.189 1.396 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.8 p -135.87 150.96 49.56 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 0.0 112.312 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.48 128.4 1.03 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.032 0.348 . . . . 0.0 112.819 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -67.17 147.25 53.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 0.0 113.228 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -99.28 157.47 16.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.074 1.75 . . . . 0.0 110.875 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.96 -18.99 69.38 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 121.586 -0.697 . . . . 0.0 113.917 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.77 -31.68 11.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 0.0 113.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -140.72 124.96 17.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.171 1.388 . . . . 0.0 110.709 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.39 160.13 14.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.485 0.714 . . . . 0.0 112.718 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.32 52.76 8.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.345 1.458 . . . . 0.0 113.205 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.24 151.37 53.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.129 1.372 . . . . 0.0 112.002 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.2 135.03 24.1 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.766 1.644 . . . . 0.0 109.375 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -24.98 39.83 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.28 150.24 35.32 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.431 1.092 . . . . 0.0 110.738 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.19 116.94 21.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.798 0.839 . . . . 0.0 111.249 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.03 110.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.573 1.149 . . . . 0.0 108.579 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.08 152.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.415 1.486 . . . . 0.0 110.871 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.96 103.25 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.4 -25.02 36.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.691 0.797 . . . . 0.0 112.113 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -154.35 161.76 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.513 0.725 . . . . 0.0 112.714 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.5 t -134.41 139.2 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.696 1.598 . . . . 0.0 110.157 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.8 m -136.54 131.01 33.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.739 1.216 . . . . 0.0 110.588 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.85 122.95 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -119.31 150.25 40.44 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.079 1.352 . . . . 0.0 112.277 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.294 1.438 . . . . 0.0 113.753 -170.37 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 131.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.989 -1.694 . . . . 0.0 111.514 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.0 m -102.32 123.93 46.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.022 0.929 . . . . 0.0 110.091 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -98.98 132.83 44.0 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.95 1.3 . . . . 0.0 110.677 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -104.83 98.89 8.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -104.6 152.51 22.36 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.962 -0.461 . . . . 0.0 110.835 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.448 HD22 HG12 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -59.44 -20.43 55.02 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -89.8 -15.92 31.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.845 1.258 . . . . 0.0 113.187 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.06 165.3 12.44 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.741 1.639 . . . . 0.0 113.191 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -72.98 137.69 45.61 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.519 1.528 . . . . 0.0 112.534 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.7 mt -134.47 140.71 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.256 1.822 . . . . 0.0 108.764 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.31 132.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 110.479 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.92 135.75 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 110.04 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -98.19 130.46 44.93 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.928 1.691 . . . . 0.0 107.224 171.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -92.13 146.57 23.62 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.22 1.008 . . . . 0.0 110.505 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -102.14 73.9 1.4 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.843 1.306 . . . . 0.0 111.006 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.97 -25.5 64.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.209 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.77 1.228 . . . . 0.0 111.508 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.08 -27.54 15.04 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.861 1.264 . . . . 0.0 112.801 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.25 58.13 3.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -61.11 -42.64 34.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.519 2.813 . . . . 0.0 113.146 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.16 -40.55 78.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.8 m -61.05 -53.57 55.58 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.541 0.736 . . . . 0.0 111.845 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.1 -41.73 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.839 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -54.14 -49.22 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.918 1.236 . . . . 0.0 111.969 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -68.52 -38.88 81.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.376 0.67 . . . . 0.0 111.935 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.67 -49.52 77.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 0.0 111.767 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.58 -34.31 67.36 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.56 0.744 . . . . 0.0 111.811 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -57.78 -33.45 68.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.69 0.796 . . . . 0.0 112.556 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -75.4 -44.21 45.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.437 -0.79 . . . . 0.0 112.333 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.2 -35.81 78.17 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.6 -0.688 . . . . 0.0 111.765 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.84 -34.54 78.15 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.353 2.261 . . . . 0.0 112.789 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -82.11 -14.12 56.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.882 0.873 . . . . 0.0 113.152 171.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.7 18.58 61.45 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.562 1.077 . . . . 0.0 113.814 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.55 -24.04 67.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.72 1.26 . . . . 0.0 114.19 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -89.21 -7.7 55.02 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.304 0.642 . . . . 0.0 112.687 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -64.36 135.67 56.38 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.938 -1.101 . . . . 0.0 108.793 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.25 22.98 12.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.5 p -88.73 162.48 16.23 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.116 -0.99 . . . . 0.0 111.392 169.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.44 HG22 HG22 ' A' ' 156' ' ' ILE . 9.0 pt -122.38 164.76 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -169.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -97.99 96.75 8.37 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -90.24 -8.27 51.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -134.37 138.49 44.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.37 1.441 . . . . 0.0 113.471 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.48 134.37 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.961 2.505 . . . . 0.0 109.272 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 90.1 mt -138.07 129.28 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.733 1.613 . . . . 0.0 108.029 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -61.63 132.77 54.34 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.25 0.62 . . . . 0.0 111.849 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.01 10.17 61.28 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.15 -177.16 5.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.892 1.677 . . . . 0.0 111.314 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -178.66 6.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.083 1.753 . . . . 0.0 115.558 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.7 pt -115.96 138.06 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.186 1.394 . . . . 0.0 112.563 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -108.68 149.35 29.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.516 1.126 . . . . 0.0 111.056 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.89 175.9 32.78 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.454 1.03 . . . . 0.0 114.965 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 6.78 83.6 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.627 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.71 -25.53 35.02 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 119.717 1.758 . . . . 0.0 115.71 -172.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -149.73 169.78 20.26 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.663 1.185 . . . . 0.0 113.054 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.46 164.47 16.58 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.892 1.677 . . . . 0.0 110.064 168.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.87 -12.88 33.98 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.877 3.051 . . . . 0.0 117.437 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.19 14.65 61.71 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.786 0.708 . . . . 0.0 114.449 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.0 mmt 59.71 29.77 19.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.396 1.878 . . . . 0.0 112.879 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.03 125.49 32.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.961 1.304 . . . . 0.0 109.367 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -71.57 121.94 19.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.412 1.085 . . . . 0.0 110.231 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -66.68 159.2 28.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.35 73.38 8.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.409 1.483 . . . . 0.0 111.57 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 p -68.03 121.27 15.74 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.507 1.123 . . . . 0.0 112.596 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -130.93 176.66 8.05 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.098 1.759 . . . . 0.0 111.954 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 49.25 67.27 4.65 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.674 1.59 . . . . 0.0 113.99 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.66 140.1 91.99 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.38 2.72 . . . . 0.0 111.765 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -111.76 152.59 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.038 1.735 . . . . 0.0 109.046 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.27 0.1 OUTLIER -76.23 158.93 31.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.237 0.615 . . . . 0.0 110.355 169.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.27 -56.58 20.0 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 70.95 3.68 4.74 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.46 -15.09 63.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 119.919 -1.738 . . . . 0.0 114.126 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -59.94 3.8 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.118 2.567 . . . . 0.0 116.151 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -84.22 5.72 25.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.421 1.489 . . . . 0.0 112.257 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.71 32.71 32.6 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.816 1.198 . . . . 0.0 113.299 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.11 140.56 39.05 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.417 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -131.69 147.74 52.53 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -99.13 85.87 3.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 111.642 -169.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.5 p -112.57 168.32 9.75 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.506 0.723 . . . . 0.0 112.109 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -55.89 130.16 42.5 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.667 1.187 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.24 35.41 33.95 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.179 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.9 p -125.92 161.91 26.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.78 1.29 . . . . 0.0 113.354 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 mp -120.49 136.09 54.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.792 0.837 . . . . 0.0 112.896 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.09 159.19 39.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.468 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -84.64 141.12 30.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.62 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.31 154.02 19.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.467 0.707 . . . . 0.0 111.112 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -133.39 162.92 30.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.827 1.251 . . . . 0.0 113.572 -171.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -76.95 -56.23 4.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.617 1.167 . . . . 0.0 113.109 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -159.09 -54.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.543 1.137 . . . . 0.0 111.76 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.28 161.82 71.45 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.509 1.124 . . . . 0.0 111.53 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.31 -20.14 69.78 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.147 2.565 . . . . 0.0 114.071 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.28 42.13 2.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.356 1.862 . . . . 0.0 111.983 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.5 p -125.79 30.79 5.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.186 1.394 . . . . 0.0 113.638 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.0 104.48 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.816 1.647 . . . . 0.0 109.527 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.2 p -89.73 -72.73 0.54 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.455 1.102 . . . . 0.0 113.204 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.27 36.43 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.32 149.8 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.03 1.332 . . . . 0.0 111.621 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.18 168.41 21.06 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.476 1.511 . . . . 0.0 111.673 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.7 p90 -146.37 162.1 38.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 30.4 mt -115.01 116.03 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.539 1.136 . . . . 0.0 108.181 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -71.31 99.09 1.87 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.72 0.808 . . . . 0.0 109.772 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.4 m -77.83 -16.36 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 113.212 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.55 166.28 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 128.292 2.637 . . . . 0.0 110.968 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.0 119.66 19.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.226 0.536 . . . . 0.0 111.331 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -126.85 55.37 1.56 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.015 1.726 . . . . 0.0 111.641 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.56 -12.14 50.37 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -69.51 -14.92 63.12 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.819 -1.176 . . . . 0.0 113.349 169.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.37 -14.91 56.69 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -66.79 172.48 4.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.071 2.148 . . . . 0.0 116.595 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.05 155.81 40.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.871 1.268 . . . . 0.0 112.402 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.7 t -140.92 -53.78 0.48 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.71 56.29 0.05 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.17 23.63 12.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.106 1.362 . . . . 0.0 114.617 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -123.85 140.58 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.414 1.486 . . . . 0.0 112.963 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.89 -39.56 81.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.467 1.107 . . . . 0.0 112.891 -169.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.98 -17.43 64.67 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.63 -90.3 1.51 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.191 2.329 . . . . 0.0 112.859 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.252 0.4 OUTLIER -71.49 128.11 34.77 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.54 -71.37 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.991 1.282 . . . . 0.0 114.048 -174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -133.73 131.85 39.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.939 0.896 . . . . 0.0 111.899 -169.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.3 t -93.04 126.16 37.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.425 0.69 . . . . 0.0 112.523 -172.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.82 89.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.189 0.995 . . . . 0.0 109.225 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -75.23 -15.18 60.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.354 1.062 . . . . 0.0 112.015 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.66 176.36 10.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.315 1.055 . . . . 0.0 113.828 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -140.37 151.19 44.78 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 112.264 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.04 133.6 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.575 0.702 . . . . 0.0 110.349 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.67 -43.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.339 1.856 . . . . 0.0 110.812 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -143.07 154.77 44.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.546 1.538 . . . . 0.0 109.964 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.75 14.92 33.05 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.787 0.708 . . . . 0.0 114.478 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 81.9 mmm -54.89 -36.11 64.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.27 1.535 . . . . 0.0 112.275 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.36 -30.48 71.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.849 0.86 . . . . 0.0 112.612 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.49 -40.77 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.978 1.311 . . . . 0.0 110.377 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.65 -42.56 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.272 -0.892 . . . . 0.0 110.93 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.08 -25.08 63.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.314 1.445 . . . . 0.0 112.22 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -75.76 -52.19 11.0 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.049 0.94 . . . . 0.0 110.398 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 53.6 mt -53.01 -36.41 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.364 1.865 . . . . 0.0 112.686 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.02 -14.44 31.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.88 -18.23 11.83 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.828 1.68 . . . . 0.0 113.882 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.31 -59.41 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.412 1.106 . . . . 0.0 113.051 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.56 162.39 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.768 1.227 . . . . 0.0 112.677 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.0 p -136.07 151.4 49.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.496 1.518 . . . . 0.0 112.389 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.43 133.71 1.64 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.146 0.403 . . . . 0.0 113.436 170.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.92 151.91 33.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.874 1.269 . . . . 0.0 113.111 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.2 p -115.29 168.75 9.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.073 1.349 . . . . 0.0 112.239 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.82 -21.27 74.99 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 121.714 -0.616 . . . . 0.0 114.576 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.18 -38.18 9.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.67 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.13 126.96 22.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.086 1.754 . . . . 0.0 110.541 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -85.28 160.42 19.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.354 0.662 . . . . 0.0 110.971 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.55 58.85 2.77 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.025 1.33 . . . . 0.0 113.581 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.93 157.8 77.45 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 126.271 1.828 . . . . 0.0 111.835 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -69.95 138.64 37.68 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.14 1.893 . . . . 0.0 109.852 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -31.18 38.0 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -79.17 149.42 31.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.83 0.852 . . . . 0.0 111.398 169.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.0 114.38 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.495 1.118 . . . . 0.0 111.229 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.24 105.67 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 108.402 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 7' ' ' ASN . 1.4 pt -128.12 143.82 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.558 0.743 . . . . 0.0 111.565 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.16 103.34 11.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.17 -36.66 66.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.294 0.637 . . . . 0.0 110.476 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 t -153.92 166.0 34.35 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.21 141.38 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.642 1.977 . . . . 0.0 110.58 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 125.09 30.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.184 1.394 . . . . 0.0 109.909 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.67 125.47 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.205 0.602 . . . . 0.0 109.878 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.2 t -111.49 150.77 29.45 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.33 1.452 . . . . 0.0 112.138 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.676 1.19 . . . . 0.0 113.241 -172.855 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.15 130.75 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.045 0.938 . . . . 0.0 109.265 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -106.19 121.69 44.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.795 1.238 . . . . 0.0 110.148 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.68 135.61 33.94 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.495 1.118 . . . . 0.0 110.72 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -107.25 101.1 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -103.92 152.75 21.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.895 -0.503 . . . . 0.0 111.016 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -60.1 -7.49 1.87 Allowed 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -109.31 -8.04 15.15 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.074 1.35 . . . . 0.0 114.215 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.52 165.89 12.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.374 1.464 . . . . 0.0 113.742 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.78 138.82 39.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.364 1.866 . . . . 0.0 112.838 174.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -135.4 140.9 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.303 1.841 . . . . 0.0 109.066 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.04 136.87 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.553 1.141 . . . . 0.0 110.562 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.22 139.43 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.73 2.012 . . . . 0.0 110.465 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -101.81 126.91 48.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.862 2.065 . . . . 0.0 107.659 171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 p -88.62 147.58 24.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.171 0.989 . . . . 0.0 111.085 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.02 74.33 1.3 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.688 1.232 . . . . 0.0 111.156 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.74 -26.92 64.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.547 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -75.73 -30.87 59.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.291 1.036 . . . . 0.0 111.437 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 -28.7 14.53 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 113.011 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.8 56.99 3.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -60.1 -43.63 34.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 112.758 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -68.08 -40.17 82.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.756 0.707 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 68' ' ' ILE . 26.6 m -65.14 -48.12 74.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.569 0.748 . . . . 0.0 111.6 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -68.38 -39.51 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.921 0.888 . . . . 0.0 112.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.16 -47.16 75.53 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.677 1.126 . . . . 0.0 111.816 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -69.3 -38.66 78.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.339 0.655 . . . . 0.0 111.88 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.09 -47.6 84.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 0.0 111.539 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.56 -38.57 74.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.25 0.62 . . . . 0.0 111.374 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -63.14 -29.66 70.97 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -73.62 -42.84 60.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.302 -0.874 . . . . 0.0 111.967 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.16 -37.61 85.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.541 -0.725 . . . . 0.0 111.463 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -58.42 -37.87 76.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.468 2.307 . . . . 0.0 113.438 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -81.73 -15.0 55.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.707 1.203 . . . . 0.0 113.531 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.8 61.03 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.872 1.225 . . . . 0.0 114.362 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -69.58 -17.72 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.542 1.537 . . . . 0.0 114.963 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.92 -13.03 21.42 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.55 1.23 8.53 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -147.19 53.59 1.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.206 1.402 . . . . 0.0 110.606 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.4 p -114.36 171.94 7.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.185 0.994 . . . . 0.0 113.121 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 156' ' ' ILE . 12.9 pt -127.65 166.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -98.93 110.44 23.05 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -109.15 0.81 19.97 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -152.66 129.94 11.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.53 1.513 . . . . 0.0 111.591 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.66 141.21 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.664 1.986 . . . . 0.0 111.168 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.61 127.62 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.142 1.377 . . . . 0.0 108.66 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -64.63 132.88 50.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 0.0 111.659 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 10.74 66.01 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.01 0.814 . . . . 0.0 114.908 -173.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -144.56 -174.84 4.43 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.82 2.048 . . . . 0.0 110.412 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.58 -179.93 7.46 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.7 pt -123.34 142.73 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.169 1.387 . . . . 0.0 113.8 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -122.79 147.81 46.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.826 1.65 . . . . 0.0 112.363 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.68 -175.74 32.02 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.73 73.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.148 1.832 . . . . 0.0 115.641 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.86 -16.05 60.33 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.79 164.87 28.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.583 1.192 . . . . 0.0 112.705 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -94.92 161.94 26.76 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.926 1.691 . . . . 0.0 110.806 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -60.75 -8.84 10.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.007 3.138 . . . . 0.0 117.613 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.68 12.96 67.08 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.151 0.882 . . . . 0.0 115.039 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mmt 59.68 29.12 18.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.282 1.833 . . . . 0.0 112.822 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.01 131.22 34.15 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.303 1.441 . . . . 0.0 109.403 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -73.53 121.02 19.93 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.094 0.958 . . . . 0.0 110.339 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -72.34 164.77 25.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.86 71.85 7.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.513 1.525 . . . . 0.0 111.332 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 p -70.86 107.92 4.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 111.824 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -111.28 175.98 5.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.454 1.902 . . . . 0.0 111.808 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.08 65.8 5.46 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.464 1.505 . . . . 0.0 113.576 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -58.03 132.12 47.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.998 2.465 . . . . 0.0 110.364 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -114.85 147.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.607 1.163 . . . . 0.0 109.656 -173.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 155.31 29.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.991 0.917 . . . . 0.0 112.145 172.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -75.14 129.56 37.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.987 0.915 . . . . 0.0 110.828 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -112.29 14.33 20.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.207 1.403 . . . . 0.0 113.124 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.99 -15.45 59.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.247 -1.533 . . . . 0.0 113.477 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -59.25 -0.97 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -80.39 -3.03 48.11 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.117 1.367 . . . . 0.0 112.095 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.8 27.19 27.31 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.099 1.333 . . . . 0.0 114.495 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.61 158.57 28.42 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.962 0.881 . . . . 0.0 112.999 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -130.58 159.24 37.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.684 1.194 . . . . 0.0 114.024 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -106.9 115.15 29.69 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.068 2.147 . . . . 0.0 109.927 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.3 p -140.95 168.41 19.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.81 1.244 . . . . 0.0 111.241 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -54.49 125.15 18.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.117 0.967 . . . . 0.0 110.91 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.84 31.97 25.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.26 1.41 . . . . 0.0 115.075 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.1 p -123.79 159.77 28.78 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.31 1.555 . . . . 0.0 113.342 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -123.68 138.47 54.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 0.0 113.191 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.9 157.78 46.0 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.823 -0.548 . . . . 0.0 112.184 169.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.0 mmm -79.6 136.17 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.865 0.466 . . . . 0.0 110.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.58 142.19 27.9 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.798 0.839 . . . . 0.0 110.749 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -85.83 154.03 21.84 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.413 1.085 . . . . 0.0 112.677 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -70.14 -51.99 27.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.801 0.841 . . . . 0.0 110.178 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -157.56 -57.96 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.424 1.489 . . . . 0.0 110.451 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.41 154.73 83.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.18 0.992 . . . . 0.0 111.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.69 -19.27 64.53 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.93 2.42 . . . . 0.0 114.45 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -112.69 38.21 2.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.845 1.658 . . . . 0.0 112.332 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -122.17 30.26 6.66 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.319 1.447 . . . . 0.0 113.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.08 61.55 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.446 1.499 . . . . 0.0 113.035 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -58.82 -65.33 0.68 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.904 1.681 . . . . 0.0 113.946 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.83 0.55 0.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.7 146.43 24.52 Favored 'General case' 0 N--CA 1.462 0.175 0 O-C-N 120.515 -1.366 . . . . 0.0 110.51 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -141.14 168.28 20.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.758 1.623 . . . . 0.0 110.479 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.1 p90 -145.33 159.27 43.31 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.103 0.561 . . . . 0.0 111.87 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.82 119.49 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.101 1.36 . . . . 0.0 108.267 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -78.28 119.74 22.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.55 0.74 . . . . 0.0 110.774 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -98.74 -8.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.9 164.51 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.689 1.596 . . . . 0.0 111.32 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -80.8 119.1 22.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.996 0.518 . . . . 0.0 109.993 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -137.58 70.67 1.4 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.955 1.359 . . . . 0.0 112.149 -169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.57 -35.79 54.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.251 2.22 . . . . 0.0 114.404 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -59.72 -14.24 13.41 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.27 -13.33 57.19 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -73.6 169.83 16.45 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.25 145.63 55.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.625 0.77 . . . . 0.0 112.981 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -115.05 -59.54 2.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.522 1.529 . . . . 0.0 113.09 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.44 55.83 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.32 1.438 . . . . 0.0 112.077 -171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.14 26.75 15.55 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.81 1.644 . . . . 0.0 114.474 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.9 p -107.93 125.34 51.38 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.0 tp -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -78.51 -10.33 59.67 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.39 -96.91 1.93 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 127.366 2.412 . . . . 0.0 112.423 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -60.56 125.45 23.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.58 -58.94 0.64 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 116.559 1.383 . . . . 0.0 116.559 -169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -141.65 151.11 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.365 1.066 . . . . 0.0 112.215 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.2 t -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.835 -0.541 . . . . 0.0 112.456 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.3 83.38 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.766 1.226 . . . . 0.0 108.594 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -77.6 -14.03 59.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.021 0.928 . . . . 0.0 112.129 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.45 177.83 7.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.771 1.272 . . . . 0.0 114.343 -169.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -141.43 153.63 45.12 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.65 1.18 . . . . 0.0 112.417 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 143.7 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.688 0.756 . . . . 0.0 110.323 173.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.45 -41.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.736 1.614 . . . . 0.0 110.936 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -147.03 154.52 41.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.678 1.591 . . . . 0.0 110.108 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.25 14.21 24.79 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 123.866 0.746 . . . . 0.0 114.603 172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -34.62 63.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.055 1.427 . . . . 0.0 112.305 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.15 -30.02 71.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.687 0.795 . . . . 0.0 112.577 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.2 t -75.97 -43.22 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.052 1.341 . . . . 0.0 110.271 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.62 -38.42 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.362 -0.836 . . . . 0.0 110.973 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -26.42 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.339 1.456 . . . . 0.0 112.6 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -76.91 -42.27 40.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.724 1.21 . . . . 0.0 110.821 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.6 mt -57.61 -29.26 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.568 1.547 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -89.82 -14.04 35.3 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.15 -14.0 17.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.745 1.64 . . . . 0.0 114.627 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 -57.74 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 118.778 1.289 . . . . 0.0 112.445 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.61 144.95 0.89 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.7 1.6 . . . . 0.0 111.157 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -129.05 150.07 50.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.043 1.337 . . . . 0.0 112.946 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 174.99 130.57 1.32 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.343 0.973 . . . . 0.0 112.256 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -66.74 150.15 49.51 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.6 t -115.8 166.85 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.554 1.942 . . . . 0.0 111.451 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.0 -30.84 72.13 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 114.285 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.4 mmt -95.11 -28.03 15.28 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -140.92 129.14 22.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.786 1.634 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -95.92 154.73 17.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.681 0.792 . . . . 0.0 112.627 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 49.86 75.1 0.18 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.627 2.371 . . . . 0.0 112.219 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.7 m -128.67 152.18 78.25 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.06 1.344 . . . . 0.0 110.912 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.47 129.29 18.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.245 1.296 . . . . 0.0 108.897 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -25.21 32.31 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.709 0.403 . . . . 0.0 111.857 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.9 146.7 37.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.004 0.922 . . . . 0.0 109.155 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.32 109.99 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.403 0.621 . . . . 0.0 111.326 -171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.88 109.1 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.218 1.007 . . . . 0.0 108.589 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.9 142.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -172.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -84.01 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -76.95 -27.07 54.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.801 1.24 . . . . 0.0 111.794 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.4 t -163.17 168.66 20.46 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.67 140.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.276 1.831 . . . . 0.0 110.488 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -131.53 133.12 44.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.355 1.462 . . . . 0.0 110.001 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.69 123.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.4 t -118.21 150.35 39.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.254 1.421 . . . . 0.0 112.533 -173.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.542 1.537 . . . . 0.0 113.649 -170.029 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.04 128.28 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.921 1.237 . . . . 0.0 110.387 174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -99.9 126.53 46.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.514 1.125 . . . . 0.0 110.262 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -102.52 127.62 49.51 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.091 1.356 . . . . 0.0 110.29 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -101.16 99.43 9.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -103.77 152.27 22.06 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.842 -0.536 . . . . 0.0 111.293 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -60.39 -9.52 3.68 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -106.99 -9.56 16.2 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.805 1.242 . . . . 0.0 114.189 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.02 163.23 11.55 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.046 1.359 . . . . 0.0 113.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.28 138.18 43.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.636 1.574 . . . . 0.0 112.736 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.18 139.85 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.521 1.928 . . . . 0.0 108.43 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.63 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 110.352 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -125.03 134.11 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.357 1.863 . . . . 0.0 110.04 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.14 127.75 47.55 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.678 . . . . 0.0 108.605 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 p -88.92 146.48 24.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -104.31 73.94 1.15 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.701 1.239 . . . . 0.0 111.434 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.19 -25.06 64.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.503 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 -24.04 46.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.593 1.157 . . . . 0.0 111.873 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -107.4 -16.74 14.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.501 1.521 . . . . 0.0 113.29 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 50.6 0.52 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.841 1.256 . . . . 0.0 114.352 -172.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.22 -40.82 56.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.568 2.845 . . . . 0.0 113.859 -170.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -71.68 -35.17 70.2 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.646 -0.659 . . . . 0.0 110.851 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.4 m -70.49 -47.95 58.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.56 -43.5 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.089 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -58.77 -45.54 89.56 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.672 1.123 . . . . 0.0 111.619 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.98 -43.78 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.342 1.057 . . . . 0.0 111.937 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.51 -47.7 84.51 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 111.693 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.98 -37.72 72.74 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.565 0.746 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.64 -29.49 70.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.92 0.888 . . . . 0.0 112.937 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -77.01 -43.14 35.82 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.512 -0.743 . . . . 0.0 112.536 170.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.0 m -62.09 -37.53 85.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.206 -0.934 . . . . 0.0 111.515 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -57.2 -37.37 72.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.127 2.571 . . . . 0.0 113.581 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.3 -15.25 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.766 1.226 . . . . 0.0 113.381 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.88 18.12 56.78 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.988 0.804 . . . . 0.0 113.935 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.2 -17.96 60.83 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -99.47 -8.37 24.76 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.147 -0.97 . . . . 0.0 112.068 169.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.35 130.24 41.43 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.01 44.37 22.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 114.226 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 p -109.9 167.7 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.214 1.006 . . . . 0.0 110.926 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 156' ' ' ILE . 15.0 pt -124.0 162.16 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.68 85.06 6.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.499 1.12 . . . . 0.0 108.033 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -74.88 -10.81 59.85 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -146.72 138.22 24.38 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.237 1.835 . . . . 0.0 114.182 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.76 146.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.155 2.582 . . . . 0.0 110.46 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.7 mt -137.94 131.86 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.183 1.793 . . . . 0.0 107.85 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.47 137.22 57.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.553 0.741 . . . . 0.0 112.049 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 12.73 62.21 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.864 0.745 . . . . 0.0 114.644 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -142.54 -177.13 5.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.169 1.788 . . . . 0.0 111.412 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -178.79 7.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.971 1.709 . . . . 0.0 114.576 -173.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.7 pt -119.49 142.62 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.417 1.087 . . . . 0.0 113.237 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -110.89 150.2 29.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.944 1.297 . . . . 0.0 111.512 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.78 176.13 35.7 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.35 0.57 67.05 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.085 1.802 . . . . 0.0 115.354 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -16.93 65.12 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.013 1.407 . . . . 0.0 115.494 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -145.38 166.4 25.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.824 1.25 . . . . 0.0 112.987 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.91 162.26 24.62 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.841 1.657 . . . . 0.0 110.493 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.96 -13.17 29.6 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.655 2.903 . . . . 0.0 117.709 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.12 16.62 60.56 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.053 0.835 . . . . 0.0 114.5 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.8 30.19 19.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 112.575 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.04 126.12 33.93 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.037 1.335 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.25 119.96 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.362 1.065 . . . . 0.0 110.675 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.86 162.78 28.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.17 70.35 3.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.769 1.628 . . . . 0.0 111.591 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -73.35 142.71 47.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.927 1.291 . . . . 0.0 113.049 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -141.76 175.46 9.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.982 2.113 . . . . 0.0 111.943 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 52.55 67.87 3.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.689 1.595 . . . . 0.0 114.09 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -60.59 134.49 54.82 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.204 2.603 . . . . 0.0 111.51 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.1 152.13 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.811 1.644 . . . . 0.0 107.999 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 160.49 19.89 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.098 0.559 . . . . 0.0 111.757 170.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.16 132.98 41.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.164 0.586 . . . . 0.0 110.998 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -118.42 15.42 13.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.425 1.49 . . . . 0.0 112.674 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -15.96 46.13 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 119.957 -1.714 . . . . 0.0 114.179 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.28 4.48 0.5 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.13 1.372 . . . . 0.0 113.568 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -75.7 -9.68 58.79 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.775 1.23 . . . . 0.0 112.898 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.62 1.67 82.89 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.754 1.645 . . . . 0.0 114.822 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.09 153.58 32.08 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.259 1.029 . . . . 0.0 112.13 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -130.98 150.85 51.94 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -87.97 77.66 8.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.625 1.97 . . . . 0.0 111.629 -169.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 p -110.34 168.07 9.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -46.19 121.82 3.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 111.372 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.6 36.78 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.23 1.395 . . . . 0.0 114.823 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -118.66 157.72 26.89 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.121 1.46 . . . . 0.0 113.586 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -117.96 135.08 54.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 112.831 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.47 159.7 40.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.485 0.659 . . . . 0.0 111.962 172.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ptp -70.12 145.12 51.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.536 0.734 . . . . 0.0 111.233 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 150.56 20.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.265 0.626 . . . . 0.0 110.066 169.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -127.68 160.5 31.45 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.519 1.127 . . . . 0.0 112.856 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -87.78 58.27 4.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.996 1.718 . . . . 0.0 110.213 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.341 18.1 pt20 54.49 -38.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 130.186 3.395 . . . . 0.0 117.648 -169.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.34 149.29 84.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.347 1.43 . . . . 0.0 111.3 173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.13 -35.18 66.03 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.471 2.114 . . . . 0.0 113.715 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -106.09 41.18 1.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 0.0 112.406 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -130.05 27.74 5.1 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.22 1.408 . . . . 0.0 113.839 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.58 104.69 16.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.47 1.508 . . . . 0.0 108.644 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -91.08 -52.31 4.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.282 1.033 . . . . 0.0 112.949 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -161.08 41.41 0.16 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.311 1.044 . . . . 0.0 113.064 -170.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -131.17 145.24 51.88 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.974 -1.078 . . . . 0.0 111.602 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.59 168.32 21.56 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.398 1.879 . . . . 0.0 111.594 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -146.5 163.78 34.62 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.029 0.932 . . . . 0.0 111.566 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.18 118.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.587 1.155 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.04 108.24 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.675 0.79 . . . . 0.0 110.915 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.74 -12.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 113.725 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.55 167.19 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.44 1.496 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.51 113.15 4.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.731 1.612 . . . . 0.0 112.115 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.7 62.34 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.309 1.443 . . . . 0.0 111.643 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.81 -35.69 66.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.343 1.457 . . . . 0.0 114.106 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -65.18 -12.98 56.94 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.51 -8.05 59.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.342 1.057 . . . . 0.0 113.443 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -77.71 -172.35 2.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.683 1.193 . . . . 0.0 113.84 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -81.87 146.43 29.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.36 1.464 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.9 p -107.58 -61.87 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.658 1.583 . . . . 0.0 113.349 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.99 56.64 0.01 OUTLIER Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.515 1.531 . . . . 0.0 112.335 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.41 24.77 13.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.114 1.766 . . . . 0.0 114.862 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.9 p -102.34 122.11 43.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.876 1.27 . . . . 0.0 112.781 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.76 -40.56 63.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.01 1.324 . . . . 0.0 114.558 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -83.08 -10.36 58.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.773 0.829 . . . . 0.0 113.047 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.87 -71.44 1.17 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.323 1.916 . . . . 0.0 113.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.407 ' HB3' ' H ' ' A' ' 111' ' ' SER 0.31 5.6 p-90 -71.87 123.51 22.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.433 1.117 . . . . 0.0 113.542 -169.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.77 -99.18 1.31 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.221 1.391 . . . . 0.0 115.388 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.5 132.92 45.88 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.306 1.042 . . . . 0.0 112.328 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.52 126.46 30.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.17 94.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.402 1.081 . . . . 0.0 108.242 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -82.05 -14.7 55.5 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.866 0.866 . . . . 0.0 111.795 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.08 175.58 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.56 1.171 . . . . 0.0 113.13 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.81 153.39 50.82 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.795 -1.191 . . . . 0.0 112.203 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.35 138.68 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.586 0.708 . . . . 0.0 109.254 169.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 t -107.82 -41.98 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.712 1.605 . . . . 0.0 110.557 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -145.58 151.07 37.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.344 1.458 . . . . 0.0 110.031 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.93 11.78 19.86 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.953 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.9 mmm -53.39 -37.42 62.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.928 1.864 . . . . 0.0 112.544 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.92 -31.76 72.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.039 0.936 . . . . 0.0 112.377 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.93 -43.75 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.174 1.39 . . . . 0.0 110.282 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.95 -38.01 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.217 -0.927 . . . . 0.0 111.031 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -71.93 -26.31 62.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.246 1.418 . . . . 0.0 112.558 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -77.89 -41.52 36.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.865 1.266 . . . . 0.0 110.886 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.89 -30.23 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.061 1.744 . . . . 0.0 112.726 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -89.43 -12.39 40.38 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -111.42 -12.88 14.08 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.542 1.544 . . . . 0.0 114.471 -171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 m -61.29 -58.07 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.733 1.266 . . . . 0.0 112.678 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.23 145.0 1.26 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.964 1.305 . . . . 0.0 112.073 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -122.5 149.37 44.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.629 1.572 . . . . 0.0 112.564 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.82 130.55 1.27 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.33 0.967 . . . . 0.0 112.053 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 149' ' ' ASP . 11.3 ptp85 -68.3 145.78 53.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.441 1.096 . . . . 0.0 113.119 -173.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.3 p -114.69 167.97 10.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.213 1.405 . . . . 0.0 112.277 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.27 76.72 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.535 0.588 . . . . 0.0 114.517 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.3 mmm -95.76 -41.53 8.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.525 1.13 . . . . 0.0 112.765 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -141.31 130.11 22.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.393 1.877 . . . . 0.0 110.174 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -90.3 153.78 20.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.579 0.751 . . . . 0.0 112.681 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 143' ' ' ARG . 3.3 m-20 53.3 65.4 1.53 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.225 2.21 . . . . 0.0 112.624 -178.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.44 160.27 63.28 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 127.58 2.352 . . . . 0.0 111.816 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.93 132.87 31.57 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.372 1.381 . . . . 0.0 109.397 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 -26.14 28.82 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.14 142.56 45.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.581 0.753 . . . . 0.0 109.644 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -81.42 112.05 18.34 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.328 0.651 . . . . 0.0 110.803 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.13 103.99 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -126.45 143.65 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.772 1.229 . . . . 0.0 111.57 -170.009 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.4 mt -86.78 102.7 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.04 -28.31 43.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.389 1.076 . . . . 0.0 112.109 -174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -153.66 161.78 41.84 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.21 140.09 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.967 1.707 . . . . 0.0 109.875 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -136.37 126.52 26.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.747 1.219 . . . . 0.0 110.343 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.5 121.77 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 t -111.75 150.45 30.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.386 1.474 . . . . 0.0 112.316 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.706 1.602 . . . . 0.0 113.502 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.84 130.36 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.0 m -103.97 124.78 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.47 1.508 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -101.08 120.04 39.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.674 1.19 . . . . 0.0 109.756 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -93.9 114.38 26.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -125.31 159.39 31.84 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -68.94 -7.99 40.22 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -106.77 -28.26 10.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.645 1.578 . . . . 0.0 113.276 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.88 146.91 4.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.323 1.916 . . . . 0.0 113.094 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.69 133.15 31.26 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.533 1.133 . . . . 0.0 112.863 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.3 mt -128.39 142.96 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.845 1.658 . . . . 0.0 109.28 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -129.27 138.6 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.165 0.986 . . . . 0.0 110.269 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 mt -128.89 138.32 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.551 1.94 . . . . 0.0 109.801 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -107.38 122.28 46.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.725 2.01 . . . . 0.0 109.419 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 p -86.74 149.3 24.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.128 0.971 . . . . 0.0 112.414 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.03 72.49 0.89 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 123.025 1.393 . . . . 0.0 111.924 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.85 -26.07 64.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.544 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.06 -29.1 54.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.241 1.016 . . . . 0.0 111.481 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -99.42 -23.18 15.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.88 1.272 . . . . 0.0 113.23 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.22 55.42 1.39 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.33 1.052 . . . . 0.0 113.41 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.77 -44.34 31.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.368 2.712 . . . . 0.0 112.99 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -69.37 -39.94 77.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.725 0.693 . . . . 0.0 111.291 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.483 ' HA ' HD13 ' A' ' 68' ' ' ILE . 18.2 m -64.86 -47.67 77.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.451 0.7 . . . . 0.0 111.245 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.7 -38.03 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.121 0.968 . . . . 0.0 112.275 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -54.21 -45.08 72.16 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.849 1.204 . . . . 0.0 112.035 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -68.26 -41.53 80.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.282 0.633 . . . . 0.0 111.467 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.6 -47.05 85.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.109 0.963 . . . . 0.0 111.611 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.55 -36.37 68.23 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.381 -0.825 . . . . 0.0 112.209 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.59 -39.15 76.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.819 0.448 . . . . 0.0 111.74 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -68.29 -43.38 77.83 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.55 -0.719 . . . . 0.0 111.932 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.8 m -60.33 -40.3 90.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.065 0.546 . . . . 0.0 111.32 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -68.78 -33.79 74.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.968 1.707 . . . . 0.0 112.821 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.35 -18.44 42.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.162 0.985 . . . . 0.0 112.994 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.87 25.91 43.63 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.919 -0.488 . . . . 0.0 112.561 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -69.78 -42.49 73.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.273 1.037 . . . . 0.0 113.156 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -81.22 -13.4 58.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.769 0.828 . . . . 0.0 111.732 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -63.14 124.96 22.5 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.684 0.794 . . . . 0.0 108.87 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.252 61.1 t30 59.1 45.52 14.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.592 1.557 . . . . 0.0 114.886 -169.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -111.66 164.3 13.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.466 1.106 . . . . 0.0 111.067 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 156' ' ' ILE . 11.5 pt -121.36 163.05 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 85.05 7.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.197 1.399 . . . . 0.0 107.978 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -75.59 -7.25 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -135.45 140.9 45.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.854 1.661 . . . . 0.0 112.252 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.53 136.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.961 2.104 . . . . 0.0 110.526 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.4 mt -140.33 130.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 108.363 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -66.93 137.21 56.37 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.099 0.96 . . . . 0.0 112.067 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 11.95 66.43 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.816 0.722 . . . . 0.0 114.492 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -146.3 -176.99 5.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.91 2.084 . . . . 0.0 110.216 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -90.51 -180.0 5.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.107 1.763 . . . . 0.0 114.45 -171.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.14 140.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.882 1.273 . . . . 0.0 111.971 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -112.49 149.03 33.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.021 1.329 . . . . 0.0 110.789 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.35 175.72 32.43 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 3.51 90.0 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.311 1.434 . . . . 0.0 115.392 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.12 -26.32 37.36 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.002 1.401 . . . . 0.0 115.031 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -143.78 160.53 40.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.2 164.31 39.05 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.319 1.447 . . . . 0.0 110.59 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.92 -14.47 37.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.381 2.721 . . . . 0.0 117.943 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.87 21.08 47.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.344 0.973 . . . . 0.0 114.451 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.78 33.68 17.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.941 1.696 . . . . 0.0 113.011 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.06 130.48 36.96 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.057 1.343 . . . . 0.0 109.772 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.62 128.92 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 123.943 1.83 . . . . 0.0 111.357 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -76.79 178.48 6.78 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 110.615 -2.993 . . . . 0.0 114.379 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.18 54.43 3.1 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.821 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.2 p -71.11 117.36 12.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.509 1.124 . . . . 0.0 111.402 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.34 -178.07 4.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.062 1.745 . . . . 0.0 111.818 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 45.95 64.19 8.43 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.649 1.58 . . . . 0.0 114.344 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -54.51 129.3 34.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.097 2.531 . . . . 0.0 110.703 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.0 OUTLIER -109.68 148.65 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.152 1.381 . . . . 0.0 109.044 -174.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 151.71 38.55 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.31 0.576 . . . . 0.0 110.787 169.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -80.11 125.17 29.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.575 0.75 . . . . 0.0 110.851 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.82 12.67 34.22 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.804 1.241 . . . . 0.0 113.152 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -16.49 49.22 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.64 -1.287 . . . . 0.0 114.409 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.89 1.11 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.437 1.495 . . . . 0.0 114.02 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -71.98 -11.6 60.85 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.878 1.271 . . . . 0.0 113.076 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 10.67 77.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.1 1.333 . . . . 0.0 114.383 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.55 154.96 34.04 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.582 1.191 . . . . 0.0 112.48 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -130.01 151.85 50.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.77 103.21 15.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.14 2.176 . . . . 0.0 109.668 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 p -134.65 170.59 15.57 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.096 1.358 . . . . 0.0 110.822 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -49.65 119.79 3.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.773 1.229 . . . . 0.0 111.116 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.08 33.31 26.77 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.832 1.206 . . . . 0.0 114.923 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -119.6 159.57 24.13 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.727 1.263 . . . . 0.0 113.09 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.75 136.37 54.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.07 156.31 49.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.03 0.532 . . . . 0.0 111.467 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -85.13 134.5 34.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.71 153.44 22.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.374 1.07 . . . . 0.0 111.122 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -105.26 158.24 16.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.071 1.349 . . . . 0.0 111.969 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.9 m -78.01 -51.6 10.09 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.987 0.915 . . . . 0.0 110.776 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -161.85 -53.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.899 1.28 . . . . 0.0 111.334 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.8 162.99 68.36 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.058 1.343 . . . . 0.0 112.315 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.5 -17.07 58.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.217 2.611 . . . . 0.0 114.263 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -122.17 50.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.569 1.547 . . . . 0.0 111.681 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.9 p -132.78 33.5 3.72 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.65 57.76 0.76 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.114 1.366 . . . . 0.0 113.475 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p -60.17 -47.67 84.97 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -169.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.12 -30.72 0.13 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -174.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -70.81 142.82 51.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.317 1.047 . . . . 0.0 111.434 -170.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -137.21 168.39 19.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.196 1.798 . . . . 0.0 110.524 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.3 p90 -148.27 160.53 42.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 112.071 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.02 115.9 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 108.903 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.7 95.97 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.175 0.99 . . . . 0.0 110.697 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.91 -24.73 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.167 -0.958 . . . . 0.0 113.388 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.9 168.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.501 . . . . 0.0 111.492 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.79 118.04 21.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.201 1.0 . . . . 0.0 110.531 169.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -141.88 68.49 1.32 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.938 1.352 . . . . 0.0 113.004 -169.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.52 -35.31 39.95 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.309 2.244 . . . . 0.0 114.538 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -58.8 -13.79 7.08 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.08 -10.45 59.2 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.58 -177.35 3.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.511 1.524 . . . . 0.0 114.814 -171.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -79.35 155.59 28.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.098 1.359 . . . . 0.0 111.64 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.5 t -136.11 -55.05 0.76 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 169.13 61.65 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.85 23.48 9.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.586 1.554 . . . . 0.0 114.847 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -114.13 137.17 52.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.023 1.329 . . . . 0.0 112.883 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.14 -31.65 71.36 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.515 1.126 . . . . 0.0 113.39 -170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -85.63 -7.29 58.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.075 0.95 . . . . 0.0 113.085 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.88 -67.86 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.43 1.967 . . . . 0.0 114.19 -174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.28 4.0 p-90 -90.2 129.85 36.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.74 -89.52 1.9 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.719 1.628 . . . . 0.0 114.802 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -140.56 146.73 38.44 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.169 1.387 . . . . 0.0 112.139 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.08 129.51 34.82 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.34 94.48 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.762 1.225 . . . . 0.0 108.585 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -79.28 -16.0 57.09 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.648 0.779 . . . . 0.0 111.976 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.96 177.8 8.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.663 1.221 . . . . 0.0 113.111 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.06 153.78 51.93 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.89 -1.131 . . . . 0.0 112.027 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.61 143.98 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.744 0.783 . . . . 0.0 109.315 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.83 -38.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 110.854 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -146.37 149.12 33.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.274 1.43 . . . . 0.0 110.906 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.48 6.09 18.03 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.65 1.119 . . . . 0.0 115.793 170.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.4 mmm -56.3 -37.14 69.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.169 1.484 . . . . 0.0 113.103 -176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.81 -30.93 71.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.724 0.809 . . . . 0.0 112.207 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.06 -41.73 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.037 1.735 . . . . 0.0 110.696 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.27 -38.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 111.05 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 6.8 t70 -75.77 -19.18 59.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.02 1.328 . . . . 0.0 113.19 175.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -79.75 -41.94 25.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.108 1.363 . . . . 0.0 111.081 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.5 mt -55.51 -35.56 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.06 1.344 . . . . 0.0 112.158 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.9 pttp -83.78 -12.36 55.81 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.87 -24.49 9.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.151 1.358 . . . . 0.0 114.197 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 m -74.16 -59.5 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.718 1.259 . . . . 0.0 114.379 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.05 154.48 9.07 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.8 p -141.94 153.63 44.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.943 1.697 . . . . 0.0 112.143 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.81 131.33 1.38 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.343 0.497 . . . . 0.0 113.176 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.97 149.71 39.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.397 1.479 . . . . 0.0 113.055 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 28.7 p -116.55 168.9 9.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.354 1.461 . . . . 0.0 112.451 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.24 -19.45 70.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.569 0.604 . . . . 0.0 114.557 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.01 -41.97 7.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.645 1.178 . . . . 0.0 112.655 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -141.45 132.91 26.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.379 1.871 . . . . 0.0 110.471 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -94.83 158.34 15.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.321 1.048 . . . . 0.0 111.813 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.52 58.15 4.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.271 1.428 . . . . 0.0 113.299 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.67 160.66 59.62 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 0.0 111.64 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.98 136.39 41.03 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.515 1.476 . . . . 0.0 110.259 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -30.11 40.76 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.88 152.28 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.078 0.951 . . . . 0.0 110.849 169.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.64 109.65 17.61 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.837 0.827 . . . . 0.0 110.799 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.1 t -105.03 93.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.54 144.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.14 103.97 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.224 1.81 . . . . 0.0 107.09 169.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.32 -29.17 42.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.254 1.021 . . . . 0.0 112.504 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -156.28 165.7 35.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.17 139.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.901 1.681 . . . . 0.0 110.741 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 m -136.58 132.71 35.51 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.004 1.322 . . . . 0.0 110.712 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.75 123.33 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -117.41 150.39 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.611 1.564 . . . . 0.0 112.41 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 125.365 1.466 . . . . 0.0 113.611 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.78 128.59 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.979 0.912 . . . . 0.0 108.742 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -104.26 124.45 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.022 1.329 . . . . 0.0 109.958 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.0 123.54 40.74 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.173 0.989 . . . . 0.0 109.74 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -99.32 105.98 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.563 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.22 159.66 20.69 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.966 -0.459 . . . . 0.0 111.555 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -70.78 -6.05 34.78 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.67 ' CE1' HD11 ' A' ' 136' ' ' ILE . 20.1 p80 -110.37 -24.66 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.528 1.531 . . . . 0.0 113.759 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.77 145.17 4.14 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.258 1.885 . . . . 0.0 113.665 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.27 135.45 38.5 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.676 1.19 . . . . 0.0 112.836 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -132.66 142.62 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.313 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.18 136.91 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.321 1.048 . . . . 0.0 110.672 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 139.33 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.778 2.031 . . . . 0.0 110.255 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -105.94 123.51 48.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.694 1.998 . . . . 0.0 108.807 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -87.63 148.6 24.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.266 1.026 . . . . 0.0 112.183 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.15 74.17 1.03 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.684 1.23 . . . . 0.0 111.684 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.75 -27.07 64.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.499 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.122 0.969 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.73 -22.65 15.77 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 113.106 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.98 2.75 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.754 1.222 . . . . 0.0 112.816 -171.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.55 -44.88 19.96 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.249 2.633 . . . . 0.0 112.708 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -70.55 -41.26 72.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.777 -0.577 . . . . 0.0 110.996 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.432 ' HA ' HD13 ' A' ' 68' ' ' ILE . 23.1 m -63.06 -47.34 83.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.907 0.483 . . . . 0.0 111.71 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.87 -38.79 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.635 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -57.46 -44.47 84.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.002 1.274 . . . . 0.0 111.484 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -68.17 -39.22 82.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.455 0.702 . . . . 0.0 111.624 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.02 -50.61 73.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.705 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.31 -37.0 77.56 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.448 0.699 . . . . 0.0 111.422 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -56.93 -37.47 71.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.824 0.85 . . . . 0.0 111.965 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -74.15 -43.53 57.05 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.416 -0.803 . . . . 0.0 112.226 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.42 -37.96 76.44 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.84 -0.537 . . . . 0.0 111.808 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -32.76 72.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.257 1.823 . . . . 0.0 112.858 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.63 -15.62 54.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.973 0.909 . . . . 0.0 113.124 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.31 19.85 65.79 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.276 0.941 . . . . 0.0 113.149 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.09 -37.03 73.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.391 1.096 . . . . 0.0 113.068 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.889 0.476 . . . . 0.0 112.139 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -63.74 132.57 51.39 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.221 -0.924 . . . . 0.0 109.112 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.253 13.9 t30 59.42 25.14 13.83 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.722 2.009 . . . . 0.0 116.118 -171.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.2 p -83.27 142.32 31.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.933 -1.105 . . . . 0.0 113.212 170.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.9 pt -95.45 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -83.6 79.16 9.53 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 168.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -73.57 4.71 4.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' HE ' ' HB2' ' A' ' 149' ' ' ASP . 9.7 tpt180 -148.06 135.6 20.7 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.269 1.395 . . . . 0.0 112.439 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.45 131.04 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 110.676 170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -137.34 128.37 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.572 1.549 . . . . 0.0 108.399 -172.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -64.25 136.68 57.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.589 0.755 . . . . 0.0 111.97 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.29 9.66 61.25 Favored Glycine 0 CA--C 1.541 1.668 0 N-CA-C 115.091 0.797 . . . . 0.0 115.091 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.25 -177.16 5.32 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.558 1.943 . . . . 0.0 110.496 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.422 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -85.97 -179.34 6.77 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.674 1.589 . . . . 0.0 115.139 -170.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.0 pt -116.76 134.88 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.78 1.232 . . . . 0.0 112.303 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -108.72 153.52 23.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.659 1.183 . . . . 0.0 111.684 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.38 -179.96 34.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.228 0.918 . . . . 0.0 114.957 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.79 84.39 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.699 1.04 . . . . 0.0 115.699 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -21.4 35.96 Favored Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.115 1.458 . . . . 0.0 115.917 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.3 162.82 35.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.269 1.034 . . . . 0.0 113.45 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -90.27 158.98 42.9 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.851 1.66 . . . . 0.0 109.804 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.98 -8.99 13.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.668 3.578 . . . . 0.0 116.113 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.74 14.63 64.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.08 0.848 . . . . 0.0 114.534 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.37 26.94 16.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.913 1.685 . . . . 0.0 113.163 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.15 131.6 36.6 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.093 1.357 . . . . 0.0 109.842 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -75.9 129.35 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.086 1.898 . . . . 0.0 111.204 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -72.2 179.54 3.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 110.447 -3.07 . . . . 0.0 114.127 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.24 51.21 2.08 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.258 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.2 p -72.28 117.17 13.59 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.594 1.158 . . . . 0.0 111.944 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -138.0 178.87 6.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.176 2.191 . . . . 0.0 111.857 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 51.13 71.4 1.54 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.324 1.45 . . . . 0.0 113.728 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.08 147.95 94.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.3 2.667 . . . . 0.0 111.889 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -126.74 147.96 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.135 1.374 . . . . 0.0 110.64 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -64.76 153.27 40.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.919 0.888 . . . . 0.0 111.107 169.433 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.96 -54.89 40.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.256 8.6 mt-10 71.62 1.66 3.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.422 2.289 . . . . 0.0 117.029 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -14.21 59.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.478 1.944 . . . . 0.0 113.972 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -62.72 2.28 0.31 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.728 1.611 . . . . 0.0 114.126 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -74.18 -12.49 60.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.244 1.418 . . . . 0.0 113.543 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.76 77.56 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.075 1.321 . . . . 0.0 114.6 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.5 157.35 30.47 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.517 1.159 . . . . 0.0 112.16 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.6 148.11 52.36 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.67 113.38 18.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.972 2.509 . . . . 0.0 109.653 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -139.44 167.43 22.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.932 1.293 . . . . 0.0 110.569 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -56.45 122.83 12.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.851 0.834 . . . . 0.0 110.9 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.45 51.74 5.48 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.926 1.25 . . . . 0.0 113.74 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 p -138.89 162.96 33.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.176 0.991 . . . . 0.0 112.156 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.5 138.12 53.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.833 0.825 . . . . 0.0 113.176 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.32 160.83 37.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.143 0.577 . . . . 0.0 111.459 171.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.7 mmt -82.4 142.71 31.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.898 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.03 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.519 1.127 . . . . 0.0 110.054 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -106.06 155.79 19.05 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.225 1.01 . . . . 0.0 113.117 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -75.01 -51.61 13.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.685 0.794 . . . . 0.0 111.099 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -156.97 -40.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.139 1.375 . . . . 0.0 113.119 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.97 32.86 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.173 1.389 . . . . 0.0 111.879 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.59 -20.52 65.06 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.303 2.669 . . . . 0.0 114.295 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -108.23 39.38 1.98 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.165 1.786 . . . . 0.0 112.244 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.9 p -128.43 31.04 5.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.059 1.344 . . . . 0.0 113.475 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.33 56.76 3.36 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.826 1.651 . . . . 0.0 113.595 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.1 p -49.69 -70.76 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.767 2.027 . . . . 0.0 115.197 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.18 -21.87 0.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.717 1.207 . . . . 0.0 113.89 -169.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.66 139.87 49.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.411 -0.806 . . . . 0.0 110.568 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.3 168.49 19.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.75 2.02 . . . . 0.0 110.837 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 20.9 p90 -144.36 160.86 40.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.593 0.757 . . . . 0.0 111.887 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.3 mt -111.46 117.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -72.76 103.02 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.071 0.549 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.04 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.08 168.18 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 127.277 2.231 . . . . 0.0 112.212 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.75 122.98 25.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.877 1.271 . . . . 0.0 111.457 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -145.32 73.13 1.34 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.68 1.229 . . . . 0.0 112.403 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.47 -34.24 68.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.675 1.59 . . . . 0.0 114.365 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -56.92 -13.69 2.88 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.82 -12.74 58.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.14 169.51 17.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.99 155.35 40.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.738 1.615 . . . . 0.0 113.133 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.7 p -134.45 -56.77 0.85 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.614 1.166 . . . . 0.0 113.197 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 169.24 70.48 0.03 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.947 0.784 . . . . 0.0 113.983 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 55.34 26.42 8.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.549 1.54 . . . . 0.0 114.52 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -119.42 123.07 43.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.719 1.208 . . . . 0.0 111.695 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.85 -32.36 67.58 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -73.0 -12.02 60.78 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.86 -88.38 1.98 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 127.627 2.537 . . . . 0.0 113.066 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.27 1.7 p-90 -62.21 129.65 41.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -169.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.97 -82.89 0.82 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.051 1.31 . . . . 0.0 115.165 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -128.93 123.55 32.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 112.548 -169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -83.06 131.77 35.15 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -75.64 99.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.011 0.924 . . . . 0.0 108.845 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -80.96 -16.78 52.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.712 0.805 . . . . 0.0 111.591 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 175.88 9.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.194 0.997 . . . . 0.0 113.624 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.51 149.65 48.27 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.481 -1.387 . . . . 0.0 112.144 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.26 135.1 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-O 121.481 0.658 . . . . 0.0 110.405 172.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.56 -41.09 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.499 1.92 . . . . 0.0 110.581 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -142.51 149.27 38.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.186 1.395 . . . . 0.0 110.313 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.32 8.54 28.89 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.342 0.972 . . . . 0.0 115.275 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 79.9 mmm -55.98 -37.68 69.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.176 1.488 . . . . 0.0 112.759 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.71 -29.96 71.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.84 . . . . 0.0 112.49 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.23 -45.26 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.021 1.728 . . . . 0.0 110.492 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.9 t -57.8 -40.11 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.392 1.077 . . . . 0.0 111.38 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 -19.47 61.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.47 1.508 . . . . 0.0 112.905 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -86.85 -39.84 15.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.67 HD11 ' CE1' ' A' ' 8' ' ' HIS . 54.1 mt -50.92 -41.72 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.499 1.52 . . . . 0.0 111.495 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -73.01 -17.71 61.42 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.34 -10.46 36.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.373 1.939 . . . . 0.0 114.796 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.62 -63.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.305 1.553 . . . . 0.0 110.471 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 156.07 2.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.907 1.283 . . . . 0.0 112.008 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.6 p -139.94 149.46 43.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.701 1.2 . . . . 0.0 112.181 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.07 118.75 0.58 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.323 0.487 . . . . 0.0 112.464 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -64.0 146.71 53.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.608 1.563 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.2 p -113.57 168.97 9.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.179 1.392 . . . . 0.0 112.584 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.42 -17.03 70.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.842 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.3 mtp -105.86 -38.06 6.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.581 1.19 . . . . 0.0 113.436 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -141.49 138.08 32.55 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.241 1.817 . . . . 0.0 110.732 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -105.33 160.46 15.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.053 1.341 . . . . 0.0 113.4 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.589 ' HB2' ' HE ' ' A' ' 43' ' ' ARG . 2.8 m-20 55.69 51.35 12.62 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.883 1.673 . . . . 0.0 112.032 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 m -117.45 152.56 49.58 Favored Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 126.161 1.785 . . . . 0.0 111.959 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -68.26 134.88 32.61 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.73 1.62 . . . . 0.0 109.03 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -29.53 61.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -86.86 159.55 19.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.593 1.157 . . . . 0.0 110.303 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -82.79 109.89 17.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.41 1.084 . . . . 0.0 111.794 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.61 94.0 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.563 1.545 . . . . 0.0 106.913 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.79 149.01 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.239 1.495 . . . . 0.0 113.342 -169.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.72 103.9 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.03 -40.14 65.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.744 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -149.52 164.26 35.56 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.57 142.05 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.888 1.675 . . . . 0.0 110.929 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 m -136.24 134.0 37.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.629 1.171 . . . . 0.0 110.983 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.58 120.52 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.0 t -117.98 150.23 39.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.537 1.535 . . . . 0.0 112.723 -171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.388 1.475 . . . . 0.0 113.907 -170.869 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 120.27 0.081 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.98 129.99 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.936 0.894 . . . . 0.0 109.905 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.1 m -104.12 124.44 49.08 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.371 1.468 . . . . 0.0 109.766 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -99.47 123.54 43.84 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.464 1.106 . . . . 0.0 110.346 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -97.61 108.09 20.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.623 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -119.14 159.08 24.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 112.223 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -68.59 -6.77 27.52 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.499 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.2 p80 -110.67 -25.13 10.11 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.466 1.506 . . . . 0.0 113.634 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.38 145.85 4.3 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.123 1.82 . . . . 0.0 113.583 173.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.32 133.81 39.88 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.474 1.109 . . . . 0.0 112.535 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.4 mt -131.1 144.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.943 1.697 . . . . 0.0 109.499 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.26 137.76 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.387 1.075 . . . . 0.0 110.463 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -124.07 138.75 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.987 2.115 . . . . 0.0 110.087 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -106.83 125.37 50.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.109 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.5 p -87.75 149.49 24.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 112.075 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -108.59 74.5 0.92 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.766 1.27 . . . . 0.0 111.726 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.76 -25.9 64.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.548 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -77.57 -26.78 51.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.619 1.168 . . . . 0.0 111.675 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -101.84 -22.39 14.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.231 1.412 . . . . 0.0 112.972 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.73 56.41 1.59 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.891 1.276 . . . . 0.0 113.103 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.09 -44.36 29.94 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.496 2.797 . . . . 0.0 112.914 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.2 -41.45 77.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.793 0.724 . . . . 0.0 111.084 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -64.77 -48.59 73.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.725 0.41 . . . . 0.0 111.549 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.7 -41.46 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.573 . . . . 0.0 111.349 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.17 -45.59 87.22 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.571 1.078 . . . . 0.0 111.623 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.1 -34.31 70.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.682 0.674 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.84 -49.68 75.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.257 1.023 . . . . 0.0 111.733 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.358 -0.839 . . . . 0.0 111.658 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -56.52 -33.05 65.67 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.183 0.993 . . . . 0.0 112.628 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -77.61 -46.43 22.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 171.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.3 m -57.72 -40.1 78.8 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.967 0.907 . . . . 0.0 112.201 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -52.86 -46.68 67.99 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.659 1.984 . . . . 0.0 112.872 173.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -83.2 -14.55 53.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.055 0.942 . . . . 0.0 112.133 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.47 52.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.289 0.947 . . . . 0.0 113.046 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.29 -37.15 69.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.402 1.101 . . . . 0.0 113.241 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -83.33 -6.44 59.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.396 0.679 . . . . 0.0 112.132 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -64.41 132.35 49.82 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.1 t30 53.82 49.91 18.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.319 1.448 . . . . 0.0 113.998 -171.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.8 p -114.44 157.14 23.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.304 1.042 . . . . 0.0 112.393 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.41 155.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -86.4 75.97 9.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.863 1.265 . . . . 0.0 107.855 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -53.16 -38.23 62.58 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.0 1.72 . . . . 0.0 114.76 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -123.64 135.53 53.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.56 1.144 . . . . 0.0 111.495 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.2 132.69 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.408 2.283 . . . . 0.0 110.578 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.44 128.9 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.622 1.569 . . . . 0.0 107.989 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 133.49 55.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 111.631 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.97 9.32 66.14 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 123.898 0.761 . . . . 0.0 114.871 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -141.52 -177.28 5.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.153 1.781 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.21 -179.55 5.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.7 136.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.054 1.342 . . . . 0.0 112.399 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.92 146.63 46.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.194 1.398 . . . . 0.0 111.094 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.92 31.03 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.18 -8.73 72.56 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.647 1.594 . . . . 0.0 115.944 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.76 -20.65 70.53 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 118.961 1.381 . . . . 0.0 115.479 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.2 164.9 28.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.482 1.113 . . . . 0.0 113.652 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -101.29 163.65 17.52 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.028 1.731 . . . . 0.0 110.629 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.01 -12.12 28.12 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.384 2.723 . . . . 0.0 118.0 -169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.08 14.59 60.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 123.452 0.549 . . . . 0.0 114.426 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.6 mmt 59.49 28.74 18.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.582 1.953 . . . . 0.0 112.757 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.81 123.01 28.95 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.1 1.36 . . . . 0.0 109.555 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.82 126.62 30.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 124.365 2.031 . . . . 0.0 110.887 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.0 179.74 2.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 110.077 -3.238 . . . . 0.0 114.408 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.06 64.11 3.27 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.372 -2.195 . . . . 0.0 112.147 -174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 p -70.22 107.29 3.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.146 1.379 . . . . 0.0 110.838 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -140.9 168.03 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.133 2.173 . . . . 0.0 112.401 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 50.13 66.94 4.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 0.0 112.487 171.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.62 145.97 97.21 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.469 2.779 . . . . 0.0 113.664 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.85 146.05 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.515 1.926 . . . . 0.0 109.053 -176.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 158.74 16.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.553 1.141 . . . . 0.0 111.143 170.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -73.44 134.55 43.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 111.614 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.04 13.63 12.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.086 1.354 . . . . 0.0 112.675 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -11.85 56.43 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.565 -1.334 . . . . 0.0 114.128 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -62.24 5.27 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.309 1.444 . . . . 0.0 114.553 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -76.53 -11.35 59.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.773 1.629 . . . . 0.0 112.826 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 6.47 85.39 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.256 1.407 . . . . 0.0 115.071 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.53 154.85 38.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.361 1.081 . . . . 0.0 112.25 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.55 149.21 51.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -86.03 64.24 8.47 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.44 1.896 . . . . 0.0 112.528 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.8 p -98.57 166.24 11.44 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.735 0.814 . . . . 0.0 112.235 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.05 123.25 11.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.878 1.671 . . . . 0.0 111.019 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.25 56.37 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.315 1.436 . . . . 0.0 114.945 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.2 p -110.51 161.36 15.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.591 1.695 . . . . 0.0 113.266 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -118.98 135.34 54.66 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.031 0.932 . . . . 0.0 112.734 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.43 159.39 41.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.652 174.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -81.7 143.04 32.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 111.204 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 153.99 18.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.953 0.901 . . . . 0.0 110.617 169.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -133.9 152.94 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.134 1.374 . . . . 0.0 111.923 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -65.32 -55.08 20.23 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.837 1.255 . . . . 0.0 112.708 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.71 -55.48 0.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.758 1.223 . . . . 0.0 111.366 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.47 159.04 86.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.574 1.15 . . . . 0.0 111.5 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.37 -26.28 81.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.005 2.47 . . . . 0.0 113.703 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -114.28 42.15 2.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.317 1.447 . . . . 0.0 111.947 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -122.61 30.64 6.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.309 1.444 . . . . 0.0 114.124 -173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.06 22.67 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.268 1.427 . . . . 0.0 107.465 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -132.51 -59.48 0.91 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.23 1.412 . . . . 0.0 112.739 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.57 -11.85 1.58 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 0.0 112.677 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -78.96 134.37 36.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.551 1.14 . . . . 0.0 110.383 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -141.32 168.1 20.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.082 1.753 . . . . 0.0 111.635 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 9.6 p90 -149.96 163.12 38.94 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.856 0.862 . . . . 0.0 111.751 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.0 mt -117.26 119.19 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.922 1.289 . . . . 0.0 108.538 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -72.59 97.57 2.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.564 0.745 . . . . 0.0 110.037 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 m -76.14 -15.54 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.8 167.01 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 128.724 2.809 . . . . 0.0 110.296 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.22 116.54 13.88 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.204 0.526 . . . . 0.0 111.525 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.9 57.25 1.28 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 111.921 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -64.82 -15.59 61.97 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -66.08 -15.12 62.8 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.779 -1.201 . . . . 0.0 113.383 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.37 -8.73 59.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.37 1.068 . . . . 0.0 113.452 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.28 179.83 3.73 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -79.08 141.09 37.66 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.561 1.544 . . . . 0.0 112.483 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.6 p -104.17 -60.31 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.638 1.175 . . . . 0.0 113.591 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.64 58.73 0.03 OUTLIER Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.818 0.723 . . . . 0.0 114.732 -172.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 57.13 26.17 11.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.756 1.622 . . . . 0.0 114.943 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.3 t -104.94 112.51 25.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.188 0.995 . . . . 0.0 109.417 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.39 -32.19 64.57 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -76.89 -15.55 59.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.43 -64.97 1.26 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 127.487 2.47 . . . . 0.0 113.512 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.299 8.0 p-90 -69.07 122.24 18.34 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.888 1.344 . . . . 0.0 113.36 -174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.84 -96.45 0.69 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.339 1.447 . . . . 0.0 115.618 -169.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.51 137.64 48.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 111.805 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.8 129.31 34.87 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.27 94.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.794 1.238 . . . . 0.0 108.455 169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -80.64 -15.38 56.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.401 0.681 . . . . 0.0 111.821 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.03 177.97 8.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.46 1.124 . . . . 0.0 113.554 -171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -137.14 153.6 50.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 120.811 -1.181 . . . . 0.0 112.105 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.84 138.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.509 0.671 . . . . 0.0 110.443 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.33 -41.95 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.993 1.717 . . . . 0.0 111.187 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -143.48 153.84 43.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.141 1.377 . . . . 0.0 110.584 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.31 39.15 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.526 1.06 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.9 mtp -60.66 -35.17 75.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.895 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -65.12 -29.07 69.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.865 0.866 . . . . 0.0 112.142 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.05 -43.6 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.491 1.517 . . . . 0.0 110.307 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.59 -38.95 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.488 1.115 . . . . 0.0 111.253 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.13 -20.09 60.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.419 1.488 . . . . 0.0 113.0 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -86.22 -40.55 15.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.761 1.624 . . . . 0.0 111.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.4 mt -54.7 -34.44 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.487 1.515 . . . . 0.0 112.065 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -83.82 -16.58 44.06 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.0 13.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.182 1.372 . . . . 0.0 114.091 -173.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.84 -62.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.405 1.102 . . . . 0.0 113.312 -174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.79 157.27 5.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.013 0.925 . . . . 0.0 113.458 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -139.47 155.14 47.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 111.772 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.75 149.42 7.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-O 123.329 1.516 . . . . 0.0 115.137 170.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -61.74 148.65 42.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.716 2.806 . . . . 0.0 112.589 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 p -120.21 169.41 10.27 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.659 1.183 . . . . 0.0 112.146 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -9.44 35.36 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 118.777 -1.013 . . . . 0.0 115.217 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 ptp -144.68 -9.28 0.63 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -134.39 159.06 42.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.701 1.6 . . . . 0.0 111.667 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -129.3 159.62 35.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.247 2.219 . . . . 0.0 111.156 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.09 39.73 28.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.97 1.308 . . . . 0.0 113.374 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.12 154.05 42.24 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.303 1.441 . . . . 0.0 111.781 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.0 135.84 28.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.703 1.602 . . . . 0.0 110.059 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.8 51.63 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -84.72 157.69 20.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 110.058 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -79.91 125.86 30.28 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.01 -1.057 . . . . 0.0 111.207 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.92 93.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.354 1.861 . . . . 0.0 107.732 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 144.27 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.98 110.51 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.96 -41.58 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.689 0.677 . . . . 0.0 110.389 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.77 165.6 33.0 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.18 142.51 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.06 1.744 . . . . 0.0 111.446 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -136.37 136.29 39.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.987 1.315 . . . . 0.0 110.683 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.71 123.95 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.2 t -122.51 143.61 49.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 112.087 -169.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.31 1.844 . . . . 0.0 112.082 178.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.08 128.34 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.988 1.267 . . . . 0.0 110.423 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.9 m -100.37 125.6 46.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.277 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -101.44 128.02 47.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.999 1.319 . . . . 0.0 110.518 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.19 95.79 6.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -99.9 152.36 20.25 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.901 -0.5 . . . . 0.0 110.829 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -60.31 -13.84 15.05 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -97.97 -11.14 23.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 113.624 171.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.87 167.84 13.72 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.651 1.596 . . . . 0.0 113.408 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.3 137.25 41.02 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.754 1.622 . . . . 0.0 112.821 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -133.2 140.48 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.752 2.021 . . . . 0.0 108.561 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.96 134.18 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.464 1.105 . . . . 0.0 110.266 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.02 133.88 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.483 1.913 . . . . 0.0 110.039 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -99.64 126.86 45.72 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.898 1.679 . . . . 0.0 108.44 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -89.08 146.77 24.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.24 1.016 . . . . 0.0 110.999 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -103.65 73.73 1.2 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 122.669 1.224 . . . . 0.0 111.458 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.86 -26.28 64.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.77 -1.104 . . . . 0.0 112.48 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.87 -27.97 49.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.253 1.021 . . . . 0.0 111.672 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.72 -18.87 15.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.104 1.362 . . . . 0.0 113.222 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.0 55.39 1.19 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.665 1.186 . . . . 0.0 113.123 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.72 -44.97 27.6 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.47 2.78 . . . . 0.0 112.952 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.27 -41.82 80.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.108 0.563 . . . . 0.0 110.971 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -65.42 -45.43 83.94 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.175 0.59 . . . . 0.0 111.789 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.97 -43.09 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.583 0.753 . . . . 0.0 111.761 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.66 -42.48 79.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.96 1.254 . . . . 0.0 111.797 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -70.2 -37.95 75.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.733 0.813 . . . . 0.0 111.626 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.91 -48.96 79.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.432 1.093 . . . . 0.0 111.713 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.98 -37.97 79.07 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.593 0.757 . . . . 0.0 111.456 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -57.25 -33.88 68.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.361 1.065 . . . . 0.0 112.808 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 18.5 m-85 -76.84 -44.73 31.13 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.462 -0.774 . . . . 0.0 112.493 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -59.98 -35.98 76.16 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.63 -0.669 . . . . 0.0 111.658 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.78 -34.28 77.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.026 2.13 . . . . 0.0 112.945 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.43 -14.48 52.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.029 0.932 . . . . 0.0 113.372 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.51 19.23 60.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.553 1.073 . . . . 0.0 113.885 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 54.4 t80 -68.27 -17.72 64.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.13 -3.63 44.19 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.269 -0.894 . . . . 0.0 113.137 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.5 135.29 54.97 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.135 -0.978 . . . . 0.0 108.952 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 54.16 47.17 23.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.531 1.533 . . . . 0.0 113.689 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.3 p -114.37 151.23 33.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.836 0.855 . . . . 0.0 112.532 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 pt -103.3 162.05 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.45 86.41 6.77 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -80.05 2.63 23.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -169.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -144.25 143.16 30.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.967 2.167 . . . . 0.0 113.46 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.14 131.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 110.271 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.2 mt -137.65 129.64 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.613 1.565 . . . . 0.0 108.15 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.84 133.5 54.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.756 0.822 . . . . 0.0 111.782 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 9.37 65.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 123.895 0.759 . . . . 0.0 114.947 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -141.89 -177.3 5.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 110.872 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -179.25 5.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.869 1.667 . . . . 0.0 115.379 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.9 pt -114.31 135.91 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.885 1.274 . . . . 0.0 112.446 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.31 150.77 25.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.434 1.094 . . . . 0.0 110.653 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.87 34.66 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.05 -2.32 61.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.811 1.672 . . . . 0.0 115.662 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.31 -14.94 65.29 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 118.921 1.361 . . . . 0.0 115.833 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.38 167.09 23.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.744 1.217 . . . . 0.0 112.782 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.55 164.5 18.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.729 1.612 . . . . 0.0 110.711 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.38 -11.91 28.02 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.514 2.809 . . . . 0.0 116.811 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.59 15.94 62.23 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.088 0.851 . . . . 0.0 114.477 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.1 mmt 61.42 26.46 16.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.058 1.743 . . . . 0.0 113.221 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -83.22 127.18 33.4 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.834 1.254 . . . . 0.0 109.357 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -73.57 119.24 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.966 0.906 . . . . 0.0 110.145 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -69.43 164.83 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.136 0.974 . . . . 0.0 113.472 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 66.04 9.47 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.814 1.645 . . . . 0.0 111.494 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.4 p -69.18 134.47 49.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.932 1.293 . . . . 0.0 112.219 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -137.71 174.05 10.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.022 2.129 . . . . 0.0 111.965 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.12 66.24 5.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.451 1.5 . . . . 0.0 113.605 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.62 135.76 62.66 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.284 2.656 . . . . 0.0 111.067 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.08 151.61 7.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 125.849 1.66 . . . . 0.0 108.166 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 157.11 27.45 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.638 0.732 . . . . 0.0 111.565 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -81.81 103.68 11.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.33 1.052 . . . . 0.0 111.198 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.75 23.83 1.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.529 1.132 . . . . 0.0 113.289 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.6 -19.86 66.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 119.863 -1.773 . . . . 0.0 113.784 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -65.44 8.82 0.14 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.344 1.458 . . . . 0.0 114.516 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -77.97 -10.06 59.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.144 1.378 . . . . 0.0 113.426 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.66 81.62 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.101 1.334 . . . . 0.0 114.83 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.77 158.61 26.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.498 1.149 . . . . 0.0 112.706 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -130.69 155.07 47.23 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.18 111.56 23.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.489 2.316 . . . . 0.0 110.478 -174.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -142.3 170.38 15.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.327 1.451 . . . . 0.0 111.175 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -38.88 117.13 0.63 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.979 1.712 . . . . 0.0 111.948 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.86 33.29 30.46 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 124.352 0.977 . . . . 0.0 114.787 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.1 p -123.39 157.68 32.82 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.897 1.348 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.78 136.7 54.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.27 160.77 38.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.982 171.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.6 mtt -84.04 143.22 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.39 147.89 22.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.641 1.176 . . . . 0.0 111.766 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 165.62 14.03 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.27 1.028 . . . . 0.0 113.518 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -81.56 -57.14 3.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.136 0.974 . . . . 0.0 110.873 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -151.47 -38.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.082 1.353 . . . . 0.0 113.68 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.89 156.46 35.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.014 1.326 . . . . 0.0 111.48 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.91 -23.91 76.44 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.63 2.22 . . . . 0.0 114.324 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -103.37 33.0 3.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.539 1.536 . . . . 0.0 112.746 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.3 p -118.2 26.09 9.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.42 1.488 . . . . 0.0 113.158 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.13 98.8 2.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.676 1.191 . . . . 0.0 108.574 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.2 p -90.04 -68.64 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.519 1.128 . . . . 0.0 111.691 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.32 20.07 1.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.731 1.212 . . . . 0.0 113.445 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -110.41 142.7 41.76 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.805 -1.185 . . . . 0.0 111.145 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -143.77 168.16 20.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.48 1.512 . . . . 0.0 111.036 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.0 p90 -142.86 158.3 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.353 0.661 . . . . 0.0 111.878 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 mt -111.12 118.38 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -75.27 108.78 8.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.08 0.552 . . . . 0.0 110.137 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.03 -11.02 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.42 165.15 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.985 2.514 . . . . 0.0 111.274 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.25 120.99 25.07 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.843 0.457 . . . . 0.0 109.843 169.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -140.93 74.81 1.48 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.711 1.243 . . . . 0.0 112.459 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.62 -34.57 62.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.153 1.781 . . . . 0.0 114.406 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -59.41 -13.71 9.53 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.89 -8.51 59.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -80.92 177.04 9.31 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.464 . . . . 0.0 114.174 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -89.77 140.76 29.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.877 1.271 . . . . 0.0 112.695 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.2 p -109.34 -61.02 1.69 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.761 1.224 . . . . 0.0 113.351 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.975 0 C-N-CA 124.459 1.028 . . . . 0.0 113.65 -173.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.31 -113.33 2.47 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.153 1.835 . . . . 0.0 114.877 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.98 148.02 50.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 113.067 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.39 126.62 31.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.05 94.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -80.46 -15.36 56.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.63 176.65 8.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.557 1.17 . . . . 0.0 113.951 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.17 154.18 48.03 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.854 -1.154 . . . . 0.0 112.335 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.49 139.49 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.651 0.739 . . . . 0.0 109.865 170.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 t -111.18 -42.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.765 1.626 . . . . 0.0 110.99 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.88 154.76 42.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.469 1.508 . . . . 0.0 109.997 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.21 16.3 25.62 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 123.849 0.737 . . . . 0.0 114.217 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -34.78 67.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.891 1.345 . . . . 0.0 112.256 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.15 -30.44 70.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.1 t -76.27 -40.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.943 1.297 . . . . 0.0 110.408 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.61 -41.89 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.277 -0.889 . . . . 0.0 110.867 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.54 -25.37 63.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.131 1.372 . . . . 0.0 112.355 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -74.57 -52.6 11.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.384 1.074 . . . . 0.0 110.208 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -53.65 -35.56 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.327 1.851 . . . . 0.0 112.793 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.47 -11.46 32.0 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.68 -15.82 10.69 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.718 1.628 . . . . 0.0 114.165 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.53 -63.33 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.45 1.125 . . . . 0.0 112.707 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -176.83 153.64 1.07 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.752 1.621 . . . . 0.0 111.499 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.4 p -125.9 148.67 49.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.985 1.314 . . . . 0.0 112.842 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.075 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.263 169.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.07 138.89 49.05 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.798 1.665 . . . . 0.0 109.559 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -30.74 54.51 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.856 -0.527 . . . . 0.0 112.152 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.15 149.04 32.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.879 0.872 . . . . 0.0 109.848 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -84.03 119.74 25.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 111.313 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.99 108.69 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.318 1.047 . . . . 0.0 109.242 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 148.28 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.884 1.326 . . . . 0.0 111.574 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.1 mt -87.24 103.35 13.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.16 -38.37 60.93 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.71 -0.619 . . . . 0.0 110.197 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 p -151.61 166.96 29.61 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.03 142.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 110.629 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -135.42 128.4 31.47 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.061 1.344 . . . . 0.0 110.205 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.74 124.04 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.518 -0.739 . . . . 0.0 109.02 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -113.36 150.5 32.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.253 1.421 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.753 1.621 . . . . 0.0 113.323 -169.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.2 t -124.68 132.45 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m -104.86 124.89 50.25 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.812 1.245 . . . . 0.0 110.152 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -98.34 132.14 44.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.659 1.184 . . . . 0.0 110.45 169.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -104.22 98.39 8.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -103.77 151.95 22.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.068 -0.395 . . . . 0.0 111.267 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -60.53 -9.36 3.65 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.27 -8.15 18.47 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.815 1.246 . . . . 0.0 114.014 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.51 163.96 10.93 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.411 1.482 . . . . 0.0 113.617 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.43 137.99 44.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.812 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.52 140.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.352 1.861 . . . . 0.0 108.886 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 t -122.34 137.66 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.566 1.147 . . . . 0.0 110.326 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.59 138.43 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.587 1.955 . . . . 0.0 110.409 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -100.5 128.76 46.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.013 2.125 . . . . 0.0 107.713 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 p -88.45 146.46 25.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.303 1.041 . . . . 0.0 111.201 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -102.85 73.79 1.29 Allowed 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 122.614 1.197 . . . . 0.0 111.293 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.59 -27.65 65.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.352 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.15 -29.19 57.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.426 1.09 . . . . 0.0 111.53 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.85 -27.56 14.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.835 1.254 . . . . 0.0 112.835 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.89 61.72 4.33 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.8 0.84 . . . . 0.0 113.188 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.11 -43.7 23.07 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.32 2.68 . . . . 0.0 112.906 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -69.2 -40.54 77.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.484 0.583 . . . . 0.0 110.852 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -64.86 -47.54 77.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.315 0.646 . . . . 0.0 111.593 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.63 -44.51 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 111.342 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -55.95 -48.26 76.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.55 1.068 . . . . 0.0 112.039 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.406 HD22 HD11 ' A' ' 68' ' ' ILE . 43.7 t30 -68.12 -38.32 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.572 0.624 . . . . 0.0 111.878 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.13 -49.04 79.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.329 1.051 . . . . 0.0 111.673 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.35 -38.18 81.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.555 0.742 . . . . 0.0 111.554 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -59.1 -33.36 70.76 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.847 0.859 . . . . 0.0 112.665 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 -43.95 50.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.909 0.777 . . . . 0.0 112.285 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.33 -36.15 79.36 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.578 -0.701 . . . . 0.0 111.687 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.71 -34.1 77.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.087 2.155 . . . . 0.0 112.86 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.71 -13.34 56.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.963 0.905 . . . . 0.0 113.267 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.97 18.61 62.83 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.628 1.109 . . . . 0.0 113.939 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.65 -17.56 64.12 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -96.7 -5.42 38.82 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.414 -0.804 . . . . 0.0 113.022 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -67.67 136.07 53.78 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.59 44.46 29.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.353 1.461 . . . . 0.0 113.828 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -109.32 164.4 12.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.865 0.866 . . . . 0.0 111.742 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 11.3 pt -124.75 159.05 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -169.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -91.14 96.59 10.66 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -88.39 -11.46 46.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -143.27 136.15 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.939 1.245 . . . . 0.0 113.374 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -135.4 145.11 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 128.145 2.578 . . . . 0.0 109.018 169.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -133.14 131.18 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.734 1.614 . . . . 0.0 108.188 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.62 126.77 28.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.111 0.964 . . . . 0.0 112.594 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.1 11.81 70.97 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 123.81 0.719 . . . . 0.0 114.81 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.15 -176.98 4.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.495 1.918 . . . . 0.0 110.979 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.72 -179.25 7.26 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.2 pt -118.95 134.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.485 1.514 . . . . 0.0 112.91 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -112.18 146.47 38.03 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.746 1.219 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.23 35.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.693 1.437 . . . . 0.0 116.693 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.94 -4.69 85.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.952 1.739 . . . . 0.0 115.602 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -15.84 64.84 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -169.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -146.61 164.71 31.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.746 1.273 . . . . 0.0 112.939 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.19 161.82 31.95 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.502 1.521 . . . . 0.0 110.003 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -63.29 -13.0 33.18 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.298 2.665 . . . . 0.0 117.729 -169.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.44 14.96 64.08 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 123.908 0.766 . . . . 0.0 114.496 171.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.1 mmm 58.1 39.44 26.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.343 1.857 . . . . 0.0 112.988 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -92.28 127.95 37.95 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.369 1.467 . . . . 0.0 109.53 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -75.37 123.67 25.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.423 1.089 . . . . 0.0 111.166 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -73.44 162.75 28.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.72 73.51 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.561 1.544 . . . . 0.0 111.538 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 p -72.0 131.58 43.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.299 1.039 . . . . 0.0 112.118 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -137.37 175.04 9.96 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.463 1.905 . . . . 0.0 112.527 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 50.62 69.49 2.57 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.746 1.619 . . . . 0.0 113.996 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.49 135.68 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.189 2.592 . . . . 0.0 111.515 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.406 HD11 HD22 ' A' ' 26' ' ' ASN . 1.4 mt -105.88 154.04 7.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.298 1.839 . . . . 0.0 108.535 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 158.07 18.47 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.23 0.612 . . . . 0.0 111.829 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -72.54 127.64 33.16 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.198 0.599 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -113.03 12.05 19.13 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.022 1.329 . . . . 0.0 112.73 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 -11.71 46.67 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.197 -1.565 . . . . 0.0 113.762 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -58.62 -1.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.95 0.83 29.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.122 1.369 . . . . 0.0 111.569 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.71 10.14 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.708 1.623 . . . . 0.0 114.094 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.8 mt -78.64 157.07 28.75 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.78 158.44 36.55 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -117.68 109.84 17.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.786 2.034 . . . . 0.0 110.717 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -136.0 169.87 16.91 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.703 1.201 . . . . 0.0 111.537 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.1 126.27 24.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.988 0.899 . . . . 0.0 111.079 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.7 24.45 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.923 1.249 . . . . 0.0 114.651 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.5 p -123.86 159.11 30.33 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.172 1.486 . . . . 0.0 113.096 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.69 137.78 54.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.3 159.0 42.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.007 0.523 . . . . 0.0 111.923 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 94.7 mmm -78.34 138.21 38.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.089 -0.382 . . . . 0.0 110.518 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.94 150.31 25.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.106 0.562 . . . . 0.0 110.66 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -115.3 160.77 19.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.536 1.134 . . . . 0.0 112.896 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.8 m -75.56 -52.46 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.054 0.942 . . . . 0.0 111.285 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.27 -57.39 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.559 1.544 . . . . 0.0 110.716 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.99 157.47 78.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.946 1.298 . . . . 0.0 112.115 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.25 -23.09 73.03 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.48 2.787 . . . . 0.0 114.068 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -111.52 36.78 3.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.739 1.615 . . . . 0.0 112.41 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 p -121.15 26.52 8.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.388 1.475 . . . . 0.0 113.843 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.62 99.67 10.34 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.364 1.466 . . . . 0.0 109.447 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -87.07 -71.55 0.55 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.186 . . . . 0.0 112.618 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.9 38.73 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -129.36 152.3 49.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.374 1.07 . . . . 0.0 111.903 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.18 168.41 19.81 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.504 1.522 . . . . 0.0 110.716 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 8.1 p90 -144.03 159.49 42.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.16 0.584 . . . . 0.0 111.055 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 mt -116.42 120.12 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.44 102.8 5.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.167 0.587 . . . . 0.0 109.525 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.28 -18.05 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.88 165.69 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.592 1.557 . . . . 0.0 111.663 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -78.48 119.4 21.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.792 0.437 . . . . 0.0 110.03 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -143.03 63.02 1.39 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 123.009 1.385 . . . . 0.0 111.758 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.27 -11.9 53.15 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -172.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -64.42 -13.68 52.6 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.579 -1.325 . . . . 0.0 113.573 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.06 -13.88 58.96 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.529 1.132 . . . . 0.0 113.431 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -69.32 167.06 17.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.39 1.476 . . . . 0.0 114.904 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -70.2 138.3 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -143.77 21.9 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.343 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.09 -54.88 0.83 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.853 1.216 . . . . 0.0 114.259 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -143.82 158.96 43.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.429 1.492 . . . . 0.0 111.72 -169.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 35.0 t -93.66 119.19 32.36 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.646 -0.658 . . . . 0.0 112.657 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.2 82.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.218 1.407 . . . . 0.0 108.66 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -77.5 -13.25 59.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.914 0.886 . . . . 0.0 112.309 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.08 177.56 8.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 122.751 1.262 . . . . 0.0 114.278 -169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -141.96 154.29 44.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.511 1.124 . . . . 0.0 112.792 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.36 143.49 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.68 0.753 . . . . 0.0 110.394 172.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.8 t -117.11 -40.99 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.79 1.636 . . . . 0.0 111.122 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -145.19 155.12 43.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.869 1.667 . . . . 0.0 109.75 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.92 16.37 23.89 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.817 0.723 . . . . 0.0 114.327 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -33.55 66.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.834 1.317 . . . . 0.0 112.33 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.52 -29.14 69.16 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.545 0.738 . . . . 0.0 112.551 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.01 -41.52 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.256 1.423 . . . . 0.0 110.238 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.24 -39.89 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.879 -1.138 . . . . 0.0 111.042 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.0 -30.47 68.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.112 1.365 . . . . 0.0 111.953 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.09 -42.89 62.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.986 0.914 . . . . 0.0 111.168 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.13 -25.12 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.494 1.517 . . . . 0.0 112.409 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -86.39 -23.3 26.18 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.39 -7.61 69.32 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.986 1.755 . . . . 0.0 114.779 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.79 -27.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 84.55 163.54 0.1 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.522 2.329 . . . . 0.0 114.057 -169.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 p -118.92 143.98 46.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.196 1.398 . . . . 0.0 113.668 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 125.034 1.302 . . . . 0.0 111.426 169.835 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 119.529 -0.272 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.54 137.57 70.17 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.709 1.606 . . . . 0.0 110.512 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -32.17 61.89 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -84.91 147.38 26.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.184 0.593 . . . . 0.0 110.544 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.18 116.73 23.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.196 0.998 . . . . 0.0 111.071 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 91.0 t -114.85 108.06 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.316 1.047 . . . . 0.0 108.483 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -129.52 141.34 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.439 1.114 . . . . 0.0 111.932 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.2 mt -83.61 103.44 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.38 -36.87 66.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.186 0.594 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.6 t -154.37 165.22 37.04 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -133.76 141.07 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.791 2.037 . . . . 0.0 110.431 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -135.76 131.75 35.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 110.187 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.62 124.07 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.309 -0.869 . . . . 0.0 108.82 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.7 t -117.36 150.3 39.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.077 1.351 . . . . 0.0 112.749 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.93 1.692 . . . . 0.0 113.629 -169.707 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 120.318 0.104 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.9 t -123.46 129.97 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.4 m -104.36 123.68 47.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.98 1.312 . . . . 0.0 110.205 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.36 132.31 42.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.568 1.147 . . . . 0.0 110.688 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -103.18 103.13 13.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -106.48 151.49 24.89 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.966 -0.459 . . . . 0.0 111.126 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -60.57 -7.63 2.3 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -108.28 -8.71 15.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.005 1.322 . . . . 0.0 114.094 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.96 163.5 11.17 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.505 1.526 . . . . 0.0 113.859 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.04 138.82 44.29 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.034 1.734 . . . . 0.0 112.957 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.82 141.51 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.512 1.925 . . . . 0.0 109.062 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -124.62 135.66 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 110.805 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 139.72 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.743 2.017 . . . . 0.0 110.389 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -105.07 125.77 51.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.638 1.975 . . . . 0.0 108.844 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -88.96 147.5 24.28 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.379 1.072 . . . . 0.0 111.553 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -104.94 74.52 1.13 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.792 1.282 . . . . 0.0 111.202 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.76 -26.3 64.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.618 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.81 -28.0 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 111.386 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -95.83 -29.13 14.39 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.388 1.475 . . . . 0.0 112.398 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.74 58.55 3.32 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 0.0 113.003 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -60.87 -43.19 32.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.493 2.795 . . . . 0.0 112.932 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -68.33 -40.38 81.63 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.741 0.7 . . . . 0.0 110.893 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 m -63.91 -51.33 64.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.641 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.57 -38.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -56.33 -49.58 73.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.601 1.091 . . . . 0.0 111.484 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -68.81 -36.74 78.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.412 0.551 . . . . 0.0 112.19 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.59 -49.63 77.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.763 1.225 . . . . 0.0 111.426 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.71 -34.71 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.368 -0.833 . . . . 0.0 112.449 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -45.2 77.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.573 0.349 . . . . 0.0 110.261 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.45 -40.68 81.0 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.593 -0.692 . . . . 0.0 111.456 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.77 -40.06 86.95 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.878 -0.514 . . . . 0.0 111.397 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -72.67 -30.07 63.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.376 1.47 . . . . 0.0 113.385 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -79.41 -16.54 56.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.631 0.65 . . . . 0.0 112.372 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.66 17.39 56.81 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.497 1.046 . . . . 0.0 113.298 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.04 -41.66 97.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.438 1.095 . . . . 0.0 113.121 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -81.49 -15.21 55.67 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.27 5.31 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.87 17.49 1.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.064 1.346 . . . . 0.0 112.986 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.7 p -81.67 163.17 22.7 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.126 -0.984 . . . . 0.0 112.345 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 156' ' ' ILE . 12.0 pt -119.26 165.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.08 89.45 6.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.412 1.485 . . . . 0.0 108.573 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -85.68 -3.06 58.78 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.92 134.6 45.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.822 1.646 . . . . 0.0 111.173 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.42 135.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.504 1.522 . . . . 0.0 110.807 169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.79 128.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.61 1.564 . . . . 0.0 108.429 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.26 132.2 49.57 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.611 0.764 . . . . 0.0 111.691 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.05 10.99 66.21 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 123.956 0.789 . . . . 0.0 115.029 -174.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.01 -177.23 5.34 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.121 1.769 . . . . 0.0 111.019 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -83.75 177.41 8.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.44 140.0 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.61 1.564 . . . . 0.0 111.857 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -123.41 148.5 46.06 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 0.0 111.287 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.16 -178.1 27.39 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.557 1.075 . . . . 0.0 114.51 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 -1.09 89.27 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.31 0.957 . . . . 0.0 115.342 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.94 -27.06 32.56 Favored Glycine 0 N--CA 1.473 1.102 0 CA-C-N 118.931 1.366 . . . . 0.0 115.391 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.22 161.86 37.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -88.62 164.46 31.96 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 126.048 1.739 . . . . 0.0 109.69 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.31 -11.49 30.42 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.337 2.692 . . . . 0.0 117.518 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 17.16 59.81 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.273 0.94 . . . . 0.0 114.61 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.7 mmm 59.46 37.83 22.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.152 1.781 . . . . 0.0 113.31 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.074 1.349 . . . . 0.0 109.468 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -74.19 131.92 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 124.143 1.925 . . . . 0.0 111.792 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -75.93 -179.29 4.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 110.322 -3.127 . . . . 0.0 114.519 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.65 56.49 3.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 112.869 -1.968 . . . . 0.0 112.066 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 p -69.41 106.25 2.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.084 1.354 . . . . 0.0 110.824 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -137.87 169.25 18.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 111.947 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 48.49 62.89 11.3 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.486 1.514 . . . . 0.0 113.183 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -58.11 134.79 64.34 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.539 2.826 . . . . 0.0 111.749 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.24 152.55 4.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.356 1.862 . . . . 0.0 107.837 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 158.67 17.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.192 0.597 . . . . 0.0 110.67 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -71.43 134.6 46.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.179 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.38 14.09 12.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.765 1.226 . . . . 0.0 112.627 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.49 59.93 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.434 -1.416 . . . . 0.0 113.93 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.93 0.21 0.24 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.629 1.972 . . . . 0.0 115.822 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -81.37 -3.45 52.79 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.036 1.334 . . . . 0.0 112.556 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.44 24.77 49.77 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.578 1.085 . . . . 0.0 114.942 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 159.1 28.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 117.707 0.753 . . . . 0.0 112.616 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -131.39 154.47 48.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -98.65 100.02 11.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.669 1.987 . . . . 0.0 110.118 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.1 p -130.68 165.24 23.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.306 1.042 . . . . 0.0 111.603 -175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -55.34 121.97 10.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.64 1.176 . . . . 0.0 110.771 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 49.82 6.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.72 1.153 . . . . 0.0 113.923 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -136.21 163.51 30.21 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.16 0.98 . . . . 0.0 112.523 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.79 140.81 51.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.725 0.81 . . . . 0.0 112.709 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.91 157.82 45.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.894 -0.504 . . . . 0.0 112.019 169.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -82.37 140.6 33.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.498 0.319 . . . . 0.0 111.303 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.64 144.68 25.08 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.575 0.75 . . . . 0.0 111.469 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -114.58 159.81 20.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.026 1.33 . . . . 0.0 112.978 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.3 m -77.67 -54.86 5.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.068 1.347 . . . . 0.0 112.051 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -153.65 -40.38 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.696 1.199 . . . . 0.0 113.078 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.04 157.18 35.41 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.868 1.267 . . . . 0.0 111.267 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.73 -26.13 64.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 114.429 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -105.77 33.9 3.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.58 1.552 . . . . 0.0 112.779 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.9 p -123.07 35.71 4.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.379 1.472 . . . . 0.0 113.161 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.66 107.93 20.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.086 1.754 . . . . 0.0 109.826 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 p -91.65 -67.82 0.83 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.393 1.077 . . . . 0.0 112.584 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.87 -17.15 1.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -78.34 143.53 36.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 122.116 0.96 . . . . 0.0 112.194 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.03 167.97 20.89 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.316 1.847 . . . . 0.0 110.816 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 5.6 p90 -145.34 161.44 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.577 0.751 . . . . 0.0 111.726 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.39 115.45 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 108.16 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -73.4 101.23 3.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.713 0.805 . . . . 0.0 110.193 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 -16.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.1 167.28 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 128.129 2.572 . . . . 0.0 111.057 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -78.31 121.84 24.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.124 0.57 . . . . 0.0 110.667 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -145.85 68.98 1.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 123.266 1.508 . . . . 0.0 111.306 -170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.59 -13.02 61.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -64.4 -12.83 46.98 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.614 -1.304 . . . . 0.0 113.224 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.98 -7.16 59.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.626 1.171 . . . . 0.0 113.972 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.18 179.6 5.61 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -79.82 142.1 35.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.361 1.465 . . . . 0.0 112.171 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -107.71 -59.45 1.83 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.459 1.104 . . . . 0.0 113.682 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.132 0 C-N-CA 123.859 0.742 . . . . 0.0 114.363 -172.439 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 5.5 p-90 . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.05 -108.17 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.617 1.58 . . . . 0.0 116.013 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.69 142.8 46.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.419 1.488 . . . . 0.0 111.554 -169.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.21 118.45 25.67 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -170.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.38 84.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.691 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -78.19 -13.75 59.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.004 0.922 . . . . 0.0 112.083 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.96 177.2 8.71 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.496 1.141 . . . . 0.0 113.672 -170.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.98 149.81 43.72 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.845 -1.159 . . . . 0.0 111.928 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.07 136.69 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.605 -0.684 . . . . 0.0 110.414 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.72 -42.29 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.356 1.862 . . . . 0.0 110.834 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -143.26 154.86 44.25 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.466 1.506 . . . . 0.0 109.862 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.36 13.9 37.24 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.911 0.767 . . . . 0.0 114.754 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.5 mmm -54.19 -35.95 62.89 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.43 1.615 . . . . 0.0 112.381 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.95 -33.43 75.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.693 0.797 . . . . 0.0 112.385 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.59 -42.64 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.925 1.29 . . . . 0.0 110.39 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.71 -40.29 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.23 1.012 . . . . 0.0 111.237 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.38 -26.01 60.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.892 1.277 . . . . 0.0 112.78 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.39 -41.51 27.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.914 1.286 . . . . 0.0 111.18 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.7 mt -54.87 -31.79 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.899 1.679 . . . . 0.0 112.771 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -90.59 -15.27 30.86 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.3 -16.24 18.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.707 1.623 . . . . 0.0 114.475 -172.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.18 -59.5 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.834 1.317 . . . . 0.0 112.29 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.96 153.53 2.61 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.471 1.508 . . . . 0.0 111.587 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.3 p -133.67 147.75 51.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.96 1.304 . . . . 0.0 112.366 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.054 0 C-N-CA 123.247 0.451 . . . . 0.0 113.201 169.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 119.528 -0.272 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.02 131.79 24.7 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 N-CA-C 108.027 -1.566 . . . . 0.0 108.027 169.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -31.15 63.44 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.67 -0.644 . . . . 0.0 111.797 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -83.26 150.3 26.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 109.103 168.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.25 117.75 23.17 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.102 -0.999 . . . . 0.0 110.651 -170.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.3 102.82 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.04 143.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 112.287 -169.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.0 mt -82.64 103.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.04 -27.34 57.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.557 1.143 . . . . 0.0 111.697 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -163.38 169.33 19.13 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.52 140.82 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.287 1.835 . . . . 0.0 110.477 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.3 m -133.84 135.0 43.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.271 1.428 . . . . 0.0 110.073 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.68 125.73 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.6 t -122.6 150.78 42.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.763 1.625 . . . . 0.0 111.927 -171.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.73 1.212 . . . . 0.0 113.246 -179.629 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -125.7 129.56 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.077 0.951 . . . . 0.0 109.41 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -104.71 123.28 47.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.589 1.156 . . . . 0.0 110.055 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.56 134.59 38.25 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 110.598 169.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -105.9 101.78 11.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -106.21 151.13 25.17 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.041 -0.412 . . . . 0.0 110.949 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -60.78 -7.8 2.57 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -108.14 -8.33 15.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.954 1.302 . . . . 0.0 114.101 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.24 160.9 9.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.046 1.307 . . . . 0.0 114.124 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.15 138.08 43.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.852 1.661 . . . . 0.0 112.702 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -134.21 141.01 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.111 1.764 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.7 t -123.16 136.65 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.736 1.214 . . . . 0.0 110.68 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mt -127.12 138.75 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.495 1.918 . . . . 0.0 110.323 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.84 122.21 45.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.492 1.917 . . . . 0.0 109.142 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 p -85.91 148.18 25.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.312 1.045 . . . . 0.0 111.83 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -104.22 73.82 1.15 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.702 1.239 . . . . 0.0 111.359 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.75 -26.85 64.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.502 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.15 -30.87 58.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.262 1.025 . . . . 0.0 111.53 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.29 -26.43 15.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.833 1.253 . . . . 0.0 112.991 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.03 59.0 3.46 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.99 0.916 . . . . 0.0 112.833 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.63 -43.77 25.22 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.251 2.634 . . . . 0.0 112.72 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -69.77 -41.15 75.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.513 0.597 . . . . 0.0 110.957 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' ILE . 24.8 m -62.73 -49.9 73.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.482 0.713 . . . . 0.0 111.265 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.63 -44.32 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.307 0.643 . . . . 0.0 111.477 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -55.72 -47.7 76.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.771 1.168 . . . . 0.0 112.014 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.442 HD22 HD11 ' A' ' 68' ' ' ILE . 44.3 t30 -68.0 -39.13 83.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.43 0.559 . . . . 0.0 111.667 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.7 -48.47 81.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.683 1.193 . . . . 0.0 111.542 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.96 -38.31 79.34 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 111.653 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.86 -33.73 70.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.956 0.902 . . . . 0.0 112.529 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.392 -0.817 . . . . 0.0 112.287 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.03 -35.2 76.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.791 -0.568 . . . . 0.0 111.596 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -64.99 -34.19 77.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.909 2.084 . . . . 0.0 113.006 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -81.78 -15.74 53.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.831 0.852 . . . . 0.0 113.086 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.89 15.18 56.83 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.121 1.344 . . . . 0.0 113.979 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -65.48 -31.58 72.73 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.198 0.999 . . . . 0.0 113.678 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -87.64 -15.47 37.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.19 0.7 5.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.435 1.494 . . . . 0.0 114.574 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -144.85 50.35 1.26 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.129 1.772 . . . . 0.0 110.252 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.5 p -119.81 169.83 9.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.466 1.106 . . . . 0.0 111.945 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 156' ' ' ILE . 19.0 pt -129.72 167.14 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -169.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -95.3 93.92 7.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.378 1.471 . . . . 0.0 107.764 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -86.46 -0.86 56.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -140.39 141.17 35.61 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.089 1.768 . . . . 0.0 112.67 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.87 132.73 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.187 1.795 . . . . 0.0 111.152 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.98 128.72 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.022 1.729 . . . . 0.0 108.292 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -68.97 139.42 55.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.782 -0.574 . . . . 0.0 111.249 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.59 9.12 68.71 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -144.79 -177.12 5.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.788 2.035 . . . . 0.0 110.55 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.87 178.1 6.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.016 1.726 . . . . 0.0 114.501 -171.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -114.21 136.94 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.016 1.326 . . . . 0.0 111.765 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -103.62 147.26 27.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.137 0.975 . . . . 0.0 110.761 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.05 31.38 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 122.637 1.132 . . . . 0.0 114.849 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.92 72.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.668 -1.073 . . . . 0.0 114.434 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.49 -22.87 41.96 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-N 119.624 1.712 . . . . 0.0 114.729 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.35 166.07 26.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.799 1.24 . . . . 0.0 112.912 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.83 162.19 27.85 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.956 1.702 . . . . 0.0 110.402 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -60.77 -13.2 25.21 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.696 2.93 . . . . 0.0 118.505 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.26 17.23 59.7 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.122 0.867 . . . . 0.0 114.592 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mmm 58.46 36.46 25.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.072 1.749 . . . . 0.0 113.114 -173.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -92.07 131.32 37.43 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.296 1.438 . . . . 0.0 109.386 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -71.04 124.43 24.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.495 1.118 . . . . 0.0 110.107 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.38 159.14 32.1 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.3 75.27 8.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.245 1.418 . . . . 0.0 111.484 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.2 p -69.0 127.53 33.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.546 1.139 . . . . 0.0 112.409 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.5 177.32 7.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.62 1.968 . . . . 0.0 111.484 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 50.42 68.33 3.52 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.593 1.557 . . . . 0.0 113.617 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.81 147.46 88.48 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.252 2.635 . . . . 0.0 111.597 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.0 OUTLIER -124.68 149.6 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.813 1.645 . . . . 0.0 109.155 -174.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 155.49 29.0 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.581 0.705 . . . . 0.0 110.419 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -78.71 134.45 37.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.397 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.69 14.39 12.61 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.941 0.896 . . . . 0.0 112.11 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.53 -17.03 64.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.569 -1.332 . . . . 0.0 113.764 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -63.5 -0.97 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.388 1.875 . . . . 0.0 115.482 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -79.77 -5.63 55.7 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.701 1.2 . . . . 0.0 113.017 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.65 21.06 49.03 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.531 1.063 . . . . 0.0 114.942 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.05 155.47 39.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.911 0.855 . . . . 0.0 111.75 170.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -133.63 155.38 49.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -90.31 107.11 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.428 2.291 . . . . 0.0 109.439 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -137.67 169.43 17.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.918 1.287 . . . . 0.0 110.869 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -49.63 124.82 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.798 1.239 . . . . 0.0 111.458 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.78 41.14 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.274 1.416 . . . . 0.0 115.048 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.9 p -121.95 160.86 23.96 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.536 1.668 . . . . 0.0 113.584 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.91 137.91 54.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.659 0.784 . . . . 0.0 112.965 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.47 160.49 38.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.817 0.447 . . . . 0.0 112.143 170.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 96.7 mmm -79.1 139.74 38.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.158 0.583 . . . . 0.0 111.341 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.45 112.22 23.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.502 0.721 . . . . 0.0 110.292 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -75.48 157.26 34.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 0.0 112.709 -174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.0 m -70.81 -51.09 28.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.873 0.869 . . . . 0.0 110.934 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -160.12 -58.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.322 1.449 . . . . 0.0 110.373 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.24 79.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.61 1.164 . . . . 0.0 111.889 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.77 -31.48 88.39 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.825 2.35 . . . . 0.0 113.459 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -101.62 46.46 0.93 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.346 1.858 . . . . 0.0 112.294 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.6 p -133.99 32.2 3.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.96 54.66 1.33 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.989 1.716 . . . . 0.0 113.643 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -54.42 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -154.74 36.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -135.27 151.54 50.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.311 1.444 . . . . 0.0 110.097 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.58 172.21 13.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.061 1.344 . . . . 0.0 111.667 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.2 p90 -147.2 161.56 40.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.402 -0.811 . . . . 0.0 111.524 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 mt -115.5 115.84 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -76.69 102.68 6.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.903 0.881 . . . . 0.0 110.156 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.81 -21.93 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.268 -0.895 . . . . 0.0 112.968 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.01 168.55 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.813 1.645 . . . . 0.0 111.959 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.22 123.44 29.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.323 0.649 . . . . 0.0 110.291 169.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -144.79 76.82 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.828 1.299 . . . . 0.0 112.707 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.07 -34.88 66.37 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.209 1.804 . . . . 0.0 114.583 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -59.88 -12.58 7.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.84 -9.57 59.26 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.48 -177.08 5.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -169.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -77.05 141.21 40.39 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.289 1.836 . . . . 0.0 112.473 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.2 p -107.79 -57.16 2.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.24 1.016 . . . . 0.0 113.59 173.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 C-N-CA 124.428 1.013 . . . . 0.0 113.427 -171.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.353 2.8 p-90 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.93 -95.35 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.387 1.47 . . . . 0.0 115.948 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -129.19 138.22 51.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.513 1.125 . . . . 0.0 112.11 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.92 121.82 26.97 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.76 87.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.013 1.325 . . . . 0.0 108.178 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -77.81 -15.61 58.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.431 0.692 . . . . 0.0 111.88 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.4 178.69 7.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.572 1.177 . . . . 0.0 113.942 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -138.93 154.38 48.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.659 1.183 . . . . 0.0 112.325 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 140.44 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.624 0.726 . . . . 0.0 110.271 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.79 -42.52 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.715 1.606 . . . . 0.0 111.213 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.49 152.86 41.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.591 1.556 . . . . 0.0 109.791 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.89 13.97 22.26 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.85 0.738 . . . . 0.0 114.67 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -34.94 68.81 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.125 1.462 . . . . 0.0 112.301 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.94 -30.7 71.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.8 0.84 . . . . 0.0 112.486 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.27 -41.38 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.416 1.087 . . . . 0.0 110.131 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.89 -40.23 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.489 -0.757 . . . . 0.0 111.091 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.58 -28.56 63.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.776 1.23 . . . . 0.0 112.349 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -74.65 -44.16 51.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.473 1.109 . . . . 0.0 110.699 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.61 -29.25 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.641 1.576 . . . . 0.0 112.633 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -94.48 -11.42 29.69 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.54 -14.65 13.77 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.631 1.586 . . . . 0.0 114.5 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.6 m -62.11 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.86 1.33 . . . . 0.0 112.428 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -175.07 156.59 2.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.658 1.583 . . . . 0.0 111.645 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 p -123.72 150.04 44.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.293 1.437 . . . . 0.0 112.281 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 CA-C-O 122.835 1.242 . . . . 0.0 113.252 172.282 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.23 142.61 46.3 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.96 1.773 . . . . 0.0 109.412 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -30.83 61.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.601 -0.687 . . . . 0.0 112.63 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.97 145.24 32.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.905 0.882 . . . . 0.0 110.078 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.64 120.59 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.383 1.073 . . . . 0.0 110.436 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.64 99.93 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.175 0.99 . . . . 0.0 108.358 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -122.32 143.0 36.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.79 1.236 . . . . 0.0 112.216 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.3 mt -83.13 103.86 10.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.89 -28.89 60.82 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.381 1.073 . . . . 0.0 111.18 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.7 t -164.02 169.54 17.8 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.0 139.85 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.716 2.007 . . . . 0.0 110.055 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -133.06 133.11 42.58 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.291 1.437 . . . . 0.0 110.134 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.73 125.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.274 -0.891 . . . . 0.0 108.864 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 t -121.55 140.44 52.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.07 1.348 . . . . 0.0 112.024 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 112.217 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.46 131.25 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.544 -1.347 . . . . 0.0 110.624 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.2 m -102.67 126.38 49.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.631 1.172 . . . . 0.0 110.184 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.1 123.34 44.23 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.875 1.27 . . . . 0.0 109.753 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -98.79 109.64 22.37 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 p -121.88 158.82 28.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 112.147 -169.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -7.2 34.94 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.62 -26.39 10.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.579 1.552 . . . . 0.0 113.392 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.68 145.52 4.24 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.311 1.91 . . . . 0.0 113.282 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.0 132.8 32.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.302 1.041 . . . . 0.0 112.277 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.43 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.828 1.651 . . . . 0.0 109.199 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.21 138.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.099 0.96 . . . . 0.0 110.506 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -131.79 135.67 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.671 1.989 . . . . 0.0 110.13 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -104.18 125.73 50.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.116 1.766 . . . . 0.0 108.946 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -88.28 146.97 25.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.108 0.963 . . . . 0.0 112.036 -175.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -104.67 74.36 1.14 Allowed 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 122.887 1.327 . . . . 0.0 110.973 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.66 -25.48 63.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.35 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.25 -31.78 60.91 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.5 1.12 . . . . 0.0 111.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -94.02 -27.28 16.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.625 1.17 . . . . 0.0 113.027 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.62 59.43 3.87 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.546 0.738 . . . . 0.0 112.919 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -61.72 -43.98 23.7 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.328 2.686 . . . . 0.0 112.723 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -67.51 -40.54 85.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.283 0.492 . . . . 0.0 110.708 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -49.16 74.74 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.597 0.759 . . . . 0.0 111.948 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.4 -40.8 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.33 -48.31 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.789 1.177 . . . . 0.0 111.718 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.51 -36.03 78.31 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.56 0.744 . . . . 0.0 112.128 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -60.4 -51.4 69.66 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.38 -34.8 73.0 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.639 -0.663 . . . . 0.0 111.558 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -55.8 -36.44 67.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.978 0.911 . . . . 0.0 112.351 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -76.35 -42.53 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.602 -0.686 . . . . 0.0 112.586 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.6 m -60.78 -35.31 76.12 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.589 -0.694 . . . . 0.0 111.779 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -32.32 73.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 112.694 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -81.7 -13.28 58.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.96 18.25 65.66 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.616 1.103 . . . . 0.0 114.14 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.58 -17.37 64.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.41 -7.22 48.26 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.459 -0.776 . . . . 0.0 112.998 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -69.17 135.41 50.61 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 51.93 45.21 28.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.992 1.717 . . . . 0.0 114.253 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -104.05 160.05 15.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.504 0.722 . . . . 0.0 110.907 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 156' ' ' ILE . 15.9 pt -123.42 162.31 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -91.42 115.76 28.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -116.7 -3.63 11.73 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -139.18 132.68 30.3 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.424 1.011 . . . . 0.0 111.291 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.18 146.48 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.91 2.084 . . . . 0.0 108.913 169.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -142.56 135.16 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.446 1.898 . . . . 0.0 107.415 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -64.21 134.8 55.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.324 0.65 . . . . 0.0 111.86 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.17 13.5 67.28 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.848 0.737 . . . . 0.0 114.848 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.15 -177.28 5.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.311 1.844 . . . . 0.0 111.033 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -88.24 -178.71 5.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.584 1.954 . . . . 0.0 115.16 -169.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 pt -120.01 142.47 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.022 1.329 . . . . 0.0 113.113 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -113.93 148.4 36.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.058 1.343 . . . . 0.0 112.083 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.41 178.79 32.71 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 -14.91 37.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 115.815 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.6 -10.67 76.15 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 116.738 1.455 . . . . 0.0 116.738 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -144.09 168.88 18.96 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.161 1.481 . . . . 0.0 113.359 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.83 162.85 18.7 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 126.895 2.078 . . . . 0.0 110.737 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -58.9 -15.22 25.98 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.019 3.146 . . . . 0.0 118.807 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 18.42 57.48 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.051 0.834 . . . . 0.0 114.715 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.0 mmt 59.4 27.3 16.37 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.588 1.555 . . . . 0.0 112.696 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.07 123.09 29.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.867 1.267 . . . . 0.0 109.169 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -73.17 121.2 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.005 0.922 . . . . 0.0 110.331 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -69.19 164.83 21.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.11 67.08 7.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.83 1.652 . . . . 0.0 111.704 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -66.17 125.93 27.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.781 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -133.09 173.66 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.827 2.051 . . . . 0.0 111.96 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 46.24 66.32 5.62 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.478 1.511 . . . . 0.0 113.711 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.55 137.52 74.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.337 2.691 . . . . 0.0 111.172 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.5 150.78 7.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.689 1.596 . . . . 0.0 108.655 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 151.92 29.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.259 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -87.37 101.59 13.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.697 1.599 . . . . 0.0 110.438 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.43 18.69 3.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.801 1.24 . . . . 0.0 113.836 -169.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.74 -21.5 63.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.432 1.493 . . . . 0.0 114.18 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.52 -2.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.846 2.058 . . . . 0.0 115.536 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -77.11 0.9 19.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.187 0.995 . . . . 0.0 112.282 169.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 35.74 27.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.905 1.24 . . . . 0.0 112.888 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.0 144.59 43.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.421 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.84 154.46 49.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.71 114.78 26.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.065 2.146 . . . . 0.0 110.572 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.5 p -138.8 171.98 13.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.933 1.293 . . . . 0.0 111.009 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -51.78 125.89 16.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.805 1.242 . . . . 0.0 110.959 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.4 36.43 39.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.848 1.213 . . . . 0.0 114.803 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.7 p -120.72 158.81 26.67 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.892 1.346 . . . . 0.0 112.89 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.44 136.3 54.54 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.61 158.23 44.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.291 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.7 mmt -81.38 132.49 35.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.69 0.396 . . . . 0.0 110.902 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.11 161.13 24.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.5 0.72 . . . . 0.0 110.573 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -133.02 158.42 42.76 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 m -74.01 -57.08 4.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.895 1.278 . . . . 0.0 112.777 -169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -158.61 -47.67 0.06 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.079 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.65 157.9 71.62 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.543 1.137 . . . . 0.0 111.359 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.84 -21.3 71.94 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.182 2.588 . . . . 0.0 114.584 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.74 42.2 2.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.604 1.962 . . . . 0.0 112.337 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.6 p -117.45 33.59 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.837 1.255 . . . . 0.0 113.861 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.63 14.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.277 1.431 . . . . 0.0 108.943 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -91.91 -60.09 1.95 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.49 33.33 0.32 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.79 140.08 53.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.216 1.406 . . . . 0.0 110.657 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -142.04 168.2 20.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.088 1.355 . . . . 0.0 111.354 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 18.6 p90 -144.12 160.3 41.15 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.538 0.735 . . . . 0.0 111.849 172.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.9 mt -114.26 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.211 1.004 . . . . 0.0 108.419 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.32 100.32 2.61 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.8 0.84 . . . . 0.0 110.217 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.23 -25.99 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 121.199 -0.938 . . . . 0.0 113.188 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 m -114.97 166.56 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.998 1.719 . . . . 0.0 111.633 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.69 122.84 27.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.02 0.528 . . . . 0.0 110.11 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -141.95 71.77 1.36 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.927 1.346 . . . . 0.0 112.596 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -52.29 -35.71 51.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.235 2.214 . . . . 0.0 114.445 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -59.88 -12.77 8.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.73 -14.18 55.01 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -73.16 161.91 30.04 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.284 1.434 . . . . 0.0 114.462 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -69.71 144.41 52.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.216 0.606 . . . . 0.0 112.312 173.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.8 p -126.22 -59.29 1.32 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.797 1.239 . . . . 0.0 113.089 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 C-N-CA 123.987 0.803 . . . . 0.0 113.974 -176.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.42 -82.3 1.36 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.564 1.078 . . . . 0.0 115.139 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -137.36 154.63 49.98 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.199 1.4 . . . . 0.0 112.176 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -84.67 117.17 23.61 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.928 -0.482 . . . . 0.0 111.801 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.1 81.0 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.842 1.257 . . . . 0.0 108.755 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.74 -13.99 60.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 0.0 112.258 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.86 178.09 8.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.74 1.257 . . . . 0.0 113.648 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -137.25 154.09 50.21 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.918 -1.113 . . . . 0.0 112.339 171.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.12 143.94 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.772 0.796 . . . . 0.0 109.697 171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.79 -39.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.734 1.614 . . . . 0.0 110.861 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -146.46 148.89 32.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.52 1.528 . . . . 0.0 110.549 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 116.98 7.45 12.79 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 77.1 mmm -56.62 -36.21 69.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.584 1.692 . . . . 0.0 113.099 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -62.87 -30.3 71.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.631 0.773 . . . . 0.0 112.202 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.98 -40.93 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.044 1.738 . . . . 0.0 110.673 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.64 -39.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.034 0.934 . . . . 0.0 110.946 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.89 -25.57 61.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.993 1.317 . . . . 0.0 112.717 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -76.55 -42.86 41.45 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.12 1.368 . . . . 0.0 110.975 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.24 -34.45 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.877 1.271 . . . . 0.0 112.111 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -91.49 -14.68 30.03 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.57 -20.64 14.42 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.106 1.336 . . . . 0.0 114.332 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.92 -63.88 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 118.598 1.199 . . . . 0.0 112.172 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.42 155.79 5.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -137.19 152.17 49.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.993 1.317 . . . . 0.0 112.135 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.857 0 C-N-CA 125.199 1.381 . . . . 0.0 111.404 170.382 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 118.805 -0.617 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -57.74 128.79 30.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 120.759 1.307 . . . . 0.0 110.248 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.74 45.28 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.55 159.45 26.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.615 0.766 . . . . 0.0 110.467 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.49 109.67 16.17 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.612 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.17 94.0 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -122.74 144.32 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -168.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.4 104.4 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 106.25 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.45 -41.02 61.53 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.811 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -151.21 166.26 31.4 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.48 141.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.052 1.741 . . . . 0.0 110.764 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.5 m -133.88 129.66 36.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.006 1.322 . . . . 0.0 110.243 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.04 120.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -109.64 137.98 46.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.706 1.202 . . . . 0.0 111.752 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.571 1.948 . . . . 0.0 112.151 -178.454 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.92 130.52 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 121.13 -0.981 . . . . 0.0 109.597 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 m -103.67 120.95 41.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.039 0.936 . . . . 0.0 110.087 172.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -92.4 119.51 32.01 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -93.88 119.07 32.31 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -121.82 160.54 24.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.976 0.893 . . . . 0.0 113.125 -169.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -73.06 -4.64 33.81 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -120.5 -20.07 7.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.441 1.497 . . . . 0.0 114.412 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.67 117.32 1.08 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.001 1.762 . . . . 0.0 110.771 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.88 145.7 55.35 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.531 0.732 . . . . 0.0 111.763 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.7 141.88 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.772 1.629 . . . . 0.0 109.664 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.08 134.09 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.465 1.106 . . . . 0.0 110.072 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.79 137.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.345 1.858 . . . . 0.0 110.102 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -105.57 123.36 47.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.446 1.898 . . . . 0.0 109.259 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.9 p -87.1 148.61 25.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.158 0.983 . . . . 0.0 112.005 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.13 72.9 0.9 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.888 1.328 . . . . 0.0 111.856 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.64 -25.58 64.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.536 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -77.25 -28.99 53.79 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.379 1.071 . . . . 0.0 111.566 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -99.29 -21.11 16.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.081 1.352 . . . . 0.0 113.406 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.52 56.22 1.31 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.274 1.029 . . . . 0.0 113.244 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.01 -45.07 25.72 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.478 2.785 . . . . 0.0 113.088 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.94 -41.29 74.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.646 0.657 . . . . 0.0 111.245 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.9 m -63.9 -48.27 77.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.551 0.74 . . . . 0.0 111.281 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.67 -43.41 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.717 0.807 . . . . 0.0 111.463 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -57.17 -45.32 83.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.816 1.189 . . . . 0.0 112.019 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -69.36 -36.8 77.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.512 0.596 . . . . 0.0 111.821 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.09 -48.91 79.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.342 1.057 . . . . 0.0 111.728 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.18 -36.84 80.24 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.269 -0.894 . . . . 0.0 111.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -58.45 -34.8 71.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 112.499 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -73.63 -43.34 59.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 112.161 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.8 m -58.38 -38.44 77.31 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.735 -0.603 . . . . 0.0 111.762 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -65.39 -35.77 81.94 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.327 2.251 . . . . 0.0 112.691 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -81.17 -16.03 54.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 0.0 113.046 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.69 19.36 63.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.962 0.792 . . . . 0.0 113.052 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.26 -37.61 75.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 113.036 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -78.37 -9.84 59.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.714 0.406 . . . . 0.0 111.892 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.27 131.04 48.05 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.297 -0.877 . . . . 0.0 108.844 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.5 t30 62.38 20.86 12.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.054 2.142 . . . . 0.0 116.7 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -82.05 144.54 30.75 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.741 -1.224 . . . . 0.0 113.414 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -101.14 155.92 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -86.41 72.97 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.87 2.068 . . . . 0.0 108.402 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -69.45 -9.61 54.41 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.62 125.26 45.29 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.572 1.149 . . . . 0.0 110.508 -172.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.95 131.01 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.767 1.227 . . . . 0.0 112.042 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.42 131.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.697 1.999 . . . . 0.0 108.182 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.06 138.14 54.13 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.624 0.77 . . . . 0.0 112.008 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.02 67.74 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.702 0.668 . . . . 0.0 114.641 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.12 -177.22 5.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.607 1.963 . . . . 0.0 110.316 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.29 177.86 6.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.218 1.807 . . . . 0.0 114.196 -171.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 pt -116.39 140.82 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.896 1.278 . . . . 0.0 111.937 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -118.4 149.04 41.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.954 1.301 . . . . 0.0 111.372 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.6 -176.61 29.85 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.052 0.834 . . . . 0.0 114.978 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 -11.41 70.47 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.054 1.312 . . . . 0.0 115.632 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.32 60.06 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 118.879 1.34 . . . . 0.0 115.839 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.0 157.05 44.25 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -83.66 164.74 43.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 126.306 1.842 . . . . 0.0 109.32 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.04 -14.61 44.49 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.509 2.806 . . . . 0.0 117.087 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.71 18.83 56.81 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.438 1.018 . . . . 0.0 114.44 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.5 34.11 15.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.2 1.8 . . . . 0.0 112.94 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.32 131.22 37.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.389 1.476 . . . . 0.0 109.448 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.41 130.81 42.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 124.172 1.939 . . . . 0.0 111.603 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.85 -176.9 1.45 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 110.212 -3.176 . . . . 0.0 113.761 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.91 54.47 2.74 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.897 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 p -73.56 104.11 4.4 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.865 1.266 . . . . 0.0 111.571 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -133.47 178.44 6.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.872 2.069 . . . . 0.0 112.067 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.93 68.11 3.86 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.417 1.487 . . . . 0.0 113.798 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -61.95 138.31 72.73 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.168 2.579 . . . . 0.0 111.338 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.39 152.83 5.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 126.268 1.827 . . . . 0.0 108.024 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 155.05 27.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.153 0.502 . . . . 0.0 111.032 169.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.9 128.98 34.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.609 0.764 . . . . 0.0 111.124 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -111.12 15.13 21.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.942 1.297 . . . . 0.0 112.867 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -11.68 28.1 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -75.19 39.24 0.14 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -113.37 -6.49 13.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.21 . . . . 0.0 114.191 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.18 3.66 65.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.444 1.497 . . . . 0.0 115.2 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.19 158.24 19.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.606 1.203 . . . . 0.0 112.878 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.49 156.8 48.09 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.7 1.2 . . . . 0.0 113.521 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -90.25 93.21 9.25 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.496 1.918 . . . . 0.0 109.755 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.7 p -122.86 166.02 15.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.261 1.025 . . . . 0.0 111.319 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -55.37 114.38 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.265 1.826 . . . . 0.0 110.26 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 43.04 5.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.904 1.24 . . . . 0.0 114.633 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.7 p -134.91 165.46 25.26 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.842 1.321 . . . . 0.0 113.512 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mp -124.35 142.84 50.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 112.775 174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.6 156.72 47.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.724 -0.61 . . . . 0.0 111.853 169.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -83.94 136.93 33.89 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.175 -0.328 . . . . 0.0 111.258 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.66 155.25 20.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.717 0.807 . . . . 0.0 111.608 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -118.91 159.22 24.19 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.677 1.191 . . . . 0.0 112.674 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.3 m -72.25 -52.23 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.011 0.924 . . . . 0.0 110.805 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -159.56 -58.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.458 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.24 157.4 85.0 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 111.75 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -55.81 -34.69 92.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.841 2.36 . . . . 0.0 113.118 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -99.59 35.3 2.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.25 1.42 . . . . 0.0 112.917 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -123.35 27.53 7.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.506 1.522 . . . . 0.0 113.491 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 103.92 16.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.623 1.569 . . . . 0.0 109.638 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.5 p -88.41 -74.78 0.45 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.851 1.26 . . . . 0.0 112.519 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.71 -20.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.042 1.337 . . . . 0.0 113.643 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -71.04 145.32 50.0 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 121.029 -1.044 . . . . 0.0 112.441 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -141.81 168.06 20.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.32 1.848 . . . . 0.0 110.402 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.7 p90 -146.05 160.14 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.576 0.75 . . . . 0.0 111.753 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.5 mt -113.27 113.9 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.226 1.01 . . . . 0.0 108.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.78 93.88 2.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.989 . . . . 0.0 110.418 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.15 -23.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 163.67 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.483 1.513 . . . . 0.0 111.223 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -77.78 117.56 19.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.174 0.59 . . . . 0.0 109.8 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -143.64 64.95 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 123.113 1.435 . . . . 0.0 112.268 -169.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -66.31 -13.24 60.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.83 -13.82 38.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.654 -1.279 . . . . 0.0 113.453 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.02 -9.81 59.72 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.45 1.1 . . . . 0.0 113.949 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.12 -177.81 3.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -81.39 145.01 31.03 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.731 1.612 . . . . 0.0 111.785 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.4 p -111.75 -59.08 2.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.478 1.111 . . . . 0.0 113.468 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.051 0 C-N-CA 124.068 0.842 . . . . 0.0 113.865 -173.296 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.327 7.0 p-90 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.33 -91.31 1.36 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.427 1.489 . . . . 0.0 115.458 -169.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -134.57 144.79 48.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.579 1.151 . . . . 0.0 112.041 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.5 t -83.67 124.06 30.45 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.978 -0.451 . . . . 0.0 112.066 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.29 88.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -78.09 -15.44 58.88 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.626 0.77 . . . . 0.0 112.14 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.23 177.87 8.68 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.599 1.19 . . . . 0.0 113.341 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -136.13 151.45 49.79 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.98 -1.075 . . . . 0.0 112.247 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.36 135.64 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.76 -40.95 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.9 1.68 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -144.28 144.71 31.62 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.19 1.396 . . . . 0.0 110.677 174.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.06 -0.09 10.69 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 124.737 1.161 . . . . 0.0 115.629 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -55.92 -37.59 69.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.435 1.618 . . . . 0.0 113.17 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.99 -34.14 75.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.703 0.801 . . . . 0.0 111.936 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.03 -39.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.16 1.784 . . . . 0.0 110.905 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.34 -39.32 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 121.204 -0.935 . . . . 0.0 111.121 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 8.8 t70 -74.3 -22.86 59.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.066 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.8 -43.2 47.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.939 1.295 . . . . 0.0 111.082 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.8 mt -54.69 -35.12 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.221 1.408 . . . . 0.0 112.195 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.2 pttp -90.31 -18.93 24.7 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -96.49 -22.06 20.13 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.977 1.275 . . . . 0.0 114.225 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.8 t -81.41 -63.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 118.378 1.089 . . . . 0.0 112.055 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -162.63 152.72 16.31 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 51.8 p -140.36 152.83 46.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.944 1.697 . . . . 0.0 111.619 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 114.386 0.515 . . . . 0.0 114.386 169.757 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.24 140.24 52.8 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -28.06 60.52 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.99 153.96 27.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.429 1.091 . . . . 0.0 110.257 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.2 109.68 11.26 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.007 -1.058 . . . . 0.0 110.788 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.24 94.28 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.828 1.251 . . . . 0.0 107.709 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.68 152.05 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.405 1.574 . . . . 0.0 113.756 -169.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.81 104.16 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.79 -39.77 66.43 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.116 -0.99 . . . . 0.0 111.01 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -152.3 170.88 18.97 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.16 143.15 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.505 1.522 . . . . 0.0 111.458 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.8 m -135.23 130.61 35.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 110.534 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.9 121.31 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -113.65 150.2 33.52 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.308 1.443 . . . . 0.0 112.525 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.317 1.447 . . . . 0.0 114.091 -169.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.72 129.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.889 0.876 . . . . 0.0 108.992 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.3 m -103.68 123.65 47.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.674 1.19 . . . . 0.0 109.891 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -97.35 132.01 43.48 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.562 1.145 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -104.99 98.71 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p -103.67 152.06 22.24 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.052 -0.405 . . . . 0.0 111.192 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -60.54 -10.35 4.95 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -103.62 -8.08 20.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.834 1.253 . . . . 0.0 113.748 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.8 165.98 12.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.921 1.724 . . . . 0.0 113.485 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.94 138.49 42.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.813 1.645 . . . . 0.0 112.949 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.93 139.26 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.271 1.828 . . . . 0.0 108.886 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -120.22 135.53 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.452 1.101 . . . . 0.0 110.002 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 138.51 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.499 1.919 . . . . 0.0 110.106 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -103.77 126.32 50.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.566 1.946 . . . . 0.0 108.912 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 p -90.29 147.96 23.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.34 1.056 . . . . 0.0 111.527 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.11 72.89 1.02 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.794 1.283 . . . . 0.0 111.35 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.56 -25.5 64.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.603 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -77.24 -24.84 51.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.464 1.105 . . . . 0.0 111.547 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -99.9 -28.1 13.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 112.381 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.68 57.9 3.0 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.803 0.841 . . . . 0.0 112.718 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -60.93 -43.42 30.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.593 2.862 . . . . 0.0 112.711 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -68.88 -40.83 79.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.819 0.736 . . . . 0.0 110.715 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' HD13 ' A' ' 68' ' ' ILE . 66.9 m -62.37 -50.37 71.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.691 0.796 . . . . 0.0 111.813 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.3 t -67.21 -38.89 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.131 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.49 -46.63 86.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.673 1.124 . . . . 0.0 111.422 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.88 -42.73 97.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.189 0.996 . . . . 0.0 111.977 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -59.27 -50.46 73.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.283 1.033 . . . . 0.0 111.619 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.22 -36.24 71.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.788 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.64 -38.07 71.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.728 0.811 . . . . 0.0 111.864 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.93 -40.77 60.64 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.727 -0.608 . . . . 0.0 112.339 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.3 m -61.34 -36.05 79.1 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.277 -0.89 . . . . 0.0 111.607 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -31.76 72.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.16 1.784 . . . . 0.0 112.93 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -81.61 -13.54 57.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.282 1.033 . . . . 0.0 113.476 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.77 18.3 61.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.51 1.052 . . . . 0.0 114.006 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.63 -17.53 62.87 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.34 -7.29 35.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.66 136.49 54.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.292 0.951 . . . . 0.0 109.154 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.5 t30 53.82 41.68 31.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.813 1.645 . . . . 0.0 114.586 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.9 p -102.11 167.31 10.1 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.908 0.883 . . . . 0.0 110.643 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 156' ' ' ILE . 24.4 pt -125.56 160.71 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -83.95 80.54 9.13 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -66.41 -14.21 61.82 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -169.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -150.96 143.74 24.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.275 1.852 . . . . 0.0 113.877 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.44 147.44 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 128.064 2.546 . . . . 0.0 108.201 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.5 mt -130.76 130.71 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.862 1.665 . . . . 0.0 107.493 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -61.63 134.95 57.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.852 0.461 . . . . 0.0 111.087 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 8.6 65.02 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.44 -176.89 5.22 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.481 1.913 . . . . 0.0 111.341 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -179.39 7.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -169.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.2 pt -115.4 135.35 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.703 1.601 . . . . 0.0 112.364 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -112.64 149.0 33.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.491 1.516 . . . . 0.0 111.351 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.55 175.76 36.39 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.11 66.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.145 1.831 . . . . 0.0 115.443 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.79 -15.02 62.1 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 118.745 1.272 . . . . 0.0 115.819 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.68 164.83 31.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.659 1.229 . . . . 0.0 113.331 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.91 164.46 28.42 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.858 1.663 . . . . 0.0 110.703 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' HG21 ' A' ' 40' ' ' ILE . 50.8 Cg_exo -61.78 -14.91 39.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.451 2.767 . . . . 0.0 117.927 -170.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.22 17.89 58.38 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.169 0.89 . . . . 0.0 114.563 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 32.7 18.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.845 1.658 . . . . 0.0 112.569 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -88.87 130.96 35.31 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.751 1.62 . . . . 0.0 109.537 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.96 124.98 27.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.322 1.049 . . . . 0.0 111.511 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -76.3 167.7 21.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.698 1.199 . . . . 0.0 113.485 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.68 77.84 3.33 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.345 1.458 . . . . 0.0 111.361 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.7 p -72.41 95.01 1.7 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.852 1.261 . . . . 0.0 111.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -110.95 171.46 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.169 1.788 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 51.45 64.48 7.88 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.548 1.539 . . . . 0.0 114.088 169.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -60.15 139.17 85.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.237 2.625 . . . . 0.0 111.808 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -102.83 150.41 6.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.348 1.459 . . . . 0.0 108.519 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.0 161.67 22.92 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.766 0.827 . . . . 0.0 111.369 169.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -73.22 121.37 20.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.403 0.681 . . . . 0.0 111.664 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -105.02 15.88 26.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.837 1.255 . . . . 0.0 113.215 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -14.09 49.75 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.307 -1.496 . . . . 0.0 114.568 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.45 2.64 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.913 2.085 . . . . 0.0 116.139 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.31 -3.39 58.22 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.421 1.489 . . . . 0.0 112.866 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 26.85 49.47 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.229 0.919 . . . . 0.0 114.976 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.75 160.54 27.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.571 0.748 . . . . 0.0 112.861 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -127.48 155.24 44.04 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -103.73 73.5 1.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.942 2.097 . . . . 0.0 111.6 -170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.9 p -103.31 167.65 9.68 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.473 0.709 . . . . 0.0 111.46 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -57.45 127.14 30.5 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.923 0.868 . . . . 0.0 111.282 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.39 26.72 42.22 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.086 1.327 . . . . 0.0 114.828 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.3 p -115.43 159.62 20.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.456 1.628 . . . . 0.0 112.777 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.53 136.32 53.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.64 161.03 37.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.273 0.559 . . . . 0.0 111.706 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -81.06 139.29 35.79 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.962 -0.461 . . . . 0.0 111.457 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 168.89 11.36 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.884 1.274 . . . . 0.0 110.905 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -105.08 160.24 15.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.164 1.385 . . . . 0.0 112.452 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.1 m -83.64 -52.16 6.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 0.0 110.719 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -161.25 -50.21 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.277 1.431 . . . . 0.0 112.217 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -85.46 160.47 53.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.943 1.297 . . . . 0.0 112.501 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.07 -16.52 55.4 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.245 2.63 . . . . 0.0 115.217 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -124.78 47.28 2.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.708 1.603 . . . . 0.0 111.141 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.9 p -119.46 25.78 9.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.26 1.424 . . . . 0.0 114.393 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.32 93.68 0.87 Allowed 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.936 -1.103 . . . . 0.0 108.907 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.5 p -89.04 -52.21 5.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.626 0.77 . . . . 0.0 111.779 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.36 -5.04 0.19 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -80.43 134.32 35.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.984 -1.072 . . . . 0.0 110.07 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.79 168.4 19.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.486 1.914 . . . . 0.0 110.673 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.5 p90 -147.1 161.82 40.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 111.842 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.83 119.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -69.76 100.15 1.46 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.22 -17.91 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.403 -0.81 . . . . 0.0 113.146 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.06 168.14 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 127.923 2.489 . . . . 0.0 111.256 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -68.92 113.47 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.706 1.202 . . . . 0.0 112.138 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.41 54.18 1.49 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.966 1.706 . . . . 0.0 111.58 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.0 -26.27 65.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -62.54 -13.73 34.21 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -85.8 -6.42 59.11 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.653 1.181 . . . . 0.0 114.069 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -71.73 179.48 3.09 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.184 1.394 . . . . 0.0 114.425 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -85.72 143.9 28.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.821 1.248 . . . . 0.0 111.991 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.8 p -112.7 -60.15 1.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 113.419 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 C-N-CA 123.797 0.713 . . . . 0.0 114.378 -173.294 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 7.5 p-90 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.32 -100.3 1.52 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.549 1.547 . . . . 0.0 115.688 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -126.3 150.6 48.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.667 1.587 . . . . 0.0 111.483 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.2 t -82.95 118.44 23.48 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.3 87.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.685 1.194 . . . . 0.0 108.227 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -78.71 -14.28 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.545 0.738 . . . . 0.0 112.234 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.89 177.62 7.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.626 1.203 . . . . 0.0 113.96 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -140.77 152.23 45.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.689 1.196 . . . . 0.0 112.345 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.91 142.89 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.598 0.713 . . . . 0.0 110.152 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.3 -41.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.86 1.664 . . . . 0.0 110.852 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -145.09 155.7 43.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.895 1.678 . . . . 0.0 109.682 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.31 23.13 Favored Glycine 0 N--CA 1.467 0.765 0 C-N-CA 123.867 0.746 . . . . 0.0 114.407 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -32.57 66.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.766 1.283 . . . . 0.0 112.325 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.83 -29.01 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 112.658 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.0 -40.05 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.315 1.446 . . . . 0.0 110.48 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.31 -39.41 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.803 -1.185 . . . . 0.0 110.982 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.35 -30.54 69.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -73.11 -44.51 60.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.829 1.252 . . . . 0.0 111.126 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.05 -25.03 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.432 1.493 . . . . 0.0 112.409 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -84.24 -25.45 29.41 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.16 -8.68 64.37 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.784 1.659 . . . . 0.0 114.747 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -60.3 -26.15 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . . . 82.83 163.46 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.313 2.245 . . . . 0.0 114.376 -169.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 68.3 p -111.8 151.05 29.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.135 1.374 . . . . 0.0 113.632 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 123.333 1.518 . . . . 0.0 112.537 169.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -59.36 135.74 67.3 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 120.756 1.306 . . . . 0.0 111.033 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -31.51 60.24 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.35 0.66 . . . . 0.0 112.687 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.48 147.87 35.65 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.486 0.714 . . . . 0.0 110.435 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.26 109.78 16.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.426 0.631 . . . . 0.0 110.027 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.41 100.14 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -120.85 141.22 42.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.525 1.13 . . . . 0.0 111.726 -169.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.3 103.41 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.39 -35.61 58.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.015 0.926 . . . . 0.0 110.859 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.56 165.01 34.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.12 139.59 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.205 1.802 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -135.39 130.31 34.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.775 1.23 . . . . 0.0 110.198 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.6 t -86.81 120.13 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t -114.18 147.3 39.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.027 1.331 . . . . 0.0 112.426 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.539 1.536 . . . . 0.0 113.46 -169.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 119.925 -0.083 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.76 128.2 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.979 0.912 . . . . 0.0 109.37 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.4 m -102.51 126.23 49.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 109.917 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -100.93 117.72 35.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.54 1.136 . . . . 0.0 109.329 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.25 112.53 24.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -118.81 163.89 16.21 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.479 0.656 . . . . 0.0 112.239 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -69.7 -6.29 30.72 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.638 ' CE1' HD11 ' A' ' 136' ' ' ILE . 29.9 p80 -118.65 -20.63 8.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 114.16 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.14 142.52 3.47 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 126.982 2.23 . . . . 0.0 113.64 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.88 136.26 47.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.65 1.18 . . . . 0.0 113.303 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.26 141.14 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.35 1.46 . . . . 0.0 109.596 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -124.92 136.34 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.912 1.285 . . . . 0.0 110.257 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -126.5 139.96 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 126.725 2.01 . . . . 0.0 110.1 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -107.14 124.72 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.587 1.955 . . . . 0.0 109.245 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -85.85 147.99 26.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.205 1.002 . . . . 0.0 111.555 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.93 74.85 1.01 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 122.651 1.215 . . . . 0.0 111.404 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.77 -26.23 64.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.503 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -77.75 -26.61 50.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.327 1.051 . . . . 0.0 111.712 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.85 -21.37 15.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.905 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.69 55.44 1.6 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.915 1.286 . . . . 0.0 113.069 -172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -60.63 -43.39 32.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.554 2.836 . . . . 0.0 112.953 -172.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -70.34 -41.11 73.62 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.553 0.615 . . . . 0.0 110.671 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' ' 68' ' ' ILE . 38.2 m -62.85 -52.37 63.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.676 0.39 . . . . 0.0 111.474 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.33 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 118.801 -0.618 . . . . 0.0 111.24 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -57.66 -48.16 80.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.569 1.077 . . . . 0.0 111.359 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.1 -41.17 82.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.954 0.902 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.18 -48.1 82.86 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.695 1.198 . . . . 0.0 111.682 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.96 -37.47 72.79 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.361 0.664 . . . . 0.0 111.415 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -59.08 -33.79 71.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.352 0.661 . . . . 0.0 112.607 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -73.77 -43.82 57.85 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.469 -0.77 . . . . 0.0 112.205 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.52 -37.19 82.83 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.33 -0.856 . . . . 0.0 111.503 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -62.61 -33.54 75.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.814 2.046 . . . . 0.0 112.883 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -83.79 -14.85 50.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.084 0.953 . . . . 0.0 113.503 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 17.5 53.5 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.082 0.849 . . . . 0.0 114.15 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -73.73 -18.47 60.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.196 1.498 . . . . 0.0 114.832 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -98.26 -6.6 30.79 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.2 -0.938 . . . . 0.0 112.35 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -71.57 129.33 38.48 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.934 -1.103 . . . . 0.0 108.792 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.7 43.99 17.95 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.089 1.355 . . . . 0.0 113.752 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.3 p -109.32 167.26 10.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.435 1.094 . . . . 0.0 111.829 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 15.8 pt -120.45 161.58 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.82 83.42 7.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.773 1.229 . . . . 0.0 108.177 168.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -60.8 -28.63 68.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.684 1.993 . . . . 0.0 115.025 -169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -132.0 136.55 47.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.787 1.176 . . . . 0.0 111.378 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.57 130.03 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.643 1.977 . . . . 0.0 110.944 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.3 mt -137.19 126.78 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 108.276 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.1 136.54 57.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.298 0.639 . . . . 0.0 111.628 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.24 9.23 63.61 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -142.54 -177.23 5.18 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.948 1.699 . . . . 0.0 111.025 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.93 179.89 6.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.835 1.654 . . . . 0.0 114.393 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.26 136.64 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.807 1.243 . . . . 0.0 112.364 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.55 141.96 34.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.661 1.184 . . . . 0.0 110.489 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.09 165.97 27.23 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 123.033 1.352 . . . . 0.0 115.801 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.62 -8.48 65.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.439 1.495 . . . . 0.0 115.831 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.54 -20.87 76.15 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.061 1.431 . . . . 0.0 116.065 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -143.68 170.06 16.56 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.757 1.278 . . . . 0.0 113.067 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -100.08 162.61 20.45 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 111.147 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.9 -13.26 29.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.838 3.025 . . . . 0.0 117.886 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 17.17 59.83 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.768 0.699 . . . . 0.0 114.389 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt 60.44 25.5 15.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.711 1.604 . . . . 0.0 112.967 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -82.77 125.17 30.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.58 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -76.08 120.28 21.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 110.952 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -72.15 163.85 27.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.226 1.011 . . . . 0.0 113.632 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.27 69.23 8.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.968 1.707 . . . . 0.0 111.542 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -72.84 130.3 40.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.514 1.526 . . . . 0.0 112.706 -173.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -133.56 174.87 9.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.467 1.907 . . . . 0.0 112.641 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 49.39 68.21 3.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.654 1.582 . . . . 0.0 114.009 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -61.14 133.93 49.72 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.171 2.581 . . . . 0.0 111.418 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.7 mt -98.61 153.26 4.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.949 1.7 . . . . 0.0 108.012 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -74.83 161.2 29.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.54 0.336 . . . . 0.0 110.156 169.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.0 -42.88 69.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -168.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 61.34 -0.21 0.38 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.205 2.602 . . . . 0.0 117.717 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.39 -12.29 61.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.763 -1.836 . . . . 0.0 113.897 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -62.74 8.05 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.969 1.708 . . . . 0.0 115.101 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -79.21 -10.94 59.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.384 1.473 . . . . 0.0 112.832 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.6 81.35 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.055 1.312 . . . . 0.0 115.193 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.13 158.58 29.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.555 1.177 . . . . 0.0 112.535 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -128.53 150.3 50.23 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -87.15 65.44 8.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.477 1.911 . . . . 0.0 112.029 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.3 p -100.39 166.99 10.68 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.812 0.845 . . . . 0.0 112.424 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -52.27 123.22 10.2 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.699 1.599 . . . . 0.0 111.09 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.0 43.65 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 114.926 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.2 p -116.25 159.28 22.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.364 1.582 . . . . 0.0 113.682 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.95 134.72 55.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.826 0.85 . . . . 0.0 112.454 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.45 157.32 44.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 173.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -80.9 140.64 35.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.327 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.14 162.19 15.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.66 0.784 . . . . 0.0 111.231 172.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -129.75 164.65 23.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.461 1.104 . . . . 0.0 112.893 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.6 m -72.4 -54.54 9.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.67 0.788 . . . . 0.0 110.905 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.11 -52.13 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.627 1.571 . . . . 0.0 112.193 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.04 157.19 76.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.751 1.221 . . . . 0.0 111.776 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.2 -24.98 76.44 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.122 2.548 . . . . 0.0 114.296 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -109.12 33.64 4.17 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.478 1.511 . . . . 0.0 112.649 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.7 p -118.84 26.3 9.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.34 1.456 . . . . 0.0 113.88 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.51 100.85 13.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.209 1.404 . . . . 0.0 109.51 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.0 p -89.15 -57.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.065 0.946 . . . . 0.0 113.201 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -162.39 48.44 0.17 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -136.71 147.5 46.8 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.832 -1.167 . . . . 0.0 111.381 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.82 168.22 20.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.114 1.366 . . . . 0.0 111.78 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -147.61 162.44 39.12 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.239 0.616 . . . . 0.0 111.371 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.1 mt -116.05 115.85 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.053 0.941 . . . . 0.0 108.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -73.6 96.12 2.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.379 0.671 . . . . 0.0 110.062 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.42 -22.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.06 -1.025 . . . . 0.0 113.189 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.55 166.66 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.633 . . . . 0.0 110.862 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.71 114.73 13.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.326 0.584 . . . . 0.0 111.629 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -124.94 59.44 1.22 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.063 1.745 . . . . 0.0 111.554 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.09 -14.89 63.32 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.15 -14.05 62.53 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.849 -1.157 . . . . 0.0 113.266 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.2 -8.27 59.64 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.379 1.072 . . . . 0.0 113.695 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.36 -176.94 2.4 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -74.69 147.51 41.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.05 1.74 . . . . 0.0 113.034 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.513 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 53.4 p -103.15 -61.19 1.44 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.652 1.581 . . . . 0.0 113.107 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 C-N-CA 125.142 1.353 . . . . 0.0 112.618 -170.016 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.513 ' N ' ' HG ' ' A' ' 111' ' ' SER 0.348 2.4 p-90 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.913 0.863 . . . . 0.0 112.958 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.88 -85.72 1.26 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.371 1.463 . . . . 0.0 115.905 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -137.1 132.97 34.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.957 1.303 . . . . 0.0 111.79 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.59 128.78 34.79 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.58 90.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.574 1.15 . . . . 0.0 107.935 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -78.94 -14.86 58.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.716 0.806 . . . . 0.0 111.904 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.01 177.33 9.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.579 1.18 . . . . 0.0 112.929 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -136.31 153.99 50.99 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.592 -1.317 . . . . 0.0 112.232 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.33 140.01 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.591 0.71 . . . . 0.0 109.403 169.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.99 -42.24 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.704 1.602 . . . . 0.0 110.519 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.43 147.0 32.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.563 1.545 . . . . 0.0 109.902 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.12 7.15 10.4 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.523 0.969 . . . . 0.0 115.523 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -56.32 -37.51 70.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.695 1.747 . . . . 0.0 112.716 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.47 -29.03 70.23 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.84 0.856 . . . . 0.0 112.431 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.11 -44.98 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.423 1.489 . . . . 0.0 110.443 172.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.84 -38.52 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.165 -0.959 . . . . 0.0 111.25 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.84 -23.51 60.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 112.457 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -78.92 -42.4 27.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.191 1.396 . . . . 0.0 111.182 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.8 mt -54.37 -35.52 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.558 1.143 . . . . 0.0 111.87 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -84.98 -18.14 35.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.1 15.41 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.179 1.371 . . . . 0.0 114.422 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.42 -57.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.806 1.303 . . . . 0.0 113.106 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.33 5.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 112.024 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.2 p -142.84 153.52 43.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.2 1.4 . . . . 0.0 112.119 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.136 0 O-C-N 122.135 -0.353 . . . . 0.0 113.234 169.744 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.08 143.79 55.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 121.711 1.607 . . . . 0.0 109.324 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.46 58.17 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.44 159.11 16.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.211 1.405 . . . . 0.0 110.216 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.51 112.57 17.98 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.854 -1.154 . . . . 0.0 111.477 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.6 94.21 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -128.15 147.49 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -168.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 63.8 mt -85.76 104.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.992 1.717 . . . . 0.0 107.988 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -78.94 -30.47 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.081 1.353 . . . . 0.0 112.612 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 t -155.29 162.43 40.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.06 0.944 . . . . 0.0 113.119 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.03 139.6 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.69 1.596 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.7 m -136.39 128.61 29.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.594 1.157 . . . . 0.0 110.779 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.79 118.08 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.2 t -112.63 150.19 31.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.635 1.574 . . . . 0.0 112.295 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.346 1.458 . . . . 0.0 113.627 -170.081 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.865 -0.588 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.39 130.27 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 120.684 1.584 . . . . 0.0 110.394 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -101.24 123.16 44.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.446 1.098 . . . . 0.0 110.346 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -97.83 130.73 44.73 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.977 1.311 . . . . 0.0 110.286 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -103.6 97.84 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -101.51 152.35 20.87 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.064 -0.398 . . . . 0.0 111.269 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -60.85 -9.09 3.62 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -107.49 -8.44 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 114.147 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.45 162.23 10.61 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 123.109 1.394 . . . . 0.0 113.653 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.13 137.72 45.34 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.452 1.501 . . . . 0.0 112.651 172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.91 140.77 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.392 1.877 . . . . 0.0 108.685 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.47 135.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.384 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.13 134.55 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.559 1.944 . . . . 0.0 110.473 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -101.73 127.64 48.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.138 1.775 . . . . 0.0 108.796 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.4 p -88.28 149.27 23.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.386 1.075 . . . . 0.0 111.25 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.81 73.26 0.94 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.898 1.332 . . . . 0.0 111.656 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.76 -26.14 64.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.518 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -78.14 -26.2 47.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.333 1.053 . . . . 0.0 111.638 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.77 -22.02 14.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 113.183 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.85 55.31 1.19 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.855 1.262 . . . . 0.0 113.674 -171.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.63 -42.98 35.38 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.532 2.821 . . . . 0.0 113.147 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.31 -38.04 78.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 111.043 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.3 m -68.28 -47.99 66.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.153 0.581 . . . . 0.0 111.904 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.48 -39.43 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.337 0.655 . . . . 0.0 111.6 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -52.64 -49.36 65.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.543 1.065 . . . . 0.0 112.104 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.6 -38.05 77.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.459 0.704 . . . . 0.0 111.562 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.01 -50.34 74.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.472 1.109 . . . . 0.0 111.82 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.31 -35.18 73.5 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.51 -0.744 . . . . 0.0 111.638 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.07 -33.19 70.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 112.694 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.54 -43.42 39.22 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.378 -0.826 . . . . 0.0 112.376 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -58.84 -40.36 84.01 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.731 -0.605 . . . . 0.0 111.706 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -61.03 -39.66 90.65 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.362 1.865 . . . . 0.0 113.387 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -77.48 -16.23 58.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.031 0.933 . . . . 0.0 112.632 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.9 62.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.988 0.804 . . . . 0.0 112.836 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.95 -35.76 75.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.53 1.165 . . . . 0.0 113.122 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.72 -8.61 59.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.733 0.413 . . . . 0.0 112.089 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.04 132.12 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.15 -0.969 . . . . 0.0 108.809 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 56.1 t30 58.17 30.82 19.95 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -170.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -88.61 167.24 13.54 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 156' ' ' ILE . 12.1 pt -124.6 162.58 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -89.11 82.72 6.57 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -70.95 -12.85 61.77 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -168.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -147.54 135.09 20.88 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.649 1.568 . . . . 0.0 112.679 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -135.45 147.61 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 127.235 2.214 . . . . 0.0 109.516 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.87 132.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.139 1.776 . . . . 0.0 107.376 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.34 133.41 55.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.355 0.662 . . . . 0.0 111.897 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.53 11.1 61.7 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.989 0.804 . . . . 0.0 115.039 -172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.63 -177.12 4.91 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 111.164 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -83.65 179.9 7.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -169.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.0 pt -115.24 136.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.075 1.75 . . . . 0.0 112.168 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -115.8 149.38 38.64 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.142 1.377 . . . . 0.0 111.413 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.49 179.99 30.2 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 122.164 0.869 . . . . 0.0 115.235 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.12 -2.14 87.47 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.627 1.108 . . . . 0.0 115.493 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -25.17 43.73 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 118.965 1.383 . . . . 0.0 115.095 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -143.5 164.83 29.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.89 164.34 16.68 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.469 1.908 . . . . 0.0 110.441 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.32 -11.53 25.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.468 2.778 . . . . 0.0 117.492 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.15 16.1 60.47 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.042 0.829 . . . . 0.0 114.575 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mmt 60.8 27.1 16.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.394 1.877 . . . . 0.0 113.16 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.49 126.92 33.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.915 1.286 . . . . 0.0 109.561 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.49 127.55 33.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 124.017 1.865 . . . . 0.0 111.002 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -71.23 174.83 5.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 110.494 -3.048 . . . . 0.0 114.95 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 47.79 1.55 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.649 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.5 p -69.75 119.56 14.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.493 1.117 . . . . 0.0 112.308 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -132.82 173.41 11.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.748 2.419 . . . . 0.0 111.377 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 44.61 73.43 0.97 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.829 1.652 . . . . 0.0 114.359 169.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.83 144.5 26.68 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.78 2.987 . . . . 0.0 113.523 171.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.18 150.96 6.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.197 1.799 . . . . 0.0 107.993 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 151.93 26.96 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.269 0.627 . . . . 0.0 110.049 169.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -74.7 116.48 15.45 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.89 -77.87 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.088 0.555 . . . . 0.0 110.08 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.66 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.934 3.293 . . . . 0.0 118.202 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -75.05 27.51 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.395 2.278 . . . . 0.0 114.327 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.33 -5.57 18.99 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.379 2.272 . . . . 0.0 113.961 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.04 82.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 115.379 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.47 155.65 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.354 1.077 . . . . 0.0 112.527 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.01 154.0 51.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -90.79 62.05 4.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.083 1.753 . . . . 0.0 112.059 -169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.6 p -96.72 169.07 10.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.75 0.82 . . . . 0.0 111.768 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -54.02 127.42 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.667 1.187 . . . . 0.0 111.268 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.84 29.23 55.17 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.78 1.181 . . . . 0.0 114.66 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.5 p -115.35 159.16 21.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.472 1.636 . . . . 0.0 112.912 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.87 137.22 52.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.976 0.893 . . . . 0.0 113.152 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.53 161.57 36.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.973 0.892 . . . . 0.0 111.693 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 138.48 31.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.242 1.417 . . . . 0.0 111.71 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.73 137.34 35.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.984 0.914 . . . . 0.0 112.45 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -81.15 155.93 25.97 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.431 1.492 . . . . 0.0 112.264 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -80.41 -55.15 5.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.191 0.996 . . . . 0.0 111.065 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -154.55 -54.87 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.475 1.51 . . . . 0.0 110.975 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.5 79.88 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.9 0.88 . . . . 0.0 111.318 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.29 -22.81 74.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.552 2.168 . . . . 0.0 114.292 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.72 37.05 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.692 1.597 . . . . 0.0 112.303 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.4 p -114.42 23.96 12.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.462 1.505 . . . . 0.0 113.691 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.25 97.79 9.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 109.173 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -83.57 -69.34 0.64 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.735 1.214 . . . . 0.0 111.868 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.44 -14.1 1.98 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 113.249 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -74.06 141.56 45.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.228 1.013 . . . . 0.0 111.821 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -141.75 168.17 20.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.093 2.157 . . . . 0.0 111.047 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 13.1 p90 -145.96 162.65 37.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.055 0.942 . . . . 0.0 111.638 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -116.57 118.85 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.583 1.153 . . . . 0.0 108.311 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -71.71 98.89 2.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.414 0.686 . . . . 0.0 109.737 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -75.2 -17.47 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 113.318 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.6 167.19 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 128.537 2.735 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -75.65 115.5 15.39 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.712 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -125.0 55.65 1.36 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.116 1.766 . . . . 0.0 111.991 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.08 -16.01 60.82 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -66.54 -14.45 62.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.83 -1.169 . . . . 0.0 113.45 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.4 mt -82.23 -9.07 59.63 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.621 1.169 . . . . 0.0 113.607 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -71.64 -178.74 2.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.155 1.382 . . . . 0.0 114.363 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -83.65 144.31 29.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.145 1.378 . . . . 0.0 113.107 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.526 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 61.3 p -104.46 -63.06 1.25 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.833 1.653 . . . . 0.0 112.911 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.016 0 C-N-CA 125.316 1.436 . . . . 0.0 112.836 -170.229 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.526 ' N ' ' HG ' ' A' ' 111' ' ' SER . 17.7 p-90 . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.13 -100.5 2.01 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.224 1.392 . . . . 0.0 114.857 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.32 141.65 51.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.116 1.366 . . . . 0.0 111.643 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 36.3 t -79.49 126.98 31.56 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.944 -0.473 . . . . 0.0 112.159 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.88 94.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -81.88 -14.41 56.24 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.301 0.64 . . . . 0.0 111.939 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 176.88 8.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.41 1.1 . . . . 0.0 113.88 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -139.76 153.78 47.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.447 1.099 . . . . 0.0 112.647 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.03 140.18 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.599 0.714 . . . . 0.0 110.132 170.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.62 -42.28 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.091 1.756 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -144.72 155.26 43.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.552 1.541 . . . . 0.0 109.771 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.67 15.78 28.33 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 123.878 0.752 . . . . 0.0 113.964 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -34.95 67.87 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.761 1.28 . . . . 0.0 112.319 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.69 -29.41 69.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.581 0.753 . . . . 0.0 112.657 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.37 -42.63 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.229 1.412 . . . . 0.0 110.278 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.96 -39.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.957 . . . . 0.0 111.357 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.42 -21.24 61.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.689 1.596 . . . . 0.0 112.71 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -86.32 -43.72 12.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.769 1.628 . . . . 0.0 111.447 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.16 -29.1 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.416 1.486 . . . . 0.0 112.585 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -81.29 -16.49 52.34 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.91 -2.35 11.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.311 1.434 . . . . 0.0 114.544 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.82 -55.07 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.039 1.419 . . . . 0.0 112.012 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 177.93 148.4 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.686 1.995 . . . . 0.0 111.258 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 p -121.66 149.86 42.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.348 1.459 . . . . 0.0 112.947 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 C-N-CA 124.875 1.226 . . . . 0.0 112.141 175.511 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 119.579 -0.248 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.4 130.49 23.93 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.088 1.192 . . . . 0.0 109.364 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -26.6 30.7 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.87 140.8 42.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.62 0.768 . . . . 0.0 109.418 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.38 109.83 17.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.419 0.628 . . . . 0.0 110.78 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.95 107.51 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.63 142.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 124.417 1.087 . . . . 0.0 111.446 -170.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.25 103.41 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.68 -37.72 62.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.21 0.604 . . . . 0.0 110.831 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 t -152.32 165.77 33.91 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 t -138.86 141.6 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.945 1.698 . . . . 0.0 110.641 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -134.0 126.1 29.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.022 1.329 . . . . 0.0 110.087 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.84 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -115.4 150.23 36.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.299 1.44 . . . . 0.0 112.412 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.429 1.492 . . . . 0.0 113.614 -169.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.17 126.39 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -97.97 124.91 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.939 1.296 . . . . 0.0 109.892 173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.95 121.69 42.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 109.974 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -97.2 108.76 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -120.16 159.61 24.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -68.54 -8.57 42.67 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.9 p80 -109.17 -25.28 10.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 113.677 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.74 145.16 4.12 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.479 1.99 . . . . 0.0 113.402 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.7 133.74 36.54 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.268 -1.136 . . . . 0.0 112.672 172.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.12 143.38 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.95 1.7 . . . . 0.0 109.252 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.8 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.308 1.043 . . . . 0.0 110.239 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.71 139.56 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.698 1.999 . . . . 0.0 110.265 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -104.09 124.55 49.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 108.132 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -85.87 148.81 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 111.547 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -106.89 73.41 0.94 Allowed 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.78 1.276 . . . . 0.0 111.608 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.72 -26.49 64.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.413 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.5 -27.14 51.75 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.327 1.051 . . . . 0.0 111.412 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -99.31 -24.64 14.76 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.213 1.405 . . . . 0.0 112.922 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.48 57.77 2.26 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.404 1.082 . . . . 0.0 113.162 -169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.66 -44.38 26.76 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.232 2.621 . . . . 0.0 112.906 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -71.95 -39.78 69.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.756 0.707 . . . . 0.0 111.38 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -64.04 -47.54 79.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 111.215 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.26 -42.37 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.612 0.765 . . . . 0.0 111.595 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -54.89 -47.42 74.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.764 1.166 . . . . 0.0 111.967 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -71.18 -36.01 71.82 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.339 0.518 . . . . 0.0 112.032 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.63 -48.88 79.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.134 0.974 . . . . 0.0 111.611 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.64 -36.05 73.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.4 -0.812 . . . . 0.0 111.826 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -58.67 -35.32 72.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.586 0.755 . . . . 0.0 112.338 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.394 -0.816 . . . . 0.0 111.958 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -58.84 -38.11 77.97 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.665 -0.647 . . . . 0.0 111.808 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -65.69 -35.83 81.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.053 2.141 . . . . 0.0 112.703 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -81.63 -16.02 52.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.704 0.802 . . . . 0.0 113.107 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.29 20.24 60.92 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.295 0.95 . . . . 0.0 113.215 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.12 -38.47 76.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.371 1.068 . . . . 0.0 113.179 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -82.12 -7.75 59.63 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.044 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.53 130.35 42.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.2 t30 55.08 46.78 23.39 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 114.262 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.6 p -110.62 162.51 14.66 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.301 1.04 . . . . 0.0 111.489 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 9.2 pt -122.72 161.85 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -86.45 81.85 8.16 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.843 1.257 . . . . 0.0 107.609 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -71.96 -7.96 51.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -146.0 135.22 22.83 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.55 1.523 . . . . 0.0 112.183 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.61 143.48 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.784 2.034 . . . . 0.0 110.556 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.35 129.72 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.853 1.661 . . . . 0.0 108.135 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -62.96 129.35 39.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.538 0.735 . . . . 0.0 111.65 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.61 10.48 67.14 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -142.49 -177.19 5.16 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.152 1.781 . . . . 0.0 110.765 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -81.71 178.82 8.11 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -169.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.29 135.81 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.679 1.591 . . . . 0.0 112.17 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -110.29 150.85 28.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.728 1.211 . . . . 0.0 111.206 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.68 175.79 33.42 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.33 2.9 85.06 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.329 1.442 . . . . 0.0 115.411 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.14 -26.14 49.45 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 118.953 1.377 . . . . 0.0 114.509 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.11 164.62 30.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.256 1.022 . . . . 0.0 113.396 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -97.41 164.59 17.36 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.768 1.627 . . . . 0.0 110.145 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -61.27 -15.26 39.1 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.51 2.807 . . . . 0.0 118.196 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.22 16.68 58.23 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.887 0.756 . . . . 0.0 114.284 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.6 mmm 58.1 37.85 26.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.818 2.047 . . . . 0.0 113.331 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -83.25 123.06 29.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.919 1.288 . . . . 0.0 109.122 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.41 119.94 17.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 124.196 1.951 . . . . 0.0 110.337 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.62 179.7 1.64 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 110.332 -3.122 . . . . 0.0 114.513 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 61.66 6.75 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.166 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -69.48 106.43 2.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.179 1.392 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.65 168.27 20.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.806 2.043 . . . . 0.0 111.995 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 49.12 61.35 14.17 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 113.007 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.4 129.85 36.88 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.731 2.954 . . . . 0.0 111.507 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.95 153.23 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.209 1.804 . . . . 0.0 108.154 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 162.66 18.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 112.19 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -76.5 123.07 25.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.796 0.838 . . . . 0.0 110.943 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.13 15.22 22.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.0 112.89 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -12.38 58.52 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.618 -1.301 . . . . 0.0 114.288 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -62.88 6.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 114.438 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -77.46 -11.54 59.86 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.134 1.774 . . . . 0.0 113.211 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.92 69.34 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.737 1.161 . . . . 0.0 114.891 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.39 156.93 26.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.882 1.341 . . . . 0.0 112.936 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -125.51 149.65 48.11 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -89.31 66.5 7.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 111.417 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.0 p -95.07 163.87 13.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.537 0.735 . . . . 0.0 111.514 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 124.88 15.74 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.765 0.793 . . . . 0.0 111.33 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.11 46.32 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.374 1.464 . . . . 0.0 115.391 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.0 p -115.17 160.37 19.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.627 1.713 . . . . 0.0 113.536 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.31 134.64 55.1 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -131.68 157.41 43.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.346 0.658 . . . . 0.0 111.381 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 35.7 mtp -84.23 138.1 33.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.223 -0.298 . . . . 0.0 111.061 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.52 155.83 17.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.161 0.985 . . . . 0.0 111.381 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -117.17 164.42 14.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.491 1.116 . . . . 0.0 113.2 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.8 m -76.66 -58.33 3.34 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.195 0.998 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -152.89 -58.31 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.991 1.716 . . . . 0.0 110.879 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.12 156.87 79.07 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.864 1.265 . . . . 0.0 112.047 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.66 -26.09 71.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.48 2.787 . . . . 0.0 114.249 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -108.18 33.37 4.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.507 1.523 . . . . 0.0 112.758 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -118.55 28.82 8.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.452 1.501 . . . . 0.0 113.693 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.13 106.28 18.26 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.732 1.613 . . . . 0.0 109.427 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.5 p -94.0 -69.02 0.77 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 0.0 113.139 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.81 -24.84 2.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.5 mp0 -67.06 140.58 57.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.528 1.131 . . . . 0.0 111.27 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -136.83 168.39 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.123 1.769 . . . . 0.0 110.358 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.9 p90 -143.23 162.04 36.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.247 0.619 . . . . 0.0 111.552 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.3 mt -114.38 118.89 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -70.12 96.76 1.1 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -73.71 -17.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.299 -0.876 . . . . 0.0 113.117 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -134.47 165.72 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 128.259 2.624 . . . . 0.0 110.78 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.57 116.58 14.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.758 0.823 . . . . 0.0 111.549 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -123.42 63.41 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.371 1.468 . . . . 0.0 112.535 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -52.34 -35.16 50.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.342 1.457 . . . . 0.0 114.327 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -65.61 -13.72 59.67 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.85 -9.05 58.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -74.01 -178.86 3.48 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -171.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -78.89 150.82 32.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.34 1.456 . . . . 0.0 112.839 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -127.48 -39.92 1.82 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.244 0 CA-C-N 118.944 0.793 . . . . 0.0 114.205 -177.683 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.286 5.4 p-90 . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.55 -105.98 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.928 1.728 . . . . 0.0 114.86 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.24 141.06 51.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.533 1.533 . . . . 0.0 111.672 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -85.15 124.58 31.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -73.59 97.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 108.414 170.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -79.76 -15.94 56.52 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.544 0.737 . . . . 0.0 111.656 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.83 8.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.567 1.175 . . . . 0.0 113.843 -170.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -139.95 153.71 46.99 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.563 -1.335 . . . . 0.0 112.466 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.46 137.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.723 0.773 . . . . 0.0 109.924 170.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.13 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.331 1.852 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -141.74 148.65 39.35 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.521 1.528 . . . . 0.0 110.031 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.89 13.2 20.63 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.944 0.783 . . . . 0.0 114.87 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 69.5 mmm -54.69 -38.06 66.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.405 1.602 . . . . 0.0 112.377 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.76 -29.04 70.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.049 0.94 . . . . 0.0 112.439 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.98 -43.55 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.689 1.596 . . . . 0.0 110.336 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.18 -38.4 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.218 1.007 . . . . 0.0 111.198 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.9 -22.26 60.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.585 1.554 . . . . 0.0 112.857 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -81.39 -43.86 18.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.368 1.467 . . . . 0.0 111.395 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.5 mt -55.18 -33.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.097 1.359 . . . . 0.0 112.045 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -85.17 -16.59 39.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.35 12.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.166 1.365 . . . . 0.0 114.268 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.5 m -72.81 -57.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.607 1.203 . . . . 0.0 113.613 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.68 156.51 7.89 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.994 0.917 . . . . 0.0 113.324 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.9 p -141.71 152.13 43.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.392 1.477 . . . . 0.0 111.972 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.953 0 C-N-CA 123.114 0.387 . . . . 0.0 113.263 171.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.0 135.36 34.71 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 121.378 1.385 . . . . 0.0 109.548 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -29.59 48.76 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 154.23 22.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 110.636 169.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -84.53 109.61 18.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.998 0.904 . . . . 0.0 111.312 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.19 94.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -123.5 141.67 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -168.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.48 103.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.596 1.958 . . . . 0.0 106.786 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.02 -39.8 60.88 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.614 -0.679 . . . . 0.0 111.119 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -150.07 165.99 31.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -137.97 142.1 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.745 1.618 . . . . 0.0 111.001 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.7 m -136.33 129.59 31.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.766 1.227 . . . . 0.0 110.384 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.74 122.55 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -118.88 150.45 39.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.705 1.602 . . . . 0.0 112.044 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.628 1.171 . . . . 0.0 113.699 -172.331 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.31 124.75 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.97 0.908 . . . . 0.0 109.575 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 125.19 45.95 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.967 0.907 . . . . 0.0 110.314 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -96.87 135.34 38.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.674 1.19 . . . . 0.0 110.6 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -105.82 101.43 10.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -106.36 151.96 24.2 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.075 -0.39 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.83 -8.09 2.82 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -105.38 -10.46 16.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.781 1.232 . . . . 0.0 114.03 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.59 162.16 10.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.124 1.345 . . . . 0.0 113.592 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.21 138.1 45.42 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.667 1.587 . . . . 0.0 112.401 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.6 mt -135.61 140.36 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.299 1.84 . . . . 0.0 108.9 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.77 133.26 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.583 1.153 . . . . 0.0 110.682 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.54 139.16 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.551 1.94 . . . . 0.0 109.909 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -101.5 129.45 47.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.884 2.074 . . . . 0.0 108.452 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -93.43 145.98 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.412 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -103.96 72.08 1.08 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.897 1.332 . . . . 0.0 111.699 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.97 -26.13 63.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.502 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -77.58 -29.43 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.201 1.001 . . . . 0.0 111.698 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.7 -20.74 16.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.943 1.297 . . . . 0.0 113.285 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.65 56.79 1.55 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.516 1.126 . . . . 0.0 113.224 -171.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.18 -45.3 23.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.433 2.756 . . . . 0.0 113.116 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -69.48 -39.73 77.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.784 0.72 . . . . 0.0 111.449 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -63.44 -48.26 78.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.723 0.809 . . . . 0.0 111.24 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.17 -41.23 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.408 0.683 . . . . 0.0 111.512 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -54.42 -48.47 71.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.705 1.139 . . . . 0.0 112.329 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -70.56 -35.99 73.38 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.608 0.64 . . . . 0.0 111.922 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.84 -50.92 71.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.447 1.099 . . . . 0.0 111.418 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 -36.35 73.17 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.697 0.799 . . . . 0.0 111.959 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.89 -34.8 70.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -76.27 -39.19 54.97 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.519 -0.738 . . . . 0.0 112.442 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.45 -35.77 76.64 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.11 -0.994 . . . . 0.0 111.565 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -31.08 71.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.105 1.762 . . . . 0.0 112.763 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.21 -14.31 57.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.225 1.01 . . . . 0.0 113.345 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.52 15.38 62.0 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.69 1.138 . . . . 0.0 114.04 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -68.17 -18.96 64.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.438 1.495 . . . . 0.0 114.689 -171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.78 -13.5 21.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.23 1.71 8.81 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -145.24 49.38 1.26 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.28 1.432 . . . . 0.0 111.055 170.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.9 p -113.57 170.39 8.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.36 162.2 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -103.15 130.93 50.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.647 1.579 . . . . 0.0 107.368 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.96 -40.39 1.51 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -87.66 116.81 26.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.609 1.095 . . . . 0.0 109.627 -175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.03 129.75 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.489 1.516 . . . . 0.0 110.413 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.7 mt -141.47 129.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.021 1.728 . . . . 0.0 107.856 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -65.96 134.94 54.01 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.697 0.799 . . . . 0.0 111.819 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.5 13.5 68.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.811 0.72 . . . . 0.0 114.79 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -142.98 -177.32 5.28 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.903 1.681 . . . . 0.0 111.542 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.58 179.93 6.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.12 1.768 . . . . 0.0 114.975 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.0 pt -120.83 142.63 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -118.19 147.7 43.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 112.225 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.34 -177.6 30.61 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 122.151 0.862 . . . . 0.0 115.216 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.74 -5.82 82.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.362 1.458 . . . . 0.0 115.622 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.01 -16.08 63.8 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 -169.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.05 163.76 34.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.805 1.302 . . . . 0.0 112.366 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.13 163.0 30.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.303 1.041 . . . . 0.0 111.11 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.54 -12.9 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.187 3.258 . . . . 0.0 117.33 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.47 13.55 67.0 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.074 0.845 . . . . 0.0 114.833 172.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.8 mmt 59.71 29.64 19.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.374 1.87 . . . . 0.0 112.868 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -81.24 124.08 29.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.827 1.251 . . . . 0.0 109.197 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -72.97 114.72 11.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.535 0.734 . . . . 0.0 109.88 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -71.99 165.2 24.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.59 73.29 10.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.798 1.639 . . . . 0.0 111.033 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -70.41 129.31 38.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.864 0.866 . . . . 0.0 111.09 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -140.29 172.09 13.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.545 1.938 . . . . 0.0 111.513 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 48.42 62.66 11.71 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.396 1.478 . . . . 0.0 113.127 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -55.87 129.23 33.84 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.125 2.55 . . . . 0.0 110.339 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.63 149.18 4.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 107.536 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 158.45 27.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.691 0.758 . . . . 0.0 111.133 171.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -85.24 131.06 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.334 1.054 . . . . 0.0 111.217 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.36 15.92 17.92 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.224 1.01 . . . . 0.0 112.715 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.01 -11.36 28.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -74.43 40.41 0.13 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.932 1.693 . . . . 0.0 112.173 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -117.88 -3.48 11.18 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.419 2.287 . . . . 0.0 114.006 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.63 4.55 72.96 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.48 1.514 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.91 157.64 20.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.614 1.207 . . . . 0.0 113.124 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.04 158.85 43.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.616 1.166 . . . . 0.0 113.754 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -94.78 102.25 14.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.983 1.713 . . . . 0.0 110.563 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.4 p -133.5 168.03 19.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.787 1.235 . . . . 0.0 111.663 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.95 121.49 7.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.848 1.259 . . . . 0.0 110.692 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.91 24.54 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.503 1.525 . . . . 0.0 114.992 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.4 p -122.31 159.96 26.34 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.38 1.59 . . . . 0.0 113.734 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -122.24 139.49 53.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.836 0.854 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.46 159.24 42.57 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.843 -0.536 . . . . 0.0 111.881 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.9 mmm -78.75 137.7 37.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.919 0.488 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.69 148.85 29.99 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.122 0.569 . . . . 0.0 110.978 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.19 162.55 18.48 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.995 1.318 . . . . 0.0 112.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.6 m -77.37 -55.48 5.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.872 0.869 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.3 -56.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.977 1.311 . . . . 0.0 111.069 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.66 157.27 86.17 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 111.556 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.96 -35.53 94.49 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.869 2.379 . . . . 0.0 113.671 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -98.82 32.62 2.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.965 1.706 . . . . 0.0 113.359 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.5 p -117.24 33.91 5.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.006 1.322 . . . . 0.0 113.426 -173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.12 109.79 21.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.793 1.637 . . . . 0.0 110.186 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 p -94.94 -66.94 0.88 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.264 1.425 . . . . 0.0 113.449 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.67 -22.64 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.52 145.18 47.66 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 120.574 -1.329 . . . . 0.0 112.088 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -140.32 168.22 20.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 127.409 2.283 . . . . 0.0 109.611 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.9 p90 -144.81 159.9 42.13 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.125 0.57 . . . . 0.0 111.703 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.52 117.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 0.0 108.273 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.78 111.44 14.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.642 0.777 . . . . 0.0 110.707 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.13 -6.32 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 m -129.11 165.06 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.895 1.678 . . . . 0.0 111.154 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -80.27 117.4 21.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.89 0.476 . . . . 0.0 109.917 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -142.14 63.92 1.4 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.019 1.39 . . . . 0.0 111.822 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.31 -13.52 60.64 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -172.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.88 -14.03 41.41 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.689 -1.257 . . . . 0.0 113.427 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.01 -10.51 59.78 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.53 1.132 . . . . 0.0 113.729 173.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -75.44 -176.45 3.18 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -82.1 143.7 31.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.693 1.597 . . . . 0.0 112.288 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.4 p -108.62 -59.28 1.89 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.499 1.119 . . . . 0.0 113.631 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.238 0 C-N-CA 124.081 0.848 . . . . 0.0 114.161 -172.708 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.288 8.3 p-90 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.7 -98.54 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.629 1.585 . . . . 0.0 116.506 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -126.31 139.83 53.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.957 1.303 . . . . 0.0 111.809 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.94 122.85 28.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.878 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.75 89.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.551 1.14 . . . . 0.0 108.182 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.43 -15.22 59.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.369 0.667 . . . . 0.0 112.36 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.72 175.8 9.39 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -138.11 152.65 48.96 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.965 -1.085 . . . . 0.0 112.458 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.37 139.63 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.542 0.687 . . . . 0.0 110.476 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.95 -43.34 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.388 1.475 . . . . 0.0 111.165 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -145.96 154.02 41.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.379 1.472 . . . . 0.0 110.339 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.88 15.06 29.8 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.009 0.814 . . . . 0.0 113.395 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 23.0 mtp -57.84 -34.64 69.93 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.65 1.18 . . . . 0.0 111.938 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.55 -31.44 72.5 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.921 0.888 . . . . 0.0 112.407 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t -72.16 -43.12 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.444 1.097 . . . . 0.0 109.89 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.585 -0.697 . . . . 0.0 111.001 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.44 -26.38 61.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.82 1.248 . . . . 0.0 112.644 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -78.32 -41.39 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.054 1.342 . . . . 0.0 110.978 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mt -55.7 -30.1 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.447 1.899 . . . . 0.0 112.772 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -92.76 -11.1 34.71 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.04 -11.95 13.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.509 1.528 . . . . 0.0 114.413 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.16 -59.32 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.572 1.186 . . . . 0.0 112.799 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.94 143.22 0.93 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 112.431 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.0 p -112.07 148.75 33.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.435 1.494 . . . . 0.0 112.587 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 CA-C-O 123.198 1.444 . . . . 0.0 113.7 174.035 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.87 137.66 45.83 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 121.66 1.573 . . . . 0.0 109.858 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -27.64 43.04 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.768 -0.582 . . . . 0.0 112.281 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.72 140.71 44.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 109.635 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -84.22 130.44 34.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.67 0.748 . . . . 0.0 109.836 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.15 109.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.329 1.452 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.89 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.384 1.074 . . . . 0.0 111.566 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 mt -84.07 103.83 11.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.75 -28.35 60.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.2 t -163.89 169.53 18.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.38 140.07 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.496 1.919 . . . . 0.0 110.416 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.8 m -130.04 124.96 34.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 109.891 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.68 123.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -115.58 150.39 36.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.808 1.243 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.775 1.63 . . . . 0.0 113.413 -169.812 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.69 127.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.236 -0.915 . . . . 0.0 109.545 169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -102.35 120.92 41.3 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 110.119 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.7 132.12 41.23 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 110.843 169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -104.51 101.42 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -106.42 152.21 23.91 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.066 -0.396 . . . . 0.0 111.193 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.48 -9.77 4.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.93 -7.55 19.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 0.0 114.027 170.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.29 166.69 12.26 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.864 1.697 . . . . 0.0 113.683 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.09 137.6 41.53 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.097 1.759 . . . . 0.0 113.044 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -133.09 141.15 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.586 1.954 . . . . 0.0 108.971 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.49 135.78 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.457 1.103 . . . . 0.0 110.359 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 mt -122.98 139.84 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 126.339 1.855 . . . . 0.0 110.162 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -107.21 123.57 48.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.168 1.787 . . . . 0.0 109.113 172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.0 p -87.85 148.1 24.81 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.486 1.115 . . . . 0.0 111.914 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -105.73 73.66 1.02 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 122.655 1.217 . . . . 0.0 111.209 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.31 -26.06 64.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.581 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.99 -24.45 47.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.327 1.051 . . . . 0.0 111.595 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.2 -21.98 13.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.342 1.457 . . . . 0.0 112.862 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.65 55.59 1.81 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.199 1.4 . . . . 0.0 112.982 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.64 -43.77 30.53 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.509 2.806 . . . . 0.0 112.762 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -69.54 -40.09 77.08 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.006 0.821 . . . . 0.0 111.055 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -63.57 -49.37 73.68 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.947 0.499 . . . . 0.0 111.423 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.23 -38.05 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.399 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -55.74 -50.43 70.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.503 1.047 . . . . 0.0 111.433 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.6 -48.28 82.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.914 1.286 . . . . 0.0 111.199 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.17 -50.52 73.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 111.171 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -73.12 -36.07 66.67 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.524 0.73 . . . . 0.0 111.654 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -58.8 -36.33 74.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.949 0.5 . . . . 0.0 111.601 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 2.9 m-85 -77.75 -39.36 44.58 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 76.1 m -61.48 -36.33 80.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.967 . . . . 0.0 111.46 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -34.2 77.07 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 112.765 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.21 -14.06 57.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.367 1.067 . . . . 0.0 113.404 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.09 16.91 62.04 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.871 1.224 . . . . 0.0 114.258 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 45.9 t80 -71.81 -17.59 62.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -93.74 -12.81 28.36 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.98 2.94 7.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -146.12 43.92 1.23 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.229 1.412 . . . . 0.0 111.357 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 p -104.8 169.45 8.44 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.262 -0.899 . . . . 0.0 112.923 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 156' ' ' ILE . 20.8 pt -127.85 163.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -89.29 119.16 29.51 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -93.08 -30.52 15.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.46 1.504 . . . . 0.0 114.289 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -133.99 138.93 45.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.997 0.919 . . . . 0.0 112.389 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.83 133.6 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 127.292 2.237 . . . . 0.0 109.699 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.2 mt -138.65 130.15 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.169 1.788 . . . . 0.0 107.891 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -63.58 135.6 56.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.439 0.696 . . . . 0.0 111.875 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.56 9.97 62.74 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -141.85 -177.09 5.03 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.439 1.896 . . . . 0.0 110.975 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.13 -178.16 5.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.961 1.704 . . . . 0.0 115.42 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 pt -121.3 136.05 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 112.559 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -116.5 149.92 38.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.429 1.092 . . . . 0.0 112.124 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.6 -179.77 36.5 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.42 1.328 . . . . 0.0 116.42 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.08 -12.16 68.58 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.668 1.604 . . . . 0.0 115.979 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.5 -15.17 69.19 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.881 1.513 . . . . 0.0 116.881 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.04 166.22 25.23 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.033 1.417 . . . . 0.0 112.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.13 163.17 20.51 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.87 1.668 . . . . 0.0 111.239 169.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.49 -13.89 27.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.051 3.167 . . . . 0.0 118.301 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.37 14.46 65.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.936 0.779 . . . . 0.0 114.677 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 mmm 57.77 38.66 27.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.776 1.63 . . . . 0.0 112.733 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.55 126.44 36.64 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.433 1.493 . . . . 0.0 109.493 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -73.44 118.46 16.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.848 0.859 . . . . 0.0 110.346 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -73.36 166.5 23.08 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.32 73.96 5.94 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.945 1.698 . . . . 0.0 111.671 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 p -68.76 122.72 19.16 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.621 1.168 . . . . 0.0 111.71 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -137.81 170.12 16.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 111.226 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 48.23 61.15 14.39 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.327 1.451 . . . . 0.0 113.386 169.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.08 139.29 89.93 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.698 2.932 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.41 148.24 6.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.457 1.503 . . . . 0.0 107.968 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 155.99 19.63 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.771 0.828 . . . . 0.0 110.843 170.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -71.71 126.1 28.83 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -107.47 11.38 28.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.79 1.236 . . . . 0.0 113.013 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -12.62 45.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -171.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.56 0.94 0.26 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.406 1.482 . . . . 0.0 113.944 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -72.25 -11.26 60.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.791 1.236 . . . . 0.0 112.939 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.61 7.59 85.91 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.305 1.431 . . . . 0.0 114.695 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.69 153.25 38.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.464 1.132 . . . . 0.0 112.226 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -130.63 151.57 50.94 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -93.45 99.52 11.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 110.921 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.2 p -129.96 168.21 17.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.555 1.142 . . . . 0.0 111.496 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 124.9 18.57 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.71 1.204 . . . . 0.0 110.976 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.61 46.99 8.27 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.537 1.065 . . . . 0.0 113.807 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.8 p -134.75 163.36 29.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 118.304 1.052 . . . . 0.0 112.942 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.36 139.08 54.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.817 . . . . 0.0 112.997 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.7 159.86 40.56 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.086 0.47 . . . . 0.0 111.731 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -82.88 141.13 32.45 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.687 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.01 162.0 14.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.188 0.995 . . . . 0.0 111.025 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -137.4 158.74 43.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.212 1.405 . . . . 0.0 112.274 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 m -72.35 -54.94 8.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.46 1.104 . . . . 0.0 111.661 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.87 -49.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.113 1.365 . . . . 0.0 112.425 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 156.1 77.77 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.594 1.158 . . . . 0.0 111.21 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.01 -27.72 80.44 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.081 2.521 . . . . 0.0 113.653 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -109.34 35.63 3.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.514 1.526 . . . . 0.0 112.515 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -118.07 31.82 6.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.517 1.527 . . . . 0.0 113.671 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.54 105.14 17.22 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.009 1.724 . . . . 0.0 109.038 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.2 p -97.57 -45.39 6.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.37 12.59 0.23 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -104.96 139.72 39.25 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.358 -1.464 . . . . 0.0 111.489 -169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -141.51 168.42 19.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.051 1.74 . . . . 0.0 111.527 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.7 p90 -147.79 162.08 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.97 117.79 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.744 1.218 . . . . 0.0 108.783 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -76.57 100.8 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.861 0.864 . . . . 0.0 110.596 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.78 -19.27 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.81 167.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.812 1.645 . . . . 0.0 111.761 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.81 120.7 24.44 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.964 -0.46 . . . . 0.0 110.092 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -146.2 62.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 123.001 1.381 . . . . 0.0 111.937 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.64 -13.23 58.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -62.76 -13.91 38.55 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.507 -1.371 . . . . 0.0 113.381 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.25 -9.26 59.72 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.583 1.153 . . . . 0.0 113.821 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -73.8 179.91 3.99 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -81.0 145.89 30.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.348 1.459 . . . . 0.0 112.257 169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.3 p -115.8 -59.34 2.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.581 1.152 . . . . 0.0 113.613 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.008 0 C-N-CA 124.17 0.891 . . . . 0.0 114.028 -172.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.282 7.2 p-90 . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.33 -93.42 1.13 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.316 1.436 . . . . 0.0 114.834 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.21 142.27 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.259 1.424 . . . . 0.0 111.721 -169.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.22 127.41 34.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.2 92.27 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.597 1.159 . . . . 0.0 108.22 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -80.38 -14.92 57.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.857 0.863 . . . . 0.0 112.031 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.98 8.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.335 1.064 . . . . 0.0 113.252 -170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -138.94 149.98 45.38 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.842 -1.161 . . . . 0.0 112.041 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 p -78.8 134.99 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.424 0.63 . . . . 0.0 110.464 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.96 -41.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.326 1.85 . . . . 0.0 110.736 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -143.98 155.81 44.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.667 1.587 . . . . 0.0 109.853 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.21 16.79 26.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.754 0.692 . . . . 0.0 114.734 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.05 -32.91 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.371 1.585 . . . . 0.0 112.437 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.66 -29.06 68.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.574 0.75 . . . . 0.0 112.684 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.06 -38.55 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.533 1.533 . . . . 0.0 110.463 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.6 -41.4 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.8 -1.188 . . . . 0.0 110.658 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.7 -30.6 70.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.134 1.373 . . . . 0.0 111.652 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.98 -46.89 61.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.51 0.724 . . . . 0.0 111.12 173.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 98.6 mt -68.73 -25.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.993 1.317 . . . . 0.0 112.142 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -85.13 -17.62 36.69 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.883 -1.136 . . . . 0.0 113.864 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.67 -8.73 54.14 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.058 1.79 . . . . 0.0 115.181 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -26.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 83.55 164.59 0.12 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.357 2.263 . . . . 0.0 114.663 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.2 p -114.27 151.5 32.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.909 1.683 . . . . 0.0 113.599 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.905 0 C-N-CA 125.032 1.301 . . . . 0.0 110.688 169.575 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -60.3 140.04 89.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.887 1.725 . . . . 0.0 110.761 169.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -32.38 62.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.62 150.18 31.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.726 0.774 . . . . 0.0 111.198 169.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.95 110.01 16.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 110.617 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.38 106.24 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.143 0.977 . . . . 0.0 108.372 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.74 142.2 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.652 1.181 . . . . 0.0 112.176 -169.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mt -84.36 103.87 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.78 -30.96 59.29 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.536 1.134 . . . . 0.0 111.533 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 p -162.76 171.47 16.73 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -135.52 143.75 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.329 1.452 . . . . 0.0 110.786 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -132.79 130.28 39.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.351 1.46 . . . . 0.0 109.764 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.66 125.46 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.1 t -121.15 150.5 41.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.588 1.555 . . . . 0.0 111.838 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.356 1.062 . . . . 0.0 112.999 -179.872 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.504 2.258 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -129.75 130.47 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 120.846 -1.159 . . . . 0.0 110.273 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.1 m -101.07 127.11 47.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.493 1.117 . . . . 0.0 110.235 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -101.66 124.03 46.63 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.778 1.231 . . . . 0.0 110.054 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.53 106.64 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.5 p -117.55 160.12 21.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.303 0.573 . . . . 0.0 112.114 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -68.5 -7.88 36.14 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.474 ' CE1' HD11 ' A' ' 136' ' ' ILE . 21.2 p80 -111.24 -25.69 9.56 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.522 . . . . 0.0 113.591 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.48 144.95 4.09 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.164 1.84 . . . . 0.0 113.538 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.96 133.6 38.06 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.383 1.073 . . . . 0.0 112.38 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -130.86 144.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.788 1.635 . . . . 0.0 109.379 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.4 136.79 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.274 1.03 . . . . 0.0 110.517 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -126.38 139.83 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.888 2.075 . . . . 0.0 110.189 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -102.46 127.69 49.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.69 1.996 . . . . 0.0 107.753 171.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -88.79 147.63 24.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.162 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -104.48 74.11 1.15 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.695 1.236 . . . . 0.0 111.391 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.69 -27.52 65.08 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.212 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.87 -31.37 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.528 1.131 . . . . 0.0 111.529 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -96.39 -24.51 16.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.6 1.16 . . . . 0.0 113.066 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.1 61.36 4.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.662 0.785 . . . . 0.0 112.971 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.37 -45.07 15.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.201 2.601 . . . . 0.0 112.583 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -69.48 -39.97 77.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.858 0.754 . . . . 0.0 111.13 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.482 ' HA ' HD13 ' A' ' 68' ' ' ILE . 20.4 m -63.23 -48.19 79.29 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.739 0.816 . . . . 0.0 111.249 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.26 -41.81 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.409 0.684 . . . . 0.0 111.803 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.26 -47.87 74.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.72 1.146 . . . . 0.0 112.129 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -37.11 73.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.097 0.559 . . . . 0.0 111.813 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.75 -49.0 79.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.333 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.78 -37.09 70.5 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.591 0.757 . . . . 0.0 111.821 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.094 0.558 . . . . 0.0 112.436 172.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.81 -41.83 59.2 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.438 -0.789 . . . . 0.0 112.522 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.21 -37.33 79.95 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.424 -0.797 . . . . 0.0 111.51 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.82 -35.04 78.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.803 2.041 . . . . 0.0 112.788 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -82.65 -13.15 56.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.023 0.929 . . . . 0.0 113.39 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.49 19.43 64.12 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.481 1.039 . . . . 0.0 114.154 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.53 -17.61 64.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.073 1.349 . . . . 0.0 114.524 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.49 -4.28 45.22 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.342 -0.848 . . . . 0.0 113.211 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -67.85 136.7 54.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 109.405 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.7 t30 49.29 46.35 23.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.829 1.652 . . . . 0.0 114.211 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -103.77 161.6 13.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.506 0.722 . . . . 0.0 111.921 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 13.7 pt -122.48 162.2 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -169.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -94.79 114.92 26.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.071 1.349 . . . . 0.0 107.945 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.96 1.11 14.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -134.22 133.55 41.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.333 1.424 . . . . 0.0 110.43 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.13 133.64 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.127 1.371 . . . . 0.0 111.125 170.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.41 130.48 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.988 1.715 . . . . 0.0 108.186 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -63.83 134.62 55.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.712 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.45 68.86 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.741 0.686 . . . . 0.0 114.667 -173.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.07 -177.19 5.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.234 1.813 . . . . 0.0 111.266 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.76 179.73 6.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.384 1.874 . . . . 0.0 114.974 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 pt -119.58 139.52 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.106 1.363 . . . . 0.0 112.317 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.4 148.74 33.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.874 1.27 . . . . 0.0 111.121 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.01 -176.41 33.09 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 115.259 0.864 . . . . 0.0 115.259 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.52 24.15 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.44 1.495 . . . . 0.0 115.252 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.56 -14.61 75.61 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.1 1.333 . . . . 0.0 115.689 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -141.5 167.66 21.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.721 1.208 . . . . 0.0 112.944 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -107.87 156.07 38.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.267 2.227 . . . . 0.0 109.329 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.83 128.8 31.44 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.102 2.535 . . . . 0.0 112.956 -170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.31 15.94 36.53 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.598 1.57 . . . . 0.0 113.505 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmm 61.66 37.44 15.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.241 1.416 . . . . 0.0 112.26 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.77 118.3 21.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.695 1.198 . . . . 0.0 108.882 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.59 126.35 29.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.491 0.663 . . . . 0.0 111.213 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -78.74 167.45 21.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.217 1.007 . . . . 0.0 113.366 171.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.47 75.1 5.19 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.833 1.653 . . . . 0.0 110.768 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.8 p -73.4 134.95 44.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.134 0.974 . . . . 0.0 111.842 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -138.68 171.93 13.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.941 2.096 . . . . 0.0 112.0 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 51.88 66.48 5.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.616 1.566 . . . . 0.0 113.365 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.27 136.06 69.75 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.297 2.665 . . . . 0.0 111.405 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -111.74 150.69 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.475 1.51 . . . . 0.0 109.413 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 157.66 21.77 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.915 0.486 . . . . 0.0 111.969 175.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -71.54 131.24 42.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.472 0.709 . . . . 0.0 110.131 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -117.44 13.58 14.47 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.054 1.342 . . . . 0.0 111.961 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.8 63.37 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.571 -1.331 . . . . 0.0 113.739 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -60.72 4.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.613 1.965 . . . . 0.0 115.914 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -84.67 4.23 33.49 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.876 1.67 . . . . 0.0 111.808 168.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.65 28.04 27.88 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.204 1.383 . . . . 0.0 113.961 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.58 143.43 40.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.002 0.921 . . . . 0.0 112.771 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.51 156.3 48.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.747 1.219 . . . . 0.0 113.702 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -110.83 110.78 21.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.598 2.359 . . . . 0.0 109.778 -171.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 p -137.65 171.65 14.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.43 1.092 . . . . 0.0 110.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -47.85 120.26 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.54 1.136 . . . . 0.0 111.362 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.03 21.5 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.717 1.151 . . . . 0.0 114.949 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.1 p -121.95 160.51 24.68 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.669 1.235 . . . . 0.0 112.937 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.15 136.49 54.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.686 0.794 . . . . 0.0 112.828 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.61 159.15 42.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.886 -0.509 . . . . 0.0 111.948 172.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 97.5 mmm -82.39 134.8 35.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.852 0.461 . . . . 0.0 110.86 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.12 154.51 21.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.244 1.018 . . . . 0.0 110.3 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -120.74 158.25 27.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.363 1.065 . . . . 0.0 113.034 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.8 m -69.27 -56.49 7.4 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.905 0.882 . . . . 0.0 110.73 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -150.69 -56.09 0.16 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.806 1.642 . . . . 0.0 110.23 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.51 157.34 72.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.947 1.299 . . . . 0.0 112.401 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -56.54 -25.77 60.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.683 2.922 . . . . 0.0 113.999 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -107.53 36.62 2.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.57 1.548 . . . . 0.0 112.687 -177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -126.74 28.03 5.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.27 1.428 . . . . 0.0 113.905 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.7 76.51 4.95 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.423 1.489 . . . . 0.0 112.469 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -70.19 -60.38 2.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.816 1.247 . . . . 0.0 114.233 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.21 -8.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -169.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -81.21 140.52 34.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.729 -1.232 . . . . 0.0 109.694 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -140.47 168.33 20.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.88 1.672 . . . . 0.0 111.251 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 19.7 p90 -146.81 161.73 40.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.657 0.783 . . . . 0.0 111.966 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.34 116.94 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.49 1.116 . . . . 0.0 108.537 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.72 98.15 4.02 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 110.689 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 -24.86 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 113.066 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.71 168.94 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.479 1.512 . . . . 0.0 112.024 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.41 120.51 23.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.732 1.213 . . . . 0.0 110.371 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -142.22 74.73 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.204 1.478 . . . . 0.0 112.209 -170.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.77 -34.93 70.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.894 2.077 . . . . 0.0 114.094 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.46 -13.17 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.46 -11.62 58.39 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -72.64 172.23 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.71 155.45 40.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.588 1.155 . . . . 0.0 112.107 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -139.65 -55.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.317 0 N-CA-C 116.769 1.467 . . . . 0.0 116.769 -177.191 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.258 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.92 -72.68 0.9 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.112 1.339 . . . . 0.0 115.378 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -139.68 150.1 44.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.04 1.336 . . . . 0.0 111.843 -169.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.6 t -87.98 120.35 29.23 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.647 -0.658 . . . . 0.0 112.543 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -77.52 82.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.253 1.421 . . . . 0.0 108.537 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -74.38 -14.52 60.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.024 0.929 . . . . 0.0 112.419 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.99 177.84 8.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.567 1.175 . . . . 0.0 113.904 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.79 153.9 47.24 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.888 -1.132 . . . . 0.0 112.606 172.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.09 141.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.711 0.767 . . . . 0.0 110.201 172.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.81 -40.2 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.786 1.634 . . . . 0.0 111.107 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -144.81 148.89 34.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.345 1.458 . . . . 0.0 110.674 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.88 10.11 21.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.579 1.085 . . . . 0.0 114.899 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -38.2 72.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.85 1.325 . . . . 0.0 112.433 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.961 0.904 . . . . 0.0 112.107 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.1 t -77.52 -43.71 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.518 . . . . 0.0 110.283 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.59 -38.16 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.291 -0.881 . . . . 0.0 111.099 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.43 -19.74 60.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.173 1.389 . . . . 0.0 113.044 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -86.19 -39.11 16.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.745 1.618 . . . . 0.0 111.669 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 8' ' ' HIS . 66.0 mt -53.13 -36.02 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.622 1.569 . . . . 0.0 112.09 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -84.61 -17.71 37.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.89 -20.36 16.77 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.291 1.424 . . . . 0.0 114.296 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.23 -59.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.614 1.207 . . . . 0.0 113.155 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.98 148.21 4.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 112.359 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.4 p -138.03 151.11 47.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.214 1.406 . . . . 0.0 111.861 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.955 0 C-N-CA 123.163 0.411 . . . . 0.0 112.639 169.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.84 134.55 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 121.386 1.391 . . . . 0.0 108.932 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -27.95 51.43 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.3 157.7 22.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.582 1.153 . . . . 0.0 110.369 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.13 111.48 18.29 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.135 -0.978 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.67 94.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.646 1.578 . . . . 0.0 107.071 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -127.42 143.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -169.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.1 mt -86.43 103.98 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.815 2.046 . . . . 0.0 106.728 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.76 -41.77 61.99 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.673 -0.642 . . . . 0.0 110.863 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.5 t -150.2 165.82 31.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.78 142.46 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.112 1.765 . . . . 0.0 111.178 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.2 m -135.21 128.58 32.24 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.89 1.276 . . . . 0.0 110.245 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.73 122.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -113.59 150.4 33.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.137 1.375 . . . . 0.0 112.275 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.061 1.344 . . . . 0.0 113.622 -170.803 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.94 127.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.909 0.884 . . . . 0.0 109.364 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.4 m -102.31 124.17 47.41 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.815 1.246 . . . . 0.0 109.901 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -101.46 125.3 48.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.588 1.155 . . . . 0.0 110.474 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -96.9 94.47 7.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 172.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -96.67 152.33 18.76 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.833 -0.542 . . . . 0.0 110.765 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -59.35 -14.34 11.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.96 -13.57 21.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.739 1.215 . . . . 0.0 113.655 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 167.74 14.94 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 123.242 1.468 . . . . 0.0 113.125 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.91 136.9 38.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.341 1.457 . . . . 0.0 112.835 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.2 mt -133.97 139.3 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.663 1.985 . . . . 0.0 108.643 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.1 t -123.56 134.93 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.594 1.158 . . . . 0.0 110.385 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -121.0 139.0 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.655 1.982 . . . . 0.0 110.094 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -103.79 125.78 50.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.56 1.944 . . . . 0.0 108.823 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -87.77 147.24 25.27 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.407 1.083 . . . . 0.0 111.361 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.52 74.41 1.25 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.692 1.234 . . . . 0.0 111.251 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.71 -25.9 64.09 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.607 1.163 . . . . 0.0 112.674 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.33 -28.01 56.72 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.559 1.144 . . . . 0.0 111.346 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -96.82 -30.6 13.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 112.725 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.61 58.59 3.38 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.761 0.824 . . . . 0.0 113.194 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -60.53 -42.71 38.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.583 2.855 . . . . 0.0 112.928 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -69.37 -41.43 76.54 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.655 0.661 . . . . 0.0 110.793 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.1 m -62.23 -49.86 74.05 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.393 0.677 . . . . 0.0 111.481 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -42.64 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.447 0.699 . . . . 0.0 111.401 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.2 -44.59 88.19 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.646 1.112 . . . . 0.0 111.567 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -65.45 -42.28 92.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.305 1.042 . . . . 0.0 111.868 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.9 -48.55 81.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.182 0.993 . . . . 0.0 111.731 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -38.49 81.49 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.91 0.884 . . . . 0.0 111.675 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -56.3 -36.24 68.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.172 0.989 . . . . 0.0 112.094 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -75.51 -43.56 48.35 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.526 -0.734 . . . . 0.0 112.626 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.7 m -61.69 -36.82 81.97 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.61 -0.681 . . . . 0.0 111.877 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.29 71.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.135 1.774 . . . . 0.0 112.824 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.42 -15.48 49.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.337 1.055 . . . . 0.0 113.378 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.66 51.57 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.524 0.583 . . . . 0.0 113.849 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -73.02 -18.11 61.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.117 1.459 . . . . 0.0 114.688 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -100.83 -5.2 26.54 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.143 -0.973 . . . . 0.0 112.273 169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -69.58 130.66 43.05 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.913 -1.117 . . . . 0.0 108.484 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t30 57.08 46.2 19.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.252 1.421 . . . . 0.0 113.698 -169.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -116.23 153.26 32.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.809 0.844 . . . . 0.0 112.449 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -104.93 163.44 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -95.7 94.81 7.92 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -89.08 -2.16 58.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -168.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -138.99 139.85 38.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.114 1.779 . . . . 0.0 112.304 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 132.0 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 126.624 1.97 . . . . 0.0 111.019 169.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.06 129.46 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.058 1.743 . . . . 0.0 108.027 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.71 133.41 55.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.387 0.675 . . . . 0.0 111.574 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.78 10.29 64.02 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -141.34 -177.34 5.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.008 1.723 . . . . 0.0 111.266 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.4 -178.9 5.72 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -169.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.6 pt -116.93 137.2 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.143 1.377 . . . . 0.0 112.275 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -109.15 149.29 29.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.685 1.194 . . . . 0.0 110.625 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.25 174.21 34.1 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 122.473 1.041 . . . . 0.0 115.381 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.72 0.74 75.3 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.932 1.253 . . . . 0.0 115.253 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 -19.27 62.74 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.255 1.527 . . . . 0.0 115.678 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -147.87 165.29 31.08 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.508 1.123 . . . . 0.0 113.193 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.69 163.88 28.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.19 1.396 . . . . 0.0 109.926 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -60.29 -15.63 36.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.551 2.834 . . . . 0.0 118.325 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.27 19.79 53.08 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.179 0.895 . . . . 0.0 114.558 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.05 32.35 19.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.92 126.7 35.2 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.321 1.448 . . . . 0.0 109.162 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.16 127.98 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.717 0.807 . . . . 0.0 110.829 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -72.69 165.52 24.62 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.268 170.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.52 74.48 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.736 1.614 . . . . 0.0 111.088 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 p -73.0 140.76 47.55 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.596 1.158 . . . . 0.0 112.703 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -141.76 178.06 7.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.991 2.116 . . . . 0.0 111.887 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 51.68 65.17 6.76 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 125.784 1.634 . . . . 0.0 114.346 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -57.12 133.26 56.54 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.316 2.677 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.16 150.87 7.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 126.101 1.76 . . . . 0.0 108.72 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 157.85 23.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 169.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -76.52 126.14 30.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.597 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -108.18 14.39 25.06 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.233 1.413 . . . . 0.0 112.915 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -15.79 62.73 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.325 -1.485 . . . . 0.0 114.111 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.94 0.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.123 1.769 . . . . 0.0 115.77 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -79.39 -3.87 48.41 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.883 1.273 . . . . 0.0 112.126 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.39 31.55 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.891 1.234 . . . . 0.0 114.619 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.3 mt -80.43 159.3 25.69 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -131.43 156.34 45.76 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -103.82 115.41 30.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.232 2.213 . . . . 0.0 110.302 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -139.94 167.91 21.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.685 1.194 . . . . 0.0 111.442 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -51.72 119.79 4.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.388 1.475 . . . . 0.0 110.715 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.16 28.87 21.69 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.922 1.249 . . . . 0.0 114.977 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.4 p -122.58 158.94 28.82 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.169 1.484 . . . . 0.0 112.897 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.69 139.28 53.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.681 0.753 . . . . 0.0 112.756 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.49 159.7 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.738 170.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -80.28 141.21 35.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.101 0.56 . . . . 0.0 111.641 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 154.18 19.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.27 0.628 . . . . 0.0 111.516 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -141.0 158.1 44.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.292 1.437 . . . . 0.0 112.713 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 m -72.25 -55.5 7.09 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.881 0.872 . . . . 0.0 113.006 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -159.47 -54.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.276 1.031 . . . . 0.0 111.57 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.71 158.84 86.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.2 1.0 . . . . 0.0 111.365 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.01 -27.69 85.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.832 2.355 . . . . 0.0 113.358 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -109.21 36.15 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.499 1.52 . . . . 0.0 112.511 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.0 p -115.58 30.56 7.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.456 1.502 . . . . 0.0 113.318 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 101.91 14.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.015 1.326 . . . . 0.0 110.092 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 p -91.52 -64.35 1.13 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.187 0.995 . . . . 0.0 113.001 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.81 42.37 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -133.87 153.91 51.42 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.069 -1.02 . . . . 0.0 112.955 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -145.54 168.21 21.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.749 2.02 . . . . 0.0 110.958 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.0 p90 -144.63 159.69 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 111.208 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.6 mt -113.0 118.07 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.19 108.22 6.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.192 0.597 . . . . 0.0 109.798 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.94 -14.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.35 168.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.376 2.271 . . . . 0.0 111.226 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.69 119.24 24.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.469 0.708 . . . . 0.0 109.525 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -141.07 77.17 1.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.975 1.369 . . . . 0.0 113.15 -169.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.24 -34.73 61.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.024 2.13 . . . . 0.0 114.514 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -61.79 -12.7 18.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.09 -10.64 57.66 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.41 178.14 6.12 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -83.94 142.38 30.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.971 1.308 . . . . 0.0 111.814 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -111.35 -58.74 2.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.599 1.159 . . . . 0.0 113.42 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 C-N-CA 124.241 0.924 . . . . 0.0 113.346 -173.187 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.306 6.6 p-90 . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.2 -86.9 1.26 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.362 1.458 . . . . 0.0 115.758 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -139.54 149.94 44.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.883 1.273 . . . . 0.0 111.796 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.9 t -81.27 119.53 23.76 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.732 -0.605 . . . . 0.0 112.408 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.44 84.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -77.06 -14.81 59.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.64 0.776 . . . . 0.0 111.942 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 177.42 8.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.622 1.201 . . . . 0.0 113.783 -170.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -140.64 154.56 46.47 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.768 -1.208 . . . . 0.0 112.333 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.48 140.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.64 0.733 . . . . 0.0 110.084 170.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.97 -42.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 111.008 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -144.5 153.54 41.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 109.93 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 103.47 15.03 24.19 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 123.878 0.751 . . . . 0.0 114.289 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.1 68.54 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.028 1.414 . . . . 0.0 112.263 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -65.74 -30.07 70.68 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.746 0.818 . . . . 0.0 112.466 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.49 -43.13 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.8 1.24 . . . . 0.0 110.092 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.25 -40.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.816 0.846 . . . . 0.0 111.332 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.83 -27.29 62.81 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.93 1.292 . . . . 0.0 112.367 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.13 -42.27 32.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.463 1.105 . . . . 0.0 111.205 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.11 -30.14 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.935 1.694 . . . . 0.0 112.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -91.82 -20.11 21.83 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.78 -17.53 27.88 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.498 1.523 . . . . 0.0 114.738 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.44 -51.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 118.887 1.344 . . . . 0.0 112.722 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.97 155.77 5.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.189 1.396 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.8 p -135.87 150.96 49.56 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 0.0 112.312 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.111 0 C-N-CA 123.032 0.348 . . . . 0.0 112.819 169.93 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.2 135.03 24.1 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.766 1.644 . . . . 0.0 109.375 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -24.98 39.83 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.28 150.24 35.32 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.431 1.092 . . . . 0.0 110.738 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.19 116.94 21.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.798 0.839 . . . . 0.0 111.249 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.03 110.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.573 1.149 . . . . 0.0 108.579 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.08 152.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.415 1.486 . . . . 0.0 110.871 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.96 103.25 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.4 -25.02 36.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.691 0.797 . . . . 0.0 112.113 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -154.35 161.76 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.513 0.725 . . . . 0.0 112.714 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.5 t -134.41 139.2 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.696 1.598 . . . . 0.0 110.157 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.8 m -136.54 131.01 33.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.739 1.216 . . . . 0.0 110.588 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.85 122.95 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -119.31 150.25 40.44 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.079 1.352 . . . . 0.0 112.277 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.294 1.438 . . . . 0.0 113.753 -170.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 131.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.989 -1.694 . . . . 0.0 111.514 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.0 m -102.32 123.93 46.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.022 0.929 . . . . 0.0 110.091 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -98.98 132.83 44.0 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.95 1.3 . . . . 0.0 110.677 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -104.83 98.89 8.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -104.6 152.51 22.36 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.962 -0.461 . . . . 0.0 110.835 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.448 HD22 HG12 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -59.44 -20.43 55.02 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -89.8 -15.92 31.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.845 1.258 . . . . 0.0 113.187 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.06 165.3 12.44 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.741 1.639 . . . . 0.0 113.191 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -72.98 137.69 45.61 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.519 1.528 . . . . 0.0 112.534 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.7 mt -134.47 140.71 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.256 1.822 . . . . 0.0 108.764 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.31 132.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 110.479 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.92 135.75 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 110.04 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -98.19 130.46 44.93 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.928 1.691 . . . . 0.0 107.224 171.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -92.13 146.57 23.62 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.22 1.008 . . . . 0.0 110.505 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -102.14 73.9 1.4 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.843 1.306 . . . . 0.0 111.006 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.97 -25.5 64.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.209 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.77 1.228 . . . . 0.0 111.508 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.08 -27.54 15.04 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.861 1.264 . . . . 0.0 112.801 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.25 58.13 3.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -61.11 -42.64 34.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.519 2.813 . . . . 0.0 113.146 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.16 -40.55 78.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.8 m -61.05 -53.57 55.58 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.541 0.736 . . . . 0.0 111.845 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.1 -41.73 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.839 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -54.14 -49.22 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.918 1.236 . . . . 0.0 111.969 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.52 -38.88 81.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.376 0.67 . . . . 0.0 111.935 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.67 -49.52 77.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 0.0 111.767 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.58 -34.31 67.36 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.56 0.744 . . . . 0.0 111.811 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -57.78 -33.45 68.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.69 0.796 . . . . 0.0 112.556 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -75.4 -44.21 45.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.437 -0.79 . . . . 0.0 112.333 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.2 -35.81 78.17 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.6 -0.688 . . . . 0.0 111.765 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.84 -34.54 78.15 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.353 2.261 . . . . 0.0 112.789 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -82.11 -14.12 56.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.882 0.873 . . . . 0.0 113.152 171.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.7 18.58 61.45 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.562 1.077 . . . . 0.0 113.814 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.55 -24.04 67.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.72 1.26 . . . . 0.0 114.19 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -89.21 -7.7 55.02 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.304 0.642 . . . . 0.0 112.687 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -64.36 135.67 56.38 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.938 -1.101 . . . . 0.0 108.793 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.25 22.98 12.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.5 p -88.73 162.48 16.23 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.116 -0.99 . . . . 0.0 111.392 169.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.44 HG22 HG22 ' A' ' 156' ' ' ILE . 9.0 pt -122.38 164.76 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -169.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -97.99 96.75 8.37 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -90.24 -8.27 51.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -134.37 138.49 44.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.37 1.441 . . . . 0.0 113.471 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.48 134.37 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.961 2.505 . . . . 0.0 109.272 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 90.1 mt -138.07 129.28 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.733 1.613 . . . . 0.0 108.029 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -61.63 132.77 54.34 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.25 0.62 . . . . 0.0 111.849 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.01 10.17 61.28 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.15 -177.16 5.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.892 1.677 . . . . 0.0 111.314 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -178.66 6.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.083 1.753 . . . . 0.0 115.558 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.7 pt -115.96 138.06 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.186 1.394 . . . . 0.0 112.563 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -108.68 149.35 29.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.516 1.126 . . . . 0.0 111.056 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.89 175.9 32.78 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.454 1.03 . . . . 0.0 114.965 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 6.78 83.6 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.627 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.71 -25.53 35.02 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 119.717 1.758 . . . . 0.0 115.71 -172.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -149.73 169.78 20.26 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.663 1.185 . . . . 0.0 113.054 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.46 164.47 16.58 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.892 1.677 . . . . 0.0 110.064 168.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.87 -12.88 33.98 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.877 3.051 . . . . 0.0 117.437 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.19 14.65 61.71 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.786 0.708 . . . . 0.0 114.449 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.0 mmt 59.71 29.77 19.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.396 1.878 . . . . 0.0 112.879 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.03 125.49 32.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.961 1.304 . . . . 0.0 109.367 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -71.57 121.94 19.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.412 1.085 . . . . 0.0 110.231 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -66.68 159.2 28.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.35 73.38 8.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.409 1.483 . . . . 0.0 111.57 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 p -68.03 121.27 15.74 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.507 1.123 . . . . 0.0 112.596 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -130.93 176.66 8.05 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.098 1.759 . . . . 0.0 111.954 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 49.25 67.27 4.65 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.674 1.59 . . . . 0.0 113.99 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.66 140.1 91.99 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.38 2.72 . . . . 0.0 111.765 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -111.76 152.59 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.038 1.735 . . . . 0.0 109.046 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.27 0.1 OUTLIER -76.23 158.93 31.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.237 0.615 . . . . 0.0 110.355 169.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.27 -56.58 20.0 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 70.95 3.68 4.74 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.46 -15.09 63.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 119.919 -1.738 . . . . 0.0 114.126 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -59.94 3.8 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.118 2.567 . . . . 0.0 116.151 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -84.22 5.72 25.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.421 1.489 . . . . 0.0 112.257 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.71 32.71 32.6 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.816 1.198 . . . . 0.0 113.299 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.11 140.56 39.05 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.417 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -131.69 147.74 52.53 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -99.13 85.87 3.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 111.642 -169.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.5 p -112.57 168.32 9.75 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.506 0.723 . . . . 0.0 112.109 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -55.89 130.16 42.5 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.667 1.187 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.24 35.41 33.95 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.179 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.9 p -125.92 161.91 26.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.78 1.29 . . . . 0.0 113.354 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 mp -120.49 136.09 54.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.792 0.837 . . . . 0.0 112.896 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.09 159.19 39.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.468 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -84.64 141.12 30.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.62 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.31 154.02 19.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.467 0.707 . . . . 0.0 111.112 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -133.39 162.92 30.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.827 1.251 . . . . 0.0 113.572 -171.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -76.95 -56.23 4.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.617 1.167 . . . . 0.0 113.109 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -159.09 -54.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.543 1.137 . . . . 0.0 111.76 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.28 161.82 71.45 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.509 1.124 . . . . 0.0 111.53 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.31 -20.14 69.78 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.147 2.565 . . . . 0.0 114.071 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.28 42.13 2.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.356 1.862 . . . . 0.0 111.983 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.5 p -125.79 30.79 5.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.186 1.394 . . . . 0.0 113.638 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.0 104.48 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.816 1.647 . . . . 0.0 109.527 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.2 p -89.73 -72.73 0.54 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.455 1.102 . . . . 0.0 113.204 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.27 36.43 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.32 149.8 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.03 1.332 . . . . 0.0 111.621 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.18 168.41 21.06 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.476 1.511 . . . . 0.0 111.673 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.7 p90 -146.37 162.1 38.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 30.4 mt -115.01 116.03 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.539 1.136 . . . . 0.0 108.181 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -71.31 99.09 1.87 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.72 0.808 . . . . 0.0 109.772 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.4 m -77.83 -16.36 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 113.212 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.55 166.28 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 128.292 2.637 . . . . 0.0 110.968 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.0 119.66 19.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.226 0.536 . . . . 0.0 111.331 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -126.85 55.37 1.56 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.015 1.726 . . . . 0.0 111.641 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.56 -12.14 50.37 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -69.51 -14.92 63.12 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.819 -1.176 . . . . 0.0 113.349 169.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.37 -14.91 56.69 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -66.79 172.48 4.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.071 2.148 . . . . 0.0 116.595 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.05 155.81 40.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.871 1.268 . . . . 0.0 112.402 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.7 t -140.92 -53.78 0.48 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -178.169 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.252 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.54 -71.37 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.991 1.282 . . . . 0.0 114.048 -174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -133.73 131.85 39.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.939 0.896 . . . . 0.0 111.899 -169.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.3 t -93.04 126.16 37.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.425 0.69 . . . . 0.0 112.523 -172.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.82 89.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.189 0.995 . . . . 0.0 109.225 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -75.23 -15.18 60.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.354 1.062 . . . . 0.0 112.015 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.66 176.36 10.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.315 1.055 . . . . 0.0 113.828 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -140.37 151.19 44.78 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 112.264 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.04 133.6 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.575 0.702 . . . . 0.0 110.349 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.67 -43.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.339 1.856 . . . . 0.0 110.812 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -143.07 154.77 44.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.546 1.538 . . . . 0.0 109.964 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.75 14.92 33.05 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.787 0.708 . . . . 0.0 114.478 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 81.9 mmm -54.89 -36.11 64.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.27 1.535 . . . . 0.0 112.275 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.36 -30.48 71.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.849 0.86 . . . . 0.0 112.612 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.49 -40.77 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.978 1.311 . . . . 0.0 110.377 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.65 -42.56 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.272 -0.892 . . . . 0.0 110.93 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.08 -25.08 63.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.314 1.445 . . . . 0.0 112.22 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -75.76 -52.19 11.0 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.049 0.94 . . . . 0.0 110.398 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 53.6 mt -53.01 -36.41 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.364 1.865 . . . . 0.0 112.686 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.02 -14.44 31.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.88 -18.23 11.83 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.828 1.68 . . . . 0.0 113.882 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.31 -59.41 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.412 1.106 . . . . 0.0 113.051 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.56 162.39 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.768 1.227 . . . . 0.0 112.677 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.0 p -136.07 151.4 49.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.496 1.518 . . . . 0.0 112.389 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.175 0 C-N-CA 123.146 0.403 . . . . 0.0 113.436 170.063 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -69.95 138.64 37.68 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.14 1.893 . . . . 0.0 109.852 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -31.18 38.0 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -79.17 149.42 31.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.83 0.852 . . . . 0.0 111.398 169.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.0 114.38 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.495 1.118 . . . . 0.0 111.229 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.24 105.67 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 108.402 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 7' ' ' ASN . 1.4 pt -128.12 143.82 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.558 0.743 . . . . 0.0 111.565 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.16 103.34 11.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.17 -36.66 66.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.294 0.637 . . . . 0.0 110.476 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 t -153.92 166.0 34.35 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.21 141.38 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.642 1.977 . . . . 0.0 110.58 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 125.09 30.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.184 1.394 . . . . 0.0 109.909 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.67 125.47 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.205 0.602 . . . . 0.0 109.878 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.2 t -111.49 150.77 29.45 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.33 1.452 . . . . 0.0 112.138 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.676 1.19 . . . . 0.0 113.241 -172.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.15 130.75 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.045 0.938 . . . . 0.0 109.265 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -106.19 121.69 44.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.795 1.238 . . . . 0.0 110.148 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.68 135.61 33.94 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.495 1.118 . . . . 0.0 110.72 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -107.25 101.1 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -103.92 152.75 21.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.895 -0.503 . . . . 0.0 111.016 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -60.1 -7.49 1.87 Allowed 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -109.31 -8.04 15.15 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.074 1.35 . . . . 0.0 114.215 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.52 165.89 12.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.374 1.464 . . . . 0.0 113.742 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.78 138.82 39.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.364 1.866 . . . . 0.0 112.838 174.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -135.4 140.9 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.303 1.841 . . . . 0.0 109.066 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.04 136.87 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.553 1.141 . . . . 0.0 110.562 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.22 139.43 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.73 2.012 . . . . 0.0 110.465 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -101.81 126.91 48.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.862 2.065 . . . . 0.0 107.659 171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 p -88.62 147.58 24.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.171 0.989 . . . . 0.0 111.085 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.02 74.33 1.3 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.688 1.232 . . . . 0.0 111.156 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.74 -26.92 64.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.547 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -75.73 -30.87 59.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.291 1.036 . . . . 0.0 111.437 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 -28.7 14.53 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 113.011 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.8 56.99 3.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -60.1 -43.63 34.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 112.758 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -68.08 -40.17 82.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.756 0.707 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 68' ' ' ILE . 26.6 m -65.14 -48.12 74.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.569 0.748 . . . . 0.0 111.6 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -68.38 -39.51 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.921 0.888 . . . . 0.0 112.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.16 -47.16 75.53 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.677 1.126 . . . . 0.0 111.816 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.443 HD22 HD11 ' A' ' 68' ' ' ILE . 64.1 t30 -69.3 -38.66 78.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.339 0.655 . . . . 0.0 111.88 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.09 -47.6 84.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 0.0 111.539 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.56 -38.57 74.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.25 0.62 . . . . 0.0 111.374 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -63.14 -29.66 70.97 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -73.62 -42.84 60.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.302 -0.874 . . . . 0.0 111.967 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.16 -37.61 85.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.541 -0.725 . . . . 0.0 111.463 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -58.42 -37.87 76.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.468 2.307 . . . . 0.0 113.438 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -81.73 -15.0 55.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.707 1.203 . . . . 0.0 113.531 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.8 61.03 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.872 1.225 . . . . 0.0 114.362 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -69.58 -17.72 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.542 1.537 . . . . 0.0 114.963 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.92 -13.03 21.42 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.55 1.23 8.53 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -147.19 53.59 1.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.206 1.402 . . . . 0.0 110.606 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.4 p -114.36 171.94 7.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.185 0.994 . . . . 0.0 113.121 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 156' ' ' ILE . 12.9 pt -127.65 166.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -98.93 110.44 23.05 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -109.15 0.81 19.97 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -152.66 129.94 11.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.53 1.513 . . . . 0.0 111.591 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.66 141.21 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.664 1.986 . . . . 0.0 111.168 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.61 127.62 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.142 1.377 . . . . 0.0 108.66 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -64.63 132.88 50.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 0.0 111.659 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 10.74 66.01 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.01 0.814 . . . . 0.0 114.908 -173.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -144.56 -174.84 4.43 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.82 2.048 . . . . 0.0 110.412 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.58 -179.93 7.46 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.7 pt -123.34 142.73 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.169 1.387 . . . . 0.0 113.8 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -122.79 147.81 46.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.826 1.65 . . . . 0.0 112.363 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.68 -175.74 32.02 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.73 73.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.148 1.832 . . . . 0.0 115.641 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.86 -16.05 60.33 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.79 164.87 28.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.583 1.192 . . . . 0.0 112.705 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -94.92 161.94 26.76 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.926 1.691 . . . . 0.0 110.806 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -60.75 -8.84 10.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.007 3.138 . . . . 0.0 117.613 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.68 12.96 67.08 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.151 0.882 . . . . 0.0 115.039 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mmt 59.68 29.12 18.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.282 1.833 . . . . 0.0 112.822 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.01 131.22 34.15 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.303 1.441 . . . . 0.0 109.403 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -73.53 121.02 19.93 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.094 0.958 . . . . 0.0 110.339 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -72.34 164.77 25.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.86 71.85 7.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.513 1.525 . . . . 0.0 111.332 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 p -70.86 107.92 4.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 111.824 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -111.28 175.98 5.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.454 1.902 . . . . 0.0 111.808 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.08 65.8 5.46 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.464 1.505 . . . . 0.0 113.576 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -58.03 132.12 47.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.998 2.465 . . . . 0.0 110.364 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -114.85 147.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.607 1.163 . . . . 0.0 109.656 -173.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 155.31 29.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.991 0.917 . . . . 0.0 112.145 172.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -75.14 129.56 37.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.987 0.915 . . . . 0.0 110.828 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -112.29 14.33 20.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.207 1.403 . . . . 0.0 113.124 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.99 -15.45 59.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.247 -1.533 . . . . 0.0 113.477 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -59.25 -0.97 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -80.39 -3.03 48.11 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.117 1.367 . . . . 0.0 112.095 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.8 27.19 27.31 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.099 1.333 . . . . 0.0 114.495 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.61 158.57 28.42 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.962 0.881 . . . . 0.0 112.999 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -130.58 159.24 37.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.684 1.194 . . . . 0.0 114.024 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -106.9 115.15 29.69 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.068 2.147 . . . . 0.0 109.927 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.3 p -140.95 168.41 19.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.81 1.244 . . . . 0.0 111.241 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -54.49 125.15 18.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.117 0.967 . . . . 0.0 110.91 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.84 31.97 25.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.26 1.41 . . . . 0.0 115.075 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.1 p -123.79 159.77 28.78 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.31 1.555 . . . . 0.0 113.342 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -123.68 138.47 54.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 0.0 113.191 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.9 157.78 46.0 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.823 -0.548 . . . . 0.0 112.184 169.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.0 mmm -79.6 136.17 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.865 0.466 . . . . 0.0 110.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.58 142.19 27.9 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.798 0.839 . . . . 0.0 110.749 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -85.83 154.03 21.84 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.413 1.085 . . . . 0.0 112.677 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -70.14 -51.99 27.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.801 0.841 . . . . 0.0 110.178 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -157.56 -57.96 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.424 1.489 . . . . 0.0 110.451 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.41 154.73 83.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.18 0.992 . . . . 0.0 111.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.69 -19.27 64.53 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.93 2.42 . . . . 0.0 114.45 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -112.69 38.21 2.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.845 1.658 . . . . 0.0 112.332 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -122.17 30.26 6.66 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.319 1.447 . . . . 0.0 113.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.08 61.55 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.446 1.499 . . . . 0.0 113.035 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -58.82 -65.33 0.68 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.904 1.681 . . . . 0.0 113.946 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.83 0.55 0.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.7 146.43 24.52 Favored 'General case' 0 N--CA 1.462 0.175 0 O-C-N 120.515 -1.366 . . . . 0.0 110.51 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -141.14 168.28 20.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.758 1.623 . . . . 0.0 110.479 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.1 p90 -145.33 159.27 43.31 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.103 0.561 . . . . 0.0 111.87 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.82 119.49 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.101 1.36 . . . . 0.0 108.267 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -78.28 119.74 22.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.55 0.74 . . . . 0.0 110.774 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -98.74 -8.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.9 164.51 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.689 1.596 . . . . 0.0 111.32 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -80.8 119.1 22.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.996 0.518 . . . . 0.0 109.993 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -137.58 70.67 1.4 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.955 1.359 . . . . 0.0 112.149 -169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.57 -35.79 54.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.251 2.22 . . . . 0.0 114.404 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -59.72 -14.24 13.41 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.27 -13.33 57.19 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -73.6 169.83 16.45 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.25 145.63 55.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.625 0.77 . . . . 0.0 112.981 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 61.0 p -115.05 -59.54 2.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.522 1.529 . . . . 0.0 113.09 -177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 C-N-CA 125.32 1.438 . . . . 0.0 112.077 -171.098 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.489 ' N ' ' HG ' ' A' ' 111' ' ' SER . 1.6 p-90 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.58 -58.94 0.64 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 116.559 1.383 . . . . 0.0 116.559 -169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -141.65 151.11 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.365 1.066 . . . . 0.0 112.215 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.2 t -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.835 -0.541 . . . . 0.0 112.456 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.3 83.38 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.766 1.226 . . . . 0.0 108.594 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -77.6 -14.03 59.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.021 0.928 . . . . 0.0 112.129 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.45 177.83 7.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.771 1.272 . . . . 0.0 114.343 -169.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -141.43 153.63 45.12 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.65 1.18 . . . . 0.0 112.417 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 143.7 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.688 0.756 . . . . 0.0 110.323 173.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.45 -41.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.736 1.614 . . . . 0.0 110.936 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -147.03 154.52 41.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.678 1.591 . . . . 0.0 110.108 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.25 14.21 24.79 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 123.866 0.746 . . . . 0.0 114.603 172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -34.62 63.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.055 1.427 . . . . 0.0 112.305 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.15 -30.02 71.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.687 0.795 . . . . 0.0 112.577 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.2 t -75.97 -43.22 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.052 1.341 . . . . 0.0 110.271 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.62 -38.42 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.362 -0.836 . . . . 0.0 110.973 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -26.42 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.339 1.456 . . . . 0.0 112.6 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -76.91 -42.27 40.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.724 1.21 . . . . 0.0 110.821 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.6 mt -57.61 -29.26 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.568 1.547 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -89.82 -14.04 35.3 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.15 -14.0 17.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.745 1.64 . . . . 0.0 114.627 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 -57.74 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 118.778 1.289 . . . . 0.0 112.445 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.61 144.95 0.89 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.7 1.6 . . . . 0.0 111.157 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -129.05 150.07 50.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.043 1.337 . . . . 0.0 112.946 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.019 0 C-N-CA 124.343 0.973 . . . . 0.0 112.256 170.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.47 129.29 18.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.245 1.296 . . . . 0.0 108.897 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -25.21 32.31 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.709 0.403 . . . . 0.0 111.857 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.9 146.7 37.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.004 0.922 . . . . 0.0 109.155 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.32 109.99 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.403 0.621 . . . . 0.0 111.326 -171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.88 109.1 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.218 1.007 . . . . 0.0 108.589 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.9 142.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -172.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -84.01 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -76.95 -27.07 54.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.801 1.24 . . . . 0.0 111.794 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.4 t -163.17 168.66 20.46 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.67 140.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.276 1.831 . . . . 0.0 110.488 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -131.53 133.12 44.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.355 1.462 . . . . 0.0 110.001 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.69 123.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.4 t -118.21 150.35 39.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.254 1.421 . . . . 0.0 112.533 -173.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.542 1.537 . . . . 0.0 113.649 -170.029 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.04 128.28 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.921 1.237 . . . . 0.0 110.387 174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -99.9 126.53 46.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.514 1.125 . . . . 0.0 110.262 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -102.52 127.62 49.51 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.091 1.356 . . . . 0.0 110.29 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -101.16 99.43 9.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -103.77 152.27 22.06 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.842 -0.536 . . . . 0.0 111.293 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -60.39 -9.52 3.68 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -106.99 -9.56 16.2 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.805 1.242 . . . . 0.0 114.189 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.02 163.23 11.55 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.046 1.359 . . . . 0.0 113.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.28 138.18 43.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.636 1.574 . . . . 0.0 112.736 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.18 139.85 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.521 1.928 . . . . 0.0 108.43 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.63 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 110.352 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -125.03 134.11 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.357 1.863 . . . . 0.0 110.04 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.14 127.75 47.55 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.678 . . . . 0.0 108.605 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 p -88.92 146.48 24.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -104.31 73.94 1.15 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.701 1.239 . . . . 0.0 111.434 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.19 -25.06 64.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.503 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 -24.04 46.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.593 1.157 . . . . 0.0 111.873 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -107.4 -16.74 14.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.501 1.521 . . . . 0.0 113.29 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 50.6 0.52 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.841 1.256 . . . . 0.0 114.352 -172.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.22 -40.82 56.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.568 2.845 . . . . 0.0 113.859 -170.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -71.68 -35.17 70.2 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.646 -0.659 . . . . 0.0 110.851 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.4 m -70.49 -47.95 58.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.56 -43.5 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.089 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -58.77 -45.54 89.56 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.672 1.123 . . . . 0.0 111.619 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.98 -43.78 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.342 1.057 . . . . 0.0 111.937 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.51 -47.7 84.51 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 111.693 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.98 -37.72 72.74 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.565 0.746 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.64 -29.49 70.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.92 0.888 . . . . 0.0 112.937 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -77.01 -43.14 35.82 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.512 -0.743 . . . . 0.0 112.536 170.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.0 m -62.09 -37.53 85.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.206 -0.934 . . . . 0.0 111.515 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -57.2 -37.37 72.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.127 2.571 . . . . 0.0 113.581 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.3 -15.25 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.766 1.226 . . . . 0.0 113.381 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.88 18.12 56.78 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.988 0.804 . . . . 0.0 113.935 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.2 -17.96 60.83 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -99.47 -8.37 24.76 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.147 -0.97 . . . . 0.0 112.068 169.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.35 130.24 41.43 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.01 44.37 22.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 114.226 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 p -109.9 167.7 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.214 1.006 . . . . 0.0 110.926 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 156' ' ' ILE . 15.0 pt -124.0 162.16 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.68 85.06 6.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.499 1.12 . . . . 0.0 108.033 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -74.88 -10.81 59.85 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -146.72 138.22 24.38 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.237 1.835 . . . . 0.0 114.182 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.76 146.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.155 2.582 . . . . 0.0 110.46 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.7 mt -137.94 131.86 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.183 1.793 . . . . 0.0 107.85 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.47 137.22 57.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.553 0.741 . . . . 0.0 112.049 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 12.73 62.21 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.864 0.745 . . . . 0.0 114.644 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -142.54 -177.13 5.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.169 1.788 . . . . 0.0 111.412 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -178.79 7.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.971 1.709 . . . . 0.0 114.576 -173.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.7 pt -119.49 142.62 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.417 1.087 . . . . 0.0 113.237 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -110.89 150.2 29.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.944 1.297 . . . . 0.0 111.512 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.78 176.13 35.7 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.35 0.57 67.05 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.085 1.802 . . . . 0.0 115.354 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -16.93 65.12 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.013 1.407 . . . . 0.0 115.494 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -145.38 166.4 25.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.824 1.25 . . . . 0.0 112.987 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.91 162.26 24.62 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.841 1.657 . . . . 0.0 110.493 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.96 -13.17 29.6 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.655 2.903 . . . . 0.0 117.709 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.12 16.62 60.56 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.053 0.835 . . . . 0.0 114.5 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.8 30.19 19.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 112.575 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.04 126.12 33.93 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.037 1.335 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.25 119.96 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.362 1.065 . . . . 0.0 110.675 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.86 162.78 28.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.17 70.35 3.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.769 1.628 . . . . 0.0 111.591 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -73.35 142.71 47.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.927 1.291 . . . . 0.0 113.049 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -141.76 175.46 9.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.982 2.113 . . . . 0.0 111.943 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 52.55 67.87 3.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.689 1.595 . . . . 0.0 114.09 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -60.59 134.49 54.82 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.204 2.603 . . . . 0.0 111.51 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.1 152.13 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.811 1.644 . . . . 0.0 107.999 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 160.49 19.89 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.098 0.559 . . . . 0.0 111.757 170.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.16 132.98 41.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.164 0.586 . . . . 0.0 110.998 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -118.42 15.42 13.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.425 1.49 . . . . 0.0 112.674 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -15.96 46.13 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 119.957 -1.714 . . . . 0.0 114.179 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.28 4.48 0.5 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.13 1.372 . . . . 0.0 113.568 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -75.7 -9.68 58.79 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.775 1.23 . . . . 0.0 112.898 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.62 1.67 82.89 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.754 1.645 . . . . 0.0 114.822 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.09 153.58 32.08 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.259 1.029 . . . . 0.0 112.13 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -130.98 150.85 51.94 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -87.97 77.66 8.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.625 1.97 . . . . 0.0 111.629 -169.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 p -110.34 168.07 9.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -46.19 121.82 3.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 111.372 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.6 36.78 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.23 1.395 . . . . 0.0 114.823 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -118.66 157.72 26.89 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.121 1.46 . . . . 0.0 113.586 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -117.96 135.08 54.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 112.831 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.47 159.7 40.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.485 0.659 . . . . 0.0 111.962 172.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ptp -70.12 145.12 51.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.536 0.734 . . . . 0.0 111.233 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 150.56 20.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.265 0.626 . . . . 0.0 110.066 169.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -127.68 160.5 31.45 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.519 1.127 . . . . 0.0 112.856 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -87.78 58.27 4.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.996 1.718 . . . . 0.0 110.213 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.341 18.1 pt20 54.49 -38.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 130.186 3.395 . . . . 0.0 117.648 -169.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.34 149.29 84.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.347 1.43 . . . . 0.0 111.3 173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.13 -35.18 66.03 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.471 2.114 . . . . 0.0 113.715 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -106.09 41.18 1.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 0.0 112.406 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -130.05 27.74 5.1 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.22 1.408 . . . . 0.0 113.839 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.58 104.69 16.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.47 1.508 . . . . 0.0 108.644 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -91.08 -52.31 4.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.282 1.033 . . . . 0.0 112.949 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -161.08 41.41 0.16 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.311 1.044 . . . . 0.0 113.064 -170.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -131.17 145.24 51.88 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.974 -1.078 . . . . 0.0 111.602 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.59 168.32 21.56 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.398 1.879 . . . . 0.0 111.594 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -146.5 163.78 34.62 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.029 0.932 . . . . 0.0 111.566 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.18 118.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.587 1.155 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.04 108.24 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.675 0.79 . . . . 0.0 110.915 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.74 -12.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 113.725 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.55 167.19 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.44 1.496 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.51 113.15 4.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.731 1.612 . . . . 0.0 112.115 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.7 62.34 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.309 1.443 . . . . 0.0 111.643 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.81 -35.69 66.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.343 1.457 . . . . 0.0 114.106 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -65.18 -12.98 56.94 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.51 -8.05 59.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.342 1.057 . . . . 0.0 113.443 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -77.71 -172.35 2.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.683 1.193 . . . . 0.0 113.84 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -81.87 146.43 29.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.36 1.464 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.522 ' HG ' ' N ' ' A' ' 118' ' ' TRP . 61.9 p -107.58 -61.87 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.658 1.583 . . . . 0.0 113.349 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.099 0 C-N-CA 125.515 1.531 . . . . 0.0 112.335 -169.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.522 ' N ' ' HG ' ' A' ' 111' ' ' SER 0.31 5.6 p-90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 122.246 1.022 . . . . 0.0 113.542 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.77 -99.18 1.31 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.221 1.391 . . . . 0.0 115.388 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.5 132.92 45.88 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.306 1.042 . . . . 0.0 112.328 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.52 126.46 30.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.17 94.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.402 1.081 . . . . 0.0 108.242 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -82.05 -14.7 55.5 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.866 0.866 . . . . 0.0 111.795 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.08 175.58 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.56 1.171 . . . . 0.0 113.13 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.81 153.39 50.82 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.795 -1.191 . . . . 0.0 112.203 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.35 138.68 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.586 0.708 . . . . 0.0 109.254 169.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 t -107.82 -41.98 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.712 1.605 . . . . 0.0 110.557 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -145.58 151.07 37.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.344 1.458 . . . . 0.0 110.031 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.93 11.78 19.86 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.953 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.9 mmm -53.39 -37.42 62.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.928 1.864 . . . . 0.0 112.544 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.92 -31.76 72.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.039 0.936 . . . . 0.0 112.377 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.93 -43.75 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.174 1.39 . . . . 0.0 110.282 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.95 -38.01 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.217 -0.927 . . . . 0.0 111.031 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -71.93 -26.31 62.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.246 1.418 . . . . 0.0 112.558 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -77.89 -41.52 36.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.865 1.266 . . . . 0.0 110.886 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.89 -30.23 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.061 1.744 . . . . 0.0 112.726 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -89.43 -12.39 40.38 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -111.42 -12.88 14.08 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.542 1.544 . . . . 0.0 114.471 -171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 m -61.29 -58.07 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.733 1.266 . . . . 0.0 112.678 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.23 145.0 1.26 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.964 1.305 . . . . 0.0 112.073 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -122.5 149.37 44.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.629 1.572 . . . . 0.0 112.564 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.825 0 C-N-CA 124.33 0.967 . . . . 0.0 112.053 175.277 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.93 132.87 31.57 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.372 1.381 . . . . 0.0 109.397 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 -26.14 28.82 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.14 142.56 45.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.581 0.753 . . . . 0.0 109.644 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -81.42 112.05 18.34 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.328 0.651 . . . . 0.0 110.803 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.13 103.99 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -126.45 143.65 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.772 1.229 . . . . 0.0 111.57 -170.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.4 mt -86.78 102.7 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.04 -28.31 43.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.389 1.076 . . . . 0.0 112.109 -174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -153.66 161.78 41.84 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.21 140.09 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.967 1.707 . . . . 0.0 109.875 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -136.37 126.52 26.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.747 1.219 . . . . 0.0 110.343 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.5 121.77 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 t -111.75 150.45 30.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.386 1.474 . . . . 0.0 112.316 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.706 1.602 . . . . 0.0 113.502 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.84 130.36 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.0 m -103.97 124.78 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.47 1.508 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -101.08 120.04 39.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.674 1.19 . . . . 0.0 109.756 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -93.9 114.38 26.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -125.31 159.39 31.84 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -68.94 -7.99 40.22 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -106.77 -28.26 10.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.645 1.578 . . . . 0.0 113.276 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.88 146.91 4.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.323 1.916 . . . . 0.0 113.094 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.69 133.15 31.26 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.533 1.133 . . . . 0.0 112.863 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.3 mt -128.39 142.96 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.845 1.658 . . . . 0.0 109.28 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -129.27 138.6 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.165 0.986 . . . . 0.0 110.269 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 mt -128.89 138.32 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.551 1.94 . . . . 0.0 109.801 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -107.38 122.28 46.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.725 2.01 . . . . 0.0 109.419 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 p -86.74 149.3 24.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.128 0.971 . . . . 0.0 112.414 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.03 72.49 0.89 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 123.025 1.393 . . . . 0.0 111.924 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.85 -26.07 64.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.544 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.06 -29.1 54.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.241 1.016 . . . . 0.0 111.481 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -99.42 -23.18 15.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.88 1.272 . . . . 0.0 113.23 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.22 55.42 1.39 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.33 1.052 . . . . 0.0 113.41 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.77 -44.34 31.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.368 2.712 . . . . 0.0 112.99 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -69.37 -39.94 77.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.725 0.693 . . . . 0.0 111.291 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.483 ' HA ' HD13 ' A' ' 68' ' ' ILE . 18.2 m -64.86 -47.67 77.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.451 0.7 . . . . 0.0 111.245 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.7 -38.03 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.121 0.968 . . . . 0.0 112.275 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -54.21 -45.08 72.16 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.849 1.204 . . . . 0.0 112.035 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.485 HD22 HD11 ' A' ' 68' ' ' ILE . 62.5 t30 -68.26 -41.53 80.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.282 0.633 . . . . 0.0 111.467 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.6 -47.05 85.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.109 0.963 . . . . 0.0 111.611 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.55 -36.37 68.23 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.381 -0.825 . . . . 0.0 112.209 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.59 -39.15 76.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.819 0.448 . . . . 0.0 111.74 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -68.29 -43.38 77.83 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.55 -0.719 . . . . 0.0 111.932 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.8 m -60.33 -40.3 90.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.065 0.546 . . . . 0.0 111.32 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -68.78 -33.79 74.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.968 1.707 . . . . 0.0 112.821 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.35 -18.44 42.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.162 0.985 . . . . 0.0 112.994 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.87 25.91 43.63 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.919 -0.488 . . . . 0.0 112.561 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -69.78 -42.49 73.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.273 1.037 . . . . 0.0 113.156 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -81.22 -13.4 58.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.769 0.828 . . . . 0.0 111.732 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -63.14 124.96 22.5 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.684 0.794 . . . . 0.0 108.87 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.252 61.1 t30 59.1 45.52 14.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.592 1.557 . . . . 0.0 114.886 -169.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -111.66 164.3 13.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.466 1.106 . . . . 0.0 111.067 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 156' ' ' ILE . 11.5 pt -121.36 163.05 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 85.05 7.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.197 1.399 . . . . 0.0 107.978 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -75.59 -7.25 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -135.45 140.9 45.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.854 1.661 . . . . 0.0 112.252 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.53 136.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.961 2.104 . . . . 0.0 110.526 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.4 mt -140.33 130.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 108.363 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -66.93 137.21 56.37 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.099 0.96 . . . . 0.0 112.067 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 11.95 66.43 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.816 0.722 . . . . 0.0 114.492 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -146.3 -176.99 5.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.91 2.084 . . . . 0.0 110.216 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -90.51 -180.0 5.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.107 1.763 . . . . 0.0 114.45 -171.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.14 140.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.882 1.273 . . . . 0.0 111.971 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -112.49 149.03 33.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.021 1.329 . . . . 0.0 110.789 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.35 175.72 32.43 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 3.51 90.0 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.311 1.434 . . . . 0.0 115.392 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.12 -26.32 37.36 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.002 1.401 . . . . 0.0 115.031 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -143.78 160.53 40.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.2 164.31 39.05 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.319 1.447 . . . . 0.0 110.59 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.92 -14.47 37.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.381 2.721 . . . . 0.0 117.943 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.87 21.08 47.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.344 0.973 . . . . 0.0 114.451 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.78 33.68 17.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.941 1.696 . . . . 0.0 113.011 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.06 130.48 36.96 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.057 1.343 . . . . 0.0 109.772 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.62 128.92 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 123.943 1.83 . . . . 0.0 111.357 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -76.79 178.48 6.78 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 110.615 -2.993 . . . . 0.0 114.379 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.18 54.43 3.1 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.821 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.2 p -71.11 117.36 12.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.509 1.124 . . . . 0.0 111.402 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.34 -178.07 4.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.062 1.745 . . . . 0.0 111.818 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 45.95 64.19 8.43 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.649 1.58 . . . . 0.0 114.344 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -54.51 129.3 34.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.097 2.531 . . . . 0.0 110.703 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -109.68 148.65 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.152 1.381 . . . . 0.0 109.044 -174.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 151.71 38.55 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.31 0.576 . . . . 0.0 110.787 169.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -80.11 125.17 29.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.575 0.75 . . . . 0.0 110.851 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.82 12.67 34.22 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.804 1.241 . . . . 0.0 113.152 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -16.49 49.22 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.64 -1.287 . . . . 0.0 114.409 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.89 1.11 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.437 1.495 . . . . 0.0 114.02 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -71.98 -11.6 60.85 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.878 1.271 . . . . 0.0 113.076 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 10.67 77.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.1 1.333 . . . . 0.0 114.383 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.55 154.96 34.04 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.582 1.191 . . . . 0.0 112.48 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -130.01 151.85 50.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.77 103.21 15.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.14 2.176 . . . . 0.0 109.668 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 p -134.65 170.59 15.57 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.096 1.358 . . . . 0.0 110.822 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -49.65 119.79 3.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.773 1.229 . . . . 0.0 111.116 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.08 33.31 26.77 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.832 1.206 . . . . 0.0 114.923 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -119.6 159.57 24.13 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.727 1.263 . . . . 0.0 113.09 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.75 136.37 54.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.07 156.31 49.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.03 0.532 . . . . 0.0 111.467 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -85.13 134.5 34.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.71 153.44 22.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.374 1.07 . . . . 0.0 111.122 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -105.26 158.24 16.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.071 1.349 . . . . 0.0 111.969 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.9 m -78.01 -51.6 10.09 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.987 0.915 . . . . 0.0 110.776 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -161.85 -53.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.899 1.28 . . . . 0.0 111.334 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.8 162.99 68.36 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.058 1.343 . . . . 0.0 112.315 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.5 -17.07 58.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.217 2.611 . . . . 0.0 114.263 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -122.17 50.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.569 1.547 . . . . 0.0 111.681 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.9 p -132.78 33.5 3.72 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.65 57.76 0.76 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.114 1.366 . . . . 0.0 113.475 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p -60.17 -47.67 84.97 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -169.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.12 -30.72 0.13 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -174.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -70.81 142.82 51.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.317 1.047 . . . . 0.0 111.434 -170.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -137.21 168.39 19.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.196 1.798 . . . . 0.0 110.524 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.3 p90 -148.27 160.53 42.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 112.071 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.02 115.9 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 108.903 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.7 95.97 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.175 0.99 . . . . 0.0 110.697 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.91 -24.73 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.167 -0.958 . . . . 0.0 113.388 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.9 168.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.501 . . . . 0.0 111.492 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.79 118.04 21.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.201 1.0 . . . . 0.0 110.531 169.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -141.88 68.49 1.32 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.938 1.352 . . . . 0.0 113.004 -169.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.52 -35.31 39.95 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.309 2.244 . . . . 0.0 114.538 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -58.8 -13.79 7.08 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.08 -10.45 59.2 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.58 -177.35 3.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.511 1.524 . . . . 0.0 114.814 -171.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -79.35 155.59 28.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.098 1.359 . . . . 0.0 111.64 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.5 t -136.11 -55.05 0.76 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -178.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.28 4.0 p-90 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.74 -89.52 1.9 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.719 1.628 . . . . 0.0 114.802 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -140.56 146.73 38.44 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.169 1.387 . . . . 0.0 112.139 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.08 129.51 34.82 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.34 94.48 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.762 1.225 . . . . 0.0 108.585 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -79.28 -16.0 57.09 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.648 0.779 . . . . 0.0 111.976 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.96 177.8 8.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.663 1.221 . . . . 0.0 113.111 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.06 153.78 51.93 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.89 -1.131 . . . . 0.0 112.027 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.61 143.98 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.744 0.783 . . . . 0.0 109.315 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.83 -38.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 110.854 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -146.37 149.12 33.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.274 1.43 . . . . 0.0 110.906 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.48 6.09 18.03 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.65 1.119 . . . . 0.0 115.793 170.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.4 mmm -56.3 -37.14 69.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.169 1.484 . . . . 0.0 113.103 -176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.81 -30.93 71.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.724 0.809 . . . . 0.0 112.207 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.06 -41.73 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.037 1.735 . . . . 0.0 110.696 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.27 -38.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 111.05 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 6.8 t70 -75.77 -19.18 59.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.02 1.328 . . . . 0.0 113.19 175.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -79.75 -41.94 25.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.108 1.363 . . . . 0.0 111.081 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.5 mt -55.51 -35.56 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.06 1.344 . . . . 0.0 112.158 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.9 pttp -83.78 -12.36 55.81 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.87 -24.49 9.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.151 1.358 . . . . 0.0 114.197 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 m -74.16 -59.5 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.718 1.259 . . . . 0.0 114.379 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.05 154.48 9.07 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.8 p -141.94 153.63 44.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.943 1.697 . . . . 0.0 112.143 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 123.343 0.497 . . . . 0.0 113.176 171.845 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 119.581 -0.247 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.98 136.39 41.03 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.515 1.476 . . . . 0.0 110.259 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -30.11 40.76 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.88 152.28 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.078 0.951 . . . . 0.0 110.849 169.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.64 109.65 17.61 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.837 0.827 . . . . 0.0 110.799 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.1 t -105.03 93.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.54 144.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.14 103.97 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.224 1.81 . . . . 0.0 107.09 169.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.32 -29.17 42.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.254 1.021 . . . . 0.0 112.504 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -156.28 165.7 35.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.17 139.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.901 1.681 . . . . 0.0 110.741 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 m -136.58 132.71 35.51 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.004 1.322 . . . . 0.0 110.712 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.75 123.33 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -117.41 150.39 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.611 1.564 . . . . 0.0 112.41 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 125.365 1.466 . . . . 0.0 113.611 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.78 128.59 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.979 0.912 . . . . 0.0 108.742 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -104.26 124.45 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.022 1.329 . . . . 0.0 109.958 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.0 123.54 40.74 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.173 0.989 . . . . 0.0 109.74 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -99.32 105.98 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.563 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.22 159.66 20.69 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.966 -0.459 . . . . 0.0 111.555 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -70.78 -6.05 34.78 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.67 ' CE1' HD11 ' A' ' 136' ' ' ILE . 20.1 p80 -110.37 -24.66 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.528 1.531 . . . . 0.0 113.759 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.77 145.17 4.14 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.258 1.885 . . . . 0.0 113.665 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.27 135.45 38.5 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.676 1.19 . . . . 0.0 112.836 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -132.66 142.62 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.313 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.18 136.91 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.321 1.048 . . . . 0.0 110.672 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 139.33 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.778 2.031 . . . . 0.0 110.255 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -105.94 123.51 48.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.694 1.998 . . . . 0.0 108.807 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -87.63 148.6 24.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.266 1.026 . . . . 0.0 112.183 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.15 74.17 1.03 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.684 1.23 . . . . 0.0 111.684 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.75 -27.07 64.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.499 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.122 0.969 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.73 -22.65 15.77 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 113.106 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.98 2.75 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.754 1.222 . . . . 0.0 112.816 -171.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.55 -44.88 19.96 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.249 2.633 . . . . 0.0 112.708 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -70.55 -41.26 72.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.777 -0.577 . . . . 0.0 110.996 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.432 ' HA ' HD13 ' A' ' 68' ' ' ILE . 23.1 m -63.06 -47.34 83.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.907 0.483 . . . . 0.0 111.71 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.87 -38.79 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.635 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -57.46 -44.47 84.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.002 1.274 . . . . 0.0 111.484 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -68.17 -39.22 82.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.455 0.702 . . . . 0.0 111.624 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.02 -50.61 73.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.705 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.31 -37.0 77.56 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.448 0.699 . . . . 0.0 111.422 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -56.93 -37.47 71.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.824 0.85 . . . . 0.0 111.965 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -74.15 -43.53 57.05 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.416 -0.803 . . . . 0.0 112.226 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.42 -37.96 76.44 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.84 -0.537 . . . . 0.0 111.808 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -32.76 72.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.257 1.823 . . . . 0.0 112.858 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.63 -15.62 54.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.973 0.909 . . . . 0.0 113.124 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.31 19.85 65.79 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.276 0.941 . . . . 0.0 113.149 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.09 -37.03 73.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.391 1.096 . . . . 0.0 113.068 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.889 0.476 . . . . 0.0 112.139 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -63.74 132.57 51.39 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.221 -0.924 . . . . 0.0 109.112 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.253 13.9 t30 59.42 25.14 13.83 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.722 2.009 . . . . 0.0 116.118 -171.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.2 p -83.27 142.32 31.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.933 -1.105 . . . . 0.0 113.212 170.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.9 pt -95.45 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -83.6 79.16 9.53 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 168.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -73.57 4.71 4.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -148.06 135.6 20.7 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.269 1.395 . . . . 0.0 112.439 171.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.45 131.04 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 110.676 170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -137.34 128.37 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.572 1.549 . . . . 0.0 108.399 -172.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -64.25 136.68 57.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.589 0.755 . . . . 0.0 111.97 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.29 9.66 61.25 Favored Glycine 0 CA--C 1.541 1.668 0 N-CA-C 115.091 0.797 . . . . 0.0 115.091 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.25 -177.16 5.32 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.558 1.943 . . . . 0.0 110.496 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.422 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -85.97 -179.34 6.77 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.674 1.589 . . . . 0.0 115.139 -170.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.0 pt -116.76 134.88 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.78 1.232 . . . . 0.0 112.303 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -108.72 153.52 23.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.659 1.183 . . . . 0.0 111.684 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.38 -179.96 34.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.228 0.918 . . . . 0.0 114.957 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.79 84.39 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.699 1.04 . . . . 0.0 115.699 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -21.4 35.96 Favored Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.115 1.458 . . . . 0.0 115.917 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.3 162.82 35.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.269 1.034 . . . . 0.0 113.45 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -90.27 158.98 42.9 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.851 1.66 . . . . 0.0 109.804 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.98 -8.99 13.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.668 3.578 . . . . 0.0 116.113 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.74 14.63 64.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.08 0.848 . . . . 0.0 114.534 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.37 26.94 16.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.913 1.685 . . . . 0.0 113.163 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.15 131.6 36.6 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.093 1.357 . . . . 0.0 109.842 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -75.9 129.35 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.086 1.898 . . . . 0.0 111.204 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -72.2 179.54 3.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 110.447 -3.07 . . . . 0.0 114.127 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.24 51.21 2.08 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.258 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.2 p -72.28 117.17 13.59 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.594 1.158 . . . . 0.0 111.944 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -138.0 178.87 6.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.176 2.191 . . . . 0.0 111.857 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 51.13 71.4 1.54 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.324 1.45 . . . . 0.0 113.728 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.08 147.95 94.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.3 2.667 . . . . 0.0 111.889 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -126.74 147.96 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.135 1.374 . . . . 0.0 110.64 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -64.76 153.27 40.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.919 0.888 . . . . 0.0 111.107 169.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.96 -54.89 40.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.256 8.6 mt-10 71.62 1.66 3.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.422 2.289 . . . . 0.0 117.029 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -14.21 59.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.478 1.944 . . . . 0.0 113.972 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -62.72 2.28 0.31 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.728 1.611 . . . . 0.0 114.126 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -74.18 -12.49 60.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.244 1.418 . . . . 0.0 113.543 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.76 77.56 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.075 1.321 . . . . 0.0 114.6 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.5 157.35 30.47 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.517 1.159 . . . . 0.0 112.16 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.6 148.11 52.36 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.67 113.38 18.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.972 2.509 . . . . 0.0 109.653 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -139.44 167.43 22.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.932 1.293 . . . . 0.0 110.569 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -56.45 122.83 12.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.851 0.834 . . . . 0.0 110.9 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.45 51.74 5.48 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.926 1.25 . . . . 0.0 113.74 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 p -138.89 162.96 33.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.176 0.991 . . . . 0.0 112.156 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.5 138.12 53.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.833 0.825 . . . . 0.0 113.176 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.32 160.83 37.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.143 0.577 . . . . 0.0 111.459 171.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.7 mmt -82.4 142.71 31.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.898 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.03 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.519 1.127 . . . . 0.0 110.054 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -106.06 155.79 19.05 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.225 1.01 . . . . 0.0 113.117 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -75.01 -51.61 13.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.685 0.794 . . . . 0.0 111.099 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -156.97 -40.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.139 1.375 . . . . 0.0 113.119 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.97 32.86 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.173 1.389 . . . . 0.0 111.879 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.59 -20.52 65.06 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.303 2.669 . . . . 0.0 114.295 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -108.23 39.38 1.98 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.165 1.786 . . . . 0.0 112.244 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.9 p -128.43 31.04 5.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.059 1.344 . . . . 0.0 113.475 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.33 56.76 3.36 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.826 1.651 . . . . 0.0 113.595 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.1 p -49.69 -70.76 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.767 2.027 . . . . 0.0 115.197 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.18 -21.87 0.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.717 1.207 . . . . 0.0 113.89 -169.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.66 139.87 49.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.411 -0.806 . . . . 0.0 110.568 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.3 168.49 19.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.75 2.02 . . . . 0.0 110.837 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 20.9 p90 -144.36 160.86 40.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.593 0.757 . . . . 0.0 111.887 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.3 mt -111.46 117.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -72.76 103.02 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.071 0.549 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.04 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.08 168.18 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 127.277 2.231 . . . . 0.0 112.212 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.75 122.98 25.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.877 1.271 . . . . 0.0 111.457 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -145.32 73.13 1.34 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.68 1.229 . . . . 0.0 112.403 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.47 -34.24 68.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.675 1.59 . . . . 0.0 114.365 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -56.92 -13.69 2.88 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.82 -12.74 58.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.14 169.51 17.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.99 155.35 40.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.738 1.615 . . . . 0.0 113.133 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.7 p -134.45 -56.77 0.85 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.614 1.166 . . . . 0.0 113.197 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 C-N-CA 123.947 0.784 . . . . 0.0 113.983 -177.681 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.27 1.7 p-90 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.97 -82.89 0.82 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.051 1.31 . . . . 0.0 115.165 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -128.93 123.55 32.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 112.548 -169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -83.06 131.77 35.15 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -75.64 99.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.011 0.924 . . . . 0.0 108.845 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -80.96 -16.78 52.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.712 0.805 . . . . 0.0 111.591 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 175.88 9.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.194 0.997 . . . . 0.0 113.624 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.51 149.65 48.27 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.481 -1.387 . . . . 0.0 112.144 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.26 135.1 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-O 121.481 0.658 . . . . 0.0 110.405 172.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.56 -41.09 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.499 1.92 . . . . 0.0 110.581 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -142.51 149.27 38.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.186 1.395 . . . . 0.0 110.313 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.32 8.54 28.89 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.342 0.972 . . . . 0.0 115.275 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 79.9 mmm -55.98 -37.68 69.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.176 1.488 . . . . 0.0 112.759 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.71 -29.96 71.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.84 . . . . 0.0 112.49 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.23 -45.26 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.021 1.728 . . . . 0.0 110.492 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.9 t -57.8 -40.11 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.392 1.077 . . . . 0.0 111.38 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 -19.47 61.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.47 1.508 . . . . 0.0 112.905 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -86.85 -39.84 15.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.67 HD11 ' CE1' ' A' ' 8' ' ' HIS . 54.1 mt -50.92 -41.72 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.499 1.52 . . . . 0.0 111.495 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -73.01 -17.71 61.42 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.34 -10.46 36.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.373 1.939 . . . . 0.0 114.796 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.62 -63.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.305 1.553 . . . . 0.0 110.471 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 156.07 2.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.907 1.283 . . . . 0.0 112.008 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.6 p -139.94 149.46 43.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.701 1.2 . . . . 0.0 112.181 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 C-N-CA 123.323 0.487 . . . . 0.0 112.464 170.941 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -68.26 134.88 32.61 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.73 1.62 . . . . 0.0 109.03 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -29.53 61.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -86.86 159.55 19.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.593 1.157 . . . . 0.0 110.303 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -82.79 109.89 17.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.41 1.084 . . . . 0.0 111.794 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.61 94.0 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.563 1.545 . . . . 0.0 106.913 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.79 149.01 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.239 1.495 . . . . 0.0 113.342 -169.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.72 103.9 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.03 -40.14 65.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.744 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -149.52 164.26 35.56 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.57 142.05 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.888 1.675 . . . . 0.0 110.929 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 m -136.24 134.0 37.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.629 1.171 . . . . 0.0 110.983 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.58 120.52 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.0 t -117.98 150.23 39.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.537 1.535 . . . . 0.0 112.723 -171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.388 1.475 . . . . 0.0 113.907 -170.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 120.27 0.081 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.98 129.99 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.936 0.894 . . . . 0.0 109.905 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.1 m -104.12 124.44 49.08 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.371 1.468 . . . . 0.0 109.766 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -99.47 123.54 43.84 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.464 1.106 . . . . 0.0 110.346 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -97.61 108.09 20.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.623 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -119.14 159.08 24.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 112.223 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -68.59 -6.77 27.52 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.499 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.2 p80 -110.67 -25.13 10.11 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.466 1.506 . . . . 0.0 113.634 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.38 145.85 4.3 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.123 1.82 . . . . 0.0 113.583 173.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.32 133.81 39.88 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.474 1.109 . . . . 0.0 112.535 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.4 mt -131.1 144.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.943 1.697 . . . . 0.0 109.499 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.26 137.76 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.387 1.075 . . . . 0.0 110.463 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -124.07 138.75 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.987 2.115 . . . . 0.0 110.087 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -106.83 125.37 50.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.109 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.5 p -87.75 149.49 24.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 112.075 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -108.59 74.5 0.92 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.766 1.27 . . . . 0.0 111.726 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.76 -25.9 64.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.548 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -77.57 -26.78 51.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.619 1.168 . . . . 0.0 111.675 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -101.84 -22.39 14.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.231 1.412 . . . . 0.0 112.972 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.73 56.41 1.59 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.891 1.276 . . . . 0.0 113.103 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.09 -44.36 29.94 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.496 2.797 . . . . 0.0 112.914 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.2 -41.45 77.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.793 0.724 . . . . 0.0 111.084 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -64.77 -48.59 73.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.725 0.41 . . . . 0.0 111.549 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.7 -41.46 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.573 . . . . 0.0 111.349 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.17 -45.59 87.22 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.571 1.078 . . . . 0.0 111.623 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.1 -34.31 70.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.682 0.674 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.84 -49.68 75.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.257 1.023 . . . . 0.0 111.733 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.358 -0.839 . . . . 0.0 111.658 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -56.52 -33.05 65.67 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.183 0.993 . . . . 0.0 112.628 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -77.61 -46.43 22.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 171.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.3 m -57.72 -40.1 78.8 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.967 0.907 . . . . 0.0 112.201 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -52.86 -46.68 67.99 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.659 1.984 . . . . 0.0 112.872 173.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -83.2 -14.55 53.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.055 0.942 . . . . 0.0 112.133 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.47 52.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.289 0.947 . . . . 0.0 113.046 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.29 -37.15 69.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.402 1.101 . . . . 0.0 113.241 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -83.33 -6.44 59.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.396 0.679 . . . . 0.0 112.132 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -64.41 132.35 49.82 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.1 t30 53.82 49.91 18.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.319 1.448 . . . . 0.0 113.998 -171.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.8 p -114.44 157.14 23.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.304 1.042 . . . . 0.0 112.393 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.41 155.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -86.4 75.97 9.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.863 1.265 . . . . 0.0 107.855 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -53.16 -38.23 62.58 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.0 1.72 . . . . 0.0 114.76 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -123.64 135.53 53.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.56 1.144 . . . . 0.0 111.495 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.2 132.69 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.408 2.283 . . . . 0.0 110.578 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.44 128.9 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.622 1.569 . . . . 0.0 107.989 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 133.49 55.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 111.631 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.97 9.32 66.14 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 123.898 0.761 . . . . 0.0 114.871 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -141.52 -177.28 5.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.153 1.781 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.21 -179.55 5.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.7 136.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.054 1.342 . . . . 0.0 112.399 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.92 146.63 46.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.194 1.398 . . . . 0.0 111.094 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.92 31.03 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.18 -8.73 72.56 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.647 1.594 . . . . 0.0 115.944 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.76 -20.65 70.53 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 118.961 1.381 . . . . 0.0 115.479 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.2 164.9 28.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.482 1.113 . . . . 0.0 113.652 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -101.29 163.65 17.52 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.028 1.731 . . . . 0.0 110.629 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.01 -12.12 28.12 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.384 2.723 . . . . 0.0 118.0 -169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.08 14.59 60.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 123.452 0.549 . . . . 0.0 114.426 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.6 mmt 59.49 28.74 18.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.582 1.953 . . . . 0.0 112.757 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.81 123.01 28.95 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.1 1.36 . . . . 0.0 109.555 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.82 126.62 30.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 124.365 2.031 . . . . 0.0 110.887 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.0 179.74 2.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 110.077 -3.238 . . . . 0.0 114.408 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.06 64.11 3.27 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.372 -2.195 . . . . 0.0 112.147 -174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 p -70.22 107.29 3.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.146 1.379 . . . . 0.0 110.838 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -140.9 168.03 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.133 2.173 . . . . 0.0 112.401 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 50.13 66.94 4.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 0.0 112.487 171.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.62 145.97 97.21 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.469 2.779 . . . . 0.0 113.664 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.85 146.05 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.515 1.926 . . . . 0.0 109.053 -176.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 158.74 16.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.553 1.141 . . . . 0.0 111.143 170.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -73.44 134.55 43.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 111.614 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.04 13.63 12.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.086 1.354 . . . . 0.0 112.675 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -11.85 56.43 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.565 -1.334 . . . . 0.0 114.128 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -62.24 5.27 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.309 1.444 . . . . 0.0 114.553 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -76.53 -11.35 59.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.773 1.629 . . . . 0.0 112.826 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 6.47 85.39 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.256 1.407 . . . . 0.0 115.071 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.53 154.85 38.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.361 1.081 . . . . 0.0 112.25 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.55 149.21 51.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -86.03 64.24 8.47 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.44 1.896 . . . . 0.0 112.528 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.8 p -98.57 166.24 11.44 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.735 0.814 . . . . 0.0 112.235 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.05 123.25 11.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.878 1.671 . . . . 0.0 111.019 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.25 56.37 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.315 1.436 . . . . 0.0 114.945 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.2 p -110.51 161.36 15.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.591 1.695 . . . . 0.0 113.266 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -118.98 135.34 54.66 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.031 0.932 . . . . 0.0 112.734 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.43 159.39 41.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.652 174.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -81.7 143.04 32.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 111.204 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 153.99 18.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.953 0.901 . . . . 0.0 110.617 169.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -133.9 152.94 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.134 1.374 . . . . 0.0 111.923 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -65.32 -55.08 20.23 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.837 1.255 . . . . 0.0 112.708 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.71 -55.48 0.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.758 1.223 . . . . 0.0 111.366 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.47 159.04 86.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.574 1.15 . . . . 0.0 111.5 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.37 -26.28 81.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.005 2.47 . . . . 0.0 113.703 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -114.28 42.15 2.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.317 1.447 . . . . 0.0 111.947 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -122.61 30.64 6.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.309 1.444 . . . . 0.0 114.124 -173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.06 22.67 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.268 1.427 . . . . 0.0 107.465 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -132.51 -59.48 0.91 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.23 1.412 . . . . 0.0 112.739 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.57 -11.85 1.58 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 0.0 112.677 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -78.96 134.37 36.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.551 1.14 . . . . 0.0 110.383 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -141.32 168.1 20.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.082 1.753 . . . . 0.0 111.635 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 9.6 p90 -149.96 163.12 38.94 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.856 0.862 . . . . 0.0 111.751 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.0 mt -117.26 119.19 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.922 1.289 . . . . 0.0 108.538 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -72.59 97.57 2.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.564 0.745 . . . . 0.0 110.037 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 m -76.14 -15.54 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.8 167.01 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 128.724 2.809 . . . . 0.0 110.296 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.22 116.54 13.88 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.204 0.526 . . . . 0.0 111.525 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.9 57.25 1.28 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 111.921 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -64.82 -15.59 61.97 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -66.08 -15.12 62.8 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.779 -1.201 . . . . 0.0 113.383 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.37 -8.73 59.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.37 1.068 . . . . 0.0 113.452 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.28 179.83 3.73 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -79.08 141.09 37.66 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.561 1.544 . . . . 0.0 112.483 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.6 p -104.17 -60.31 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.638 1.175 . . . . 0.0 113.591 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 123.818 0.723 . . . . 0.0 114.732 -172.176 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.299 8.0 p-90 . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 122.044 0.926 . . . . 0.0 113.36 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.84 -96.45 0.69 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.339 1.447 . . . . 0.0 115.618 -169.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.51 137.64 48.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 111.805 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.8 129.31 34.87 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.27 94.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.794 1.238 . . . . 0.0 108.455 169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -80.64 -15.38 56.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.401 0.681 . . . . 0.0 111.821 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.03 177.97 8.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.46 1.124 . . . . 0.0 113.554 -171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -137.14 153.6 50.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 120.811 -1.181 . . . . 0.0 112.105 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.84 138.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.509 0.671 . . . . 0.0 110.443 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.33 -41.95 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.993 1.717 . . . . 0.0 111.187 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -143.48 153.84 43.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.141 1.377 . . . . 0.0 110.584 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.31 39.15 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.526 1.06 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.9 mtp -60.66 -35.17 75.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.895 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -65.12 -29.07 69.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.865 0.866 . . . . 0.0 112.142 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.05 -43.6 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.491 1.517 . . . . 0.0 110.307 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.59 -38.95 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.488 1.115 . . . . 0.0 111.253 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.13 -20.09 60.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.419 1.488 . . . . 0.0 113.0 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -86.22 -40.55 15.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.761 1.624 . . . . 0.0 111.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.4 mt -54.7 -34.44 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.487 1.515 . . . . 0.0 112.065 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -83.82 -16.58 44.06 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.0 13.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.182 1.372 . . . . 0.0 114.091 -173.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.84 -62.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.405 1.102 . . . . 0.0 113.312 -174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.79 157.27 5.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.013 0.925 . . . . 0.0 113.458 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -139.47 155.14 47.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 111.772 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.612 0 CA-C-O 123.329 1.516 . . . . 0.0 115.137 170.266 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.0 135.84 28.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.703 1.602 . . . . 0.0 110.059 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.8 51.63 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -84.72 157.69 20.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 110.058 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -79.91 125.86 30.28 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.01 -1.057 . . . . 0.0 111.207 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.92 93.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.354 1.861 . . . . 0.0 107.732 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 144.27 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.98 110.51 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.96 -41.58 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.689 0.677 . . . . 0.0 110.389 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.77 165.6 33.0 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.18 142.51 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.06 1.744 . . . . 0.0 111.446 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -136.37 136.29 39.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.987 1.315 . . . . 0.0 110.683 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.71 123.95 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.2 t -122.51 143.61 49.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 112.087 -169.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.31 1.844 . . . . 0.0 112.082 178.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttm . . . . . 0 N--CA 1.503 2.22 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.5 t -127.08 128.34 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.988 1.267 . . . . 0.0 110.423 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.9 m -100.37 125.6 46.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.277 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -101.44 128.02 47.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.999 1.319 . . . . 0.0 110.518 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -101.19 95.79 6.77 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -99.9 152.36 20.25 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.901 -0.5 . . . . 0.0 110.829 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -60.31 -13.84 15.05 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -97.97 -11.14 23.4 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.701 1.2 . . . . 0.0 113.624 171.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.87 167.84 13.72 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.651 1.596 . . . . 0.0 113.408 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -75.3 137.25 41.02 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.754 1.622 . . . . 0.0 112.821 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -133.2 140.48 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.752 2.021 . . . . 0.0 108.561 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.96 134.18 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.464 1.105 . . . . 0.0 110.266 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -123.02 133.88 67.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.483 1.913 . . . . 0.0 110.039 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -99.64 126.86 45.72 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.898 1.679 . . . . 0.0 108.44 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -89.08 146.77 24.61 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.24 1.016 . . . . 0.0 110.999 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -103.65 73.73 1.2 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 122.669 1.224 . . . . 0.0 111.458 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.86 -26.28 64.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.77 -1.104 . . . . 0.0 112.48 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.87 -27.97 49.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.253 1.021 . . . . 0.0 111.672 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -101.72 -18.87 15.62 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.104 1.362 . . . . 0.0 113.222 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.0 55.39 1.19 Allowed Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.665 1.186 . . . . 0.0 113.123 -172.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.72 -44.97 27.6 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.47 2.78 . . . . 0.0 112.952 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -68.27 -41.82 80.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.108 0.563 . . . . 0.0 110.971 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.0 m -65.42 -45.43 83.94 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.175 0.59 . . . . 0.0 111.789 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.97 -43.09 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.583 0.753 . . . . 0.0 111.761 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -56.66 -42.48 79.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.96 1.254 . . . . 0.0 111.797 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -70.2 -37.95 75.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.733 0.813 . . . . 0.0 111.626 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.91 -48.96 79.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.432 1.093 . . . . 0.0 111.713 173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.98 -37.97 79.07 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.593 0.757 . . . . 0.0 111.456 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -57.25 -33.88 68.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.361 1.065 . . . . 0.0 112.808 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 18.5 m-85 -76.84 -44.73 31.13 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.462 -0.774 . . . . 0.0 112.493 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.2 m -59.98 -35.98 76.16 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.63 -0.669 . . . . 0.0 111.658 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.78 -34.28 77.55 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.026 2.13 . . . . 0.0 112.945 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.43 -14.48 52.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.029 0.932 . . . . 0.0 113.372 172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.51 19.23 60.57 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.553 1.073 . . . . 0.0 113.885 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.403 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 54.4 t80 -68.27 -17.72 64.36 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -96.13 -3.63 44.19 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.269 -0.894 . . . . 0.0 113.137 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -65.5 135.29 54.97 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.135 -0.978 . . . . 0.0 108.952 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.9 t30 54.16 47.17 23.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.531 1.533 . . . . 0.0 113.689 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.3 p -114.37 151.23 33.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.836 0.855 . . . . 0.0 112.532 173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.5 pt -103.3 162.05 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.45 86.41 6.77 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -80.05 2.63 23.11 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -169.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -144.25 143.16 30.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.967 2.167 . . . . 0.0 113.46 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.14 131.21 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 110.271 169.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.2 mt -137.65 129.64 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.613 1.565 . . . . 0.0 108.15 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.84 133.5 54.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.756 0.822 . . . . 0.0 111.782 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.85 9.37 65.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 123.895 0.759 . . . . 0.0 114.947 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -141.89 -177.3 5.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 110.872 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -179.25 5.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.869 1.667 . . . . 0.0 115.379 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.9 pt -114.31 135.91 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.885 1.274 . . . . 0.0 112.446 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.31 150.77 25.64 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.434 1.094 . . . . 0.0 110.653 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.1 172.87 34.66 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.05 -2.32 61.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.811 1.672 . . . . 0.0 115.662 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.31 -14.94 65.29 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 118.921 1.361 . . . . 0.0 115.833 -170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.38 167.09 23.74 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.744 1.217 . . . . 0.0 112.782 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -96.55 164.5 18.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.729 1.612 . . . . 0.0 110.711 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.38 -11.91 28.02 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.514 2.809 . . . . 0.0 116.811 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.59 15.94 62.23 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.088 0.851 . . . . 0.0 114.477 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.1 mmt 61.42 26.46 16.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.058 1.743 . . . . 0.0 113.221 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -83.22 127.18 33.4 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.834 1.254 . . . . 0.0 109.357 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -73.57 119.24 17.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.966 0.906 . . . . 0.0 110.145 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -69.43 164.83 22.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.136 0.974 . . . . 0.0 113.472 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.85 66.04 9.47 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.814 1.645 . . . . 0.0 111.494 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.4 p -69.18 134.47 49.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.932 1.293 . . . . 0.0 112.219 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -137.71 174.05 10.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.022 2.129 . . . . 0.0 111.965 -172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 47.12 66.24 5.9 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.451 1.5 . . . . 0.0 113.605 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.62 135.76 62.66 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.284 2.656 . . . . 0.0 111.067 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -105.08 151.61 7.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 125.849 1.66 . . . . 0.0 108.166 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 157.11 27.45 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.638 0.732 . . . . 0.0 111.565 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -81.81 103.68 11.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.33 1.052 . . . . 0.0 111.198 -171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.75 23.83 1.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.529 1.132 . . . . 0.0 113.289 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.6 -19.86 66.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 119.863 -1.773 . . . . 0.0 113.784 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 -65.44 8.82 0.14 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.344 1.458 . . . . 0.0 114.516 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -77.97 -10.06 59.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.144 1.378 . . . . 0.0 113.426 170.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.66 81.62 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.101 1.334 . . . . 0.0 114.83 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.77 158.61 26.82 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.498 1.149 . . . . 0.0 112.706 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -130.69 155.07 47.23 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.18 111.56 23.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.489 2.316 . . . . 0.0 110.478 -174.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.0 p -142.3 170.38 15.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.327 1.451 . . . . 0.0 111.175 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.0 mtm180 -38.88 117.13 0.63 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.979 1.712 . . . . 0.0 111.948 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.86 33.29 30.46 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 124.352 0.977 . . . . 0.0 114.787 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.1 p -123.39 157.68 32.82 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 118.897 1.348 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.78 136.7 54.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.27 160.77 38.59 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.982 171.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.6 mtt -84.04 143.22 29.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.39 147.89 22.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.641 1.176 . . . . 0.0 111.766 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.8 165.62 14.03 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.27 1.028 . . . . 0.0 113.518 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -81.56 -57.14 3.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.136 0.974 . . . . 0.0 110.873 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -151.47 -38.65 0.12 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.082 1.353 . . . . 0.0 113.68 173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.89 156.46 35.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.014 1.326 . . . . 0.0 111.48 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.91 -23.91 76.44 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.63 2.22 . . . . 0.0 114.324 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -103.37 33.0 3.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.539 1.536 . . . . 0.0 112.746 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.3 p -118.2 26.09 9.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.42 1.488 . . . . 0.0 113.158 178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.13 98.8 2.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.676 1.191 . . . . 0.0 108.574 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.2 p -90.04 -68.64 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.519 1.128 . . . . 0.0 111.691 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.32 20.07 1.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.731 1.212 . . . . 0.0 113.445 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -110.41 142.7 41.76 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.805 -1.185 . . . . 0.0 111.145 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -143.77 168.16 20.57 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.48 1.512 . . . . 0.0 111.036 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.0 p90 -142.86 158.3 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.353 0.661 . . . . 0.0 111.878 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 mt -111.12 118.38 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -75.27 108.78 8.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.08 0.552 . . . . 0.0 110.137 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.03 -11.02 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.42 165.15 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.985 2.514 . . . . 0.0 111.274 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.25 120.99 25.07 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.843 0.457 . . . . 0.0 109.843 169.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -140.93 74.81 1.48 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.711 1.243 . . . . 0.0 112.459 -169.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.62 -34.57 62.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.153 1.781 . . . . 0.0 114.406 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -59.41 -13.71 9.53 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.89 -8.51 59.57 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -80.92 177.04 9.31 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.464 . . . . 0.0 114.174 -173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -89.77 140.76 29.27 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.877 1.271 . . . . 0.0 112.695 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.2 p -109.34 -61.02 1.69 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.761 1.224 . . . . 0.0 113.351 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 163.89 69.43 0.02 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.459 1.028 . . . . 0.0 113.65 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.59 26.01 5.35 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.133 1.773 . . . . 0.0 115.089 171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -111.09 116.62 31.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.164 . . . . 0.0 110.106 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 tp -54.1 -36.19 62.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -74.68 -10.96 60.03 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.57 -71.06 0.97 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 127.24 2.352 . . . . 0.0 114.0 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 14.0 p-90 -73.49 135.09 44.02 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -94.31 -113.33 2.47 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.153 1.835 . . . . 0.0 114.877 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.98 148.02 50.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.134 1.374 . . . . 0.0 113.067 -169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.9 t -76.39 126.62 31.31 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -77.05 94.94 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -80.46 -15.36 56.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.463 0.705 . . . . 0.0 111.896 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.63 176.65 8.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.557 1.17 . . . . 0.0 113.951 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.17 154.18 48.03 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 120.854 -1.154 . . . . 0.0 112.335 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.49 139.49 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.651 0.739 . . . . 0.0 109.865 170.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 t -111.18 -42.99 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.765 1.626 . . . . 0.0 110.99 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.88 154.76 42.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.469 1.508 . . . . 0.0 109.997 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.21 16.3 25.62 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 123.849 0.737 . . . . 0.0 114.217 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -34.78 67.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.891 1.345 . . . . 0.0 112.256 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.15 -30.44 70.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.1 t -76.27 -40.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.943 1.297 . . . . 0.0 110.408 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t -59.61 -41.89 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 121.277 -0.889 . . . . 0.0 110.867 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.54 -25.37 63.07 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.131 1.372 . . . . 0.0 112.355 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -74.57 -52.6 11.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.384 1.074 . . . . 0.0 110.208 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -53.65 -35.56 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.327 1.851 . . . . 0.0 112.793 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.47 -11.46 32.0 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -110.68 -15.82 10.69 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.718 1.628 . . . . 0.0 114.165 -169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.53 -63.33 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.45 1.125 . . . . 0.0 112.707 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -176.83 153.64 1.07 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.752 1.621 . . . . 0.0 111.499 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.4 p -125.9 148.67 49.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.985 1.314 . . . . 0.0 112.842 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.37 125.04 0.92 Allowed Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.263 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -73.5 151.36 41.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -170.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.4 p -111.28 168.93 9.14 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.599 1.56 . . . . 0.0 112.689 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.9 -21.95 75.46 Favored Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.144 0.818 . . . . 0.0 115.144 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.5 mtp -105.61 -34.89 7.6 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.48 1.14 . . . . 0.0 113.558 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -134.14 127.41 32.0 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.664 1.586 . . . . 0.0 111.223 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.94 161.93 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.332 1.053 . . . . 0.0 112.142 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 55.93 55.64 6.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.846 1.658 . . . . 0.0 112.34 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.05 152.46 54.31 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 127.083 2.153 . . . . 0.0 111.795 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.07 138.89 49.05 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.798 1.665 . . . . 0.0 109.559 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -30.74 54.51 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.856 -0.527 . . . . 0.0 112.152 177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.15 149.04 32.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.879 0.872 . . . . 0.0 109.848 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -84.03 119.74 25.31 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 111.313 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.99 108.69 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.318 1.047 . . . . 0.0 109.242 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 148.28 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.884 1.326 . . . . 0.0 111.574 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.1 mt -87.24 103.35 13.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -75.16 -38.37 60.93 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.71 -0.619 . . . . 0.0 110.197 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 p -151.61 166.96 29.61 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.03 142.78 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 110.629 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -135.42 128.4 31.47 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.061 1.344 . . . . 0.0 110.205 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.74 124.04 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.518 -0.739 . . . . 0.0 109.02 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -113.36 150.5 32.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.253 1.421 . . . . 0.0 112.395 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.753 1.621 . . . . 0.0 113.323 -169.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.2 t -124.68 132.45 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 169.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m -104.86 124.89 50.25 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.812 1.245 . . . . 0.0 110.152 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -98.34 132.14 44.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.659 1.184 . . . . 0.0 110.45 169.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -104.22 98.39 8.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -103.77 151.95 22.44 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 122.068 -0.395 . . . . 0.0 111.267 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -60.53 -9.36 3.65 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.27 -8.15 18.47 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.815 1.246 . . . . 0.0 114.014 170.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.51 163.96 10.93 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.411 1.482 . . . . 0.0 113.617 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.43 137.99 44.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.812 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.52 140.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 126.352 1.861 . . . . 0.0 108.886 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 t -122.34 137.66 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.566 1.147 . . . . 0.0 110.326 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.59 138.43 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.587 1.955 . . . . 0.0 110.409 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -100.5 128.76 46.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.013 2.125 . . . . 0.0 107.713 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 p -88.45 146.46 25.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.303 1.041 . . . . 0.0 111.201 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -102.85 73.79 1.29 Allowed 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 122.614 1.197 . . . . 0.0 111.293 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.59 -27.65 65.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.352 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.15 -29.19 57.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.426 1.09 . . . . 0.0 111.53 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -96.85 -27.56 14.64 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.835 1.254 . . . . 0.0 112.835 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.89 61.72 4.33 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.8 0.84 . . . . 0.0 113.188 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.11 -43.7 23.07 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.32 2.68 . . . . 0.0 112.906 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -69.2 -40.54 77.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.484 0.583 . . . . 0.0 110.852 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.4 m -64.86 -47.54 77.54 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.315 0.646 . . . . 0.0 111.593 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.63 -44.51 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.259 0.624 . . . . 0.0 111.342 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -55.95 -48.26 76.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.55 1.068 . . . . 0.0 112.039 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.406 HD22 HD11 ' A' ' 68' ' ' ILE . 43.7 t30 -68.12 -38.32 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.572 0.624 . . . . 0.0 111.878 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -60.13 -49.04 79.21 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.329 1.051 . . . . 0.0 111.673 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.35 -38.18 81.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.555 0.742 . . . . 0.0 111.554 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -59.1 -33.36 70.76 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.847 0.859 . . . . 0.0 112.665 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 -43.95 50.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.909 0.777 . . . . 0.0 112.285 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.33 -36.15 79.36 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.578 -0.701 . . . . 0.0 111.687 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.71 -34.1 77.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.087 2.155 . . . . 0.0 112.86 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.71 -13.34 56.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.963 0.905 . . . . 0.0 113.267 171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.97 18.61 62.83 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.628 1.109 . . . . 0.0 113.939 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -68.65 -17.56 64.12 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -96.7 -5.42 38.82 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.414 -0.804 . . . . 0.0 113.022 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -67.67 136.07 53.78 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.951 -1.093 . . . . 0.0 108.938 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.4 t30 53.59 44.46 29.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.353 1.461 . . . . 0.0 113.828 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -109.32 164.4 12.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.865 0.866 . . . . 0.0 111.742 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 11.3 pt -124.75 159.05 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -169.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -91.14 96.59 10.66 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -88.39 -11.46 46.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -143.27 136.15 27.73 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.939 1.245 . . . . 0.0 113.374 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -135.4 145.11 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 128.145 2.578 . . . . 0.0 109.018 169.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -133.14 131.18 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.734 1.614 . . . . 0.0 108.188 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.62 126.77 28.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.111 0.964 . . . . 0.0 112.594 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.1 11.81 70.97 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 123.81 0.719 . . . . 0.0 114.81 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.15 -176.98 4.8 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.495 1.918 . . . . 0.0 110.979 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.72 -179.25 7.26 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.2 pt -118.95 134.77 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.485 1.514 . . . . 0.0 112.91 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -112.18 146.47 38.03 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.746 1.219 . . . . 0.0 112.265 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.75 178.23 35.03 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.693 1.437 . . . . 0.0 116.693 -177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.94 -4.69 85.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.952 1.739 . . . . 0.0 115.602 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -15.84 64.84 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -169.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -146.61 164.71 31.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.746 1.273 . . . . 0.0 112.939 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.19 161.82 31.95 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.502 1.521 . . . . 0.0 110.003 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -63.29 -13.0 33.18 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.298 2.665 . . . . 0.0 117.729 -169.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.44 14.96 64.08 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 123.908 0.766 . . . . 0.0 114.496 171.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.1 mmm 58.1 39.44 26.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.343 1.857 . . . . 0.0 112.988 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -92.28 127.95 37.95 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.369 1.467 . . . . 0.0 109.53 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -75.37 123.67 25.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.423 1.089 . . . . 0.0 111.166 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -73.44 162.75 28.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.72 73.51 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.561 1.544 . . . . 0.0 111.538 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 p -72.0 131.58 43.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.299 1.039 . . . . 0.0 112.118 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -137.37 175.04 9.96 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.463 1.905 . . . . 0.0 112.527 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 50.62 69.49 2.57 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.746 1.619 . . . . 0.0 113.996 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.49 135.68 58.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.189 2.592 . . . . 0.0 111.515 174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.406 HD11 HD22 ' A' ' 26' ' ' ASN . 1.4 mt -105.88 154.04 7.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.298 1.839 . . . . 0.0 108.535 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 158.07 18.47 Favored 'General case' 0 CA--C 1.526 0.055 0 C-N-CA 123.23 0.612 . . . . 0.0 111.829 173.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -72.54 127.64 33.16 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.198 0.599 . . . . 0.0 110.416 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -113.03 12.05 19.13 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.022 1.329 . . . . 0.0 112.73 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.59 -11.71 46.67 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.197 -1.565 . . . . 0.0 113.762 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -58.62 -1.81 0.17 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -79.95 0.83 29.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.122 1.369 . . . . 0.0 111.569 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.71 10.14 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.708 1.623 . . . . 0.0 114.094 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.8 mt -78.64 157.07 28.75 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -170.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.78 158.44 36.55 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -117.68 109.84 17.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.786 2.034 . . . . 0.0 110.717 -175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -136.0 169.87 16.91 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.703 1.201 . . . . 0.0 111.537 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.1 126.27 24.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.988 0.899 . . . . 0.0 111.079 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.7 24.45 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.923 1.249 . . . . 0.0 114.651 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.5 p -123.86 159.11 30.33 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.172 1.486 . . . . 0.0 113.096 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.69 137.78 54.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.3 159.0 42.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.007 0.523 . . . . 0.0 111.923 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 94.7 mmm -78.34 138.21 38.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.089 -0.382 . . . . 0.0 110.518 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.94 150.31 25.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.106 0.562 . . . . 0.0 110.66 171.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -115.3 160.77 19.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.536 1.134 . . . . 0.0 112.896 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.8 m -75.56 -52.46 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.054 0.942 . . . . 0.0 111.285 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.27 -57.39 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.559 1.544 . . . . 0.0 110.716 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.99 157.47 78.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.946 1.298 . . . . 0.0 112.115 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.25 -23.09 73.03 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.48 2.787 . . . . 0.0 114.068 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -111.52 36.78 3.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.739 1.615 . . . . 0.0 112.41 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 p -121.15 26.52 8.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.388 1.475 . . . . 0.0 113.843 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.62 99.67 10.34 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.364 1.466 . . . . 0.0 109.447 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -87.07 -71.55 0.55 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.186 . . . . 0.0 112.618 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.9 38.73 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -169.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -129.36 152.3 49.07 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.374 1.07 . . . . 0.0 111.903 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -142.18 168.41 19.81 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.504 1.522 . . . . 0.0 110.716 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 8.1 p90 -144.03 159.49 42.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.16 0.584 . . . . 0.0 111.055 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.2 mt -116.42 120.12 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.44 102.8 5.31 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.167 0.587 . . . . 0.0 109.525 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.28 -18.05 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.88 165.69 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.592 1.557 . . . . 0.0 111.663 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -78.48 119.4 21.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.792 0.437 . . . . 0.0 110.03 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -143.03 63.02 1.39 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 123.009 1.385 . . . . 0.0 111.758 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.27 -11.9 53.15 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -172.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -64.42 -13.68 52.6 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.579 -1.325 . . . . 0.0 113.573 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.06 -13.88 58.96 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.529 1.132 . . . . 0.0 113.431 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -69.32 167.06 17.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.39 1.476 . . . . 0.0 114.904 -170.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -70.2 138.3 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 t -143.77 21.9 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.5 63.02 0.66 Allowed Glycine 0 N--CA 1.476 1.364 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 56.33 26.35 10.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.56 1.544 . . . . 0.0 114.916 169.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -127.2 136.85 52.61 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.601 1.16 . . . . 0.0 112.353 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.902 1.281 . . . . 0.0 113.916 -170.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -72.93 -17.26 61.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.836 0.454 . . . . 0.0 112.209 172.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.26 -94.82 1.09 Allowed Glycine 0 CA--C 1.533 1.177 0 C-N-CA 127.194 2.33 . . . . 0.0 111.72 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -72.94 126.2 29.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.09 -54.88 0.83 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.853 1.216 . . . . 0.0 114.259 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -143.82 158.96 43.33 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.429 1.492 . . . . 0.0 111.72 -169.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 35.0 t -93.66 119.19 32.36 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.646 -0.658 . . . . 0.0 112.657 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.2 82.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.218 1.407 . . . . 0.0 108.66 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -77.5 -13.25 59.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.914 0.886 . . . . 0.0 112.309 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.08 177.56 8.34 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 122.751 1.262 . . . . 0.0 114.278 -169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -141.96 154.29 44.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.511 1.124 . . . . 0.0 112.792 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.36 143.49 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.68 0.753 . . . . 0.0 110.394 172.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.8 t -117.11 -40.99 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.79 1.636 . . . . 0.0 111.122 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -145.19 155.12 43.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.869 1.667 . . . . 0.0 109.75 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.92 16.37 23.89 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 123.817 0.723 . . . . 0.0 114.327 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -33.55 66.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.834 1.317 . . . . 0.0 112.33 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.52 -29.14 69.16 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.545 0.738 . . . . 0.0 112.551 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.9 t -77.01 -41.52 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.256 1.423 . . . . 0.0 110.238 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.2 t -59.24 -39.89 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.879 -1.138 . . . . 0.0 111.042 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.0 -30.47 68.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.112 1.365 . . . . 0.0 111.953 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.09 -42.89 62.51 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.986 0.914 . . . . 0.0 111.168 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.13 -25.12 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.494 1.517 . . . . 0.0 112.409 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -86.39 -23.3 26.18 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.39 -7.61 69.32 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.986 1.755 . . . . 0.0 114.779 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.79 -27.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 84.55 163.54 0.1 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.522 2.329 . . . . 0.0 114.057 -169.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 p -118.92 143.98 46.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.196 1.398 . . . . 0.0 113.668 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -165.16 128.84 1.85 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.034 1.302 . . . . 0.0 111.426 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -62.61 146.01 53.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.52 1.128 . . . . 0.0 113.344 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.3 p -98.42 169.62 9.42 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.392 1.477 . . . . 0.0 111.755 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -5.66 12.55 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.043 -0.865 . . . . 0.0 115.064 170.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -119.82 -37.99 3.03 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.986 1.314 . . . . 0.0 113.574 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -141.55 137.38 31.95 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.98 1.712 . . . . 0.0 110.767 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -95.08 156.04 16.48 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.373 1.069 . . . . 0.0 113.443 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.6 t70 58.22 31.59 20.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 114.523 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.1 m -86.61 156.37 56.08 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.317 1.447 . . . . 0.0 111.429 175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.54 137.57 70.17 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.709 1.606 . . . . 0.0 110.512 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -32.17 61.89 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -84.91 147.38 26.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.184 0.593 . . . . 0.0 110.544 169.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.18 116.73 23.08 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.196 0.998 . . . . 0.0 111.071 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 91.0 t -114.85 108.06 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.316 1.047 . . . . 0.0 108.483 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -129.52 141.34 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.439 1.114 . . . . 0.0 111.932 -169.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.2 mt -83.61 103.44 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.38 -36.87 66.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.186 0.594 . . . . 0.0 110.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.6 t -154.37 165.22 37.04 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -133.76 141.07 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.791 2.037 . . . . 0.0 110.431 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -135.76 131.75 35.92 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.956 1.302 . . . . 0.0 110.187 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.62 124.07 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.309 -0.869 . . . . 0.0 108.82 171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.7 t -117.36 150.3 39.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.077 1.351 . . . . 0.0 112.749 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.93 1.692 . . . . 0.0 113.629 -169.707 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.501 2.103 0 CA-C-O 120.318 0.104 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.9 t -123.46 129.97 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.4 m -104.36 123.68 47.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.98 1.312 . . . . 0.0 110.205 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.36 132.31 42.0 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.568 1.147 . . . . 0.0 110.688 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -103.18 103.13 13.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -106.48 151.49 24.89 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.966 -0.459 . . . . 0.0 111.126 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -60.57 -7.63 2.3 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 173.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -108.28 -8.71 15.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.005 1.322 . . . . 0.0 114.094 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.96 163.5 11.17 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.505 1.526 . . . . 0.0 113.859 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -74.04 138.82 44.29 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.034 1.734 . . . . 0.0 112.957 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.82 141.51 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.512 1.925 . . . . 0.0 109.062 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 t -124.62 135.66 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 110.805 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 139.72 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.743 2.017 . . . . 0.0 110.389 -175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -105.07 125.77 51.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.638 1.975 . . . . 0.0 108.844 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 p -88.96 147.5 24.28 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.379 1.072 . . . . 0.0 111.553 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -104.94 74.52 1.13 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.792 1.282 . . . . 0.0 111.202 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.76 -26.3 64.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.618 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -76.81 -28.0 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.362 1.065 . . . . 0.0 111.386 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -95.83 -29.13 14.39 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.388 1.475 . . . . 0.0 112.398 -177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.74 58.55 3.32 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 0.0 113.003 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -60.87 -43.19 32.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.493 2.795 . . . . 0.0 112.932 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -68.33 -40.38 81.63 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.741 0.7 . . . . 0.0 110.893 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.5 m -63.91 -51.33 64.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.195 0.598 . . . . 0.0 111.641 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.57 -38.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -56.33 -49.58 73.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.601 1.091 . . . . 0.0 111.484 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -68.81 -36.74 78.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.412 0.551 . . . . 0.0 112.19 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.59 -49.63 77.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.763 1.225 . . . . 0.0 111.426 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.9 mt -70.71 -34.71 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.368 -0.833 . . . . 0.0 112.449 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -45.2 77.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.573 0.349 . . . . 0.0 110.261 170.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -68.45 -40.68 81.0 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.593 -0.692 . . . . 0.0 111.456 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 75.2 m -59.77 -40.06 86.95 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.878 -0.514 . . . . 0.0 111.397 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -72.67 -30.07 63.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.376 1.47 . . . . 0.0 113.385 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -79.41 -16.54 56.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.631 0.65 . . . . 0.0 112.372 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.66 17.39 56.81 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.497 1.046 . . . . 0.0 113.298 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.04 -41.66 97.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.438 1.095 . . . . 0.0 113.121 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -81.49 -15.21 55.67 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.27 5.31 1.0 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -145.87 17.49 1.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.064 1.346 . . . . 0.0 112.986 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.7 p -81.67 163.17 22.7 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.126 -0.984 . . . . 0.0 112.345 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 156' ' ' ILE . 12.0 pt -119.26 165.48 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.08 89.45 6.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.412 1.485 . . . . 0.0 108.573 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -85.68 -3.06 58.78 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -131.92 134.6 45.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.822 1.646 . . . . 0.0 111.173 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.42 135.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.504 1.522 . . . . 0.0 110.807 169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -137.79 128.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.61 1.564 . . . . 0.0 108.429 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.26 132.2 49.57 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.611 0.764 . . . . 0.0 111.691 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.05 10.99 66.21 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 123.956 0.789 . . . . 0.0 115.029 -174.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -144.01 -177.23 5.34 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.121 1.769 . . . . 0.0 111.019 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -83.75 177.41 8.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.44 140.0 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.61 1.564 . . . . 0.0 111.857 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -123.41 148.5 46.06 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 0.0 111.287 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.16 -178.1 27.39 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.557 1.075 . . . . 0.0 114.51 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 -1.09 89.27 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.31 0.957 . . . . 0.0 115.342 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.94 -27.06 32.56 Favored Glycine 0 N--CA 1.473 1.102 0 CA-C-N 118.931 1.366 . . . . 0.0 115.391 -173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.22 161.86 37.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -88.62 164.46 31.96 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 126.048 1.739 . . . . 0.0 109.69 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.31 -11.49 30.42 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.337 2.692 . . . . 0.0 117.518 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 17.16 59.81 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.273 0.94 . . . . 0.0 114.61 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.7 mmm 59.46 37.83 22.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.152 1.781 . . . . 0.0 113.31 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -93.83 130.89 39.69 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.074 1.349 . . . . 0.0 109.468 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -74.19 131.92 41.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 124.143 1.925 . . . . 0.0 111.792 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -75.93 -179.29 4.78 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 110.322 -3.127 . . . . 0.0 114.519 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.65 56.49 3.88 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 112.869 -1.968 . . . . 0.0 112.066 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 p -69.41 106.25 2.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.084 1.354 . . . . 0.0 110.824 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -137.87 169.25 18.11 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.694 1.998 . . . . 0.0 111.947 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 48.49 62.89 11.3 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.486 1.514 . . . . 0.0 113.183 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -58.11 134.79 64.34 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.539 2.826 . . . . 0.0 111.749 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.24 152.55 4.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.356 1.862 . . . . 0.0 107.837 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 158.67 17.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.192 0.597 . . . . 0.0 110.67 172.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -71.43 134.6 46.72 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.179 -174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.38 14.09 12.82 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.765 1.226 . . . . 0.0 112.627 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.49 59.93 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.434 -1.416 . . . . 0.0 113.93 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.93 0.21 0.24 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.629 1.972 . . . . 0.0 115.822 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -81.37 -3.45 52.79 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.036 1.334 . . . . 0.0 112.556 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.44 24.77 49.77 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.578 1.085 . . . . 0.0 114.942 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 159.1 28.52 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 117.707 0.753 . . . . 0.0 112.616 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -131.39 154.47 48.6 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -98.65 100.02 11.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.669 1.987 . . . . 0.0 110.118 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.1 p -130.68 165.24 23.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.306 1.042 . . . . 0.0 111.603 -175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.2 ptt-85 -55.34 121.97 10.1 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.64 1.176 . . . . 0.0 110.771 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 49.82 6.24 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.72 1.153 . . . . 0.0 113.923 -174.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.7 p -136.21 163.51 30.21 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.16 0.98 . . . . 0.0 112.523 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.79 140.81 51.89 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.725 0.81 . . . . 0.0 112.709 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.91 157.82 45.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.894 -0.504 . . . . 0.0 112.019 169.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -82.37 140.6 33.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.498 0.319 . . . . 0.0 111.303 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.64 144.68 25.08 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.575 0.75 . . . . 0.0 111.469 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -114.58 159.81 20.0 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.026 1.33 . . . . 0.0 112.978 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.3 m -77.67 -54.86 5.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.068 1.347 . . . . 0.0 112.051 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -153.65 -40.38 0.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.696 1.199 . . . . 0.0 113.078 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -97.04 157.18 35.41 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.868 1.267 . . . . 0.0 111.267 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.73 -26.13 64.16 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.115 2.543 . . . . 0.0 114.429 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -105.77 33.9 3.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.58 1.552 . . . . 0.0 112.779 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.9 p -123.07 35.71 4.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.379 1.472 . . . . 0.0 113.161 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.66 107.93 20.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.086 1.754 . . . . 0.0 109.826 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 p -91.65 -67.82 0.83 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.393 1.077 . . . . 0.0 112.584 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.87 -17.15 1.92 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -78.34 143.53 36.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 122.116 0.96 . . . . 0.0 112.194 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.03 167.97 20.89 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.316 1.847 . . . . 0.0 110.816 175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 5.6 p90 -145.34 161.44 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.577 0.751 . . . . 0.0 111.726 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 mt -116.39 115.45 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.758 1.223 . . . . 0.0 108.16 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -73.4 101.23 3.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.713 0.805 . . . . 0.0 110.193 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -81.86 -16.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.1 167.28 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 128.129 2.572 . . . . 0.0 111.057 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -78.31 121.84 24.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.124 0.57 . . . . 0.0 110.667 169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -145.85 68.98 1.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 123.266 1.508 . . . . 0.0 111.306 -170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.59 -13.02 61.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -64.4 -12.83 46.98 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.614 -1.304 . . . . 0.0 113.224 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.98 -7.16 59.59 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.626 1.171 . . . . 0.0 113.972 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.18 179.6 5.61 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -171.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -79.82 142.1 35.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.361 1.465 . . . . 0.0 112.171 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.1 p -107.71 -59.45 1.83 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.459 1.104 . . . . 0.0 113.682 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.18 60.21 0.02 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.859 0.742 . . . . 0.0 114.363 -172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 59.2 21.33 9.43 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.216 1.806 . . . . 0.0 115.303 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -98.61 126.23 44.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.357 1.063 . . . . 0.0 112.804 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.8 tp -54.78 -37.21 65.74 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.669 1.188 . . . . 0.0 113.81 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -88.34 -3.92 58.76 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.058 0.943 . . . . 0.0 113.14 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.69 -72.77 1.07 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.547 2.022 . . . . 0.0 114.026 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 5.5 p-90 -69.73 127.58 33.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -169.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.05 -108.17 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.617 1.58 . . . . 0.0 116.013 -169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.69 142.8 46.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.419 1.488 . . . . 0.0 111.554 -169.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -86.21 118.45 25.67 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -170.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.38 84.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.691 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -78.19 -13.75 59.73 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.004 0.922 . . . . 0.0 112.083 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.96 177.2 8.71 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.496 1.141 . . . . 0.0 113.672 -170.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -139.98 149.81 43.72 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.845 -1.159 . . . . 0.0 111.928 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.07 136.69 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.605 -0.684 . . . . 0.0 110.414 172.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.72 -42.29 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.356 1.862 . . . . 0.0 110.834 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -143.26 154.86 44.25 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.466 1.506 . . . . 0.0 109.862 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.36 13.9 37.24 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.911 0.767 . . . . 0.0 114.754 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.5 mmm -54.19 -35.95 62.89 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.43 1.615 . . . . 0.0 112.381 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -63.95 -33.43 75.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.693 0.797 . . . . 0.0 112.385 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.59 -42.64 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.925 1.29 . . . . 0.0 110.39 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.71 -40.29 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.23 1.012 . . . . 0.0 111.237 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.38 -26.01 60.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.892 1.277 . . . . 0.0 112.78 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -79.39 -41.51 27.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.914 1.286 . . . . 0.0 111.18 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.7 mt -54.87 -31.79 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.899 1.679 . . . . 0.0 112.771 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -90.59 -15.27 30.86 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.3 -16.24 18.99 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.707 1.623 . . . . 0.0 114.475 -172.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -63.18 -59.5 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 118.834 1.317 . . . . 0.0 112.29 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.96 153.53 2.61 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.471 1.508 . . . . 0.0 111.587 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.3 p -133.67 147.75 51.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.96 1.304 . . . . 0.0 112.366 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.96 136.44 2.22 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.247 0.451 . . . . 0.0 113.201 169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -62.97 153.35 33.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.493 1.117 . . . . 0.0 113.291 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.7 t -134.73 169.28 17.57 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.408 1.883 . . . . 0.0 111.645 -169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.03 121.39 15.76 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.295 -0.878 . . . . 0.0 112.471 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.8 mtt 59.93 3.07 0.44 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.36 2.264 . . . . 0.0 116.659 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -141.38 111.39 6.69 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.838 1.199 . . . . 0.0 111.757 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -99.65 158.05 16.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.029 0.931 . . . . 0.0 112.364 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 57.49 56.04 5.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.69 1.233 . . . . 0.0 112.699 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.65 154.55 57.16 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 125.71 1.604 . . . . 0.0 111.179 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.02 131.79 24.7 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 N-CA-C 108.027 -1.566 . . . . 0.0 108.027 169.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -31.15 63.44 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.67 -0.644 . . . . 0.0 111.797 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -83.26 150.3 26.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.233 1.013 . . . . 0.0 109.103 168.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.25 117.75 23.17 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.102 -0.999 . . . . 0.0 110.651 -170.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.3 102.82 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.533 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.04 143.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 124.659 1.184 . . . . 0.0 112.287 -169.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.0 mt -82.64 103.86 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -76.04 -27.34 57.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.557 1.143 . . . . 0.0 111.697 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -163.38 169.33 19.13 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.52 140.82 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.287 1.835 . . . . 0.0 110.477 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 26.3 m -133.84 135.0 43.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.271 1.428 . . . . 0.0 110.073 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.68 125.73 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.6 t -122.6 150.78 42.16 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.763 1.625 . . . . 0.0 111.927 -171.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.73 1.212 . . . . 0.0 113.246 -179.629 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -125.7 129.56 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.077 0.951 . . . . 0.0 109.41 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -104.71 123.28 47.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.589 1.156 . . . . 0.0 110.055 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.56 134.59 38.25 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 110.598 169.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -105.9 101.78 11.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 p -106.21 151.13 25.17 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.041 -0.412 . . . . 0.0 110.949 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -60.78 -7.8 2.57 Favored 'General case' 0 CA--C 1.556 1.197 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -108.14 -8.33 15.82 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.954 1.302 . . . . 0.0 114.101 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.24 160.9 9.84 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.046 1.307 . . . . 0.0 114.124 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -74.15 138.08 43.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.852 1.661 . . . . 0.0 112.702 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -134.21 141.01 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.111 1.764 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.7 t -123.16 136.65 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.736 1.214 . . . . 0.0 110.68 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mt -127.12 138.75 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.495 1.918 . . . . 0.0 110.323 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -105.84 122.21 45.64 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.492 1.917 . . . . 0.0 109.142 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 p -85.91 148.18 25.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.312 1.045 . . . . 0.0 111.83 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -104.22 73.82 1.15 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 122.702 1.239 . . . . 0.0 111.359 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.75 -26.85 64.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.502 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.15 -30.87 58.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.262 1.025 . . . . 0.0 111.53 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.29 -26.43 15.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.833 1.253 . . . . 0.0 112.991 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.03 59.0 3.46 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.99 0.916 . . . . 0.0 112.833 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.63 -43.77 25.22 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.251 2.634 . . . . 0.0 112.72 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -69.77 -41.15 75.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.513 0.597 . . . . 0.0 110.957 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' ILE . 24.8 m -62.73 -49.9 73.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.482 0.713 . . . . 0.0 111.265 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.63 -44.32 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.307 0.643 . . . . 0.0 111.477 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -55.72 -47.7 76.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.771 1.168 . . . . 0.0 112.014 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.442 HD22 HD11 ' A' ' 68' ' ' ILE . 44.3 t30 -68.0 -39.13 83.27 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.43 0.559 . . . . 0.0 111.667 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.7 -48.47 81.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.683 1.193 . . . . 0.0 111.542 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.96 -38.31 79.34 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 111.653 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.86 -33.73 70.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.956 0.902 . . . . 0.0 112.529 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.392 -0.817 . . . . 0.0 112.287 172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.03 -35.2 76.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.791 -0.568 . . . . 0.0 111.596 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -64.99 -34.19 77.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.909 2.084 . . . . 0.0 113.006 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -81.78 -15.74 53.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.831 0.852 . . . . 0.0 113.086 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.89 15.18 56.83 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.121 1.344 . . . . 0.0 113.979 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -65.48 -31.58 72.73 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.198 0.999 . . . . 0.0 113.678 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -87.64 -15.47 37.16 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.19 0.7 5.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.435 1.494 . . . . 0.0 114.574 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -144.85 50.35 1.26 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.129 1.772 . . . . 0.0 110.252 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.5 p -119.81 169.83 9.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.466 1.106 . . . . 0.0 111.945 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 156' ' ' ILE . 19.0 pt -129.72 167.14 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -169.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -95.3 93.92 7.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.378 1.471 . . . . 0.0 107.764 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -86.46 -0.86 56.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -140.39 141.17 35.61 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.089 1.768 . . . . 0.0 112.67 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -139.87 132.73 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 126.187 1.795 . . . . 0.0 111.152 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.98 128.72 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.022 1.729 . . . . 0.0 108.292 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -68.97 139.42 55.04 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.782 -0.574 . . . . 0.0 111.249 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.59 9.12 68.71 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -144.79 -177.12 5.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.788 2.035 . . . . 0.0 110.55 -175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.87 178.1 6.12 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.016 1.726 . . . . 0.0 114.501 -171.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 pt -114.21 136.94 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.016 1.326 . . . . 0.0 111.765 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -103.62 147.26 27.42 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.137 0.975 . . . . 0.0 110.761 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.05 31.38 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 122.637 1.132 . . . . 0.0 114.849 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.92 72.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.668 -1.073 . . . . 0.0 114.434 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.49 -22.87 41.96 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-N 119.624 1.712 . . . . 0.0 114.729 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.35 166.07 26.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.799 1.24 . . . . 0.0 112.912 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.83 162.19 27.85 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.956 1.702 . . . . 0.0 110.402 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -60.77 -13.2 25.21 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.696 2.93 . . . . 0.0 118.505 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.26 17.23 59.7 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.122 0.867 . . . . 0.0 114.592 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.4 mmm 58.46 36.46 25.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.072 1.749 . . . . 0.0 113.114 -173.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -92.07 131.32 37.43 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.296 1.438 . . . . 0.0 109.386 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -71.04 124.43 24.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.495 1.118 . . . . 0.0 110.107 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.38 159.14 32.1 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.3 75.27 8.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.245 1.418 . . . . 0.0 111.484 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.2 p -69.0 127.53 33.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.546 1.139 . . . . 0.0 112.409 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.5 177.32 7.96 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.62 1.968 . . . . 0.0 111.484 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 50.42 68.33 3.52 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.593 1.557 . . . . 0.0 113.617 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -58.81 147.46 88.48 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.252 2.635 . . . . 0.0 111.597 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.0 OUTLIER -124.68 149.6 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.813 1.645 . . . . 0.0 109.155 -174.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 155.49 29.0 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.581 0.705 . . . . 0.0 110.419 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -78.71 134.45 37.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.397 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -119.69 14.39 12.61 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.941 0.896 . . . . 0.0 112.11 -174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.53 -17.03 64.58 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.569 -1.332 . . . . 0.0 113.764 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -63.5 -0.97 1.03 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.388 1.875 . . . . 0.0 115.482 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -79.77 -5.63 55.7 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.701 1.2 . . . . 0.0 113.017 169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.65 21.06 49.03 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.531 1.063 . . . . 0.0 114.942 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -73.05 155.47 39.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 117.911 0.855 . . . . 0.0 111.75 170.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -133.63 155.38 49.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -90.31 107.11 18.94 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.428 2.291 . . . . 0.0 109.439 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -137.67 169.43 17.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.918 1.287 . . . . 0.0 110.869 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -49.63 124.82 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.798 1.239 . . . . 0.0 111.458 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.24 31.78 41.14 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.274 1.416 . . . . 0.0 115.048 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.9 p -121.95 160.86 23.96 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 119.536 1.668 . . . . 0.0 113.584 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.91 137.91 54.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.659 0.784 . . . . 0.0 112.965 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.47 160.49 38.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.817 0.447 . . . . 0.0 112.143 170.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 96.7 mmm -79.1 139.74 38.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.158 0.583 . . . . 0.0 111.341 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.45 112.22 23.77 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.502 0.721 . . . . 0.0 110.292 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -75.48 157.26 34.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 0.0 112.709 -174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.0 m -70.81 -51.09 28.99 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.873 0.869 . . . . 0.0 110.934 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -160.12 -58.6 0.06 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.322 1.449 . . . . 0.0 110.373 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.17 158.24 79.98 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 124.61 1.164 . . . . 0.0 111.889 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.77 -31.48 88.39 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.825 2.35 . . . . 0.0 113.459 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -101.62 46.46 0.93 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.346 1.858 . . . . 0.0 112.294 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.6 p -133.99 32.2 3.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.96 54.66 1.33 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.989 1.716 . . . . 0.0 113.643 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.5 p -54.42 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -154.74 36.8 0.41 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -135.27 151.54 50.66 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.311 1.444 . . . . 0.0 110.097 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.58 172.21 13.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.061 1.344 . . . . 0.0 111.667 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.2 p90 -147.2 161.56 40.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.402 -0.811 . . . . 0.0 111.524 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 mt -115.5 115.84 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -76.69 102.68 6.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.903 0.881 . . . . 0.0 110.156 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -82.81 -21.93 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.268 -0.895 . . . . 0.0 112.968 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.01 168.55 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.813 1.645 . . . . 0.0 111.959 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -83.22 123.44 29.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.323 0.649 . . . . 0.0 110.291 169.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -144.79 76.82 1.51 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.828 1.299 . . . . 0.0 112.707 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.07 -34.88 66.37 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.209 1.804 . . . . 0.0 114.583 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -59.88 -12.58 7.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.84 -9.57 59.26 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -79.48 -177.08 5.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -169.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -77.05 141.21 40.39 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.289 1.836 . . . . 0.0 112.473 172.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.2 p -107.79 -57.16 2.13 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.24 1.016 . . . . 0.0 113.59 173.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.19 68.96 0.02 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.428 1.013 . . . . 0.0 113.427 -171.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 54.15 24.3 4.78 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.311 1.844 . . . . 0.0 115.289 171.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.0 m -110.2 119.32 38.89 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.639 1.176 . . . . 0.0 111.188 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.9 mt -49.81 -39.68 39.26 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -86.91 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.51 -62.47 1.09 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 126.567 2.032 . . . . 0.0 113.966 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.353 2.8 p-90 -73.02 126.79 30.8 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.581 1.191 . . . . 0.0 112.634 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.93 -95.35 0.96 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.387 1.47 . . . . 0.0 115.948 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -129.19 138.22 51.6 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.513 1.125 . . . . 0.0 112.11 -168.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.92 121.82 26.97 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.76 87.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.013 1.325 . . . . 0.0 108.178 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -77.81 -15.61 58.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.431 0.692 . . . . 0.0 111.88 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.4 178.69 7.27 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.572 1.177 . . . . 0.0 113.942 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -138.93 154.38 48.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.659 1.183 . . . . 0.0 112.325 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.91 140.44 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.624 0.726 . . . . 0.0 110.271 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.79 -42.52 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.715 1.606 . . . . 0.0 111.213 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -144.49 152.86 41.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.591 1.556 . . . . 0.0 109.791 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.89 13.97 22.26 Favored Glycine 0 N--CA 1.47 0.936 0 C-N-CA 123.85 0.738 . . . . 0.0 114.67 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -34.94 68.81 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.125 1.462 . . . . 0.0 112.301 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.94 -30.7 71.71 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.8 0.84 . . . . 0.0 112.486 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.27 -41.38 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.416 1.087 . . . . 0.0 110.131 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.89 -40.23 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.489 -0.757 . . . . 0.0 111.091 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.58 -28.56 63.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.776 1.23 . . . . 0.0 112.349 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -74.65 -44.16 51.74 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.473 1.109 . . . . 0.0 110.699 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 55.1 mt -56.61 -29.25 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.641 1.576 . . . . 0.0 112.633 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -94.48 -11.42 29.69 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.54 -14.65 13.77 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.631 1.586 . . . . 0.0 114.5 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.6 m -62.11 -60.94 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.86 1.33 . . . . 0.0 112.428 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -175.07 156.59 2.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.658 1.583 . . . . 0.0 111.645 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 p -123.72 150.04 44.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.293 1.437 . . . . 0.0 112.281 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.75 142.91 3.65 Favored Glycine 0 N--CA 1.465 0.572 0 CA-C-O 122.835 1.242 . . . . 0.0 113.252 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -65.78 153.62 41.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.209 2.204 . . . . 0.0 113.693 -169.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.9 p -117.91 169.16 9.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.05 1.34 . . . . 0.0 112.089 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.1 -14.78 66.54 Favored Glycine 0 CA--C 1.54 1.601 0 N-CA-C 115.663 1.025 . . . . 0.0 115.663 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 37.8 ttp -133.3 -19.53 2.17 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -133.45 134.05 43.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.601 1.56 . . . . 0.0 110.947 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -105.55 163.68 12.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.032 1.733 . . . . 0.0 111.393 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 58.14 46.7 15.61 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.17 1.388 . . . . 0.0 113.208 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.07 152.43 54.3 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.764 1.625 . . . . 0.0 112.574 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.23 142.61 46.3 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 121.96 1.773 . . . . 0.0 109.412 169.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -30.83 61.6 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.601 -0.687 . . . . 0.0 112.63 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.97 145.24 32.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.905 0.882 . . . . 0.0 110.078 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -83.64 120.59 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.383 1.073 . . . . 0.0 110.436 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.64 99.93 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.175 0.99 . . . . 0.0 108.358 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -122.32 143.0 36.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.79 1.236 . . . . 0.0 112.216 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.3 mt -83.13 103.86 10.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 169.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.89 -28.89 60.82 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.381 1.073 . . . . 0.0 111.18 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.7 t -164.02 169.54 17.8 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.0 139.85 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.716 2.007 . . . . 0.0 110.055 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -133.06 133.11 42.58 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.291 1.437 . . . . 0.0 110.134 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -86.73 125.62 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.274 -0.891 . . . . 0.0 108.864 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 t -121.55 140.44 52.21 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.07 1.348 . . . . 0.0 112.024 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 112.217 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.46 131.25 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.544 -1.347 . . . . 0.0 110.624 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.2 m -102.67 126.38 49.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.631 1.172 . . . . 0.0 110.184 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.1 123.34 44.23 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.875 1.27 . . . . 0.0 109.753 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -98.79 109.64 22.37 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.7 p -121.88 158.82 28.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.171 0.51 . . . . 0.0 112.147 -169.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -69.3 -7.2 34.94 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.62 -26.39 10.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.579 1.552 . . . . 0.0 113.392 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.68 145.52 4.24 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.311 1.91 . . . . 0.0 113.282 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.0 132.8 32.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.302 1.041 . . . . 0.0 112.277 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.43 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.828 1.651 . . . . 0.0 109.199 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.21 138.21 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.099 0.96 . . . . 0.0 110.506 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -131.79 135.67 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.671 1.989 . . . . 0.0 110.13 -172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -104.18 125.73 50.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.116 1.766 . . . . 0.0 108.946 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -88.28 146.97 25.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.108 0.963 . . . . 0.0 112.036 -175.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -104.67 74.36 1.14 Allowed 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 122.887 1.327 . . . . 0.0 110.973 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.66 -25.48 63.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.35 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -75.25 -31.78 60.91 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.5 1.12 . . . . 0.0 111.462 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -94.02 -27.28 16.4 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.625 1.17 . . . . 0.0 113.027 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.62 59.43 3.87 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.546 0.738 . . . . 0.0 112.919 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -61.72 -43.98 23.7 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.328 2.686 . . . . 0.0 112.723 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -67.51 -40.54 85.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.283 0.492 . . . . 0.0 110.708 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.8 m -63.46 -49.16 74.74 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.597 0.759 . . . . 0.0 111.948 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.4 -40.8 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 119.008 -0.52 . . . . 0.0 111.068 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.33 -48.31 80.94 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.789 1.177 . . . . 0.0 111.718 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.51 -36.03 78.31 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.56 0.744 . . . . 0.0 112.128 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -60.4 -51.4 69.66 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.38 -34.8 73.0 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.639 -0.663 . . . . 0.0 111.558 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -55.8 -36.44 67.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.978 0.911 . . . . 0.0 112.351 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -76.35 -42.53 44.53 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.602 -0.686 . . . . 0.0 112.586 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.6 m -60.78 -35.31 76.12 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.589 -0.694 . . . . 0.0 111.779 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -32.32 73.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 112.694 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -81.7 -13.28 58.05 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.96 18.25 65.66 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.616 1.103 . . . . 0.0 114.14 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.58 -17.37 64.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -92.41 -7.22 48.26 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.459 -0.776 . . . . 0.0 112.998 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -69.17 135.41 50.61 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 51.93 45.21 28.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.992 1.717 . . . . 0.0 114.253 -169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.7 p -104.05 160.05 15.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.504 0.722 . . . . 0.0 110.907 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 156' ' ' ILE . 15.9 pt -123.42 162.31 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -169.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -91.42 115.76 28.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -116.7 -3.63 11.73 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -139.18 132.68 30.3 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.424 1.011 . . . . 0.0 111.291 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.18 146.48 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.91 2.084 . . . . 0.0 108.913 169.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.5 mt -142.56 135.16 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.446 1.898 . . . . 0.0 107.415 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -64.21 134.8 55.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.324 0.65 . . . . 0.0 111.86 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.17 13.5 67.28 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.848 0.737 . . . . 0.0 114.848 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.15 -177.28 5.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.311 1.844 . . . . 0.0 111.033 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -88.24 -178.71 5.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.584 1.954 . . . . 0.0 115.16 -169.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.8 pt -120.01 142.47 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.022 1.329 . . . . 0.0 113.113 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -113.93 148.4 36.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.058 1.343 . . . . 0.0 112.083 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.41 178.79 32.71 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 -14.91 37.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 115.815 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.6 -10.67 76.15 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 116.738 1.455 . . . . 0.0 116.738 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -144.09 168.88 18.96 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.161 1.481 . . . . 0.0 113.359 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.83 162.85 18.7 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 126.895 2.078 . . . . 0.0 110.737 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -58.9 -15.22 25.98 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 124.019 3.146 . . . . 0.0 118.807 -169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 18.42 57.48 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.051 0.834 . . . . 0.0 114.715 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.0 mmt 59.4 27.3 16.37 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.588 1.555 . . . . 0.0 112.696 -170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -83.07 123.09 29.16 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.867 1.267 . . . . 0.0 109.169 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -73.17 121.2 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.005 0.922 . . . . 0.0 110.331 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -69.19 164.83 21.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.11 67.08 7.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.83 1.652 . . . . 0.0 111.704 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.8 p -66.17 125.93 27.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.842 1.657 . . . . 0.0 112.781 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -133.09 173.66 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.827 2.051 . . . . 0.0 111.96 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 46.24 66.32 5.62 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.478 1.511 . . . . 0.0 113.711 169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.55 137.52 74.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.337 2.691 . . . . 0.0 111.172 176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mt -105.5 150.78 7.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.689 1.596 . . . . 0.0 108.655 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.94 151.92 29.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.259 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -87.37 101.59 13.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.697 1.599 . . . . 0.0 110.438 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.43 18.69 3.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.801 1.24 . . . . 0.0 113.836 -169.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.74 -21.5 63.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.432 1.493 . . . . 0.0 114.18 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -60.52 -2.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.846 2.058 . . . . 0.0 115.536 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -77.11 0.9 19.81 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.187 0.995 . . . . 0.0 112.282 169.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.93 35.74 27.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.905 1.24 . . . . 0.0 112.888 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.0 144.59 43.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.421 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.84 154.46 49.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.71 114.78 26.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.065 2.146 . . . . 0.0 110.572 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 80.5 p -138.8 171.98 13.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.933 1.293 . . . . 0.0 111.009 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -51.78 125.89 16.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.805 1.242 . . . . 0.0 110.959 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.4 36.43 39.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.848 1.213 . . . . 0.0 114.803 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.7 p -120.72 158.81 26.67 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.892 1.346 . . . . 0.0 112.89 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.44 136.3 54.54 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.61 158.23 44.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.291 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.7 mmt -81.38 132.49 35.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.69 0.396 . . . . 0.0 110.902 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.11 161.13 24.23 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.5 0.72 . . . . 0.0 110.573 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -133.02 158.42 42.76 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.747 1.219 . . . . 0.0 112.868 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 m -74.01 -57.08 4.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.895 1.278 . . . . 0.0 112.777 -169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -158.61 -47.67 0.06 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.079 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.65 157.9 71.62 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.543 1.137 . . . . 0.0 111.359 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.84 -21.3 71.94 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.182 2.588 . . . . 0.0 114.584 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -117.74 42.2 2.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.604 1.962 . . . . 0.0 112.337 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.6 p -117.45 33.59 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.837 1.255 . . . . 0.0 113.861 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.43 102.63 14.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.277 1.431 . . . . 0.0 108.943 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -91.91 -60.09 1.95 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -156.49 33.33 0.32 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.79 140.08 53.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.216 1.406 . . . . 0.0 110.657 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -142.04 168.2 20.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.088 1.355 . . . . 0.0 111.354 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 18.6 p90 -144.12 160.3 41.15 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.538 0.735 . . . . 0.0 111.849 172.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.9 mt -114.26 115.34 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.211 1.004 . . . . 0.0 108.419 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -72.32 100.32 2.61 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.8 0.84 . . . . 0.0 110.217 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.23 -25.99 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 121.199 -0.938 . . . . 0.0 113.188 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.0 m -114.97 166.56 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.998 1.719 . . . . 0.0 111.633 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.69 122.84 27.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.02 0.528 . . . . 0.0 110.11 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -141.95 71.77 1.36 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.927 1.346 . . . . 0.0 112.596 -169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -52.29 -35.71 51.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.235 2.214 . . . . 0.0 114.445 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -59.88 -12.77 8.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.73 -14.18 55.01 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -73.16 161.91 30.04 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.284 1.434 . . . . 0.0 114.462 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -69.71 144.41 52.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.216 0.606 . . . . 0.0 112.312 173.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.8 p -126.22 -59.29 1.32 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.797 1.239 . . . . 0.0 113.089 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 167.81 70.31 0.03 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.987 0.803 . . . . 0.0 113.974 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.17 25.25 7.02 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.797 1.639 . . . . 0.0 114.826 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.1 m -113.95 123.15 49.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.907 1.283 . . . . 0.0 111.364 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.01 -33.71 67.44 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -169.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -75.72 -10.28 59.3 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.88 -88.52 1.95 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.178 2.323 . . . . 0.0 113.053 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -65.96 135.27 54.49 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.42 -82.3 1.36 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.564 1.078 . . . . 0.0 115.139 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -137.36 154.63 49.98 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.199 1.4 . . . . 0.0 112.176 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 40.7 t -84.67 117.17 23.61 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.928 -0.482 . . . . 0.0 111.801 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -77.1 81.0 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.842 1.257 . . . . 0.0 108.755 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.74 -13.99 60.67 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 0.0 112.258 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.86 178.09 8.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.74 1.257 . . . . 0.0 113.648 -171.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -137.25 154.09 50.21 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.918 -1.113 . . . . 0.0 112.339 171.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.12 143.94 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.772 0.796 . . . . 0.0 109.697 171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.79 -39.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.734 1.614 . . . . 0.0 110.861 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -146.46 148.89 32.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.52 1.528 . . . . 0.0 110.549 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 116.98 7.45 12.79 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 77.1 mmm -56.62 -36.21 69.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.584 1.692 . . . . 0.0 113.099 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -62.87 -30.3 71.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.631 0.773 . . . . 0.0 112.202 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 t -77.98 -40.93 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.044 1.738 . . . . 0.0 110.673 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.64 -39.59 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.034 0.934 . . . . 0.0 110.946 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.89 -25.57 61.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.993 1.317 . . . . 0.0 112.717 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -76.55 -42.86 41.45 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.12 1.368 . . . . 0.0 110.975 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.5 mt -54.24 -34.45 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.877 1.271 . . . . 0.0 112.111 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -91.49 -14.68 30.03 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.57 -20.64 14.42 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.106 1.336 . . . . 0.0 114.332 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.92 -63.88 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 118.598 1.199 . . . . 0.0 112.172 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.42 155.79 5.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -137.19 152.17 49.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.993 1.317 . . . . 0.0 112.135 169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.78 137.76 4.67 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.199 1.381 . . . . 0.0 111.404 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -66.57 145.18 55.89 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -169.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.0 p -98.97 169.7 9.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.439 1.896 . . . . 0.0 111.149 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.15 -4.44 8.08 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.301 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 49.7 tpp -123.17 -33.19 3.34 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.958 1.379 . . . . 0.0 114.057 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -141.43 133.67 27.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.573 1.549 . . . . 0.0 110.723 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.05 152.97 18.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.7 t0 50.41 38.04 17.1 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.857 2.063 . . . . 0.0 114.564 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.97 161.24 44.6 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 125.472 1.509 . . . . 0.0 111.187 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -57.74 128.79 30.53 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 120.759 1.307 . . . . 0.0 110.248 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.74 45.28 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.55 159.45 26.87 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.615 0.766 . . . . 0.0 110.467 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.49 109.67 16.17 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.27 -0.894 . . . . 0.0 110.612 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.17 94.0 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.477 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -122.74 144.32 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -168.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.4 mt -86.4 104.4 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 106.25 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.45 -41.02 61.53 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.811 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -151.21 166.26 31.4 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.48 141.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.052 1.741 . . . . 0.0 110.764 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.5 m -133.88 129.66 36.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.006 1.322 . . . . 0.0 110.243 174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.04 120.89 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -109.64 137.98 46.67 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.706 1.202 . . . . 0.0 111.752 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.571 1.948 . . . . 0.0 112.151 -178.454 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.501 2.109 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.92 130.52 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 121.13 -0.981 . . . . 0.0 109.597 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.5 m -103.67 120.95 41.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.039 0.936 . . . . 0.0 110.087 172.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -92.4 119.51 32.01 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 169.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -93.88 119.07 32.31 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -121.82 160.54 24.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.976 0.893 . . . . 0.0 113.125 -169.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -73.06 -4.64 33.81 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -120.5 -20.07 7.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.441 1.497 . . . . 0.0 114.412 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.67 117.32 1.08 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.001 1.762 . . . . 0.0 110.771 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -63.88 145.7 55.35 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.531 0.732 . . . . 0.0 111.763 -169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.8 mt -121.7 141.88 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.772 1.629 . . . . 0.0 109.664 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.08 134.09 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.465 1.106 . . . . 0.0 110.072 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.79 137.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 126.345 1.858 . . . . 0.0 110.102 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -105.57 123.36 47.78 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.446 1.898 . . . . 0.0 109.259 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.9 p -87.1 148.61 25.16 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.158 0.983 . . . . 0.0 112.005 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.13 72.9 0.9 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 122.888 1.328 . . . . 0.0 111.856 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.64 -25.58 64.0 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.536 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -77.25 -28.99 53.79 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.379 1.071 . . . . 0.0 111.566 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -99.29 -21.11 16.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.081 1.352 . . . . 0.0 113.406 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.52 56.22 1.31 Allowed Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.274 1.029 . . . . 0.0 113.244 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -60.01 -45.07 25.72 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.478 2.785 . . . . 0.0 113.088 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.94 -41.29 74.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.646 0.657 . . . . 0.0 111.245 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.9 m -63.9 -48.27 77.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.551 0.74 . . . . 0.0 111.281 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.8 t -62.67 -43.41 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.717 0.807 . . . . 0.0 111.463 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -57.17 -45.32 83.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.816 1.189 . . . . 0.0 112.019 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -69.36 -36.8 77.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.512 0.596 . . . . 0.0 111.821 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.09 -48.91 79.49 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.342 1.057 . . . . 0.0 111.728 171.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.6 mt -68.18 -36.84 80.24 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.269 -0.894 . . . . 0.0 111.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -58.45 -34.8 71.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 112.499 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -73.63 -43.34 59.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 112.161 172.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.8 m -58.38 -38.44 77.31 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.735 -0.603 . . . . 0.0 111.762 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -65.39 -35.77 81.94 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.327 2.251 . . . . 0.0 112.691 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -81.17 -16.03 54.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 0.0 113.046 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.69 19.36 63.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.962 0.792 . . . . 0.0 113.052 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.26 -37.61 75.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.506 1.122 . . . . 0.0 113.036 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -78.37 -9.84 59.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.714 0.406 . . . . 0.0 111.892 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.27 131.04 48.05 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.297 -0.877 . . . . 0.0 108.844 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.5 t30 62.38 20.86 12.15 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.054 2.142 . . . . 0.0 116.7 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -82.05 144.54 30.75 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.741 -1.224 . . . . 0.0 113.414 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -101.14 155.92 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -86.41 72.97 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.87 2.068 . . . . 0.0 108.402 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -69.45 -9.61 54.41 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.62 125.26 45.29 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.572 1.149 . . . . 0.0 110.508 -172.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.95 131.01 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.767 1.227 . . . . 0.0 112.042 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.42 131.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.697 1.999 . . . . 0.0 108.182 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.06 138.14 54.13 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.624 0.77 . . . . 0.0 112.008 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.02 67.74 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.702 0.668 . . . . 0.0 114.641 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.12 -177.22 5.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.607 1.963 . . . . 0.0 110.316 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.29 177.86 6.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.218 1.807 . . . . 0.0 114.196 -171.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 pt -116.39 140.82 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.896 1.278 . . . . 0.0 111.937 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -118.4 149.04 41.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.954 1.301 . . . . 0.0 111.372 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.6 -176.61 29.85 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.052 0.834 . . . . 0.0 114.978 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.77 -11.41 70.47 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.054 1.312 . . . . 0.0 115.632 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.32 60.06 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 118.879 1.34 . . . . 0.0 115.839 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -145.0 157.05 44.25 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -83.66 164.74 43.46 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 126.306 1.842 . . . . 0.0 109.32 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.04 -14.61 44.49 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.509 2.806 . . . . 0.0 117.087 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.71 18.83 56.81 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.438 1.018 . . . . 0.0 114.44 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.5 34.11 15.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.2 1.8 . . . . 0.0 112.94 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.32 131.22 37.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.389 1.476 . . . . 0.0 109.448 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.41 130.81 42.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 124.172 1.939 . . . . 0.0 111.603 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.85 -176.9 1.45 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 110.212 -3.176 . . . . 0.0 113.761 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.91 54.47 2.74 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.897 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.2 p -73.56 104.11 4.4 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.865 1.266 . . . . 0.0 111.571 -175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -133.47 178.44 6.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.872 2.069 . . . . 0.0 112.067 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 48.93 68.11 3.86 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.417 1.487 . . . . 0.0 113.798 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -61.95 138.31 72.73 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.168 2.579 . . . . 0.0 111.338 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.39 152.83 5.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 126.268 1.827 . . . . 0.0 108.024 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 155.05 27.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.153 0.502 . . . . 0.0 111.032 169.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -77.9 128.98 34.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.609 0.764 . . . . 0.0 111.124 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -111.12 15.13 21.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.942 1.297 . . . . 0.0 112.867 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -11.68 28.1 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -75.19 39.24 0.14 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -113.37 -6.49 13.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.226 2.21 . . . . 0.0 114.191 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.18 3.66 65.18 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.444 1.497 . . . . 0.0 115.2 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.19 158.24 19.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.606 1.203 . . . . 0.0 112.878 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.49 156.8 48.09 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.7 1.2 . . . . 0.0 113.521 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -90.25 93.21 9.25 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.496 1.918 . . . . 0.0 109.755 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.7 p -122.86 166.02 15.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.261 1.025 . . . . 0.0 111.319 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -55.37 114.38 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.265 1.826 . . . . 0.0 110.26 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.15 43.04 5.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.904 1.24 . . . . 0.0 114.633 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.7 p -134.91 165.46 25.26 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.842 1.321 . . . . 0.0 113.512 174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.6 mp -124.35 142.84 50.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 112.775 174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.6 156.72 47.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.724 -0.61 . . . . 0.0 111.853 169.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -83.94 136.93 33.89 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 122.175 -0.328 . . . . 0.0 111.258 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.66 155.25 20.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.717 0.807 . . . . 0.0 111.608 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -118.91 159.22 24.19 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.677 1.191 . . . . 0.0 112.674 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 50.3 m -72.25 -52.23 17.33 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.011 0.924 . . . . 0.0 110.805 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -159.56 -58.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 110.458 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.24 157.4 85.0 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 111.75 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -55.81 -34.69 92.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.841 2.36 . . . . 0.0 113.118 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -99.59 35.3 2.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.25 1.42 . . . . 0.0 112.917 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -123.35 27.53 7.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.506 1.522 . . . . 0.0 113.491 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 103.92 16.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.623 1.569 . . . . 0.0 109.638 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.5 p -88.41 -74.78 0.45 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.851 1.26 . . . . 0.0 112.519 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.71 -20.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.042 1.337 . . . . 0.0 113.643 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -71.04 145.32 50.0 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 121.029 -1.044 . . . . 0.0 112.441 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -141.81 168.06 20.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.32 1.848 . . . . 0.0 110.402 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.7 p90 -146.05 160.14 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.576 0.75 . . . . 0.0 111.753 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.5 mt -113.27 113.9 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.226 1.01 . . . . 0.0 108.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.78 93.88 2.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.174 0.989 . . . . 0.0 110.418 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.15 -23.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 163.67 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.483 1.513 . . . . 0.0 111.223 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -77.78 117.56 19.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.174 0.59 . . . . 0.0 109.8 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -143.64 64.95 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 123.113 1.435 . . . . 0.0 112.268 -169.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -66.31 -13.24 60.2 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -172.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.83 -13.82 38.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.654 -1.279 . . . . 0.0 113.453 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.02 -9.81 59.72 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.45 1.1 . . . . 0.0 113.949 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.12 -177.81 3.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -81.39 145.01 31.03 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.731 1.612 . . . . 0.0 111.785 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.4 p -111.75 -59.08 2.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.478 1.111 . . . . 0.0 113.468 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.16 61.49 0.02 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.068 0.842 . . . . 0.0 113.865 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.28 24.9 12.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.839 1.656 . . . . 0.0 114.791 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.6 t -104.56 121.22 43.04 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.165 . . . . 0.0 111.743 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -33.59 71.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -169.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -78.77 -9.16 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 -70.65 0.93 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.61 2.052 . . . . 0.0 113.94 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.327 7.0 p-90 -70.6 124.81 25.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -169.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.33 -91.31 1.36 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.427 1.489 . . . . 0.0 115.458 -169.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -134.57 144.79 48.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.579 1.151 . . . . 0.0 112.041 -169.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.5 t -83.67 124.06 30.45 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.978 -0.451 . . . . 0.0 112.066 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -75.29 88.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -78.09 -15.44 58.88 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.626 0.77 . . . . 0.0 112.14 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.23 177.87 8.68 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.599 1.19 . . . . 0.0 113.341 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -136.13 151.45 49.79 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.98 -1.075 . . . . 0.0 112.247 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.36 135.64 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.482 0.658 . . . . 0.0 110.055 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.76 -40.95 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.9 1.68 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -144.28 144.71 31.62 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.19 1.396 . . . . 0.0 110.677 174.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.06 -0.09 10.69 Favored Glycine 0 N--CA 1.475 1.265 0 C-N-CA 124.737 1.161 . . . . 0.0 115.629 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -55.92 -37.59 69.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.435 1.618 . . . . 0.0 113.17 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -61.99 -34.14 75.63 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.703 0.801 . . . . 0.0 111.936 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.03 -39.98 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.16 1.784 . . . . 0.0 110.905 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.34 -39.32 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 O-C-N 121.204 -0.935 . . . . 0.0 111.121 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 8.8 t70 -74.3 -22.86 59.09 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.387 1.075 . . . . 0.0 113.066 174.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.8 -43.2 47.34 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.939 1.295 . . . . 0.0 111.082 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 58.8 mt -54.69 -35.12 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.221 1.408 . . . . 0.0 112.195 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.2 pttp -90.31 -18.93 24.7 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -96.49 -22.06 20.13 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.977 1.275 . . . . 0.0 114.225 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.8 t -81.41 -63.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 118.378 1.089 . . . . 0.0 112.055 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -162.63 152.72 16.31 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 51.8 p -140.36 152.83 46.1 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.944 1.697 . . . . 0.0 111.619 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.16 132.34 1.75 Allowed Glycine 0 CA--C 1.53 1.004 0 N-CA-C 114.386 0.515 . . . . 0.0 114.386 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -61.85 152.61 31.22 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.452 1.501 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.4 t -141.99 102.18 4.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.708 1.203 . . . . 0.0 111.184 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.6 -120.8 23.13 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.165 0.888 . . . . 0.0 113.139 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.3 ttm -69.17 -21.15 64.0 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.876 1.27 . . . . 0.0 113.675 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -108.9 111.65 23.47 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.697 1.199 . . . . 0.0 110.917 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -96.84 156.21 16.45 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.325 1.05 . . . . 0.0 112.364 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 57.76 38.62 27.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.473 1.109 . . . . 0.0 113.76 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.3 156.92 43.25 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.335 1.454 . . . . 0.0 110.385 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.24 140.24 52.8 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 N-CA-C 109.121 -1.146 . . . . 0.0 109.121 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -28.06 60.52 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.99 153.96 27.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.429 1.091 . . . . 0.0 110.257 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.2 109.68 11.26 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.007 -1.058 . . . . 0.0 110.788 172.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.24 94.28 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.828 1.251 . . . . 0.0 107.709 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.68 152.05 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 123.405 1.574 . . . . 0.0 113.756 -169.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.81 104.16 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.79 -39.77 66.43 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.116 -0.99 . . . . 0.0 111.01 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -152.3 170.88 18.97 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.16 143.15 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.505 1.522 . . . . 0.0 111.458 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.8 m -135.23 130.61 35.5 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 110.534 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.9 121.31 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -113.65 150.2 33.52 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.308 1.443 . . . . 0.0 112.525 -176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.317 1.447 . . . . 0.0 114.091 -169.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.72 129.09 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.889 0.876 . . . . 0.0 108.992 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.3 m -103.68 123.65 47.39 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.674 1.19 . . . . 0.0 109.891 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -97.35 132.01 43.48 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.562 1.145 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -104.99 98.71 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p -103.67 152.06 22.24 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.052 -0.405 . . . . 0.0 111.192 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -60.54 -10.35 4.95 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -103.62 -8.08 20.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.834 1.253 . . . . 0.0 113.748 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.8 165.98 12.0 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.921 1.724 . . . . 0.0 113.485 175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -74.94 138.49 42.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.813 1.645 . . . . 0.0 112.949 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.0 mt -133.93 139.26 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.271 1.828 . . . . 0.0 108.886 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -120.22 135.53 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.452 1.101 . . . . 0.0 110.002 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.91 138.51 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.499 1.919 . . . . 0.0 110.106 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -103.77 126.32 50.83 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.566 1.946 . . . . 0.0 108.912 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.7 p -90.29 147.96 23.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.34 1.056 . . . . 0.0 111.527 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.11 72.89 1.02 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 122.794 1.283 . . . . 0.0 111.35 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.56 -25.5 64.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.603 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -77.24 -24.84 51.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.464 1.105 . . . . 0.0 111.547 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -99.9 -28.1 13.27 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 112.381 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.68 57.9 3.0 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.803 0.841 . . . . 0.0 112.718 -170.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -60.93 -43.42 30.76 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.593 2.862 . . . . 0.0 112.711 -173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -68.88 -40.83 79.04 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.819 0.736 . . . . 0.0 110.715 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' HD13 ' A' ' 68' ' ' ILE . 66.9 m -62.37 -50.37 71.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.691 0.796 . . . . 0.0 111.813 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.3 t -67.21 -38.89 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.131 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -58.49 -46.63 86.28 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.673 1.124 . . . . 0.0 111.422 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.88 -42.73 97.42 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.189 0.996 . . . . 0.0 111.977 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -59.27 -50.46 73.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.283 1.033 . . . . 0.0 111.619 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.22 -36.24 71.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.698 0.799 . . . . 0.0 111.788 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -56.64 -38.07 71.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.728 0.811 . . . . 0.0 111.864 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.93 -40.77 60.64 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.727 -0.608 . . . . 0.0 112.339 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.3 m -61.34 -36.05 79.1 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.277 -0.89 . . . . 0.0 111.607 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.97 -31.76 72.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.16 1.784 . . . . 0.0 112.93 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -81.61 -13.54 57.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.282 1.033 . . . . 0.0 113.476 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.77 18.3 61.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.51 1.052 . . . . 0.0 114.006 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.63 -17.53 62.87 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -96.34 -7.29 35.64 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.66 136.49 54.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.292 0.951 . . . . 0.0 109.154 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.5 t30 53.82 41.68 31.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.813 1.645 . . . . 0.0 114.586 -173.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.9 p -102.11 167.31 10.1 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.908 0.883 . . . . 0.0 110.643 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 156' ' ' ILE . 24.4 pt -125.56 160.71 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -83.95 80.54 9.13 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -66.41 -14.21 61.82 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 -169.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -150.96 143.74 24.49 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 121.275 1.852 . . . . 0.0 113.877 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.44 147.44 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 128.064 2.546 . . . . 0.0 108.201 169.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.5 mt -130.76 130.71 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.862 1.665 . . . . 0.0 107.493 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -61.63 134.95 57.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.852 0.461 . . . . 0.0 111.087 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 8.6 65.02 Favored Glycine 0 CA--C 1.542 1.781 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.44 -176.89 5.22 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.481 1.913 . . . . 0.0 111.341 -171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -179.39 7.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -169.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.2 pt -115.4 135.35 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.703 1.601 . . . . 0.0 112.364 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -112.64 149.0 33.45 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.491 1.516 . . . . 0.0 111.351 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.55 175.76 36.39 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 -173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 -2.11 66.01 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.145 1.831 . . . . 0.0 115.443 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.79 -15.02 62.1 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 118.745 1.272 . . . . 0.0 115.819 -170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.68 164.83 31.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.659 1.229 . . . . 0.0 113.331 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.91 164.46 28.42 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 125.858 1.663 . . . . 0.0 110.703 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HA ' HG21 ' A' ' 40' ' ' ILE . 50.8 Cg_exo -61.78 -14.91 39.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.451 2.767 . . . . 0.0 117.927 -170.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.22 17.89 58.38 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.169 0.89 . . . . 0.0 114.563 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.46 32.7 18.85 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.845 1.658 . . . . 0.0 112.569 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -88.87 130.96 35.31 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.751 1.62 . . . . 0.0 109.537 177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.96 124.98 27.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.322 1.049 . . . . 0.0 111.511 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -76.3 167.7 21.39 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.698 1.199 . . . . 0.0 113.485 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.68 77.84 3.33 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.345 1.458 . . . . 0.0 111.361 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.7 p -72.41 95.01 1.7 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.852 1.261 . . . . 0.0 111.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -110.95 171.46 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.169 1.788 . . . . 0.0 112.555 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 51.45 64.48 7.88 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.548 1.539 . . . . 0.0 114.088 169.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -60.15 139.17 85.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.237 2.625 . . . . 0.0 111.808 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -102.83 150.41 6.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.348 1.459 . . . . 0.0 108.519 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.0 161.67 22.92 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.766 0.827 . . . . 0.0 111.369 169.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -73.22 121.37 20.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.403 0.681 . . . . 0.0 111.664 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -105.02 15.88 26.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.837 1.255 . . . . 0.0 113.215 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -14.09 49.75 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.307 -1.496 . . . . 0.0 114.568 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -60.45 2.64 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.913 2.085 . . . . 0.0 116.139 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.31 -3.39 58.22 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.421 1.489 . . . . 0.0 112.866 169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.59 26.85 49.47 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.229 0.919 . . . . 0.0 114.976 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.75 160.54 27.38 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.571 0.748 . . . . 0.0 112.861 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -127.48 155.24 44.04 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -103.73 73.5 1.18 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.942 2.097 . . . . 0.0 111.6 -170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.9 p -103.31 167.65 9.68 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.473 0.709 . . . . 0.0 111.46 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -57.45 127.14 30.5 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.923 0.868 . . . . 0.0 111.282 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.39 26.72 42.22 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.086 1.327 . . . . 0.0 114.828 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.3 p -115.43 159.62 20.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.456 1.628 . . . . 0.0 112.777 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.53 136.32 53.9 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.64 161.03 37.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.273 0.559 . . . . 0.0 111.706 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.3 mmt -81.06 139.29 35.79 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.962 -0.461 . . . . 0.0 111.457 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.89 168.89 11.36 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.884 1.274 . . . . 0.0 110.905 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -105.08 160.24 15.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.164 1.385 . . . . 0.0 112.452 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.1 m -83.64 -52.16 6.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 0.0 110.719 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -161.25 -50.21 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.277 1.431 . . . . 0.0 112.217 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -85.46 160.47 53.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.943 1.297 . . . . 0.0 112.501 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.07 -16.52 55.4 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.245 2.63 . . . . 0.0 115.217 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -124.78 47.28 2.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.708 1.603 . . . . 0.0 111.141 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.9 p -119.46 25.78 9.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.26 1.424 . . . . 0.0 114.393 -175.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.32 93.68 0.87 Allowed 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.936 -1.103 . . . . 0.0 108.907 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.5 p -89.04 -52.21 5.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.626 0.77 . . . . 0.0 111.779 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.36 -5.04 0.19 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -80.43 134.32 35.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.984 -1.072 . . . . 0.0 110.07 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -134.79 168.4 19.12 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.486 1.914 . . . . 0.0 110.673 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 12.5 p90 -147.1 161.82 40.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 111.842 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.8 mt -115.83 119.28 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -69.76 100.15 1.46 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.22 -17.91 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.403 -0.81 . . . . 0.0 113.146 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.06 168.14 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 127.923 2.489 . . . . 0.0 111.256 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -68.92 113.47 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.706 1.202 . . . . 0.0 112.138 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -125.41 54.18 1.49 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.966 1.706 . . . . 0.0 111.58 -171.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.0 -26.27 65.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -62.54 -13.73 34.21 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -85.8 -6.42 59.11 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.653 1.181 . . . . 0.0 114.069 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -71.73 179.48 3.09 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.184 1.394 . . . . 0.0 114.425 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -85.72 143.9 28.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.821 1.248 . . . . 0.0 111.991 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.8 p -112.7 -60.15 1.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 113.419 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.61 61.26 0.03 OUTLIER Glycine 0 CA--C 1.531 1.087 0 C-N-CA 123.797 0.713 . . . . 0.0 114.378 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.72 23.48 11.15 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.743 1.617 . . . . 0.0 115.02 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.6 t -105.36 123.05 47.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.399 1.08 . . . . 0.0 111.971 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.96 -31.2 66.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -169.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -81.23 -8.82 59.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -102.27 -73.22 0.98 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.732 2.11 . . . . 0.0 114.289 -173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.272 7.5 p-90 -70.23 127.77 33.95 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.32 -100.3 1.52 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.549 1.547 . . . . 0.0 115.688 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -126.3 150.6 48.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.667 1.587 . . . . 0.0 111.483 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.2 t -82.95 118.44 23.48 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.3 87.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.685 1.194 . . . . 0.0 108.227 170.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -78.71 -14.28 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.545 0.738 . . . . 0.0 112.234 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.89 177.62 7.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.626 1.203 . . . . 0.0 113.96 -169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -140.77 152.23 45.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.689 1.196 . . . . 0.0 112.345 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.91 142.89 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.598 0.713 . . . . 0.0 110.152 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.3 -41.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.86 1.664 . . . . 0.0 110.852 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -145.09 155.7 43.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.895 1.678 . . . . 0.0 109.682 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.31 23.13 Favored Glycine 0 N--CA 1.467 0.765 0 C-N-CA 123.867 0.746 . . . . 0.0 114.407 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -32.57 66.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.766 1.283 . . . . 0.0 112.325 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.83 -29.01 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.634 0.774 . . . . 0.0 112.658 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -78.0 -40.05 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.315 1.446 . . . . 0.0 110.48 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.2 t -58.31 -39.41 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 120.803 -1.185 . . . . 0.0 110.982 172.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.35 -30.54 69.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -73.11 -44.51 60.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.829 1.252 . . . . 0.0 111.126 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.6 mt -68.05 -25.03 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.432 1.493 . . . . 0.0 112.409 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -84.24 -25.45 29.41 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.16 -8.68 64.37 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.784 1.659 . . . . 0.0 114.747 -172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -60.3 -26.15 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . . . 82.83 163.46 0.13 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.313 2.245 . . . . 0.0 114.376 -169.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 68.3 p -111.8 151.05 29.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.135 1.374 . . . . 0.0 113.632 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -166.22 149.92 16.54 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 123.333 1.518 . . . . 0.0 112.537 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -64.78 144.55 57.17 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.067 2.147 . . . . 0.0 114.133 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.1 t -137.46 74.77 1.5 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.843 1.657 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.72 -113.09 5.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.015 0.817 . . . . 0.0 112.374 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 66.0 mtt -72.78 -13.63 61.36 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.573 1.149 . . . . 0.0 113.746 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -104.18 111.76 24.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.474 1.51 . . . . 0.0 110.127 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -106.21 148.0 28.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.266 1.427 . . . . 0.0 112.714 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 52.25 30.19 7.59 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.116 1.766 . . . . 0.0 114.847 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 34.8 m -79.97 156.1 74.81 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.708 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -59.36 135.74 67.3 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 120.756 1.306 . . . . 0.0 111.033 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -31.51 60.24 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.35 0.66 . . . . 0.0 112.687 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.48 147.87 35.65 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.486 0.714 . . . . 0.0 110.435 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.26 109.78 16.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.426 0.631 . . . . 0.0 110.027 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.41 100.14 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -120.85 141.22 42.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 124.525 1.13 . . . . 0.0 111.726 -169.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.3 103.41 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.39 -35.61 58.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.015 0.926 . . . . 0.0 110.859 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.56 165.01 34.6 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.12 139.59 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.205 1.802 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 m -135.39 130.31 34.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.775 1.23 . . . . 0.0 110.198 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.6 t -86.81 120.13 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t -114.18 147.3 39.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.027 1.331 . . . . 0.0 112.426 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.539 1.536 . . . . 0.0 113.46 -169.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 119.925 -0.083 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.76 128.2 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.979 0.912 . . . . 0.0 109.37 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 96.4 m -102.51 126.23 49.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.672 1.189 . . . . 0.0 109.917 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -100.93 117.72 35.54 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.54 1.136 . . . . 0.0 109.329 169.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -93.25 112.53 24.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 p -118.81 163.89 16.21 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.479 0.656 . . . . 0.0 112.239 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -69.7 -6.29 30.72 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.638 ' CE1' HD11 ' A' ' 136' ' ' ILE . 29.9 p80 -118.65 -20.63 8.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.407 1.483 . . . . 0.0 114.16 -174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.14 142.52 3.47 Favored Glycine 0 CA--C 1.542 1.773 0 C-N-CA 126.982 2.23 . . . . 0.0 113.64 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.88 136.26 47.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.65 1.18 . . . . 0.0 113.303 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.26 141.14 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.35 1.46 . . . . 0.0 109.596 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -124.92 136.34 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.912 1.285 . . . . 0.0 110.257 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -126.5 139.96 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 126.725 2.01 . . . . 0.0 110.1 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -107.14 124.72 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.587 1.955 . . . . 0.0 109.245 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -85.85 147.99 26.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.205 1.002 . . . . 0.0 111.555 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.93 74.85 1.01 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 122.651 1.215 . . . . 0.0 111.404 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.77 -26.23 64.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.503 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -77.75 -26.61 50.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.327 1.051 . . . . 0.0 111.712 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -100.85 -21.37 15.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.329 1.452 . . . . 0.0 112.905 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.69 55.44 1.6 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.915 1.286 . . . . 0.0 113.069 -172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -60.63 -43.39 32.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.554 2.836 . . . . 0.0 112.953 -172.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -70.34 -41.11 73.62 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.553 0.615 . . . . 0.0 110.671 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HA ' HD13 ' A' ' 68' ' ' ILE . 38.2 m -62.85 -52.37 63.41 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.676 0.39 . . . . 0.0 111.474 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.33 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 118.801 -0.618 . . . . 0.0 111.24 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -57.66 -48.16 80.25 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.569 1.077 . . . . 0.0 111.359 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -68.1 -41.17 82.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.954 0.902 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.18 -48.1 82.86 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.695 1.198 . . . . 0.0 111.682 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.96 -37.47 72.79 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.361 0.664 . . . . 0.0 111.415 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -59.08 -33.79 71.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.352 0.661 . . . . 0.0 112.607 173.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -73.77 -43.82 57.85 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.469 -0.77 . . . . 0.0 112.205 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.7 m -61.52 -37.19 82.83 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.33 -0.856 . . . . 0.0 111.503 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -62.61 -33.54 75.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.814 2.046 . . . . 0.0 112.883 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -83.79 -14.85 50.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.084 0.953 . . . . 0.0 113.503 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.02 17.5 53.5 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.082 0.849 . . . . 0.0 114.15 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -73.73 -18.47 60.99 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.196 1.498 . . . . 0.0 114.832 -172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -98.26 -6.6 30.79 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.2 -0.938 . . . . 0.0 112.35 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -71.57 129.33 38.48 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.934 -1.103 . . . . 0.0 108.792 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.7 43.99 17.95 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.089 1.355 . . . . 0.0 113.752 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 81.3 p -109.32 167.26 10.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.435 1.094 . . . . 0.0 111.829 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 15.8 pt -120.45 161.58 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -85.82 83.42 7.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.773 1.229 . . . . 0.0 108.177 168.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -60.8 -28.63 68.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.684 1.993 . . . . 0.0 115.025 -169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HE ' ' HB2' ' A' ' 149' ' ' ASP . 40.1 mmm-85 -132.0 136.55 47.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.787 1.176 . . . . 0.0 111.378 -177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.57 130.03 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.643 1.977 . . . . 0.0 110.944 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.3 mt -137.19 126.78 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.621 1.568 . . . . 0.0 108.276 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -64.1 136.54 57.35 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.298 0.639 . . . . 0.0 111.628 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.24 9.23 63.61 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 -173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -142.54 -177.23 5.18 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.948 1.699 . . . . 0.0 111.025 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.93 179.89 6.63 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.835 1.654 . . . . 0.0 114.393 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.26 136.64 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.807 1.243 . . . . 0.0 112.364 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.55 141.96 34.51 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.661 1.184 . . . . 0.0 110.489 175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.09 165.97 27.23 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 123.033 1.352 . . . . 0.0 115.801 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.62 -8.48 65.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.439 1.495 . . . . 0.0 115.831 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.54 -20.87 76.15 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.061 1.431 . . . . 0.0 116.065 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -143.68 170.06 16.56 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.757 1.278 . . . . 0.0 113.067 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -100.08 162.61 20.45 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 126.233 1.813 . . . . 0.0 111.147 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.9 -13.26 29.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.838 3.025 . . . . 0.0 117.886 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.99 17.17 59.83 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.768 0.699 . . . . 0.0 114.389 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt 60.44 25.5 15.07 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.711 1.604 . . . . 0.0 112.967 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -82.77 125.17 30.98 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.58 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -76.08 120.28 21.17 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.299 1.04 . . . . 0.0 110.952 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -72.15 163.85 27.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.226 1.011 . . . . 0.0 113.632 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.27 69.23 8.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.968 1.707 . . . . 0.0 111.542 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -72.84 130.3 40.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.514 1.526 . . . . 0.0 112.706 -173.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -133.56 174.87 9.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.467 1.907 . . . . 0.0 112.641 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 49.39 68.21 3.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 125.654 1.582 . . . . 0.0 114.009 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -61.14 133.93 49.72 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.171 2.581 . . . . 0.0 111.418 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.7 mt -98.61 153.26 4.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.949 1.7 . . . . 0.0 108.012 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -74.83 161.2 29.79 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.54 0.336 . . . . 0.0 110.156 169.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.0 -42.88 69.55 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -168.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 61.34 -0.21 0.38 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.205 2.602 . . . . 0.0 117.717 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.39 -12.29 61.48 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.763 -1.836 . . . . 0.0 113.897 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -62.74 8.05 0.06 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.969 1.708 . . . . 0.0 115.101 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -79.21 -10.94 59.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.384 1.473 . . . . 0.0 112.832 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.6 81.35 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.055 1.312 . . . . 0.0 115.193 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.13 158.58 29.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.555 1.177 . . . . 0.0 112.535 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -128.53 150.3 50.23 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -87.15 65.44 8.86 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.477 1.911 . . . . 0.0 112.029 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.3 p -100.39 166.99 10.68 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.812 0.845 . . . . 0.0 112.424 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -52.27 123.22 10.2 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.699 1.599 . . . . 0.0 111.09 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.0 43.65 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 114.926 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.2 p -116.25 159.28 22.08 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.364 1.582 . . . . 0.0 113.682 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.95 134.72 55.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.826 0.85 . . . . 0.0 112.454 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.45 157.32 44.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.403 173.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -80.9 140.64 35.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.327 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.14 162.19 15.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.66 0.784 . . . . 0.0 111.231 172.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -129.75 164.65 23.55 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.461 1.104 . . . . 0.0 112.893 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.6 m -72.4 -54.54 9.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.67 0.788 . . . . 0.0 110.905 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.11 -52.13 0.06 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.627 1.571 . . . . 0.0 112.193 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.04 157.19 76.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.751 1.221 . . . . 0.0 111.776 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.2 -24.98 76.44 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.122 2.548 . . . . 0.0 114.296 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -109.12 33.64 4.17 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.478 1.511 . . . . 0.0 112.649 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.7 p -118.84 26.3 9.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.34 1.456 . . . . 0.0 113.88 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.51 100.85 13.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.209 1.404 . . . . 0.0 109.51 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.0 p -89.15 -57.76 2.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.065 0.946 . . . . 0.0 113.201 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -162.39 48.44 0.17 Allowed 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -136.71 147.5 46.8 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.832 -1.167 . . . . 0.0 111.381 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.82 168.22 20.74 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.114 1.366 . . . . 0.0 111.78 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -147.61 162.44 39.12 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.239 0.616 . . . . 0.0 111.371 175.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.1 mt -116.05 115.85 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.053 0.941 . . . . 0.0 108.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -73.6 96.12 2.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.379 0.671 . . . . 0.0 110.062 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.42 -22.71 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.06 -1.025 . . . . 0.0 113.189 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.55 166.66 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.633 . . . . 0.0 110.862 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -74.71 114.73 13.47 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.326 0.584 . . . . 0.0 111.629 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -124.94 59.44 1.22 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.063 1.745 . . . . 0.0 111.554 -171.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -68.09 -14.89 63.32 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -169.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.15 -14.05 62.53 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.849 -1.157 . . . . 0.0 113.266 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.2 -8.27 59.64 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.379 1.072 . . . . 0.0 113.695 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -73.36 -176.94 2.4 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -74.69 147.51 41.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.05 1.74 . . . . 0.0 113.034 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.4 p -103.15 -61.19 1.44 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.652 1.581 . . . . 0.0 113.107 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.27 56.2 0.01 OUTLIER Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.142 1.353 . . . . 0.0 112.618 -170.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.61 28.26 15.41 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.209 1.804 . . . . 0.0 114.421 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.8 p -106.82 114.43 28.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.764 1.225 . . . . 0.0 111.222 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.9 mt -58.22 -32.31 68.18 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -75.64 -14.89 60.38 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -93.05 -68.24 1.1 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.578 2.513 . . . . 0.0 113.604 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.348 2.4 p-90 -66.1 121.97 16.37 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.237 1.518 . . . . 0.0 112.958 -171.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.88 -85.72 1.26 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 125.371 1.463 . . . . 0.0 115.905 -169.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -137.1 132.97 34.83 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.957 1.303 . . . . 0.0 111.79 -169.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 43.2 t -83.59 128.78 34.79 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.58 90.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.574 1.15 . . . . 0.0 107.935 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -78.94 -14.86 58.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.716 0.806 . . . . 0.0 111.904 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.01 177.33 9.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.579 1.18 . . . . 0.0 112.929 -172.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -136.31 153.99 50.99 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 120.592 -1.317 . . . . 0.0 112.232 172.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.33 140.01 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.591 0.71 . . . . 0.0 109.403 169.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.99 -42.24 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.704 1.602 . . . . 0.0 110.519 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -144.43 147.0 32.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.563 1.545 . . . . 0.0 109.902 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.12 7.15 10.4 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.523 0.969 . . . . 0.0 115.523 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 73.4 mmm -56.32 -37.51 70.04 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.695 1.747 . . . . 0.0 112.716 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.47 -29.03 70.23 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.84 0.856 . . . . 0.0 112.431 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.11 -44.98 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.423 1.489 . . . . 0.0 110.443 172.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.84 -38.52 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.165 -0.959 . . . . 0.0 111.25 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.84 -23.51 60.77 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 112.457 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -78.92 -42.4 27.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.191 1.396 . . . . 0.0 111.182 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.8 mt -54.37 -35.52 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.558 1.143 . . . . 0.0 111.87 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -84.98 -18.14 35.43 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.1 15.41 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.179 1.371 . . . . 0.0 114.422 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.4 m -73.42 -57.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.806 1.303 . . . . 0.0 113.106 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.33 5.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 112.024 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.2 p -142.84 153.52 43.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.2 1.4 . . . . 0.0 112.119 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.84 121.93 0.72 Allowed Glycine 0 CA--C 1.532 1.136 0 O-C-N 122.135 -0.353 . . . . 0.0 113.234 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -65.5 158.99 25.45 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.816 1.246 . . . . 0.0 113.483 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.3 p -116.0 168.58 9.95 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 112.173 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.06 -21.56 75.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 123.578 0.609 . . . . 0.0 114.546 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.3 mmt -99.48 -35.61 9.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.31 1.044 . . . . 0.0 113.386 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -141.37 129.6 22.25 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.107 1.763 . . . . 0.0 110.482 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -96.81 158.12 15.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.273 1.029 . . . . 0.0 113.026 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.478 ' HB2' ' HE ' ' A' ' 43' ' ' ARG . 5.7 m-20 59.74 18.24 7.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.063 1.745 . . . . 0.0 114.697 -171.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m -70.69 149.14 95.28 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.966 -1.084 . . . . 0.0 111.597 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.08 143.79 55.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 121.711 1.607 . . . . 0.0 109.324 169.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.46 58.17 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.44 159.11 16.72 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.211 1.405 . . . . 0.0 110.216 169.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -80.51 112.57 17.98 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.854 -1.154 . . . . 0.0 111.477 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.6 94.21 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -128.15 147.49 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -168.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 63.8 mt -85.76 104.13 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.992 1.717 . . . . 0.0 107.988 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -78.94 -30.47 44.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.081 1.353 . . . . 0.0 112.612 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 t -155.29 162.43 40.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.06 0.944 . . . . 0.0 113.119 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.03 139.6 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.69 1.596 . . . . 0.0 110.351 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.7 m -136.39 128.61 29.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.594 1.157 . . . . 0.0 110.779 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.79 118.08 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.2 t -112.63 150.19 31.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.635 1.574 . . . . 0.0 112.295 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.346 1.458 . . . . 0.0 113.627 -170.081 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.865 -0.588 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.39 130.27 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 120.684 1.584 . . . . 0.0 110.394 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -101.24 123.16 44.92 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.446 1.098 . . . . 0.0 110.346 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -97.83 130.73 44.73 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.977 1.311 . . . . 0.0 110.286 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -103.6 97.84 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -101.51 152.35 20.87 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.064 -0.398 . . . . 0.0 111.269 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -60.85 -9.09 3.62 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -107.49 -8.44 16.24 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.779 1.232 . . . . 0.0 114.147 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.45 162.23 10.61 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 123.109 1.394 . . . . 0.0 113.653 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.13 137.72 45.34 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.452 1.501 . . . . 0.0 112.651 172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.91 140.77 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.392 1.877 . . . . 0.0 108.685 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.47 135.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.497 1.119 . . . . 0.0 110.384 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.13 134.55 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.559 1.944 . . . . 0.0 110.473 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -101.73 127.64 48.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.138 1.775 . . . . 0.0 108.796 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.4 p -88.28 149.27 23.9 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.386 1.075 . . . . 0.0 111.25 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -106.81 73.26 0.94 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.898 1.332 . . . . 0.0 111.656 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.76 -26.14 64.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.518 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -78.14 -26.2 47.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.333 1.053 . . . . 0.0 111.638 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.77 -22.02 14.48 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.337 1.455 . . . . 0.0 113.183 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.85 55.31 1.19 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.855 1.262 . . . . 0.0 113.674 -171.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.63 -42.98 35.38 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.532 2.821 . . . . 0.0 113.147 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.31 -38.04 78.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.195 0.598 . . . . 0.0 111.043 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.3 m -68.28 -47.99 66.2 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.153 0.581 . . . . 0.0 111.904 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.48 -39.43 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.337 0.655 . . . . 0.0 111.6 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -52.64 -49.36 65.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.543 1.065 . . . . 0.0 112.104 175.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -69.6 -38.05 77.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.459 0.704 . . . . 0.0 111.562 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -60.01 -50.34 74.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.472 1.109 . . . . 0.0 111.82 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.31 -35.18 73.5 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.51 -0.744 . . . . 0.0 111.638 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.07 -33.19 70.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 112.694 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.54 -43.42 39.22 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.378 -0.826 . . . . 0.0 112.376 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.2 m -58.84 -40.36 84.01 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.731 -0.605 . . . . 0.0 111.706 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -61.03 -39.66 90.65 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.362 1.865 . . . . 0.0 113.387 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -77.48 -16.23 58.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.031 0.933 . . . . 0.0 112.632 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.9 62.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.988 0.804 . . . . 0.0 112.836 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -59.95 -35.76 75.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.53 1.165 . . . . 0.0 113.122 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.72 -8.61 59.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.733 0.413 . . . . 0.0 112.089 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.04 132.12 47.24 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.15 -0.969 . . . . 0.0 108.809 176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 56.1 t30 58.17 30.82 19.95 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -170.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -88.61 167.24 13.54 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 168.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 156' ' ' ILE . 12.1 pt -124.6 162.58 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -89.11 82.72 6.57 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -70.95 -12.85 61.77 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -168.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -147.54 135.09 20.88 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.649 1.568 . . . . 0.0 112.679 -173.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -135.45 147.61 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 127.235 2.214 . . . . 0.0 109.516 169.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.87 132.27 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.139 1.776 . . . . 0.0 107.376 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.34 133.41 55.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.355 0.662 . . . . 0.0 111.897 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.53 11.1 61.7 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.989 0.804 . . . . 0.0 115.039 -172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.63 -177.12 4.91 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 111.164 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -83.65 179.9 7.49 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -169.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.0 pt -115.24 136.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.075 1.75 . . . . 0.0 112.168 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -115.8 149.38 38.64 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.142 1.377 . . . . 0.0 111.413 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.49 179.99 30.2 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 122.164 0.869 . . . . 0.0 115.235 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.12 -2.14 87.47 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.627 1.108 . . . . 0.0 115.493 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -25.17 43.73 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 118.965 1.383 . . . . 0.0 115.095 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -143.5 164.83 29.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -99.89 164.34 16.68 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 126.469 1.908 . . . . 0.0 110.441 169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -63.32 -11.53 25.99 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.468 2.778 . . . . 0.0 117.492 -170.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.15 16.1 60.47 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.042 0.829 . . . . 0.0 114.575 171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mmt 60.8 27.1 16.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.394 1.877 . . . . 0.0 113.16 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.49 126.92 33.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.915 1.286 . . . . 0.0 109.561 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -73.49 127.55 33.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 124.017 1.865 . . . . 0.0 111.002 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -71.23 174.83 5.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 110.494 -3.048 . . . . 0.0 114.95 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 47.79 1.55 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.649 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.5 p -69.75 119.56 14.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.493 1.117 . . . . 0.0 112.308 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -132.82 173.41 11.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.748 2.419 . . . . 0.0 111.377 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 44.61 73.43 0.97 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.829 1.652 . . . . 0.0 114.359 169.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.83 144.5 26.68 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.78 2.987 . . . . 0.0 113.523 171.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.18 150.96 6.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.197 1.799 . . . . 0.0 107.993 172.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 151.93 26.96 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.269 0.627 . . . . 0.0 110.049 169.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -74.7 116.48 15.45 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -83.89 -77.87 0.25 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.088 0.555 . . . . 0.0 110.08 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.66 -20.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.934 3.293 . . . . 0.0 118.202 170.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -75.05 27.51 0.09 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 127.395 2.278 . . . . 0.0 114.327 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.33 -5.57 18.99 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.379 2.272 . . . . 0.0 113.961 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.04 82.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.601 1.572 . . . . 0.0 115.379 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.47 155.65 36.02 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.354 1.077 . . . . 0.0 112.527 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -134.01 154.0 51.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -90.79 62.05 4.93 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.083 1.753 . . . . 0.0 112.059 -169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 59.6 p -96.72 169.07 10.13 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.75 0.82 . . . . 0.0 111.768 -174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -54.02 127.42 26.4 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.667 1.187 . . . . 0.0 111.268 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.84 29.23 55.17 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.78 1.181 . . . . 0.0 114.66 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.5 p -115.35 159.16 21.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.472 1.636 . . . . 0.0 112.912 175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.87 137.22 52.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.976 0.893 . . . . 0.0 113.152 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.53 161.57 36.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.973 0.892 . . . . 0.0 111.693 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 138.48 31.37 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.242 1.417 . . . . 0.0 111.71 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.73 137.34 35.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.984 0.914 . . . . 0.0 112.45 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -81.15 155.93 25.97 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.431 1.492 . . . . 0.0 112.264 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -80.41 -55.15 5.09 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.191 0.996 . . . . 0.0 111.065 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -154.55 -54.87 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.475 1.51 . . . . 0.0 110.975 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 155.5 79.88 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.9 0.88 . . . . 0.0 111.318 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.29 -22.81 74.68 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.552 2.168 . . . . 0.0 114.292 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.72 37.05 3.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.692 1.597 . . . . 0.0 112.303 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.4 p -114.42 23.96 12.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.462 1.505 . . . . 0.0 113.691 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.25 97.79 9.06 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 109.173 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -83.57 -69.34 0.64 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.735 1.214 . . . . 0.0 111.868 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.44 -14.1 1.98 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.251 1.42 . . . . 0.0 113.249 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -74.06 141.56 45.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 122.228 1.013 . . . . 0.0 111.821 -172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -141.75 168.17 20.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 127.093 2.157 . . . . 0.0 111.047 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 13.1 p90 -145.96 162.65 37.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.055 0.942 . . . . 0.0 111.638 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -116.57 118.85 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.583 1.153 . . . . 0.0 108.311 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -71.71 98.89 2.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.414 0.686 . . . . 0.0 109.737 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 m -75.2 -17.47 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 113.318 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.6 167.19 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 128.537 2.735 . . . . 0.0 110.516 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -75.65 115.5 15.39 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.436 0.636 . . . . 0.0 111.712 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -125.0 55.65 1.36 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.116 1.766 . . . . 0.0 111.991 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.08 -16.01 60.82 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -66.54 -14.45 62.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.83 -1.169 . . . . 0.0 113.45 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.4 mt -82.23 -9.07 59.63 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.621 1.169 . . . . 0.0 113.607 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -71.64 -178.74 2.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.155 1.382 . . . . 0.0 114.363 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -83.65 144.31 29.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.145 1.378 . . . . 0.0 113.107 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.485 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.3 p -104.46 -63.06 1.25 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.833 1.653 . . . . 0.0 112.911 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.83 55.32 0.01 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.316 1.436 . . . . 0.0 112.836 -170.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 57.95 26.51 13.49 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.934 1.693 . . . . 0.0 114.999 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 p -100.66 116.69 33.17 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.88 1.272 . . . . 0.0 110.939 174.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 tp -57.14 -34.89 68.86 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -169.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -79.87 -10.9 59.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.74 -72.74 1.21 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 127.132 2.301 . . . . 0.0 113.151 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.485 ' HB3' ' H ' ' A' ' 111' ' ' SER . 17.7 p-90 -71.88 131.42 42.98 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.13 -100.5 2.01 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.224 1.392 . . . . 0.0 114.857 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.32 141.65 51.83 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.116 1.366 . . . . 0.0 111.643 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 36.3 t -79.49 126.98 31.56 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.944 -0.473 . . . . 0.0 112.159 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.5 t -78.88 94.15 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -81.88 -14.41 56.24 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.301 0.64 . . . . 0.0 111.939 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.78 176.88 8.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 122.41 1.1 . . . . 0.0 113.88 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -139.76 153.78 47.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.447 1.099 . . . . 0.0 112.647 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.03 140.18 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.599 0.714 . . . . 0.0 110.132 170.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -112.62 -42.28 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 126.091 1.756 . . . . 0.0 110.885 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -144.72 155.26 43.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.552 1.541 . . . . 0.0 109.771 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.67 15.78 28.33 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 123.878 0.752 . . . . 0.0 113.964 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -34.95 67.87 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.761 1.28 . . . . 0.0 112.319 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.69 -29.41 69.95 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.581 0.753 . . . . 0.0 112.657 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.37 -42.63 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.229 1.412 . . . . 0.0 110.278 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.96 -39.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.091 0.957 . . . . 0.0 111.357 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -72.42 -21.24 61.29 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.689 1.596 . . . . 0.0 112.71 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -86.32 -43.72 12.67 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.769 1.628 . . . . 0.0 111.447 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.16 -29.1 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.416 1.486 . . . . 0.0 112.585 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -81.29 -16.49 52.34 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.91 -2.35 11.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.311 1.434 . . . . 0.0 114.544 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.82 -55.07 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.039 1.419 . . . . 0.0 112.012 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 177.93 148.4 0.17 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.686 1.995 . . . . 0.0 111.258 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.5 p -121.66 149.86 42.6 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.348 1.459 . . . . 0.0 112.947 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.18 134.84 1.78 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.875 1.226 . . . . 0.0 112.141 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -61.97 144.78 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.034 0.934 . . . . 0.0 113.323 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.8 p -98.32 169.49 9.53 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.959 1.704 . . . . 0.0 111.519 174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.71 -7.89 30.72 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.002 -0.888 . . . . 0.0 115.221 173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 62.6 mtm -125.51 -24.09 3.96 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.918 1.359 . . . . 0.0 114.536 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -141.42 129.22 21.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.388 1.475 . . . . 0.0 110.6 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -96.0 153.3 17.84 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.6 t0 55.6 54.55 8.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.473 1.509 . . . . 0.0 112.972 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.89 159.17 45.67 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.495 1.918 . . . . 0.0 111.515 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.4 130.49 23.93 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.088 1.192 . . . . 0.0 109.364 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -26.6 30.7 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.87 140.8 42.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.62 0.768 . . . . 0.0 109.418 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.38 109.83 17.64 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.419 0.628 . . . . 0.0 110.78 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.95 107.51 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.63 142.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 124.417 1.087 . . . . 0.0 111.446 -170.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.5 mt -85.25 103.41 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.68 -37.72 62.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.21 0.604 . . . . 0.0 110.831 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 t -152.32 165.77 33.91 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 t -138.86 141.6 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.945 1.698 . . . . 0.0 110.641 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -134.0 126.1 29.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.022 1.329 . . . . 0.0 110.087 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.84 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -115.4 150.23 36.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.299 1.44 . . . . 0.0 112.412 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.429 1.492 . . . . 0.0 113.614 -169.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.501 2.101 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.17 126.39 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.251 -0.906 . . . . 0.0 109.836 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -97.97 124.91 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.939 1.296 . . . . 0.0 109.892 173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -100.95 121.69 42.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.763 1.225 . . . . 0.0 109.974 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -97.2 108.76 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -120.16 159.61 24.53 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -68.54 -8.57 42.67 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.9 p80 -109.17 -25.28 10.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 113.677 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.74 145.16 4.12 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.479 1.99 . . . . 0.0 113.402 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.7 133.74 36.54 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.268 -1.136 . . . . 0.0 112.672 172.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.12 143.38 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.95 1.7 . . . . 0.0 109.252 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.8 136.04 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.308 1.043 . . . . 0.0 110.239 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.71 139.56 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.698 1.999 . . . . 0.0 110.265 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -104.09 124.55 49.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.81 2.044 . . . . 0.0 108.132 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -85.87 148.81 25.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 111.547 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -106.89 73.41 0.94 Allowed 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 122.78 1.276 . . . . 0.0 111.608 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.72 -26.49 64.36 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.667 -1.151 . . . . 0.0 112.413 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -77.5 -27.14 51.75 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.327 1.051 . . . . 0.0 111.412 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -99.31 -24.64 14.76 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.213 1.405 . . . . 0.0 112.922 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.48 57.77 2.26 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.404 1.082 . . . . 0.0 113.162 -169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.66 -44.38 26.76 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.232 2.621 . . . . 0.0 112.906 -170.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -71.95 -39.78 69.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.756 0.707 . . . . 0.0 111.38 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.0 m -64.04 -47.54 79.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 111.215 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.26 -42.37 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.612 0.765 . . . . 0.0 111.595 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -54.89 -47.42 74.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.764 1.166 . . . . 0.0 111.967 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -71.18 -36.01 71.82 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.339 0.518 . . . . 0.0 112.032 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.63 -48.88 79.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.134 0.974 . . . . 0.0 111.611 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.64 -36.05 73.23 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.4 -0.812 . . . . 0.0 111.826 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -58.67 -35.32 72.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.586 0.755 . . . . 0.0 112.338 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.394 -0.816 . . . . 0.0 111.958 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 84.2 m -58.84 -38.11 77.97 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.665 -0.647 . . . . 0.0 111.808 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -65.69 -35.83 81.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.053 2.141 . . . . 0.0 112.703 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -81.63 -16.02 52.76 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.704 0.802 . . . . 0.0 113.107 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.29 20.24 60.92 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.295 0.95 . . . . 0.0 113.215 -176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -58.12 -38.47 76.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.371 1.068 . . . . 0.0 113.179 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -82.12 -7.75 59.63 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.365 0.666 . . . . 0.0 112.044 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.53 130.35 42.9 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.2 t30 55.08 46.78 23.39 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.256 1.422 . . . . 0.0 114.262 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.6 p -110.62 162.51 14.66 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.301 1.04 . . . . 0.0 111.489 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 156' ' ' ILE . 9.2 pt -122.72 161.85 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -86.45 81.85 8.16 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.843 1.257 . . . . 0.0 107.609 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -71.96 -7.96 51.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.9 tpt85 -146.0 135.22 22.83 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.55 1.523 . . . . 0.0 112.183 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.61 143.48 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.784 2.034 . . . . 0.0 110.556 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.35 129.72 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.853 1.661 . . . . 0.0 108.135 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -62.96 129.35 39.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.538 0.735 . . . . 0.0 111.65 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.61 10.48 67.14 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -175.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -142.49 -177.19 5.16 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.152 1.781 . . . . 0.0 110.765 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -81.71 178.82 8.11 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -169.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.3 pt -118.29 135.81 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.679 1.591 . . . . 0.0 112.17 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -110.29 150.85 28.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.728 1.211 . . . . 0.0 111.206 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.68 175.79 33.42 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.33 2.9 85.06 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.329 1.442 . . . . 0.0 115.411 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.14 -26.14 49.45 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 118.953 1.377 . . . . 0.0 114.509 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -144.11 164.62 30.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.256 1.022 . . . . 0.0 113.396 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -97.41 164.59 17.36 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.768 1.627 . . . . 0.0 110.145 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -61.27 -15.26 39.1 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.51 2.807 . . . . 0.0 118.196 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.22 16.68 58.23 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.887 0.756 . . . . 0.0 114.284 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.6 mmm 58.1 37.85 26.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.818 2.047 . . . . 0.0 113.331 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -83.25 123.06 29.22 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.919 1.288 . . . . 0.0 109.122 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.41 119.94 17.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 124.196 1.951 . . . . 0.0 110.337 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.62 179.7 1.64 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 110.332 -3.122 . . . . 0.0 114.513 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 61.66 6.75 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 112.405 -2.18 . . . . 0.0 112.166 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -69.48 106.43 2.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.179 1.392 . . . . 0.0 110.943 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -139.65 168.27 20.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.806 2.043 . . . . 0.0 111.995 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 49.12 61.35 14.17 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 113.007 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.4 129.85 36.88 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.731 2.954 . . . . 0.0 111.507 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.95 153.23 4.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 126.209 1.804 . . . . 0.0 108.154 -172.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 162.66 18.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 112.19 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -76.5 123.07 25.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.796 0.838 . . . . 0.0 110.943 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -110.13 15.22 22.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.469 1.108 . . . . 0.0 112.89 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -12.38 58.52 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.618 -1.301 . . . . 0.0 114.288 -172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -62.88 6.95 0.09 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 114.438 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -77.46 -11.54 59.86 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.134 1.774 . . . . 0.0 113.211 169.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.92 69.34 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.737 1.161 . . . . 0.0 114.891 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.39 156.93 26.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.882 1.341 . . . . 0.0 112.936 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -125.51 149.65 48.11 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -89.31 66.5 7.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.553 2.341 . . . . 0.0 111.417 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.0 p -95.07 163.87 13.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.537 0.735 . . . . 0.0 111.514 -173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 124.88 15.74 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.765 0.793 . . . . 0.0 111.33 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 24.11 46.32 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.374 1.464 . . . . 0.0 115.391 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.0 p -115.17 160.37 19.78 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.627 1.713 . . . . 0.0 113.536 177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 mp -119.31 134.64 55.1 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -131.68 157.41 43.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.346 0.658 . . . . 0.0 111.381 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 35.7 mtp -84.23 138.1 33.13 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.223 -0.298 . . . . 0.0 111.061 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.52 155.83 17.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.161 0.985 . . . . 0.0 111.381 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -117.17 164.42 14.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.491 1.116 . . . . 0.0 113.2 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.8 m -76.66 -58.33 3.34 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.195 0.998 . . . . 0.0 110.674 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -152.89 -58.31 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.991 1.716 . . . . 0.0 110.879 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.12 156.87 79.07 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.864 1.265 . . . . 0.0 112.047 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.66 -26.09 71.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.48 2.787 . . . . 0.0 114.249 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -108.18 33.37 4.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.507 1.523 . . . . 0.0 112.758 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -118.55 28.82 8.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.452 1.501 . . . . 0.0 113.693 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.13 106.28 18.26 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.732 1.613 . . . . 0.0 109.427 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.5 p -94.0 -69.02 0.77 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 0.0 113.139 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.81 -24.84 2.14 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -169.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.5 mp0 -67.06 140.58 57.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.528 1.131 . . . . 0.0 111.27 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -136.83 168.39 19.64 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.123 1.769 . . . . 0.0 110.358 172.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.9 p90 -143.23 162.04 36.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.247 0.619 . . . . 0.0 111.552 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.3 mt -114.38 118.89 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -70.12 96.76 1.1 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -73.71 -17.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.299 -0.876 . . . . 0.0 113.117 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.7 m -134.47 165.72 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 128.259 2.624 . . . . 0.0 110.78 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.57 116.58 14.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.758 0.823 . . . . 0.0 111.549 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -123.42 63.41 1.02 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.371 1.468 . . . . 0.0 112.535 -169.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -52.34 -35.16 50.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.342 1.457 . . . . 0.0 114.327 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -65.61 -13.72 59.67 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.85 -9.05 58.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -74.01 -178.86 3.48 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -171.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -78.89 150.82 32.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.34 1.456 . . . . 0.0 112.839 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.0 m -127.48 -39.92 1.82 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 143.99 63.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.244 0 CA-C-N 118.944 0.793 . . . . 0.0 114.205 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 53.66 24.0 3.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.142 1.777 . . . . 0.0 115.151 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.3 m -116.19 119.84 37.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.054 1.342 . . . . 0.0 110.573 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.4 mt -55.37 -32.61 62.73 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -169.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -75.41 -12.26 60.21 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.24 -78.7 1.42 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.116 2.293 . . . . 0.0 113.743 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.286 5.4 p-90 -66.43 128.61 36.84 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.55 -105.98 2.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.928 1.728 . . . . 0.0 114.86 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.24 141.06 51.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.533 1.533 . . . . 0.0 111.672 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -85.15 124.58 31.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -73.59 97.75 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 124.244 1.018 . . . . 0.0 108.414 170.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -79.76 -15.94 56.52 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.544 0.737 . . . . 0.0 111.656 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.83 8.39 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.567 1.175 . . . . 0.0 113.843 -170.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -139.95 153.71 46.99 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.563 -1.335 . . . . 0.0 112.466 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.46 137.67 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.723 0.773 . . . . 0.0 109.924 170.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.13 -41.76 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.331 1.852 . . . . 0.0 110.801 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -141.74 148.65 39.35 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.521 1.528 . . . . 0.0 110.031 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.89 13.2 20.63 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.944 0.783 . . . . 0.0 114.87 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 69.5 mmm -54.69 -38.06 66.54 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.405 1.602 . . . . 0.0 112.377 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.76 -29.04 70.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.049 0.94 . . . . 0.0 112.439 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.98 -43.55 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.689 1.596 . . . . 0.0 110.336 173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.18 -38.4 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.218 1.007 . . . . 0.0 111.198 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.9 -22.26 60.77 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.585 1.554 . . . . 0.0 112.857 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -81.39 -43.86 18.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.368 1.467 . . . . 0.0 111.395 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.5 mt -55.18 -33.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.097 1.359 . . . . 0.0 112.045 -178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -85.17 -16.59 39.87 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.35 12.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.166 1.365 . . . . 0.0 114.268 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.5 m -72.81 -57.7 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.607 1.203 . . . . 0.0 113.613 -173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.68 156.51 7.89 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.994 0.917 . . . . 0.0 113.324 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.9 p -141.71 152.13 43.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.392 1.477 . . . . 0.0 111.972 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.25 133.27 1.65 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.114 0.387 . . . . 0.0 113.263 171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -61.82 149.29 40.53 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.876 1.27 . . . . 0.0 112.99 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.3 p -110.47 168.89 9.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.193 1.397 . . . . 0.0 111.742 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.21 -22.2 72.51 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 114.699 0.639 . . . . 0.0 114.699 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.8 ttm -105.49 -34.32 7.83 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.517 1.127 . . . . 0.0 113.375 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -136.72 124.47 22.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.881 1.672 . . . . 0.0 110.598 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -92.23 156.75 17.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.492 1.117 . . . . 0.0 112.452 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 56.35 54.62 7.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.521 1.528 . . . . 0.0 113.481 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.14 159.49 49.29 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 127.203 2.201 . . . . 0.0 111.354 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.0 135.36 34.71 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 121.378 1.385 . . . . 0.0 109.548 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -29.59 48.76 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 154.23 22.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.413 1.085 . . . . 0.0 110.636 169.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -84.53 109.61 18.06 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.998 0.904 . . . . 0.0 111.312 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.19 94.02 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -123.5 141.67 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -168.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.48 103.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 126.596 1.958 . . . . 0.0 106.786 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.02 -39.8 60.88 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.614 -0.679 . . . . 0.0 111.119 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -150.07 165.99 31.09 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -137.97 142.1 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.745 1.618 . . . . 0.0 111.001 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.7 m -136.33 129.59 31.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.766 1.227 . . . . 0.0 110.384 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.74 122.55 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 169.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.9 t -118.88 150.45 39.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.705 1.602 . . . . 0.0 112.044 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.628 1.171 . . . . 0.0 113.699 -172.331 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.31 124.75 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.97 0.908 . . . . 0.0 109.575 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.3 m -99.97 125.19 45.95 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.967 0.907 . . . . 0.0 110.314 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -96.87 135.34 38.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.674 1.19 . . . . 0.0 110.6 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -105.82 101.43 10.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -106.36 151.96 24.2 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.075 -0.39 . . . . 0.0 111.038 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.83 -8.09 2.82 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -105.38 -10.46 16.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.781 1.232 . . . . 0.0 114.03 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.59 162.16 10.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.124 1.345 . . . . 0.0 113.592 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.21 138.1 45.42 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.667 1.587 . . . . 0.0 112.401 172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.6 mt -135.61 140.36 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.299 1.84 . . . . 0.0 108.9 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 t -121.77 133.26 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.583 1.153 . . . . 0.0 110.682 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.54 139.16 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.551 1.94 . . . . 0.0 109.909 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -101.5 129.45 47.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.884 2.074 . . . . 0.0 108.452 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 p -93.43 145.98 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 111.412 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -103.96 72.08 1.08 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.897 1.332 . . . . 0.0 111.699 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.97 -26.13 63.95 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.502 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -77.58 -29.43 52.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.201 1.001 . . . . 0.0 111.698 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -99.7 -20.74 16.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.943 1.297 . . . . 0.0 113.285 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.65 56.79 1.55 Allowed Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.516 1.126 . . . . 0.0 113.224 -171.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.18 -45.3 23.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.433 2.756 . . . . 0.0 113.116 -172.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -69.48 -39.73 77.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.784 0.72 . . . . 0.0 111.449 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -63.44 -48.26 78.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.723 0.809 . . . . 0.0 111.24 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.17 -41.23 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.408 0.683 . . . . 0.0 111.512 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -54.42 -48.47 71.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.705 1.139 . . . . 0.0 112.329 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -70.56 -35.99 73.38 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.608 0.64 . . . . 0.0 111.922 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -59.84 -50.92 71.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.447 1.099 . . . . 0.0 111.418 172.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 -36.35 73.17 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.697 0.799 . . . . 0.0 111.959 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.89 -34.8 70.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -76.27 -39.19 54.97 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.519 -0.738 . . . . 0.0 112.442 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 80.6 m -60.45 -35.77 76.64 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.11 -0.994 . . . . 0.0 111.565 175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -31.08 71.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.105 1.762 . . . . 0.0 112.763 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -81.21 -14.31 57.66 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.225 1.01 . . . . 0.0 113.345 170.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.52 15.38 62.0 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.69 1.138 . . . . 0.0 114.04 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -68.17 -18.96 64.74 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.438 1.495 . . . . 0.0 114.689 -171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.78 -13.5 21.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -73.23 1.71 8.81 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -169.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -145.24 49.38 1.26 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.28 1.432 . . . . 0.0 111.055 170.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.9 p -113.57 170.39 8.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 pt -125.36 162.2 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -103.15 130.93 50.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.647 1.579 . . . . 0.0 107.368 168.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.96 -40.39 1.51 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -87.66 116.81 26.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.609 1.095 . . . . 0.0 109.627 -175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 p -125.03 129.75 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.489 1.516 . . . . 0.0 110.413 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 77.7 mt -141.47 129.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.021 1.728 . . . . 0.0 107.856 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -65.96 134.94 54.01 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.697 0.799 . . . . 0.0 111.819 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.5 13.5 68.25 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 123.811 0.72 . . . . 0.0 114.79 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -142.98 -177.32 5.28 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.903 1.681 . . . . 0.0 111.542 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.58 179.93 6.44 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.12 1.768 . . . . 0.0 114.975 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.0 pt -120.83 142.63 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -118.19 147.7 43.11 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 112.225 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.34 -177.6 30.61 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 122.151 0.862 . . . . 0.0 115.216 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.74 -5.82 82.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.362 1.458 . . . . 0.0 115.622 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.01 -16.08 63.8 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 117.483 1.753 . . . . 0.0 117.483 -169.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.05 163.76 34.25 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.805 1.302 . . . . 0.0 112.366 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.13 163.0 30.97 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.303 1.041 . . . . 0.0 111.11 169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.54 -12.9 18.84 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.187 3.258 . . . . 0.0 117.33 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.47 13.55 67.0 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.074 0.845 . . . . 0.0 114.833 172.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.8 mmt 59.71 29.64 19.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.374 1.87 . . . . 0.0 112.868 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -81.24 124.08 29.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.827 1.251 . . . . 0.0 109.197 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -72.97 114.72 11.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.535 0.734 . . . . 0.0 109.88 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -71.99 165.2 24.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.898 1.074 . . . . 0.0 113.898 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.59 73.29 10.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.798 1.639 . . . . 0.0 111.033 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -70.41 129.31 38.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.864 0.866 . . . . 0.0 111.09 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mttm -140.29 172.09 13.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.545 1.938 . . . . 0.0 111.513 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 48.42 62.66 11.71 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.396 1.478 . . . . 0.0 113.127 169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -55.87 129.23 33.84 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.125 2.55 . . . . 0.0 110.339 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mt -93.63 149.18 4.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 107.536 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 158.45 27.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.691 0.758 . . . . 0.0 111.133 171.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -85.24 131.06 34.48 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.334 1.054 . . . . 0.0 111.217 -171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.36 15.92 17.92 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.224 1.01 . . . . 0.0 112.715 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.01 -11.36 28.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -74.43 40.41 0.13 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.932 1.693 . . . . 0.0 112.173 171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.6 p30 -117.88 -3.48 11.18 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.419 2.287 . . . . 0.0 114.006 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.63 4.55 72.96 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.48 1.514 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.91 157.64 20.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.614 1.207 . . . . 0.0 113.124 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.04 158.85 43.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.616 1.166 . . . . 0.0 113.754 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -94.78 102.25 14.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.983 1.713 . . . . 0.0 110.563 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.4 p -133.5 168.03 19.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.787 1.235 . . . . 0.0 111.663 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.95 121.49 7.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.848 1.259 . . . . 0.0 110.692 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.91 24.54 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.503 1.525 . . . . 0.0 114.992 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.4 p -122.31 159.96 26.34 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.38 1.59 . . . . 0.0 113.734 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -122.24 139.49 53.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.836 0.854 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -138.46 159.24 42.57 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.843 -0.536 . . . . 0.0 111.881 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.9 mmm -78.75 137.7 37.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.919 0.488 . . . . 0.0 110.477 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.69 148.85 29.99 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.122 0.569 . . . . 0.0 110.978 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -119.19 162.55 18.48 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.995 1.318 . . . . 0.0 112.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.6 m -77.37 -55.48 5.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.872 0.869 . . . . 0.0 111.23 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -159.3 -56.73 0.06 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.977 1.311 . . . . 0.0 111.069 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.66 157.27 86.17 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 111.556 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.96 -35.53 94.49 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.869 2.379 . . . . 0.0 113.671 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -98.82 32.62 2.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.965 1.706 . . . . 0.0 113.359 -174.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.5 p -117.24 33.91 5.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.006 1.322 . . . . 0.0 113.426 -173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.12 109.79 21.93 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.793 1.637 . . . . 0.0 110.186 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 p -94.94 -66.94 0.88 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.264 1.425 . . . . 0.0 113.449 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.67 -22.64 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.52 145.18 47.66 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 120.574 -1.329 . . . . 0.0 112.088 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -140.32 168.22 20.3 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 127.409 2.283 . . . . 0.0 109.611 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.9 p90 -144.81 159.9 42.13 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.125 0.57 . . . . 0.0 111.703 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.5 mt -115.52 117.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.783 1.233 . . . . 0.0 108.273 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.78 111.44 14.91 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.642 0.777 . . . . 0.0 110.707 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.13 -6.32 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 m -129.11 165.06 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.895 1.678 . . . . 0.0 111.154 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -80.27 117.4 21.02 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.89 0.476 . . . . 0.0 109.917 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -142.14 63.92 1.4 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 123.019 1.39 . . . . 0.0 111.822 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.31 -13.52 60.64 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -172.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -62.88 -14.03 41.41 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.689 -1.257 . . . . 0.0 113.427 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.01 -10.51 59.78 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.53 1.132 . . . . 0.0 113.729 173.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -75.44 -176.45 3.18 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -172.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -82.1 143.7 31.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.693 1.597 . . . . 0.0 112.288 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.4 p -108.62 -59.28 1.89 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.499 1.119 . . . . 0.0 113.631 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.6 60.94 0.02 OUTLIER Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.081 0.848 . . . . 0.0 114.161 -172.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 58.39 23.51 10.67 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.012 1.725 . . . . 0.0 115.05 174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 t -101.78 122.18 43.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.857 1.263 . . . . 0.0 111.848 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.1 tp -52.43 -43.46 64.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.907 1.283 . . . . 0.0 114.152 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -81.92 -6.61 59.25 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.644 1.178 . . . . 0.0 113.785 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.49 -69.9 1.08 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.705 2.098 . . . . 0.0 113.893 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.288 8.3 p-90 -72.07 130.53 41.14 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -171.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.7 -98.54 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.629 1.585 . . . . 0.0 116.506 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -126.31 139.83 53.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.957 1.303 . . . . 0.0 111.809 -168.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.3 t -82.94 122.85 28.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.878 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.75 89.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.551 1.14 . . . . 0.0 108.182 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -77.43 -15.22 59.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.369 0.667 . . . . 0.0 112.36 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.72 175.8 9.39 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -138.11 152.65 48.96 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.965 -1.085 . . . . 0.0 112.458 172.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.37 139.63 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-O 121.542 0.687 . . . . 0.0 110.476 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.4 t -112.95 -43.34 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.388 1.475 . . . . 0.0 111.165 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -145.96 154.02 41.45 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.379 1.472 . . . . 0.0 110.339 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.88 15.06 29.8 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.009 0.814 . . . . 0.0 113.395 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 23.0 mtp -57.84 -34.64 69.93 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.65 1.18 . . . . 0.0 111.938 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.55 -31.44 72.5 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.921 0.888 . . . . 0.0 112.407 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t -72.16 -43.12 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.444 1.097 . . . . 0.0 109.89 173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.585 -0.697 . . . . 0.0 111.001 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.44 -26.38 61.81 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.82 1.248 . . . . 0.0 112.644 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -78.32 -41.39 33.8 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.054 1.342 . . . . 0.0 110.978 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.9 mt -55.7 -30.1 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.447 1.899 . . . . 0.0 112.772 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -92.76 -11.1 34.71 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.04 -11.95 13.05 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.509 1.528 . . . . 0.0 114.413 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.16 -59.32 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.572 1.186 . . . . 0.0 112.799 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.94 143.22 0.93 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 112.431 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.0 p -112.07 148.75 33.24 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.435 1.494 . . . . 0.0 112.587 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.97 144.1 3.97 Favored Glycine 0 N--CA 1.464 0.526 0 CA-C-O 123.198 1.444 . . . . 0.0 113.7 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -61.83 144.25 55.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.405 2.282 . . . . 0.0 113.347 -169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.4 t -107.43 158.72 16.96 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.053 1.741 . . . . 0.0 110.936 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.7 -16.02 62.87 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.578 -0.702 . . . . 0.0 114.069 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 94.9 mtp -114.11 -22.26 10.11 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.025 1.33 . . . . 0.0 114.407 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -141.56 140.77 33.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.176 1.39 . . . . 0.0 111.519 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.65 154.37 22.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.392 1.477 . . . . 0.0 111.778 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 56.81 49.2 14.65 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.907 1.683 . . . . 0.0 113.558 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.17 158.77 54.49 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 126.239 1.816 . . . . 0.0 112.414 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.87 137.66 45.83 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 121.66 1.573 . . . . 0.0 109.858 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -27.64 43.04 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.768 -0.582 . . . . 0.0 112.281 175.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.72 140.71 44.32 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.622 0.769 . . . . 0.0 109.635 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -84.22 130.44 34.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.67 0.748 . . . . 0.0 109.836 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.0 t -126.15 109.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.329 1.452 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.89 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 124.384 1.074 . . . . 0.0 111.566 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 mt -84.07 103.83 11.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 169.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.75 -28.35 60.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.2 t -163.89 169.53 18.03 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.38 140.07 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.496 1.919 . . . . 0.0 110.416 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.8 m -130.04 124.96 34.11 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.277 1.431 . . . . 0.0 109.891 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 50.8 t -86.68 123.35 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -115.58 150.39 36.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.808 1.243 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.775 1.63 . . . . 0.0 113.413 -169.812 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.69 127.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.236 -0.915 . . . . 0.0 109.545 169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -102.35 120.92 41.3 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 110.119 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -95.7 132.12 41.23 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 110.843 169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -104.51 101.42 11.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.2 p -106.42 152.21 23.91 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.066 -0.396 . . . . 0.0 111.193 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -60.48 -9.77 4.12 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.93 -7.55 19.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.952 1.301 . . . . 0.0 114.027 170.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.29 166.69 12.26 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.864 1.697 . . . . 0.0 113.683 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.09 137.6 41.53 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.097 1.759 . . . . 0.0 113.044 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.7 mt -133.09 141.15 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.586 1.954 . . . . 0.0 108.971 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.49 135.78 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.457 1.103 . . . . 0.0 110.359 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 mt -122.98 139.84 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 126.339 1.855 . . . . 0.0 110.162 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -107.21 123.57 48.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.168 1.787 . . . . 0.0 109.113 172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.0 p -87.85 148.1 24.81 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.486 1.115 . . . . 0.0 111.914 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -105.73 73.66 1.02 Allowed 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 122.655 1.217 . . . . 0.0 111.209 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.31 -26.06 64.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.581 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.99 -24.45 47.98 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.327 1.051 . . . . 0.0 111.595 174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.2 -21.98 13.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.342 1.457 . . . . 0.0 112.862 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.65 55.59 1.81 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.199 1.4 . . . . 0.0 112.982 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -60.64 -43.77 30.53 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.509 2.806 . . . . 0.0 112.762 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -69.54 -40.09 77.08 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.006 0.821 . . . . 0.0 111.055 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -63.57 -49.37 73.68 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.947 0.499 . . . . 0.0 111.423 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.23 -38.05 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.399 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -55.74 -50.43 70.4 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.503 1.047 . . . . 0.0 111.433 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.6 -48.28 82.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.914 1.286 . . . . 0.0 111.199 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.17 -50.52 73.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 111.171 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -73.12 -36.07 66.67 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.524 0.73 . . . . 0.0 111.654 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -58.8 -36.33 74.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.949 0.5 . . . . 0.0 111.601 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' CD2' ' A' ' 35' ' ' PHE . 2.9 m-85 -77.75 -39.36 44.58 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 76.1 m -61.48 -36.33 80.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.967 . . . . 0.0 111.46 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -34.2 77.07 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.993 1.717 . . . . 0.0 112.765 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -81.21 -14.06 57.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.367 1.067 . . . . 0.0 113.404 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.09 16.91 62.04 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.871 1.224 . . . . 0.0 114.258 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.402 ' CD2' ' CD1' ' A' ' 30' ' ' TYR . 45.9 t80 -71.81 -17.59 62.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -93.74 -12.81 28.36 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.98 2.94 7.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -146.12 43.92 1.23 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.229 1.412 . . . . 0.0 111.357 170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.7 p -104.8 169.45 8.44 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.262 -0.899 . . . . 0.0 112.923 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 156' ' ' ILE . 20.8 pt -127.85 163.35 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -89.29 119.16 29.51 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -93.08 -30.52 15.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.46 1.504 . . . . 0.0 114.289 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -133.99 138.93 45.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.997 0.919 . . . . 0.0 112.389 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.83 133.6 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 127.292 2.237 . . . . 0.0 109.699 169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.2 mt -138.65 130.15 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.169 1.788 . . . . 0.0 107.891 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -63.58 135.6 56.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.439 0.696 . . . . 0.0 111.875 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.56 9.97 62.74 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -141.85 -177.09 5.03 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.439 1.896 . . . . 0.0 110.975 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.13 -178.16 5.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.961 1.704 . . . . 0.0 115.42 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.3 pt -121.3 136.05 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 112.559 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -116.5 149.92 38.76 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.429 1.092 . . . . 0.0 112.124 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.6 -179.77 36.5 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.42 1.328 . . . . 0.0 116.42 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.08 -12.16 68.58 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.668 1.604 . . . . 0.0 115.979 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.5 -15.17 69.19 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 116.881 1.513 . . . . 0.0 116.881 -169.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.04 166.22 25.23 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.033 1.417 . . . . 0.0 112.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -97.13 163.17 20.51 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.87 1.668 . . . . 0.0 111.239 169.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.49 -13.89 27.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.051 3.167 . . . . 0.0 118.301 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.37 14.46 65.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.936 0.779 . . . . 0.0 114.677 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 42.5 mmm 57.77 38.66 27.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.776 1.63 . . . . 0.0 112.733 -174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.55 126.44 36.64 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.433 1.493 . . . . 0.0 109.493 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -73.44 118.46 16.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.848 0.859 . . . . 0.0 110.346 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -73.36 166.5 23.08 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.32 73.96 5.94 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.945 1.698 . . . . 0.0 111.671 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 p -68.76 122.72 19.16 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.621 1.168 . . . . 0.0 111.71 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -137.81 170.12 16.6 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.13 2.172 . . . . 0.0 111.226 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 48.23 61.15 14.39 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.327 1.451 . . . . 0.0 113.386 169.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.08 139.29 89.93 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.698 2.932 . . . . 0.0 111.777 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.41 148.24 6.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.457 1.503 . . . . 0.0 107.968 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 155.99 19.63 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.771 0.828 . . . . 0.0 110.843 170.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -71.71 126.1 28.83 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -107.47 11.38 28.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.79 1.236 . . . . 0.0 113.013 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -12.62 45.59 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -171.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.56 0.94 0.26 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.406 1.482 . . . . 0.0 113.944 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -72.25 -11.26 60.64 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.791 1.236 . . . . 0.0 112.939 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.61 7.59 85.91 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.305 1.431 . . . . 0.0 114.695 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.69 153.25 38.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.464 1.132 . . . . 0.0 112.226 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -130.63 151.57 50.94 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -93.45 99.52 11.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.136 1.774 . . . . 0.0 110.921 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 71.2 p -129.96 168.21 17.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.555 1.142 . . . . 0.0 111.496 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.31 124.9 18.57 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.71 1.204 . . . . 0.0 110.976 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.61 46.99 8.27 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.537 1.065 . . . . 0.0 113.807 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 66.8 p -134.75 163.36 29.97 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 118.304 1.052 . . . . 0.0 112.942 173.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.36 139.08 54.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.817 . . . . 0.0 112.997 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.7 159.86 40.56 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.086 0.47 . . . . 0.0 111.731 171.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -82.88 141.13 32.45 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.147 -0.346 . . . . 0.0 111.687 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.01 162.0 14.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.188 0.995 . . . . 0.0 111.025 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -137.4 158.74 43.74 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.212 1.405 . . . . 0.0 112.274 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.2 m -72.35 -54.94 8.0 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.46 1.104 . . . . 0.0 111.661 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.87 -49.26 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.113 1.365 . . . . 0.0 112.425 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 156.1 77.77 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.594 1.158 . . . . 0.0 111.21 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -58.01 -27.72 80.44 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.081 2.521 . . . . 0.0 113.653 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -109.34 35.63 3.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.514 1.526 . . . . 0.0 112.515 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.5 p -118.07 31.82 6.48 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.517 1.527 . . . . 0.0 113.671 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.54 105.14 17.22 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.009 1.724 . . . . 0.0 109.038 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.2 p -97.57 -45.39 6.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.37 12.59 0.23 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -104.96 139.72 39.25 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.358 -1.464 . . . . 0.0 111.489 -169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -141.51 168.42 19.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.051 1.74 . . . . 0.0 111.527 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 10.7 p90 -147.79 162.08 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.97 117.79 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.744 1.218 . . . . 0.0 108.783 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -76.57 100.8 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.861 0.864 . . . . 0.0 110.596 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.78 -19.27 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.81 167.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.812 1.645 . . . . 0.0 111.761 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.81 120.7 24.44 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.964 -0.46 . . . . 0.0 110.092 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -146.2 62.58 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 123.001 1.381 . . . . 0.0 111.937 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -65.64 -13.23 58.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -62.76 -13.91 38.55 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.507 -1.371 . . . . 0.0 113.381 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.25 -9.26 59.72 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.583 1.153 . . . . 0.0 113.821 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -73.8 179.91 3.99 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -81.0 145.89 30.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.348 1.459 . . . . 0.0 112.257 169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.3 p -115.8 -59.34 2.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.581 1.152 . . . . 0.0 113.613 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.04 66.21 0.03 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.17 0.891 . . . . 0.0 114.028 -172.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.29 23.54 5.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.055 1.742 . . . . 0.0 115.05 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.6 m -111.46 119.0 37.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.999 1.319 . . . . 0.0 110.342 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.93 -32.17 63.56 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -79.25 -9.9 59.69 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.04 -72.23 1.03 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.125 2.298 . . . . 0.0 113.97 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.282 7.2 p-90 -70.68 122.29 19.52 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.33 -93.42 1.13 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.316 1.436 . . . . 0.0 114.834 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.21 142.27 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.259 1.424 . . . . 0.0 111.721 -169.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.22 127.41 34.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.2 92.27 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.597 1.159 . . . . 0.0 108.22 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -80.38 -14.92 57.93 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.857 0.863 . . . . 0.0 112.031 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.7 177.98 8.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.335 1.064 . . . . 0.0 113.252 -170.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -138.94 149.98 45.38 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.842 -1.161 . . . . 0.0 112.041 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 p -78.8 134.99 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.424 0.63 . . . . 0.0 110.464 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 t -106.96 -41.89 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.326 1.85 . . . . 0.0 110.736 -175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -143.98 155.81 44.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.667 1.587 . . . . 0.0 109.853 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.21 16.79 26.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.754 0.692 . . . . 0.0 114.734 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.05 -32.91 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.371 1.585 . . . . 0.0 112.437 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.66 -29.06 68.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.574 0.75 . . . . 0.0 112.684 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.06 -38.55 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.533 1.533 . . . . 0.0 110.463 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.6 -41.4 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.8 -1.188 . . . . 0.0 110.658 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.7 -30.6 70.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.134 1.373 . . . . 0.0 111.652 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.98 -46.89 61.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.51 0.724 . . . . 0.0 111.12 173.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 98.6 mt -68.73 -25.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.993 1.317 . . . . 0.0 112.142 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 pttt -85.13 -17.62 36.69 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.883 -1.136 . . . . 0.0 113.864 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.67 -8.73 54.14 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.058 1.79 . . . . 0.0 115.181 -176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -26.31 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 83.55 164.59 0.12 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.357 2.263 . . . . 0.0 114.663 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.2 p -114.27 151.5 32.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.909 1.683 . . . . 0.0 113.599 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.05 117.85 0.79 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.032 1.301 . . . . 0.0 110.688 169.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -63.77 150.82 43.75 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.218 1.007 . . . . 0.0 113.411 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.7 p -115.08 168.26 10.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.303 1.441 . . . . 0.0 111.958 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.59 -21.81 72.97 Favored Glycine 0 CA--C 1.539 1.582 0 O-C-N 121.811 -0.556 . . . . 0.0 114.252 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 98.1 mmm -92.65 -43.9 8.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.361 1.065 . . . . 0.0 112.821 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -141.73 131.61 24.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.037 1.735 . . . . 0.0 111.129 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.37 163.27 20.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.754 0.822 . . . . 0.0 112.825 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . 0.324 3.4 p30 54.82 18.14 2.05 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.09 154.66 93.56 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.319 1.447 . . . . 0.0 112.246 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -60.3 140.04 89.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 121.887 1.725 . . . . 0.0 110.761 169.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -32.38 62.84 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.62 150.18 31.08 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.726 0.774 . . . . 0.0 111.198 169.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.95 110.01 16.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.465 0.706 . . . . 0.0 110.617 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.38 106.24 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.143 0.977 . . . . 0.0 108.372 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -128.74 142.2 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.652 1.181 . . . . 0.0 112.176 -169.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mt -84.36 103.87 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.78 -30.96 59.29 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.536 1.134 . . . . 0.0 111.533 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 p -162.76 171.47 16.73 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.3 t -135.52 143.75 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.329 1.452 . . . . 0.0 110.786 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.5 m -132.79 130.28 39.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.351 1.46 . . . . 0.0 109.764 174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.66 125.46 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.1 t -121.15 150.5 41.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.588 1.555 . . . . 0.0 111.838 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.356 1.062 . . . . 0.0 112.999 -179.872 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.504 2.258 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -129.75 130.47 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 120.846 -1.159 . . . . 0.0 110.273 174.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.1 m -101.07 127.11 47.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.493 1.117 . . . . 0.0 110.235 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -101.66 124.03 46.63 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.778 1.231 . . . . 0.0 110.054 169.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -99.53 106.64 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.5 p -117.55 160.12 21.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.303 0.573 . . . . 0.0 112.114 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -68.5 -7.88 36.14 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.474 ' CE1' HD11 ' A' ' 136' ' ' ILE . 21.2 p80 -111.24 -25.69 9.56 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.522 . . . . 0.0 113.591 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 158.48 144.95 4.09 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.164 1.84 . . . . 0.0 113.538 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.96 133.6 38.06 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.383 1.073 . . . . 0.0 112.38 172.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -130.86 144.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.788 1.635 . . . . 0.0 109.379 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -128.4 136.79 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.274 1.03 . . . . 0.0 110.517 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 mt -126.38 139.83 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.888 2.075 . . . . 0.0 110.189 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -102.46 127.69 49.39 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.69 1.996 . . . . 0.0 107.753 171.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -88.79 147.63 24.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.162 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -104.48 74.11 1.15 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 122.695 1.236 . . . . 0.0 111.391 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.69 -27.52 65.08 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.212 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -75.87 -31.37 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.528 1.131 . . . . 0.0 111.529 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -96.39 -24.51 16.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.6 1.16 . . . . 0.0 113.066 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.1 61.36 4.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 123.662 0.785 . . . . 0.0 112.971 -170.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.37 -45.07 15.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.201 2.601 . . . . 0.0 112.583 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -69.48 -39.97 77.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.858 0.754 . . . . 0.0 111.13 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 ' HA ' HD13 ' A' ' 68' ' ' ILE . 20.4 m -63.23 -48.19 79.29 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.739 0.816 . . . . 0.0 111.249 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.5 t -67.26 -41.81 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 123.409 0.684 . . . . 0.0 111.803 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -55.26 -47.87 74.83 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.72 1.146 . . . . 0.0 112.129 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -70.57 -37.11 73.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.097 0.559 . . . . 0.0 111.813 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -59.75 -49.0 79.44 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.505 1.122 . . . . 0.0 111.333 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.78 -37.09 70.5 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.591 0.757 . . . . 0.0 111.821 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.094 0.558 . . . . 0.0 112.436 172.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -74.81 -41.83 59.2 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.438 -0.789 . . . . 0.0 112.522 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.5 m -60.21 -37.33 79.95 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.424 -0.797 . . . . 0.0 111.51 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -62.82 -35.04 78.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.803 2.041 . . . . 0.0 112.788 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -82.65 -13.15 56.97 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.023 0.929 . . . . 0.0 113.39 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.49 19.43 64.12 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.481 1.039 . . . . 0.0 114.154 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -67.53 -17.61 64.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.073 1.349 . . . . 0.0 114.524 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.49 -4.28 45.22 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.342 -0.848 . . . . 0.0 113.211 170.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -67.85 136.7 54.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.283 0.947 . . . . 0.0 109.405 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.7 t30 49.29 46.35 23.05 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.829 1.652 . . . . 0.0 114.211 -170.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.1 p -103.77 161.6 13.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.506 0.722 . . . . 0.0 111.921 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 156' ' ' ILE . 13.7 pt -122.48 162.2 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -169.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -94.79 114.92 26.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.071 1.349 . . . . 0.0 107.945 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -113.96 1.11 14.59 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -134.22 133.55 41.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.333 1.424 . . . . 0.0 110.43 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.13 133.64 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.127 1.371 . . . . 0.0 111.125 170.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -138.41 130.48 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.988 1.715 . . . . 0.0 108.186 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -63.83 134.62 55.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.712 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.45 68.86 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.741 0.686 . . . . 0.0 114.667 -173.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -144.07 -177.19 5.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.234 1.813 . . . . 0.0 111.266 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.76 179.73 6.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.384 1.874 . . . . 0.0 114.974 -169.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.6 pt -119.58 139.52 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.106 1.363 . . . . 0.0 112.317 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -112.4 148.74 33.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.874 1.27 . . . . 0.0 111.121 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.01 -176.41 33.09 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 115.259 0.864 . . . . 0.0 115.259 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.2 -8.52 24.15 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.44 1.495 . . . . 0.0 115.252 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.56 -14.61 75.61 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.1 1.333 . . . . 0.0 115.689 -174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -141.5 167.66 21.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.721 1.208 . . . . 0.0 112.944 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -107.87 156.07 38.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 127.267 2.227 . . . . 0.0 109.329 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -56.83 128.8 31.44 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.102 2.535 . . . . 0.0 112.956 -170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.31 15.94 36.53 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.598 1.57 . . . . 0.0 113.505 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.4 mmm 61.66 37.44 15.98 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.241 1.416 . . . . 0.0 112.26 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.77 118.3 21.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.695 1.198 . . . . 0.0 108.882 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.59 126.35 29.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.491 0.663 . . . . 0.0 111.213 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -78.74 167.45 21.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.217 1.007 . . . . 0.0 113.366 171.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.47 75.1 5.19 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.833 1.653 . . . . 0.0 110.768 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.8 p -73.4 134.95 44.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.134 0.974 . . . . 0.0 111.842 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -138.68 171.93 13.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.941 2.096 . . . . 0.0 112.0 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 51.88 66.48 5.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.616 1.566 . . . . 0.0 113.365 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -59.27 136.06 69.75 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.297 2.665 . . . . 0.0 111.405 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -111.74 150.69 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.475 1.51 . . . . 0.0 109.413 -170.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 157.66 21.77 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.915 0.486 . . . . 0.0 111.969 175.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -71.54 131.24 42.97 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.472 0.709 . . . . 0.0 110.131 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -117.44 13.58 14.47 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.054 1.342 . . . . 0.0 111.961 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.8 63.37 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.571 -1.331 . . . . 0.0 113.739 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -60.72 4.44 0.07 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.613 1.965 . . . . 0.0 115.914 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -84.67 4.23 33.49 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.876 1.67 . . . . 0.0 111.808 168.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.65 28.04 27.88 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.204 1.383 . . . . 0.0 113.961 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.4 mt -76.58 143.43 40.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.002 0.921 . . . . 0.0 112.771 -175.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -137.51 156.3 48.29 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.747 1.219 . . . . 0.0 113.702 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -110.83 110.78 21.53 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.598 2.359 . . . . 0.0 109.778 -171.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.1 p -137.65 171.65 14.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.43 1.092 . . . . 0.0 110.799 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -47.85 120.26 3.32 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.54 1.136 . . . . 0.0 111.362 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 34.03 21.5 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.717 1.151 . . . . 0.0 114.949 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.1 p -121.95 160.51 24.68 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.669 1.235 . . . . 0.0 112.937 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -124.15 136.49 54.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.686 0.794 . . . . 0.0 112.828 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -136.61 159.15 42.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.886 -0.509 . . . . 0.0 111.948 172.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 97.5 mmm -82.39 134.8 35.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.852 0.461 . . . . 0.0 110.86 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.12 154.51 21.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.244 1.018 . . . . 0.0 110.3 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -120.74 158.25 27.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.363 1.065 . . . . 0.0 113.034 -170.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.8 m -69.27 -56.49 7.4 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.905 0.882 . . . . 0.0 110.73 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -150.69 -56.09 0.16 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.806 1.642 . . . . 0.0 110.23 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.51 157.34 72.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.947 1.299 . . . . 0.0 112.401 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -56.54 -25.77 60.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.683 2.922 . . . . 0.0 113.999 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -107.53 36.62 2.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.57 1.548 . . . . 0.0 112.687 -177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.6 p -126.74 28.03 5.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.27 1.428 . . . . 0.0 113.905 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.7 76.51 4.95 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.423 1.489 . . . . 0.0 112.469 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.1 p -70.19 -60.38 2.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.816 1.247 . . . . 0.0 114.233 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.21 -8.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -169.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -81.21 140.52 34.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.729 -1.232 . . . . 0.0 109.694 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -140.47 168.33 20.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.88 1.672 . . . . 0.0 111.251 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 19.7 p90 -146.81 161.73 40.07 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.657 0.783 . . . . 0.0 111.966 177.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.34 116.94 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.49 1.116 . . . . 0.0 108.537 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.72 98.15 4.02 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 110.689 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 -24.86 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.287 -0.883 . . . . 0.0 113.066 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.71 168.94 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.479 1.512 . . . . 0.0 112.024 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.41 120.51 23.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.732 1.213 . . . . 0.0 110.371 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -142.22 74.73 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.204 1.478 . . . . 0.0 112.209 -170.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.77 -34.93 70.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.894 2.077 . . . . 0.0 114.094 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.46 -13.17 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.46 -11.62 58.39 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 174.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -72.64 172.23 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.71 155.45 40.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.588 1.155 . . . . 0.0 112.107 169.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -139.65 -55.26 0.56 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 177.22 53.16 0.07 OUTLIER Glycine 0 N--CA 1.476 1.317 0 N-CA-C 116.769 1.467 . . . . 0.0 116.769 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 55.12 25.92 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.96 1.704 . . . . 0.0 114.099 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 m -125.29 136.37 53.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.126 1.37 . . . . 0.0 111.685 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 mp -56.14 -30.63 62.42 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -82.42 -8.88 59.62 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.51 -71.42 1.1 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.256 1.884 . . . . 0.0 113.746 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.1 136.06 33.22 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -169.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.92 -72.68 0.9 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.112 1.339 . . . . 0.0 115.378 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -139.68 150.1 44.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.04 1.336 . . . . 0.0 111.843 -169.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.6 t -87.98 120.35 29.23 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.647 -0.658 . . . . 0.0 112.543 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -77.52 82.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.253 1.421 . . . . 0.0 108.537 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -74.38 -14.52 60.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.024 0.929 . . . . 0.0 112.419 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.99 177.84 8.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.567 1.175 . . . . 0.0 113.904 -170.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -139.79 153.9 47.24 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.888 -1.132 . . . . 0.0 112.606 172.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.09 141.32 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.711 0.767 . . . . 0.0 110.201 172.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 t -113.81 -40.2 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.786 1.634 . . . . 0.0 111.107 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -144.81 148.89 34.57 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.345 1.458 . . . . 0.0 110.674 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.88 10.11 21.54 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.579 1.085 . . . . 0.0 114.899 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -38.2 72.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.85 1.325 . . . . 0.0 112.433 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -61.69 -30.91 71.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.961 0.904 . . . . 0.0 112.107 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.1 t -77.52 -43.71 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.496 1.518 . . . . 0.0 110.283 175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.59 -38.16 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.291 -0.881 . . . . 0.0 111.099 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -74.43 -19.74 60.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.173 1.389 . . . . 0.0 113.044 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -86.19 -39.11 16.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.745 1.618 . . . . 0.0 111.669 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.474 HD11 ' CE1' ' A' ' 8' ' ' HIS . 66.0 mt -53.13 -36.02 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.622 1.569 . . . . 0.0 112.09 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -84.61 -17.71 37.81 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.89 -20.36 16.77 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.291 1.424 . . . . 0.0 114.296 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 5.7 m -71.23 -59.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.614 1.207 . . . . 0.0 113.155 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -168.98 148.21 4.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.472 1.109 . . . . 0.0 112.359 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.4 p -138.03 151.11 47.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.214 1.406 . . . . 0.0 111.861 173.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.2 131.38 1.74 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.163 0.411 . . . . 0.0 112.639 169.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -63.84 149.98 45.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.345 1.058 . . . . 0.0 113.494 -174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.5 t -113.04 160.82 17.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.342 1.857 . . . . 0.0 110.905 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.08 -23.32 71.24 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 113.818 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.2 tpt -87.55 -42.58 12.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.09 0.945 . . . . 0.0 112.57 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -141.28 132.35 26.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.085 1.754 . . . . 0.0 110.863 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -87.02 160.41 18.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.687 0.795 . . . . 0.0 111.714 171.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 57.39 62.05 2.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.177 . . . . 0.0 112.724 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 m -127.63 154.18 77.69 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 125.76 1.624 . . . . 0.0 111.749 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.84 134.55 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 121.386 1.391 . . . . 0.0 108.932 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -27.95 51.43 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -83.3 157.7 22.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.582 1.153 . . . . 0.0 110.369 169.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.13 111.48 18.29 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.135 -0.978 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -108.67 94.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.646 1.578 . . . . 0.0 107.071 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.481 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -127.42 143.9 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -169.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.1 mt -86.43 103.98 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 126.815 2.046 . . . . 0.0 106.728 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.76 -41.77 61.99 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.673 -0.642 . . . . 0.0 110.863 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.5 t -150.2 165.82 31.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.78 142.46 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.112 1.765 . . . . 0.0 111.178 -175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.2 m -135.21 128.58 32.24 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.89 1.276 . . . . 0.0 110.245 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.73 122.92 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -113.59 150.4 33.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.137 1.375 . . . . 0.0 112.275 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.061 1.344 . . . . 0.0 113.622 -170.803 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.502 2.153 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.94 127.53 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.909 0.884 . . . . 0.0 109.364 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.4 m -102.31 124.17 47.41 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.815 1.246 . . . . 0.0 109.901 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -101.46 125.3 48.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.588 1.155 . . . . 0.0 110.474 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -96.9 94.47 7.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 172.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -96.67 152.33 18.76 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.833 -0.542 . . . . 0.0 110.765 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -59.35 -14.34 11.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -97.96 -13.57 21.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.739 1.215 . . . . 0.0 113.655 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.93 167.74 14.94 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 123.242 1.468 . . . . 0.0 113.125 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.91 136.9 38.84 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 125.341 1.457 . . . . 0.0 112.835 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.2 mt -133.97 139.3 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.663 1.985 . . . . 0.0 108.643 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.1 t -123.56 134.93 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.594 1.158 . . . . 0.0 110.385 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -121.0 139.0 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.655 1.982 . . . . 0.0 110.094 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -103.79 125.78 50.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.56 1.944 . . . . 0.0 108.823 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -87.77 147.24 25.27 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.407 1.083 . . . . 0.0 111.361 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.52 74.41 1.25 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.692 1.234 . . . . 0.0 111.251 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.71 -25.9 64.09 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 124.607 1.163 . . . . 0.0 112.674 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.33 -28.01 56.72 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.559 1.144 . . . . 0.0 111.346 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -96.82 -30.6 13.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 112.725 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.61 58.59 3.38 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.761 0.824 . . . . 0.0 113.194 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -60.53 -42.71 38.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.583 2.855 . . . . 0.0 112.928 -174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -69.37 -41.43 76.54 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.655 0.661 . . . . 0.0 110.793 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.1 m -62.23 -49.86 74.05 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.393 0.677 . . . . 0.0 111.481 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -42.64 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.447 0.699 . . . . 0.0 111.401 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.2 -44.59 88.19 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.646 1.112 . . . . 0.0 111.567 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -65.45 -42.28 92.51 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.305 1.042 . . . . 0.0 111.868 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -60.9 -48.55 81.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.182 0.993 . . . . 0.0 111.731 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -38.49 81.49 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.91 0.884 . . . . 0.0 111.675 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -56.3 -36.24 68.43 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.172 0.989 . . . . 0.0 112.094 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -75.51 -43.56 48.35 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.526 -0.734 . . . . 0.0 112.626 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 73.7 m -61.69 -36.82 81.97 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.61 -0.681 . . . . 0.0 111.877 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.29 71.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.135 1.774 . . . . 0.0 112.824 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -83.42 -15.48 49.54 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.337 1.055 . . . . 0.0 113.378 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.66 51.57 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 123.524 0.583 . . . . 0.0 113.849 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -73.02 -18.11 61.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.117 1.459 . . . . 0.0 114.688 -174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -100.83 -5.2 26.54 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.143 -0.973 . . . . 0.0 112.273 169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -69.58 130.66 43.05 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.913 -1.117 . . . . 0.0 108.484 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t30 57.08 46.2 19.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.252 1.421 . . . . 0.0 113.698 -169.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -116.23 153.26 32.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.809 0.844 . . . . 0.0 112.449 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -104.93 163.44 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -95.7 94.81 7.92 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -89.08 -2.16 58.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 -168.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -138.99 139.85 38.02 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 121.114 1.779 . . . . 0.0 112.304 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 132.0 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 126.624 1.97 . . . . 0.0 111.019 169.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.06 129.46 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.058 1.743 . . . . 0.0 108.027 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.71 133.41 55.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.387 0.675 . . . . 0.0 111.574 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.78 10.29 64.02 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -141.34 -177.34 5.09 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.008 1.723 . . . . 0.0 111.266 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -89.4 -178.9 5.72 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -169.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.6 pt -116.93 137.2 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.143 1.377 . . . . 0.0 112.275 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -109.15 149.29 29.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.685 1.194 . . . . 0.0 110.625 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.25 174.21 34.1 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 122.473 1.041 . . . . 0.0 115.381 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.72 0.74 75.3 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.932 1.253 . . . . 0.0 115.253 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.32 -19.27 62.74 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 119.255 1.527 . . . . 0.0 115.678 -172.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -147.87 165.29 31.08 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.508 1.123 . . . . 0.0 113.193 -175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.69 163.88 28.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.19 1.396 . . . . 0.0 109.926 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -60.29 -15.63 36.09 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.551 2.834 . . . . 0.0 118.325 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.27 19.79 53.08 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.179 0.895 . . . . 0.0 114.558 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.05 32.35 19.8 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.92 126.7 35.2 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.321 1.448 . . . . 0.0 109.162 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -73.16 127.98 34.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.717 0.807 . . . . 0.0 110.829 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -72.69 165.52 24.62 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.268 170.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.52 74.48 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.736 1.614 . . . . 0.0 111.088 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.7 p -73.0 140.76 47.55 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.596 1.158 . . . . 0.0 112.703 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -141.76 178.06 7.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.991 2.116 . . . . 0.0 111.887 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 51.68 65.17 6.76 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 125.784 1.634 . . . . 0.0 114.346 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -57.12 133.26 56.54 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.316 2.677 . . . . 0.0 111.575 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.16 150.87 7.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 126.101 1.76 . . . . 0.0 108.72 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 157.85 23.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 169.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -76.52 126.14 30.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.597 -175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -108.18 14.39 25.06 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.233 1.413 . . . . 0.0 112.915 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -15.79 62.73 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.325 -1.485 . . . . 0.0 114.111 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -60.94 0.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.123 1.769 . . . . 0.0 115.77 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -79.39 -3.87 48.41 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.883 1.273 . . . . 0.0 112.126 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.39 31.55 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.891 1.234 . . . . 0.0 114.619 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.3 mt -80.43 159.3 25.69 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -131.43 156.34 45.76 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -103.82 115.41 30.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.232 2.213 . . . . 0.0 110.302 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -139.94 167.91 21.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.685 1.194 . . . . 0.0 111.442 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -51.72 119.79 4.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.388 1.475 . . . . 0.0 110.715 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.16 28.87 21.69 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.922 1.249 . . . . 0.0 114.977 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 70.4 p -122.58 158.94 28.82 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.169 1.484 . . . . 0.0 112.897 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.69 139.28 53.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.681 0.753 . . . . 0.0 112.756 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.49 159.7 41.2 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.738 170.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -80.28 141.21 35.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.101 0.56 . . . . 0.0 111.641 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 154.18 19.71 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.27 0.628 . . . . 0.0 111.516 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -141.0 158.1 44.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.292 1.437 . . . . 0.0 112.713 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 m -72.25 -55.5 7.09 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.881 0.872 . . . . 0.0 113.006 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -159.47 -54.97 0.06 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.276 1.031 . . . . 0.0 111.57 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.71 158.84 86.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.2 1.0 . . . . 0.0 111.365 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.01 -27.69 85.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.832 2.355 . . . . 0.0 113.358 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -109.21 36.15 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.499 1.52 . . . . 0.0 112.511 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.0 p -115.58 30.56 7.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.456 1.502 . . . . 0.0 113.318 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.37 101.91 14.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.015 1.326 . . . . 0.0 110.092 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.8 p -91.52 -64.35 1.13 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.187 0.995 . . . . 0.0 113.001 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -157.81 42.37 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -133.87 153.91 51.42 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.069 -1.02 . . . . 0.0 112.955 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -145.54 168.21 21.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.749 2.02 . . . . 0.0 110.958 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 11.0 p90 -144.63 159.69 42.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.49 0.716 . . . . 0.0 111.208 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.6 mt -113.0 118.07 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.19 108.22 6.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.192 0.597 . . . . 0.0 109.798 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.94 -14.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 m -124.35 168.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 127.376 2.271 . . . . 0.0 111.226 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.69 119.24 24.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.469 0.708 . . . . 0.0 109.525 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -141.07 77.17 1.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.975 1.369 . . . . 0.0 113.15 -169.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.24 -34.73 61.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.024 2.13 . . . . 0.0 114.514 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -61.79 -12.7 18.35 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.3 mt -84.09 -10.64 57.66 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.41 178.14 6.12 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -169.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -83.94 142.38 30.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.971 1.308 . . . . 0.0 111.814 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -111.35 -58.74 2.07 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.599 1.159 . . . . 0.0 113.42 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 163.45 67.87 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.241 0.924 . . . . 0.0 113.346 -173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 54.23 25.51 5.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.107 1.763 . . . . 0.0 114.801 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.3 m -111.93 117.72 33.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.702 1.201 . . . . 0.0 110.752 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.2 -37.19 54.17 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -78.05 -14.3 59.55 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.74 -72.76 1.21 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.509 2.48 . . . . 0.0 114.261 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.306 6.6 p-90 -71.15 127.23 31.88 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -169.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -89.2 -86.9 1.26 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.362 1.458 . . . . 0.0 115.758 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -139.54 149.94 44.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.883 1.273 . . . . 0.0 111.796 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.9 t -81.27 119.53 23.76 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.732 -0.605 . . . . 0.0 112.408 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.44 84.57 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -77.06 -14.81 59.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.64 0.776 . . . . 0.0 111.942 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 177.42 8.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 122.622 1.201 . . . . 0.0 113.783 -170.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -140.64 154.56 46.47 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.768 -1.208 . . . . 0.0 112.333 174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.48 140.24 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.64 0.733 . . . . 0.0 110.084 170.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 t -111.97 -42.57 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 111.008 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -144.5 153.54 41.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.502 1.521 . . . . 0.0 109.93 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 103.47 15.03 24.19 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 123.878 0.751 . . . . 0.0 114.289 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.1 68.54 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.028 1.414 . . . . 0.0 112.263 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -65.74 -30.07 70.68 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.746 0.818 . . . . 0.0 112.466 175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.49 -43.13 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.8 1.24 . . . . 0.0 110.092 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.25 -40.31 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.816 0.846 . . . . 0.0 111.332 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.83 -27.29 62.81 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.93 1.292 . . . . 0.0 112.367 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -78.13 -42.27 32.36 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.463 1.105 . . . . 0.0 111.205 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.11 -30.14 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.935 1.694 . . . . 0.0 112.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -91.82 -20.11 21.83 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.78 -17.53 27.88 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.498 1.523 . . . . 0.0 114.738 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.44 -51.71 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 118.887 1.344 . . . . 0.0 112.722 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -169.97 155.77 5.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.189 1.396 . . . . 0.0 111.73 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.8 p -135.87 150.96 49.56 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 0.0 112.312 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.48 128.4 1.03 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.032 0.348 . . . . 0.0 112.819 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -67.17 147.25 53.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 0.0 113.228 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -99.28 157.47 16.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.074 1.75 . . . . 0.0 110.875 174.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -66.96 -18.99 69.38 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 121.586 -0.697 . . . . 0.0 113.917 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mmt -100.77 -31.68 11.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.86 1.264 . . . . 0.0 113.127 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -140.72 124.96 17.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.171 1.388 . . . . 0.0 110.709 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.39 160.13 14.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.485 0.714 . . . . 0.0 112.718 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.32 52.76 8.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.345 1.458 . . . . 0.0 113.205 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.24 151.37 53.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.129 1.372 . . . . 0.0 112.002 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.2 135.03 24.1 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.766 1.644 . . . . 0.0 109.375 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -24.98 39.83 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.28 150.24 35.32 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.431 1.092 . . . . 0.0 110.738 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.19 116.94 21.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.798 0.839 . . . . 0.0 111.249 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.03 110.36 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.573 1.149 . . . . 0.0 108.579 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.08 152.89 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.415 1.486 . . . . 0.0 110.871 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.96 103.25 14.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 169.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -81.4 -25.02 36.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.691 0.797 . . . . 0.0 112.113 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -154.35 161.76 41.56 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.513 0.725 . . . . 0.0 112.714 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 44.5 t -134.41 139.2 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.696 1.598 . . . . 0.0 110.157 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.8 m -136.54 131.01 33.3 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.739 1.216 . . . . 0.0 110.588 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.85 122.95 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.0 t -119.31 150.25 40.44 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.079 1.352 . . . . 0.0 112.277 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.294 1.438 . . . . 0.0 113.753 -170.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.501 2.098 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 131.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.989 -1.694 . . . . 0.0 111.514 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.0 m -102.32 123.93 46.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.022 0.929 . . . . 0.0 110.091 169.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -98.98 132.83 44.0 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.95 1.3 . . . . 0.0 110.677 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -104.83 98.89 8.56 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -104.6 152.51 22.36 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.962 -0.461 . . . . 0.0 110.835 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.448 HD22 HG12 ' A' ' 156' ' ' ILE . 0.2 OUTLIER -59.44 -20.43 55.02 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -89.8 -15.92 31.29 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.845 1.258 . . . . 0.0 113.187 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.06 165.3 12.44 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.741 1.639 . . . . 0.0 113.191 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -72.98 137.69 45.61 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.519 1.528 . . . . 0.0 112.534 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.7 mt -134.47 140.71 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.256 1.822 . . . . 0.0 108.764 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.31 132.62 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 110.479 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.92 135.75 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.68 1.992 . . . . 0.0 110.04 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -98.19 130.46 44.93 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.928 1.691 . . . . 0.0 107.224 171.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -92.13 146.57 23.62 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.22 1.008 . . . . 0.0 110.505 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -102.14 73.9 1.4 Allowed 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.843 1.306 . . . . 0.0 111.006 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.97 -25.5 64.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.209 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -75.91 -30.13 58.65 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.77 1.228 . . . . 0.0 111.508 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.08 -27.54 15.04 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.861 1.264 . . . . 0.0 112.801 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.25 58.13 3.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -61.11 -42.64 34.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.519 2.813 . . . . 0.0 113.146 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -69.16 -40.55 78.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.49 0.586 . . . . 0.0 110.585 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.8 m -61.05 -53.57 55.58 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.541 0.736 . . . . 0.0 111.845 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.1 -41.73 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 118.624 -0.703 . . . . 0.0 110.839 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -54.14 -49.22 69.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.918 1.236 . . . . 0.0 111.969 174.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.52 -38.88 81.28 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.376 0.67 . . . . 0.0 111.935 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.67 -49.52 77.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 0.0 111.767 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.58 -34.31 67.36 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.56 0.744 . . . . 0.0 111.811 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -57.78 -33.45 68.54 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.69 0.796 . . . . 0.0 112.556 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -75.4 -44.21 45.9 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.437 -0.79 . . . . 0.0 112.333 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 86.5 m -61.2 -35.81 78.17 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.6 -0.688 . . . . 0.0 111.765 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -63.84 -34.54 78.15 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.353 2.261 . . . . 0.0 112.789 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -82.11 -14.12 56.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.882 0.873 . . . . 0.0 113.152 171.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.7 18.58 61.45 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.562 1.077 . . . . 0.0 113.814 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -65.55 -24.04 67.01 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.72 1.26 . . . . 0.0 114.19 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -89.21 -7.7 55.02 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.304 0.642 . . . . 0.0 112.687 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -64.36 135.67 56.38 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.938 -1.101 . . . . 0.0 108.793 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.4 t30 60.25 22.98 12.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.5 p -88.73 162.48 16.23 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.116 -0.99 . . . . 0.0 111.392 169.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.44 HG22 HG22 ' A' ' 156' ' ' ILE . 9.0 pt -122.38 164.76 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -169.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -97.99 96.75 8.37 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -90.24 -8.27 51.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 -169.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -134.37 138.49 44.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.37 1.441 . . . . 0.0 113.471 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.48 134.37 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 127.961 2.505 . . . . 0.0 109.272 169.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 90.1 mt -138.07 129.28 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.733 1.613 . . . . 0.0 108.029 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -61.63 132.77 54.34 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.25 0.62 . . . . 0.0 111.849 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.01 10.17 61.28 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -142.15 -177.16 5.1 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.892 1.677 . . . . 0.0 111.314 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -178.66 6.05 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.083 1.753 . . . . 0.0 115.558 -169.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.7 pt -115.96 138.06 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.186 1.394 . . . . 0.0 112.563 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -108.68 149.35 29.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.516 1.126 . . . . 0.0 111.056 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.89 175.9 32.78 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.454 1.03 . . . . 0.0 114.965 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.1 6.78 83.6 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.627 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.71 -25.53 35.02 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 119.717 1.758 . . . . 0.0 115.71 -172.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -149.73 169.78 20.26 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.663 1.185 . . . . 0.0 113.054 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.46 164.47 16.58 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.892 1.677 . . . . 0.0 110.064 168.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.87 -12.88 33.98 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.877 3.051 . . . . 0.0 117.437 -169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.19 14.65 61.71 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.786 0.708 . . . . 0.0 114.449 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.0 mmt 59.71 29.77 19.34 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.396 1.878 . . . . 0.0 112.879 -172.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -84.03 125.49 32.14 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.961 1.304 . . . . 0.0 109.367 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -71.57 121.94 19.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.412 1.085 . . . . 0.0 110.231 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -66.68 159.2 28.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.35 73.38 8.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.409 1.483 . . . . 0.0 111.57 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.3 p -68.03 121.27 15.74 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.507 1.123 . . . . 0.0 112.596 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -130.93 176.66 8.05 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.098 1.759 . . . . 0.0 111.954 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 49.25 67.27 4.65 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.674 1.59 . . . . 0.0 113.99 169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -59.66 140.1 91.99 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.38 2.72 . . . . 0.0 111.765 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -111.76 152.59 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.038 1.735 . . . . 0.0 109.046 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.27 0.1 OUTLIER -76.23 158.93 31.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.237 0.615 . . . . 0.0 110.355 169.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -57.27 -56.58 20.0 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -168.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 70.95 3.68 4.74 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.46 -15.09 63.07 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 119.919 -1.738 . . . . 0.0 114.126 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -59.94 3.8 0.06 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 128.118 2.567 . . . . 0.0 116.151 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -84.22 5.72 25.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.421 1.489 . . . . 0.0 112.257 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.71 32.71 32.6 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.816 1.198 . . . . 0.0 113.299 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.11 140.56 39.05 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 112.417 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -131.69 147.74 52.53 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -99.13 85.87 3.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.409 2.284 . . . . 0.0 111.642 -169.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.5 p -112.57 168.32 9.75 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.506 0.723 . . . . 0.0 112.109 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -55.89 130.16 42.5 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.667 1.187 . . . . 0.0 111.019 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.24 35.41 33.95 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.179 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 47.9 p -125.92 161.91 26.39 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.78 1.29 . . . . 0.0 113.354 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 mp -120.49 136.09 54.87 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.792 0.837 . . . . 0.0 112.896 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -132.09 159.19 39.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.468 170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -84.64 141.12 30.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.62 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.31 154.02 19.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.467 0.707 . . . . 0.0 111.112 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.1 ptt85 -133.39 162.92 30.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.827 1.251 . . . . 0.0 113.572 -171.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.8 m -76.95 -56.23 4.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.617 1.167 . . . . 0.0 113.109 -169.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -159.09 -54.85 0.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.543 1.137 . . . . 0.0 111.76 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.28 161.82 71.45 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.509 1.124 . . . . 0.0 111.53 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.31 -20.14 69.78 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.147 2.565 . . . . 0.0 114.071 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -116.28 42.13 2.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.356 1.862 . . . . 0.0 111.983 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.5 p -125.79 30.79 5.63 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.186 1.394 . . . . 0.0 113.638 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.0 104.48 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.816 1.647 . . . . 0.0 109.527 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.2 p -89.73 -72.73 0.54 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.455 1.102 . . . . 0.0 113.204 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.27 36.43 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -169.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -127.32 149.8 49.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.03 1.332 . . . . 0.0 111.621 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -146.18 168.41 21.06 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.476 1.511 . . . . 0.0 111.673 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 14.7 p90 -146.37 162.1 38.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 30.4 mt -115.01 116.03 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.539 1.136 . . . . 0.0 108.181 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -71.31 99.09 1.87 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.72 0.808 . . . . 0.0 109.772 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.4 m -77.83 -16.36 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 113.212 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.55 166.28 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 128.292 2.637 . . . . 0.0 110.968 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.0 119.66 19.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.226 0.536 . . . . 0.0 111.331 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -126.85 55.37 1.56 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.015 1.726 . . . . 0.0 111.641 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.56 -12.14 50.37 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -69.51 -14.92 63.12 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.819 -1.176 . . . . 0.0 113.349 169.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.37 -14.91 56.69 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -66.79 172.48 4.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 127.071 2.148 . . . . 0.0 116.595 -169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -70.05 155.81 40.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.871 1.268 . . . . 0.0 112.402 169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.7 t -140.92 -53.78 0.48 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.71 56.29 0.05 OUTLIER Glycine 0 N--CA 1.474 1.181 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.17 23.63 12.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.106 1.362 . . . . 0.0 114.617 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -123.85 140.58 52.84 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.414 1.486 . . . . 0.0 112.963 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.89 -39.56 81.8 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.467 1.107 . . . . 0.0 112.891 -169.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.98 -17.43 64.67 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.63 -90.3 1.51 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.191 2.329 . . . . 0.0 112.859 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.252 0.4 OUTLIER -71.49 128.11 34.77 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -115.54 -71.37 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.991 1.282 . . . . 0.0 114.048 -174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -133.73 131.85 39.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.939 0.896 . . . . 0.0 111.899 -169.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 46.3 t -93.04 126.16 37.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.425 0.69 . . . . 0.0 112.523 -172.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.82 89.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.189 0.995 . . . . 0.0 109.225 173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -75.23 -15.18 60.56 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.354 1.062 . . . . 0.0 112.015 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.66 176.36 10.42 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.315 1.055 . . . . 0.0 113.828 -170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -140.37 151.19 44.78 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 112.264 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -80.04 133.6 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.575 0.702 . . . . 0.0 110.349 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 t -106.67 -43.4 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.339 1.856 . . . . 0.0 110.812 -174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -143.07 154.77 44.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.546 1.538 . . . . 0.0 109.964 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.75 14.92 33.05 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.787 0.708 . . . . 0.0 114.478 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 81.9 mmm -54.89 -36.11 64.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.27 1.535 . . . . 0.0 112.275 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -65.36 -30.48 71.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.849 0.86 . . . . 0.0 112.612 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.49 -40.77 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.978 1.311 . . . . 0.0 110.377 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.65 -42.56 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 121.272 -0.892 . . . . 0.0 110.93 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.08 -25.08 63.36 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.314 1.445 . . . . 0.0 112.22 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -75.76 -52.19 11.0 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.049 0.94 . . . . 0.0 110.398 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 53.6 mt -53.01 -36.41 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.364 1.865 . . . . 0.0 112.686 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.02 -14.44 31.4 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.88 -18.23 11.83 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.828 1.68 . . . . 0.0 113.882 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.31 -59.41 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 118.412 1.106 . . . . 0.0 113.051 -174.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -172.56 162.39 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.768 1.227 . . . . 0.0 112.677 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.0 p -136.07 151.4 49.8 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.496 1.518 . . . . 0.0 112.389 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.43 133.71 1.64 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.146 0.403 . . . . 0.0 113.436 170.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.92 151.91 33.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.874 1.269 . . . . 0.0 113.111 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.2 p -115.29 168.75 9.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.073 1.349 . . . . 0.0 112.239 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.82 -21.27 74.99 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 121.714 -0.616 . . . . 0.0 114.576 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.18 -38.18 9.01 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.67 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -139.13 126.96 22.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.086 1.754 . . . . 0.0 110.541 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -85.28 160.42 19.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.354 0.662 . . . . 0.0 110.971 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.55 58.85 2.77 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.025 1.33 . . . . 0.0 113.581 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.93 157.8 77.45 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 126.271 1.828 . . . . 0.0 111.835 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -69.95 138.64 37.68 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.14 1.893 . . . . 0.0 109.852 169.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -31.18 38.0 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -79.17 149.42 31.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.83 0.852 . . . . 0.0 111.398 169.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.0 114.38 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.495 1.118 . . . . 0.0 111.229 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.24 105.67 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 108.402 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 7' ' ' ASN . 1.4 pt -128.12 143.82 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.558 0.743 . . . . 0.0 111.565 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.16 103.34 11.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -73.17 -36.66 66.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.294 0.637 . . . . 0.0 110.476 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 t -153.92 166.0 34.35 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.21 141.38 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.642 1.977 . . . . 0.0 110.58 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 125.09 30.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.184 1.394 . . . . 0.0 109.909 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.67 125.47 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.205 0.602 . . . . 0.0 109.878 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.2 t -111.49 150.77 29.45 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.33 1.452 . . . . 0.0 112.138 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.676 1.19 . . . . 0.0 113.241 -172.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.502 2.162 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.15 130.75 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.045 0.938 . . . . 0.0 109.265 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.6 m -106.19 121.69 44.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.795 1.238 . . . . 0.0 110.148 177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.68 135.61 33.94 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.495 1.118 . . . . 0.0 110.72 169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -107.25 101.1 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -103.92 152.75 21.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.895 -0.503 . . . . 0.0 111.016 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -60.1 -7.49 1.87 Allowed 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -109.31 -8.04 15.15 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.074 1.35 . . . . 0.0 114.215 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.52 165.89 12.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.374 1.464 . . . . 0.0 113.742 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.78 138.82 39.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.364 1.866 . . . . 0.0 112.838 174.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -135.4 140.9 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.303 1.841 . . . . 0.0 109.066 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.04 136.87 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.553 1.141 . . . . 0.0 110.562 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -125.22 139.43 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.73 2.012 . . . . 0.0 110.465 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -101.81 126.91 48.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.862 2.065 . . . . 0.0 107.659 171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 p -88.62 147.58 24.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.171 0.989 . . . . 0.0 111.085 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -103.02 74.33 1.3 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.688 1.232 . . . . 0.0 111.156 176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.74 -26.92 64.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.547 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -75.73 -30.87 59.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.291 1.036 . . . . 0.0 111.437 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -95.98 -28.7 14.53 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 113.011 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.8 56.99 3.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -60.1 -43.63 34.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 112.758 -174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -68.08 -40.17 82.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.756 0.707 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 68' ' ' ILE . 26.6 m -65.14 -48.12 74.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.569 0.748 . . . . 0.0 111.6 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -68.38 -39.51 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.921 0.888 . . . . 0.0 112.103 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.16 -47.16 75.53 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.677 1.126 . . . . 0.0 111.816 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.443 HD22 HD11 ' A' ' 68' ' ' ILE . 64.1 t30 -69.3 -38.66 78.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.339 0.655 . . . . 0.0 111.88 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -59.09 -47.6 84.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 0.0 111.539 173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.56 -38.57 74.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.25 0.62 . . . . 0.0 111.374 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -63.14 -29.66 70.97 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -73.62 -42.84 60.95 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.302 -0.874 . . . . 0.0 111.967 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 78.5 m -62.16 -37.61 85.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.541 -0.725 . . . . 0.0 111.463 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -58.42 -37.87 76.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.468 2.307 . . . . 0.0 113.438 172.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -81.73 -15.0 55.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.707 1.203 . . . . 0.0 113.531 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.54 14.8 61.03 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.872 1.225 . . . . 0.0 114.362 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -69.58 -17.72 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.542 1.537 . . . . 0.0 114.963 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -97.92 -13.03 21.42 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 171.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.55 1.23 8.53 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -147.19 53.59 1.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.206 1.402 . . . . 0.0 110.606 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.4 p -114.36 171.94 7.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.185 0.994 . . . . 0.0 113.121 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 156' ' ' ILE . 12.9 pt -127.65 166.95 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -98.93 110.44 23.05 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -109.15 0.81 19.97 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -152.66 129.94 11.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 120.53 1.513 . . . . 0.0 111.591 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 p -143.66 141.21 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.664 1.986 . . . . 0.0 111.168 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.61 127.62 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.142 1.377 . . . . 0.0 108.66 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -64.63 132.88 50.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 0.0 111.659 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.13 10.74 66.01 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.01 0.814 . . . . 0.0 114.908 -173.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -144.56 -174.84 4.43 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.82 2.048 . . . . 0.0 110.412 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.58 -179.93 7.46 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.7 pt -123.34 142.73 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.169 1.387 . . . . 0.0 113.8 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -122.79 147.81 46.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.826 1.65 . . . . 0.0 112.363 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.68 -175.74 32.02 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 115.497 0.959 . . . . 0.0 115.497 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.85 -3.73 73.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.148 1.832 . . . . 0.0 115.641 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.86 -16.05 60.33 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 -169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -142.79 164.87 28.93 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.583 1.192 . . . . 0.0 112.705 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -94.92 161.94 26.76 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.926 1.691 . . . . 0.0 110.806 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -60.75 -8.84 10.12 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.007 3.138 . . . . 0.0 117.613 -175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.68 12.96 67.08 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.151 0.882 . . . . 0.0 115.039 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mmt 59.68 29.12 18.67 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.282 1.833 . . . . 0.0 112.822 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.01 131.22 34.15 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.303 1.441 . . . . 0.0 109.403 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -73.53 121.02 19.93 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.094 0.958 . . . . 0.0 110.339 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -72.34 164.77 25.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.86 71.85 7.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.513 1.525 . . . . 0.0 111.332 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 p -70.86 107.92 4.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 111.824 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -111.28 175.98 5.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.454 1.902 . . . . 0.0 111.808 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.08 65.8 5.46 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.464 1.505 . . . . 0.0 113.576 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -58.03 132.12 47.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.998 2.465 . . . . 0.0 110.364 169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 23' ' ' THR . 1.2 mt -114.85 147.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.607 1.163 . . . . 0.0 109.656 -173.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 155.31 29.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.991 0.917 . . . . 0.0 112.145 172.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -75.14 129.56 37.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.987 0.915 . . . . 0.0 110.828 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -112.29 14.33 20.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.207 1.403 . . . . 0.0 113.124 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.99 -15.45 59.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.247 -1.533 . . . . 0.0 113.477 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -59.25 -0.97 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -80.39 -3.03 48.11 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.117 1.367 . . . . 0.0 112.095 169.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.8 27.19 27.31 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.099 1.333 . . . . 0.0 114.495 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.61 158.57 28.42 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.962 0.881 . . . . 0.0 112.999 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -130.58 159.24 37.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.684 1.194 . . . . 0.0 114.024 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -106.9 115.15 29.69 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.068 2.147 . . . . 0.0 109.927 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 68.3 p -140.95 168.41 19.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.81 1.244 . . . . 0.0 111.241 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -54.49 125.15 18.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.117 0.967 . . . . 0.0 110.91 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.84 31.97 25.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.26 1.41 . . . . 0.0 115.075 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.1 p -123.79 159.77 28.78 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.31 1.555 . . . . 0.0 113.342 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -123.68 138.47 54.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.744 0.818 . . . . 0.0 113.191 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.9 157.78 46.0 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.823 -0.548 . . . . 0.0 112.184 169.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 98.0 mmm -79.6 136.17 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.865 0.466 . . . . 0.0 110.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.58 142.19 27.9 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.798 0.839 . . . . 0.0 110.749 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -85.83 154.03 21.84 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.413 1.085 . . . . 0.0 112.677 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -70.14 -51.99 27.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.801 0.841 . . . . 0.0 110.178 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -157.56 -57.96 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.424 1.489 . . . . 0.0 110.451 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.41 154.73 83.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.18 0.992 . . . . 0.0 111.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.69 -19.27 64.53 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.93 2.42 . . . . 0.0 114.45 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -112.69 38.21 2.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.845 1.658 . . . . 0.0 112.332 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.0 p -122.17 30.26 6.66 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.319 1.447 . . . . 0.0 113.35 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.08 61.55 4.69 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.446 1.499 . . . . 0.0 113.035 -172.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -58.82 -65.33 0.68 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.904 1.681 . . . . 0.0 113.946 -169.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -150.83 0.55 0.41 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -169.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.7 146.43 24.52 Favored 'General case' 0 N--CA 1.462 0.175 0 O-C-N 120.515 -1.366 . . . . 0.0 110.51 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -141.14 168.28 20.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.758 1.623 . . . . 0.0 110.479 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.1 p90 -145.33 159.27 43.31 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.103 0.561 . . . . 0.0 111.87 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.1 mt -117.82 119.49 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.101 1.36 . . . . 0.0 108.267 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -78.28 119.74 22.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.55 0.74 . . . . 0.0 110.774 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 30.9 m -98.74 -8.13 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.9 164.51 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.689 1.596 . . . . 0.0 111.32 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -80.8 119.1 22.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.996 0.518 . . . . 0.0 109.993 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -137.58 70.67 1.4 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.955 1.359 . . . . 0.0 112.149 -169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.57 -35.79 54.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.251 2.22 . . . . 0.0 114.404 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -59.72 -14.24 13.41 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.9 mt -82.27 -13.33 57.19 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -73.6 169.83 16.45 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.25 145.63 55.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.625 0.77 . . . . 0.0 112.981 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.0 p -115.05 -59.54 2.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.522 1.529 . . . . 0.0 113.09 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.44 55.83 0.01 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.32 1.438 . . . . 0.0 112.077 -171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 59.14 26.75 15.55 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.81 1.644 . . . . 0.0 114.474 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.9 p -107.93 125.34 51.38 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.0 tp -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -78.51 -10.33 59.67 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.39 -96.91 1.93 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 127.366 2.412 . . . . 0.0 112.423 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -60.56 125.45 23.73 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -105.58 -58.94 0.64 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 116.559 1.383 . . . . 0.0 116.559 -169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -141.65 151.11 42.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.365 1.066 . . . . 0.0 112.215 -168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 37.2 t -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.835 -0.541 . . . . 0.0 112.456 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.3 83.38 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.766 1.226 . . . . 0.0 108.594 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -77.6 -14.03 59.75 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.021 0.928 . . . . 0.0 112.129 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.45 177.83 7.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.771 1.272 . . . . 0.0 114.343 -169.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -141.43 153.63 45.12 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.65 1.18 . . . . 0.0 112.417 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 143.7 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.688 0.756 . . . . 0.0 110.323 173.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 20.5 t -116.45 -41.42 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.736 1.614 . . . . 0.0 110.936 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -147.03 154.52 41.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.678 1.591 . . . . 0.0 110.108 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.25 14.21 24.79 Favored Glycine 0 N--CA 1.471 0.978 0 C-N-CA 123.866 0.746 . . . . 0.0 114.603 172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.95 -34.62 63.41 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.055 1.427 . . . . 0.0 112.305 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.15 -30.02 71.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.687 0.795 . . . . 0.0 112.577 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.2 t -75.97 -43.22 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.052 1.341 . . . . 0.0 110.271 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.62 -38.42 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.362 -0.836 . . . . 0.0 110.973 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -72.85 -26.42 61.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.339 1.456 . . . . 0.0 112.6 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -76.91 -42.27 40.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.724 1.21 . . . . 0.0 110.821 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.6 mt -57.61 -29.26 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.568 1.547 . . . . 0.0 112.782 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -89.82 -14.04 35.3 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.384 1.254 . . . . 0.0 114.384 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.15 -14.0 17.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.745 1.64 . . . . 0.0 114.627 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 -57.74 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 118.778 1.289 . . . . 0.0 112.445 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.61 144.95 0.89 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.7 1.6 . . . . 0.0 111.157 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -129.05 150.07 50.6 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.043 1.337 . . . . 0.0 112.946 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 174.99 130.57 1.32 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.343 0.973 . . . . 0.0 112.256 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -66.74 150.15 49.51 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.6 t -115.8 166.85 11.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.554 1.942 . . . . 0.0 111.451 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.0 -30.84 72.13 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 114.285 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.4 mmt -95.11 -28.03 15.28 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -140.92 129.14 22.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.786 1.634 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -95.92 154.73 17.08 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.681 0.792 . . . . 0.0 112.627 177.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 49.86 75.1 0.18 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.627 2.371 . . . . 0.0 112.219 -174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.7 m -128.67 152.18 78.25 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.06 1.344 . . . . 0.0 110.912 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.47 129.29 18.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.245 1.296 . . . . 0.0 108.897 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -25.21 32.31 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.709 0.403 . . . . 0.0 111.857 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -76.9 146.7 37.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.004 0.922 . . . . 0.0 109.155 168.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.32 109.99 16.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.403 0.621 . . . . 0.0 111.326 -171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.88 109.1 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.218 1.007 . . . . 0.0 108.589 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.417 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -130.9 142.92 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -172.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -84.01 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -76.95 -27.07 54.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.801 1.24 . . . . 0.0 111.794 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.4 t -163.17 168.66 20.46 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.67 140.52 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.276 1.831 . . . . 0.0 110.488 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 m -131.53 133.12 44.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.355 1.462 . . . . 0.0 110.001 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.69 123.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.4 t -118.21 150.35 39.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.254 1.421 . . . . 0.0 112.533 -173.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.542 1.537 . . . . 0.0 113.649 -170.029 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.502 2.161 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.04 128.28 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 119.921 1.237 . . . . 0.0 110.387 174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.7 m -99.9 126.53 46.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.514 1.125 . . . . 0.0 110.262 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -102.52 127.62 49.51 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.091 1.356 . . . . 0.0 110.29 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -101.16 99.43 9.84 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 p -103.77 152.27 22.06 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.842 -0.536 . . . . 0.0 111.293 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -60.39 -9.52 3.68 Favored 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -106.99 -9.56 16.2 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.805 1.242 . . . . 0.0 114.189 170.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.02 163.23 11.55 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.046 1.359 . . . . 0.0 113.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.28 138.18 43.42 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.636 1.574 . . . . 0.0 112.736 173.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.18 139.85 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.521 1.928 . . . . 0.0 108.43 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.63 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 110.352 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -125.03 134.11 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.357 1.863 . . . . 0.0 110.04 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.14 127.75 47.55 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.896 1.678 . . . . 0.0 108.605 174.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 p -88.92 146.48 24.89 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -104.31 73.94 1.15 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.701 1.239 . . . . 0.0 111.434 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.19 -25.06 64.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.503 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 -24.04 46.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.593 1.157 . . . . 0.0 111.873 174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -107.4 -16.74 14.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.501 1.521 . . . . 0.0 113.29 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 50.6 0.52 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.841 1.256 . . . . 0.0 114.352 -172.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -60.22 -40.82 56.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.568 2.845 . . . . 0.0 113.859 -170.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -71.68 -35.17 70.2 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.646 -0.659 . . . . 0.0 110.851 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.4 m -70.49 -47.95 58.05 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.56 -43.5 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.089 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -58.77 -45.54 89.56 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.672 1.123 . . . . 0.0 111.619 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -64.98 -43.78 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.342 1.057 . . . . 0.0 111.937 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.51 -47.7 84.51 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.768 1.227 . . . . 0.0 111.693 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.98 -37.72 72.74 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.565 0.746 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.64 -29.49 70.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.92 0.888 . . . . 0.0 112.937 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -77.01 -43.14 35.82 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.512 -0.743 . . . . 0.0 112.536 170.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.0 m -62.09 -37.53 85.41 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.206 -0.934 . . . . 0.0 111.515 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -57.2 -37.37 72.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.127 2.571 . . . . 0.0 113.581 172.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.3 -15.25 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.766 1.226 . . . . 0.0 113.381 174.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.88 18.12 56.78 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.988 0.804 . . . . 0.0 113.935 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.2 -17.96 60.83 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -99.47 -8.37 24.76 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.147 -0.97 . . . . 0.0 112.068 169.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.35 130.24 41.43 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.01 44.37 22.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 114.226 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.9 p -109.9 167.7 9.97 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.214 1.006 . . . . 0.0 110.926 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 156' ' ' ILE . 15.0 pt -124.0 162.16 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -88.68 85.06 6.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.499 1.12 . . . . 0.0 108.033 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -74.88 -10.81 59.85 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 -169.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -146.72 138.22 24.38 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 121.237 1.835 . . . . 0.0 114.182 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.76 146.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 128.155 2.582 . . . . 0.0 110.46 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.7 mt -137.94 131.86 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.183 1.793 . . . . 0.0 107.85 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.47 137.22 57.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.553 0.741 . . . . 0.0 112.049 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 12.73 62.21 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 123.864 0.745 . . . . 0.0 114.644 -173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -142.54 -177.13 5.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.169 1.788 . . . . 0.0 111.412 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.27 -178.79 7.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.971 1.709 . . . . 0.0 114.576 -173.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.7 pt -119.49 142.62 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.417 1.087 . . . . 0.0 113.237 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -110.89 150.2 29.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.944 1.297 . . . . 0.0 111.512 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -158.78 176.13 35.7 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.35 0.57 67.05 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.085 1.802 . . . . 0.0 115.354 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.54 -16.93 65.12 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.013 1.407 . . . . 0.0 115.494 -171.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -145.38 166.4 25.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.824 1.25 . . . . 0.0 112.987 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.91 162.26 24.62 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.841 1.657 . . . . 0.0 110.493 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.96 -13.17 29.6 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.655 2.903 . . . . 0.0 117.709 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.12 16.62 60.56 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.053 0.835 . . . . 0.0 114.5 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.8 30.19 19.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 112.575 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -86.04 126.12 33.93 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.037 1.335 . . . . 0.0 109.572 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.25 119.96 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.362 1.065 . . . . 0.0 110.675 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.86 162.78 28.64 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.17 70.35 3.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.769 1.628 . . . . 0.0 111.591 -172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -73.35 142.71 47.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.927 1.291 . . . . 0.0 113.049 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -141.76 175.46 9.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.982 2.113 . . . . 0.0 111.943 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 52.55 67.87 3.57 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.689 1.595 . . . . 0.0 114.09 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -60.59 134.49 54.82 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.204 2.603 . . . . 0.0 111.51 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.1 152.13 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 125.811 1.644 . . . . 0.0 107.999 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 160.49 19.89 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.098 0.559 . . . . 0.0 111.757 170.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -75.16 132.98 41.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.164 0.586 . . . . 0.0 110.998 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -118.42 15.42 13.84 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.425 1.49 . . . . 0.0 112.674 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -15.96 46.13 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 119.957 -1.714 . . . . 0.0 114.179 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.28 4.48 0.5 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.13 1.372 . . . . 0.0 113.568 169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -75.7 -9.68 58.79 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.775 1.23 . . . . 0.0 112.898 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.62 1.67 82.89 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.754 1.645 . . . . 0.0 114.822 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -78.09 153.58 32.08 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.259 1.029 . . . . 0.0 112.13 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -130.98 150.85 51.94 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -87.97 77.66 8.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.625 1.97 . . . . 0.0 111.629 -169.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 p -110.34 168.07 9.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.196 0.998 . . . . 0.0 112.091 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -46.19 121.82 3.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 111.372 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.6 36.78 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.23 1.395 . . . . 0.0 114.823 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -118.66 157.72 26.89 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 119.121 1.46 . . . . 0.0 113.586 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -117.96 135.08 54.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 112.831 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -134.47 159.7 40.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.485 0.659 . . . . 0.0 111.962 172.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.9 ptp -70.12 145.12 51.81 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.536 0.734 . . . . 0.0 111.233 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 150.56 20.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.265 0.626 . . . . 0.0 110.066 169.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -127.68 160.5 31.45 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.519 1.127 . . . . 0.0 112.856 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.6 m -87.78 58.27 4.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.996 1.718 . . . . 0.0 110.213 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . 0.341 18.1 pt20 54.49 -38.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 130.186 3.395 . . . . 0.0 117.648 -169.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.34 149.29 84.23 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.347 1.43 . . . . 0.0 111.3 173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.13 -35.18 66.03 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.471 2.114 . . . . 0.0 113.715 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -106.09 41.18 1.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.625 1.17 . . . . 0.0 112.406 -171.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 p -130.05 27.74 5.1 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.22 1.408 . . . . 0.0 113.839 -170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -95.58 104.69 16.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.47 1.508 . . . . 0.0 108.644 176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.2 p -91.08 -52.31 4.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.282 1.033 . . . . 0.0 112.949 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -161.08 41.41 0.16 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.311 1.044 . . . . 0.0 113.064 -170.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -131.17 145.24 51.88 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.974 -1.078 . . . . 0.0 111.602 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.59 168.32 21.56 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.398 1.879 . . . . 0.0 111.594 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 7.7 p90 -146.5 163.78 34.62 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.029 0.932 . . . . 0.0 111.566 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 18.9 mt -118.18 118.52 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.587 1.155 . . . . 0.0 109.39 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -77.04 108.24 9.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.675 0.79 . . . . 0.0 110.915 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.74 -12.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.028 -1.045 . . . . 0.0 113.725 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.55 167.19 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.44 1.496 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.51 113.15 4.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.731 1.612 . . . . 0.0 112.115 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.7 62.34 1.31 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.309 1.443 . . . . 0.0 111.643 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -55.81 -35.69 66.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.343 1.457 . . . . 0.0 114.106 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -65.18 -12.98 56.94 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.9 mt -83.51 -8.05 59.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.342 1.057 . . . . 0.0 113.443 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -77.71 -172.35 2.58 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.683 1.193 . . . . 0.0 113.84 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -81.87 146.43 29.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.36 1.464 . . . . 0.0 113.242 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' ' 118' ' ' TRP . 61.9 p -107.58 -61.87 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.658 1.583 . . . . 0.0 113.349 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 152.99 56.64 0.01 OUTLIER Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.515 1.531 . . . . 0.0 112.335 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.41 24.77 13.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.114 1.766 . . . . 0.0 114.862 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.9 p -102.34 122.11 43.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.876 1.27 . . . . 0.0 112.781 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 43.7 tp -52.76 -40.56 63.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.01 1.324 . . . . 0.0 114.558 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -83.08 -10.36 58.75 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.773 0.829 . . . . 0.0 113.047 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.87 -71.44 1.17 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.323 1.916 . . . . 0.0 113.542 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.407 ' HB3' ' H ' ' A' ' 111' ' ' SER 0.31 5.6 p-90 -71.87 123.51 22.85 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.433 1.117 . . . . 0.0 113.542 -169.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -91.77 -99.18 1.31 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.221 1.391 . . . . 0.0 115.388 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -130.5 132.92 45.88 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.306 1.042 . . . . 0.0 112.328 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -77.52 126.46 30.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.17 94.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.402 1.081 . . . . 0.0 108.242 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -82.05 -14.7 55.5 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.866 0.866 . . . . 0.0 111.795 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.08 175.58 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.56 1.171 . . . . 0.0 113.13 -170.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -136.81 153.39 50.82 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.795 -1.191 . . . . 0.0 112.203 173.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.35 138.68 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.586 0.708 . . . . 0.0 109.254 169.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 t -107.82 -41.98 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.712 1.605 . . . . 0.0 110.557 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -145.58 151.07 37.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.344 1.458 . . . . 0.0 110.031 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.93 11.78 19.86 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.953 171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.9 mmm -53.39 -37.42 62.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.928 1.864 . . . . 0.0 112.544 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -62.92 -31.76 72.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.039 0.936 . . . . 0.0 112.377 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.93 -43.75 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.174 1.39 . . . . 0.0 110.282 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.1 t -61.95 -38.01 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.217 -0.927 . . . . 0.0 111.031 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -71.93 -26.31 62.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.246 1.418 . . . . 0.0 112.558 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -77.89 -41.52 36.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.865 1.266 . . . . 0.0 110.886 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.1 mt -56.89 -30.23 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.061 1.744 . . . . 0.0 112.726 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 42.0 pttt -89.43 -12.39 40.38 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -111.42 -12.88 14.08 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.542 1.544 . . . . 0.0 114.471 -171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 m -61.29 -58.07 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 118.733 1.266 . . . . 0.0 112.678 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -173.23 145.0 1.26 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.964 1.305 . . . . 0.0 112.073 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -122.5 149.37 44.0 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.629 1.572 . . . . 0.0 112.564 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.82 130.55 1.27 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.33 0.967 . . . . 0.0 112.053 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 149' ' ' ASP . 11.3 ptp85 -68.3 145.78 53.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.441 1.096 . . . . 0.0 113.119 -173.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.3 p -114.69 167.97 10.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.213 1.405 . . . . 0.0 112.277 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -70.37 -20.27 76.72 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.535 0.588 . . . . 0.0 114.517 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.3 mmm -95.76 -41.53 8.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.525 1.13 . . . . 0.0 112.765 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -141.31 130.11 22.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.393 1.877 . . . . 0.0 110.174 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -90.3 153.78 20.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.579 0.751 . . . . 0.0 112.681 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 143' ' ' ARG . 3.3 m-20 53.3 65.4 1.53 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.225 2.21 . . . . 0.0 112.624 -178.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.44 160.27 63.28 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 127.58 2.352 . . . . 0.0 111.816 -172.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.93 132.87 31.57 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.372 1.381 . . . . 0.0 109.397 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 -26.14 28.82 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.14 142.56 45.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.581 0.753 . . . . 0.0 109.644 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -81.42 112.05 18.34 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.328 0.651 . . . . 0.0 110.803 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.13 103.99 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.438 HG22 HG22 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -126.45 143.65 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.772 1.229 . . . . 0.0 111.57 -170.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.4 mt -86.78 102.7 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.04 -28.31 43.24 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.389 1.076 . . . . 0.0 112.109 -174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.3 t -153.66 161.78 41.84 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.21 140.09 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.967 1.707 . . . . 0.0 109.875 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 m -136.37 126.52 26.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.747 1.219 . . . . 0.0 110.343 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.5 121.77 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 t -111.75 150.45 30.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.386 1.474 . . . . 0.0 112.316 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.706 1.602 . . . . 0.0 113.502 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpp? . . . . . 0 N--CA 1.501 2.092 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.84 130.36 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.27 -0.894 . . . . 0.0 109.657 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.0 m -103.97 124.78 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.47 1.508 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -101.08 120.04 39.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.674 1.19 . . . . 0.0 109.756 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -93.9 114.38 26.59 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -125.31 159.39 31.84 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -68.94 -7.99 40.22 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -106.77 -28.26 10.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.645 1.578 . . . . 0.0 113.276 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.88 146.91 4.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.323 1.916 . . . . 0.0 113.094 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -51.69 133.15 31.26 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.533 1.133 . . . . 0.0 112.863 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.3 mt -128.39 142.96 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.845 1.658 . . . . 0.0 109.28 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -129.27 138.6 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.165 0.986 . . . . 0.0 110.269 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.1 mt -128.89 138.32 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 126.551 1.94 . . . . 0.0 109.801 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.7 tttt -107.38 122.28 46.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.725 2.01 . . . . 0.0 109.419 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 p -86.74 149.3 24.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.128 0.971 . . . . 0.0 112.414 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.03 72.49 0.89 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 123.025 1.393 . . . . 0.0 111.924 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.85 -26.07 64.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.544 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -77.06 -29.1 54.96 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.241 1.016 . . . . 0.0 111.481 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -99.42 -23.18 15.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.88 1.272 . . . . 0.0 113.23 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.22 55.42 1.39 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.33 1.052 . . . . 0.0 113.41 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -59.77 -44.34 31.77 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.368 2.712 . . . . 0.0 112.99 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -69.37 -39.94 77.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.725 0.693 . . . . 0.0 111.291 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.483 ' HA ' HD13 ' A' ' 68' ' ' ILE . 18.2 m -64.86 -47.67 77.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.451 0.7 . . . . 0.0 111.245 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.7 -38.03 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.121 0.968 . . . . 0.0 112.275 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -54.21 -45.08 72.16 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.849 1.204 . . . . 0.0 112.035 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.485 HD22 HD11 ' A' ' 68' ' ' ILE . 62.5 t30 -68.26 -41.53 80.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.282 0.633 . . . . 0.0 111.467 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.6 -47.05 85.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.109 0.963 . . . . 0.0 111.611 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.55 -36.37 68.23 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.381 -0.825 . . . . 0.0 112.209 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.59 -39.15 76.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.819 0.448 . . . . 0.0 111.74 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -68.29 -43.38 77.83 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.55 -0.719 . . . . 0.0 111.932 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.8 m -60.33 -40.3 90.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.065 0.546 . . . . 0.0 111.32 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -68.78 -33.79 74.47 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.968 1.707 . . . . 0.0 112.821 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.35 -18.44 42.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.162 0.985 . . . . 0.0 112.994 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.87 25.91 43.63 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.919 -0.488 . . . . 0.0 112.561 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -69.78 -42.49 73.72 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.273 1.037 . . . . 0.0 113.156 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -81.22 -13.4 58.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.769 0.828 . . . . 0.0 111.732 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -63.14 124.96 22.5 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.684 0.794 . . . . 0.0 108.87 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.252 61.1 t30 59.1 45.52 14.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.592 1.557 . . . . 0.0 114.886 -169.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.1 p -111.66 164.3 13.17 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.466 1.106 . . . . 0.0 111.067 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 156' ' ' ILE . 11.5 pt -121.36 163.05 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -173.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -85.93 85.05 7.39 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.197 1.399 . . . . 0.0 107.978 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -75.59 -7.25 53.76 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 116.558 2.059 . . . . 0.0 116.558 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -135.45 140.9 45.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 120.854 1.661 . . . . 0.0 112.252 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.6 p -141.53 136.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.961 2.104 . . . . 0.0 110.526 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.4 mt -140.33 130.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 108.363 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -66.93 137.21 56.37 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.099 0.96 . . . . 0.0 112.067 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.66 11.95 66.43 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.816 0.722 . . . . 0.0 114.492 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -146.3 -176.99 5.38 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.91 2.084 . . . . 0.0 110.216 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -90.51 -180.0 5.71 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.107 1.763 . . . . 0.0 114.45 -171.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.6 pt -116.14 140.39 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.882 1.273 . . . . 0.0 111.971 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -112.49 149.03 33.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.021 1.329 . . . . 0.0 110.789 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -154.35 175.72 32.43 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.643 1.017 . . . . 0.0 115.643 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.45 3.51 90.0 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.311 1.434 . . . . 0.0 115.392 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.12 -26.32 37.36 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.002 1.401 . . . . 0.0 115.031 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -143.78 160.53 40.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -86.2 164.31 39.05 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.319 1.447 . . . . 0.0 110.59 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.92 -14.47 37.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.381 2.721 . . . . 0.0 117.943 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.87 21.08 47.7 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.344 0.973 . . . . 0.0 114.451 171.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.78 33.68 17.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.941 1.696 . . . . 0.0 113.011 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.06 130.48 36.96 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.057 1.343 . . . . 0.0 109.772 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.62 128.92 36.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 123.943 1.83 . . . . 0.0 111.357 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -76.79 178.48 6.78 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 110.615 -2.993 . . . . 0.0 114.379 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.18 54.43 3.1 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.821 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.2 p -71.11 117.36 12.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.509 1.124 . . . . 0.0 111.402 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -134.34 -178.07 4.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.062 1.745 . . . . 0.0 111.818 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 45.95 64.19 8.43 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.649 1.58 . . . . 0.0 114.344 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -54.51 129.3 34.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.097 2.531 . . . . 0.0 110.703 171.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 26' ' ' ASN . 1.0 OUTLIER -109.68 148.65 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.152 1.381 . . . . 0.0 109.044 -174.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 151.71 38.55 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.31 0.576 . . . . 0.0 110.787 169.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -80.11 125.17 29.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.575 0.75 . . . . 0.0 110.851 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.82 12.67 34.22 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.804 1.241 . . . . 0.0 113.152 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -16.49 49.22 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.64 -1.287 . . . . 0.0 114.409 -173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.89 1.11 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.437 1.495 . . . . 0.0 114.02 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -71.98 -11.6 60.85 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.878 1.271 . . . . 0.0 113.076 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 10.67 77.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.1 1.333 . . . . 0.0 114.383 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.55 154.96 34.04 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.582 1.191 . . . . 0.0 112.48 175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -130.01 151.85 50.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.77 103.21 15.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.14 2.176 . . . . 0.0 109.668 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.9 p -134.65 170.59 15.57 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.096 1.358 . . . . 0.0 110.822 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -49.65 119.79 3.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.773 1.229 . . . . 0.0 111.116 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.08 33.31 26.77 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.832 1.206 . . . . 0.0 114.923 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -119.6 159.57 24.13 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.727 1.263 . . . . 0.0 113.09 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mp -122.75 136.37 54.85 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.07 156.31 49.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.03 0.532 . . . . 0.0 111.467 173.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.8 mtp -85.13 134.5 34.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.876 0.37 . . . . 0.0 110.842 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.71 153.44 22.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.374 1.07 . . . . 0.0 111.122 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -105.26 158.24 16.75 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.071 1.349 . . . . 0.0 111.969 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.9 m -78.01 -51.6 10.09 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.987 0.915 . . . . 0.0 110.776 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -161.85 -53.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.899 1.28 . . . . 0.0 111.334 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.8 162.99 68.36 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.058 1.343 . . . . 0.0 112.315 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -64.5 -17.07 58.38 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.217 2.611 . . . . 0.0 114.263 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -122.17 50.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.569 1.547 . . . . 0.0 111.681 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.9 p -132.78 33.5 3.72 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.65 57.76 0.76 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.114 1.366 . . . . 0.0 113.475 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.8 p -60.17 -47.67 84.97 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -169.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.12 -30.72 0.13 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -174.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -70.81 142.82 51.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.317 1.047 . . . . 0.0 111.434 -170.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -137.21 168.39 19.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.196 1.798 . . . . 0.0 110.524 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 24.3 p90 -148.27 160.53 42.87 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.325 0.65 . . . . 0.0 112.071 177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.7 mt -114.02 115.9 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 108.903 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -74.7 95.97 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.175 0.99 . . . . 0.0 110.697 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.91 -24.73 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.167 -0.958 . . . . 0.0 113.388 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.9 168.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.501 . . . . 0.0 111.492 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.79 118.04 21.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.201 1.0 . . . . 0.0 110.531 169.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -141.88 68.49 1.32 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.938 1.352 . . . . 0.0 113.004 -169.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -51.52 -35.31 39.95 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.309 2.244 . . . . 0.0 114.538 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -58.8 -13.79 7.08 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.08 -10.45 59.2 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.58 -177.35 3.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.511 1.524 . . . . 0.0 114.814 -171.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -79.35 155.59 28.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.098 1.359 . . . . 0.0 111.64 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.5 t -136.11 -55.05 0.76 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 173.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 169.13 61.65 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 57.85 23.48 9.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.586 1.554 . . . . 0.0 114.847 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -114.13 137.17 52.09 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.023 1.329 . . . . 0.0 112.883 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.14 -31.65 71.36 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.515 1.126 . . . . 0.0 113.39 -170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -85.63 -7.29 58.91 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.075 0.95 . . . . 0.0 113.085 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.88 -67.86 0.99 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.43 1.967 . . . . 0.0 114.19 -174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.28 4.0 p-90 -90.2 129.85 36.41 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -97.74 -89.52 1.9 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.719 1.628 . . . . 0.0 114.802 -173.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -140.56 146.73 38.44 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.169 1.387 . . . . 0.0 112.139 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -86.08 129.51 34.82 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.6 t -75.34 94.48 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.762 1.225 . . . . 0.0 108.585 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -79.28 -16.0 57.09 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.648 0.779 . . . . 0.0 111.976 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.96 177.8 8.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.663 1.221 . . . . 0.0 113.111 -171.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -135.06 153.78 51.93 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.89 -1.131 . . . . 0.0 112.027 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.61 143.98 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.744 0.783 . . . . 0.0 109.315 170.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 t -113.83 -38.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.401 1.48 . . . . 0.0 110.854 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -146.37 149.12 33.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.274 1.43 . . . . 0.0 110.906 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.48 6.09 18.03 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.65 1.119 . . . . 0.0 115.793 170.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 72.4 mmm -56.3 -37.14 69.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.169 1.484 . . . . 0.0 113.103 -176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -61.81 -30.93 71.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.724 0.809 . . . . 0.0 112.207 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -78.06 -41.73 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.037 1.735 . . . . 0.0 110.696 174.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.27 -38.37 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 111.05 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.489 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 6.8 t70 -75.77 -19.18 59.19 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.02 1.328 . . . . 0.0 113.19 175.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -79.75 -41.94 25.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.108 1.363 . . . . 0.0 111.081 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 63.5 mt -55.51 -35.56 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.06 1.344 . . . . 0.0 112.158 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 134' ' ' ASP . 20.9 pttp -83.78 -12.36 55.81 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.87 -24.49 9.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.151 1.358 . . . . 0.0 114.197 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.9 m -74.16 -59.5 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.718 1.259 . . . . 0.0 114.379 -171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -167.05 154.48 9.07 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.8 p -141.94 153.63 44.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.943 1.697 . . . . 0.0 112.143 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 173.81 131.33 1.38 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.343 0.497 . . . . 0.0 113.176 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.97 149.71 39.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.397 1.479 . . . . 0.0 113.055 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 28.7 p -116.55 168.9 9.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.354 1.461 . . . . 0.0 112.451 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -67.24 -19.45 70.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 123.569 0.604 . . . . 0.0 114.557 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.01 -41.97 7.32 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.645 1.178 . . . . 0.0 112.655 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -141.45 132.91 26.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.379 1.871 . . . . 0.0 110.471 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -94.83 158.34 15.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.321 1.048 . . . . 0.0 111.813 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.52 58.15 4.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.271 1.428 . . . . 0.0 113.299 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.9 m -127.67 160.66 59.62 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 0.0 111.64 -176.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.98 136.39 41.03 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 121.515 1.476 . . . . 0.0 110.259 169.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -30.11 40.76 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -81.88 152.28 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.078 0.951 . . . . 0.0 110.849 169.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -83.64 109.65 17.61 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.837 0.827 . . . . 0.0 110.799 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.1 t -105.03 93.89 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.605 HG22 HG22 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -120.54 144.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.14 103.97 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.224 1.81 . . . . 0.0 107.09 169.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.32 -29.17 42.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.254 1.021 . . . . 0.0 112.504 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -156.28 165.7 35.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.17 139.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.901 1.681 . . . . 0.0 110.741 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 m -136.58 132.71 35.51 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.004 1.322 . . . . 0.0 110.712 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.75 123.33 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -117.41 150.39 38.96 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.611 1.564 . . . . 0.0 112.41 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 125.365 1.466 . . . . 0.0 113.611 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.9 t -124.78 128.59 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.979 0.912 . . . . 0.0 108.742 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -104.26 124.45 49.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.022 1.329 . . . . 0.0 109.958 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.0 123.54 40.74 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.173 0.989 . . . . 0.0 109.74 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -99.32 105.98 18.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.563 172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.22 159.66 20.69 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.966 -0.459 . . . . 0.0 111.555 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -70.78 -6.05 34.78 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.67 ' CE1' HD11 ' A' ' 136' ' ' ILE . 20.1 p80 -110.37 -24.66 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.528 1.531 . . . . 0.0 113.759 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.77 145.17 4.14 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.258 1.885 . . . . 0.0 113.665 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -53.27 135.45 38.5 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.676 1.19 . . . . 0.0 112.836 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -132.66 142.62 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.672 1.589 . . . . 0.0 109.313 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.18 136.91 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.321 1.048 . . . . 0.0 110.672 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mp -122.51 139.33 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.778 2.031 . . . . 0.0 110.255 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -105.94 123.51 48.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.694 1.998 . . . . 0.0 108.807 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -87.63 148.6 24.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.266 1.026 . . . . 0.0 112.183 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.15 74.17 1.03 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.684 1.23 . . . . 0.0 111.684 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.75 -27.07 64.64 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.696 -1.138 . . . . 0.0 112.499 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.122 0.969 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -98.73 -22.65 15.77 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 113.106 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.74 57.98 2.75 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.754 1.222 . . . . 0.0 112.816 -171.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -61.55 -44.88 19.96 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.249 2.633 . . . . 0.0 112.708 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -70.55 -41.26 72.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.777 -0.577 . . . . 0.0 110.996 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.432 ' HA ' HD13 ' A' ' 68' ' ' ILE . 23.1 m -63.06 -47.34 83.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.907 0.483 . . . . 0.0 111.71 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.87 -38.79 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.635 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -57.46 -44.47 84.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.002 1.274 . . . . 0.0 111.484 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -68.17 -39.22 82.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.455 0.702 . . . . 0.0 111.624 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.02 -50.61 73.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.705 173.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.6 mt -69.31 -37.0 77.56 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.448 0.699 . . . . 0.0 111.422 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -56.93 -37.47 71.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.824 0.85 . . . . 0.0 111.965 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -74.15 -43.53 57.05 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.416 -0.803 . . . . 0.0 112.226 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.42 -37.96 76.44 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.84 -0.537 . . . . 0.0 111.808 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -32.76 72.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.257 1.823 . . . . 0.0 112.858 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.63 -15.62 54.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.973 0.909 . . . . 0.0 113.124 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.31 19.85 65.79 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.276 0.941 . . . . 0.0 113.149 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.09 -37.03 73.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.391 1.096 . . . . 0.0 113.068 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.889 0.476 . . . . 0.0 112.139 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -63.74 132.57 51.39 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.221 -0.924 . . . . 0.0 109.112 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.253 13.9 t30 59.42 25.14 13.83 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.722 2.009 . . . . 0.0 116.118 -171.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.2 p -83.27 142.32 31.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.933 -1.105 . . . . 0.0 113.212 170.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.9 pt -95.45 162.57 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -83.6 79.16 9.53 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 168.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -73.57 4.71 4.58 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -169.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.589 ' HE ' ' HB2' ' A' ' 149' ' ' ASP . 9.7 tpt180 -148.06 135.6 20.7 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.269 1.395 . . . . 0.0 112.439 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.45 131.04 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 110.676 170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -137.34 128.37 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.572 1.549 . . . . 0.0 108.399 -172.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -64.25 136.68 57.42 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.589 0.755 . . . . 0.0 111.97 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.29 9.66 61.25 Favored Glycine 0 CA--C 1.541 1.668 0 N-CA-C 115.091 0.797 . . . . 0.0 115.091 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.25 -177.16 5.32 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.558 1.943 . . . . 0.0 110.496 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.422 ' HE2' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -85.97 -179.34 6.77 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.674 1.589 . . . . 0.0 115.139 -170.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 34.0 pt -116.76 134.88 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.78 1.232 . . . . 0.0 112.303 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -108.72 153.52 23.33 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.659 1.183 . . . . 0.0 111.684 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.38 -179.96 34.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.228 0.918 . . . . 0.0 114.957 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.79 84.39 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 115.699 1.04 . . . . 0.0 115.699 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.03 -21.4 35.96 Favored Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.115 1.458 . . . . 0.0 115.917 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -144.3 162.82 35.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.269 1.034 . . . . 0.0 113.45 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -90.27 158.98 42.9 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.851 1.66 . . . . 0.0 109.804 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.98 -8.99 13.02 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.668 3.578 . . . . 0.0 116.113 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.74 14.63 64.88 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.08 0.848 . . . . 0.0 114.534 170.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.37 26.94 16.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.913 1.685 . . . . 0.0 113.163 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.15 131.6 36.6 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.093 1.357 . . . . 0.0 109.842 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -75.9 129.35 36.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.086 1.898 . . . . 0.0 111.204 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -72.2 179.54 3.3 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 110.447 -3.07 . . . . 0.0 114.127 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.24 51.21 2.08 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 112.388 -2.187 . . . . 0.0 112.258 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.2 p -72.28 117.17 13.59 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.594 1.158 . . . . 0.0 111.944 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -138.0 178.87 6.8 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.176 2.191 . . . . 0.0 111.857 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 51.13 71.4 1.54 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.324 1.45 . . . . 0.0 113.728 169.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.08 147.95 94.11 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.3 2.667 . . . . 0.0 111.889 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 23' ' ' THR . 0.5 OUTLIER -126.74 147.96 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.135 1.374 . . . . 0.0 110.64 -172.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -64.76 153.27 40.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.919 0.888 . . . . 0.0 111.107 169.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.96 -54.89 40.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.256 8.6 mt-10 71.62 1.66 3.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.422 2.289 . . . . 0.0 117.029 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.96 -14.21 59.5 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 121.478 1.944 . . . . 0.0 113.972 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -62.72 2.28 0.31 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.728 1.611 . . . . 0.0 114.126 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -74.18 -12.49 60.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.244 1.418 . . . . 0.0 113.543 169.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.76 77.56 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.075 1.321 . . . . 0.0 114.6 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.5 157.35 30.47 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.517 1.159 . . . . 0.0 112.16 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.6 148.11 52.36 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.67 113.38 18.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.972 2.509 . . . . 0.0 109.653 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -139.44 167.43 22.1 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.932 1.293 . . . . 0.0 110.569 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -56.45 122.83 12.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.851 0.834 . . . . 0.0 110.9 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.45 51.74 5.48 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.926 1.25 . . . . 0.0 113.74 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 p -138.89 162.96 33.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.176 0.991 . . . . 0.0 112.156 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.5 138.12 53.36 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.833 0.825 . . . . 0.0 113.176 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -137.32 160.83 37.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.143 0.577 . . . . 0.0 111.459 171.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.7 mmt -82.4 142.71 31.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.898 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.79 151.03 20.79 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.519 1.127 . . . . 0.0 110.054 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -106.06 155.79 19.05 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.225 1.01 . . . . 0.0 113.117 -173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.1 m -75.01 -51.61 13.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.685 0.794 . . . . 0.0 111.099 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -156.97 -40.16 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.139 1.375 . . . . 0.0 113.119 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.17 157.97 32.86 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.173 1.389 . . . . 0.0 111.879 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.59 -20.52 65.06 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.303 2.669 . . . . 0.0 114.295 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -108.23 39.38 1.98 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.165 1.786 . . . . 0.0 112.244 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 56.9 p -128.43 31.04 5.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.059 1.344 . . . . 0.0 113.475 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.33 56.76 3.36 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.826 1.651 . . . . 0.0 113.595 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.1 p -49.69 -70.76 0.08 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.767 2.027 . . . . 0.0 115.197 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.18 -21.87 0.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.717 1.207 . . . . 0.0 113.89 -169.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.66 139.87 49.43 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.411 -0.806 . . . . 0.0 110.568 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.3 168.49 19.63 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.75 2.02 . . . . 0.0 110.837 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 20.9 p90 -144.36 160.86 40.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.593 0.757 . . . . 0.0 111.887 175.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.3 mt -111.46 117.53 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -72.76 103.02 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.071 0.549 . . . . 0.0 110.038 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.04 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.08 168.18 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 127.277 2.231 . . . . 0.0 112.212 176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -76.75 122.98 25.51 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.877 1.271 . . . . 0.0 111.457 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -145.32 73.13 1.34 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.68 1.229 . . . . 0.0 112.403 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.47 -34.24 68.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.675 1.59 . . . . 0.0 114.365 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -56.92 -13.69 2.88 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.82 -12.74 58.37 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.14 169.51 17.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 -169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -70.99 155.35 40.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.738 1.615 . . . . 0.0 113.133 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 91.7 p -134.45 -56.77 0.85 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.614 1.166 . . . . 0.0 113.197 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 169.24 70.48 0.03 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.947 0.784 . . . . 0.0 113.983 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 55.34 26.42 8.65 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.549 1.54 . . . . 0.0 114.52 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.6 m -119.42 123.07 43.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.719 1.208 . . . . 0.0 111.695 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.85 -32.36 67.58 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -73.0 -12.02 60.78 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.86 -88.38 1.98 Allowed Glycine 0 CA--C 1.531 1.092 0 C-N-CA 127.627 2.537 . . . . 0.0 113.066 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.27 1.7 p-90 -62.21 129.65 41.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -169.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.97 -82.89 0.82 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.051 1.31 . . . . 0.0 115.165 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -128.93 123.55 32.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 112.548 -169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.1 t -83.06 131.77 35.15 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -75.64 99.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.011 0.924 . . . . 0.0 108.845 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -80.96 -16.78 52.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.712 0.805 . . . . 0.0 111.591 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.91 175.88 9.96 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.194 0.997 . . . . 0.0 113.624 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.51 149.65 48.27 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.481 -1.387 . . . . 0.0 112.144 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.26 135.1 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-O 121.481 0.658 . . . . 0.0 110.405 172.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.56 -41.09 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.499 1.92 . . . . 0.0 110.581 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -142.51 149.27 38.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.186 1.395 . . . . 0.0 110.313 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.32 8.54 28.89 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.342 0.972 . . . . 0.0 115.275 176.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 79.9 mmm -55.98 -37.68 69.41 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.176 1.488 . . . . 0.0 112.759 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.71 -29.96 71.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.84 . . . . 0.0 112.49 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.23 -45.26 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.021 1.728 . . . . 0.0 110.492 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.9 t -57.8 -40.11 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.392 1.077 . . . . 0.0 111.38 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 -19.47 61.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.47 1.508 . . . . 0.0 112.905 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -86.85 -39.84 15.46 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.67 HD11 ' CE1' ' A' ' 8' ' ' HIS . 54.1 mt -50.92 -41.72 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.499 1.52 . . . . 0.0 111.495 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -73.01 -17.71 61.42 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.34 -10.46 36.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.373 1.939 . . . . 0.0 114.796 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.62 -63.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.305 1.553 . . . . 0.0 110.471 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -174.16 156.07 2.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.907 1.283 . . . . 0.0 112.008 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.6 p -139.94 149.46 43.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.701 1.2 . . . . 0.0 112.181 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.07 118.75 0.58 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.323 0.487 . . . . 0.0 112.464 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -64.0 146.71 53.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.608 1.563 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.2 p -113.57 168.97 9.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.179 1.392 . . . . 0.0 112.584 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.42 -17.03 70.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.842 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 97.3 mtp -105.86 -38.06 6.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.581 1.19 . . . . 0.0 113.436 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -141.49 138.08 32.55 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.241 1.817 . . . . 0.0 110.732 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -105.33 160.46 15.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.053 1.341 . . . . 0.0 113.4 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.589 ' HB2' ' HE ' ' A' ' 43' ' ' ARG . 2.8 m-20 55.69 51.35 12.62 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.883 1.673 . . . . 0.0 112.032 -172.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.3 m -117.45 152.56 49.58 Favored Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 126.161 1.785 . . . . 0.0 111.959 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -68.26 134.88 32.61 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.73 1.62 . . . . 0.0 109.03 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -29.53 61.08 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -86.86 159.55 19.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.593 1.157 . . . . 0.0 110.303 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -82.79 109.89 17.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.41 1.084 . . . . 0.0 111.794 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.9 t -109.61 94.0 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.563 1.545 . . . . 0.0 106.913 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.79 149.01 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 123.239 1.495 . . . . 0.0 113.342 -169.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.72 103.9 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -73.03 -40.14 65.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.744 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.5 t -149.52 164.26 35.56 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.4 t -135.57 142.05 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.888 1.675 . . . . 0.0 110.929 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.0 m -136.24 134.0 37.63 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.629 1.171 . . . . 0.0 110.983 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.58 120.52 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.0 t -117.98 150.23 39.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.537 1.535 . . . . 0.0 112.723 -171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.388 1.475 . . . . 0.0 113.907 -170.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 N--CA 1.499 1.975 0 CA-C-O 120.27 0.081 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.98 129.99 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.936 0.894 . . . . 0.0 109.905 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 88.1 m -104.12 124.44 49.08 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.371 1.468 . . . . 0.0 109.766 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -99.47 123.54 43.84 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.464 1.106 . . . . 0.0 110.346 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -97.61 108.09 20.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.366 -1.288 . . . . 0.0 107.623 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -119.14 159.08 24.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.116 0.484 . . . . 0.0 112.223 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -68.59 -6.77 27.52 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.499 ' CE1' HD11 ' A' ' 136' ' ' ILE . 17.2 p80 -110.67 -25.13 10.11 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.466 1.506 . . . . 0.0 113.634 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 156.38 145.85 4.3 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 126.123 1.82 . . . . 0.0 113.583 173.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.32 133.81 39.88 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.474 1.109 . . . . 0.0 112.535 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.4 mt -131.1 144.18 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.943 1.697 . . . . 0.0 109.499 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.26 137.76 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.387 1.075 . . . . 0.0 110.463 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 mt -124.07 138.75 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.987 2.115 . . . . 0.0 110.087 -176.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -106.83 125.37 50.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.8 1.64 . . . . 0.0 109.109 171.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.5 p -87.75 149.49 24.17 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 112.075 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -108.59 74.5 0.92 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.766 1.27 . . . . 0.0 111.726 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.76 -25.9 64.04 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.548 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -77.57 -26.78 51.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.619 1.168 . . . . 0.0 111.675 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -101.84 -22.39 14.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.231 1.412 . . . . 0.0 112.972 -176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.73 56.41 1.59 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.891 1.276 . . . . 0.0 113.103 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -60.09 -44.36 29.94 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.496 2.797 . . . . 0.0 112.914 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.2 -41.45 77.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.793 0.724 . . . . 0.0 111.084 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -64.77 -48.59 73.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.725 0.41 . . . . 0.0 111.549 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.7 -41.46 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.573 . . . . 0.0 111.349 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -58.17 -45.59 87.22 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.571 1.078 . . . . 0.0 111.623 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -71.1 -34.31 70.99 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.682 0.674 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -61.84 -49.68 75.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.257 1.023 . . . . 0.0 111.733 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.24 -36.71 77.47 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.358 -0.839 . . . . 0.0 111.658 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -56.52 -33.05 65.67 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.183 0.993 . . . . 0.0 112.628 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -77.61 -46.43 22.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 171.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 81.3 m -57.72 -40.1 78.8 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.967 0.907 . . . . 0.0 112.201 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -52.86 -46.68 67.99 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.659 1.984 . . . . 0.0 112.872 173.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -83.2 -14.55 53.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.055 0.942 . . . . 0.0 112.133 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.47 52.42 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.289 0.947 . . . . 0.0 113.046 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.29 -37.15 69.47 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.402 1.101 . . . . 0.0 113.241 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -83.33 -6.44 59.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.396 0.679 . . . . 0.0 112.132 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -64.41 132.35 49.82 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.1 t30 53.82 49.91 18.11 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.319 1.448 . . . . 0.0 113.998 -171.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.8 p -114.44 157.14 23.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.304 1.042 . . . . 0.0 112.393 172.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.2 pt -110.41 155.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -86.4 75.97 9.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.863 1.265 . . . . 0.0 107.855 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -53.16 -38.23 62.58 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.0 1.72 . . . . 0.0 114.76 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -123.64 135.53 53.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.56 1.144 . . . . 0.0 111.495 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.2 132.69 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.408 2.283 . . . . 0.0 110.578 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.44 128.9 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.622 1.569 . . . . 0.0 107.989 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 133.49 55.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 111.631 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.97 9.32 66.14 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 123.898 0.761 . . . . 0.0 114.871 -172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -141.52 -177.28 5.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.153 1.781 . . . . 0.0 110.97 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -89.21 -179.55 5.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -169.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.7 136.46 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.054 1.342 . . . . 0.0 112.399 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.92 146.63 46.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.194 1.398 . . . . 0.0 111.094 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.92 31.03 Favored Glycine 0 CA--C 1.534 1.249 0 N-CA-C 116.162 1.225 . . . . 0.0 116.162 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.18 -8.73 72.56 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.647 1.594 . . . . 0.0 115.944 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.76 -20.65 70.53 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 118.961 1.381 . . . . 0.0 115.479 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.2 164.9 28.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.482 1.113 . . . . 0.0 113.652 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -101.29 163.65 17.52 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.028 1.731 . . . . 0.0 110.629 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.01 -12.12 28.12 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.384 2.723 . . . . 0.0 118.0 -169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.08 14.59 60.25 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 123.452 0.549 . . . . 0.0 114.426 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.6 mmt 59.49 28.74 18.2 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.582 1.953 . . . . 0.0 112.757 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.81 123.01 28.95 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.1 1.36 . . . . 0.0 109.555 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -71.82 126.62 30.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 124.365 2.031 . . . . 0.0 110.887 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.0 179.74 2.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 110.077 -3.238 . . . . 0.0 114.408 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.06 64.11 3.27 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.372 -2.195 . . . . 0.0 112.147 -174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 p -70.22 107.29 3.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.146 1.379 . . . . 0.0 110.838 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -140.9 168.03 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.133 2.173 . . . . 0.0 112.401 -169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 50.13 66.94 4.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 0.0 112.487 171.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.62 145.97 97.21 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.469 2.779 . . . . 0.0 113.664 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.85 146.05 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.515 1.926 . . . . 0.0 109.053 -176.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 158.74 16.29 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.553 1.141 . . . . 0.0 111.143 170.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -73.44 134.55 43.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.162 0.585 . . . . 0.0 111.614 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.04 13.63 12.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.086 1.354 . . . . 0.0 112.675 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.76 -11.85 56.43 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.565 -1.334 . . . . 0.0 114.128 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -62.24 5.27 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.309 1.444 . . . . 0.0 114.553 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -76.53 -11.35 59.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.773 1.629 . . . . 0.0 112.826 169.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.74 6.47 85.39 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 125.256 1.407 . . . . 0.0 115.071 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.53 154.85 38.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.361 1.081 . . . . 0.0 112.25 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.55 149.21 51.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -86.03 64.24 8.47 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.44 1.896 . . . . 0.0 112.528 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.8 p -98.57 166.24 11.44 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.735 0.814 . . . . 0.0 112.235 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.05 123.25 11.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.878 1.671 . . . . 0.0 111.019 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.25 56.37 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.315 1.436 . . . . 0.0 114.945 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.2 p -110.51 161.36 15.77 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.591 1.695 . . . . 0.0 113.266 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -118.98 135.34 54.66 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.031 0.932 . . . . 0.0 112.734 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -135.43 159.39 41.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.652 174.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -81.7 143.04 32.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 111.204 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.37 153.99 18.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.953 0.901 . . . . 0.0 110.617 169.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.5 ptt85 -133.9 152.94 52.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.134 1.374 . . . . 0.0 111.923 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 m -65.32 -55.08 20.23 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.837 1.255 . . . . 0.0 112.708 -169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.71 -55.48 0.05 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.758 1.223 . . . . 0.0 111.366 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.47 159.04 86.69 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.574 1.15 . . . . 0.0 111.5 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.37 -26.28 81.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.005 2.47 . . . . 0.0 113.703 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -114.28 42.15 2.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.317 1.447 . . . . 0.0 111.947 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.1 p -122.61 30.64 6.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.309 1.444 . . . . 0.0 114.124 -173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.06 22.67 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.268 1.427 . . . . 0.0 107.465 169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -132.51 -59.48 0.91 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.23 1.412 . . . . 0.0 112.739 169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.57 -11.85 1.58 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 0.0 112.677 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -78.96 134.37 36.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.551 1.14 . . . . 0.0 110.383 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -141.32 168.1 20.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.082 1.753 . . . . 0.0 111.635 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 9.6 p90 -149.96 163.12 38.94 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.856 0.862 . . . . 0.0 111.751 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.0 mt -117.26 119.19 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.922 1.289 . . . . 0.0 108.538 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -72.59 97.57 2.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.564 0.745 . . . . 0.0 110.037 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 m -76.14 -15.54 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.8 167.01 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 128.724 2.809 . . . . 0.0 110.296 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.22 116.54 13.88 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.204 0.526 . . . . 0.0 111.525 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.9 57.25 1.28 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 111.921 -173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -64.82 -15.59 61.97 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -66.08 -15.12 62.8 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.779 -1.201 . . . . 0.0 113.383 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -81.37 -8.73 59.78 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.37 1.068 . . . . 0.0 113.452 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -73.28 179.83 3.73 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -79.08 141.09 37.66 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.561 1.544 . . . . 0.0 112.483 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 67.6 p -104.17 -60.31 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.638 1.175 . . . . 0.0 113.591 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.64 58.73 0.03 OUTLIER Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.818 0.723 . . . . 0.0 114.732 -172.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 57.13 26.17 11.78 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.756 1.622 . . . . 0.0 114.943 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.3 t -104.94 112.51 25.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.188 0.995 . . . . 0.0 109.417 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.39 -32.19 64.57 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -76.89 -15.55 59.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.43 -64.97 1.26 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 127.487 2.47 . . . . 0.0 113.512 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . 0.299 8.0 p-90 -69.07 122.24 18.34 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.888 1.344 . . . . 0.0 113.36 -174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.84 -96.45 0.69 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.339 1.447 . . . . 0.0 115.618 -169.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -131.51 137.64 48.61 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 111.805 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.8 129.31 34.87 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.27 94.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.794 1.238 . . . . 0.0 108.455 169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -80.64 -15.38 56.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.401 0.681 . . . . 0.0 111.821 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.03 177.97 8.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.46 1.124 . . . . 0.0 113.554 -171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -137.14 153.6 50.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 120.811 -1.181 . . . . 0.0 112.105 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.84 138.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.509 0.671 . . . . 0.0 110.443 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 t -112.33 -41.95 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.993 1.717 . . . . 0.0 111.187 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -143.48 153.84 43.04 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.141 1.377 . . . . 0.0 110.584 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.34 13.31 39.15 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.526 1.06 . . . . 0.0 113.074 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 25.9 mtp -60.66 -35.17 75.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.073 1.349 . . . . 0.0 111.895 -175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -65.12 -29.07 69.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.865 0.866 . . . . 0.0 112.142 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 t -78.05 -43.6 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.491 1.517 . . . . 0.0 110.307 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.59 -38.95 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.488 1.115 . . . . 0.0 111.253 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.13 -20.09 60.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.419 1.488 . . . . 0.0 113.0 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -86.22 -40.55 15.46 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.761 1.624 . . . . 0.0 111.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.499 HD11 ' CE1' ' A' ' 8' ' ' HIS . 82.4 mt -54.7 -34.44 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.487 1.515 . . . . 0.0 112.065 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -83.82 -16.58 44.06 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.36 -19.0 13.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.182 1.372 . . . . 0.0 114.091 -173.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.84 -62.71 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.405 1.102 . . . . 0.0 113.312 -174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -170.79 157.27 5.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.013 0.925 . . . . 0.0 113.458 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 p -139.47 155.14 47.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 111.772 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.75 149.42 7.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-O 123.329 1.516 . . . . 0.0 115.137 170.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -61.74 148.65 42.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.716 2.806 . . . . 0.0 112.589 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 p -120.21 169.41 10.27 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.659 1.183 . . . . 0.0 112.146 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -9.44 35.36 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-O 118.777 -1.013 . . . . 0.0 115.217 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 24.6 ptp -144.68 -9.28 0.63 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -134.39 159.06 42.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.701 1.6 . . . . 0.0 111.667 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -129.3 159.62 35.58 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.247 2.219 . . . . 0.0 111.156 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 57.09 39.73 28.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.97 1.308 . . . . 0.0 113.374 -173.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.12 154.05 42.24 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.303 1.441 . . . . 0.0 111.781 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.0 135.84 28.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.703 1.602 . . . . 0.0 110.059 170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.8 51.63 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -84.72 157.69 20.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.42 1.088 . . . . 0.0 110.058 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -79.91 125.86 30.28 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.01 -1.057 . . . . 0.0 111.207 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.92 93.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 126.354 1.861 . . . . 0.0 107.732 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 144.27 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -169.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.1 mt -80.98 110.51 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 169.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -78.96 -41.58 28.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.689 0.677 . . . . 0.0 110.389 177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.4 t -150.77 165.6 33.0 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.18 142.51 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.06 1.744 . . . . 0.0 111.446 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.8 m -136.37 136.29 39.51 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.987 1.315 . . . . 0.0 110.683 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.71 123.95 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.2 t -122.51 143.61 49.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.583 1.553 . . . . 0.0 112.087 -169.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 126.31 1.844 . . . . 0.0 112.082 178.783 . . . . . . . . 0 0 . 1 stop_ save_